Kondáš Michal
Kondáš Michal
2015-12-18T09:13:29Z
2015-11-23T09:09:44Z
14.00
7995
9000
105
105
False
False
ATC |
|
OL |
|
Názov |
Doplnok |
ŠDL |
JD |
|
|
|
|
|
|
|
|
UZP2 |
Podmienená |
Dočasná |
Uhr./Špec. |
Kód |
GP |
PL |
Typ lieku |
|
|
CRP |
Štát |
ŠDL počet |
Konečná c. |
UZP |
s.u. |
DOP |
DOP% |
PDOP Limit |
PO |
IO |
kateg. |
kateg. |
skupina |
A02BC01 |
|
|
|
Omeprazol |
p.o. 10 mg (28 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
57408 |
X |
|
G |
HELICID 10 |
cps 28x10 mg |
ZNT-SK-2 |
SK |
14 |
3.95 |
0.66 |
S |
3.29 |
0.83291099999999996 |
3.29 |
|
|
|
|
U1 |
A02BC01 |
|
|
|
Omeprazol |
p.o. 20 mg (14 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
92476 |
X |
|
G |
OPRAZOLE |
tbl ent 14x20 mg |
HKP |
JO |
14 |
1.52 |
0.66 |
S |
0.86 |
0.56578899999999999 |
0.21 |
|
|
|
|
U1 |
56500 |
X |
|
G |
HELICID 20 |
cps 14x20 mg |
ZNT-SK-2 |
SK |
14 |
2.4700000000000002 |
0.66 |
S |
1.81 |
0.73279399999999995 |
0.21 |
|
|
|
|
U1 |
A02BC01 |
|
|
|
Omeprazol |
p.o. 20 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
06657 |
X |
|
G |
Omeprazol Mylan 20 mg |
cps end 28 x 20 mg (blis. AL/polyamid/PVC) |
GNC |
GB |
28 |
1.75 |
1.32 |
S |
0.43 |
0.24571400000000002 |
0.43 |
|
|
|
|
U1 |
49710 |
X |
|
G |
Tevazol 20 mg |
cps end 28x20 mg |
BE |
ES |
28 |
1.75 |
1.32 |
S |
0.43 |
0.24571400000000002 |
0.43 |
|
|
|
|
U1 |
75577 |
X |
|
G |
Omeprazol STADA 20 mg |
cps end 30x20 mg |
STD |
DE |
30 |
2.78 |
1.41 |
S |
1.37 |
0.49280600000000002 |
0.46 |
|
|
|
|
U1 |
98712 |
X |
|
G |
Omeprazol Sandoz 20 mg |
cps 28x20 mg |
SAN |
AT |
28 |
2.91 |
1.32 |
S |
1.59 |
0.54639199999999999 |
0.43 |
|
|
|
|
U1 |
42665 |
X |
|
G |
OPRAZOLE |
tbl ent 28x20 mg |
HKP |
JO |
28 |
3.04 |
1.32 |
S |
1.72 |
0.56578899999999999 |
0.43 |
|
|
|
|
U1 |
03076 |
X |
|
G |
LOMAC |
cps 28x20 mg |
CIA |
IN |
28 |
3.4 |
1.32 |
S |
2.08 |
0.611765 |
0.43 |
|
|
|
|
U1 |
0923B |
X |
|
G |
Omeprazol Farmax 20 mg tvrdá gastrorezistentná kapsula |
cps end 28x20 mg (fľ.HDPE) |
SVS |
CZ |
28 |
3.56 |
1.32 |
S |
2.2400000000000002 |
0.62921300000000002 |
0.43 |
|
|
|
|
U1 |
59897 |
X |
|
G |
HELICID 20 |
cps 28x20 mg |
ZNT-SK-2 |
SK |
28 |
4.47 |
1.32 |
S |
3.15 |
0.70469800000000005 |
0.43 |
|
|
|
|
U1 |
A02BC01 |
|
|
|
Omeprazol |
p.o. 20 mg (56 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
0926B |
X |
|
G |
Omeprazol Farmax 20 mg tvrdá gastrorezistentná kapsula |
cps end 56x20 mg (fľ.HDPE) |
SVS |
CZ |
56 |
6.46 |
2.63 |
S |
3.83 |
0.59287900000000004 |
0.86 |
|
|
|
|
U1 |
03077 |
X |
|
G |
LOMAC |
cps 56x20 mg |
CIA |
GB |
56 |
6.58 |
2.63 |
S |
3.95 |
0.60030399999999995 |
0.86 |
|
|
|
|
U1 |
A02BC01 |
|
|
|
Omeprazol |
p.o. 20 mg (90-100 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
06678 |
X |
|
G |
Omeprazol Mylan 20 mg |
cps end 100 x 20 mg (blis. AL/polyamid/PVC) |
GNC |
GB |
100 |
6.25 |
4.7 |
S |
1.55 |
0.248 |
1.54 |
|
|
|
|
U1 |
86923 |
X |
|
G |
OPRAZOLE |
tbl ent 90x20 mg (liek.HDPE) |
HKP-P |
PT |
90 |
8.1300000000000008 |
4.2300000000000004 |
S |
3.9 |
0.47970499999999999 |
1.38 |
|
|
|
|
U1 |
0928B |
X |
|
G |
Omeprazol Farmax 20 mg tvrdá gastrorezistentná kapsula |
cps end 90x20 mg (fľ.HDPE) |
SVS |
CZ |
90 |
8.18 |
4.2300000000000004 |
S |
3.95 |
0.48288500000000001 |
1.38 |
|
|
|
|
U1 |
90313 |
X |
|
G |
Helicid 20 |
cps 90x20 mg |
ZNT-SK-2 |
SK |
90 |
8.19 |
4.2300000000000004 |
S |
3.96 |
0.483516 |
1.38 |
|
|
|
|
U1 |
75583 |
X |
|
G |
Omeprazol STADA 20 mg |
cps end 100x20 mg |
STD |
DE |
100 |
9.15 |
4.7 |
S |
4.45 |
0.48633899999999997 |
1.54 |
|
|
|
|
U1 |
A02BC01 |
|
|
|
Omeprazol |
p.o. 40 mg (28 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
6155A |
|
|
G |
Helicid 40 |
cps end 28x40 mg (fľ.skl.hnedá-40 ml) |
ZNT-1 |
CZ |
56 |
5.81 |
2.63 |
S |
3.18 |
0.54733199999999993 |
3.18 |
|
|
|
|
U1 |
A02BC02 |
|
|
|
Pantoprazol |
p.o. 20 mg (28-30 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
05044 |
X |
|
G |
Ozzion 20 mg gastrorezistentné tablety |
tbl ent 28x20 mg (blis.nylon Al/PVC/Al), |
ZNT |
CZ |
14 |
2.1800000000000002 |
0.66 |
S |
1.52 |
0.69724799999999998 |
1.17 |
|
|
|
|
U1 |
43791 |
X |
|
G |
Pantoprazol Sandoz 20 mg gastrorezistentné tablety |
tbl ent 28x20 mg (blis.) |
SAN |
DE |
14 |
2.1800000000000002 |
0.66 |
S |
1.52 |
0.69724799999999998 |
1.17 |
|
|
|
|
U1 |
88176 |
X |
|
G |
Pantoprazol Mylan 20 mg |
tbl ent 28 x 20 mg |
GNC |
GB |
14 |
2.77 |
0.66 |
S |
2.11 |
0.76173299999999999 |
1.17 |
|
|
|
|
U1 |
86764 |
X |
|
G |
ULPRIX 20 mg |
tbl ent 28x20 mg (blis.OPA/Al/PVC/Al) |
GLM-CZ |
CZ |
14 |
2.77 |
0.66 |
S |
2.11 |
0.76173299999999999 |
1.17 |
|
|
|
|
U1 |
43345 |
X |
|
G |
NOLPAZA 20mg |
tbl ent 30x20mg |
KRK |
SI |
15 |
3.01 |
0.71 |
S |
2.2999999999999998 |
0.76412000000000002 |
1.26 |
|
|
|
|
U1 |
40447 |
X |
|
O |
Controloc 20 mg |
tbl ent 28x20 mg |
ALA |
DE |
14 |
4.74 |
0.66 |
S |
4.08 |
0.86075900000000005 |
1.17 |
|
|
|
|
U1 |
A02BC02 |
|
|
|
Pantoprazol |
p.o. 20 mg (98-100 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
2423B |
X |
|
G |
Pantomyl 20 mg |
tbl ent 98 x 20 mg(blis. Al/Al bez vrstvy vysušovadla) |
GNS |
UK |
49 |
6.31 |
2.2999999999999998 |
S |
4.01 |
0.63549900000000004 |
4.01 |
|
|
|
|
U1 |
0570B |
X |
|
G |
Ozzion 20 mg gastrorezistentné tablety |
tbl ent 98x20 mg (blis.nylon/Al/PVC/Al) |
ZNT |
CZ |
49 |
6.41 |
2.2999999999999998 |
S |
4.1100000000000003 |
0.64118600000000003 |
4.1100000000000003 |
|
|
|
|
U1 |
43349 |
X |
|
G |
Nolpaza 20mg |
tbl ent 100x20mg |
KRK |
SI |
50 |
6.55 |
2.35 |
S |
4.2 |
0.64122100000000004 |
4.1900000000000004 |
|
|
|
|
U1 |
A02BC02 |
|
|
|
Pantoprazol |
p.o. 40 mg (28-30 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
86793 |
X |
|
G |
ULPRIX 40 mg |
tbl ent 30x40 mg (blis.OPA/Al/PVC/Al) |
GLM-CZ |
CZ |
30 |
3.36 |
1.41 |
S |
1.95 |
0.58035700000000001 |
1.52 |
|
|
|
|
U1 |
05041 |
X |
|
G |
Ozzion 40 mg gastrorezistentné tablety |
tbl ent 28x40 mg (blis.nylon Al/PVC/Al), |
ZNT |
CZ |
28 |
3.23 |
1.32 |
S |
1.91 |
0.59133099999999994 |
1.42 |
|
|
|
|
U1 |
43814 |
X |
|
G |
Pantoprazol Sandoz 40 mg gastrorezistentné tablety |
tbl ent 28x40 mg (blis.) |
SAN |
DE |
28 |
3.23 |
1.32 |
S |
1.91 |
0.59133099999999994 |
1.42 |
|
|
|
|
U1 |
88187 |
X |
|
G |
Pantoprazol Mylan 40 mg |
tbl ent 30 x 40 mg (blis Al/Al) |
GNS |
UK |
30 |
3.99 |
1.41 |
S |
2.58 |
0.646617 |
1.52 |
|
|
|
|
U1 |
43358 |
X |
|
G |
NOLPAZA 40mg |
tbl ent 30x40mg |
KRK |
SI |
30 |
4.1100000000000003 |
1.41 |
S |
2.7 |
0.65693400000000002 |
1.52 |
|
|
|
|
U1 |
90544 |
X |
|
O |
CONTROLOC 40 mg (liek.) |
tbl ent 28x40 mg |
BGL |
DE |
28 |
6.97 |
1.32 |
S |
5.65 |
0.81061700000000003 |
1.42 |
|
|
|
|
U1 |
A02BC02 |
|
|
|
Pantoprazol |
p.o. 40 mg (98-100 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
2430B |
X |
|
G |
Pantomyl 40 mg |
tbl ent 98 x 40 mg(blis. Al/Al bez vrstvy vysušovadla) |
GNS |
UK |
98 |
9.26 |
4.6100000000000003 |
S |
4.6500000000000004 |
0.50216000000000005 |
4.6500000000000004 |
|
|
|
|
U1 |
0567B |
X |
|
G |
Ozzion 40 mg gastrorezistentné tablety |
tbl ent 98x40 mg (blis.nylon/Al/PVC/Al) |
ZNT |
CZ |
98 |
9.59 |
4.6100000000000003 |
S |
4.9800000000000004 |
0.51929099999999995 |
4.9800000000000004 |
|
|
|
|
U1 |
43362 |
X |
|
G |
Nolpaza 40mg |
tbl ent 100x40mg |
KRK |
SI |
100 |
9.8000000000000007 |
4.7 |
S |
5.0999999999999996 |
0.52040799999999998 |
5.08 |
|
|
|
|
U1 |
86798 |
X |
|
G |
ULPRIX 40 mg |
tbl ent 100x40 mg (blis.OPA/Al/PVC/Al) |
GLM-CZ |
CZ |
100 |
9.8000000000000007 |
4.7 |
S |
5.0999999999999996 |
0.52040799999999998 |
5.08 |
|
|
|
|
U1 |
A02BC03 |
|
|
|
Lanzoprazol |
p.o. 30 mg (28 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
34640 |
X |
|
G |
LANZUL |
cps 28x30 mg |
KRK |
SI |
28 |
6.38 |
1.32 |
S |
5.0599999999999996 |
0.793103 |
5.0599999999999996 |
|
|
|
|
U1 |
A02BC04 |
|
|
|
Rabeprazol |
p.o. 10 mg (28 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
2644A |
|
|
G |
Noflux 10 mg |
tbl ent 28x10 mg (blis.Al/Al) |
EGI |
HU |
14 |
3.56 |
0.66 |
S |
2.9 |
0.81460700000000008 |
2.9 |
|
|
|
|
|
A02BC04 |
|
|
|
Rabeprazol |
p.o. 20 mg (28 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
2631A |
|
|
G |
Noflux 20 mg |
tbl ent 28x20 mg (blis.Al/Al) |
EGI |
HU |
28 |
5.03 |
1.32 |
S |
3.71 |
0.73757499999999998 |
3.71 |
|
|
|
|
|
A02BC05 |
|
|
|
Ezomeprazol |
p.o. 20 mg (28 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
4551A |
X |
|
G |
Remesolin 20 mg |
tbl ent 28x20 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
28 |
4.2699999999999996 |
1.32 |
S |
2.95 |
0.6908669999999999 |
1.49 |
|
|
|
|
U1 |
86846 |
X |
|
G |
Emanera 20mg |
cps end 28x20mg |
KRK |
SI |
28 |
4.29 |
1.32 |
S |
2.97 |
0.69230800000000003 |
1.49 |
|
|
|
|
U1 |
A02BC05 |
|
|
|
Ezomeprazol |
p.o. 20 mg (90 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
4594A |
X |
|
G |
Emanera 20mg tvrdé gastrorezistentné kapsuly |
cps end 90x20mg (blis.OPA/Al/PVC/Al |
KRK |
SL |
90 |
9.0299999999999994 |
4.2300000000000004 |
S |
4.8 |
0.53156100000000006 |
4.8 |
|
|
|
|
U1 |
A02BC05 |
|
|
|
Ezomeprazol |
p.o. 40 mg (28 ks ) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
86858 |
X |
|
G |
Emanera 40 mg |
cps end 28x40 mg |
KRK |
SI |
56 |
6.72 |
2.63 |
S |
4.09 |
0.60863100000000003 |
1.87 |
|
|
|
|
U1 |
4577A |
X |
|
G |
Remesolin 40 mg |
tbl ent 28x40 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
56 |
7.59 |
2.63 |
S |
4.96 |
0.65349100000000004 |
1.87 |
|
|
|
|
U1 |
01215 |
X |
|
G |
Dereflin 40 mg |
cps end 28x40 mg (blis. PA/Al/PVC/Al) |
ZNT |
CZ |
56 |
7.62 |
2.63 |
S |
4.99 |
0.6548560000000001 |
1.87 |
|
|
|
|
U1 |
A02BC05 |
|
|
|
Ezomeprazol |
p.o. 40 mg (90 ks ) |
20 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
4605A |
X |
|
G |
Emanera 40mg tvrdé gastrorezistentné kapsuly |
cps end 90x40mg (blis.OPA/Al/PVC/Al |
KRK |
SL |
180 |
14.46 |
8.4600000000000009 |
S |
6 |
0.41493800000000003 |
6 |
|
|
|
|
U1 |
A02BX02 |
|
|
|
Sukralfát |
p.o. 1 g (50 ks) |
4 |
g |
|
|
|
|
|
|
|
|
0.126 |
|
|
|
91217 |
X |
|
G |
VENTER |
tbl 50x1 g |
KRK |
SI |
12.505000000000001 |
4.1399999999999997 |
1.58 |
S |
2.56 |
0.61835700000000005 |
2.56 |
|
|
|
|
|
A03AA04 |
|
|
|
Mebeverín |
p.o. predĺžené uvoľňovanie 200 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.18099999999999999 |
|
|
|
54490 |
X |
|
O |
DUSPATALIN 200 |
cps plg 30x200 mg |
SYF |
NL |
20 |
5.54 |
3.62 |
S |
1.92 |
0.34656999999999999 |
1.92 |
|
|
|
|
|
A03AD02 |
|
|
|
Drotaverín |
parent. 20 mg/ml |
0.1 |
g |
|
|
|
|
|
|
|
|
1.0649999999999999 |
|
|
|
02552 |
|
|
O |
NO-SPA |
sol inj 5x2 ml/40 mg |
CHN |
HU |
2 |
2.13 |
2.13 |
A |
0 |
0 |
0 |
|
|
|
|
|
A03AX04 |
|
|
|
Pinavérium |
p.o. 100 mg (20 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.23569999999999999 |
|
|
|
26277 |
X |
|
O |
DICETEL |
tbl flm 20x100 mg |
SYF |
FR |
13.337999999999999 |
6.02 |
3.14 |
S |
2.88 |
0.47840499999999997 |
2.88 |
|
|
|
|
|
A03BA01 |
|
|
|
Atropín |
parent. 0,5 mg/ml |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.84299999999999997 |
|
|
|
00392 |
|
|
G |
ATROPIN BIOTIKA 0,5 mg |
sol inj 10x1 ml/0,5 mg |
HBS |
SK |
3.3330000000000002 |
2.81 |
2.81 |
A |
0 |
0 |
0 |
|
|
|
|
|
A03BA01 |
|
|
|
Atropín |
parent. 1 mg/ml |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.84299999999999997 |
|
|
|
00394 |
|
|
G |
ATROPIN BIOTIKA 1 mg |
sol inj 10x1 ml/1 mg |
HBS |
SK |
6.6669999999999998 |
3.44 |
3.44 |
A |
0 |
0 |
0 |
|
|
|
|
|
A03BB01 |
|
|
|
Butylskopolamín |
parent. 20 mg/ml |
60 |
mg |
|
|
|
|
|
|
|
|
1.72 |
|
|
|
98169 |
|
|
O |
BUSCOPAN |
sol inj 5x1 ml/20 mg |
BOE |
ES |
1.667 |
2.86 |
2.86 |
A |
0 |
0 |
0 |
|
|
|
|
|
A03DA02 |
|
|
|
Pitofenón kombinovaný s analgetikami |
parent. 2 mg/ml |
2 |
DF |
|
|
|
|
|
|
|
|
2.02 |
|
|
|
88709 |
|
|
O |
ANALGIN inj |
sol inj 5x5 ml |
BTA |
SK |
2.5 |
5.03 |
5.03 |
A |
0 |
0 |
0 |
|
|
|
|
|
A03FA03 |
|
|
|
Domperidón |
p.o. 10 mg (20 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
67531 |
X |
|
G |
COSTI 10 mg |
tbl 20x10 mg |
MOE |
CY |
6.6669999999999998 |
2.09 |
0.67 |
S |
1.42 |
0.67942599999999997 |
1.42 |
|
|
|
|
|
A03FA03 |
|
|
|
Domperidón |
p.o. 10 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
15573 |
X |
|
G |
COSTI 10 mg |
tbl 30x10 mg |
MOE |
CY |
10 |
3.22 |
1 |
S |
2.2200000000000002 |
0.68944100000000008 |
2.13 |
|
|
|
|
|
A03FA07 |
|
|
|
Itoprid hydrochlorid |
p.o. 50 mg (40 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.90100000000000002 |
|
|
|
11814 |
X |
|
G |
Itoprid PMCS 50 mg |
tbl flm 40x50 mg |
PMP |
CZ |
13.333 |
13.13 |
12.01 |
S |
1.1200000000000001 |
8.5300999999999988E-2 |
1.1200000000000001 |
DIA, GER, GIT, INT, KLF, ONK |
|
|
|
|
01348 |
X |
|
G |
Kinito |
tbl flm 40x50 mg (blis. PVC/PVDC/Al) |
ZNT-SK-2 |
SK |
13.333 |
13.13 |
12.01 |
S |
1.1200000000000001 |
8.5300999999999988E-2 |
1.1200000000000001 |
DIA, GER, GIT, INT, KLF, ONK |
|
|
|
|
59210 |
X |
|
O |
GANATON |
tbl flm 40x50 mg |
ABB-SK |
SK |
13.333 |
14.34 |
12.01 |
S |
2.33 |
0.16248300000000002 |
1.1200000000000001 |
DIA, GER, GIT, INT, KLF, ONK |
|
|
|
|
A03FA07 |
|
|
|
Itoprid hydrochlorid |
p.o. 50 mg (100 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.90100000000000002 |
|
|
|
11815 |
X |
|
G |
Itoprid PMCS 50 mg |
tbl flm 100x50 mg |
PMP |
CZ |
33.332999999999998 |
32.840000000000003 |
30.03 |
S |
2.81 |
8.5565999999999989E-2 |
2.8 |
DIA, GER, GIT, INT, KLF, ONK |
|
|
|
|
01349 |
X |
|
G |
Kinito |
tbl flm 100x50 mg (blis. PVC/PVDC/Al) |
ZNT-SK-2 |
SK |
33.332999999999998 |
32.840000000000003 |
30.03 |
S |
2.81 |
8.5565999999999989E-2 |
2.8 |
DIA, GER, GIT, INT, KLF, ONK |
|
|
|
|
59211 |
X |
|
G |
GANATON |
tbl flm 100x50 mg |
ABB |
DE |
33.332999999999998 |
34.61 |
30.03 |
S |
4.58 |
0.13233200000000001 |
2.8 |
DIA, GER, GIT, INT, KLF, ONK |
|
|
|
|
A04AA01 |
|
|
|
Ondasetrón |
p.o. 8 mg (10 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
2.93 |
|
|
|
95221 |
X |
|
G |
Onsetrogen 8 mg |
tbl flm 10x8 mg |
GNS |
GB |
5 |
14.61 |
14.61 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA01 |
|
|
|
Ondasetrón |
parent. 2 mg/ml |
16 |
mg |
|
|
|
|
|
|
|
|
3.95 |
|
|
|
35816 |
|
|
G |
Ondansetron Kabi 2 mg/ml |
sol inj 5x4 ml |
FRK |
DE |
2.5 |
9.84 |
9.84 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
20654 |
|
|
G |
Ondasetron Accord 2 mg/ml injekčný alebo infúzny roztok |
sol ijf 5x4 ml/8 mg (amp.skl.) |
ACC |
GB |
2.5 |
9.84 |
9.84 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
95220 |
|
|
G |
Onsetrogen 2 mg/ml |
sol inj 5x4 ml |
GNS |
GB |
2.5 |
9.84 |
9.84 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
30124 |
|
|
G |
Ondansetron B. Braun 2mg/ ml injekčný roztok |
sol inj 20x4 ml/8mg (amp.LDPE) |
BME |
DE |
10 |
52.55 |
39.5 |
AS |
13.05 |
0.248335 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA02 |
|
|
|
Granisetrón |
p.o. 1 mg (10 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.2619999999999996 |
|
|
|
35777 |
X |
|
G |
Emegar 1 mg |
tbl flm 10x1 mg |
STD |
GB |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
76410 |
X |
|
G |
Granegis 1 mg |
tbl flm 10x1 mg (blis. PVC/AI) |
EGI |
HU |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
36399 |
X |
|
G |
Granisetron Mylan 1 mg |
tbl flm 10x1 mg |
GNS |
GB |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
77279 |
X |
|
G |
Rasetron 1 mg |
tbl flm 10x1 mg (blis.PVC/Al) |
ACT |
IS |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA02 |
|
|
|
Granisetrón |
p.o. 2 mg (5 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.2619999999999996 |
|
|
|
35796 |
X |
|
G |
Emegar 2 mg |
tbl flm 5x2 mg |
STD |
DE |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
76412 |
X |
|
G |
Granegis 2 mg |
tbl flm 5x2 mg (blis. PVC/AI) |
EGI |
HU |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA02 |
|
|
|
Granisetrón |
p.o. 2 mg (10 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.2619999999999996 |
|
|
|
35799 |
X |
|
G |
Emegar 2 mg |
tbl flm 10x2 mg |
STD |
DE |
10 |
52.62 |
52.62 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
77469 |
X |
|
G |
Rasetron 2 mg |
tbl flm 10x2 mg (blis.PVC/Al) |
ACT |
IS |
10 |
52.62 |
52.62 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA02 |
|
|
|
Granisetrón |
parent. 1 mg/ml |
3 |
mg |
|
|
|
|
|
|
|
|
8.0399999999999991 |
|
|
|
58987 |
|
|
G |
Granisetron Kabi 1 mg/ml |
con ijf 5x3 ml/3 mg |
FRK |
CZ |
5 |
37.450000000000003 |
37.450000000000003 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
49905 |
|
|
G |
Granisetron-Teva 3 mg/3 ml injekčný roztok |
con ijf 5x3 mg/3 ml (inj.liek.) |
PHM |
NL |
5 |
37.450000000000003 |
37.450000000000003 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA05 |
|
|
|
Palonosetrón |
p.o. 500 mcg (1 ks) |
100 |
mcg |
|
|
|
|
|
|
|
|
15.04 |
|
|
|
89919 |
|
|
O |
Aloxi 500 mcg mäkké kapsuly |
cps mol 1x500 mcg /blis.PA/Al/PVC/ |
HHC |
IE |
5 |
75.180000000000007 |
75.180000000000007 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA05 |
|
|
|
Palonosetrón |
parent. 50 mcg/ml |
50 |
mcg |
|
|
|
|
|
|
|
|
13.893000000000001 |
|
|
|
90114 |
|
|
O |
ALOXI |
sol inj 1x5 ml (250 mcg v amp.) |
HLS |
IE |
5 |
69.47 |
69.47 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
A04AD12 |
|
|
|
Aprepitant |
p.o. 80 mg (2 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
21.7 |
|
|
|
40848 |
X |
|
O |
EMEND |
cps dur 2x80 mg |
MSD |
GB |
2 |
43.37 |
43.37 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
A04AD12 |
|
|
|
Aprepitant |
p.o. 1x125 mg + 2x80 mg |
95 |
mg |
|
|
|
|
|
|
|
|
18.600000000000001 |
|
|
|
40852 |
X |
|
O |
EMEND |
cps dur 1x125 mg+ 2x80 mg |
MSD |
GB |
3 |
55.79 |
55.79 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
A05AA02 |
|
|
|
Kyselina ursodeoxycholínová |
p.o. 250 mg ( 50 ks) |
0.75 |
g |
|
|
|
|
|
|
|
|
0.78500000000000003 |
|
|
|
97864 |
X |
|
G |
URSOSAN |
cps 50x250 mg |
PMP |
CZ |
16.667000000000002 |
16.309999999999999 |
13.08 |
S |
3.23 |
0.19803799999999999 |
0 |
GER, GIT, HEP, INF, INT, KLF |
|
|
|
|
A05AA02 |
|
|
|
Kyselina ursodeoxycholínová |
p.o. 250 mg ( 100 ks) |
0.75 |
g |
|
|
|
|
|
|
|
|
0.78500000000000003 |
|
|
|
91017 |
X |
|
O |
URSOFALK |
cps 100x250 mg |
FAK |
DE |
33.332999999999998 |
26.09 |
26.09 |
I |
0 |
0 |
0 |
GER, GIT, HEP, INF, INT, KLF |
|
|
|
|
95094 |
X |
|
G |
URSOSAN |
cps 100x250 mg |
PMP |
CZ |
33.332999999999998 |
27.47 |
26.17 |
S |
1.3 |
4.7324000000000005E-2 |
0 |
GER, GIT, HEP, INF, INT, KLF |
|
|
|
|
A05AA02 |
|
|
|
Kyselina ursodeoxycholínová |
p.o. 500 mg ( 100 ks) |
0.75 |
g |
|
|
|
|
|
|
|
|
0.92300000000000004 |
|
|
|
89458 |
X |
|
O |
Ursofalk |
tbl flm 100x500mg |
FAK |
DE |
66.667000000000002 |
61.47 |
61.47 |
I |
0 |
0 |
0 |
GER, GIT, HEP, INF, INT, KLF |
|
|
|
|
A05BA03 |
|
|
|
Silymarín |
p.o. prepoč. na sylibinín 150 mg (50 ks) |
0.21 |
g |
|
|
|
|
|
|
|
|
0.10100000000000001 |
|
|
|
84369 |
X |
|
|
LAGOSA |
tbl obd 50x150 mg |
WGP |
DE |
35.72 |
8.66 |
3.61 |
S |
5.05 |
0.58314100000000002 |
1.96 |
DIA, GER, GIT, INF, INT, NEF, ONK, PSY, HEP, KLF |
|
|
|
|
A05BA03 |
|
|
|
Silymarín |
p.o. prepoč. na sylibinín 150 mg (100 ks) |
0.21 |
g |
|
|
|
|
|
|
|
|
0.10100000000000001 |
|
|
|
84370 |
X |
|
G |
LAGOSA |
tbl obd 100x150 mg |
WGP |
DE |
71.42 |
11.12 |
7.21 |
S |
3.91 |
0.35161900000000001 |
3.91 |
DIA, GER, GIT, INF, INT, NEF, ONK, PSY, HEP, KLF |
|
|
|
|
A06AB58 |
|
|
|
Dinátriumpikosulfát, kombinácie |
p.o. citrát horečnatý 10 mg/3,5 g |
2 |
DF |
|
|
|
|
|
|
|
|
3.99 |
|
|
|
20368 |
|
|
O |
PICOPREP |
plo por 2 x 10 mg/3,5 g/12 g |
FEI-CZ |
CZ |
1 |
9.1999999999999993 |
3.99 |
S |
5.21 |
0.56630400000000003 |
5.21 |
CCH, CHI, GER, GIT, GYN, INT, KLF, ONK |
|
|
|
|
A06AD |
|
|
|
Makrogol, kombinácie minerálnych solí |
p.o. 100 g (2 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
4.2140000000000004 |
|
|
|
04241 |
|
|
G |
MOVIPREP |
plo por 1x(2x112 g + 2x11 g) )vre Al/LDPE/papier |
NGN |
GB |
1 |
12.91 |
4.21 |
S |
8.6999999999999993 |
0.67389600000000005 |
8.6999999999999993 |
CCH, CHI, GER, GIT, GYN, INT, KLF, ONK |
|
|
|
|
A06AD10 |
|
|
|
Kombinácie minerálnych solí |
p.o. 64 g (4 ks) |
4 |
DF |
|
|
|
|
|
|
|
|
4.43 |
|
|
|
69482 |
|
|
G |
FORTRANS |
plv por 4 sáčky |
BFN |
FR |
1 |
10.26 |
4.43 |
S |
5.83 |
0.56822600000000001 |
5.83 |
CCH, CHI, GER, GIT, GYN, INT, KLF, ONK |
|
|
|
|
A06AD11 |
|
|
|
Laktulóza |
p.o. 50 % (200 ml) |
6.7 |
g |
|
|
|
|
|
|
|
|
0.114 |
|
|
|
40124 |
X |
|
G |
LAEVOLAC |
sol por 1x200 ml (PET fľ.) |
FRK |
AT |
20 |
4.25 |
2.2799999999999998 |
S |
1.97 |
0.46352899999999997 |
0.2 |
AGG, GER, GIT, HEP, INT, KLF, ONK, PED, PLM |
|
|
|
|
A06AD11 |
|
|
|
Laktulóza |
p.o. 50 % (250 ml) |
6.7 |
g |
|
|
|
|
|
|
|
|
0.114 |
|
|
|
86612 |
X |
|
G |
LACTULOSA BIOMEDICA |
sir 1x250 ml 50% |
BCS |
CZ |
24.882000000000001 |
5.86 |
2.84 |
S |
3.02 |
0.51535799999999998 |
0.25 |
AGG, GER, GIT, HEP, INT, KLF, ONK, PED, PLM |
|
|
|
|
A06AD11 |
|
|
|
Laktulóza |
p.o. 50 % (500 ml) |
6.7 |
g |
|
|
|
|
|
|
|
|
0.114 |
|
|
|
02816 |
X |
|
G |
LACTULOSA BIOMEDICA |
sir 1x500 ml 50% |
BCS |
CZ |
49.776000000000003 |
6.19 |
5.67 |
S |
0.52 |
8.4006000000000011E-2 |
0.49 |
AGG, GER, GIT, HEP, INT, KLF, ONK, PED, PLM |
|
|
|
|
40127 |
X |
|
G |
LAEVOLAC |
sol por 1x500 ml (PET fľ.) |
FRK |
AT |
49.776000000000003 |
6.19 |
5.67 |
S |
0.52 |
8.4006000000000011E-2 |
0.49 |
AGG, GER, GIT, HEP, INT, KLF, ONK, PED, PLM |
|
|
|
|
62565 |
X |
|
O |
DUPHALAC |
sir 1x500 ml |
ABB-NL-3 |
NL |
49.776000000000003 |
6.37 |
5.67 |
S |
0.7 |
0.10989 |
0.49 |
AGG, GER, GIT, HEP, INT, KLF, ONK, PED, PLM |
|
|
|
|
A06AD11 |
|
|
|
Laktulóza |
p.o. 50 % (1000 ml) |
6.7 |
g |
|
|
|
|
|
|
|
|
0.114 |
|
|
|
40128 |
X |
|
G |
LAEVOLAC |
sol por 1x1000 ml (PET fľ.) |
FRK |
AT |
100 |
12.39 |
11.4 |
S |
0.99 |
7.9903000000000002E-2 |
0.99 |
AGG, GER, GIT, HEP, INT, KLF, ONK, PED, PLM |
|
|
|
|
A06AG10 |
|
|
|
Dokusát sodný, vrátane kombinácií |
p.rect. 0,01 g (2 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
4.5110999999999999 |
|
|
|
12770 |
|
|
G |
YAL |
sol rec 2x67,5 ml |
TRM |
DE |
1 |
8.57 |
4.51 |
S |
4.0599999999999996 |
0.473746 |
0 |
CCH, CHI, GER, GIT, GYN, INT, KLF, ONK, PLM |
ind.obm. |
|
|
|
A06AG10 |
|
|
|
Dokusát sodný, vrátane kombinácií |
p.rect. 0,01 g (10 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
6.9539999999999997 |
|
|
|
92489 |
|
|
G |
YAL |
sol rec 10x67,5 ml |
TRM |
DE |
5 |
34.770000000000003 |
34.770000000000003 |
A |
0 |
0 |
0 |
CCH, CHI, GER, GIT, GYN, INT, KLF, ONK, PLM |
ind.obm. |
|
|
|
A06AH01 |
|
|
|
Metylnaltrexóniumbromid |
parent. 20 mg/ml |
12 |
mg |
|
|
|
|
|
|
|
|
25.283000000000001 |
|
|
|
51897 |
|
|
O |
RELISTOR |
sol inj 7 x 0,6 ml/12 mg |
TMC |
GB |
7 |
176.98 |
176.98 |
I |
0 |
0 |
0 |
AGG, ONK, PLM |
ind.obm. |
|
|
|
A06AX05 |
|
|
|
Prukaloprid |
p.o. 1 mg (28 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
3.6139999999999999 |
|
|
|
81447 |
|
|
O |
Resolor 1 mg filmom obalené tablety |
tbl flm 28x1x1 mg (blis.Al/Al) |
SHP-IE |
IE |
14 |
50.49 |
50.49 |
I |
0 |
0 |
0 |
GER, GIT, GYN, INT |
ind.obm. |
|
|
|
A06AX05 |
|
|
|
Prukaloprid |
p.o. 2 mg (28 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
2.71 |
|
|
|
81448 |
|
|
O |
Resolor 2 mg filmom obalené tablety |
tbl flm 28x1x2 mg (blis.Al/Al) |
SHP-IE |
IE |
28 |
75.67 |
75.67 |
I |
0 |
0 |
0 |
GER, GIT, GYN, INT |
ind.obm. |
|
|
|
A07AA11 |
|
|
|
Rifaximín |
p.o. 200 mg (12 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
2.1989999999999998 |
|
|
|
44285 |
X |
|
O |
NORMIX 200 mg |
tbl obd 12x200 mg |
ASW |
IT |
3 |
7.59 |
6.6 |
S |
0.99 |
0.130435 |
0.99 |
CCH, CHI, GER, GIT, HEP, INF, INT, KLF |
ind.obm. |
|
|
|
A07AA11 |
|
|
|
Rifaximín |
p.o. 200 mg (28 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
2.1989999999999998 |
|
|
|
7753A |
X |
|
O |
NORMIX 200 mg |
tbl obd 28x200 mg (blis.PVC/PE/PVDC/Al) |
ASW |
IT |
7 |
17.989999999999998 |
15.39 |
S |
2.6 |
0.14452500000000001 |
2.31 |
CCH, CHI, GER, GIT, HEP, INF, INT, KLF |
ind.obm. |
|
|
|
A07DA |
|
|
|
Antipropulzíva |
p.o. difenoxylát/atropín 2,5 mg/0,025 mg |
15 |
mg |
|
|
|
|
|
|
|
|
0.29210000000000003 |
|
|
|
30639 |
|
|
O |
REASEC |
tbl 20x2,5 mg |
GDN |
HU |
3.3279999999999998 |
3.02 |
0.97 |
S |
2.0499999999999998 |
0.67880799999999997 |
2.0499999999999998 |
|
|
|
|
|
A07EA06 |
|
|
|
Budezonid |
p.o. 3 mg (50 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
2.4569999999999999 |
|
|
|
64786 |
X |
|
G |
BUDENOFALK |
cps ent 50x3 mg |
FAK |
DE |
16.667000000000002 |
41.23 |
40.950000000000003 |
S |
0.28000000000000003 |
6.7910000000000002E-3 |
0.28000000000000003 |
GER, GIT, INT, KLF |
|
|
|
|
12701 |
X |
|
O |
ENTOCORT 3 mg |
cps mod 50x3 mg |
AZC |
SE |
16.667000000000002 |
50.21 |
40.950000000000003 |
S |
9.26 |
0.18442499999999998 |
0.28000000000000003 |
GER, GIT, INT, KLF |
|
|
|
|
A07EA06 |
|
|
|
Budezonid |
p.rect. 2 mg |
2 |
mg |
|
|
|
|
|
|
|
|
4.8280000000000003 |
|
|
|
83424 |
|
|
O |
ENTOCORT 2 mg |
tbl reu 7x2 mg (+7 sol.) |
AZC |
SE |
7 |
35.340000000000003 |
33.799999999999997 |
S |
1.54 |
4.3577000000000005E-2 |
1.54 |
GER, GIT, INT, KLF |
|
|
|
|
A07EC01 |
|
|
|
Sulfasalazín |
p.o. 500 mg (100 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.53110000000000002 |
|
|
|
04304 |
X |
|
G |
SULFASALAZIN-EN |
tbl 100x578 mg |
KRK |
SI |
28.9 |
15.31 |
15.31 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF, REU |
|
|
|
|
A07EC02 |
|
|
|
Mesalazín |
p.o. 250 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
93235 |
X |
|
G |
SALOFALK 250 |
tbl ent 100x250 mg |
FAK |
DE |
16.666 |
15.66 |
15.66 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF |
|
|
|
U73 |
A07EC02 |
|
|
|
Mesalazín |
p.o. 500 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
75567 |
X |
|
G |
SALOFALK 500 |
tbl ent 100x500 mg |
FAK |
DE |
33.332999999999998 |
24.54 |
24.54 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF |
|
|
|
U73 |
A07EC02 |
|
|
|
Mesalazín |
p.o. predĺžené uvoľňovanie 500 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
83136 |
X |
|
O |
Pentasa Slow release tablets 500 mg |
tbl ret 100x500 mg (bli.Alu) |
FEI-CZ |
CZ |
33.332999999999998 |
33.479999999999997 |
33 |
S |
0.48 |
1.4336999999999999E-2 |
0 |
GER, GIT, INT, KLF |
ind.obm. |
|
|
U73 |
A07EC02 |
|
|
|
Mesalazín |
p.o. predĺžené uvoľňovanie 1000 mg (60 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
22127 |
X |
|
O |
Pentasa Slow release tablets 1g |
tbl plg 60 x 1g |
FEI-CZ |
CZ |
40 |
42.06 |
39.6 |
S |
2.46 |
5.8487999999999998E-2 |
2.46 |
GER, GIT, INT, KLF |
ind.obm. |
|
|
U73 |
A07EC02 |
|
|
|
Mesalazín |
p.o. predĺžené uvoľňovanie 1500 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
7252A |
|
|
O |
Salofalk 1,5 g gastrorezistentný granulát s predĺženým uvoľňovaním |
gra mdf 100x1,5 g (vre.PES/Al/PE) |
FAK |
DE |
100 |
104.06 |
99 |
S |
5.0599999999999996 |
4.8625999999999996E-2 |
5.0599999999999996 |
GIT, INT |
ind.obm. |
|
|
U73 |
A07EC02 |
|
|
|
Mesalazín |
p.o. predĺžené uvoľňovanie 2000 mg (60 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
39559 |
X |
|
O |
Pentasa Sachet 2 g |
gra plg 1x60 vreciek |
FEI |
DE |
80 |
87.69 |
79.2 |
S |
8.49 |
9.6818000000000015E-2 |
8.49 |
GER, GIT, INT, KLF |
ind.obm. |
|
|
U73 |
A07EC02 |
|
|
|
Mesalazín |
p.o. predĺžené uvoľňovanie 3000 mg (30 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
7257A |
|
|
O |
Salofalk 3 g gastrorezistentný granulát s predĺženým uvoľňovaním |
gra mdf 30x3 g (vre.PES/Al/PE) |
FAK |
DE |
60 |
63.91 |
59.4 |
S |
4.51 |
7.0568000000000006E-2 |
4.51 |
GIT, INT |
ind.obm. |
|
|
U73 |
A07EC02 |
|
|
|
Mesalazín |
p.rect. 500 mg |
1.5 |
g |
|
|
|
|
|
|
|
|
2.1459999999999999 |
|
|
|
75569 |
|
|
O |
SALOFALK 500 |
sup 30x500 mg |
FAK |
DE |
10 |
21.75 |
21.46 |
S |
0.28999999999999998 |
1.3332999999999999E-2 |
0.28999999999999998 |
GER, GIT, INT, KLF |
|
|
|
|
A07EC02 |
|
|
|
Mesalazín |
p.rect. 1000 mg (28-30 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
1.99 |
|
|
|
23407 |
|
|
O |
Salofalk 1 g čapíky |
sup 30x1 g (blis.PVC/PE) |
FAK |
DE |
20 |
40.85 |
39.799999999999997 |
S |
1.05 |
2.5703999999999998E-2 |
1.05 |
GER, GIT, INT, KLF |
|
|
|
|
83135 |
|
|
O |
PENTASA |
sup 28x1 g |
FEI |
DK |
18.667000000000002 |
38.24 |
37.15 |
S |
1.0900000000000001 |
2.8504000000000002E-2 |
0.98 |
GER, GIT, INT, KLF |
|
|
|
|
A07EC02 |
|
|
|
Mesalazín |
p.rect. sus rec 1000 mg |
1.5 |
g |
|
|
|
|
|
|
|
|
4.641 |
|
|
|
45744 |
|
|
O |
PENTASA 1 G |
sus rec 7x1 g |
FEI |
DK |
4.6669999999999998 |
21.66 |
21.66 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF |
|
|
|
|
A07EC02 |
|
|
|
Mesalazín |
p.rect. sus rec 4000 mg |
1.5 |
g |
|
|
|
|
|
|
|
|
1.79 |
|
|
|
93770 |
|
|
O |
SALOFALK KLYSMEN |
sus rec 7x4 g/60 ml |
FAK |
DE |
18.667000000000002 |
33.26 |
33.26 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF |
|
|
|
|
A07FA |
|
|
|
Antidiarhoické mikroorganizmy |
p.o. 100 mg (20 ks) |
200 |
mg |
|
|
|
|
|
|
|
|
0.92700000000000005 |
|
|
|
66062 |
|
|
O |
MUTAFLOR 100 MG |
cps ent 20x100 mg |
ARP |
DE |
10 |
15.4 |
9.27 |
S |
6.13 |
0.39805200000000002 |
4 |
GER, GIT, INT, KLF, PED |
ind.obm. |
|
|
|
A07FA |
|
|
|
Antidiarhoické mikroorganizmy |
p.o. 100 mg (100 ks) |
200 |
mg |
|
|
|
|
|
|
|
|
0.92700000000000005 |
|
|
|
66063 |
|
|
O |
MUTAFLOR 100 MG |
cps ent 100x100 mg |
ARP |
DE |
50 |
66.34 |
46.35 |
S |
19.989999999999998 |
0.30132599999999998 |
19.989999999999998 |
GER, GIT, INT, KLF, PED |
ind.obm. |
|
|
|
A09AA02 |
|
|
|
Multienzýmy (lipáza, proteáza) |
p.o. podľa lipáz 10000 FI 150 mg (20 ks) |
5000 |
FI |
|
|
|
|
|
|
|
|
5.2999999999999999E-2 |
|
|
|
2631B |
|
|
O |
Kreon 10 000 |
cps end 20x150 mg (blis.Al/Al) |
ABB-DE-4 |
DE |
40 |
3.88 |
2.12 |
S |
1.76 |
0.45360799999999996 |
1.76 |
GIT, PED, TRN |
ind.obm. |
|
|
U2 |
26525 |
|
|
O |
KREON 10000 |
cps 20x150 mg |
SYF |
DE |
40 |
3.88 |
2.12 |
S |
1.76 |
0.45360799999999996 |
0.87 |
GIT, PED, TRN |
ind.obm. |
|
|
U2 |
A09AA02 |
|
|
|
Multienzýmy (lipáza, proteáza) |
p.o. podľa lipáz 10000 FI 150 mg (50 ks) |
5000 |
FI |
|
|
|
|
|
|
|
|
5.2999999999999999E-2 |
|
|
|
26526 |
|
|
O |
KREON 10000 |
cps 50x150 mg |
SYF |
DE |
100 |
7.48 |
5.3 |
S |
2.1800000000000002 |
0.29144400000000004 |
2.1800000000000002 |
GIT, PED, TRN |
ind.obm. |
|
|
U2 |
A09AA02 |
|
|
|
Multienzýmy (lipáza, proteáza) |
p.o. podľa lipáz 20000 FI (30 ks) |
5000 |
FI |
|
|
|
|
|
|
|
|
3.5000000000000003E-2 |
|
|
|
93538 |
|
|
O |
PANZYNORM FORTE - N |
tbl flm 1x30 |
KRK |
SI |
120 |
6.02 |
4.2 |
S |
1.82 |
0.30232600000000004 |
1.23 |
GER, GIT, INT, KLF, PED, TRN |
ind.obm. |
|
|
U3 |
A09AA02 |
|
|
|
Multienzýmy (lipáza, proteáza) |
p.o. podľa lipáz 20000 FI (50 ks) |
5000 |
FI |
|
|
|
|
|
|
|
|
3.5000000000000003E-2 |
|
|
|
56167 |
|
|
O |
PANGROL 20000 |
tbl flm 50 |
BCE |
DE |
200 |
10.31 |
7 |
S |
3.31 |
0.321048 |
2.0499999999999998 |
GER, GIT, INT, KLF, PED, TRN |
ind.obm. |
|
|
U3 |
A09AA02 |
|
|
|
Multienzýmy (lipáza, proteáza) |
p.o. podľa lipáz 20000 FI (100 ks) |
5000 |
FI |
|
|
|
|
|
|
|
|
3.5000000000000003E-2 |
|
|
|
93539 |
|
|
O |
PANZYNORM FORTE - N |
tbl flm 1x100 |
KRK |
SI |
400 |
18.09 |
14 |
S |
4.09 |
0.22609200000000002 |
4.09 |
GER, GIT, INT, KLF, PED, TRN |
ind.obm. |
|
|
U3 |
A09AA02 |
|
|
|
Multienzýmy (lipáza, proteáza) |
p.o. podľa lipáz 25000 FI 250mg (50 ks) |
5000 |
FI |
|
|
|
|
|
|
|
|
3.5000000000000003E-2 |
|
|
|
92507 |
|
|
G |
PANZYTRAT 25000 |
cps 50x250 mg |
AAX-F |
FR |
250 |
15.6 |
8.75 |
S |
6.85 |
0.43910300000000002 |
6.25 |
GER, GIT, INT, KLF, PED, TRN |
ind.obm. |
|
|
U3 |
A09AA02 |
|
|
|
Multienzýmy (lipáza, proteáza) |
p.o. podľa lipáz 25000 FI 300 mg (50 ks) |
5000 |
FI |
|
|
|
|
|
|
|
|
3.5000000000000003E-2 |
|
|
|
26529 |
|
|
O |
KREON 25000 |
cps 50x300 mg |
SYF |
DE |
250 |
15 |
8.75 |
S |
6.25 |
0.41666700000000001 |
6.25 |
GER, GIT, INT, KLF, PED, TRN |
ind.obm. |
|
|
U3 |
A09AA02 |
|
|
|
Multienzýmy (lipáza, proteáza) |
p.o. podľa lipáz 40000 FI 400 mg (50 ks) |
5000 |
FI |
|
|
|
|
|
|
|
|
3.5000000000000003E-2 |
|
|
|
37344 |
|
|
O |
Kreon 40 000 |
cps dur 50x400 mg (fľ.HDPE) |
ABB-DE-1 |
DE |
400 |
26.49 |
14 |
S |
12.49 |
0.471499 |
12.49 |
GER, GIT, INT, PED, TRN, KLF |
ind.obm. |
|
|
U3 |
A10AB01 |
|
|
|
Inzulín humánny |
parent. rýchle pôsobiaci 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.55000000000000004 |
|
|
|
28593 |
|
|
O |
INSUMAN RAPID 100 IU/ml (liekovka) |
sol inj 1x5 ml/500 IU (100 IU/ml) (skl. liek.) |
AVT-D |
DE |
12.5 |
6.72 |
6.72 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10AB01 |
|
|
|
Inzulín humánny |
parent. rýchle pôsobiaci náplne 100 IU/ml (5 ks) |
40 |
UT |
|
|
|
|
|
|
|
|
0.59 |
|
|
|
66114 |
|
|
O |
Insuman Rapid |
sol inj 5x3 ml/300 IU (SoloStar-skl.nápl.v naplnen..pere) |
SAV-D |
DE |
37.5 |
21.99 |
21.99 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
28595 |
|
|
O |
INSUMAN RAPID 100 IU/ml (pre Optipen) |
sol inj 5x3 ml/300 IU (100 IU/ml) (napl. skl.) |
AVT-D |
DE |
37.5 |
23.48 |
22.13 |
S |
1.35 |
5.7495999999999998E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
24872 |
|
|
O |
HUMULIN R CARTRIDGE |
sol inj 5x3 ml/300 IU |
LIL |
FR |
37.5 |
24.41 |
22.13 |
S |
2.2799999999999998 |
9.3404000000000001E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB01 |
|
|
|
Inzulín humánny |
parent. rýchle pôsobiaci náplne 100 IU/ml (10 ks) |
40 |
UT |
|
|
|
|
|
|
|
|
0.59 |
|
|
|
0195B |
|
|
O |
Humulin R Cartridge |
sol inj 10(2x5)x3ml)/300IU (náplň skl.) |
LIL |
CZ |
75 |
47.5 |
44.25 |
S |
3.25 |
6.842100000000001E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
41355 |
|
|
O |
Actrapid Penfill |
sol inj 10x3ml/ 300 IU (náplň skl. 3,5 mg/ml) |
NOO |
DK |
75 |
56.16 |
44.25 |
S |
11.91 |
0.21207300000000001 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB04 |
|
|
|
Inzulín lispro |
parent. KwikPen 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.90200000000000002 |
|
|
|
54300 |
|
|
O |
HUMALOG 100 U/ml KwikPen |
sol inj 2x (5 x 3 ml), skl nap. v napl. pere |
LIL |
NL |
75 |
72.86 |
67.650000000000006 |
S |
5.21 |
7.1507000000000001E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB04 |
|
|
|
Inzulín lispro |
parent. pôsobiace krátkodobo 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.78 |
|
|
|
89134 |
|
|
O |
HUMALOG 100 IU |
sol inj 1x10 ml |
LIL |
FR |
25 |
19.420000000000002 |
19.420000000000002 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB04 |
|
|
|
Inzulín lispro |
parent. pôsobiace krátkodobo náplne 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.80300000000000005 |
|
|
|
25884 |
|
|
O |
HUMALOG CARTRIDGE 100 IU |
sol inj 5x3 ml |
LIL |
FR |
37.500999999999998 |
32.64 |
30.11 |
S |
2.5299999999999998 |
7.7511999999999998E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB04 |
|
|
|
Inzulín lispro |
s.c. KwikPen 200 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.90200000000000002 |
|
|
|
2012B |
|
|
O |
Humalog 200 jednotiek/ml, injekčný roztok naplnený v injekčnom pere. |
sol. Inj. 5x3 ml (skl. nap. v napl. pere) |
LIL-NL-1 |
NL |
75 |
72.86 |
67.650000000000006 |
S |
5.21 |
7.1507000000000001E-2 |
5.21 |
DIA |
ind.obm. |
|
|
|
A10AB05 |
|
|
|
Inzulín aspart |
parent. náplne 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.80300000000000005 |
|
|
|
41377 |
|
|
O |
NovoRapid Penfill |
sol inj 10x3 ml/300 IU (skl. náplň) |
NOO |
DK |
75 |
71.09 |
60.23 |
S |
10.86 |
0.15276400000000001 |
10.86 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB05 |
|
|
|
Inzulín aspart |
parent. FlexPen 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.90200000000000002 |
|
|
|
41382 |
|
|
O |
NovoRapid FlexPen |
sol inj. 10x3 ml/300 IU (skl. náplň v predpl. pere) |
NOO |
DK |
75 |
80.67 |
67.650000000000006 |
S |
13.02 |
0.16139800000000001 |
10.86 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB06 |
|
|
|
Inzulín glulizín |
parent. 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.78300000000000003 |
|
|
|
41438 |
|
|
O |
APIDRA (liekovka) |
sol inj 1x10 ml (100 IU/ ml) (skl. liekov.) |
SAV-D |
DE |
25 |
20.18 |
19.579999999999998 |
S |
0.6 |
2.9731999999999998E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB06 |
|
|
|
Inzulín glulizín |
parent. SoloStar 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.81 |
|
|
|
36550 |
|
|
O |
APIDRA (SoloStar) |
sol inj 5x3 ml (100 IU/ml) (napl.pero-sklo-SoloStar) |
SAV-D |
DE |
37.5 |
29.86 |
29.86 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB06 |
|
|
|
Inzulín glulizín |
parent. náplň 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.73699999999999999 |
|
|
|
41445 |
|
|
O |
APIDRA (skl. náplň) |
sol inj 5x3 ml (100 IU/ml) (skl. náplň) |
SAV-D |
DE |
37.5 |
29.9 |
27.64 |
S |
2.2599999999999998 |
7.5584999999999999E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AC01 |
|
|
|
Inzulín humánny |
parent. strednodobo pôsobiaci 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.61 |
|
|
|
28589 |
|
|
O |
INSUMAN BASAL 100 IU/ml (liekovka) |
sus inj 1x5 ml/500 IU (100 IU/ml) (skl. liek.) |
AVT-D |
DE |
12.5 |
7.5 |
7.5 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10AC01 |
|
|
|
Inzulín humánny |
parent. strednodobo pôsobiaci náplne 100 IU/ml (5ks) |
40 |
UT |
|
|
|
|
|
|
|
|
0.63500000000000001 |
|
|
|
28591 |
|
|
O |
INSUMAN BASAL 100 IU/ml (pre Optipen) |
sus inj 5x3 ml/300 IU (100 IU/ml) (napl. skl.) |
AVT-D |
DE |
37.5 |
23.47 |
23.47 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
66120 |
|
|
O |
Insuman Basal |
sus inj 5x3 ml/300 IU (SoloStar-skl.nápl.v naplnen.pere) |
SAV-D |
DE |
37.5 |
23.8 |
23.8 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
24871 |
|
|
O |
HUMULIN N(NPH)CARTRIDGE |
sus inj 5x3 ml/300 IU |
LIL |
FR |
37.5 |
24.8 |
23.81 |
S |
0.99 |
3.9918999999999996E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AC01 |
|
|
|
Inzulín humánny |
parent. strednodobo pôsobiaci náplne 100 IU/ml (10 ks) |
40 |
UT |
|
|
|
|
|
|
|
|
0.63500000000000001 |
|
|
|
0196B |
|
|
O |
Humulin N (NPH) Cartridge |
sus inj 10 ( 2x5) x 3 ml/300IU (náplň skl.) |
LIL |
CZ |
75 |
47.5 |
47.5 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
40946 |
|
|
O |
Insulatard Penfill |
sus inj 10x3 ml/ 300 IU (náplň skl. 3,5 mg/ml) |
NOO |
DK |
75 |
56.16 |
47.63 |
S |
8.5299999999999994 |
0.15188699999999999 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AD01 |
|
|
|
Inzulín humánny |
parent. komb. stred. a rých. pôsobiaci 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.69 |
|
|
|
28581 |
|
|
O |
INSUMAN COMB 25 |
sus inj 1x5 ml/500 IU (100 IU/ml) (skl. liek.) |
AVT-D |
DE |
12.5 |
8.48 |
8.48 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10AD01 |
|
|
|
Inzulín humánny |
parent. komb. stred. a rých. pôsobiaci náplne 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.63500000000000001 |
|
|
|
28583 |
|
|
O |
INSUMAN COMB 25 (pre Optipen) |
inj 5x3 ml/300 IU (100 IU/ml) (napl.skl.) |
AVT-D |
DE |
37.5 |
23.48 |
23.48 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
0197B |
|
|
O |
Humulin M3(30/70) Cartridge |
sus inj 10 (2x5) x 3 ml/300 IU (náplň skl.) |
LIL |
CZ |
75 |
47.5 |
47.5 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
66133 |
|
|
O |
Insuman Comb 25 |
sus inj 5x3 ml/300 IU (SoloStar-skl.nápl.v naplnen..pere) |
SAV-D |
DE |
37.5 |
23.8 |
23.8 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
24868 |
|
|
O |
HUMULIN M3(30/70)CARTRIDGE |
sus inj 5x3 ml/300 IU |
LIL |
FR |
37.5 |
24.42 |
23.81 |
S |
0.61 |
2.4980000000000002E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AD04 |
|
|
|
Inzulín lispro |
parent. dual release náplne 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.82 |
|
|
|
54040 |
|
|
O |
HUMALOG MIX 50 |
sus inj 5x3 ml (100 IU/ ml) |
LIL |
FR |
37.5 |
33.08 |
30.75 |
S |
2.33 |
7.0434999999999998E-2 |
1.62 |
DIA, ENP |
ind.obm. |
|
|
|
54051 |
|
|
O |
HUMALOG MIX 25 |
sus inj 5x3 ml (100 IU/ ml) |
LIL |
FR |
37.5 |
33.9 |
30.75 |
S |
3.15 |
9.2920000000000003E-2 |
1.62 |
DIA, ENP |
ind.obm. |
|
|
|
A10AD04 |
|
|
|
Inzulín lispro |
parent. KwikPen 25 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.95050000000000001 |
|
|
|
54301 |
|
|
O |
Humalog Mix 25 100 IU/ml KwikPen |
sus inj 5x3ml (skl. nap. v napln. pere) |
LIL |
NL |
37.5 |
37.26 |
35.64 |
S |
1.62 |
4.3478000000000003E-2 |
1.62 |
DIA, ENP |
ind.obm. |
|
|
|
A10AD04 |
|
|
|
Inzulín lispro |
parent. KwikPen 50 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.94569999999999999 |
|
|
|
54305 |
|
|
O |
Humalog Mix 50 100U/ml KwikPen |
sus inj 5x3 ml(skl.nap.v napl.pere) |
LIL |
NL |
37.5 |
37.26 |
35.46 |
S |
1.8 |
4.8308999999999998E-2 |
1.62 |
DIA, ENP |
ind.obm. |
|
|
|
A10AD05 |
|
|
|
Inzulín aspart |
parent. dual release FlexPen 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
1.0277000000000001 |
|
|
|
41374 |
|
|
O |
NovoMix 30 FlexPen |
sus inj 10x3 ml/300 U (skl. náplň v pere) |
NOO |
DK |
75 |
80.89 |
77.08 |
S |
3.81 |
4.7100999999999997E-2 |
3.81 |
DIA, ENP |
ind.obm. |
|
|
|
A10AD05 |
|
|
|
Inzulín aspart |
parent. dual release sus. inj. 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.86639999999999995 |
|
|
|
41370 |
|
|
O |
NovoMix 30 Penfill |
sus inj 10x3 ml/300 U (skl. náplň) |
NOO |
DK |
75 |
71.290000000000006 |
64.98 |
S |
6.31 |
8.8512000000000007E-2 |
3.81 |
DIA, ENP |
ind.obm. |
|
|
|
A10AE04 |
|
|
|
Inzulín glargín |
parent. pôsobiace dlhodobo liekovka 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
1.4870000000000001 |
|
|
|
34002 |
|
|
O |
LANTUS (liekovka) |
sol inj 1x10 ml (skl. liek.) |
SAV-D |
DE |
25 |
40.119999999999997 |
37.18 |
S |
2.94 |
7.3279999999999998E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AE04 |
|
|
|
Inzulín glargín |
parent. pôsobiace dlhodobo náplň 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
1.1419999999999999 |
|
|
|
3137B |
|
|
B |
ABASAGLAR 100 jednotiek/ml injekčný roztok v náhradnej náplni |
sol inj 10x3 ml (náplň skl.) |
LIL - AT |
AT |
75 |
85.6 |
85.6 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
13271 |
|
|
O |
LANTUS (náplň) |
sol inj 5x3 ml (skl. náplň) |
SAV-D |
DE |
37.500999999999998 |
53.28 |
42.83 |
S |
10.45 |
0.19613399999999998 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
13272 |
|
|
O |
LANTUS |
sol inj 10x3 ml (skl. náplň) |
SAV-D |
DE |
75 |
112.08 |
85.65 |
S |
26.43 |
0.235814 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AE04 |
|
|
|
Inzulín glargín |
parent. pôsobiace dlhodobo SoloStar 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
1.1299999999999999 |
|
|
|
2151B |
|
|
B |
ABASAGLAR 100 jednotiek/ml injekčný roztok naplnený v injekčnom pere |
sol inj 10(2x5)x3 ml (pero napl. skl.- KwikPen- multibal) |
LIL - AT |
AT |
75 |
84.58 |
84.58 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
36570 |
|
|
O |
LANTUS |
sol inj 10x3 ml (skl.náplň v pere pre SoloStar) |
SAV-D |
D |
75 |
102.07 |
84.75 |
S |
17.32 |
0.16968699999999998 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
36566 |
|
|
O |
LANTUS (SoloStar) |
sol inj 5x3 ml (skl. náplň v pere pre SoloStar) |
SAV-D |
DE |
37.5 |
52.68 |
42.38 |
S |
10.3 |
0.19552 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AE05 |
|
|
|
Inzulín detemir |
parent. pôsobiace dlhodobo náplň 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
1.4790000000000001 |
|
|
|
40817 |
|
|
O |
Levemir |
sol inj. 10x3 ml (náplň skl. Penfill) |
NOO |
DK |
75 |
122.58 |
110.93 |
S |
11.65 |
9.5039999999999999E-2 |
11.65 |
DIA, ENP |
ind.obm. |
|
|
|
A10AE05 |
|
|
|
Inzulín detemir |
parent. FlexPen 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
1.419 |
|
|
|
40820 |
|
|
O |
Levemir |
sol inj. 10x3 ml (náplň skl. v naplnenom pere FlexPen) |
NOO |
DK |
75 |
123.89 |
106.43 |
S |
17.46 |
0.140931 |
11.65 |
DIA, ENP |
ind.obm. |
|
|
|
A10AE06 |
|
|
|
Inzulín degludek |
parent. FlexTouch 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
1.6990000000000001 |
|
|
|
4145A |
|
|
O |
Tresiba 100 jednotiek/ml injekčný roztok v naplnenom pere |
sol inj 5x3 ml(pero napl.skl.FlexTouch) |
NOO |
DK |
37.5 |
104.15 |
63.71 |
S |
40.44 |
0.38828600000000002 |
40.44 |
DIA |
ind.obm. |
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 500 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
7.5300000000000006E-2 |
|
|
|
33921 |
X |
|
G |
METFOGAMMA 500 |
tbl obd 30x500 MG |
WGP |
DE |
7.5 |
1.52 |
0.56000000000000005 |
S |
0.96 |
0.631579 |
0 |
|
|
|
|
|
1959A |
X |
|
G |
Metformin Vitabalans 500 mg filmom obalené tablety |
tbl flm 30x500 mg (obal HDPE) |
VTB |
FI |
7.5 |
1.62 |
0.56000000000000005 |
S |
1.06 |
0.65432100000000004 |
0 |
|
|
|
|
|
59713 |
X |
|
G |
Normaglyc 500 mg filmom obalené tablety |
tbl flm 30x500 mg |
PRW |
CZ |
7.5 |
1.67 |
0.56000000000000005 |
S |
1.1100000000000001 |
0.66467100000000001 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 500 mg (50-60 ks) |
2 |
g |
|
|
|
|
|
|
|
|
7.5300000000000006E-2 |
|
|
|
76266 |
X |
|
G |
Metformín Bluefish 500 mg |
tbl flm 60x500 mg (blis. PVC/PVDC/Al) |
BLR |
SE |
15 |
1.1299999999999999 |
1.1299999999999999 |
I |
0 |
0 |
0 |
|
|
|
|
|
34289 |
X |
|
G |
STADAMET 500 |
tbl flm 60x500 mg |
STD |
DE |
15 |
1.79 |
1.1299999999999999 |
S |
0.66 |
0.36871499999999996 |
0 |
|
|
|
|
|
56503 |
X |
|
G |
SIOFOR 500 |
tbl flm 60x500 mg |
BCE |
DE |
15 |
2.38 |
1.1299999999999999 |
S |
1.25 |
0.52520999999999995 |
0 |
|
|
|
|
|
1960A |
X |
|
G |
Metformin Vitabalans 500 mg filmom obalené tablety |
tbl flm 60x500 mg (obal HDPE) |
VTB |
FI |
15 |
2.73 |
1.1299999999999999 |
S |
1.6 |
0.58608099999999996 |
0 |
|
|
|
|
|
25295 |
X |
|
O |
GLUCOPHAGE 500 mg |
tbl flm 50x500 mg |
LIP |
FR |
12.5 |
3.67 |
0.94 |
S |
2.73 |
0.743869 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 500 mg (90-100 ks) |
2 |
g |
|
|
|
|
|
|
|
|
7.5300000000000006E-2 |
|
|
|
59731 |
X |
|
G |
Normaglyc 500 mg filmom obalené tablety |
tbl flm 90x500 mg |
PRW |
CZ |
22.5 |
3.72 |
1.69 |
S |
2.0299999999999998 |
0.54569899999999993 |
0 |
|
|
|
|
|
1961A |
X |
|
G |
Metformin Vitabalans 500 mg filmom obalené tablety |
tbl flm 100x500 mg (obal HDPE) |
VTB |
FI |
25 |
4.16 |
1.88 |
S |
2.2799999999999998 |
0.54807699999999993 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 500 mg (120 ks) |
2 |
g |
|
|
|
|
|
|
|
|
7.5300000000000006E-2 |
|
|
|
34295 |
X |
|
G |
STADAMET 500 |
tbl flm 120x500 mg |
STD |
DE |
30 |
3.57 |
2.2599999999999998 |
S |
1.31 |
0.36694699999999997 |
0 |
|
|
|
|
|
33922 |
X |
|
G |
METFOGAMMA 500 |
tbl obd 120x500 MG |
WGP |
DE |
30 |
4.16 |
2.2599999999999998 |
S |
1.9 |
0.456731 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 850 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
5.96E-2 |
|
|
|
32783 |
X |
|
G |
METFOGAMMA 850 |
tbl obd 30x850 MG |
WGP |
DE |
12.75 |
1.41 |
0.76 |
S |
0.65 |
0.46099299999999999 |
0 |
|
|
|
|
|
59746 |
X |
|
G |
Normaglyc 850 mg filmom obalené tablety |
tbl flm 30x850 mg |
PRW |
CZ |
12.75 |
2.36 |
0.76 |
S |
1.6 |
0.67796599999999996 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 850 mg (60 ks) |
2 |
g |
|
|
|
|
|
|
|
|
5.96E-2 |
|
|
|
34292 |
X |
|
G |
STADAMET 850 |
tbl flm 60x850 mg |
STD |
DE |
25.5 |
3.04 |
1.52 |
S |
1.52 |
0.5 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 850 mg (90-100 ks) |
2 |
g |
|
|
|
|
|
|
|
|
5.96E-2 |
|
|
|
09113 |
X |
|
O |
GLUCOPHAGE 850 mg |
tbl flm 100x850 mg |
LIP |
FR |
42.5 |
5.0599999999999996 |
2.5299999999999998 |
S |
2.5299999999999998 |
0.5 |
0 |
|
|
|
|
|
59755 |
X |
|
G |
Normaglyc 850 mg filmom obalené tablety |
tbl flm 90x850 mg |
PRW |
CZ |
38.299999999999997 |
5.09 |
2.2799999999999998 |
S |
2.81 |
0.55206299999999997 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 850 mg (120 ks) |
2 |
g |
|
|
|
|
|
|
|
|
5.96E-2 |
|
|
|
76294 |
X |
|
G |
Metformín Bluefish 850 mg |
tbl flm 120x850 mg (blis. PVC/PVDC/Al) |
BLR |
SE |
51 |
3.04 |
3.04 |
I |
0 |
0 |
0 |
|
|
|
|
|
85937 |
X |
|
G |
Metformin Mylan 850 mg filmom obalené tablety |
tbl flm 120 x 850 mg(blis. PVC/Al) |
GNS |
UK |
51 |
3.83 |
3.04 |
S |
0.79 |
0.206266 |
0 |
|
|
|
|
|
34294 |
X |
|
G |
STADAMET 850 |
tbl flm 120x850 mg |
STD |
DE |
51 |
3.99 |
3.04 |
S |
0.95 |
0.238095 |
0 |
|
|
|
|
|
32784 |
X |
|
G |
METFOGAMMA 850 |
tbl obd 120x850 MG |
WGP |
DE |
51 |
4.04 |
3.04 |
S |
1 |
0.24752500000000002 |
0 |
|
|
|
|
|
24519 |
X |
|
G |
SIOFOR 850 |
tbl flm 120x850 mg |
BCE |
DE |
51 |
5.81 |
3.04 |
S |
2.77 |
0.47676400000000002 |
0 |
|
|
|
|
|
46871 |
X |
|
G |
GLUMETSAN 850 mg filmom obalené tablety |
tbl flm 120x850mg |
PMP |
CZ |
51 |
8.99 |
3.04 |
S |
5.95 |
0.66184600000000005 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 1000 mg (60 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
76302 |
X |
|
G |
Metformín Bluefish 1000 mg |
tbl flm 60x1000 mg (blis. PVC/PVDC/Al) |
BLR |
SE |
30 |
2.73 |
2.4 |
S |
0.33 |
0.120879 |
0 |
|
|
|
|
|
95278 |
X |
|
G |
STADAMET |
tbl flm 60x1000 mg |
STD |
DE |
30 |
3.23 |
2.4 |
S |
0.83 |
0.25696600000000003 |
0 |
|
|
|
|
|
90453 |
X |
|
G |
SIOFOR 1000 |
tbl flm 60x1000 mg (blister PVC/Al) |
BCE |
DE |
30 |
3.96 |
2.4 |
S |
1.56 |
0.39393900000000004 |
0 |
|
|
|
|
|
10872 |
X |
|
O |
Glucophage 1000 mg |
tbl flm 60 x 1000 mg |
LIP |
FR |
30 |
5.51 |
2.4 |
S |
3.11 |
0.56442799999999993 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 1000 mg (90 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
59769 |
X |
|
G |
Normaglyc 1000 mg filmom obalené tablety |
tbl flm 90x1000 mg |
PRW |
CZ |
45 |
4.95 |
3.6 |
S |
1.35 |
0.272727 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 1000 mg (120 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
85957 |
X |
|
G |
Metformin Mylan 1000 mg filmom obalené tablety (blis. PVC/Al) |
tbl flm 120x1000 mg |
GNS |
GB |
60 |
4.6500000000000004 |
4.6500000000000004 |
I |
0 |
0 |
0 |
|
|
|
|
|
9244A |
X |
|
G |
Diareg 1000 mg filmom obalené tablety |
tbl flm 120x1000 mg (blis.PVC/AL) |
MRG |
CR |
60 |
4.8 |
4.8 |
I |
0 |
0 |
0 |
|
|
|
|
|
47009 |
X |
|
G |
Metfogamma 1000 |
tbl flm 120x1000 mg |
WGP |
DE |
60 |
5.59 |
4.8 |
S |
0.79 |
0.14132400000000001 |
0 |
|
|
|
|
|
76307 |
X |
|
G |
Metformín Bluefish 1000 mg |
tbl flm 120x1000 mg (blis. PVC/PVDC/Al) |
BLR |
SE |
60 |
5.86 |
4.8 |
S |
1.06 |
0.18088699999999999 |
0 |
|
|
|
|
|
95281 |
X |
|
G |
STADAMET |
tbl flm 120x1000 mg |
STD |
DE |
60 |
6.46 |
4.8 |
S |
1.66 |
0.25696600000000003 |
0 |
|
|
|
|
|
90455 |
X |
|
G |
SIOFOR 1000 (blister PVC/Al) |
tbl flm 120x1000 mg (blister PVC/Al) |
BCE |
DE |
60 |
7.67 |
4.8 |
S |
2.87 |
0.37418499999999999 |
0 |
|
|
|
|
|
33372 |
X |
|
O |
Glucophage 1000 mg |
tbl flm 120x1000 mg |
MCK |
FR |
60 |
12.14 |
4.8 |
S |
7.34 |
0.60461300000000007 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. predĺžené uvoľňovanie 500 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.11899999999999999 |
|
|
|
42154 |
X |
|
G |
Glucophage XR |
tbl plg 60x500mg |
MES |
FR |
30 |
8.39 |
3.57 |
S |
4.82 |
0.57449300000000003 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. predĺžené uvoľňovanie 750 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.21 |
|
|
|
37586 |
X |
|
G |
Glucophage XR 750mg |
tbl plg 60x750mg |
MES |
FR |
30 |
13.88 |
6.3 |
S |
7.58 |
0.54610999999999998 |
7.58 |
DIA, ENP |
ind.obm. |
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. predĺžené uvoľňovanie 1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.41199999999999998 |
|
|
|
87403 |
X |
|
G |
GLUCOPHAGE XR 1000 mg |
tbl plg 60 x 1000 mg (blis PVC/PVDC/A) |
MES |
FR |
30 |
13.56 |
12.36 |
S |
1.2 |
8.8496000000000005E-2 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10BB01 |
|
|
|
Glibenklamid |
p.o. 5 mg (120 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.6499999999999998E-2 |
|
|
|
91880 |
X |
|
G |
MANINIL 5 |
tbl 120x5 mg |
BCE |
DE |
60 |
2.1800000000000002 |
2.1800000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
A10BB01 |
|
|
|
Glibenklamid |
p.o. mikrokryšt. 3,5 mg (120 ks) |
7 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
18703 |
X |
|
G |
MANINIL 3,5 |
tbl 120x3,5 mg |
BCE |
DE |
60 |
2.64 |
2.64 |
I |
0 |
0 |
0 |
|
|
|
|
|
A10BB07 |
|
|
|
Glipizid |
p.o. 5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13300000000000001 |
|
|
|
88628 |
X |
|
G |
MINIDIAB |
tbl 30x5 mg (blis. PVC/Al) |
PFI-GB-3 |
GB |
15 |
2.57 |
2 |
S |
0.56999999999999995 |
0.22178999999999999 |
0.56999999999999995 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB07 |
|
|
|
Glipizid |
p.o. GITS predĺžené uvoľňovanie 5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.29599999999999999 |
|
|
|
27292 |
X |
|
O |
GLUCOTROL XL 5 mg |
tbl mod 30x5 mg |
PFI-GB-3 |
GB |
15 |
5.57 |
4.4400000000000004 |
S |
1.1299999999999999 |
0.20287299999999997 |
0.56999999999999995 |
DIA, ENP, GER, INT, KLF |
|
|
|
U74 |
A10BB07 |
|
|
|
Glipizid |
p.o. GITS predĺžené uvoľňovanie 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.29599999999999999 |
|
|
|
27293 |
X |
|
O |
GLUCOTROL XL 10 mg |
tbl mod 30x10 mg |
PFI-GB-3 |
GB |
30 |
11.05 |
8.8800000000000008 |
S |
2.17 |
0.19638000000000003 |
2.17 |
DIA, ENP, GER, INT, KLF |
|
|
|
U74 |
A10BB08 |
|
|
|
Gliquidon |
p.o. 30 mg (30 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.18260000000000001 |
|
|
|
99336 |
X |
|
G |
GLURENORM |
tbl 30x30 mg |
ZNT |
SK |
15 |
3.9 |
2.74 |
S |
1.1599999999999999 |
0.29743600000000003 |
1.1599999999999999 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB09 |
|
|
|
Gliklazid |
p.o. predĺžené uvoľňovanie 30 mg (120ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.1517 |
|
|
|
78487 |
X |
|
G |
Gliclazid Mylan 30 mg |
tbl mod 120x30 mg |
GNC |
GB |
60 |
7.61 |
7.61 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
47664 |
X |
|
G |
Gliclada 30 mg |
tbl mod 120x30 mg (blis.) |
KRK |
SI |
60 |
7.71 |
7.71 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
23399 |
X |
|
G |
Gliclazide GAMMA 30 mg MR |
tbl mod 120x30 mg |
WGP |
DE |
60 |
10.19 |
9.1 |
S |
1.0900000000000001 |
0.10696799999999999 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB09 |
|
|
|
Gliklazid |
p.o. predĺžené uvoľňovanie 30 mg (180 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.1517 |
|
|
|
47665 |
X |
|
G |
Gliclada 30 mg |
tbl mod 180x30 mg |
KRK |
SI |
90 |
13.67 |
13.65 |
S |
0.02 |
1.4630000000000001E-3 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB09 |
|
|
|
Gliklazid |
p.o. predĺžené uvoľňovanie 60 mg (60 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.108 |
|
|
|
4846A |
X |
|
G |
Gliclada 60 mg |
tbl mod 60x60 mg (blis.PVC/PVDC/Al) |
KRK |
SL |
60 |
8.18 |
6.48 |
S |
1.7 |
0.20782399999999998 |
1.43 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB09 |
|
|
|
Gliklazid |
p.o. predĺžené uvoľňovanie 60 mg (90 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.108 |
|
|
|
4848A |
X |
|
G |
Gliclada 60 mg |
tbl mod 90x60 mg (blis.PVC/PVDC/Al) |
KRK |
SL |
90 |
12.19 |
9.7200000000000006 |
S |
2.4700000000000002 |
0.202625 |
2.14 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB09 |
|
|
|
Gliklazid |
p.o. predĺžené uvoľňovanie MR 60 mg (60 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.108 |
|
|
|
2362B |
X |
|
G |
Gliclazide MR Stada |
tbl mod 60x60 mg (blis.PVC/Al) |
STD |
DE |
60 |
8.18 |
6.48 |
S |
1.7 |
0.20782399999999998 |
1.43 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
82645 |
X |
|
O |
DIAPREL MR 60 mg |
tbl mod 60x60 mg |
SVE |
FR |
60 |
11.12 |
6.48 |
S |
4.6399999999999997 |
0.41726599999999997 |
1.43 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB09 |
|
|
|
Gliklazid |
p.o. predĺžené uvoľňovanie MR 60 mg (120 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.108 |
|
|
|
2364B |
X |
|
G |
Gliclazide MR Stada |
tbl mod 120x60 mg (blis.PVC/Al) |
STD |
DE |
120 |
15.82 |
12.96 |
S |
2.86 |
0.18078399999999997 |
2.86 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
82651 |
X |
|
O |
DIAPREL MR 60 mg |
tbl mod 120x 60 mg (blis.priehľ.PVC/Al) |
SVE-2 |
FR |
120 |
21.32 |
12.96 |
S |
8.36 |
0.39212000000000002 |
2.86 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 1 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
92856 |
X |
|
G |
Glimepirid Sandoz 1 mg |
tbl 30x1 mg |
SAN |
AT |
15 |
0.99 |
0.99 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35083 |
X |
|
G |
Glibezid 1 |
tbl 30x1 mg |
PRW |
CZ |
15 |
1.5 |
1.5 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 1 mg (120 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
35088 |
X |
|
G |
Glibezid 1 |
tbl 120x1 mg |
PRW |
CZ |
60 |
3.96 |
3.96 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 2 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
6.9000000000000006E-2 |
|
|
|
92869 |
X |
|
G |
Glimepirid Sandoz 2 mg |
tbl 30x2 mg |
SAN |
AT |
30 |
1.92 |
1.92 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
26874 |
X |
|
O |
AMARYL 2,0 |
tbl 30x2 mg |
HBS |
SK |
30 |
2.09 |
2.0699999999999998 |
S |
0.02 |
9.5689999999999994E-3 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35057 |
X |
|
G |
Melyd 2 mg tablety |
tbl 30x2 mg |
STD |
DE |
30 |
2.1800000000000002 |
2.0699999999999998 |
S |
0.11 |
5.0458999999999997E-2 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
93289 |
X |
|
G |
Oltar 2 mg |
tbl 30x2 mg |
BCE |
DE |
30 |
2.81 |
2.0699999999999998 |
S |
0.74 |
0.263345 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35092 |
X |
|
G |
Glibezid 2 |
tbl 30x2 mg |
PRW |
CZ |
30 |
2.83 |
2.0699999999999998 |
S |
0.76 |
0.26855099999999998 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 2 mg (60 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
6.9000000000000006E-2 |
|
|
|
35059 |
X |
|
G |
Melyd 2 mg tablety |
tbl 60x2 mg |
STD |
DE |
60 |
4.1399999999999997 |
4.1399999999999997 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 2 mg (120 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
6.9000000000000006E-2 |
|
|
|
35097 |
X |
|
G |
Glibezid 2 |
tbl 120x2 mg |
PRW |
CZ |
120 |
8.69 |
8.2799999999999994 |
S |
0.41 |
4.7181000000000001E-2 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35061 |
X |
|
G |
Melyd 2 mg tablety |
tbl 120x2 mg (blister PVC/Al) |
STD |
DE |
120 |
9.17 |
8.2799999999999994 |
S |
0.89 |
9.7056000000000003E-2 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 3 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
92887 |
X |
|
G |
Glimepirid Sandoz 3 mg |
tbl 30x3 mg |
SAN |
AT |
45 |
3.04 |
3.04 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35064 |
X |
|
G |
Melyd 3 mg tablety |
tbl 30x3 mg |
STD |
DE |
45 |
3.22 |
3.15 |
S |
7.0000000000000007E-2 |
2.1739000000000001E-2 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
26875 |
X |
|
O |
AMARYL 3,0 |
tbl 30x3 mg |
HBS |
SK |
45 |
3.74 |
3.15 |
S |
0.59 |
0.15775400000000001 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35106 |
X |
|
G |
Glibezid 3 |
tbl 30x3 mg |
PRW |
CZ |
45 |
4.1399999999999997 |
3.15 |
S |
0.99 |
0.23913000000000001 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
93259 |
X |
|
G |
Oltar 3 mg |
tbl 30x3 mg |
BCE |
DE |
45 |
4.41 |
3.15 |
S |
1.26 |
0.28571400000000002 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 3 mg (60 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
35066 |
X |
|
G |
Melyd 3 mg tablety |
tbl 60x3 mg |
STD |
DE |
90 |
9.06 |
6.3 |
S |
2.76 |
0.30463600000000002 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 3 mg (120 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
35111 |
X |
|
G |
Glibezid 3 |
tbl 120x3 mg |
PRW |
CZ |
180 |
14.36 |
12.6 |
S |
1.76 |
0.12256299999999999 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35068 |
X |
|
G |
Melyd 3 mg tablety |
tbl 120x3 mg (blister PVC/Al) |
STD |
DE |
180 |
14.6 |
12.6 |
S |
2 |
0.136986 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 4 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.5E-2 |
|
|
|
92900 |
X |
|
G |
Glimepirid Sandoz 4 mg |
tbl 30x4 mg |
SAN |
AT |
60 |
3.36 |
3.3 |
S |
0.06 |
1.7857000000000001E-2 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
26878 |
X |
|
O |
AMARYL 4,0 |
tbl 30x4 mg |
HBS |
SK |
60 |
3.82 |
3.3 |
S |
0.52 |
0.136126 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35071 |
X |
|
G |
Melyd 4 mg tablety |
tbl 30x4 mg |
STD |
DE |
60 |
4.12 |
3.3 |
S |
0.82 |
0.19902899999999998 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
36609 |
X |
|
G |
Oltar 4 mg |
tbl 30x4 mg |
MNR |
LU |
60 |
4.91 |
3.3 |
S |
1.61 |
0.32790199999999997 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
36648 |
X |
|
G |
Glibezid 4 |
tbl 30x4 mg (blis.) |
PRW |
CZ |
60 |
5.41 |
3.3 |
S |
2.11 |
0.39001800000000003 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 4 mg (60 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.5E-2 |
|
|
|
35073 |
X |
|
G |
Melyd 4 mg tablety |
tbl 60x4 mg |
STD |
DE |
120 |
7.73 |
6.6 |
S |
1.1299999999999999 |
0.14618399999999998 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 4 mg (120 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.5E-2 |
|
|
|
36653 |
X |
|
G |
Glibezid 4 |
tbl 120x4 mg (blis.) |
PRW |
CZ |
240 |
12.54 |
12.54 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35075 |
X |
|
G |
Melyd 4 mg tablety |
tbl 120x4 mg (blister PVC/Al) |
STD |
DE |
240 |
12.54 |
12.54 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 6 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
0.12 |
|
|
|
36628 |
X |
|
G |
Oltar 6 mg |
tbl 30 x 6 mg |
MNR |
LU |
90 |
10.79 |
10.79 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
95532 |
X |
|
G |
GLEMID 6 mg |
tbl 30 x 6 mg |
EGI |
HU |
90 |
11.65 |
10.8 |
S |
0.85 |
7.2960999999999998E-2 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 6 mg (120 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
0.12 |
|
|
|
36672 |
X |
|
G |
Glibezid 6 |
tbl 120x6 mg (bli.AI/PVC/PVDc) |
PRW |
CZ |
360 |
42.7 |
42.7 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BD02 |
|
|
|
Metformín, glibenklamid |
p.o. kombinácie 400 mg/2,5 mg (100 ks) |
4 |
DF |
|
|
|
|
|
|
|
|
9.6699999999999994E-2 |
|
|
|
28652 |
|
|
O |
GLIBOMET |
tbl flm 100 |
GUI |
IT |
25 |
10.01 |
2.42 |
S |
7.59 |
0.75824200000000008 |
7.59 |
|
|
|
|
|
A10BD02 |
|
|
|
Metformín, glibenklamid |
p.o. kombinácie 500 mg/2,5 mg (60 ks) |
3 |
DF |
|
|
|
|
|
|
|
|
8.3900000000000002E-2 |
|
|
|
33776 |
|
|
O |
GLUCOVANCE 500 mg/2,5 mg |
tbl flm 60 |
LIP |
FR |
20 |
7.51 |
1.68 |
S |
5.83 |
0.77629800000000004 |
5.83 |
|
|
|
|
|
A10BD02 |
|
|
|
Metformín, glibenklamid |
p.o. kombinácie 500 mg/5 mg (60 ks) |
3 |
DF |
|
|
|
|
|
|
|
|
0.111 |
|
|
|
33779 |
|
|
O |
GLUCOVANCE 500 mg/5 mg |
tbl flm 60 |
LIP |
FR |
20 |
7.58 |
2.2200000000000002 |
S |
5.36 |
0.70712399999999997 |
5.36 |
|
|
|
|
|
A10BD05 |
|
|
|
Metformín a pioglitazón |
p.o. 15 mg/850 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.81299999999999994 |
|
|
|
36490 |
|
|
O |
Competact |
tbl flm 56 x 15 mg /850mg |
TAK |
GB |
28 |
24.65 |
22.76 |
S |
1.89 |
7.6673000000000005E-2 |
1.89 |
DIA |
ind.obm. |
|
|
|
A10BD07 |
|
|
|
Sitagliptín a metformín |
p.o. 50 mg/850 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.4607000000000001 |
|
|
|
52208 |
|
|
O |
JANUMET |
tbl flm 56 x 50 mg/850 mg |
MSD |
GB |
28 |
43.65 |
40.9 |
S |
2.75 |
6.3001000000000001E-2 |
1.1200000000000001 |
DIA |
ind.obm. |
|
|
|
A10BD07 |
|
|
|
Sitagliptín a metformín |
p.o. 50 mg/850 mg (168-196 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.4607000000000001 |
|
|
|
76788 |
|
|
O |
JANUMET |
tbl flm 196 x 50 mg/850 mg |
MSD |
GB |
98 |
147.07 |
143.15 |
S |
3.92 |
2.6654000000000001E-2 |
3.92 |
DIA |
ind.obm. |
|
|
|
A10BD07 |
|
|
|
Sitagliptín a metformín |
p.o. 50 mg/1000 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.5049999999999999 |
|
|
|
52215 |
|
|
O |
JANUMET |
tbl flm 56 x 50 mg/1000 mg |
MSD |
GB |
28 |
39.950000000000003 |
39.950000000000003 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD07 |
|
|
|
Sitagliptín a metformín |
p.o. 50 mg/1000 mg (168-196 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.5049999999999999 |
|
|
|
76789 |
|
|
O |
JANUMET |
tbl flm 196 x 50 mg/1000 mg |
MSD |
GB |
98 |
146.85 |
146.85 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD08 |
|
|
|
Vildagliptín a metformín |
p.o. 50 mg/850 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.4357 |
|
|
|
5885A |
|
|
O |
Eucreas 50mg/850mg |
tbl flm 60x50mg/850mg (blis.PCTFE/PVC/AI) |
NEH |
GB |
30 |
45.58 |
43.07 |
S |
2.5099999999999998 |
5.5067999999999999E-2 |
1.27 |
DIA |
ind.obm. |
|
|
|
A10BD08 |
|
|
|
Vildagliptín a metformín |
p.o. 50 mg/850 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.4357 |
|
|
|
5896A |
|
|
O |
Eucreas 50mg/850mg |
tbl flm 180(3x60)x50mg/850mg (blis.PCTF/PVC/AI) |
NEH |
GB |
90 |
133.02000000000001 |
129.21 |
S |
3.81 |
2.8641999999999997E-2 |
3.81 |
DIA |
ind.obm. |
|
|
|
A10BD08 |
|
|
|
Vildagliptín a metformín |
p.o. 50 mg/1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.48 |
|
|
|
5891A |
|
|
O |
Eucreas 50mg/1000mg |
tbl flm 60x50mg/1000mg (blis.PCTFE/PVC/AI) |
NEH |
GB |
30 |
43.23 |
43.23 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD08 |
|
|
|
Vildagliptín a metformín |
p.o. 50 mg/1000 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.48 |
|
|
|
6116A |
|
|
O |
Eucreas 50mg/1000mg |
tbl flm 180(3x60)x50mg/1000mg (blis.PCTF/PVC/AI) |
NEH |
GB |
90 |
135.69999999999999 |
133.19999999999999 |
S |
2.5 |
1.8423000000000002E-2 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD09 |
|
|
|
Pioglitazón a alogliptín |
p.o. 25 mg/30 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.325 |
|
|
|
7317A |
|
|
O |
Incresync 25 mg/30 mg filmom obalené tablety |
tbl flm 28x25 mg/30 mg (blis.NYL/Al/PVC) |
TAA |
DK |
28 |
37.090000000000003 |
37.090000000000003 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD10 |
|
|
|
Saxagliptín a metformín |
p.o. 2,5 mg/850 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.4 |
|
|
|
30893 |
|
|
O |
Komboglyze 2,5 mg/850 mg filmom obalené tablety |
tbl flm 60x2,5 mg/850 mg (blis.Al/Al) |
BMS-GB-3 |
GB |
30 |
43.38 |
42 |
S |
1.38 |
3.1812E-2 |
1.38 |
DIA |
ind.obm. |
|
|
|
A10BD10 |
|
|
|
Saxagliptín a metformín |
p.o. 2,5 mg/850 mg (196 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.4 |
|
|
|
30895 |
|
|
O |
Komboglyze 2,5 mg/850 mg filmom obalené tablety |
tbl flm 196x2,5 mg/850 mg (blis.Al/Al) |
BMS-GB-3 |
GB |
98 |
142.41999999999999 |
137.19999999999999 |
S |
5.22 |
3.6651999999999997E-2 |
4.51 |
DIA |
ind.obm. |
|
|
|
A10BD10 |
|
|
|
Saxagliptín a metformín |
p.o. 2,5 mg/1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.444 |
|
|
|
30899 |
|
|
O |
Komboglyze 2,5 mg/1000 mg filmom obalené tablety |
tbl flm 60x2,5 mg/1000 mg (blis.Al/Al) |
BMS-GB-3 |
GB |
30 |
43.23 |
43.23 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD10 |
|
|
|
Saxagliptín a metformín |
p.o. 2,5 mg/1000 mg (196 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.444 |
|
|
|
30902 |
|
|
O |
Komboglyze 2,5 mg/1000 mg filmom obalené tablety |
tbl flm 196x2,5 mg/1000 mg (blis.Al/Al) |
BMS-GB-3 |
GB |
98 |
142.41999999999999 |
141.51 |
S |
0.91 |
6.3899999999999998E-3 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD11 |
|
|
|
Linagliptín a metformín |
p.o. 2,5 mg/850 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.476 |
|
|
|
2270A |
|
|
O |
Jentadueto 2,5mg/850 mg filmom obalené tablety |
tbl flm 60x1x2,5 mg/850 mg (blis.Al/PVC/PCTFE/PVC-perf.) |
BOE |
DE |
30 |
43.36 |
43.36 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD11 |
|
|
|
Linagliptín a metformín |
p.o. 2,5 mg/850 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.476 |
|
|
|
3746A |
|
|
O |
Jentadueto 2,5 mg/850 mg filmom obalené tablety |
tbl flm 180(2x90x1)x2,5 mg/850 mg (blis.Al/PVC/PCTFE/PVC-perf.viacpoč.) |
BOE |
DE |
90 |
131.72 |
131.72 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD11 |
|
|
|
Linagliptín a metformín |
p.o. 2,5 mg/1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
2284A |
|
|
O |
Jentadueto 2,5mg/1000 mg filmom obalené tablety |
tbl flm 60x1x2,5 mg/1000 mg (blis.Al/PVC/PCTFE/PVC-perf.) |
BOE |
DE |
30 |
43.36 |
43.36 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD11 |
|
|
|
Linagliptín a metformín |
p.o. 2,5 mg/1000 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
3749A |
|
|
O |
Jentadueto 2,5 mg/1000 mg filmom obalené tablety |
tbl flm 180(2x90x1)x2,5 mg/1000 mg (blis.Al/PVC/PCTFE/PVC-perf.viacpoč.) |
BOE |
DE |
90 |
131.72 |
131.72 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD13 |
|
|
|
Metformín a alogliptín |
p.o. 12,5 mg/850 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.325 |
|
|
|
7337A |
|
|
O |
Vipdomet 12,5 mg/850 mg filmom obalené tablety |
tbl flm 56x12,5 mg/850 mg (blis.PCTFE/PVC/Al) |
TAA |
DK |
28 |
36.85 |
36.85 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD13 |
|
|
|
Metformín a alogliptín |
p.o. 12,5 mg/1000 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.325 |
|
|
|
7349A |
|
|
O |
Vipdomet 12,5 mg/1000 mg filmom obalené tablety |
tbl flm 56x12,5 mg/1000 mg (blis.PCTFE/PVC/Al) |
TAA |
DK |
28 |
36.85 |
36.85 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD15 |
|
|
|
Metformín a dapagliflozín |
p.o. 5 mg/1000 mg (196 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.675 |
|
|
|
8855A |
|
|
O |
Xigduo 5 mg/1000 mg filmom obalené tablety |
tbl flm 196(2x98)x5 mg/1000 mg (blis.PVC/Aclar/Al) |
AZC |
GB |
98 |
166.19 |
164.15 |
S |
2.04 |
1.2275000000000001E-2 |
2.04 |
DIA |
ind.obm. |
|
|
|
A10BD15 |
|
|
|
Metformín a dapagliflozín |
p.o. 5 mg/1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.675 |
|
|
|
8853A |
|
|
O |
Xigduo 5 mg/1000 mg filmom obalené tablety |
tbl flm 60x5 mg/1000 mg (blis.PVC/Aclar/Al) |
AZC |
GB |
30 |
52.2 |
50.25 |
S |
1.95 |
3.7356E-2 |
0.62 |
DIA |
ind.obm. |
|
|
|
A10BD16 |
|
|
|
Metformín a kanagliflozín |
p.o. 50 mg / 850 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.6910000000000001 |
|
|
|
9956A |
|
|
O |
Vokanamet 50 mg/850 mg filmom obalené tablety |
tbl flm 60x50 mg/850 mg (fľ.HDPE) |
JNS |
BE |
30 |
50.72 |
50.72 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD16 |
|
|
|
Metformín a kanagliflozín |
p.o. 50 mg / 1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.7350000000000001 |
|
|
|
9959A |
|
|
O |
Vokanamet 50 mg/1000 mg filmom obalené tablety |
tbl flm 60x50 mg/1000 mg (fľ.HDPE) |
JNS |
BE |
30 |
52.05 |
52.05 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD16 |
|
|
|
Metformín a kanagliflozín |
p.o. 150 mg / 850 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.8370000000000002 |
|
|
|
9962A |
|
|
O |
Vokanamet 150 mg/850 mg filmom obalené tablety |
tbl flm 60x150 mg/850 mg (fľ.HDPE) |
JNS |
BE |
30 |
85.11 |
85.11 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD16 |
|
|
|
Metformín a kanagliflozín |
p.o. 150 mg / 1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.8370000000000002 |
|
|
|
9965A |
|
|
O |
Vokanamet 150 mg/1000 mg filmom obalené tablety |
tbl flm 60x150 mg/1000 mg (fľ.HDPE) |
JNS |
BE |
30 |
85.11 |
85.11 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BG03 |
|
|
|
Pioglitazón |
p.o. 15 mg (28 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.73199999999999998 |
|
|
|
13410 |
X |
|
O |
ACTOS 15 mg |
tbl 28x15 mg |
LIL |
ES |
14 |
12.5 |
10.25 |
S |
2.25 |
0.18 |
2.25 |
DIA |
ind.obm. |
|
|
|
A10BG03 |
|
|
|
Pioglitazón |
p.o.30 mg (28 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.36499999999999999 |
|
|
|
1072A |
X |
|
G |
Pioglitazone Accord 30 mg tablety |
tbl 28x30 mg (blis.Al/Al) |
ACC |
GB |
28 |
13.26 |
10.220000000000001 |
S |
3.04 |
0.22926100000000002 |
3.04 |
DIA |
ind.obm. |
|
|
|
0162A |
X |
|
G |
Pioglitazone Actavis 30 mg |
tbl 28x30 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
13.26 |
10.220000000000001 |
S |
3.04 |
0.22926100000000002 |
3.04 |
DIA |
ind.obm. |
|
|
|
13414 |
X |
|
O |
ACTOS 30 mg |
tbl 28x30 mg |
LIL |
ES |
28 |
17.59 |
10.220000000000001 |
S |
7.37 |
0.41898800000000003 |
3.04 |
DIA |
ind.obm. |
|
|
|
A10BG03 |
|
|
|
Pioglitazón |
p.o. 45 mg (28 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.35299999999999998 |
|
|
|
1082A |
X |
|
G |
Pioglitazone Accord 45 mg tablety |
tbl 28x45 mg (blis.Al/Al) |
ACC |
GB |
42 |
18.010000000000002 |
14.83 |
S |
3.18 |
0.176569 |
3.18 |
DIA |
ind.obm. |
|
|
|
0171A |
X |
|
G |
Pioglitazone Actavis 45 mg |
tbl 28x45 mg (blis.Al/Al) |
ACT-5 |
IS |
42 |
18.010000000000002 |
14.83 |
S |
3.18 |
0.176569 |
3.18 |
DIA |
ind.obm. |
|
|
|
41014 |
X |
|
O |
ACTOS 45 mg |
tbl 28x45 mg |
TAK |
GB |
42 |
26.14 |
14.83 |
S |
11.31 |
0.43267000000000005 |
3.18 |
DIA |
ind.obm. |
|
|
|
A10BH01 |
|
|
|
Sitagliptín |
p.o. 50 mg (28 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
1.41 |
|
|
|
39022 |
|
|
O |
Januvia 50 mg filmom obalené tablety |
tbl flm 28x50 mg |
MSD |
GB |
14 |
24.08 |
19.739999999999998 |
S |
4.34 |
0.18023299999999998 |
4.34 |
DIA |
ind.obm. |
|
|
|
A10BH01 |
|
|
|
Sitagliptín |
p.o. 100 mg (28 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
1.3480000000000001 |
|
|
|
39028 |
X |
|
O |
JANUVIA |
tbl flm 28 x 100 mg |
MSD |
GB |
28 |
38.86 |
37.74 |
S |
1.1200000000000001 |
2.8820999999999999E-2 |
1.1200000000000001 |
DIA |
ind.obm. |
|
|
|
A10BH01 |
|
|
|
Sitagliptín |
p.o. 100 mg (84-98 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
1.3480000000000001 |
|
|
|
39031 |
X |
|
O |
JANUVIA |
tbl flm 98x100 mg |
MSD |
GB |
98 |
136.02000000000001 |
132.1 |
S |
3.92 |
2.8818999999999997E-2 |
3.92 |
DIA |
ind.obm. |
|
|
|
A10BH02 |
|
|
|
Vildagliptín |
p.o. 50 mg (60 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
1.385 |
|
|
|
45466 |
X |
|
O |
GALVUS 50 mg |
tbl 60 x 50 mg |
NEH |
GB |
30 |
44.86 |
41.55 |
S |
3.31 |
7.3785000000000003E-2 |
0.93 |
DIA |
ind.obm. |
|
|
|
A10BH02 |
|
|
|
Vildagliptín |
p.o. 50 mg (180 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
1.385 |
|
|
|
45469 |
X |
|
O |
GALVUS 50 mg |
tbl 180 x 50 mg |
NEH |
GB |
90 |
127.44 |
124.65 |
S |
2.79 |
2.1892999999999999E-2 |
2.79 |
DIA |
ind.obm. |
|
|
|
A10BH03 |
|
|
|
Saxagliptín |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
1.3129999999999999 |
|
|
|
81106 |
X |
|
O |
Onglyza |
tbl flm 30 x 1 x 5 mg (blister Al/Al,perfor.) |
BMS |
GB |
30 |
41.71 |
39.39 |
S |
2.3199999999999998 |
5.5621999999999998E-2 |
2.3199999999999998 |
DIA |
ind.obm. |
|
|
|
A10BH04 |
|
|
|
Alogliptín |
p.o. 12,5 mg (28 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
1.274 |
|
|
|
7381A |
|
|
O |
Vipidia 12,5 mg filmom obalené tablety |
tbl flm 28x12,5 mg (blis. PCTFE/PVC/Al) |
TAA |
DK |
14 |
18.68 |
17.84 |
S |
0.84 |
4.4968000000000001E-2 |
0.84 |
DIA |
ind.obm. |
|
|
|
A10BH04 |
|
|
|
Alogliptín |
p.o. 25 mg (28 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
1.274 |
|
|
|
7390A |
|
|
O |
Vipidia 25 mg filmom obalené tablety |
tbl flm 28x25 mg (blis. PCTFE/PVC/Al) |
TAA |
DK |
28 |
36.369999999999997 |
35.67 |
S |
0.7 |
1.9247E-2 |
0.7 |
DIA |
ind.obm. |
|
|
|
A10BH05 |
|
|
|
Linagliptín |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
1.413 |
|
|
|
10791 |
|
|
O |
Trajenta 5 mg filmom obalené tablety |
tbl flm 30x5 mg |
BOE |
DE |
30 |
42.99 |
42.39 |
S |
0.6 |
1.3956999999999999E-2 |
0.6 |
DIA |
ind.obm. |
|
|
|
A10BH05 |
|
|
|
Linagliptín |
p.o. 5 mg (90 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
1.413 |
|
|
|
10795 |
|
|
O |
Trajenta 5 mg filmom obalené tablety |
tbl flm 90x5mg (blis Al/Al) |
BOE |
DE |
90 |
129.55000000000001 |
127.17 |
S |
2.38 |
1.8370999999999998E-2 |
1.8 |
DIA |
ind.obm. |
|
|
|
A10BX02 |
|
|
|
Repaglinid |
p.o. 2 mg (90 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
0.34160000000000001 |
|
|
|
59299 |
X |
|
O |
NOVONORM 2 mg |
tbl 90x2 mg |
NOO |
DK |
30 |
11.9 |
10.25 |
S |
1.65 |
0.138655 |
1.65 |
DIA |
ind.obm. |
|
|
|
A10BX04 |
|
|
|
Exenatid |
s.c. predĺžené uvoľňovanie |
1 |
DF |
|
|
|
|
|
|
|
|
2.7549999999999999 |
|
|
|
08664 |
|
|
O |
Bydureon 2 mg prášok a disperz. prostredie na inj. suspenziu s predlž. uvoľňovaním |
plu igf 4x(2 mg práš.+0,65ml disperz. prostr.-jednodávk. súprava) |
LIL |
NL |
28 |
98.9 |
77.14 |
S |
21.76 |
0.22001999999999999 |
21.76 |
DIA |
ind.obm. |
|
|
|
1461B |
|
|
O |
Bydureon 2 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním v naplnenom pere |
plu igf 4x1 (2 mg práš.+0,65 ml disperz.prostr.-pero jednodávk. napl.) |
BMS/AZ |
GB |
28 |
98.9 |
77.14 |
S |
21.76 |
0.22001999999999999 |
21.76 |
DIA |
ind.obm. |
|
|
|
A10BX04 |
|
|
|
Exenatid |
s.c. 5 mcg (1 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.4790000000000001 |
|
|
|
37395 |
|
|
O |
Byetta 5 mikrogramov |
sol inj 1 x 1,2 ml |
LIL |
NL |
30 |
79.14 |
74.37 |
S |
4.7699999999999996 |
6.0273E-2 |
4.7699999999999996 |
DIA |
ind.obm. |
|
|
|
A10BX04 |
|
|
|
Exenatid |
s.c. 10 mcg (1 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.4 |
|
|
|
37397 |
|
|
O |
Byetta 10 mikrogramov |
sol inj 1 x 2,4 ml |
LIL |
NL |
30 |
81.99 |
72 |
S |
9.99 |
0.12184400000000001 |
9.99 |
DIA |
ind.obm. |
|
|
|
A10BX07 |
|
|
|
Liraglutid |
parent. 6 mg/ml (3 ks) |
1.2 |
mg |
|
|
|
|
|
|
|
|
2.9870000000000001 |
|
|
|
78427 |
|
|
O |
Victoza |
sol ira 3x3 ml |
NOO |
DK |
45 |
160.86000000000001 |
134.41999999999999 |
S |
26.44 |
0.16436699999999999 |
26.44 |
DIA |
ind.obm. |
|
|
|
A10BX09 |
|
|
|
Dapagliflozín |
p.o. 10 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.544 |
|
|
|
3303A |
|
|
O |
Forxiga 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.Al/Al-kalend.bal) |
BMS/AZ |
GB |
28 |
43.23 |
43.23 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX09 |
|
|
|
Dapagliflozín |
p.o. 10 mg (98 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.544 |
|
|
|
3304A |
|
|
O |
Forxiga 10 mg filmom obalené tablety |
tbl flm 98x10 mg (blis.Al/Al-kalend.bal) |
BMS/AZ |
GB |
98 |
151.31 |
151.31 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX10 |
|
|
|
Lixisenatid |
s.c. 10 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
2.6 |
|
|
|
4258A |
|
|
O |
Lyxumia 10 mikrogramov injekčný roztok |
sol inj 1x3 ml (napl.pero) |
SOI |
FR |
14 |
43.01 |
36.4 |
S |
6.61 |
0.15368499999999999 |
6.61 |
DIA |
ind.obm. |
|
|
|
A10BX10 |
|
|
|
Lixisenatid |
s.c. 20 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
2.4169999999999998 |
|
|
|
4260A |
|
|
O |
Lyxumia 20 mikrogramov injekčný roztok |
sol inj 2x3 ml (napl.pero) |
SOI |
FR |
28 |
79.84 |
67.680000000000007 |
S |
12.16 |
0.152305 |
12.16 |
DIA |
ind.obm. |
|
|
|
A10BX11 |
|
|
|
Kanagliflozín |
p.o. 100 mg (30 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
1.6120000000000001 |
|
|
|
8114A |
|
|
O |
Invokana 100 mg filmom obalené tablety |
tbl flm 30x1x100 mg (blis.PVC/Al-perf.) |
JNS |
BE |
30 |
49.17 |
48.36 |
S |
0.81 |
1.6473000000000002E-2 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX11 |
|
|
|
Kanagliflozín |
p.o. 100 mg (100 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
1.6120000000000001 |
|
|
|
8116A |
|
|
O |
Invokana 100 mg filmom obalené tablety |
tbl flm 100x1x100 mg (blis.PVC/Al-perf.) |
JNS |
BE |
100 |
161.13 |
161.13 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX12 |
|
|
|
Empagliflozín |
p.o. 10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
0694B |
|
|
O |
Jardiance 10 mg filmom obalené tablety |
tbl flm 30x1x10 mg (blis PVC/Al.-perf.) |
BOE |
DE |
30 |
45.58 |
45.58 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX12 |
|
|
|
Empagliflozín |
p.o. 10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
0697B |
|
|
O |
Jardiance 10 mg filmom obalené tablety |
tbl flm 90x1x10 mg (blis PVC/Al.-perf.) |
BOE |
DE |
90 |
136.74 |
136.74 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX12 |
|
|
|
Empagliflozín |
p.o. 25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
0685B |
|
|
O |
Jardiance 25 mg filmom obalené tablety |
tbl flm 30x1x25 mg (blis PVC/Al.-perf.) |
BOE |
DE |
30 |
45.58 |
45.58 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX12 |
|
|
|
Empagliflozín |
p.o. 25 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
0688B |
|
|
O |
Jardiance 25 mg filmom obalené tablety |
tbl flm 90x1x25 mg (blis PVC/Al.-perf.) |
BOE |
DE |
90 |
136.74 |
136.74 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A11CA01 |
|
|
|
Retinol |
p.o. 30 KU (50 ks) |
50 |
KU |
|
|
|
|
|
|
|
|
6.3100000000000003E-2 |
|
|
|
00347 |
X |
|
G |
VITAMIN A SLOVAKOFARMA |
cps 50x30 KU |
ZNT |
SK |
30 |
2.39 |
1.89 |
S |
0.5 |
0.209205 |
0.5 |
GIT, HEP |
ind.obm. |
|
|
|
A11CA01 |
|
|
|
Retinol |
parent. 50 KU/ml |
50 |
KU |
|
|
|
|
|
|
|
|
0.27400000000000002 |
|
|
|
00396 |
|
|
G |
AXEROPHTHOL BIOTIKA |
sol inj 5x1 ml 50 ku |
BTA |
SK |
5 |
2.33 |
1.37 |
S |
0.96 |
0.41201700000000002 |
0.96 |
GIT, HEP |
ind.obm. |
|
|
|
A11CB |
|
|
|
Vitamíny A a D, kombinácie |
p.o. 25 KU/5 KU (30 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.1095 |
|
|
|
00348 |
|
|
O |
VITAMIN AD SLOVAKOFARMA |
cps 30 |
ZNT |
SK |
15 |
2.7 |
1.64 |
S |
1.06 |
0.39259300000000003 |
1.06 |
GIT, HEP |
ind.obm. |
|
|
|
A11CC01 |
|
|
|
Ergokalciferol |
p.o. vitamín D a jeho analógy 300 KU (1 ks) |
6 |
KU |
|
|
|
|
|
|
|
|
2.9899999999999999E-2 |
|
|
|
00353 |
X |
|
G |
VITAMIN D SLOVAKOFARMA |
cps 1x300 KU |
ZNT |
SK |
50 |
1.37 |
1.37 |
I |
0 |
0 |
0 |
|
|
|
|
|
A11CC01 |
|
|
|
Ergokalciferol |
parent. 7,5 mg/ml (1 ks) |
6 |
KU |
|
|
|
|
|
|
|
|
2.1999999999999999E-2 |
|
|
|
00405 |
|
|
G |
CALCIFEROL BIOTIKA FORTE |
inj 1x1 ml 7,5 mg |
BTA |
SK |
50 |
1.7 |
1.1000000000000001 |
S |
0.6 |
0.352941 |
0.2 |
|
|
|
|
|
A11CC01 |
|
|
|
Ergokalciferol |
parent. 7,5 mg/ml (5 ks) |
6 |
KU |
|
|
|
|
|
|
|
|
2.1999999999999999E-2 |
|
|
|
24814 |
|
|
G |
CALCIFEROL BIOTIKA FORTE |
inj 5x1 ml 7,5 mg |
BTA |
SK |
250 |
6.48 |
5.5 |
S |
0.98 |
0.15123500000000001 |
0.98 |
|
|
|
|
|
A11CC03 |
|
|
|
Alfakalcidol |
p.o. 1 mcg (30 ks) |
1 |
mcg |
|
|
|
|
|
|
|
|
0.33700000000000002 |
|
|
|
10780 |
X |
|
G |
Alfakalcidol SANDOZ 1 µg mäkké kapsuly |
cps mol 30x1 µg (blis. PVC/PVDC/Al) |
SAN |
SI |
30 |
10.19 |
10.11 |
S |
0.08 |
7.8510000000000003E-3 |
0.08 |
|
|
|
|
|
92973 |
X |
|
G |
ALPHA D3 1mcg |
cps mol 30x1mcg |
PHM |
NL |
30 |
10.19 |
10.11 |
S |
0.08 |
7.8510000000000003E-3 |
0.08 |
|
|
|
|
|
A11CC03 |
|
|
|
Alfakalcidol |
p.o. 1 mcg (60 ks) |
1 |
mcg |
|
|
|
|
|
|
|
|
0.33700000000000002 |
|
|
|
10782 |
X |
|
G |
Alfakalcidol SANDOZ 1 µg mäkké kapsuly |
cps mol 60x1 µg (blis. PVC/PVDC/Al) |
SAN |
SI |
60 |
20.399999999999999 |
20.22 |
S |
0.18 |
8.8240000000000002E-3 |
0.16 |
|
|
|
|
|
A11CC03 |
|
|
|
Alfakalcidol |
p.o. 1 mcg (90 ks) |
1 |
mcg |
|
|
|
|
|
|
|
|
0.33700000000000002 |
|
|
|
13846 |
X |
|
O |
ALPHA D3 1 µg |
cps mol 90x1 µg (fľaš.) |
TEV |
SK |
90 |
30.58 |
30.33 |
S |
0.25 |
8.175E-3 |
0.24 |
|
|
|
|
|
A11CC04 |
|
|
|
Kalcitriol |
p.o. 0,25 mcg (30 ks) |
1 |
mcg |
|
|
|
|
|
|
|
|
0.56000000000000005 |
|
|
|
92962 |
X |
|
O |
ROCALTROL 0,25 µg |
cps 30x0,25 mcg (blis.) |
HLR |
CH |
7.5 |
5.78 |
4.2 |
S |
1.58 |
0.27335599999999999 |
1.58 |
END, GER, INT, NEF, PED, REU, ENP, HEP, KLF |
ind.obm. |
|
|
|
A11CC05 |
|
|
|
Cholekalciferol |
p.o. 0,5 mg/ml (10 ml) |
0.5 |
mg |
|
|
|
|
|
|
|
|
0.1593 |
|
|
|
12023 |
X |
|
O |
VIGANTOL OIL |
sol 10 ml 500 ug/ ml |
MEC |
DE |
10 |
1.57 |
1.57 |
I |
0 |
0 |
0 |
|
|
|
|
|
A11DA01 |
|
|
|
Tiamín (vitamín B1) |
parent. 50 mg/ml |
50 |
mg |
|
|
|
|
|
|
|
|
0.16600000000000001 |
|
|
|
00616 |
|
|
O |
THIAMIN LÉČIVA |
sol inj 10x2 ml 100 mg |
ZNT |
CZ |
20 |
4.97 |
3.32 |
S |
1.65 |
0.33199199999999995 |
1.65 |
|
|
|
|
|
A11DB |
|
|
|
Vitamin B1 v kombinácii s vitamínom B6 |
parent. 100 mg/50 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
0.48799999999999999 |
|
|
|
92222 |
|
|
O |
Milgamma NA injekt |
sol inj 10 |
WGP |
DE |
10 |
9.02 |
4.88 |
S |
4.1399999999999997 |
0.45898000000000005 |
4.1399999999999997 |
|
|
|
|
|
A11GA01 |
|
|
|
Kyselina askorbová |
parent. 100 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
0.18260000000000001 |
|
|
|
24836 |
|
|
O |
ACIDUM ASCORBICUM BIOTIKA |
sol inj 5x5 ml/500 mg |
HBS |
SK |
12.5 |
2.5499999999999998 |
2.2799999999999998 |
S |
0.27 |
0.105882 |
0.27 |
NEF |
ind.obm. |
|
|
|
A11HA03 |
|
|
|
Tokoferol (vitamín E) |
parent. 30 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
0.42820000000000003 |
|
|
|
00448 |
|
|
G |
EREVIT 30 |
sol inj 5x1 ml/30 mg |
BTA |
SK |
0.75 |
3.01 |
0.32 |
S |
2.69 |
0.89368799999999993 |
2.69 |
|
|
|
|
|
A11HA03 |
|
|
|
Tokoferol (vitamín E) |
parent. 300 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
5.9700000000000003E-2 |
|
|
|
00449 |
|
|
G |
EREVIT 300 |
sol inj 5x1 ml/300 mg |
BTA |
SK |
7.6 |
3.12 |
0.45 |
S |
2.67 |
0.855769 |
2.67 |
|
|
|
|
|
A12AA03 |
|
|
|
Glukonát vápenatý |
parent. 100 mg/ml |
3 |
g |
|
|
|
|
|
|
|
|
2.65 |
|
|
|
00407 |
|
|
G |
CALCIUM BIOTIKA |
sol inj 10x10 ml/1 g |
HBS |
SK |
3.3330000000000002 |
8.81 |
8.81 |
A |
0 |
0 |
0 |
|
|
|
|
|
A12AA04 |
|
|
|
Uhličitan vápenatý |
p.o. 250 mg (60 ks) |
3 |
g |
|
|
|
|
|
|
|
|
0.1759 |
|
|
|
25955 |
X |
|
G |
VITACALCIN |
tbl 60x250 mg |
ZNT |
SK |
13.879 |
4.4400000000000004 |
2.44 |
S |
2 |
0.45045000000000002 |
2 |
|
|
|
|
|
A12AA04 |
|
|
|
Uhličitan vápenatý |
p.o. 500 mg (20 ks) |
3 |
g |
|
|
|
|
|
|
|
|
0.1759 |
|
|
|
99889 |
X |
|
G |
CALCIUM 500 mg PHARMAVIT |
tbl eff 20x500 mg |
PVI |
HU |
8.3330000000000002 |
2.2999999999999998 |
1.47 |
S |
0.83 |
0.36087000000000002 |
0.83 |
|
|
|
|
|
62322 |
X |
|
G |
MAXI-KALZ 500 |
tbl eff 20x500 mg |
MDM-A |
AT |
8.3330000000000002 |
2.75 |
1.47 |
S |
1.28 |
0.46545499999999995 |
0.83 |
|
|
|
|
|
A12AA04 |
|
|
|
Uhličitan vápenatý |
p.o. 500 mg (50 ks) |
3 |
g |
|
|
|
|
|
|
|
|
0.1759 |
|
|
|
13698 |
X |
|
G |
CALCII CARBONICI 500 MG TBL. GALVEX, Kalciové tablety 500 mg Galvex |
tbl 50x0,5 g |
XGA |
SK |
8.3330000000000002 |
2.34 |
1.47 |
S |
0.87 |
0.37179499999999999 |
0.87 |
|
|
|
|
|
A12AA04 |
|
|
|
Uhličitan vápenatý |
p.o. 1000 mg (10 ks) |
3 |
g |
|
|
|
|
|
|
|
|
0.1759 |
|
|
|
62323 |
X |
|
G |
MAXI-KALZ 1000 |
tbl eff 10x1000 mg |
MDM-A |
AT |
8.3330000000000002 |
2.62 |
1.47 |
S |
1.1499999999999999 |
0.43893099999999996 |
1.1499999999999999 |
|
|
|
|
|
A12AA07 |
|
|
|
Chlorid vápenatý |
parent. 100 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
0.14000000000000001 |
|
|
|
00409 |
|
|
G |
CALCIUM CHLORATUM BIOTIKA |
sol inj 5x10 ml 10% |
HBS |
SK |
25 |
3.2 |
3.2 |
A |
0 |
0 |
0 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s inými iónmi 3 g (30 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
6.9000000000000006E-2 |
|
|
|
24027 |
|
|
O |
BIOMIN H |
plv por 30x3 g |
BMN |
SK |
66.587999999999994 |
5.83 |
4.59 |
S |
1.24 |
0.21269300000000002 |
0.79 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s inými iónmi 3 g (60 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
6.9000000000000006E-2 |
|
|
|
99808 |
|
|
O |
BIOMIN H |
plv por 60x3 g |
BMN |
SK |
133.17599999999999 |
10.77 |
9.19 |
S |
1.58 |
0.146704 |
1.58 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s inými iónmi 3 g (90 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
6.9000000000000006E-2 |
|
|
|
5814A |
|
|
O |
Biomin H |
plv.por 90x3g |
BMN |
SK |
199.76400000000001 |
17.12 |
13.78 |
S |
3.34 |
0.19509299999999999 |
2.37 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s vitamínom D a minerálmi |
2 |
DF |
|
|
|
|
|
|
|
|
0.18099999999999999 |
|
|
|
34205 |
|
|
O |
CALTRATE PLUS |
tbl flm 30 (fľaša HDPE) |
PFI-AT |
AT |
15 |
5.13 |
2.72 |
S |
2.41 |
0.46978599999999998 |
2.41 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s vitamínom D3 500 mg/400 IU (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.152 |
|
|
|
3101A |
|
|
O |
Calcichew-D3 Citron 500 mg/400 IU |
tbl mnd 60x500 mg/10 µg (obal HDPE) |
NCR |
SK |
30 |
9.26 |
4.5599999999999996 |
S |
4.7 |
0.50755899999999998 |
4.7 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s vitamínom D3 500 mg/400 IU (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.152 |
|
|
|
3106A |
|
|
O |
Calcichew-D3 Citron 500 mg/400 IU |
tbl mnd 180x500 mg/10 µg (obal HDPE) |
NCR |
SK |
90 |
22.42 |
13.68 |
S |
8.74 |
0.38983099999999998 |
8.74 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s vitamínom D3 600 mg/400 IU (90 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.18099999999999999 |
|
|
|
78784 |
|
|
O |
Caltrate 600 mg/400 IU D3 filmom obalená tableta |
tbl flm 90x600 mg/400 IU (fľ. PE) |
PFI-AT |
AT |
45 |
12.8 |
8.15 |
S |
4.6500000000000004 |
0.36328099999999997 |
4.6500000000000004 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s vitamínom D3 500 mg/800 IU (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.126 |
|
|
|
1828A |
|
|
O |
Kombi-Kalz 500 mg/800 IU filmom obalené tablety |
tbl flm 30x500 mg/800 IU (obal HDPE) |
MPH |
SK |
30 |
7.06 |
3.78 |
S |
3.28 |
0.46458899999999997 |
1.67 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s vitamínom D3 500 mg/800 IU (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.126 |
|
|
|
1832A |
|
|
O |
Kombi-Kalz 500 mg/800 IU filmom obalené tablety |
tbl flm 90x500 mg/800 IU (obal HDPE) |
MPH |
SK |
90 |
16.34 |
11.34 |
S |
5 |
0.30599799999999999 |
5 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. komb. s vitamínom D3 1000 mg/800 IU (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.124 |
|
|
|
3118A |
|
|
O |
Calcichew-D3 Citron 1 000 mg/800 IU |
tbl mnd 30x1g/20 µg (obal HDPE) |
NCR |
SK |
30 |
9.26 |
3.72 |
S |
5.54 |
0.59827200000000003 |
5.54 |
|
|
|
|
|
A12AX |
|
|
|
Vápnik, kombinácie s inými liečivami |
p.o. ostatné kombinácie 1000 mg/880 |
1 |
DF |
|
|
|
|
|
|
|
|
0.184 |
|
|
|
13189 |
|
|
G |
KOMBI-KALZ 1000/880 |
gra eff 30x8 g |
MDM-A |
AT |
30 |
7.85 |
5.52 |
S |
2.33 |
0.296815 |
2.33 |
|
|
|
|
|
A12BA |
|
|
|
Draslík, horčík |
p.o. 175 mg (100 tbl) |
1 |
g |
|
|
|
|
|
|
|
|
1.1817 |
|
|
|
88356 |
X |
|
G |
CARDILAN |
tbl 100x175 mg |
ZNT |
SK |
3.798 |
4.46 |
4.46 |
I |
0 |
0 |
0 |
|
|
|
|
|
A12BA |
|
|
|
Draslík, horčík |
parent. |
3 |
DF |
|
|
|
|
|
|
|
|
1.8062 |
|
|
|
02132 |
|
|
G |
CARDILAN |
sol inj 10x10 ml |
HBS |
SK |
3.3330000000000002 |
6.02 |
6.02 |
A |
0 |
0 |
0 |
|
|
|
|
|
A12BA01 |
|
|
|
Chlorid draselný |
p.o. 500 mg (100 ks) |
3 |
g |
|
|
|
|
|
|
|
|
0.10290000000000001 |
|
|
|
25553 |
X |
|
G |
KALIUM CHLORATUM BIOMEDICA |
tbl obd 100x500 mg (blis.) |
BCS |
CZ |
16.655000000000001 |
2.15 |
1.71 |
S |
0.44 |
0.204651 |
0.44 |
|
|
|
|
|
A12BA01 |
|
|
|
Chlorid draselný |
p.o. predĺžené uvoľňovanie 600 mg (50 ks) |
3 |
g |
|
|
|
|
|
|
|
|
0.15049999999999999 |
|
|
|
14714 |
X |
|
G |
KALDYUM |
cps plg 50x600 mg |
EGI |
HU |
10 |
3.25 |
1.51 |
S |
1.74 |
0.535385 |
1.74 |
|
|
|
|
|
A12CC02 |
|
|
|
Síran horečnatý |
parent. 10 % |
1 |
g |
|
|
|
|
|
|
|
|
0.87 |
|
|
|
00498 |
|
|
G |
MAGNESIUM SULFURICUM BIOTIKA |
sol inj 5x10 ml 10% |
HBS |
SK |
5 |
4.3499999999999996 |
4.3499999999999996 |
A |
0 |
0 |
0 |
|
|
|
|
|
A12CC02 |
|
|
|
Síran horečnatý |
parent. 20 % |
1 |
g |
|
|
|
|
|
|
|
|
0.45200000000000001 |
|
|
|
00499 |
|
|
G |
MAGNESIUM SULFURICUM BIOTIKA |
sol inj 5x10 ml 20% |
HBS |
SK |
10 |
4.5199999999999996 |
4.5199999999999996 |
A |
0 |
0 |
0 |
|
|
|
|
|
A12CC06 |
|
|
|
Mliečnan horečnatý |
p.o. 500 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
5.6399999999999999E-2 |
|
|
|
13700 |
X |
|
G |
MAGNESII LACTICI 500 MG TBL. GALVEX, Magnéziové tablety 500 mg Galvex |
tbl 50x500 mg |
XGA |
SK |
25 |
2.86 |
1.41 |
S |
1.45 |
0.50699300000000003 |
1.45 |
|
|
|
|
|
A12CC30 |
|
|
|
Horčík (rôzne soli v kombinácii) |
p.o. 365 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
4.1000000000000002E-2 |
|
|
|
66555 |
|
|
O |
Magnosolv |
gra eff 30x6,1 g (vre.papier/Al/PE) |
MDM |
AT |
30 |
6.28 |
1.23 |
S |
5.05 |
0.80413999999999997 |
5.05 |
|
|
|
|
|
A16AA01 |
|
|
|
Levokarnitín |
parent. 200 mg/ml |
2 |
g |
|
|
|
|
|
|
|
|
11.4 |
|
|
|
75602 |
|
|
O |
L-CARNITIN 'Fresenius' 1 g |
sol inj 5x5 ml/1 g |
FRK |
AT |
2.5 |
28.5 |
28.5 |
A |
0 |
0 |
0 |
GER, INT, KLF, NEF, PED |
|
|
|
|
A16AB02 |
|
|
|
Imigluceráza |
parent. 40 IU/ml |
300 |
IU |
|
|
|
|
|
|
|
|
1111.42 |
|
|
|
40761 |
|
|
O |
CEREZYME |
plv ifo 1x400 UT (40 IU/ ml) (skl. liekov.) |
GZE |
NL |
1.333 |
1481.52 |
1481.52 |
A |
0 |
0 |
0 |
PED |
ind.obm., ZP |
|
|
|
A16AB03 |
|
|
|
Agalzidáza alfa |
parent. 1mg/ml |
1 |
mg |
|
|
|
|
|
|
|
|
538.572 |
|
|
|
41875 |
|
|
O |
REPLAGAL |
con inf 10x3,5 ml (1 mg/ ml) |
SHH |
IE |
35 |
19285.740000000002 |
18850.02 |
AS |
435.72 |
2.2593000000000002E-2 |
435.72 |
PED |
ind.obm., ZP |
|
|
|
A16AB04 |
|
|
|
Agalzydáza beta |
parent. 5 mg/ml |
5 |
mg |
|
|
|
|
|
|
|
|
442.66399999999999 |
|
|
|
32646 |
|
|
O |
FABRAZYME 35 mg |
plc ifo 1x35 mg |
GBZ |
GB |
7 |
3098.65 |
3098.65 |
A |
0 |
0 |
0 |
PED |
ind.obm., ZP |
|
|
|
A16AB05 |
|
|
|
Laronidáza |
parent. 100 IU/ml |
100 |
IU |
|
|
|
|
|
|
|
|
123.59 |
|
|
|
40757 |
|
|
O |
ALDURAZYME |
con inf 1x5 ml (100 IU/ ml) (skl. liekov.) |
GZE |
NL |
5 |
617.94000000000005 |
617.94000000000005 |
A |
0 |
0 |
0 |
PED |
ind.obm., ZP |
|
|
|
A16AB07 |
|
|
|
Aglukozidáza |
parent. 50 mg (1ks) |
800 |
mg |
|
|
|
|
|
|
|
|
8427.83 |
|
|
|
98891 |
|
|
O |
Myozyme |
plc ifo 1x50 mg |
GZE |
NL |
0.06 |
505.67 |
505.67 |
A |
0 |
0 |
0 |
|
ind.obm., ZP |
|
|
|
A16AB10 |
|
|
|
Velagluceráza alfa |
parent. 100 IU/ml |
300 |
IU |
|
|
|
|
|
|
|
|
1122.25 |
|
|
|
1300A |
|
|
O |
VPRIV 400 jednotiek prášok na infúzny roztok |
plv ifo 5x400 U (liek.inj.skl.) |
SHP-IE |
IE |
6.6669999999999998 |
10172.299999999999 |
7482.04 |
AS |
2690.26 |
0.26446900000000001 |
2690.26 |
PED |
ind.obm., ZP |
|
|
|
A16AX01 |
|
|
|
Kyselina tioktová |
p.o. 600 mg (30 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.16200000000000001 |
|
|
|
86085 |
X |
|
O |
THIOCTACID 600 HR |
tbl flm 30x600 mg |
MDM |
DE |
90 |
16.09 |
14.58 |
S |
1.51 |
9.3847E-2 |
0.35 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
28169 |
X |
|
G |
THIOGAMMA 600 ORAL |
tbl flm 30x600 mg |
WGP |
DE |
90 |
16.09 |
14.58 |
S |
1.51 |
9.3847E-2 |
0.35 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
A16AX01 |
|
|
|
Kyselina tioktová |
p.o. 600 mg (60 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.16200000000000001 |
|
|
|
86086 |
X |
|
O |
THIOCTACID 600 HR |
tbl flm 60x600 mg |
MDM |
DE |
180 |
29.87 |
29.16 |
S |
0.71 |
2.3769999999999999E-2 |
0.71 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
A16AX01 |
|
|
|
Kyselina tioktová |
p.o. 600 mg (90-100 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.16200000000000001 |
|
|
|
86087 |
X |
|
O |
THIOCTACID 600 HR |
tbl flm 100x600 mg |
MDM |
DE |
300 |
49.83 |
48.6 |
S |
1.23 |
2.4683999999999998E-2 |
1.18 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
0734A |
X |
|
G |
THIOGAMMA 600 ORAL |
tbl flm 90x600 mg (blis.PVC/Al) |
WGP |
DE |
270 |
44.94 |
43.74 |
S |
1.2 |
2.6702E-2 |
1.06 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
A16AX01 |
|
|
|
Kyselina tioktová |
parent. 12 mg/ml (1 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
1.75 |
|
|
|
10889 |
|
|
G |
THIOGAMMA TURBO-SET |
sol inf 1x50 ml/600 mg |
WGP |
DE |
3 |
5.89 |
5.25 |
AS |
0.64 |
0.10865900000000001 |
0 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
A16AX01 |
|
|
|
Kyselina tioktová |
parent. 12 mg/ml (10 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
1.75 |
|
|
|
10890 |
|
|
G |
THIOGAMMA TURBO-SET |
sol inf 10x50 ml/600 mg |
WGP |
DE |
30 |
52.38 |
52.38 |
A |
0 |
0 |
0 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
A16AX01 |
|
|
|
Kyselina tioktová |
parent. 25 mg/ml (5 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
1.82 |
|
|
|
86092 |
|
|
O |
THIOCTACID 600 T |
sol inj 5x24 ml/600 mg |
MDM |
DE |
15 |
26.95 |
26.95 |
A |
0 |
0 |
0 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
A16AX06 |
|
|
|
Miglustat |
p.o. 100 mg (84 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
227.18 |
|
|
|
41411 |
|
|
O |
Zavesca 100 mg tvrdé kapsuly |
cps dur 84x100 mg (blis.Aclar/Al) |
ACB |
GB |
28 |
6360.95 |
6360.95 |
I |
0 |
0 |
0 |
|
ind.obm., ZP |
|
|
|
A16AX07 |
|
|
|
Sapropterin |
p.o. 100 mg (120 ks) |
20 |
mg/kg/deň |
|
|
|
|
|
|
|
|
4.8899999999999997 |
|
|
|
59281 |
|
|
O |
Kuvan |
tbl sol 120 x 100 mg |
MEC |
DE |
600 |
2932.32 |
2932.32 |
I |
0 |
0 |
0 |
|
ind.obm., ZP |
|
|
|
B01AA03 |
|
|
|
Warfarín |
p.o. 2 mg (100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
9.5000000000000001E-2 |
|
|
|
12848 |
|
|
G |
Warfarin PMCS 2 mg |
tbl 100x2 mg (blis.PVC/Al) |
PMP |
CZ |
26.667000000000002 |
2.72 |
2.5299999999999998 |
S |
0.19 |
6.9852999999999998E-2 |
0.19 |
|
|
|
|
U4 |
B01AA03 |
|
|
|
Warfarín |
p.o. 3 mg (100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
9.5000000000000001E-2 |
|
|
|
24079 |
|
|
O |
WARFARIN ORION 3 mg |
tbl 100x3 mg |
ORN |
FI |
40 |
4.07 |
3.8 |
S |
0.27 |
6.6338999999999995E-2 |
0.27 |
|
|
|
|
U4 |
B01AA03 |
|
|
|
Warfarín |
p.o. 5 mg (100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
9.5000000000000001E-2 |
|
|
|
24663 |
|
|
O |
WARFARIN ORION 5 mg |
tbl 100x5 mg |
ORN |
FI |
66.667000000000002 |
5.83 |
5.83 |
I |
0 |
0 |
0 |
|
|
|
|
U4 |
12849 |
|
|
G |
Warfarin PMCS 5 mg |
tbl 100x5 mg (blis.PVC/Al) |
PMP |
CZ |
66.667000000000002 |
6.49 |
6.33 |
S |
0.16 |
2.4653000000000001E-2 |
0 |
|
|
|
|
U4 |
B01AB01 |
|
|
|
Heparín |
parent. 5 KU/ml |
10 |
KU |
|
|
|
|
|
|
|
|
3.5030000000000001 |
|
|
|
93746 |
|
|
O |
HEPARIN LÉČIVA |
sol inj 1x10 ml/50 KU |
ZNT |
CZ |
5 |
17.52 |
17.52 |
A |
0 |
0 |
0 |
|
|
|
|
|
B01AB04 |
|
|
|
Dalteparín |
parent. 12,5 KU/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
14814 |
|
|
O |
FRAGMIN 2500 IU (anti-Xa)/0,2 ml |
sol inj 10x0,2 ml (striek.inj.napl.jednor.) |
PFI-GB-3 |
GB |
8.3330000000000002 |
16.03 |
14.42 |
S |
1.61 |
0.100437 |
1.61 |
|
ind.obm. |
|
|
|
B01AB04 |
|
|
|
Dalteparín |
parent. 25 KU/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
14825 |
|
|
O |
FRAGMIN 7500 IU (anti-Xa)/0,3 ml |
sol inj 10x0,3 ml (striek.inj.napl.jednor.) |
PFI-GB-3 |
GB |
25 |
36.270000000000003 |
36.270000000000003 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
14817 |
|
|
O |
FRAGMIN 5000 IU (anti-Xa)/0,2 ml |
sol inj 10x0,2 ml (striek.inj.napl.jednor.) |
PFI-GB-3 |
GB |
16.667000000000002 |
27.55 |
27.55 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
14835 |
|
|
O |
FRAGMIN 15000 IU (anti-Xa)/0,6 ml |
sol inj 10x0,6 ml (striek.inj.napl.jednor.) |
PFI-GB-3 |
GB |
50 |
93.5 |
86.5 |
S |
7 |
7.4866000000000002E-2 |
0 |
|
ind.obm. |
|
|
|
14838 |
|
|
O |
FRAGMIN 18000 IU (anti-Xa)/0,72 ml |
sol inj 10x0,72 ml (striek.inj.napl.jednor.) |
PFI-GB-3 |
GB |
60 |
112.2 |
103.8 |
S |
8.4 |
7.4866000000000002E-2 |
0 |
|
ind.obm. |
|
|
|
14832 |
|
|
O |
FRAGMIN 12500 IU (anti-Xa)/0,5 ml |
sol inj 10x0,5 ml (striek.inj.napl.jednor.) |
PFI-GB-3 |
GB |
41.667000000000002 |
77.92 |
72.08 |
S |
5.84 |
7.4949000000000002E-2 |
0 |
|
ind.obm. |
|
|
|
14829 |
|
|
O |
FRAGMIN 10000 IU (anti-Xa)/0,4 ml |
sol inj 10x0,4 ml (striek.inj.napl.jednor.) |
PFI-GB-3 |
GB |
33.332999999999998 |
64.67 |
57.67 |
S |
7 |
0.10824199999999999 |
0 |
|
ind.obm. |
|
|
|
B01AB05 |
|
|
|
Enoxaparín |
parent. 100 mg/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
25133 |
|
|
O |
CLEXANE |
sol inj 10x0,8 ml/80 mg |
XAM |
FR |
26.667000000000002 |
46.15 |
46.13 |
S |
0.02 |
4.3300000000000001E-4 |
0.02 |
|
ind.obm. |
|
|
|
25132 |
|
|
O |
CLEXANE |
sol inj 10x0,6 ml/60 mg |
XAM |
FR |
20 |
34.630000000000003 |
34.6 |
S |
0.03 |
8.6600000000000002E-4 |
0.02 |
|
ind.obm. |
|
|
|
25134 |
|
|
O |
CLEXANE |
sol inj 10x1 ml/100 mg |
XAM |
FR |
33.332999999999998 |
58.61 |
57.67 |
S |
0.94 |
1.6038E-2 |
0.02 |
|
ind.obm. |
|
|
|
25131 |
|
|
O |
CLEXANE |
sol inj 10x0,4 ml/40 mg |
XAM |
FR |
13.333 |
26.46 |
23.07 |
S |
3.39 |
0.12811800000000001 |
0.01 |
|
ind.obm. |
|
|
|
25130 |
|
|
O |
CLEXANE |
sol inj 10x0,2 ml/20 mg |
XAM |
FR |
6.6669999999999998 |
14.73 |
11.53 |
S |
3.2 |
0.21724399999999999 |
0.01 |
|
ind.obm. |
|
|
|
B01AB05 |
|
|
|
Enoxaparín |
parent. 150 mg/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
58810 |
|
|
O |
CLEXANE FORTE |
sol inj 10x1,0ml/150 mg |
AVT |
FR |
50 |
83.38 |
83.38 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
58809 |
|
|
O |
CLEXANE FORTE |
sol inj 10x0,8ml/120 mg |
AVT |
FR |
40 |
72.42 |
69.2 |
S |
3.22 |
4.4463000000000003E-2 |
0 |
|
ind.obm. |
|
|
|
B01AB06 |
|
|
|
Nadroparín |
parent. 9,5 KU/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
62402 |
|
|
O |
FRAXIPARINE |
sol inj 10x0,8 ml/7,6 ku |
GLA |
GB |
25.332999999999998 |
37.450000000000003 |
37.450000000000003 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
96986 |
|
|
O |
FRAXIPARINE |
sol inj 10x0,6 ml/5,7 ku |
GLA |
GB |
19 |
29.84 |
29.84 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
97858 |
|
|
O |
FRAXIPARINE |
sol inj 10x0,4 ml/3,8 ku |
GLA |
GB |
12.667 |
20.149999999999999 |
20.149999999999999 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
96970 |
|
|
O |
FRAXIPARINE |
sol inj 10x0,3 ml/2,85 ku |
GLA |
GB |
9.5 |
15.73 |
15.73 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
B01AB06 |
|
|
|
Nadroparín |
parent. 9,5 KU/ml (10 ml) |
3 |
KU |
|
|
|
|
|
|
|
|
1.395 |
|
|
|
96988 |
|
|
O |
FRAXIPARINE |
sol inj 10x1 ml/9,5 ku |
GLA |
GB |
31.667000000000002 |
43.98 |
43.98 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
B01AB06 |
|
|
|
Nadroparín |
parent. 19 KU/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
59810 |
|
|
O |
FRAXIPARINE FORTE (19KU) |
sol inj 10x1,0 ml |
GLA |
GB |
63.332999999999998 |
91.58 |
91.58 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
59806 |
|
|
O |
FRAXIPARINE FORTE (11,4KU) |
sol inj 10x0,6 ml |
GLA |
GB |
38 |
56.56 |
56.56 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
59808 |
|
|
O |
FRAXIPARINE FORTE (15,2KU) |
sol inj 10x0,8 ml |
GLA |
GB |
50.667000000000002 |
80.22 |
80.22 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
B01AB11 |
|
|
|
Sulodexid |
p.o. 250 LSU (50 ks) |
500 |
LSU |
|
|
|
|
|
|
|
|
0.73499999999999999 |
|
|
|
96118 |
|
|
O |
VESSEL DUE F |
cps 50x250 LSU |
ASW |
IT |
25 |
23.3 |
18.38 |
S |
4.92 |
0.21115899999999999 |
4.92 |
ANG, GER, HEM, CHI, INT, KAR, NEU, OPH, CCH, KLF |
ind.obm. |
|
|
|
B01AB12 |
|
|
|
Bemiparín |
parent. 12,5 KU/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
99271 |
|
|
O |
Zibor 2500 IU |
sol inj 10x0,2 ml |
MNR |
ES |
8.3330000000000002 |
22.92 |
14.42 |
S |
8.5 |
0.37085500000000005 |
8.5 |
|
ind.obm. |
|
|
|
B01AB12 |
|
|
|
Bemiparín |
parent. 17,5 KU/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
99289 |
|
|
O |
Zibor 3500 IU |
sol inj 10x0,2 ml |
MNR |
ES |
11.667 |
34.950000000000003 |
20.18 |
S |
14.77 |
0.42260399999999998 |
14.77 |
|
ind.obm. |
|
|
|
B01AC04 |
|
|
|
Klopidogrel |
p.o. 75 mg (14 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
0.128 |
|
|
|
80260 |
X |
|
G |
Clopigamma 75 mg |
tbl flm 14x75 mg (blis.Al/PVC-PE-PVDC) |
WGP |
DE |
14 |
2.12 |
1.79 |
S |
0.33 |
0.15566000000000002 |
0.26 |
|
|
|
|
U6 |
B01AC04 |
|
|
|
Klopidogrel |
p.o. 75 mg (28-30 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
0.128 |
|
|
|
20057 |
X |
|
G |
Clopidogrel Actavis 75 mg |
tbl flm 30x75 mg (blis.Al/Al) |
ACT |
IS |
30 |
4.4000000000000004 |
3.84 |
S |
0.56000000000000005 |
0.127273 |
0.56000000000000005 |
|
|
|
|
U6 |
2575A |
X |
|
G |
Clopidogrel Accord 75 mg filmom obalené tablety |
tbl flm 28x75 mg (blis.Al/Al) |
ACC |
GB |
28 |
4.1100000000000003 |
3.58 |
S |
0.53 |
0.12895400000000001 |
0.52 |
|
|
|
|
U6 |
78899 |
X |
|
G |
Clopidogrel Teva |
tbl flm 28x75 mg (blister Al/Al) |
TEV |
NL |
28 |
4.1100000000000003 |
3.58 |
S |
0.53 |
0.12895400000000001 |
0.52 |
|
|
|
|
U6 |
21481 |
X |
|
G |
Trombex 75 mg filmom obalené tablety |
tbl flm 28x75 mg (blis. PVC/PVDC/Al) |
ZNT |
CZ |
28 |
4.1100000000000003 |
3.58 |
S |
0.53 |
0.12895400000000001 |
0.52 |
|
|
|
|
U6 |
80636 |
X |
|
O |
Zyllt 75 mg |
tbl flm 28x75 mg |
KRK |
SI |
28 |
4.5199999999999996 |
3.58 |
S |
0.94 |
0.20796500000000001 |
0.52 |
|
|
|
|
U6 |
78885 |
X |
|
O |
Grepid |
tbl flm 30x75 mg |
PRS |
GR |
30 |
6.22 |
3.84 |
S |
2.38 |
0.382637 |
0.56000000000000005 |
|
|
|
|
U6 |
B01AC04 |
|
|
|
Klopidogrel |
p.o. 75 mg (84 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
0.128 |
|
|
|
2578A |
X |
|
G |
Clopidogrel Accord 75 mg filmom obalené tablety |
tbl flm 84x75 mg (blis.Al/Al) |
ACC |
GB |
84 |
12.32 |
10.75 |
S |
1.57 |
0.12743499999999999 |
1.57 |
|
|
|
|
U6 |
80727 |
X |
|
G |
Clopidogrel Krka d.d. 75mg filmom obalené tablety |
tbl flm 84x75mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
84 |
12.32 |
10.75 |
S |
1.57 |
0.12743499999999999 |
1.57 |
|
|
|
|
U6 |
78902 |
X |
|
G |
Clopidogrel Teva |
tbl flm 84x1X75 mg (blister Al/Al) |
TEV |
NL |
84 |
12.32 |
10.75 |
S |
1.57 |
0.12743499999999999 |
1.57 |
|
|
|
|
U6 |
22154 |
X |
|
G |
Trombex 75 mg filmom obalené tablety |
tbl flm 84x75 mg (blis. PVC/PVDC/Al) |
ZNT |
CZ |
84 |
12.32 |
10.75 |
S |
1.57 |
0.12743499999999999 |
1.57 |
|
|
|
|
U6 |
80641 |
X |
|
O |
Zyllt 75 mg |
tbl flm 84x75 mg |
KRK |
SI |
84 |
13.33 |
10.75 |
S |
2.58 |
0.193548 |
1.57 |
|
|
|
|
U6 |
80262 |
X |
|
G |
Clopigamma 75 mg |
tbl flm 84x75 mg (blis. Al/PVC-PE-PVDC) |
WGP |
DE |
84 |
13.35 |
10.75 |
S |
2.6 |
0.19475699999999999 |
1.57 |
|
|
|
|
U6 |
76576 |
X |
|
G |
Egitromb 75 mg filmom obalené tablety |
tbl flm 84x75 mg (blis. OPA/AI/PVDC/AI) |
EGI |
HU |
84 |
21 |
10.75 |
S |
10.25 |
0.488095 |
1.57 |
|
|
|
|
U6 |
B01AC04 |
|
|
|
Klopidogrel |
p.o. 75 mg (90-100 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
0.128 |
|
|
|
20061 |
X |
|
G |
Clopidogrel Actavis 75 mg |
tbl flm 90x75 mg (blis Al/Al) |
ACT-5 |
IS |
90 |
13.21 |
11.52 |
S |
1.69 |
0.12793299999999999 |
1.68 |
|
|
|
|
U6 |
78708 |
X |
|
G |
Clopidogrel Mylan |
tbl flm 90x75mg |
MLB |
FR |
90 |
13.21 |
11.52 |
S |
1.69 |
0.12793299999999999 |
1.68 |
|
|
|
|
U6 |
78888 |
X |
|
O |
Grepid |
tbl flm 90 x75 mg |
PRS |
GR |
90 |
15.77 |
11.52 |
S |
4.25 |
0.26949899999999999 |
1.68 |
|
|
|
|
U6 |
B01AC05 |
|
|
|
Ticlopidín |
p.o. 250 mg (30 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.128 |
|
|
|
14624 |
X |
|
G |
TICLOPIDIN-RATIOPHARM 250 MG |
tbl flm 30x250 MG |
MCK |
DE |
15 |
3.95 |
1.92 |
S |
2.0299999999999998 |
0.51392400000000005 |
1.75 |
|
|
|
|
U6 |
B01AC05 |
|
|
|
Ticlopidín |
p.o. 250 mg (60 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.128 |
|
|
|
79359 |
X |
|
G |
Aclotin |
tbl obd 60x250 mg |
PRW |
CZ |
30 |
7.38 |
3.84 |
S |
3.54 |
0.47967500000000002 |
3.49 |
|
|
|
|
U6 |
B01AC05 |
|
|
|
Ticlopidín |
p.o. 250 mg (90 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.128 |
|
|
|
14625 |
X |
|
G |
TICLOPIDIN-RATIOPHARM 250 MG |
tbl flm 90x250 mg |
MCK |
DE |
45 |
11 |
5.76 |
S |
5.24 |
0.47636400000000001 |
5.24 |
|
|
|
|
U6 |
B01AC06 |
|
|
|
Kyselina acetylsalicylová |
p.o. 30 mg (50 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.3199999999999998E-2 |
|
|
|
72812 |
X |
|
G |
ANOPYRIN 30 mg |
tbl 50x30 mg |
ZNT |
SK |
50 |
1.36 |
1.1599999999999999 |
S |
0.2 |
0.147059 |
0.2 |
|
|
|
|
|
B01AC06 |
|
|
|
Kyselina acetylsalicylová |
p.o. 100 mg (20 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
3.6999999999999998E-2 |
|
|
|
12459 |
X |
|
O |
ASPIRIN PROTECT 100 |
tbl ent 20x100 mg |
BBA |
DE |
20 |
1.5 |
0.74 |
S |
0.76 |
0.50666699999999998 |
0.25 |
|
|
|
|
|
B01AC06 |
|
|
|
Kyselina acetylsalicylová |
p.o. 100 mg (28 - 30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
3.6999999999999998E-2 |
|
|
|
23028 |
X |
|
G |
ANOPYRIN 100 mg |
tbl 28x100 mg (blis.PVC/Al) |
ZNT |
SK |
28 |
1.39 |
1.04 |
S |
0.35 |
0.251799 |
0.35 |
|
|
|
|
|
B01AC06 |
|
|
|
Kyselina acetylsalicylová |
p.o. 100 mg (50-60 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
3.6999999999999998E-2 |
|
|
|
23029 |
X |
|
G |
ANOPYRIN 100 mg |
tbl 56x100 mg (blis.PVC/Al) |
ZNT |
SK |
56 |
2.94 |
2.0699999999999998 |
S |
0.87 |
0.29591800000000001 |
0.7 |
|
|
|
|
|
3492A |
X |
|
G |
STADAPYRIN 100 mg |
tbl ent 60x100 mg (blis.PVC/Al) |
STD |
DE |
60 |
3.33 |
2.2200000000000002 |
S |
1.1100000000000001 |
0.33333299999999999 |
0.75 |
|
|
|
|
|
89676 |
X |
|
G |
Preventax 100 mg |
tbl ent 50x100 mg (blis.Al/PVC) |
RAT |
DE |
50 |
3.96 |
1.85 |
S |
2.11 |
0.53282799999999997 |
0.63 |
|
|
|
|
|
12460 |
X |
|
O |
ASPIRIN PROTECT 100 |
tbl ent 50x100 mg |
BBA |
DE |
50 |
4.38 |
1.85 |
S |
2.5299999999999998 |
0.57762599999999997 |
0.63 |
|
|
|
|
|
B01AC06 |
|
|
|
Kyselina acetylsalicylová |
p.o. 100 mg (84-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
3.6999999999999998E-2 |
|
|
|
23030 |
X |
|
G |
ANOPYRIN 100 mg |
tbl 84x100 mg (blis.PVC/Al) |
ZNT |
SK |
84 |
4.17 |
3.11 |
S |
1.06 |
0.25419700000000001 |
1.05 |
|
|
|
|
|
B01AC06 |
|
|
|
Kyselina acetylsalicylová |
p.o. 100 mg (120 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
3.6999999999999998E-2 |
|
|
|
5131A |
X |
|
G |
STADAPYRIN 100 mg |
tbl ent 120x100 mg (blis.PVC/Al) |
STD |
DE |
120 |
6.34 |
4.4400000000000004 |
S |
1.9 |
0.29968499999999998 |
1.5 |
|
|
|
|
|
B01AC10 |
|
|
|
Indobufén |
p.o. 200 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.125 |
|
|
|
91497 |
X |
|
O |
IBUSTRIN 200 mg |
tbl 30x200 mg |
PFI-GB-3 |
GB |
20 |
10.71 |
2.5 |
S |
8.2100000000000009 |
0.76657300000000006 |
8.2100000000000009 |
GER, HEM, INT, KAR, KLF, NEF, NEU |
|
|
|
|
B01AC11 |
|
|
|
Iloprost |
inhal.10 mcg/ml |
30 |
mcg |
|
|
|
|
|
|
|
|
36.871000000000002 |
|
|
|
40892 |
|
|
O |
VENTAVIS |
sol neb 30x2 ml/20 mcg |
BAS |
DE |
20 |
737.41 |
737.41 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
B01AC21 |
|
|
|
Treprostinil |
parent. 1mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
184.61 |
|
|
|
93637 |
|
|
O |
REMODULIN 1 mg/ml |
sol inf 1x20 ml/20 mg |
UNT |
GB |
15 |
2769.13 |
2769.13 |
A |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
B01AC21 |
|
|
|
Treprostinil |
parent. 2,5 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
162.83000000000001 |
|
|
|
93639 |
|
|
O |
REMODULIN 2,5 mg/ml |
sol inf 1x20 ml/50 mg |
UNT |
GB |
37.5 |
6105.94 |
6105.94 |
A |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
B01AC21 |
|
|
|
Treprostinil |
parent. 5 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
145.78 |
|
|
|
93638 |
|
|
O |
REMODULIN 5 mg/ml |
sol inf 1x20 ml/100 mg |
UNT |
GB |
75 |
10933.29 |
10933.29 |
A |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
B01AC22 |
|
|
|
Prasugrel |
p.o. 5 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.1990000000000001 |
|
|
|
66209 |
|
|
O |
Efient 5 mg filmom obalené tablety |
tbl flm 28 x 5 mg |
LIL |
ES |
14 |
44.18 |
16.79 |
S |
27.39 |
0.61996399999999996 |
27.39 |
KAR |
ind.obm. |
|
|
|
B01AC22 |
|
|
|
Prasugrel |
p.o. 10 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.585 |
|
|
|
66216 |
|
|
O |
Efient 10 mg filmom obalené tablety |
tbl flm 28 x 10 mg |
LIL |
ES |
28 |
48.92 |
44.38 |
S |
4.54 |
9.2804999999999999E-2 |
4.54 |
KAR |
ind.obm. |
|
|
|
B01AC23 |
|
|
|
Cilostazol |
p.o. 100 mg (50 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
0792B |
|
|
G |
Cilostazol Stada 100 mg |
tbl 50x100 mg (blis.PVC/PVDC/Al) |
STD |
DE |
25 |
20.54 |
1 |
S |
19.54 |
0.95131500000000002 |
19.54 |
ANG |
ind.obm. |
|
|
|
B01AC24 |
|
|
|
Tikagrelor |
p.o. 90 mg (56 ks) |
180 |
mg |
|
|
|
|
|
|
|
|
2.2930000000000001 |
|
|
|
03776 |
|
|
O |
Brilique 90 mg filmom obalené tablety |
tbl flm 56(4x14)x90 mg (blis. PVC/PVDC/Al) kalend.bal. |
AZC |
SE |
28 |
69.489999999999995 |
64.2 |
S |
5.29 |
7.6125999999999999E-2 |
5.29 |
KAR |
ind.obm. |
|
|
|
B01AC30 |
|
|
|
Kombinácie |
p.o. dipyridamol a kyselina acetylsalicylová |
2 |
DF |
|
|
|
|
|
|
|
|
0.45600000000000002 |
|
|
|
57363 |
|
|
O |
Aggrenox 200/25 mg |
cps mod 30 |
BOE |
DE |
15 |
9.48 |
6.84 |
S |
2.64 |
0.27848099999999998 |
2.64 |
ANG, GER, INT, KAR, NEU, CCH, KLF |
ind.obm. |
|
|
|
B01AD11 |
|
|
|
Tenektepláza |
parent. 5 mg/ml (10 ml) |
10 |
KU |
|
|
|
|
|
|
|
|
811 |
|
|
|
40738 |
|
|
O |
METALYSE 10 KU |
plv iol 1x10 KU (50 mg) (1 liek. + 1 napln. striek. plast. 10 ml) |
BOE |
DE |
1 |
811 |
811 |
A |
0 |
0 |
0 |
ANS, INT, KAR, KLF, URM |
ind.obm. |
|
|
|
B01AE07 |
|
|
|
Dabigatranetexilát |
p.o. 75 mg (30 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
50504 |
X |
|
O |
Pradaxa |
cps dur 30x1x75 mg (blister) |
BOE |
DE |
15 |
38.020000000000003 |
35.700000000000003 |
S |
2.3199999999999998 |
6.1020999999999999E-2 |
2.3199999999999998 |
ORT, UCH |
ind.obm. |
|
|
U5 |
B01AE07 |
|
|
|
Dabigatranetexilát |
p.o. 110 mg (10 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
50507 |
X |
|
O |
Pradaxa |
cps dur 10x1x110 mg (blister) |
BOE |
DE |
5 |
14.23 |
11.9 |
S |
2.33 |
0.163739 |
0 |
ANG, CCH, HEM, INT, KAR, NEU, ORT, UCH |
ind.obm. |
|
|
U5 |
B01AE07 |
|
|
|
Dabigatranetexilát |
p.o. 110 mg (30 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
50508 |
X |
|
O |
Pradaxa |
cps dur 30x1x110 mg (blister) |
BOE |
DE |
15 |
38.020000000000003 |
35.700000000000003 |
S |
2.3199999999999998 |
6.1020999999999999E-2 |
0 |
ANG, CCH, HEM, INT, KAR, NEU, ORT, UCH |
ind.obm. |
|
|
U5 |
B01AE07 |
|
|
|
Dabigatranetexilát |
p.o. 110 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
50509 |
X |
|
O |
Pradaxa 110 mg tvrdé kapsuly |
cps dur 60x1x110 mg (blis.Al/Al) |
BOE |
DE |
30 |
71.81 |
71.400000000000006 |
S |
0.41 |
5.7099999999999998E-3 |
0 |
ANG, CCH, HEM, INT, KAR, NEU, ORT, UCH |
ind.obm. |
|
|
U5 |
B01AE07 |
|
|
|
Dabigatranetexilát |
p.o. 110 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
08300 |
X |
|
O |
Pradaxa 110 mg tvrdé kapsuly |
cps dur 180(3x60x1)x110 mg (blis.Al/Al) |
BOE |
DE |
90 |
213.99 |
213.99 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU, ORT, UCH |
ind.obm. |
|
|
U5 |
B01AE07 |
|
|
|
Dabigatranetexilát |
p.o. 150 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
08297 |
X |
|
O |
Pradaxa 150 mg tvrdé kapsuly |
cps dur 60x1x150 mg (blis.Al/Al) |
BOE |
DE |
30 |
72.72 |
71.400000000000006 |
S |
1.32 |
1.8151999999999998E-2 |
0 |
ANG, CCH, HEM, INT, KAR, NEU |
ind.obm. |
|
|
U5 |
B01AE07 |
|
|
|
Dabigatranetexilát |
p.o. 150 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
08298 |
X |
|
O |
Pradaxa 150 mg tvrdé kapsuly |
cps dur 180(3x60x1)x150 mg (blis.Al/Al) |
BOE |
DE |
90 |
213.99 |
213.99 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU |
ind.obm. |
|
|
U5 |
B01AF02 |
|
|
|
Apixabán |
p.o. 2,5 mg (20 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
08363 |
|
|
O |
ELIQUIS 2,5 mg filmom obalené tablety |
tbl flm 20x2,5 mg (blis.PVC/PVDC/Al) |
BMS-GB-4 |
GB |
10 |
26.5 |
23.8 |
S |
2.7 |
0.10188700000000001 |
0 |
ANG, CCH, HEM, INT, KAR, NEU, ORT, UCH |
ind.obm. |
|
|
U5 |
B01AF02 |
|
|
|
Apixabán |
p.o. 2,5 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
08364 |
|
|
O |
ELIQUIS 2,5 mg filmom obalené tablety |
tbl flm 60x2,5 mg (blis.PVC/PVDC/Al) |
BMS-GB-4 |
GB |
30 |
72.91 |
71.400000000000006 |
S |
1.51 |
2.0710000000000003E-2 |
0 |
ANG, CCH, HEM, INT, KAR, NEU, ORT, UCH |
ind.obm. |
|
|
U5 |
B01AF02 |
|
|
|
Apixabán |
p.o. 2,5 mg (168 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
3808A |
|
|
O |
Eliquis 2,5 mg filmom obalené tablety |
tbl flm 168x2,5 mg (blis.PVC/PVDC/Al) |
BMS-GB-4 |
GB |
84 |
199.75 |
199.75 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU, ORT, UCH |
ind.obm. |
|
|
U5 |
B01AF02 |
|
|
|
Apixabán |
p.o. 5 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
3804A |
|
|
O |
ELIQUIS 5 mg filmom obalené tablety |
tbl flm 60x5 mg (blis.PVC/PVDC/Al) |
BMS-GB-4 |
GB |
30 |
71.290000000000006 |
71.290000000000006 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU |
ind.obm. |
|
|
U5 |
B01AF02 |
|
|
|
Apixabán |
p.o. 5 mg (168 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
3806A |
|
|
O |
Eliquis 5 mg filmom obalené tablety |
tbl flm 168x5 mg (blis.PVC/PVDC/Al) |
BMS-GB-4 |
GB |
84 |
199.75 |
199.75 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU |
ind.obm. |
|
|
U5 |
B01AX05 |
|
|
|
Fondaparín |
parent. 5 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
4.734 |
|
|
|
41091 |
|
|
O |
ARIXTRA |
sol inj 20x0,5 ml/2,5 mg |
GLA |
GB |
20 |
105.21 |
94.68 |
S |
10.53 |
0.10008599999999999 |
10.53 |
ANG, CCH, HEM |
ind.obm. |
|
|
|
B01AX06 |
|
|
|
Rivaroxaban |
p.o. 10 mg (10 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
53541 |
X |
|
O |
Xarelto |
tbl flm 10x10 mg (bli.PP/Al) |
BAS |
DE |
10 |
25.86 |
23.8 |
S |
2.06 |
7.9660000000000009E-2 |
2.06 |
ORT, UCH |
ind.obm. |
|
|
U5 |
B01AX06 |
|
|
|
Rivaroxaban |
p.o. 15 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
30832 |
|
|
O |
Xarelto 15 mg filmom obalené tablety |
tbl flm 28x15 mg (blis.PP/Al) |
BYE |
DE |
28 |
67.75 |
66.64 |
S |
1.1100000000000001 |
1.6383999999999999E-2 |
0 |
ANG, HEM, INT, KAR, NEU, CCH |
ind.obm. |
|
|
U5 |
B01AX06 |
|
|
|
Rivaroxaban |
p.o. 15 mg (42 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
30833 |
|
|
O |
Xarelto 15 mg filmom obalené tablety |
tbl flm 42x15 mg (blis.PP/AI) |
BYE |
DE |
42 |
99.86 |
99.86 |
I |
0 |
0 |
0 |
ANG, HEM, INT, KAR, NEU, CCH |
ind.obm. |
|
|
U5 |
B01AX06 |
|
|
|
Rivaroxaban |
p.o. 20 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
30838 |
|
|
O |
Xarelto 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PP/Al) |
BYE |
DE |
28 |
67.75 |
66.64 |
S |
1.1100000000000001 |
1.6383999999999999E-2 |
1.1100000000000001 |
ANG, HEM, INT, KAR, NEU, CCH |
ind.obm. |
|
|
U5 |
B02AA03 |
|
|
|
Kyselina aminometylbenzoová |
p.o. 250 mg (10 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
0.51400000000000001 |
|
|
|
02123 |
X |
|
G |
PAMBA |
tbl 10x250 mg |
CWO |
DE |
10 |
6.2 |
5.14 |
S |
1.06 |
0.17096800000000001 |
1.06 |
|
|
|
|
|
B02AA03 |
|
|
|
Kyselina aminometylbenzoová |
parent. 10 mg/ml |
0.25 |
g |
|
|
|
|
|
|
|
|
6.63 |
|
|
|
69793 |
|
|
G |
PAMBA |
sol inj 5x5 ml/50 mg |
CWO |
DE |
1 |
6.63 |
6.63 |
I |
0 |
0 |
0 |
|
|
|
|
|
B02BA01 |
|
|
|
Fytomenadión |
p.o. 20 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
0.82799999999999996 |
|
|
|
00720 |
X |
|
G |
KANAVIT |
gte por 5 ml 20 mg/ ml |
ZNT |
SK |
5 |
4.1399999999999997 |
4.1399999999999997 |
I |
0 |
0 |
0 |
|
|
|
|
|
B02BA01 |
|
|
|
Fytomenadión |
parent. 10 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
0.88629999999999998 |
|
|
|
00489 |
|
|
O |
KANAVIT |
sol inj 5x1 ml/10 mg |
HBS |
SK |
2.5 |
2.2200000000000002 |
2.2200000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
B02BC |
|
|
|
Fibrínový lepiaci systém |
loc. |
1 |
ml |
|
|
|
|
|
|
|
|
98.53 |
|
|
|
14209 |
|
|
O |
Beriplast P Combi-Set 3 ml |
plv gtv 1x3 ml (liek.inj.skl.) |
CSL |
DE |
3 |
223.73 |
223.73 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
14208 |
|
|
O |
BERIPLAST P COMBI-SET |
plv gtv 1x1 ml |
CSL |
DE |
1 |
91.28 |
91.28 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD01 |
|
|
|
Koagulačné faktory IX., II.,VII. a X. v kombinácii |
parent. 500 IU |
350 |
UT |
|
|
|
|
|
|
|
|
278.43 |
|
|
|
36360 |
|
|
O |
Octaplex |
plv iol 1x 500 I.U. |
OPU |
AT |
1 |
249.32 |
249.32 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. 250 IU |
500 |
UT |
|
|
|
|
|
|
|
|
211.12 |
|
|
|
58278 |
|
|
O |
OCTANATE 250 IU |
plv iol 1x250 UT+ sol. |
OCP |
AT |
0.5 |
91.31 |
91.31 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. rekomb. 250 IU |
500 |
UT |
|
|
|
|
|
|
|
|
354.69 |
|
|
|
36432 |
|
|
O |
KOGENATE Bayer |
plv iol 1x250 IU (1x skl. liek. – powder +1x skl. naplnená striek. - solv. + 1x adaptér pre liek.) |
BAS |
DE |
0.5 |
177.34 |
177.34 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
13143 |
|
|
O |
ReFacto AF 250 IU, prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x250 IU (liek.skl.)+4 ml solv. |
PFI-GB-1 |
GB |
0.5 |
177.34 |
177.34 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
95649 |
|
|
O |
RECOMBINATE 250 IU |
plv iol 1x250 IU (plv)+ 10 ml (solv.) |
BXI |
BE |
0.5 |
186.8 |
177.35 |
AS |
9.4499999999999993 |
5.0589000000000002E-2 |
0 |
HEM |
ind.obm. |
|
|
|
3428B |
|
|
O |
Nuwiq 250 IU prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x250 IU+1x2,5 ml solv.+adapter inj.liek. |
OCP-S |
SE |
0.5 |
187.1 |
177.35 |
AS |
9.75 |
5.2110999999999998E-2 |
0 |
HEM |
ind.obm. |
|
|
|
40831 |
|
|
O |
ADVATE |
plv iol 1x5 ml (50 IU/ ml) (liekov.+ inj.kit) 250 IU |
BAX |
AT |
0.5 |
187.3 |
177.35 |
AS |
9.9499999999999993 |
5.3122999999999997E-2 |
0 |
HEM |
ind.obm. |
|
|
|
8476A |
|
|
O |
NovoEight 250 IU prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x250 IU+4 ml solv.+1 adaptér inj.liek |
NOO |
DK |
0.5 |
200.84 |
177.35 |
AS |
23.49 |
0.11695899999999999 |
0 |
HEM |
ind.obm. |
|
|
|
32330 |
|
|
O |
Advate |
plv iol 1x250 IU+1x2 ml solv. (liek.inj.skl.+liek.inj.skl.+ inj.kit) |
BAX-A |
AT |
0.5 |
223.93 |
177.35 |
AS |
46.58 |
0.20801100000000003 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
178.8 |
|
|
|
58279 |
|
|
O |
OCTANATE 500 IU |
plv iol 1x500 UT+ sol. |
OCP |
AT |
1 |
175.13 |
175.13 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
26821 |
|
|
O |
BERIATE P 500 |
plv iol 1x 500 IU + solv. |
CSL |
DE |
1 |
209.7 |
178.8 |
AS |
30.9 |
0.14735300000000001 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. rekomb. 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
346.06 |
|
|
|
36433 |
|
|
O |
KOGENATE Bayer |
plv iol 1x500 IU (1x skl. liek. – powder +1x skl. naplnená striek. - solv. + 1x adaptér pre liek.) |
BAS |
DE |
1 |
346.06 |
346.06 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
13142 |
|
|
O |
ReFacto AF 500 IU, prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x500 IU (liek.skl.)+4 ml solv. |
PFI-GB-1 |
GB |
1 |
346.06 |
346.06 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
40832 |
|
|
O |
ADVATE |
plv iol 1x5 ml (100 IU/ ml) (liekov.+ inj.kit) 500 IU |
BAX |
AT |
1 |
354.43 |
346.06 |
AS |
8.3699999999999992 |
2.3615000000000001E-2 |
0 |
HEM |
ind.obm. |
|
|
|
3429B |
|
|
O |
Nuwiq 500 IU prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x500 IU+1x2,5 ml solv.+adapter inj.liek. |
OCP-S |
SE |
1 |
365.37 |
346.06 |
AS |
19.309999999999999 |
5.2851000000000002E-2 |
0 |
HEM |
ind.obm. |
|
|
|
95648 |
|
|
O |
RECOMBINATE 500 IU |
plv iol 1x500IU (plv)+ 10 ml (solv.) |
BXI |
BE |
1 |
366.71 |
346.06 |
AS |
20.65 |
5.6312000000000001E-2 |
0 |
HEM |
ind.obm. |
|
|
|
8477A |
|
|
O |
NovoEight 500 IU prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x500 IU+4 ml solv. +1 adaptér inj.liek. |
NOO |
DK |
1 |
396.78 |
346.06 |
AS |
50.72 |
0.127829 |
0 |
HEM |
ind.obm. |
|
|
|
32331 |
|
|
O |
Advate |
plv iol 1x500 IU+1x2 ml solv. (liek.inj.skl.+liek.inj.skl.+ inj.kit) |
BAX-A |
AT |
1 |
444.07 |
346.06 |
AS |
98.01 |
0.22070799999999999 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. nad 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
163.58000000000001 |
|
|
|
15009 |
|
|
O |
OCTANATE 1000 IU |
plv iol 1x1000 UT+ sol. |
OCP |
AT |
2 |
327.14 |
327.14 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. rekomb. nad 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
346.06 |
|
|
|
36434 |
|
|
O |
KOGENATE Bayer |
plv iol 1x1000 IU (1x skl. liek. – powder +1x skl. naplnená striek. - solv. + 1x adaptér pre liek.) |
BAS |
DE |
2 |
682.29 |
682.29 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
13141 |
|
|
O |
ReFacto AF 1000 IU, prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x1000 IU (liek.skl.)+4 ml solv. |
PFI-GB-1 |
GB |
2 |
682.29 |
682.29 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
3431B |
|
|
O |
Nuwiq 2000 IU prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x2000 IU+1x2,5 ml solv.+adapter inj.liek. |
OCP-S |
SE |
4 |
1427.5 |
1384.24 |
AS |
43.26 |
3.0304999999999999E-2 |
0 |
HEM |
ind.obm. |
|
|
|
3430B |
|
|
O |
Nuwiq 1000 IU prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x1000 IU+1x2,5 ml solv.+adapter inj.liek. |
OCP-S |
SE |
2 |
719.79 |
692.12 |
AS |
27.67 |
3.8441999999999997E-2 |
0 |
HEM |
ind.obm. |
|
|
|
95650 |
|
|
O |
RECOMBINATE 1000 IU |
plv iol 1x1000 IU (plv)+ 10 ml (solv.) |
BXI |
BE |
2 |
724.62 |
692.12 |
AS |
32.5 |
4.4851000000000002E-2 |
0 |
HEM |
ind.obm. |
|
|
|
40833 |
|
|
O |
ADVATE |
plv iol 1x5 ml (200 IU/ ml) (liekov.+ inj.kit) 1000 IU |
BAX |
AT |
2 |
744.98 |
692.12 |
AS |
52.86 |
7.0955000000000004E-2 |
0 |
HEM |
ind.obm. |
|
|
|
8999A |
|
|
O |
NovoEight 2000 IU prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x2000 IU+4 ml. solv.+1adaptér inj. liek. |
NOO |
DK |
4 |
1563.25 |
1384.24 |
AS |
179.01 |
0.114511 |
0 |
HEM |
ind.obm. |
|
|
|
32333 |
|
|
O |
Advate |
plv iol 1x1500 IU+1x2 ml solv. (liek.inj.skl.+liek.inj.skl.+ inj.kit) |
BAX-A |
AT |
3 |
1318.37 |
1038.18 |
AS |
280.19 |
0.21252799999999999 |
0 |
HEM |
ind.obm. |
|
|
|
32332 |
|
|
O |
Advate |
plv iol 1x1000 IU+1x2 ml solv. (liek.inj.skl.+liek.inj.skl.+ inj.kit) |
BAX-A |
AT |
2 |
882.43 |
692.12 |
AS |
190.31 |
0.21566600000000002 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD03 |
|
|
|
Faktor VIII. |
parent. inhibitor bypassing. aktivity 500 IU |
10 |
KU |
|
|
|
|
|
|
|
|
7.81 |
|
|
|
85676 |
|
|
O |
FEIBA NF |
plo jof 1x500 ut+solv. |
BXG |
AT |
50 |
390.27 |
390.27 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD03 |
|
|
|
Faktor VIII. |
parent. inhibitor bypassing. aktivity 1000 IU |
10 |
KU |
|
|
|
|
|
|
|
|
9.02 |
|
|
|
85677 |
|
|
O |
FEIBA NF |
plo jof 1x1000 ut + solv. |
BXG |
AT |
100 |
900.56 |
900.56 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD04 |
|
|
|
Faktor IX. |
parent. 500 IU |
350 |
UT |
|
|
|
|
|
|
|
|
150.82 |
|
|
|
14110 |
|
|
O |
OCTANINE F 500 IU |
plv iol 1x500 UT+ sol. |
OCP |
AT |
1.4 |
211.14 |
211.14 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD04 |
|
|
|
Faktor IX. |
parent. 600 IU |
350 |
UT |
|
|
|
|
|
|
|
|
132.92099999999999 |
|
|
|
75079 |
|
|
O |
IMMUNINE 600I.E. |
plv iio 1x600 ut+5 ml |
BXG |
AT |
1.714 |
249.17 |
227.83 |
AS |
21.34 |
8.5643999999999998E-2 |
21.34 |
HEM |
ind.obm. |
|
|
|
B02BD04 |
|
|
|
Faktor IX. |
parent. 1000 IU |
350 |
UT |
|
|
|
|
|
|
|
|
115.01300000000001 |
|
|
|
14112 |
|
|
O |
OCTANINE F 1000 IU |
plv iol 1x1000 UT+ sol. |
OCP |
AT |
2.9 |
333.54 |
333.54 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD04 |
|
|
|
Faktor IX. |
parent. 1200 IU |
350 |
UT |
|
|
|
|
|
|
|
|
130.38999999999999 |
|
|
|
75080 |
|
|
O |
IMMUNINE 1200I.E. |
plv iio 1,2 ku+10 ml |
BXG |
AT |
3.4289999999999998 |
447.1 |
447.1 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD05 |
|
|
|
Faktor VII. |
parent. |
6 |
KU |
|
|
|
|
|
|
|
|
3890.3613999999998 |
|
|
|
90099 |
|
|
O |
FACTOR VII NF Baxter |
plv iol 600 ut+solv. |
BAX |
AT |
8.3000000000000004E-2 |
322.89999999999998 |
322.89999999999998 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD06 |
|
|
|
Faktor VIII. a VWF |
parent. 250 IU |
500 |
UT |
|
|
|
|
|
|
|
|
255.67 |
|
|
|
89027 |
|
|
O |
IMMUNATE BAXTER 250 |
plv iol 1x250 IU+ 5 ml solv. |
BXG |
AT |
0.5 |
95.2 |
95.2 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
87238 |
|
|
O |
FANHDI 25 I.U./ml |
plv iol 1x250 UT + sol. |
GFO |
ES |
0.5 |
123.46 |
123.46 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD06 |
|
|
|
Faktor VIII. a VWF |
parent. 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
221.84 |
|
|
|
89028 |
|
|
O |
IMMUNATE BAXTER 500 |
plv iol 1x500 IU+ 5 ml solv. |
BXG |
AT |
1 |
174.76 |
174.76 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
87239 |
|
|
O |
FANHDI 50 I.U./ml |
plv iol 1x500 UT + sol. |
GFO |
ES |
1 |
207.91 |
207.91 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
26109 |
|
|
O |
HAEMATE P |
plv iol 500 ut |
XCP |
DE |
1 |
229.02 |
221.84 |
AS |
7.18 |
3.1350999999999997E-2 |
0 |
HEM |
ind.obm. |
|
|
|
30669 |
|
|
O |
Wilate 500 |
plv iol 1x500 IU FVIII/500IU VWF a 5 ml solv. (liek. skl.) |
OCP |
GB |
1 |
235.87 |
221.84 |
AS |
14.03 |
5.9482E-2 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD06 |
|
|
|
Faktor VIII. a VWF |
parent. 1000 IU |
500 |
UT |
|
|
|
|
|
|
|
|
216.36 |
|
|
|
89029 |
|
|
O |
IMMUNATE BAXTER 1000 |
plv iol 1x1000 IU+10 ml solv. |
BAX |
AT |
2 |
343.21 |
343.21 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
87240 |
|
|
O |
FANHDI 100 I.U./ml |
plv iol 1x1 KU + sol. |
GFO |
ES |
2 |
409.45 |
409.45 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
26105 |
|
|
O |
Haemate P |
plv iio 1x1000 IU+1x15 ml solv. |
CSL |
DE |
2 |
458.96 |
432.72 |
AS |
26.24 |
5.7173000000000002E-2 |
0 |
HEM |
ind.obm. |
|
|
|
30670 |
|
|
O |
Wilate 1000 |
plv iol 1x1000 IU FVIII/500IU VWF a 10 ml solv. (liek.skl.) |
OCP |
GB |
2 |
469.5 |
432.72 |
AS |
36.78 |
7.8338999999999992E-2 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD06 |
|
|
|
Faktor VIII. a VWF |
parent. 1500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
248.63 |
|
|
|
92698 |
|
|
O |
FANHDI 100 IU/ml |
plv iol 1x1500 IU+15 ml sol. |
GFO |
ES |
3 |
745.86 |
745.86 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD08 |
|
|
|
Eptakog alfa aktivovaný |
parent. termostabilný 50 KIU |
2500 |
U |
|
|
|
|
|
|
|
|
32.53 |
|
|
|
50726 |
|
|
O |
NovoSeven 1mg (50KIU) |
plv iol 1x1mg+solv. (skl. liek.) |
NOO |
DK |
20 |
650.39 |
650.39 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD08 |
|
|
|
Eptakog alfa aktivovaný |
parent. termostabilný 100 KIU |
2500 |
U |
|
|
|
|
|
|
|
|
32.290999999999997 |
|
|
|
50727 |
|
|
O |
NovoSeven 2mg (100KIU) |
plv iol 1x2mg+solv. (skl. liek.) |
NOO |
DK |
40 |
1291.6300000000001 |
1291.6300000000001 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD10 |
|
|
|
Von Willebrandov faktor |
parent. 1000 IU |
1000 |
IU |
|
|
|
|
|
|
|
|
901.56 |
|
|
|
05883 |
|
|
O |
Willfact |
plv io 1x1000 IU + 1x10 ml solv. (liek.inj.skl.) |
LFM |
FR |
1 |
901.56 |
901.56 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BX01 |
|
|
|
Etamsylát |
p.o. 500 mg (30 ks) |
1 |
g |
|
|
|
|
|
|
|
|
1.5932999999999999 |
|
|
|
51191 |
X |
|
O |
DICYNONE 500 kapsuly |
cps 30x500 mg |
OAA-2 |
PT |
15 |
26.81 |
23.9 |
S |
2.91 |
0.108542 |
2.91 |
|
|
|
|
|
B02BX01 |
|
|
|
Etamsylát |
parent. 125 mg/ml |
0.75 |
g |
|
|
|
|
|
|
|
|
1.8768 |
|
|
|
08843 |
|
|
O |
DICYNONE 250 |
sol inj 4x2 ml/250 mg |
OMR |
CH |
1.333 |
4.1100000000000003 |
2.5 |
S |
1.61 |
0.39172699999999999 |
1.61 |
|
|
|
|
|
B02BX04 |
|
|
|
Romiplostim |
parent. 500 mcg/ml |
30 |
mcg |
|
|
|
|
|
|
|
|
72.881 |
|
|
|
86037 |
|
|
O |
Nplate |
plv iol 1x(250 mcg+0,72 ml solv.)(liek.skl.+napl.inj.striek.) |
AMG |
NL |
8.3330000000000002 |
607.32000000000005 |
607.32000000000005 |
A |
0 |
0 |
0 |
HEM |
ind.obm., ZP |
|
|
|
86049 |
|
|
O |
Nplate |
plv iol 1x(500 mcg+1,2 ml solv.)(liek.skl.+napl.inj.striek.) |
AMG |
NL |
16.667000000000002 |
1220.51 |
1214.71 |
AS |
5.8 |
4.7520000000000001E-3 |
0 |
HEM |
ind.obm., ZP |
|
|
|
B02BX05 |
|
|
|
Eltrombopag |
p.o. 25 mg (28 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
68.77 |
|
|
|
87601 |
|
|
O |
Revolade |
tbl flm 28x25 mg |
NEH-1 |
GB |
14 |
962.71 |
962.71 |
I |
0 |
0 |
0 |
HEM |
ind.obm., ZP |
|
|
|
B02BX05 |
|
|
|
Eltrombopag |
p.o. 50 mg (28 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
69.293000000000006 |
|
|
|
87609 |
|
|
O |
Revolade |
tbl flm 28x50mg |
NEH-1 |
GB |
28 |
1940.2 |
1940.2 |
I |
0 |
0 |
0 |
HEM |
ind.obm., ZP |
|
|
|
B03AB05 |
|
|
|
Komplex železo - hydroxy-polymaltózový komplex |
p.o. 100 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.107 |
|
|
|
25769 |
|
|
O |
MALTOFER |
tbl mnd 30x100 mg |
VIF |
CH |
30 |
6.08 |
3.21 |
S |
2.87 |
0.47203899999999999 |
2.87 |
|
|
|
|
|
B03AB05 |
|
|
|
Komplex železo - hydroxy-polymaltózový komplex |
p.o. 10 mg/ml (150 ml) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.19400000000000001 |
|
|
|
25771 |
|
|
O |
MALTOFER |
sir 1x150 ml |
VIF |
CH |
15 |
5.39 |
2.91 |
S |
2.48 |
0.46011099999999999 |
2.48 |
|
|
|
|
|
B03AB05 |
|
|
|
Komplex železo - hydroxy-polymaltózový komplex |
p.o. 50 mg/ml (30 ml) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.19400000000000001 |
|
|
|
25764 |
|
|
O |
MALTOFER |
gto por 1x30 ml 50 mg/ ml |
VIF |
CH |
15 |
5.57 |
2.91 |
S |
2.66 |
0.47755799999999998 |
2.66 |
|
|
|
|
|
B03AC01 |
|
|
|
Dextriferon |
parent. 50 mg/ml (10 ml) |
0.1 |
g |
|
|
|
|
|
|
|
|
13.84 |
|
|
|
59861 |
|
|
O |
Ferinject |
sol ijf 1x10 ml |
VIF |
CH |
5 |
109.72 |
69.2 |
AS |
40.520000000000003 |
0.36930399999999997 |
40.520000000000003 |
|
|
|
|
|
B03AC02 |
|
|
|
Sacharózový komplex s trojmocným železom |
parent. na prvkové železo i.v. 20 mg/ml |
0.1 |
g |
|
|
|
|
|
|
|
|
12.56 |
|
|
|
07620 |
|
|
O |
Venofer |
sol inj 5 x 5 ml/100 mg |
VIF |
CH |
5 |
62.79 |
62.79 |
A |
0 |
0 |
0 |
|
|
|
|
|
B03AD |
|
|
|
Železo v kombinácii s kyselinou listovou |
p.o. 80 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.106 |
|
|
|
66805 |
|
|
O |
TARDYFERON-FOL |
tbl plg 30 |
PFB |
FR |
24 |
3.49 |
2.54 |
S |
0.95 |
0.272206 |
0.95 |
|
|
|
|
|
B03AD |
|
|
|
Železo v kombinácii s kyselinou listovou |
p.o. 100 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
4.3999999999999997E-2 |
|
|
|
25766 |
|
|
O |
MALTOFER FOL |
tbl mnd 30 |
VIF |
CH |
30 |
5.57 |
1.32 |
S |
4.25 |
0.76301599999999992 |
4.25 |
|
|
|
|
|
B03AD02 |
|
|
|
Fumaran železnatý a kyselina listová |
p.o. 50 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.1116 |
|
|
|
51550 |
|
|
O |
Ferretab comp. |
cps dur 30 (blister Al/PVC) |
LAR |
AT |
15 |
5.25 |
1.67 |
S |
3.58 |
0.68190499999999998 |
2.56 |
|
|
|
|
|
B03AD02 |
|
|
|
Fumaran železnatý a kyselina listová |
p.o. 50 mg (100 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.1116 |
|
|
|
51573 |
|
|
O |
Ferretab comp. |
cps dur 100 (blister Al/PVC) |
LAR |
AT |
50 |
14.1 |
5.58 |
S |
8.52 |
0.60425499999999999 |
8.52 |
|
|
|
|
|
B03AE01 |
|
|
|
Železo, vit. B12, kyselina listová a kyselina askorbová |
p.o. 112,6 mg (20 ks) |
0.1 |
G |
|
|
|
|
|
|
|
|
0.1195 |
|
|
|
67045 |
|
|
O |
Ferro-Folgamma |
cps 20 |
WGP |
DE |
7 |
2.57 |
0.84 |
S |
1.73 |
0.67315200000000008 |
1.21 |
|
|
|
|
U75 |
B03AE01 |
|
|
|
Železo, vit. B12, kyselina listová a kyselina askorbová |
p.o. 112,6 mg (50 ks) |
0.1 |
G |
|
|
|
|
|
|
|
|
0.1195 |
|
|
|
67046 |
|
|
O |
Ferro-Folgamma |
cps 50 |
WGP |
DE |
17.5 |
5.78 |
2.09 |
S |
3.69 |
0.63840799999999998 |
3.04 |
|
|
|
|
U75 |
B03AE01 |
|
|
|
Železo, vit. B12, kyselina listová a kyselina askorbová |
p.o. 112,6 mg (100 ks) |
0.1 |
G |
|
|
|
|
|
|
|
|
0.1195 |
|
|
|
67047 |
|
|
O |
Ferro-Folgamma |
cps 100 |
WGP |
DE |
35 |
10.25 |
4.18 |
S |
6.07 |
0.59219499999999992 |
6.07 |
|
|
|
|
U75 |
B03AE10 |
|
|
|
Rôzne kombinácie |
p.o. predĺžené uvoľňovanie 80 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
09783 |
|
|
G |
TARDYFERON |
tbl plg 30x250 mg |
PFB |
FR |
24 |
2.96 |
2.4 |
S |
0.56000000000000005 |
0.189189 |
0.56000000000000005 |
|
|
|
|
|
B03AE10 |
|
|
|
Rôzne kombinácie |
p.o. 100 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.1008 |
|
|
|
97402 |
|
|
G |
SORBIFER DURULES |
tbl flm 50x100 mg |
EGI |
HU |
50 |
4.53 |
4.53 |
I |
0 |
0 |
0 |
|
|
|
|
|
B03AE10 |
|
|
|
Rôzne kombinácie |
p.o. síran želez./serin. na železo 6,8 mg/ml (100 ml) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.307 |
|
|
|
94328 |
|
|
G |
AKTIFERRIN |
sir 100 ml |
MCK |
DE |
6.835 |
2.65 |
2.1 |
S |
0.55000000000000004 |
0.20754700000000001 |
0.55000000000000004 |
|
|
|
|
|
B03BA01 |
|
|
|
Kyanokobalamín |
parent. 0,3 mg/ml |
0.02 |
mg |
|
|
|
|
|
|
|
|
0.06 |
|
|
|
00641 |
|
|
O |
VITAMIN B12 LÉČIVA |
sol inj 5x1 ml/300 ug |
ZNT |
CZ |
75 |
1.7 |
1.7 |
I |
0 |
0 |
0 |
|
|
|
|
|
B03BA01 |
|
|
|
Kyanokobalamín |
parent. 1 mg/ml |
0.02 |
mg |
|
|
|
|
|
|
|
|
0.01 |
|
|
|
00643 |
|
|
O |
VITAMIN B12 LÉČIVA |
sol inj 5x1 ml/1000 ug |
ZNT |
CZ |
250 |
2.2799999999999998 |
2.2799999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
B03BB01 |
|
|
|
Kyselina listová |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
7.9699999999999993E-2 |
|
|
|
15284 |
X |
|
G |
ACIDUM FOLICUM LÉČIVA |
tbl obd 30x10 mg |
ZNT |
CZ |
30 |
3.72 |
2.39 |
S |
1.33 |
0.35752699999999998 |
1.33 |
|
|
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 2000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
6.3 |
|
|
|
28689 |
|
|
O |
NEORECORMON 2000 IU |
sol inj 6x 0,3 ml/2000 IU (predp.inj.striek.) |
HLR |
GB |
12 |
75.510000000000005 |
75.510000000000005 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 3000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
6.54 |
|
|
|
14548 |
|
|
O |
NEORECORMON 3000 IU |
sol inj 6x 0,3 ml/3000 IU (predp.inj.striek.) |
HLR |
GB |
18 |
117.54 |
117.54 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 4000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
6.09 |
|
|
|
06221 |
|
|
O |
NEORECORMON 4000 IU |
sol inj 6x0,3 ml/4000 IU(predp.inj.striek.) |
HLR |
GB |
24 |
145.99 |
145.99 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 5000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
7.17 |
|
|
|
28690 |
|
|
O |
NEORECORMON 5000 IU |
sol inj 6x 0,3 ml/5000 IU (predp.inj.striek.) |
HLR |
GB |
30 |
214.86 |
214.86 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 6000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
6.48 |
|
|
|
41488 |
|
|
O |
NEORECORMON 6000 IU |
sol inj 6x0,3 ml/6000 IU(predp.inj.striek.) |
HLR |
GB |
36 |
232.79 |
232.79 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 10 000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
4.4000000000000004 |
|
|
|
45105 |
|
|
O |
Binocrit 10 000IU/1 ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj 6x1,0 ml/10000 IU |
SAN |
AT |
60 |
263.93 |
263.93 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
81634 |
|
|
O |
Biopoin 10000 IU/1 ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj, 6x1,0 ml/10000 IU (striek.skl.napl.s bezpeč.zar.) |
CTA |
DE |
60 |
263.93 |
263.93 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 20 000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
4.93 |
|
|
|
81640 |
|
|
O |
Biopoin 20000 IU/1 ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj, 6x1,0 ml/20000 IU (striek.skl.napl.s bezpeč.zar.) |
CTA |
DE |
120 |
574.76 |
574.76 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 30 000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
4.3099999999999996 |
|
|
|
05752 |
|
|
O |
Binocrit |
sol iru 6x0,75 ml/30000 IU (striek.inj.skl.napl.+ochr.kryt ihly) |
SAN |
AT |
180 |
774 |
774 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
81646 |
|
|
O |
Biopoin 30000 IU/1 ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj, 6x1,0 ml/30000 IU (striek.skl.napl.s bezpeč.zar.) |
CTA |
DE |
180 |
774 |
774 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
65691 |
|
|
B |
Retacrit |
sol inj 6x0,75 ml/30 000 IU |
HSP |
GB |
180 |
774 |
774 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 40 000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
4.83 |
|
|
|
05754 |
|
|
O |
Binocrit |
sol iru 6x1 ml/40000 IU (striek.inj.skl.napl.+ochr.kryt ihly) |
SAN |
AT |
240 |
1159.1400000000001 |
1159.1400000000001 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
65693 |
|
|
B |
Retacrit |
sol inj 6x1 ml/40 000 IU |
HSP |
GB |
240 |
1159.1400000000001 |
1159.1400000000001 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 10 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
8.3109999999999999 |
|
|
|
40697 |
|
|
O |
Aranesp 10 mcg |
sol inj 1x0,4 ml/10 µg (napl.skl.striek.- blistr.bal.) |
AMG |
NL |
2.222 |
18.47 |
18.47 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 20 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
7.4539999999999997 |
|
|
|
76210 |
|
|
O |
Aranesp 20 mcg |
sol inj 1x0,5 ml/20 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
4.444 |
33.130000000000003 |
33.130000000000003 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 60 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.84 |
|
|
|
76238 |
|
|
O |
Aranesp 60 mcg |
sol inj 1x0,3 ml/60 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
13.333 |
91.14 |
91.14 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 80 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.9640000000000004 |
|
|
|
76247 |
|
|
O |
Aranesp 80 mcg |
sol inj 1x0,4 ml/80 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
17.777999999999999 |
123.81 |
123.81 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 100 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
7.2750000000000004 |
|
|
|
76249 |
|
|
O |
Aranesp 100 mcg |
sol inj 1x0,5 ml/100 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
22.222000000000001 |
161.65 |
161.65 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 150 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.782 |
|
|
|
76253 |
|
|
O |
Aranesp 150 mcg |
sol inj 1x0,3 ml/150 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
33.332999999999998 |
225.86 |
225.86 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 300 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.7 |
|
|
|
76255 |
|
|
O |
Aranesp 300 mcg |
sol inj 1x0,6 ml/300 mcg (napl. skl.striek.+ kryt ihly) |
AMG |
NL |
66.667000000000002 |
446.59 |
446.59 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 500 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.7830000000000004 |
|
|
|
76257 |
|
|
O |
Aranesp 500 mcg |
sol inj 1x1 ml/500 mcg (napl. skl.striek.+ kryt ihly) |
AMG |
NL |
111.111 |
753.62 |
753.62 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 30 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.5430000000000001 |
|
|
|
53298 |
|
|
O |
MIRCERA 30 mcg/0,3 ml |
sol inj 1x0,3 ml/30 mcg (napl. inj. striek.) |
HLR |
GB |
7.5 |
56.56 |
56.56 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 50 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.27 |
|
|
|
44653 |
|
|
O |
MIRCERA 50 mcg/0,3 ml |
sol inj 1x0,3 ml/50 mcg (napl. inj. striek.) |
HLR |
GB |
12.5 |
90.84 |
90.84 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 75 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.1420000000000003 |
|
|
|
44654 |
|
|
O |
MIRCERA 75 mcg/0,3 ml |
sol inj 1x0,3 ml/75 mcg (napl. inj. striek.) |
HLR |
GB |
18.8 |
134.27000000000001 |
134.27000000000001 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 100 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.11 |
|
|
|
44660 |
|
|
O |
MIRCERA 100 mcg/0,3 ml |
sol inj 1x0,3 ml/100 mcg (napl. inj. striek.) |
HLR |
GB |
25 |
177.69 |
177.69 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 120 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.1630000000000003 |
|
|
|
53301 |
|
|
O |
MIRCERA 120 mcg/0,3 ml |
sol inj 1x0,3 ml/120 mcg (napl. inj. striek.) |
HLR |
GB |
30 |
214.89 |
214.89 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 150 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.05 |
|
|
|
44661 |
|
|
O |
MIRCERA 150 mcg/0,3 ml |
sol inj 1x0,3 ml/150 mcg (napl. inj. striek.) |
HLR |
GB |
37.5 |
264.24 |
264.24 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 200 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.0149999999999997 |
|
|
|
44662 |
|
|
O |
MIRCERA 200 mcg/0,3 ml |
sol inj 1x0,3 ml/200 mcg (napl. inj. striek.) |
HLR |
GB |
50 |
350.69 |
350.69 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 250 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.0750000000000002 |
|
|
|
44663 |
|
|
O |
MIRCERA 250 mcg/0,3 ml |
sol inj 1x0,3 ml/250 mcg (napl. inj. striek.) |
HLR |
GB |
62.5 |
442.16 |
442.16 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B05AA01 |
|
|
|
Albumín |
parent. 5% |
20 |
g |
|
|
|
|
|
|
|
|
76.3 |
|
|
|
97907 |
|
|
O |
HUMAN ALBUMIN GRIFOLS 5% I.V. |
sol inf 1x250 ml |
GFO |
ES |
0.625 |
47.68 |
47.68 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05AA01 |
|
|
|
Albumín |
parent. 20% |
20 |
g |
|
|
|
|
|
|
|
|
64.319999999999993 |
|
|
|
62471 |
|
|
O |
HUMAN ALBUMIN 20% IMMUNO |
sol inf 1x100 ml |
BXG |
AT |
1 |
64.31 |
64.31 |
A |
0 |
0 |
0 |
|
|
|
|
|
1229A |
|
|
O |
Flexbumin 200 g/ l |
sol inf 1x100 ml (vak PE) |
BAX |
CZ |
1 |
70.97 |
64.319999999999993 |
AS |
6.65 |
9.3702000000000008E-2 |
0 |
|
|
|
|
|
B05AA06 |
|
|
|
Želatína |
parent. 4 % (500 ml) |
27.5 |
g |
|
|
|
|
|
|
|
|
5.47 |
|
|
|
27455 |
|
|
G |
Gelofusine |
sol inf 10x500 ml (PE fľa.-Ecoflac Plus) |
BME |
DE |
7.27 |
39.67 |
39.67 |
A |
0 |
0 |
0 |
|
|
|
|
|
10440 |
|
|
G |
Gelaspan 4% |
sol inf 20x500 ml (vak plast.-Ecobag) |
BME |
DE |
14.545 |
127.31 |
79.56 |
AS |
47.75 |
0.37506900000000004 |
0 |
|
|
|
|
|
B05AA07 |
|
|
|
Hydroxyetylškrob |
parent. 6 % |
50 |
g |
|
|
|
|
|
|
|
|
12.18 |
|
|
|
37061 |
|
|
G |
Tetraspan 6% |
sol inf 20x500 ml (vak) |
BME |
DE |
12 |
146.11000000000001 |
146.11000000000001 |
A |
0 |
0 |
0 |
|
|
|
|
|
34359 |
|
|
O |
VOLUVEN |
sol inf 1x500 ml (vak+obal) |
FRK |
DE |
0.6 |
14.96 |
7.31 |
AS |
7.65 |
0.51136400000000004 |
0 |
|
|
|
|
|
B05AA07 |
|
|
|
Hydroxyetylškrob |
parent. 10 % |
50 |
g |
|
|
|
|
|
|
|
|
10.220000000000001 |
|
|
|
37067 |
|
|
G |
Tetraspan 10% |
sol inf 20x500 ml (vak) |
BME |
DE |
20 |
204.16 |
204.16 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 5% (100 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.9 |
|
|
|
97728 |
|
|
G |
GLUCOSE 5%W/V I.V.B.P. BIEFFE |
sol inf 1x100 ml (sklo) |
BFF |
IT |
1 |
0.89 |
0.89 |
A |
0 |
0 |
0 |
|
|
|
|
|
62370 |
|
|
O |
INFUSIO GLUCOSI 5 IMUNA |
sol inf 1x100 ml-skl.f. |
IMA |
SK |
1 |
1.25 |
0.9 |
AS |
0.35 |
0.28000000000000003 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 5% (250 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.40100000000000002 |
|
|
|
34406 |
|
|
O |
Glukóza 5% Baxter-Viaflo |
sol inf 30x250 ml (vak POF/PA) |
BAX-CZ-1 |
CZ |
75 |
29.76 |
29.76 |
A |
0 |
0 |
0 |
|
|
|
|
|
34253 |
|
|
G |
Glukóza 5 Braun inf. |
sol inf 10x250 ml (PE fľa.) |
BME |
DE |
25 |
10.01 |
10.01 |
A |
0 |
0 |
0 |
|
|
|
|
|
97729 |
|
|
G |
GLUCOSE 5%W/V I.V.B.P. BIEFFE |
sol inf 1x250 ml (sklo) |
BFF |
IT |
2.5 |
1.07 |
1 |
AS |
7.0000000000000007E-2 |
6.5420999999999993E-2 |
0 |
|
|
|
|
|
33614 |
|
|
O |
5 % GLUCOSE IN WATER FOR INJECTION FRESENIUS |
sol inf 1x250 ml (LDPE fľa.) |
FRK |
IT |
2.5 |
1.25 |
1 |
AS |
0.25 |
0.2 |
0 |
|
|
|
|
|
62372 |
|
|
O |
INFUSIO GLUCOSI 5 IMUNA |
sol inf 1x250 ml-skl.fľ. |
IMA |
SK |
2.5 |
1.34 |
1 |
AS |
0.34 |
0.25373099999999998 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 5% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
34254 |
|
|
G |
Glukóza 5 Braun inf. |
sol inf 10x500 ml (PE fľa.) |
BME |
DE |
50 |
10.49 |
10.49 |
A |
0 |
0 |
0 |
|
|
|
|
|
34407 |
|
|
O |
Glukóza 5% Baxter-Viaflo |
sol inf 20x500 ml (vak POF/PA) |
BAX-CZ-1 |
CZ |
100 |
24.52 |
22 |
AS |
2.52 |
0.102773 |
0 |
|
|
|
|
|
97730 |
|
|
G |
GLUCOSE 5%W/V I.V.B.P. BIEFFE |
sol inf 1x500 ml (sklo) |
BFF |
IT |
5 |
1.23 |
1.1000000000000001 |
AS |
0.13 |
0.10569100000000001 |
0 |
|
|
|
|
|
33611 |
|
|
O |
5% GLUKOSE IN WATER FOR INJECTION FRESENIUS |
sol inf 1x500 ml (LDPE fľa.) |
FRK-I |
IT |
5 |
1.55 |
1.1000000000000001 |
AS |
0.45 |
0.290323 |
0 |
|
|
|
|
|
62373 |
|
|
O |
INFUSIO GLUCOSI 5 IMUNA |
sol inf 1x500 ml-skl.f. |
IMA |
SK |
5 |
1.62 |
1.1000000000000001 |
AS |
0.52 |
0.320988 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 10% (200-250 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.43 |
|
|
|
62376 |
|
|
O |
INFUSIO GLUCOSI 10 IMUNA |
sol inf 1x250 ml-skl.f. |
IMA |
SK |
2.5 |
1.41 |
1.08 |
AS |
0.33 |
0.234043 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 10% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.26100000000000001 |
|
|
|
34261 |
|
|
G |
Glukóza 10 Braun inf. |
sol inf 10x500 ml (PE fľa.) |
BME |
DE |
50 |
12.93 |
12.93 |
A |
0 |
0 |
0 |
|
|
|
|
|
97736 |
|
|
G |
GLUCOSE 10%W/V I.V.B.P.BIEFFE |
sol inf 1x500 ml (sklo) |
BFF |
IT |
5 |
1.31 |
1.31 |
A |
0 |
0 |
0 |
|
|
|
|
|
89744 |
|
|
O |
Glukóza 10% Baxter-Viaflo |
sol inf 20x500 ml (vak POF/PA) |
BAX-CZ-1 |
CZ |
100 |
31.67 |
26.1 |
AS |
5.57 |
0.17587599999999998 |
0 |
|
|
|
|
|
62377 |
|
|
O |
INFUSIO GLUCOSI 10 IMUNA |
sol inf 1x500 ml-skl.f. |
IMA |
SK |
5 |
1.73 |
1.31 |
AS |
0.42 |
0.24277499999999999 |
0 |
|
|
|
|
|
33635 |
|
|
O |
10% GLUKOSE IN WATER FOR INJECTION FRESENIUS |
sol inf 1x500 ml (LDPE fľa.) |
FRK-I |
IT |
5 |
1.88 |
1.31 |
AS |
0.56999999999999995 |
0.30319099999999999 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 20% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.32300000000000001 |
|
|
|
97738 |
|
|
G |
GLUCOSE 20%W/V I.V.B.P.BIEFFE |
sol inf 1x500 ml (sklo) |
BFF |
IT |
5 |
1.62 |
1.62 |
A |
0 |
0 |
0 |
|
|
|
|
|
34268 |
|
|
G |
Glukóza 20 Braun inf. |
sol inf 10x500 ml (PE fľa.) |
BME |
DE |
50 |
16.899999999999999 |
16.149999999999999 |
AS |
0.75 |
4.4379000000000002E-2 |
0 |
|
|
|
|
|
18543 |
|
|
O |
INFUSIO GLUCOSI 20 IMUNA |
sol inf 1x500 ml-skl.f. |
IMA |
SK |
5 |
1.88 |
1.62 |
AS |
0.26 |
0.138298 |
0 |
|
|
|
|
|
91657 |
|
|
G |
INFUSIO GLUCOSI 20% INFUSIA |
sol inf 1x500 ml (sklo) |
IHO |
CZ |
5 |
2.12 |
1.62 |
AS |
0.5 |
0.235849 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 40% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.42 |
|
|
|
34273 |
|
|
G |
Glukóza 40 Braun inf. |
sol inf 10x500 ml (PE fľa.) |
BME |
DE |
50 |
20.53 |
20.53 |
A |
0 |
0 |
0 |
|
|
|
|
|
18548 |
|
|
O |
INFUSIO GLUCOSI 40 IMUNA |
sol inf 1x500 ml-skl.f. |
IMA |
SK |
5 |
2.2599999999999998 |
2.1 |
AS |
0.16 |
7.0795999999999998E-2 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (5- 10 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
2.2200000000000002 |
|
|
|
27789 |
|
|
G |
Chlorid sodný 0,9% Braun Injekčný roztok |
sol inj 20x10 ml (PE amp.) |
BME |
DE |
2 |
4.4400000000000004 |
4.4400000000000004 |
A |
0 |
0 |
0 |
|
|
|
|
|
00516 |
|
|
G |
NATRIUM CHLORATUM BIOTIKA ISOT. |
sol inj 10x10 ml |
HBS |
SK |
1 |
4.55 |
2.2200000000000002 |
AS |
2.33 |
0.51208799999999999 |
0 |
|
|
|
|
|
00514 |
|
|
G |
NATRIUM CHLORATUM BIOTIKA ISOT. |
sol inj 10x5 ml |
HBS |
SK |
0.5 |
4.07 |
1.1100000000000001 |
AS |
2.96 |
0.72727299999999995 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (100 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.89 |
|
|
|
97748 |
|
|
G |
SODIUM CHLORIDE 0,9%W/V I.V. INF |
sol inf 1x100 ml (sklo) |
BFF |
IT |
1 |
0.89 |
0.89 |
A |
0 |
0 |
0 |
|
|
|
|
|
13892 |
|
|
G |
Chlorid sodný 0,9 % Braun Infúzny Intravenózny roztok |
sol inf 20x100 ml (PE obal) |
BME |
DE |
20 |
19.59 |
17.8 |
AS |
1.79 |
9.1372999999999996E-2 |
0 |
|
|
|
|
|
34398 |
|
|
O |
0,9 % Chlorid sodný Baxter-Viaflo |
sol inf 50x100 ml (vak POF/PA) |
BAX-CZ-1 |
CZ |
50 |
50.36 |
44.5 |
AS |
5.86 |
0.11636200000000001 |
0.15 |
|
|
|
|
|
37743 |
|
|
O |
0,9 % SODIUM CHLORIDE IN WATER FOR INJECTION „FRESENIUS“ |
sol inf 1x100 ml (LDPE fľa.) |
FRK |
IT |
1 |
1.1499999999999999 |
0.89 |
AS |
0.26 |
0.22608699999999998 |
0 |
|
|
|
|
|
62326 |
|
|
O |
INFUSIO NATR.CHLOR.ISOT.IMUNA |
sol inf 1x100 ml-skl.f. |
IMA |
SK |
1 |
1.31 |
0.89 |
AS |
0.42 |
0.32061100000000003 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (200- 250 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.38 |
|
|
|
97749 |
|
|
G |
SODIUM CHLORIDE 0,9%W/V I.V. INF |
sol inf 1x250 ml (sklo) |
BFF |
IT |
2.5 |
0.95 |
0.95 |
A |
0 |
0 |
0 |
|
|
|
|
|
13897 |
|
|
G |
Chlorid sodný 0,9 % Braun Infúzny Intravenózny roztok |
sol inf 10x250 ml (PE obal) |
BME |
DE |
25 |
10.33 |
9.5 |
AS |
0.83 |
8.0348000000000003E-2 |
0 |
|
|
|
|
|
34400 |
|
|
O |
0,9 % Chlorid sodný Baxter-Viaflo |
sol inf 30x250 ml (vak POF/PA) |
BAX-CZ-1 |
CZ |
75 |
31.37 |
28.5 |
AS |
2.87 |
9.1488999999999987E-2 |
0.22 |
|
|
|
|
|
62328 |
|
|
O |
INFUSIO NATR.CHLOR.ISOT.IMUNA |
sol inf 1x250 ml-skl.f. |
IMA |
SK |
2.5 |
1.28 |
0.95 |
AS |
0.33 |
0.25781300000000001 |
0 |
|
|
|
|
|
33593 |
|
|
O |
0,9% SODIUM ChL.IN W.F.I.FRESENIUS |
sol inf 1x250 ml (PE) |
FRK |
IT |
2.5 |
1.29 |
0.95 |
AS |
0.34 |
0.26356600000000002 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
97750 |
|
|
G |
SODIUM CHLORIDE 0,9%W/V I.V. INF B |
sol inf 1x500 ml (sklo) |
BFF |
IT |
5 |
1.1299999999999999 |
1.1299999999999999 |
A |
0 |
0 |
0 |
|
|
|
|
|
34401 |
|
|
O |
0,9 % Chlorid sodný Baxter-Viaflo |
sol inf 20x500 ml (vak POF/PA) |
BAX-CZ-1 |
CZ |
100 |
23.29 |
23 |
AS |
0.28999999999999998 |
1.2452000000000001E-2 |
0.28999999999999998 |
|
|
|
|
|
13902 |
|
|
G |
Chlorid sodný 0,9 % Braun Infúzny Intravenózny roztok |
sol inf 10x500 ml (PE obal) |
BME |
DE |
50 |
12.81 |
11.5 |
AS |
1.31 |
0.10226399999999999 |
0 |
|
|
|
|
|
33590 |
|
|
O |
0,9% SODIUM ChL.IN W.F.I.FRESENIUS |
sol inf 1x500 ml (PE) |
FRK |
DE |
5 |
1.34 |
1.1499999999999999 |
AS |
0.19 |
0.141791 |
0 |
|
|
|
|
|
62329 |
|
|
O |
INFUSIO NATR.CHLOR.ISOT.IMUNA |
sol inf 1x500 ml-skl.f. |
IMA |
SK |
5 |
1.47 |
1.1499999999999999 |
AS |
0.32 |
0.21768699999999999 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (1000 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.21 |
|
|
|
13907 |
|
|
G |
Chlorid sodný 0,9 % Braun Infúzny Intravenózny roztok |
sol inf 10x1000 ml (PE obal) |
BME |
DE |
100 |
14.92 |
14.92 |
A |
0 |
0 |
0 |
|
|
|
|
|
33596 |
|
|
O |
0,9% SODIUM ChL.IN W.F.I.FRESENIUS |
sol inf 1x1000 ml (PE) |
FRK |
DE |
10 |
1.96 |
1.96 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% a kalcium (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.3 |
|
|
|
33636 |
|
|
G |
Compound Sodium Lactate Ringer-Lactat (PE) |
sol inf 10x500 ml |
BME |
DE |
50 |
14.55 |
14.55 |
A |
0 |
0 |
0 |
|
|
|
|
|
40312 |
|
|
O |
Ringer laktát Baxter-Viaflo |
sol inf 20x500 ml |
BAX-CZ-1 |
CZ |
100 |
31.99 |
30 |
AS |
1.99 |
6.2206999999999998E-2 |
0.28999999999999998 |
|
|
|
|
|
37985 |
|
|
O |
HARTMANN´S SOLUTION BP FRESENIUS |
sol inf 1 x 500 ml (LDPE fľa.) |
FRK |
IT |
5 |
1.6 |
1.5 |
AS |
0.1 |
6.25E-2 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. Ringer (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
33976 |
|
|
G |
Ringer´s Braun Injection (PL.) |
sol inf 10x500ml |
BME |
DE |
50 |
10.77 |
10.77 |
A |
0 |
0 |
0 |
|
|
|
|
|
40309 |
|
|
O |
Ringerov roztok Baxter-Viaflo |
sol inf 20x500 ml (vak POF/PA) |
BAX-CZ-1 |
CZ |
100 |
28.52 |
23 |
AS |
5.52 |
0.193548 |
5.52 |
|
|
|
|
|
99170 |
|
|
O |
INFUSIO RINGERI IMUNA |
sol inf 1x500 ml-skl.fľ. |
IMA |
SK |
5 |
1.52 |
1.1499999999999999 |
AS |
0.37 |
0.243421 |
0 |
|
|
|
|
|
37997 |
|
|
G |
Ringer´s injection „Fresenius“, |
sol inf 1x500 ml (LDPE fľa.), |
FRK |
IT |
5 |
2.33 |
1.1499999999999999 |
AS |
1.18 |
0.50643799999999994 |
0 |
|
|
|
|
|
B05BC01 |
|
|
|
Manitol |
parent. (200-250 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.79 |
|
|
|
90530 |
|
|
O |
INFUSIO MANNITOLI IMUNA 10% |
sol inf 1x250 ml-skl.f. |
IMA |
SK |
2.5 |
1.97 |
1.97 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05XA01 |
|
|
|
Chlorid draselný |
parent. 7,45 % (100 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
1.46 |
|
|
|
18346 |
|
|
G |
INFUSIO KALII CHLORATI CONC. |
sol inf 1x100 ml |
IMA |
SK |
1 |
1.46 |
1.46 |
A |
0 |
0 |
0 |
|
|
|
|
|
B06AC04 |
|
|
|
Konestat alfa |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
883.69 |
|
|
|
03531 |
|
|
O |
Ruconest |
plv ino 1x2100 U (liek.inj.skl.) |
PNV |
NL |
1 |
878.38 |
878.38 |
I |
0 |
0 |
0 |
ALG |
ind.obm., ZP |
|
|
|
C01AA05 |
|
|
|
Digoxín |
p.o. 0,125 mg (30 ks) |
0.25 |
mg |
|
|
|
|
|
|
|
|
5.8599999999999999E-2 |
|
|
|
83318 |
|
|
G |
DIGOXIN LÉČIVA |
tbl 30x0,125 mg |
ZNT |
CZ |
15 |
1.23 |
0.88 |
S |
0.35 |
0.284553 |
0.35 |
|
|
|
|
|
C01AA05 |
|
|
|
Digoxín |
p.o. 0,25 mg (30 ks) |
0.25 |
mg |
|
|
|
|
|
|
|
|
6.4500000000000002E-2 |
|
|
|
03542 |
|
|
G |
DIGOXIN LÉČIVA |
tbl 30x0,25 mg |
ZNT |
CZ |
30 |
1.91 |
1.91 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01BA08 |
|
|
|
Prajmalín |
p.o. 20 mg (50 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.44 |
|
|
|
26531 |
|
|
O |
NEO-GILURYTMAL |
tbl obd 50x20 mg |
SYF |
DE |
33.335000000000001 |
14.54 |
14.54 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
p.o. 150 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.24299999999999999 |
|
|
|
91276 |
|
|
G |
PROLEKOFEN |
tbl flm 50x150 mg |
LEK |
SI |
25 |
6.08 |
6.08 |
I |
0 |
0 |
0 |
|
|
|
|
|
91003 |
|
|
O |
RYTMONORM 150 |
tbl obd 50x150 mg |
KNO |
DE |
25 |
6.28 |
6.08 |
S |
0.2 |
3.1847E-2 |
0 |
|
|
|
|
|
59942 |
|
|
G |
PROPANORM 150 mg |
tbl flm 50x150 mg |
PMP |
CZ |
25 |
6.82 |
6.08 |
S |
0.74 |
0.108504 |
0 |
|
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
p.o. 300 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.27300000000000002 |
|
|
|
91277 |
|
|
G |
PROLEKOFEN |
tbl flm 50x300 mg |
LEK |
SI |
50 |
9.91 |
9.91 |
I |
0 |
0 |
0 |
|
|
|
|
|
58838 |
|
|
G |
PROPANORM 300 mg |
tbl flm 50x300 mg |
PMP |
CZ |
50 |
11.09 |
11.09 |
I |
0 |
0 |
0 |
|
|
|
|
|
91004 |
|
|
O |
RYTMONORM 300 |
tbl obd 50x300 mg |
KNO |
DE |
50 |
11.65 |
11.65 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
p.o. predĺžené uvoľňovanie 225 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.38169999999999998 |
|
|
|
92994 |
|
|
O |
Rytmonorm SR 225 mg |
cps pld 60x225 mg |
TPH |
SK |
45 |
19 |
17.18 |
S |
1.82 |
9.5789000000000013E-2 |
1.82 |
|
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
p.o. predĺžené uvoľňovanie 325 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
93535 |
|
|
O |
Rytmonorm SR 325 mg |
cps pld 60x325 mg |
TPH |
SK |
65 |
21.41 |
21.41 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
p.o. predĺžené uvoľňovanie 425 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.38169999999999998 |
|
|
|
93563 |
|
|
O |
Rytmonorm SR 425 mg |
cps pld 60x425 mg |
TPH |
SK |
85 |
34.630000000000003 |
32.44 |
S |
2.19 |
6.3240000000000005E-2 |
2.19 |
|
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
parent. |
0.3 |
g |
|
|
|
|
|
|
|
|
4.6319999999999997 |
|
|
|
08151 |
|
|
G |
Propanorm 35 mg/10 ml |
sol inj 10x10 ml (amp.skl.) |
PMP |
CZ |
1.167 |
5.41 |
5.41 |
A |
0 |
0 |
0 |
|
|
|
|
|
C01BC04 |
|
|
|
Flekainid |
p.o. 50 mg (30 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
0.63400000000000001 |
|
|
|
36573 |
|
|
G |
Flekainid Sandoz 50mg tablety |
tbl 30x50mg |
SAN |
SI |
15 |
10.220000000000001 |
9.51 |
S |
0.71 |
6.9471999999999992E-2 |
0.71 |
KAR |
|
|
|
|
C01BC04 |
|
|
|
Flekainid |
p.o. 100 mg (30 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
0.3 |
|
|
|
36590 |
|
|
G |
Flekainid Sandoz 100 mg tablety |
tbl 30x100 mg |
SAN |
SI |
30 |
8.6 |
8.6 |
I |
0 |
0 |
0 |
KAR |
|
|
|
|
C01BD01 |
|
|
|
Amiodarón |
p.o. 200 mg (30 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.10100000000000001 |
|
|
|
80157 |
|
|
O |
CORDARONE |
tbl 30x200 mg |
SWA |
FR |
30 |
3.38 |
3.03 |
S |
0.35 |
0.10355 |
0.23 |
GER, INT, KAR, KLF |
|
|
|
|
37079 |
|
|
G |
RIVODARON 200 |
tbl 30 x200 mg |
PMP |
SK |
30 |
5.62 |
3.03 |
S |
2.59 |
0.46085399999999999 |
0.23 |
GER, INT, KAR, KLF |
|
|
|
|
C01BD01 |
|
|
|
Amiodarón |
p.o. 200 mg (50-60 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.10100000000000001 |
|
|
|
14511 |
|
|
G |
AMIOKORDIN |
tbl 60x200 mg |
KRK |
SI |
60 |
6.52 |
6.06 |
S |
0.46 |
7.0552000000000004E-2 |
0.46 |
GER, INT, KAR, KLF |
|
|
|
|
37080 |
|
|
G |
RIVODARON 200 |
tbl 60 x200 mg |
PMP |
SK |
60 |
10.1 |
6.06 |
S |
4.04 |
0.4 |
0.46 |
GER, INT, KAR, KLF |
|
|
|
|
C01BD01 |
|
|
|
Amiodarón |
parent. 50 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
0.65 |
|
|
|
80155 |
|
|
O |
CORDARONE |
sol inj 6x3 ml/150 mg |
SWA |
FR |
4.5 |
2.89 |
2.89 |
A |
0 |
0 |
0 |
|
|
|
|
|
C01BD07 |
|
|
|
Dronedarón |
p.o. 400 mg (60 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
2.31 |
|
|
|
84132 |
|
|
O |
Multaq |
tbl flm 60x400 mg (blis.PVC/Al) |
SSS1 |
FR |
30 |
73.61 |
69.3 |
S |
4.3099999999999996 |
5.8552E-2 |
4.3099999999999996 |
KAR |
ind.obm. |
|
|
|
C01BG11 |
|
|
|
Vernakalant |
parent. 20 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
449.62 |
|
|
|
23386 |
|
|
O |
BRINAVESS 20 mg/ml |
con inf 1x25 ml/500 mg |
MSD |
GB |
1 |
449.61 |
449.61 |
A |
0 |
0 |
0 |
KAR |
ind.obm. |
|
|
|
C01CA03 |
|
|
|
Noradrenalín |
parent. 1 mg/ml |
6 |
mg |
|
|
|
|
|
|
|
|
7.56 |
|
|
|
00536 |
|
|
G |
NORADRENALIN LÉČIVA |
sol inj 5x1 ml 1 mg |
ZNT |
CZ |
0.83299999999999996 |
6.48 |
6.3 |
AS |
0.18 |
2.7778000000000001E-2 |
0.18 |
|
|
|
|
|
C01CA04 |
|
|
|
Dopamín |
parent. 40 mg/ml |
0.5 |
g |
|
|
|
|
|
|
|
|
5.82 |
|
|
|
04380 |
|
|
G |
TENSAMIN |
sol inj 10x5 ml |
ZNT |
CZ |
4 |
23.25 |
23.25 |
A |
0 |
0 |
0 |
|
|
|
|
|
C01CA24 |
|
|
|
Epinefrín |
parent. 0,15 mg |
1 |
DF |
|
|
|
|
|
|
|
|
35.131999999999998 |
|
|
|
32652 |
|
|
O |
EpiPen Jr. |
sol inj 2x2 ml/0,15 mg (amp.inj.skl.) |
MPH |
SK |
2 |
72 |
70.260000000000005 |
S |
1.74 |
2.4167000000000001E-2 |
1.74 |
ALG, DER |
|
|
|
|
00542 |
|
|
O |
Jext 150 mikrogramov |
sol ira 1x0,15ml/150µg (pero inj. napl.) |
AAO |
DK |
1 |
37.299999999999997 |
35.130000000000003 |
S |
2.17 |
5.8177000000000006E-2 |
2.17 |
ALG, DER |
|
|
|
|
25608 |
|
|
O |
EpiPen Jr. |
sol inj 1x2 ml/0,15 mg (amp.inj.skl.) |
MPH |
SK |
1 |
37.4 |
35.130000000000003 |
S |
2.27 |
6.0694999999999999E-2 |
2.17 |
ALG, DER |
|
|
|
|
C01CA24 |
|
|
|
Epinefrín |
parent. 0,3 mg |
1 |
DF |
|
|
|
|
|
|
|
|
32.200000000000003 |
|
|
|
25607 |
|
|
O |
EpiPen |
sol inj 1x2 ml/0,3 mg (amp.inj.skl.) |
MPH |
SK |
1 |
33 |
32.200000000000003 |
S |
0.8 |
2.4242E-2 |
0.8 |
ALG, DER |
|
|
|
|
00959 |
|
|
O |
Jext 300 mikrogramov |
sol ira 1x0,30 ml/300 µg(pero inj. napl.) |
AAO |
DK |
1 |
35.47 |
32.200000000000003 |
S |
3.27 |
9.2190999999999995E-2 |
0.8 |
ALG, DER |
|
|
|
|
32651 |
|
|
O |
EpiPen |
sol inj 2x2 ml/0,3 mg (amp.inj.skl.) |
MPH |
SK |
2 |
72 |
64.400000000000006 |
S |
7.6 |
0.105556 |
7.6 |
ALG, DER |
|
|
|
|
C01CA24 |
|
|
|
Epinefrín |
parent. 1 mg/ml |
0.5 |
mg |
|
|
|
|
|
|
|
|
0.47099999999999997 |
|
|
|
00362 |
|
|
G |
ADRENALIN LÉČIVA |
sol inj 5x1 ml/1 mg |
ZNT |
CZ |
10 |
4.6399999999999997 |
4.6399999999999997 |
A |
0 |
0 |
0 |
|
|
|
|
|
C01DA02 |
|
|
|
Glycerol trinitrát |
inhal. 1% |
2.5 |
mg |
|
|
|
|
|
|
|
|
7.4099999999999999E-2 |
|
|
|
24682 |
|
|
G |
NITROMINT AEROSOL |
aer slg 1x10 g |
EGI |
HU |
32 |
3.64 |
2.37 |
S |
1.27 |
0.34890099999999996 |
1.27 |
|
|
|
|
|
C01DA02 |
|
|
|
Glycerol trinitrát |
sublng. 0,5 mg (20 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
0.33300000000000002 |
|
|
|
00231 |
|
|
G |
NITROGLYCERIN SLOVAKOFARMA |
tbl slg 20x0,5 mg |
ZNT |
SK |
4 |
1.33 |
1.33 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01DA08 |
|
|
|
Izosorbid dinitrát |
inhal. spray 1,25 mg/d |
20 |
mg |
|
|
|
|
|
|
|
|
0.33189999999999997 |
|
|
|
85719 |
|
|
G |
ISOKET SPRAY |
aer ora 12,4 g (=15 ml) |
SWP |
DE |
18.747 |
9.0500000000000007 |
6.22 |
S |
2.83 |
0.31270700000000001 |
2.83 |
|
|
|
|
|
C01DA08 |
|
|
|
Izosorbid dinitrát |
p.o. predĺžené uvoľňovanie 40 mg (50 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
3.6499999999999998E-2 |
|
|
|
91484 |
X |
|
G |
CARDIKET RETARD 40 (ISOKET) |
tbl plg 50x40 mg |
SWP |
DE |
33.375 |
4.83 |
1.22 |
S |
3.61 |
0.74741200000000008 |
3.61 |
|
|
|
|
|
C01DA08 |
|
|
|
Izosorbid dinitrát |
p.o. predĺžené uvoľňovanie 120 mg (20 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
3.9800000000000002E-2 |
|
|
|
91591 |
X |
|
G |
CARDIKET RETARD 120 (ISOKET) |
cps plg 20x120 mg |
SWP |
DE |
40 |
6.88 |
1.59 |
S |
5.29 |
0.768895 |
5.29 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. 20 mg (20 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
9.2899999999999996E-2 |
|
|
|
34171 |
X |
|
G |
Monotab 20 |
tbl 20x20mg |
ZNT |
SK |
10 |
1.2 |
0.93 |
S |
0.27 |
0.22500000000000001 |
0.04 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. 20 mg (30 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
9.2899999999999996E-2 |
|
|
|
46125 |
X |
|
G |
Isosorbide mononitrate Vitabalans 20 mg tablety |
tbl 30x20 mg |
VTB |
FI |
15 |
1.52 |
1.39 |
S |
0.13 |
8.5526000000000005E-2 |
0.05 |
|
|
|
|
|
96190 |
X |
|
G |
MONOSAN 20 mg |
tbl 30x20 mg |
PMP |
CZ |
15 |
1.63 |
1.39 |
S |
0.24 |
0.14723900000000001 |
0.05 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. 20 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
9.2899999999999996E-2 |
|
|
|
96187 |
X |
|
G |
MONOSAN 20 mg |
tbl 50x20 mg |
PMP |
CZ |
25 |
2.57 |
2.3199999999999998 |
S |
0.25 |
9.7276000000000001E-2 |
0.09 |
|
|
|
|
|
76401 |
X |
|
G |
SORBIMON 20MG |
tbl 50x20 mg |
MCK |
DE |
25 |
2.85 |
2.3199999999999998 |
S |
0.53 |
0.18596499999999999 |
0.09 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. 20 mg (100 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
9.2899999999999996E-2 |
|
|
|
46126 |
X |
|
G |
Isosorbide mononitrate Vitabalans 20 mg tablety |
tbl 100x20 mg |
VTB |
FI |
50 |
4.83 |
4.6500000000000004 |
S |
0.18 |
3.7267000000000002E-2 |
0.18 |
|
|
|
|
|
76402 |
X |
|
G |
SORBIMON 20MG |
tbl 100x20 mg |
MCK |
DE |
50 |
5.54 |
4.6500000000000004 |
S |
0.89 |
0.16065000000000002 |
0.18 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. 40 mg (30 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
96191 |
X |
|
G |
MONOSAN 40 mg |
tbl 30x40 mg |
PMP |
CZ |
30 |
2.88 |
2.13 |
S |
0.75 |
0.26041700000000001 |
0.13 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. 40 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
96188 |
X |
|
G |
MONOSAN 40 mg |
tbl 50x40 mg |
PMP |
CZ |
50 |
3.77 |
3.55 |
S |
0.22 |
5.8354999999999997E-2 |
0.22 |
|
|
|
|
|
76404 |
X |
|
G |
SORBIMON 40MG |
tbl 50x40 mg |
MCK |
DE |
50 |
4.32 |
3.55 |
S |
0.77 |
0.17824100000000001 |
0.22 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. predĺžené uvoľňovanie 40 mg (20 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
26572 |
X |
|
O |
OLICARD 40 mg RETARD |
cps plg 20x40 mg (blis. PVC/PVDC/Al) |
BMN |
SK |
20 |
2.17 |
1.42 |
S |
0.75 |
0.34562199999999998 |
0.09 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. predĺžené uvoľňovanie 40 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
26573 |
X |
|
O |
OLICARD 40 mg RETARD |
cps plg 50x40 mg (blis. PVC/PVDC/Al) |
BMN |
SK |
50 |
5.34 |
3.55 |
S |
1.79 |
0.335206 |
0.22 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. predĺžené uvoľňovanie 60 mg (20 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
8.9599999999999999E-2 |
|
|
|
26575 |
X |
|
O |
OLICARD 60 mg RETARD |
cps plg 20x60 mg (blis. PVC/PVDC/Al) |
BMN |
SK |
30 |
5.63 |
2.69 |
S |
2.94 |
0.52220199999999994 |
2.4500000000000002 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. predĺžené uvoľňovanie 60 mg (28 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
8.9599999999999999E-2 |
|
|
|
28615 |
X |
|
O |
IMDUR 60 mg (blis.) |
tbl plg 28x60 mg |
AZC |
SE |
42 |
7.36 |
3.76 |
S |
3.6 |
0.48912999999999995 |
3.43 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. predĺžené uvoľňovanie 60 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
8.9599999999999999E-2 |
|
|
|
26576 |
X |
|
O |
OLICARD 60 mg RETARD |
cps plg 50x60 mg (blis. PVC/PVDC/Al) |
BMN |
SK |
75 |
12.84 |
6.72 |
S |
6.12 |
0.476636 |
6.12 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. predĺžené uvoľňovanie 100 mg (28 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
8.7999999999999995E-2 |
|
|
|
59467 |
X |
|
O |
MONO MACK DEPOT |
tbl plg 28x100 mg |
PFI-GB-3 |
GB |
70 |
7.65 |
6.16 |
S |
1.49 |
0.194771 |
1.49 |
|
|
|
|
|
C01DA14 |
|
|
|
Izosorbid mononitrát |
p.o. predĺžené uvoľňovanie 100 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
8.7999999999999995E-2 |
|
|
|
34178 |
X |
|
G |
Monotab SR |
tbl plg 50x100mg |
ZNT |
SK |
125 |
14.61 |
11 |
S |
3.61 |
0.24709100000000001 |
2.66 |
|
|
|
|
|
C01DX12 |
|
|
|
Molsidomín |
p.o. 2 mg (30 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
8.5000000000000006E-2 |
|
|
|
15114 |
X |
|
O |
CORVATON |
tbl 30x2 mg |
HBS |
SK |
10 |
2.96 |
0.85 |
S |
2.11 |
0.71283799999999997 |
2.11 |
|
|
|
|
|
C01DX12 |
|
|
|
Molsidomín |
p.o. 4 mg (30 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
7.9000000000000001E-2 |
|
|
|
15115 |
X |
|
O |
CORVATON FORTE |
tbl 30x4 mg |
HBS |
SK |
20 |
3.2 |
1.58 |
S |
1.62 |
0.50624999999999998 |
1.62 |
|
|
|
|
|
C01DX12 |
|
|
|
Molsidomín |
p.o. predĺžené uvoľňovanie 8 mg (30 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
5.2999999999999999E-2 |
|
|
|
15116 |
X |
|
O |
CORVATON RETARD |
tbl plg 30x8 mg |
HBS |
SK |
40 |
2.1 |
2.1 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01EA01 |
|
|
|
Alprostadil |
parent. |
20 |
µg |
|
|
|
|
|
|
|
|
4.24 |
|
|
|
92305 |
|
|
G |
ALPROSTAN |
con inf 10x0,2 ml |
ZNT |
CZ |
50 |
211.96 |
211.96 |
A |
0 |
0 |
0 |
ANG, CCH, CHI, KAR |
ind.obm. |
|
|
|
91731 |
|
|
G |
PROSTAVASIN |
plv ifo 10x5 ml |
SWP |
DE |
10 |
132.81 |
42.4 |
AS |
90.41 |
0.6807470000000001 |
90.41 |
ANG, CCH, CHI, KAR |
ind.obm. |
|
|
|
44168 |
|
|
G |
ALPROSTAPINT 20 ug/ ml |
con inf 5x1 ml/20 ug |
GBK-1 |
AT |
5 |
70.33 |
21.2 |
AS |
49.13 |
0.69856399999999996 |
45.21 |
ANG, CCH, CHI, KAR |
ind.obm. |
|
|
|
C01EB15 |
|
|
|
Trimetazidín |
p.o. 20 mg (90 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.1346 |
|
|
|
40498 |
X |
|
G |
TRIMETAZIDIN-RATIOPHARM 20 mg |
tbl flm 90x20 mg |
RAT |
DE |
45 |
6.66 |
6.06 |
S |
0.6 |
9.0090000000000003E-2 |
0.6 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
20736 |
X |
|
G |
Angitrim |
tbl flm 90x20 mg |
PMP |
CZ |
45 |
6.84 |
6.06 |
S |
0.78 |
0.114035 |
0.6 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
C01EB15 |
|
|
|
Trimetazidín |
p.o. predĺžené alebo riadené uvoľňovanie 35 mg (60 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.10199999999999999 |
|
|
|
02078 |
X |
|
G |
Trimetazidin - DemlGroup PR 35 mg |
tbl flp 60x35 mg (blis. PVC/PVDC/Al) |
CIA |
IN |
52.5 |
5.78 |
5.36 |
S |
0.42 |
7.2664000000000006E-2 |
0.42 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
04210 |
X |
|
G |
Trimetazidin Mylan 35mg |
tbl plg 60 x 35 mg(blis PVC/Aclar/Al) |
MYL |
FR |
52.5 |
5.78 |
5.36 |
S |
0.42 |
7.2664000000000006E-2 |
0.42 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
22114 |
X |
|
G |
Vascotazin |
tbl mod 60x35 mg (blis. PVC/PVDC/Al) |
ACT-5 |
IS |
52.5 |
6.05 |
5.36 |
S |
0.69 |
0.11405 |
0.42 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
30454 |
X |
|
G |
Trimepect 35 mg |
tbl plg 60 x 35 mg (blis.Al/Al) |
PRW |
CZ |
52.5 |
6.35 |
5.36 |
S |
0.99 |
0.15590599999999999 |
0.42 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
09510 |
X |
|
G |
PROTEVASC 35 mg |
tbl plg 60x35 mg |
GDN |
HU |
52.5 |
6.6 |
5.36 |
S |
1.24 |
0.18787900000000002 |
0.42 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
33342 |
X |
|
O |
Preductal MR |
tbl mod 60x35 mg |
LLG |
FR |
52.5 |
9.23 |
5.36 |
S |
3.87 |
0.41928500000000002 |
0.42 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
C01EB15 |
|
|
|
Trimetazidín |
p.o. predĺžené alebo riadené uvoľňovanie 35 mg (120 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.10199999999999999 |
|
|
|
32501 |
X |
|
G |
Protevasc 35 mg tablety s predĺženým uvoľňovaním |
tbl plg 120 x 35 mg (blis. Al/PVC) |
GDN |
HU |
105 |
12.12 |
10.71 |
S |
1.41 |
0.116337 |
0.84 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
33348 |
X |
|
O |
PREDUCTAL MR |
tbl mod 120x35 mg |
SVE |
FR |
105 |
18.29 |
10.71 |
S |
7.58 |
0.41443399999999997 |
0.84 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
C01EB17 |
|
|
|
Ivabradín |
p.o. 5 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.675 |
|
|
|
95129 |
X |
|
O |
Procoralan |
tbl flm 56x5 mg |
SVE |
FR |
28 |
47.75 |
46.9 |
S |
0.85 |
1.7801000000000001E-2 |
0.85 |
INT, KAR, KLF |
ind.obm. |
|
|
|
C01EB17 |
|
|
|
Ivabradín |
p.o. 7,5 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.087 |
|
|
|
95136 |
X |
|
O |
Procoralan |
tbl flm 56x7,5 mg |
SVE |
FR |
42 |
46.75 |
45.65 |
S |
1.1000000000000001 |
2.3529000000000001E-2 |
1.1000000000000001 |
INT, KAR, KLF |
ind.obm. |
|
|
|
C02AB01 |
|
|
|
L- metyldopa |
p.o. 250 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.46899999999999997 |
|
|
|
01328 |
X |
|
G |
DOPEGYT |
tbl 50x250 mg |
EGI |
HU |
12.5 |
6.63 |
5.86 |
S |
0.77 |
0.11613899999999999 |
0.77 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,2 mg (28-30 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.17299999999999999 |
|
|
|
37735 |
X |
|
G |
Moxonidin Actavis 0,2mg |
tbl flm 30x0,2 mg |
ACT |
IS |
20 |
3.44 |
3.44 |
I |
0 |
0 |
0 |
|
|
|
|
|
37695 |
X |
|
G |
Moxonidin ratiopharm 0,2mg |
tbl flm 30x0,2 mg |
RAT |
DE |
20 |
3.44 |
3.44 |
I |
0 |
0 |
0 |
|
|
|
|
|
42231 |
X |
|
G |
MOXOSTAD 0,2 mg |
tbl flm 30x0,2 mg |
STD |
DE |
20 |
3.44 |
3.44 |
I |
0 |
0 |
0 |
|
|
|
|
|
42638 |
X |
|
G |
Moxogamma 0,2 mg |
tbl flm 30x0,2 mg |
WGP |
DE |
20 |
3.61 |
3.46 |
S |
0.15 |
4.1550999999999998E-2 |
0 |
|
|
|
|
|
28720 |
X |
|
O |
CYNT 0,2 |
tbl flm 30x0,2 mg (blis.) |
BMN |
SK |
20 |
6.29 |
3.46 |
S |
2.83 |
0.44992100000000002 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,2 mg (100 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.17299999999999999 |
|
|
|
42235 |
X |
|
G |
MOXOSTAD 0,2 mg |
tbl flm 100x0,2 mg |
STD |
DE |
66.667000000000002 |
11.47 |
11.47 |
I |
0 |
0 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,3 mg (28-30 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.13500000000000001 |
|
|
|
37749 |
X |
|
G |
Moxonidin Actavis 0,3mg |
tbl flm 30x0,3 mg |
ACT |
IS |
30 |
4.04 |
4.04 |
I |
0 |
0 |
0 |
|
|
|
|
|
37700 |
X |
|
G |
Moxonidin ratiopharm 0,3mg |
tbl flm 30x0,3 mg |
RAT |
DE |
30 |
4.04 |
4.04 |
I |
0 |
0 |
0 |
|
|
|
|
|
42636 |
X |
|
G |
Moxogamma 0,3 mg |
tbl flm 30x0,3 mg |
WGP |
DE |
30 |
4.4000000000000004 |
4.05 |
S |
0.35 |
7.9545000000000005E-2 |
0 |
|
|
|
|
|
42241 |
X |
|
G |
MOXOSTAD 0,3 mg |
tbl flm 30x0,3 mg |
STD |
DE |
30 |
5.18 |
4.05 |
S |
1.1299999999999999 |
0.21814699999999998 |
0 |
|
|
|
|
|
28725 |
X |
|
O |
CYNT 0,3 |
tbl flm 30x0,3 mg (blis.) |
BMN |
SK |
30 |
8.0299999999999994 |
4.05 |
S |
3.98 |
0.49564100000000005 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,3 mg (98-100 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.13500000000000001 |
|
|
|
37755 |
X |
|
G |
Moxonidin Actavis 0,3 mg filmom obalená tableta |
tbl flm 100x0,3 mg |
ACT-3 |
IS |
100 |
13.47 |
13.47 |
I |
0 |
0 |
0 |
|
|
|
|
|
42246 |
X |
|
G |
MOXOSTAD 0,3 mg |
tbl flm 100x0,3 mg |
STD |
DE |
100 |
13.47 |
13.47 |
I |
0 |
0 |
0 |
|
|
|
|
|
10462 |
X |
|
O |
CYNT 0,3 |
tbl flm 98 x 0,3 mg (blis.PVC/PVDC/ALU) |
BMN |
SK |
98 |
20.72 |
13.23 |
S |
7.49 |
0.36148600000000003 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,4 mg (28-30 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.14499999999999999 |
|
|
|
37763 |
X |
|
G |
Moxonidin Actavis 0,4mg |
tbl flm 30x0,4 mg |
ACT |
IS |
40 |
5.41 |
5.41 |
I |
0 |
0 |
0 |
|
|
|
|
|
37705 |
X |
|
G |
Moxonidin ratiopharm 0,4mg |
tbl flm 30x0,4 mg |
RAT |
DE |
40 |
5.41 |
5.41 |
I |
0 |
0 |
0 |
|
|
|
|
|
42252 |
X |
|
G |
MOXOSTAD 0,4 mg |
tbl flm 30x0,4 mg |
STD |
DE |
40 |
5.41 |
5.41 |
I |
0 |
0 |
0 |
|
|
|
|
|
42658 |
X |
|
G |
Moxogamma 0,4 mg |
tbl flm 30x0,4 mg |
WGP |
DE |
40 |
5.57 |
5.57 |
I |
0 |
0 |
0 |
|
|
|
|
|
28730 |
X |
|
O |
CYNT 0,4 |
tbl flm 30x0,4 mg (blis.) |
BMN |
SK |
40 |
7.71 |
5.8 |
S |
1.91 |
0.24773000000000001 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,4 mg (98-100 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.14499999999999999 |
|
|
|
37777 |
X |
|
G |
Moxonidin Actavis 0,4 mg filmom obalená tableta |
tbl flm 100x0,4 mg |
ACT-3 |
IS |
133.333 |
18 |
18 |
I |
0 |
0 |
0 |
|
|
|
|
|
42256 |
X |
|
G |
MOXOSTAD 0,4 mg |
tbl flm 100x0,4 mg |
STD |
DE |
133.333 |
18 |
18 |
I |
0 |
0 |
0 |
|
|
|
|
|
10463 |
X |
|
O |
CYNT 0,4 |
tbl flm 98 x 0,4 mg (blis.PVC/PVDC/ALU) |
BMN |
SK |
130.667 |
21.49 |
18.95 |
S |
2.54 |
0.11819499999999999 |
0 |
|
|
|
|
|
C02AC06 |
|
|
|
Rilmenidín |
p.o. 1 mg (30 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
22777 |
X |
|
G |
Rilmenidin Teva 1 mg |
tbl 30x1 mg (blis.Al/Al) |
DEL |
FR |
30 |
6.16 |
5.64 |
S |
0.52 |
8.4415999999999991E-2 |
0.52 |
|
|
|
|
|
23521 |
X |
|
G |
Rilmex 1 mg tablety |
tbl 30x1 mg (blis.Al/Al) |
ZNT |
CZ |
30 |
6.16 |
5.64 |
S |
0.52 |
8.4415999999999991E-2 |
0.52 |
|
|
|
|
|
84360 |
X |
|
O |
TENAXUM |
tbl 30x1 mg |
LLG |
FR |
30 |
9.5 |
5.64 |
S |
3.86 |
0.40631600000000001 |
0.52 |
|
|
|
|
|
C02AC06 |
|
|
|
Rilmenidín |
p.o. 1 mg (60 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
42683 |
X |
|
O |
TENAXUM |
tbl 60x1 mg |
SVE |
FR |
60 |
17.809999999999999 |
11.28 |
S |
6.53 |
0.36664799999999997 |
1.03 |
|
|
|
|
|
C02AC06 |
|
|
|
Rilmenidín |
p.o. 1 mg (90 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
22779 |
X |
|
G |
Rilmenidin Teva 1 mg |
tbl 90x1 mg (blis.Al/Al) |
TEV |
SK |
90 |
18.47 |
16.920000000000002 |
S |
1.55 |
8.3919999999999995E-2 |
1.55 |
|
|
|
|
|
23523 |
X |
|
G |
Rilmex 1 mg tablety |
tbl 90x1 mg (blis.Al/Al) |
ZNT |
CZ |
90 |
18.47 |
16.920000000000002 |
S |
1.55 |
8.3919999999999995E-2 |
1.55 |
|
|
|
|
|
50408 |
X |
|
O |
TENAXUM |
tbl 90x1 mg |
SVE |
FR |
90 |
28.15 |
16.920000000000002 |
S |
11.23 |
0.39893400000000001 |
1.55 |
|
|
|
|
|
C02CA04 |
|
|
|
Doxazosín |
p.o. predĺžené uvoľňovanie 4 mg (28-30 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.17100000000000001 |
|
|
|
97797 |
X |
|
G |
KAMIREN XL 4 mg |
tbl mod 30x4mg |
KRK |
SI |
30 |
7.61 |
5.13 |
S |
2.48 |
0.32588700000000004 |
1.63 |
END, INT, KAR, KLF, NEF, URO |
|
|
|
U20 |
C02CA04 |
|
|
|
Doxazosín |
p.o. predĺžené uvoľňovanie 4 mg (90 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.17100000000000001 |
|
|
|
97798 |
X |
|
G |
KAMIREN XL 4 mg |
tbl mod 90x4mg |
KRK |
SI |
90 |
20.29 |
15.39 |
S |
4.9000000000000004 |
0.24149799999999999 |
4.9000000000000004 |
END, INT, KAR, KLF, NEF, URO |
|
|
|
U20 |
C02CA06 |
|
|
|
Urapidil |
p.o. predĺžené uvoľňovanie 30 mg (50 ks) |
0.12 |
g |
|
|
|
|
|
|
|
|
0.77010000000000001 |
|
|
|
90760 |
X |
|
O |
EBRANTIL RETARD |
cps 50x30 mg |
BGL |
DE |
12.5 |
9.58 |
9.58 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C02CA06 |
|
|
|
Urapidil |
p.o. predĺžené uvoľňovanie 60 mg (50 ks) |
0.12 |
g |
|
|
|
|
|
|
|
|
0.65 |
|
|
|
89771 |
X |
|
O |
EBRANTIL RETARD |
cps 50x60 mg |
BGL |
DE |
25 |
15.89 |
15.89 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C02KX01 |
|
|
|
Bosentan |
p.o. 62,5 mg (56 ks) |
250 |
mg |
|
|
|
|
|
|
|
|
150.37 |
|
|
|
41413 |
|
|
O |
Tracleer 62,5 mg filmom obalené tablety |
tbl flm 56x62,5 mg (blis.PVC/PE/PVDC/Al) |
ACB |
GB |
14 |
2105 |
2105 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
C02KX01 |
|
|
|
Bosentan |
p.o. 125 mg (56 ks) |
250 |
mg |
|
|
|
|
|
|
|
|
76.105000000000004 |
|
|
|
41415 |
|
|
O |
Tracleer 125 mg filmom obalené tablety |
tbl flm 56x125 mg (blis.PVC/PE/PVDC/Al) |
ACB |
GB |
28 |
2130.92 |
2130.92 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
C02KX02 |
|
|
|
Ambrisentan |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
74.352000000000004 |
|
|
|
50467 |
|
|
O |
Volibris |
tbl flm 30x5 mg |
GLA |
GB |
30 |
2230.54 |
2230.54 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
C02KX02 |
|
|
|
Ambrisentan |
p.o. 10 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
37.950000000000003 |
|
|
|
50469 |
|
|
O |
Volibris |
tbl flm 30x10 mg |
GLA |
GB |
60 |
2276.56 |
2276.56 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
C03AA03 |
|
|
|
Hydrochlórotiazid |
p.o. 25 mg (20 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
0.10299999999999999 |
|
|
|
00168 |
X |
|
G |
HYDROCHLOROTHIAZID LÉČIVA |
tbl 20x25 mg |
ZNT |
CZ |
20 |
2.0099999999999998 |
2.0099999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03BA |
|
|
|
Sulfonamidy, samotné, metipamid |
p.o. 2,5 mg (30 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
6.83E-2 |
|
|
|
94810 |
X |
|
G |
HYPOTYLIN |
tbl 30x2,5 mg |
ZNT |
CZ |
30 |
2.46 |
2.0499999999999998 |
S |
0.41 |
0.16666699999999998 |
0.41 |
|
|
|
|
|
C03BA11 |
|
|
|
Indapamid |
p.o. 2,5 mg (30 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
3.9800000000000002E-2 |
|
|
|
96696 |
X |
|
G |
INDAP |
cps 30x2,5 mg |
PMP |
CZ |
50 |
1.91 |
1.91 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03BA11 |
|
|
|
Indapamid |
p.o. predĺžené uvoľňovanie 1,5 mg (30 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
52163 |
X |
|
G |
Actapam 1,5 mg |
tbl plg 30x1,5 mg |
ACT |
IS |
30 |
2.2999999999999998 |
2.2999999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
49965 |
X |
|
G |
Indapamid STADA 1,5 mg |
tbl plg 30x1,5 mg |
STD |
NO |
30 |
2.2999999999999998 |
2.2999999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
53477 |
X |
|
G |
Indapamide Orion 1,5 mg |
tbl plg 30x1,5 mg |
ORN |
FI |
30 |
2.2999999999999998 |
2.2999999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
69884 |
X |
|
G |
Indapamid ratiopharm 1,5mg |
tbl plg 30x1,5 mg |
RAT |
DE |
30 |
2.39 |
2.39 |
I |
0 |
0 |
0 |
|
|
|
|
|
93320 |
X |
|
G |
RAWEL SR |
tbl flp 30x1,5 mg |
KRK |
SI |
30 |
2.41 |
2.4 |
S |
0.01 |
4.1489999999999999E-3 |
0 |
|
|
|
|
|
12581 |
X |
|
O |
TERTENSIF SR |
tbl flp 30x1,5 mg |
LLG |
FR |
30 |
4.1900000000000004 |
2.4 |
S |
1.79 |
0.42720799999999998 |
0 |
|
|
|
|
|
91992 |
X |
|
O |
Apadex |
tbl flp 30x1,5 mg |
EGI |
HU |
30 |
4.37 |
2.4 |
S |
1.97 |
0.45080100000000001 |
0 |
|
|
|
|
|
C03BA11 |
|
|
|
Indapamid |
p.o. predĺžené uvoľňovanie 1,5 mg (90-100 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
53479 |
X |
|
G |
Indapamide Orion 1,5 mg |
tbl plg 90x1,5 mg |
ORN |
FI |
90 |
7.29 |
7.2 |
S |
0.09 |
1.2345999999999999E-2 |
0 |
|
|
|
|
|
64182 |
X |
|
G |
RAWEL SR |
tbl flp 90x1,5 mg |
KRK |
SI |
90 |
7.58 |
7.2 |
S |
0.38 |
5.0132000000000003E-2 |
0 |
|
|
|
|
|
49969 |
X |
|
G |
Indapamid STADA 1,5 mg |
tbl plg 100x1,5 mg |
STD |
DE |
100 |
9.27 |
8 |
S |
1.27 |
0.13700100000000001 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
p.o. 40 mg (20 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
3.9800000000000002E-2 |
|
|
|
02079 |
X |
|
G |
FUROSEMID SLOVAKOFARMA |
tbl 2x10x40 mg |
ZNT |
SK |
20 |
0.91 |
0.8 |
S |
0.11 |
0.120879 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
p.o. 40 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
3.9800000000000002E-2 |
|
|
|
98219 |
X |
|
G |
FURON |
tbl 50x40 mg |
MCK |
DE |
50 |
1.94 |
1.94 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
p.o. 250 mg (10 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
02785 |
X |
|
G |
FUROSEMID SLOVAKOFARMA FORTE |
tbl 10x250 mg |
ZNT |
SK |
62.537999999999997 |
2.62 |
2.06 |
S |
0.56000000000000005 |
0.21373999999999999 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
p.o. 250 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
56811 |
X |
|
G |
FURORESE 250 |
tbl 50x250 mg |
SFS |
DE |
312.5 |
10.31 |
10.31 |
I |
0 |
0 |
0 |
|
|
|
|
|
90108 |
X |
|
G |
Furosemid-Slovakofarma forte |
tbl 50x250 mg (blis.PVC/Al) |
ZNT |
SK |
312.5 |
10.31 |
10.31 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
p.o. 250 mg (100 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
56812 |
X |
|
G |
FURORESE 250 |
tbl 100x250 mg |
SFS |
DE |
625 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
parent. 10 mg/ml |
40 |
mg |
|
|
|
|
|
|
|
|
0.41 |
|
|
|
02133 |
|
|
G |
FUROSEMID BIOTIKA |
sol inj 5x2 ml/20 mg |
HBS |
SK |
2.5 |
1.44 |
1.03 |
S |
0.41 |
0.28472200000000003 |
0.41 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
parent. 12,5 mg/ml |
40 |
mg |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
99333 |
|
|
G |
FUROSEMID BIOTIKA FORTE |
sol inj 10x10 ml/125 mg |
HBS |
SK |
31.25 |
10.25 |
10.25 |
A |
0 |
0 |
0 |
|
|
|
|
|
C03DA01 |
|
|
|
Spironolaktón |
p.o. 25 mg (100 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
0.129 |
|
|
|
8859A |
X |
|
G |
MEDOSPIR 25 mg |
tbl 100x25 mg (blis.PVC/Al) |
MPM-1 |
CZ |
33.33 |
7 |
4.3 |
S |
2.7 |
0.38571399999999995 |
2.7 |
|
|
|
|
|
30434 |
X |
|
O |
VEROSPIRON (BLIST.) |
tbl 100x25 mg |
GDN |
HU |
33.33 |
7.26 |
4.3 |
S |
2.96 |
0.40771299999999999 |
2.7 |
|
|
|
|
|
C03DA04 |
|
|
|
Eplerenón |
p.o. 25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.78400000000000003 |
|
|
|
0678A |
X |
|
G |
Eleveon 25 mg |
tbl flm 30x25 mg (blis.PVC/Al nepriehľ.) |
ZNT |
CZ |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
7039A |
X |
|
G |
Eplerenon Mylan 25 mg filmom obalené rablety |
tbl flm 30 x 25 mg (fľ. HDPE) |
GNS |
UK |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
08245 |
X |
|
G |
Eplerenon STADA 25 mg filmom obalené tablety |
tbl flm 30x25 mg (blis.PVC/Al) |
STD |
DE |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3378B |
X |
|
G |
Eplerenone Actavis 25 mg |
tbl flm 30x25 mg (blis.PVC/Al) |
ACT-5 |
IS |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3399A |
X |
|
G |
Eplerenone Teva 25 mg |
tbl flm 30x1x25 mg (blis.PVC/PVDC/Al perf.) |
TEV-SK |
SK |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
96327 |
X |
|
O |
INSPRA 25 mg filmom obalené tablety |
tbl flm 30x1x25 mg (blis.PVC/Al nepriehľ.perf.) |
PFI-GB-3 |
GB |
30 |
32.76 |
23.52 |
S |
9.24 |
0.282051 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
C03DA04 |
|
|
|
Eplerenón |
p.o. 25 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.78400000000000003 |
|
|
|
0680A |
X |
|
G |
Eleveon 25 mg |
tbl flm 90x25 mg (blis.PVC/Al nepriehľ.) |
ZNT |
CZ |
90 |
70.53 |
70.53 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3401A |
X |
|
G |
Eplerenone Teva 25 mg |
tbl flm 90x1x25 mg (blis.PVC/PVDC/Al perf.) |
TEV-SK |
SK |
90 |
70.53 |
70.53 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
9253A |
X |
|
G |
Eplerenon STADA 25 mg filmom obalené tablety |
tbl flm 100x25 mg (blis.PVC/Al) |
STD |
DE |
100 |
78.38 |
78.38 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
C03DA04 |
|
|
|
Eplerenón |
p.o. 50 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.78400000000000003 |
|
|
|
0625A |
X |
|
G |
Eleveon 50 mg |
tbl flm 30x50 mg (blis.PVC/Al nepriehľ.) |
ZNT |
CZ |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
7043A |
X |
|
G |
Eplerenon Mylan 50 mg filmom obalené tablety |
tbl flm 30 x 50 mg (fľ.HDPE) |
GNS |
UK |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
08247 |
X |
|
G |
Eplerenon STADA 50 mg filmom obalené tablety |
tbl flm 30x50 mg (blis.PVC/Al) |
STD |
DE |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3390B |
X |
|
G |
Eplerenone Actavis 50 mg |
tbl flm 30x50 mg (blis.PVC/Al) |
ACT-5 |
IS |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3381A |
X |
|
G |
Eplerenone Teva 50 mg |
tbl flm 30x1x50 mg (blis.PVC/PVDC/Al perf.) |
TEV-SK |
SK |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
96408 |
X |
|
O |
INSPRA 50 mg filmom obalené tablety |
tbl flm 30x1x50 mg (blis.PVC/Al nepriehľ.perf.) |
PFI-GB-3 |
GB |
30 |
32.76 |
23.52 |
S |
9.24 |
0.282051 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
C03DA04 |
|
|
|
Eplerenón |
p.o. 50 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.78400000000000003 |
|
|
|
0627A |
X |
|
G |
Eleveon 50 mg |
tbl flm 90x50 mg (blis.PVC/Al nepriehľ.) |
ZNT |
CZ |
90 |
70.53 |
70.53 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3383A |
X |
|
G |
Eplerenone Teva 50 mg |
tbl flm 90x1x50 mg (blis.PVC/PVDC/Al perf.) |
TEV-SK |
SK |
90 |
70.53 |
70.53 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
9257A |
X |
|
G |
Eplerenon STADA 50 mg filmom obalené tablety |
tbl flm 100x50 mg (blis.PVC/Al) |
STD |
DE |
100 |
78.38 |
78.38 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
C03EA01 |
|
|
|
Hydrochlórotiazid a liečivá šetriace draslík |
p.o. (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.1999999999999995E-2 |
|
|
|
70425 |
|
|
G |
RHEFLUIN |
tbl 30 |
ZNT-1 |
CZ |
30 |
2.0699999999999998 |
2.0699999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
68965 |
|
|
O |
MODURETIC |
tbl 30 |
MSD |
NL |
30 |
2.09 |
2.09 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03EA06 |
|
|
|
Chlórtalidon a draslík šetriace diuretikum |
p.o. (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.4999999999999997E-2 |
|
|
|
88518 |
|
|
G |
AMICLOTON |
tbl 30 |
ZNT |
SK |
30 |
1.99 |
1.99 |
I |
0 |
0 |
0 |
|
|
|
|
|
C04AX21 |
|
|
|
Naftidrofuryl |
p.o. predĺžené uvoľňovanie 100 mg (50 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.14399999999999999 |
|
|
|
97026 |
X |
|
G |
ENELBIN 100 RETARD (BLIST.) |
tbl flp 50x100 mg |
STD |
DE |
25 |
5.0599999999999996 |
3.6 |
S |
1.46 |
0.28853800000000002 |
1.1200000000000001 |
|
|
|
|
|
C04AX21 |
|
|
|
Naftidrofuryl |
p.o. predĺžené uvoľňovanie 100 mg (100 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.14399999999999999 |
|
|
|
66015 |
X |
|
G |
ENELBIN 100 RETARD (FĽAŠ.PE) |
tbl flp 100x100 mg |
STD |
DE |
50 |
9.44 |
7.2 |
S |
2.2400000000000002 |
0.237288 |
2.2400000000000002 |
|
|
|
|
|
C05AE01 |
|
|
|
Glyceroltrinitrát |
loc. rektálna masť |
3 |
mg |
|
|
|
|
|
|
|
|
1.01 |
|
|
|
35672 |
|
|
O |
RECTOGESIC 4mg/g rektálna masť |
ung rec 1x30mg |
STR |
GB |
40 |
45.51 |
40.4 |
S |
5.1100000000000003 |
0.11228300000000001 |
5.1100000000000003 |
CCH, CHI, GIT |
|
|
|
|
C07AB02 |
|
|
|
Metoprolol |
p.o. 25 mg (60 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
54150 |
X |
|
G |
EGILOK 25 mg |
tbl 60x25 mg |
EGI |
HU |
10 |
1.41 |
1.22 |
S |
0.19 |
0.13475199999999998 |
0 |
|
|
|
|
U77 |
C07AB02 |
|
|
|
Metoprolol |
p.o. 50 mg (50-60 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
25634 |
X |
|
G |
VASOCARDIN 50(BLIST.5X10 TAB) |
tbl 50x50 mg |
ZNT |
SK |
16.657 |
2.02 |
2.02 |
I |
0 |
0 |
0 |
|
|
|
|
U77 |
84093 |
X |
|
G |
CORVITOL 50 |
tbl 50x50 mg |
BCE |
DE |
16.657 |
2.12 |
2.0299999999999998 |
S |
0.09 |
4.2453000000000005E-2 |
0 |
|
|
|
|
U77 |
54151 |
X |
|
G |
EGILOK 50 mg |
tbl 60x50 mg |
EGI |
HU |
20 |
2.59 |
2.44 |
S |
0.15 |
5.7915000000000001E-2 |
0 |
|
|
|
|
U77 |
C07AB02 |
|
|
|
Metoprolol |
p.o. 100 mg (50-60 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
27978 |
X |
|
G |
EGILOK 100 mg |
tbl 60x100 mg |
EGI |
HU |
40 |
4.8 |
4.8 |
I |
0 |
0 |
0 |
|
|
|
|
U77 |
26610 |
X |
|
G |
VASOCARDIN 100 (blis.5x10 tbl.) |
tbl 50x100 mg |
ZNT |
SK |
33.343000000000004 |
4.04 |
4.04 |
I |
0 |
0 |
0 |
|
|
|
|
U77 |
C07AB02 |
|
|
|
Metoprolol |
p.o. predĺžené uvoľňovanie 25 mg (28-30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.41 |
|
|
|
81678 |
X |
|
G |
Metoprolol Mylan 23,75mg |
tbl plg 30x23,75 mg |
GNC |
GB |
5 |
2.0499999999999998 |
2.0499999999999998 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
69814 |
X |
|
G |
Metoprolol ratiopharm 25 mg |
tbl plg 30x25 mg |
RAT |
DE |
5 |
2.0499999999999998 |
2.0499999999999998 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
0093A |
X |
|
G |
Egilok XL 25mg (blis. PVC/PE/PVDC/AL) |
tbl plg 30x25mg |
EGI |
HU |
5 |
3.65 |
2.0499999999999998 |
S |
1.6 |
0.43835599999999997 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
14959 |
X |
|
O |
BETALOC ZOK 25MG (blist.) |
tbl mod 28x25 mg |
AZC |
SE |
4.6680000000000001 |
4.92 |
1.91 |
S |
3.01 |
0.61178900000000003 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB02 |
|
|
|
Metoprolol |
p.o. predĺžené uvoľňovanie 50 mg (28-30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.17399999999999999 |
|
|
|
69827 |
X |
|
G |
Metoprolol ratiopharm 50 mg |
tbl plg 30x50mg |
RAT |
DE |
10 |
1.67 |
1.67 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
0104A |
X |
|
G |
Egilok XL 50mg (blis. PVC/PE/PVDC/Al) |
tbl plg 30x50mg |
EGI |
HU |
10 |
3.41 |
1.74 |
S |
1.67 |
0.48973599999999995 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
28641 |
X |
|
O |
BETALOC ZOK 50MG (blist.) |
tbl mod 28x50 mg |
AZC |
SE |
9.3360000000000003 |
5.07 |
1.62 |
S |
3.45 |
0.68047300000000011 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB02 |
|
|
|
Metoprolol |
p.o. predĺžené uvoľňovanie 50 mg (100 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.17399999999999999 |
|
|
|
0110A |
X |
|
G |
Egilok XL 50mg |
tbl plg 100x50mg |
EGI |
HU |
33.332999999999998 |
10.47 |
5.8 |
S |
4.67 |
0.44603599999999999 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB02 |
|
|
|
Metoprolol |
p.o. predĺžené uvoľňovanie 100 mg (28-30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.17 |
|
|
|
81715 |
X |
|
G |
Metoprolol Mylan 95mg |
tbl plg 30x95 mg |
GNC |
GB |
20 |
3.17 |
3.17 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
69840 |
X |
|
G |
Metoprolol ratiopharm 100 mg |
tbl plg 30x100 mg |
RAT |
DE |
20 |
3.17 |
3.17 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
0128A |
X |
|
G |
Egilok XL 100mg |
tbl plg 30x100mg |
EGI |
HU |
20 |
4.76 |
3.4 |
S |
1.36 |
0.28571400000000002 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
28639 |
X |
|
O |
BETALOC ZOK 100 mg (blist.) |
tbl mod 28x100 mg |
AZC |
SE |
18.669 |
6.23 |
3.17 |
S |
3.06 |
0.49117199999999994 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB02 |
|
|
|
Metoprolol |
p.o. predĺžené uvoľňovanie 200 mg (28-30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.10290000000000001 |
|
|
|
33279 |
X |
|
G |
VASOCARDIN SR 200 (BLIST.) |
tbl plg 30x200 mg |
ZNT |
SK |
40 |
5.34 |
4.12 |
S |
1.22 |
0.228464 |
1.22 |
|
|
|
|
|
C07AB03 |
|
|
|
Atenolol |
p.o. 50 mg (50 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
5.5E-2 |
|
|
|
24949 |
X |
|
G |
ATENOBENE |
tbl obd 50x50 mg |
MCK |
DE |
33.317999999999998 |
2.75 |
1.83 |
S |
0.92 |
0.33454500000000004 |
0.92 |
|
|
|
|
U78 |
C07AB03 |
|
|
|
Atenolol |
p.o. 100 mg (50 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
5.5E-2 |
|
|
|
24950 |
X |
|
G |
ATENOBENE |
tbl obd 50x100 mg |
MCK |
DE |
66.667000000000002 |
3.62 |
3.62 |
I |
0 |
0 |
0 |
|
|
|
|
U78 |
C07AB05 |
|
|
|
Betaxolol |
p.o. 20 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
96475 |
X |
|
O |
LOKREN 20 mg |
tbl flm 28x20 mg |
XSB |
FR |
28 |
4.03 |
4.03 |
I |
0 |
0 |
0 |
|
|
|
|
|
59188 |
X |
|
G |
BETAC |
tbl flm 30x20mg |
MOE |
CY |
30 |
4.5 |
4.5 |
I |
0 |
0 |
0 |
|
|
|
|
|
C07AB05 |
|
|
|
Betaxolol |
p.o. 20 mg (50-56 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
33497 |
X |
|
O |
LOKREN 20 mg |
tbl flm 56x20 mg |
XSB |
FR |
56 |
10.72 |
8.4 |
S |
2.3199999999999998 |
0.216418 |
0 |
|
|
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. cor 2,5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.14499999999999999 |
|
|
|
8137A |
X |
|
G |
Sobycor 2,5 mg filmom obalené tablety |
tbl flm 30x2,5mg(blis.Al/Al) |
KRK |
SL |
7.5 |
1.99 |
1.0900000000000001 |
S |
0.9 |
0.45226100000000002 |
0.9 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
1531A |
X |
|
G |
TYREZ 2,5 mg |
tbl flm 30x2,5 mg(blis.PVC/TE/PVDC/Al-perf.) |
ALK |
SI |
7.5 |
1.99 |
1.0900000000000001 |
S |
0.9 |
0.45226100000000002 |
0.9 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
84822 |
X |
|
G |
Bisobela 2,5 mg tablety |
tbl 30x2,5 mg |
BLU |
SR |
7.5 |
2.4300000000000002 |
1.0900000000000001 |
S |
1.34 |
0.55143999999999993 |
0.9 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
33427 |
X |
|
O |
Concor COR 2,5 mg |
tbl flm 30x2,5 mg |
MEC |
DE |
7.5 |
3.64 |
1.0900000000000001 |
S |
2.5499999999999998 |
0.70054900000000009 |
0.9 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. cor 5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.11700000000000001 |
|
|
|
47492 |
X |
|
G |
Bisobela 5 mg tablety |
tbl 30x5 mg |
BLU |
SK |
15 |
3.85 |
1.76 |
S |
2.09 |
0.54285700000000003 |
0.21 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
33428 |
X |
|
O |
Concor COR 5 mg |
tbl flm 30x5 mg |
MEC |
DE |
15 |
5.38 |
1.76 |
S |
3.62 |
0.67286199999999996 |
0.21 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. cor 5 mg (50 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.11700000000000001 |
|
|
|
47494 |
X |
|
G |
Bisobela 5 mg tablety |
tbl 50x5 mg |
BLU |
SK |
25 |
6.43 |
2.93 |
S |
3.5 |
0.544323 |
0.35 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. cor 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.105 |
|
|
|
33429 |
X |
|
O |
Concor COR 10 mg |
tbl flm 30x10 mg |
MEC |
DE |
30 |
6.76 |
3.15 |
S |
3.61 |
0.53402400000000005 |
0.22 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. 5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
7.1999999999999995E-2 |
|
|
|
33446 |
X |
|
G |
Bisoprolol-ratiopharm 5 mg |
tbl 30x5 mg |
MCK |
DE |
15 |
1.29 |
1.08 |
S |
0.21 |
0.16279099999999999 |
0.21 |
|
|
|
|
|
8147A |
X |
|
G |
Sobycor 5 mg filmom obalené tablety |
tbl flm 30x5mg(blis.Al/Al) |
KRK |
SL |
15 |
1.49 |
1.08 |
S |
0.41 |
0.27516800000000002 |
0.21 |
|
|
|
|
|
90028 |
X |
|
G |
CORONAL 5 |
tbl flm 30x5 mg (PVC/PE/PVDC/Alu blist.) |
ZNT |
SK |
15 |
1.57 |
1.08 |
S |
0.49 |
0.31210199999999999 |
0.21 |
|
|
|
|
|
1521A |
X |
|
G |
TYREZ 5 mg |
tbl flm 30x5 mg(blis.PVC/TE/PVDC/Al-perf.) |
ALK |
SI |
15 |
1.58 |
1.08 |
S |
0.5 |
0.31645600000000002 |
0.21 |
|
|
|
|
|
54448 |
X |
|
G |
Bisoprolol Vitabalans 5 mg tablety |
tbl 30x5 mg |
VTB |
FI |
15 |
1.68 |
1.08 |
S |
0.6 |
0.35714299999999999 |
0.21 |
|
|
|
|
|
58856 |
X |
|
G |
BISOCARD 5 mg |
tbl flm 30x5 mg |
PRW |
CZ |
15 |
1.71 |
1.08 |
S |
0.63 |
0.368421 |
0.21 |
|
|
|
|
|
37078 |
X |
|
G |
RIVOCOR 5 |
tbl flm 30x5 mg |
PMP |
SK |
15 |
1.84 |
1.08 |
S |
0.76 |
0.41304299999999999 |
0.21 |
|
|
|
|
|
97761 |
X |
|
O |
BISOMERCK 5 |
tbl flm 30x5 mg |
MEC |
DE |
15 |
2.2999999999999998 |
1.08 |
S |
1.22 |
0.53043499999999999 |
0.21 |
|
|
|
|
|
94164 |
X |
|
O |
CONCOR |
tbl flm 30x5 mg |
MEC |
DE |
15 |
3.67 |
1.08 |
S |
2.59 |
0.70572199999999996 |
0.21 |
|
|
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. 5 mg (60 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
7.1999999999999995E-2 |
|
|
|
58857 |
X |
|
G |
BISOCARD 5 mg |
tbl flm 60x5 mg |
PRW |
CZ |
30 |
2.8 |
2.16 |
S |
0.64 |
0.228571 |
0.42 |
|
|
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. 5 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
7.1999999999999995E-2 |
|
|
|
8152A |
X |
|
G |
Sobycor 5 mg filmom obalené tablety |
tbl flm 90x5mg(blis.Al/Al) |
KRK |
SL |
45 |
3.88 |
3.24 |
S |
0.64 |
0.16494800000000001 |
0.63 |
|
|
|
|
|
54452 |
X |
|
G |
Bisoprolol Vitabalans 5 mg tablety |
tbl 100x5 mg |
VTB |
FI |
50 |
4.6500000000000004 |
3.6 |
S |
1.05 |
0.22580600000000001 |
0.7 |
|
|
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
6.8000000000000005E-2 |
|
|
|
33453 |
X |
|
G |
Bisoprolol-ratiopharm 10 mg |
tbl 30x10 mg |
MCK |
DE |
30 |
2.2599999999999998 |
2.04 |
S |
0.22 |
9.7345000000000001E-2 |
0.22 |
|
|
|
|
|
8157A |
X |
|
G |
Sobycor 10 mg filmom obalené tablety |
tbl flm 30x10mg(blis.Al/Al) |
KRK |
SL |
30 |
2.4700000000000002 |
2.04 |
S |
0.43 |
0.17408899999999999 |
0.22 |
|
|
|
|
|
1534A |
X |
|
G |
TYREZ 10 mg |
tbl flm 30x10 mg(blis.PVC/TE/PVDC/Al-perf.) |
ALK |
SI |
30 |
2.59 |
2.04 |
S |
0.55000000000000004 |
0.21235499999999999 |
0.22 |
|
|
|
|
|
54464 |
X |
|
G |
Bisoprolol Vitabalans 10 mg tablety |
tbl 30x10 mg |
VTB |
FI |
30 |
2.83 |
2.04 |
S |
0.79 |
0.27915200000000001 |
0.22 |
|
|
|
|
|
37077 |
X |
|
G |
RIVOCOR 10 |
tbl flm 30x10 mg |
PMP |
SK |
30 |
2.86 |
2.04 |
S |
0.82 |
0.286713 |
0.22 |
|
|
|
|
|
90050 |
X |
|
G |
CORONAL 10 |
tbl flm 30x10 mg (PVC/PE/PVDC/Alu blist.) |
ZNT |
SK |
30 |
2.89 |
2.04 |
S |
0.85 |
0.29411799999999999 |
0.22 |
|
|
|
|
|
58858 |
X |
|
G |
BISOCARD 10 mg |
tbl flm 30x10 mg |
PRW |
CZ |
30 |
3.15 |
2.04 |
S |
1.1100000000000001 |
0.35238100000000006 |
0.22 |
|
|
|
|
|
97762 |
X |
|
O |
BISOMERCK 10 |
tbl flm 30x10 mg |
MEC |
DE |
30 |
4.5599999999999996 |
2.04 |
S |
2.52 |
0.55263200000000001 |
0.22 |
|
|
|
|
|
94163 |
X |
|
O |
CONCOR |
tbl flm 30x10 mg |
MEC |
DE |
30 |
6.63 |
2.04 |
S |
4.59 |
0.69230800000000003 |
0.22 |
|
|
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. 10 mg (60 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
6.8000000000000005E-2 |
|
|
|
58859 |
X |
|
G |
BISOCARD 10 mg |
tbl flm 60x10 mg |
PRW |
CZ |
60 |
5.62 |
4.08 |
S |
1.54 |
0.27402100000000001 |
0.44 |
|
|
|
|
|
C07AB07 |
|
|
|
Bisoprolol |
p.o. 10 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
6.8000000000000005E-2 |
|
|
|
54468 |
X |
|
G |
Bisoprolol Vitabalans 10 mg tablety |
tbl 100x10 mg |
VTB |
FI |
100 |
7.59 |
6.8 |
S |
0.79 |
0.10408400000000001 |
0.73 |
|
|
|
|
|
8162A |
X |
|
G |
Sobycor10 mg filmom obalené tablety |
tbl flm 90x10mg(blis.Al/Al) |
KRK |
SL |
90 |
6.84 |
6.12 |
S |
0.72 |
0.10526300000000001 |
0.66 |
|
|
|
|
|
C07AB08 |
|
|
|
Celiprolol |
p.o. 200 mg (30 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.15770000000000001 |
|
|
|
21234 |
X |
|
G |
Celiprolol Vitabalans 200 mg filmom obalené tablety |
tbl flm 30x200 mg (obal HDPE) |
VTB |
FI |
30 |
5.72 |
4.7300000000000004 |
S |
0.99 |
0.17307700000000001 |
0.99 |
|
|
|
|
|
C07AB12 |
|
|
|
Nebivolol |
p.o. 5 mg (28-30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.13400000000000001 |
|
|
|
76073 |
X |
|
G |
Nebitrix 5 mg |
tbl 30x5 mg (blis. PVC/PVDC/Al) |
GLM |
CZ |
30 |
4.01 |
4.01 |
I |
0 |
0 |
0 |
|
|
|
|
|
53761 |
X |
|
O |
NEBILET 5 mg |
tbl 28x5 mg |
BCE |
DE |
28 |
5.13 |
3.75 |
S |
1.38 |
0.26900600000000002 |
0 |
|
|
|
|
|
76072 |
X |
|
G |
Nebitrix 5 mg |
tbl 28x5 mg (blis. PVC/PVDC/Al) |
GLM |
CZ |
28 |
5.13 |
3.75 |
S |
1.38 |
0.26900600000000002 |
0 |
|
|
|
|
|
45261 |
X |
|
G |
TEVANEB 5 mg |
tbl 30x5 mg |
TEV-SK |
SK |
30 |
5.5 |
4.0199999999999996 |
S |
1.48 |
0.26909099999999997 |
0 |
|
|
|
|
|
C07AB12 |
|
|
|
Nebivolol |
p.o. 5 mg (100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.13400000000000001 |
|
|
|
76075 |
X |
|
G |
Nebitrix 5 mg |
tbl 100x5 mg (blis. PVC/PVDC/Al) |
GLM |
CZ |
100 |
18.32 |
13.4 |
S |
4.92 |
0.26855899999999999 |
0 |
|
|
|
|
|
C07AB57 |
|
|
|
Bisoprolol, kombinácie |
p.o. kyselina acetylsalicylová 5/75 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.1000000000000001E-2 |
|
|
|
01675 |
|
|
O |
Betapres 5 mg/75 mg kapsuly |
cps dur 30x5 mg/75 mg (Aclar/PVC/Al/PVC) |
PHC-2 |
PL |
30 |
3.22 |
0.63 |
S |
2.59 |
0.80434799999999995 |
2.59 |
|
|
|
|
|
C07AB57 |
|
|
|
Bisoprolol, kombinácie |
p.o. kyselina acetylsalicylová 10/75 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.9000000000000001E-2 |
|
|
|
01661 |
|
|
O |
Betapres 10 mg/75 mg kapsuly |
cps dur 30x10 mg/75 mg (Aclar/PVC/Al/PVC) |
PHC-2 |
PL |
30 |
4.3499999999999996 |
0.87 |
S |
3.48 |
0.8 |
3.48 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 6,25 mg (28-30 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.21 |
|
|
|
90389 |
X |
|
G |
Carvedilol-Teva 6,25 mg |
tbl 30x6,25 mg |
PHM |
NL |
5 |
1.42 |
1.05 |
S |
0.37 |
0.26056299999999999 |
0.03 |
|
|
|
|
|
34703 |
X |
|
G |
Talliton 6,25mg |
tbl 30x6,25 mg |
EGI |
HU |
5 |
1.55 |
1.05 |
S |
0.5 |
0.32258100000000001 |
0.03 |
|
|
|
|
|
90148 |
X |
|
G |
Carvedigamma 6,25 mg filmom obalené tablety |
tbl flm 30x6,25 mg |
WGP |
DE |
5 |
1.58 |
1.05 |
S |
0.53 |
0.33544299999999999 |
0.03 |
|
|
|
|
|
38513 |
X |
|
G |
CARVEDILOL ORION 6,25 mg |
tbl flm 30x6,25 mg |
ORN |
FI |
5 |
1.58 |
1.05 |
S |
0.53 |
0.33544299999999999 |
0.03 |
|
|
|
|
|
34580 |
X |
|
G |
CORYOL 6,25 |
tbl 30x6,25 mg |
KRK |
SI |
5 |
1.58 |
1.05 |
S |
0.53 |
0.33544299999999999 |
0.03 |
|
|
|
|
|
1643A |
X |
|
G |
OCAROX 6,25 mg filmom obalené tablety |
tbl flm 30x6,25 mg (blis.PVC/PE/PVDC/Al) |
ORN |
FI |
5 |
1.58 |
1.05 |
S |
0.53 |
0.33544299999999999 |
0.03 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 6,25 mg (60 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.21 |
|
|
|
38461 |
X |
|
G |
Talliton |
tbl 60x6,25 mg |
EGI |
HU |
10 |
4.6399999999999997 |
2.1 |
S |
2.54 |
0.54741399999999996 |
0.05 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 6,25 mg (100 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.21 |
|
|
|
38517 |
X |
|
G |
CARVEDILOL ORION 6,25 mg |
tbl flm 100x6,25 mg |
ORN |
FI |
16.667000000000002 |
3.59 |
3.5 |
S |
0.09 |
2.5070000000000002E-2 |
0.09 |
|
|
|
|
|
1650A |
X |
|
G |
OCAROX 6,25 mg filmom obalené tablety |
tbl flm 100x6,25 mg (blis.PVC/PE/PVDC/Al) |
ORN |
FI |
16.667000000000002 |
3.59 |
3.5 |
S |
0.09 |
2.5070000000000002E-2 |
0.09 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 12,5 mg (28-30 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.19919999999999999 |
|
|
|
38523 |
X |
|
G |
CARVEDILOL ORION 12,5 mg |
tbl flm 30x12,5 mg |
ORN |
FI |
10 |
1.99 |
1.99 |
I |
0 |
0 |
0 |
|
|
|
|
|
1583A |
X |
|
G |
OCAROX 12,5 mg filmom obalené tablety |
tbl flm 30x12,5 mg (blis.PVC/PE/PVDC/Al) |
ORN |
FI |
10 |
1.99 |
1.99 |
I |
0 |
0 |
0 |
|
|
|
|
|
90397 |
X |
|
G |
Carvedilol-Teva 12,5 mg |
tbl 30x12,5 mg |
PHM |
NL |
10 |
2.0699999999999998 |
1.99 |
S |
0.08 |
3.8647000000000001E-2 |
0 |
|
|
|
|
|
90159 |
X |
|
G |
Carvedigamma 12,5 mg filmom obalené tablety |
tbl flm 30x12,5 mg |
WGP |
DE |
10 |
2.31 |
1.99 |
S |
0.32 |
0.13852800000000001 |
0 |
|
|
|
|
|
34582 |
X |
|
G |
CORYOL 12,5 |
tbl 30x12,5 mg |
KRK |
SI |
10 |
2.8 |
1.99 |
S |
0.81 |
0.28928599999999999 |
0 |
|
|
|
|
|
34704 |
X |
|
G |
Talliton 12,5mg |
tbl 30x12,5 mg |
EGI |
HU |
10 |
2.81 |
1.99 |
S |
0.82 |
0.29181499999999999 |
0 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 12,5 mg (60 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.19919999999999999 |
|
|
|
38463 |
X |
|
G |
Talliton |
tbl 60x12,5 mg |
EGI |
HU |
20 |
6.78 |
3.98 |
S |
2.8 |
0.41297899999999998 |
0 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 12,5 mg (100 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.19919999999999999 |
|
|
|
38527 |
X |
|
G |
CARVEDILOL ORION 12,5 mg |
tbl flm 100x12,5 mg |
ORN |
FI |
33.332999999999998 |
6.64 |
6.64 |
I |
0 |
0 |
0 |
|
|
|
|
|
1590A |
X |
|
G |
OCAROX 12,5 mg filmom obalené tablety |
tbl flm 100x12,5 mg (blis.PVC/PE/PVDC/Al) |
ORN |
FI |
33.332999999999998 |
6.64 |
6.64 |
I |
0 |
0 |
0 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 25 mg (28-30 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.14000000000000001 |
|
|
|
90406 |
X |
|
G |
Carvedilol-Teva 25 mg |
tbl 30x25 mg |
PHM |
NL |
20 |
3.04 |
2.8 |
S |
0.24 |
7.8947000000000003E-2 |
0 |
|
|
|
|
|
34584 |
X |
|
G |
CORYOL 25 |
tbl 30x25 mg |
KRK |
SI |
20 |
3.46 |
2.8 |
S |
0.66 |
0.190751 |
0 |
|
|
|
|
|
90171 |
X |
|
G |
Carvedigamma 25 mg filmom obalené tablety |
tbl flm 30x25 mg |
WGP |
DE |
20 |
3.56 |
2.8 |
S |
0.76 |
0.21348299999999998 |
0 |
|
|
|
|
|
38539 |
X |
|
G |
CARVEDILOL ORION 25 mg |
tbl flm 30x25 mg |
ORN |
FI |
20 |
4.46 |
2.8 |
S |
1.66 |
0.37219700000000006 |
0 |
|
|
|
|
|
1613A |
X |
|
G |
OCAROX 25 mg filmom obalené tablety |
tbl flm 30x25 mg (blis.PVC/PE/PVDC/Al) |
ORN |
FI |
20 |
4.46 |
2.8 |
S |
1.66 |
0.37219700000000006 |
0 |
|
|
|
|
|
34705 |
X |
|
G |
Talliton 25 mg |
tbl 30x25 mg |
EGI |
HU |
20 |
5.12 |
2.8 |
S |
2.3199999999999998 |
0.453125 |
0 |
|
|
|
|
|
28624 |
X |
|
O |
DILATREND 25 mg |
tbl 28x25 mg |
ROC |
DE |
18.670999999999999 |
6.02 |
2.61 |
S |
3.41 |
0.56644499999999998 |
0 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 25 mg (60 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.14000000000000001 |
|
|
|
38465 |
X |
|
G |
Talliton |
tbl 60x25 mg |
EGI |
HU |
40 |
10.11 |
5.6 |
S |
4.51 |
0.44609299999999996 |
0 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 25 mg (90-100 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.14000000000000001 |
|
|
|
38543 |
X |
|
G |
CARVEDILOL ORION 25 mg |
tbl flm 100x25 mg |
ORN |
FI |
66.667000000000002 |
9.09 |
9.09 |
I |
0 |
0 |
0 |
|
|
|
|
|
1620A |
X |
|
G |
OCAROX 25 mg filmom obalené tablety |
tbl flm 100x25 mg (blis.PVC/PE/PVDC/Al) |
ORN |
FI |
66.667000000000002 |
9.09 |
9.09 |
I |
0 |
0 |
0 |
|
|
|
|
|
3535A |
X |
|
G |
Coryol 25 |
tbl 90x25 mg (blis.PVC/PVDC/AL) |
KRK |
Sl |
60 |
9.3800000000000008 |
8.4 |
S |
0.98 |
0.10447800000000002 |
0 |
|
|
|
|
|
C07BB03 |
|
|
|
Atenolol a tiazidy |
p.o. 100/25 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.17599999999999999 |
|
|
|
76715 |
|
|
O |
TENORETIC |
tbl flm 28 |
AZC |
GB |
28 |
6.05 |
4.93 |
S |
1.1200000000000001 |
0.18512399999999998 |
1.1200000000000001 |
|
|
|
|
|
C07BB07 |
|
|
|
Bisoprolol a tiazidy |
p.o. 2,5/6,25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
4.3999999999999997E-2 |
|
|
|
30797 |
|
|
G |
Bisomyl Combi 2,5 mg/6,25 mg |
tbl flm 30x2,5 mg/6,25 mg (blis.OPA/Al/PVC/Al) |
GNS |
UK |
30 |
3.99 |
1.32 |
S |
2.67 |
0.66917300000000002 |
2.67 |
|
|
|
|
|
34862 |
|
|
O |
Lodoz 2,5/6,25 |
tbl flm 30 |
MEC |
FR |
30 |
6.26 |
1.32 |
S |
4.9400000000000004 |
0.78913700000000009 |
2.67 |
|
|
|
|
|
C07BB07 |
|
|
|
Bisoprolol a tiazidy |
p.o. 5/6,25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
6.2E-2 |
|
|
|
30786 |
|
|
G |
Bisomyl Combi 5 mg/6,25 mg |
tbl flm 30x5 mg/6,25 mg (blis.OPA/Al/PVC/Al) |
GNS |
UK |
30 |
4.6399999999999997 |
1.86 |
S |
2.78 |
0.59913800000000006 |
2.78 |
|
|
|
|
|
34859 |
|
|
O |
Lodoz 5/6,25 |
tbl flm 30 |
MEC |
FR |
30 |
7 |
1.86 |
S |
5.14 |
0.73428599999999999 |
2.78 |
|
|
|
|
|
C07BB07 |
|
|
|
Bisoprolol a tiazidy |
p.o. 10/6,25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.4E-2 |
|
|
|
34865 |
|
|
O |
Lodoz 10/6,25 |
tbl flm 30 |
MEC |
DE |
30 |
6.78 |
2.82 |
S |
3.96 |
0.58407100000000001 |
3.96 |
|
|
|
|
|
C07BB07 |
|
|
|
Bisoprolol a tiazidy |
p.o. 5/12,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
8.7999999999999995E-2 |
|
|
|
44080 |
|
|
G |
Bisoprolol/Hydrochlorothiazid - Teva 5 mg/12,5 mg filmom obalené tablety |
tbl flm 30x5 mg/12,5 mg |
TEV |
GB |
30 |
3.44 |
2.64 |
S |
0.8 |
0.23255800000000001 |
0.8 |
|
|
|
|
|
C07BB12 |
|
|
|
Nebivolol a tiazidy (hydrochlórtiazid) |
p.o. 5/12,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.23599999999999999 |
|
|
|
75656 |
|
|
O |
Nebilet HCTZ 5 mg/12,5 mg |
tbl flm 28x 5 mg/12,5 mg |
MEN |
IT |
28 |
7.88 |
6.61 |
S |
1.27 |
0.16116800000000001 |
1.27 |
DIA, GER, INT, KAR, KLF |
|
|
|
|
C07FB07 |
|
|
|
Bisoprolol a amlodipín |
p.o. 5 mg/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
0957B |
|
|
G |
Sobycombi 5 mg/5 mg tablety |
tbl 30x5mg/5mg(blis. OPA/Al/PVC/Al) |
KRK |
SL |
30 |
3.41 |
1.92 |
S |
1.49 |
0.43695000000000001 |
1.49 |
|
|
|
|
|
0589B |
|
|
G |
Bigital 5mg/5mg |
tbl 30x5mg/5mg(blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
3.96 |
1.92 |
S |
2.04 |
0.51515200000000005 |
1.49 |
|
|
|
|
|
02946 |
|
|
G |
Concor Combi 5 mg/5 mg |
tbl 30x5 mg/5 mg |
MRS |
SK |
30 |
9.16 |
1.92 |
S |
7.24 |
0.79039300000000001 |
1.49 |
|
|
|
|
|
C07FB07 |
|
|
|
Bisoprolol a amlodipín |
p.o. 5 mg/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
6.6000000000000003E-2 |
|
|
|
0963B |
|
|
G |
Sobycombi 5 mg/10 mg tablety |
tbl 30x5mg/10mg(blis. OPA/Al/PVC/Al) |
KRK |
SL |
30 |
3.48 |
1.98 |
S |
1.5 |
0.43103400000000003 |
1.49 |
|
|
|
|
|
0593B |
|
|
G |
Bigital 5mg/10mg |
tbl 30x5mg/10mg(blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
4.97 |
1.98 |
S |
2.99 |
0.60160999999999998 |
1.49 |
|
|
|
|
|
02973 |
|
|
G |
Concor Combi 5 mg/10 mg |
tbl 30x5 mg/10 mg |
MRS |
SK |
30 |
10.81 |
1.98 |
S |
8.83 |
0.81683600000000001 |
1.49 |
|
|
|
|
|
C07FB07 |
|
|
|
Bisoprolol a amlodipín |
p.o. 10 mg/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.6000000000000002E-2 |
|
|
|
0969B |
|
|
G |
Sobycombi 10 mg/5 mg tablety |
tbl 30x10mg/5mg(blis. OPA/Al/PVC/Al) |
KRK |
SL |
30 |
4.38 |
2.88 |
S |
1.5 |
0.34246599999999999 |
1.5 |
|
|
|
|
|
0597B |
|
|
G |
Bigital10mg/5mg |
tbl 30x10mg/5mg(blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
5.13 |
2.88 |
S |
2.25 |
0.43859599999999999 |
1.5 |
|
|
|
|
|
02951 |
|
|
G |
Concor Combi 10 mg/5 mg |
tbl 30x10 mg/5 mg |
MRS |
SK |
30 |
10.81 |
2.88 |
S |
7.93 |
0.73358000000000001 |
1.5 |
|
|
|
|
|
C08CA01 |
|
|
|
Amlodipín |
p.o. 5 mg (28-30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
2.8000000000000001E-2 |
|
|
|
34886 |
X |
|
G |
Amlodipin-ratiopharm 5 mg |
tbl 30x5 mg |
RAT |
SI |
30 |
0.89 |
0.84 |
S |
0.05 |
5.6180000000000001E-2 |
0.05 |
|
|
|
|
|
13556 |
X |
|
G |
AGEN 5 |
tbl 30x5 mg |
ZNT |
CZ |
30 |
0.91 |
0.84 |
S |
7.0000000000000007E-2 |
7.6923000000000005E-2 |
0.05 |
|
|
|
|
|
37500 |
X |
|
G |
Amlopin S 5 mg tablety |
tbl flm 30x5 mg (bli. PVC/Al) |
SAN |
SI |
30 |
0.95 |
0.84 |
S |
0.11 |
0.115789 |
0.05 |
|
|
|
|
|
11030 |
X |
|
G |
Amlodipin Vitabalans 5 mg tablety |
tbl 30x5 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
30 |
1.52 |
0.84 |
S |
0.68 |
0.44736800000000004 |
0.05 |
|
|
|
|
|
46294 |
X |
|
G |
Recotens 5 mg |
tbl 30x5 mg |
PRW |
CZ |
30 |
1.92 |
0.84 |
S |
1.08 |
0.5625 |
0.05 |
|
|
|
|
|
46759 |
X |
|
G |
ACCEL 5 mg |
tbl 30x5 mg |
MOE |
CY |
30 |
1.97 |
0.84 |
S |
1.1299999999999999 |
0.573604 |
0.05 |
|
|
|
|
|
88610 |
X |
|
G |
Amlodipin Ivowen 5 mg |
tbl 30x5 mg |
IVW |
IE |
30 |
1.99 |
0.84 |
S |
1.1499999999999999 |
0.57788899999999999 |
0.05 |
|
|
|
|
|
33788 |
X |
|
G |
CARDILOPIN 5MG |
tbl 30x5 mg |
EGI |
HU |
30 |
2.0699999999999998 |
0.84 |
S |
1.23 |
0.59420299999999993 |
0.05 |
|
|
|
|
|
41557 |
X |
|
G |
TENOX 5 mg |
tbl 30x5 mg (blis.) |
KRK |
SI |
30 |
2.2599999999999998 |
0.84 |
S |
1.42 |
0.62831899999999996 |
0.05 |
|
|
|
|
|
33208 |
X |
|
G |
NORMODIPINE 5 mg |
tbl 30x5 mg |
GDN |
HU |
30 |
2.31 |
0.84 |
S |
1.47 |
0.63636400000000004 |
0.05 |
|
|
|
|
|
62569 |
X |
|
O |
Norvasc 5 mg tablety |
tbl 30x5 mg (blis.PVC/PVDC/Al) |
PFI-GB-3 |
GB |
30 |
4.0599999999999996 |
0.84 |
S |
3.22 |
0.793103 |
0.05 |
|
|
|
|
|
C08CA01 |
|
|
|
Amlodipín |
p.o. 5 mg (90-100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
2.8000000000000001E-2 |
|
|
|
11032 |
X |
|
G |
Amlodipin Vitabalans 5 mg tablety |
tbl 100x5 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
100 |
3.12 |
2.8 |
S |
0.32 |
0.10256399999999999 |
0.17 |
|
|
|
|
|
36443 |
X |
|
G |
Agen 5 |
tbl 90x5 mg |
ZNT |
CZ |
90 |
5.31 |
2.52 |
S |
2.79 |
0.525424 |
0.15 |
|
|
|
|
|
C08CA01 |
|
|
|
Amlodipín |
p.o. 10 mg (28-30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
1.4999999999999999E-2 |
|
|
|
34889 |
X |
|
G |
Amlodipin-ratiopharm 10 mg |
tbl 30x10 mg |
RAT |
DE |
60 |
0.87 |
0.87 |
I |
0 |
0 |
0 |
|
|
|
|
|
37528 |
X |
|
G |
Amlopin S 10 mg tablety |
tbl flm 30x10 mg (bli. PVC/Al) |
SAN |
SI |
60 |
1.54 |
0.9 |
S |
0.64 |
0.41558400000000001 |
0 |
|
|
|
|
|
11033 |
X |
|
G |
Amlodipin Vitabalans 10 mg tablety |
tbl 30x10 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
60 |
1.96 |
0.9 |
S |
1.06 |
0.54081599999999996 |
0 |
|
|
|
|
|
13558 |
X |
|
G |
AGEN 10 |
tbl 30x10 mg |
ZNT |
CZ |
60 |
2.4300000000000002 |
0.9 |
S |
1.53 |
0.62963000000000002 |
0 |
|
|
|
|
|
88639 |
X |
|
G |
Amlodipin Ivowen 10mg |
tbl 30x10mg |
IVW |
IE |
60 |
2.7 |
0.9 |
S |
1.8 |
0.66666700000000001 |
0 |
|
|
|
|
|
46761 |
X |
|
G |
ACCEL 10 mg |
tbl 30x10 mg |
MOE |
CY |
60 |
2.98 |
0.9 |
S |
2.08 |
0.69798699999999991 |
0 |
|
|
|
|
|
46301 |
X |
|
G |
Recotens 10 mg |
tbl 30x10 mg |
PRW |
CZ |
60 |
3.46 |
0.9 |
S |
2.56 |
0.73988399999999999 |
0 |
|
|
|
|
|
41572 |
X |
|
G |
TENOX 10 mg |
tbl 30x10 mg (blist.) |
KRK |
SI |
60 |
3.83 |
0.9 |
S |
2.93 |
0.76501300000000005 |
0 |
|
|
|
|
|
33789 |
X |
|
G |
CARDILOPIN 10MG |
tbl 30x10 mg |
EGI |
HU |
60 |
4.16 |
0.9 |
S |
3.26 |
0.78365399999999996 |
0 |
|
|
|
|
|
62568 |
X |
|
O |
Norvasc 10 mg tablety |
tbl 30x10 mg (blis.PVC/PVDC/Al) |
PFI-GB-3 |
GB |
60 |
5.5 |
0.9 |
S |
4.5999999999999996 |
0.836364 |
0 |
|
|
|
|
|
C08CA01 |
|
|
|
Amlodipín |
p.o. 10 mg (90-100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
1.4999999999999999E-2 |
|
|
|
11035 |
X |
|
G |
Amlodipin Vitabalans 10 mg tablety |
tbl 100x10 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
200 |
4.34 |
3 |
S |
1.34 |
0.30875599999999997 |
0 |
|
|
|
|
|
36444 |
X |
|
G |
Agen 10 |
tbl 90x10 mg |
ZNT |
CZ |
180 |
7.82 |
2.7 |
S |
5.12 |
0.65473100000000006 |
0 |
|
|
|
|
|
C08CA02 |
|
|
|
Felodipín |
p.o. predĺžené uvoľňovanie 2,5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
9.2999999999999999E-2 |
|
|
|
02961 |
X |
|
G |
Presid |
tbl flp 30x2,5 mg |
IVX |
CZ |
15 |
2.02 |
1.4 |
S |
0.62 |
0.30693100000000001 |
0.62 |
|
|
|
|
|
C08CA02 |
|
|
|
Felodipín |
p.o. predĺžené uvoľňovanie 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.09 |
|
|
|
02957 |
X |
|
G |
Presid |
tbl flp 30x5 mg |
IVX |
CZ |
30 |
3.22 |
2.7 |
S |
0.52 |
0.161491 |
0.52 |
|
|
|
|
|
40053 |
X |
|
G |
Felodipin-ratiopharm 5 mg |
tbl plg 30x5 mg |
MCK |
DE |
30 |
3.41 |
2.7 |
S |
0.71 |
0.20821100000000001 |
0.52 |
|
|
|
|
|
94169 |
X |
|
O |
PLENDIL 5 |
tbl plg 30x5 mg |
AZC |
SE |
30 |
6.32 |
2.7 |
S |
3.62 |
0.57278499999999999 |
0.52 |
|
|
|
|
|
C08CA02 |
|
|
|
Felodipín |
p.o. predĺžené uvoľňovanie 10 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
9.7000000000000003E-2 |
|
|
|
02959 |
X |
|
G |
Presid |
tbl flp 30x10 mg |
IVX |
CZ |
60 |
6.6 |
5.82 |
S |
0.78 |
0.118182 |
0.78 |
|
|
|
|
|
20317 |
X |
|
G |
Felodipin-ratiopharm 10 mg |
tbl plg 30x10 mg |
MCK |
DE |
60 |
6.91 |
5.82 |
S |
1.0900000000000001 |
0.15774199999999999 |
0.78 |
|
|
|
|
|
94167 |
X |
|
O |
PLENDIL 10 |
tbl plg 30x10 mg |
AZC |
SE |
60 |
11.63 |
5.82 |
S |
5.81 |
0.49957000000000001 |
0.78 |
|
|
|
|
|
C08CA03 |
|
|
|
Isradipín |
p.o. predĺžené uvoľňovanie 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.18260000000000001 |
|
|
|
83370 |
X |
|
O |
LOMIR SRO 5 mg |
cps plg 30x5 mg |
NOB |
ES |
30 |
7.92 |
5.48 |
S |
2.44 |
0.30808099999999999 |
2.44 |
|
|
|
|
|
C08CA05 |
|
|
|
Nifedipín |
p.o. predĺžené uvoľňovanie 20 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
8.3000000000000004E-2 |
|
|
|
93460 |
X |
|
G |
CORDIPIN RETARD |
tbl plg 30x20 mg |
KRK |
SI |
20 |
1.63 |
1.63 |
I |
0 |
0 |
0 |
|
|
|
|
|
C08CA06 |
|
|
|
Nimodipín |
p.o. 30 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
3.012 |
|
|
|
67523 |
X |
|
G |
NEMOTAN 30MG |
tbl flm 50x30 mg |
MOE |
CY |
5 |
16.260000000000002 |
15.06 |
S |
1.2 |
7.3800999999999992E-2 |
1.2 |
NEU |
ind.obm. |
|
|
|
C08CA08 |
|
|
|
Nitrendipín |
p.o. 10 mg (20 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
69305 |
X |
|
G |
UNIPRES 10 |
tbl 20x10 mg |
KRK |
SI |
10 |
1.33 |
0.71 |
S |
0.62 |
0.466165 |
0.62 |
|
|
|
|
U79 |
C08CA08 |
|
|
|
Nitrendipín |
p.o. 10 mg (30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
45939 |
X |
|
G |
NITRESAN 10 mg |
tbl 30x10mg |
PMP |
CZ |
15 |
2.13 |
1.07 |
S |
1.06 |
0.49765300000000001 |
0.93 |
|
|
|
|
U79 |
C08CA08 |
|
|
|
Nitrendipín |
p.o. 20 mg (20 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
69306 |
X |
|
G |
UNIPRES 20 |
tbl 20x20 mg |
KRK |
SI |
20 |
4.24 |
1.42 |
S |
2.82 |
0.66509399999999996 |
0.15 |
|
|
|
|
U79 |
C08CA08 |
|
|
|
Nitrendipín |
p.o. 20 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
45943 |
X |
|
G |
NITRESAN 20 mg |
tbl 30x20mg |
PMP |
CZ |
30 |
2.73 |
2.13 |
S |
0.6 |
0.21978 |
0.23 |
|
|
|
|
U79 |
83082 |
X |
|
O |
LUSOPRESS |
tbl 28x20 mg |
INL |
IT |
28 |
5.24 |
1.99 |
S |
3.25 |
0.62022900000000003 |
0.21 |
|
|
|
|
U79 |
C08CA08 |
|
|
|
Nitrendipín |
p.o. 20 mg (98-100 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
45948 |
X |
|
G |
Nitresan 20 mg |
tbl 100x20 mg (blis. Al/PVC) |
PMP |
ČR |
100 |
7.86 |
7.1 |
S |
0.76 |
9.6692E-2 |
0.76 |
|
|
|
|
U79 |
3658A |
X |
|
G |
Lusopress |
tbl 98x20 mg (blis. PAD/AI/PVC/AI) |
INL |
IT |
98 |
11.6 |
6.96 |
S |
4.6399999999999997 |
0.4 |
0.74 |
|
|
|
|
U79 |
C08CA09 |
|
|
|
Lacidipín |
p.o. 4 mg (28 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.14499999999999999 |
|
|
|
28718 |
X |
|
O |
LACIPIL 4 mg |
tbl flm 28x4 mg |
GWE |
ES |
28 |
5.38 |
4.0599999999999996 |
S |
1.32 |
0.24535299999999999 |
1.32 |
|
|
|
|
|
C08CA09 |
|
|
|
Lacidipín |
p.o. 6 mg (28 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.16600000000000001 |
|
|
|
42280 |
X |
|
O |
Lacipil 6 mg |
tbl flm 28x6 mg |
GLA |
GB |
42 |
8.16 |
6.97 |
S |
1.19 |
0.14583299999999999 |
1.19 |
|
|
|
|
|
C08DA01 |
|
|
|
Verapamil |
p.o. 40 mg (50 ks) |
240 |
mg |
|
|
|
|
|
|
|
|
0.21199999999999999 |
|
|
|
09201 |
X |
|
G |
ISOPTIN 40 |
tbl flm 50x40 mg |
ABB |
DE |
8.3330000000000002 |
2.2200000000000002 |
1.77 |
S |
0.45 |
0.20270299999999999 |
0.45 |
|
|
|
|
|
C08DA01 |
|
|
|
Verapamil |
p.o. 80 mg (50 ks) |
240 |
mg |
|
|
|
|
|
|
|
|
0.2 |
|
|
|
09205 |
X |
|
G |
ISOPTIN 80 |
tbl flm 50x80 mg |
ABB |
DE |
16.667000000000002 |
3.67 |
3.33 |
S |
0.34 |
9.2643000000000003E-2 |
0.34 |
|
|
|
|
|
C08DA01 |
|
|
|
Verapamil |
p.o. predĺžené uvoľňovanie 120 mg (50 ks) |
0.24 |
g |
|
|
|
|
|
|
|
|
0.16800000000000001 |
|
|
|
15918 |
X |
|
G |
ISOPTIN ICHS RETARD |
tbl obd 50x120 mg |
ABB |
DE |
25 |
6.08 |
4.2 |
S |
1.88 |
0.30921100000000001 |
1.88 |
|
|
|
|
|
C08DA01 |
|
|
|
Verapamil |
p.o. predĺžené uvoľňovanie 240 mg (30 ks) |
0.24 |
g |
|
|
|
|
|
|
|
|
0.1676 |
|
|
|
43877 |
X |
|
G |
VEROGALID ER 240MG |
tbl plg 30x240 mg |
IVX |
CZ |
30 |
5.47 |
5.03 |
S |
0.44 |
8.043900000000001E-2 |
0.44 |
|
|
|
|
|
71950 |
X |
|
G |
ISOPTIN SR 240 |
tbl obd 30x240 mg |
ABB |
DE |
30 |
6.85 |
5.03 |
S |
1.82 |
0.26569299999999996 |
0.44 |
|
|
|
|
|
C08DA51 |
|
|
|
Verapamil komb. trandolapril |
p.o. 180/2 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
43044 |
|
|
G |
Tarka |
tbl obd 28x180mg/2mg |
TPH |
SK |
28 |
10.65 |
6.16 |
S |
4.49 |
0.42159599999999997 |
4.49 |
|
|
|
|
|
C08DA51 |
|
|
|
Verapamil komb. trandolapril |
p.o. 240/2 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.26200000000000001 |
|
|
|
37378 |
|
|
O |
Tarka 240mg/2mg tablety |
tbl flm 28x240mg/2mg |
TPH |
SK |
28 |
12.98 |
7.34 |
S |
5.64 |
0.43451500000000004 |
3.95 |
|
|
|
|
|
C08DA51 |
|
|
|
Verapamil komb. trandolapril |
p.o. 240/2 mg (56 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.26200000000000001 |
|
|
|
37381 |
|
|
O |
Tarka 240mg/2mg tablety |
tbl flm 56x240mg/2mg |
TPH |
SK |
56 |
22.57 |
14.67 |
S |
7.9 |
0.350022 |
7.9 |
|
|
|
|
|
C08DA51 |
|
|
|
Verapamil komb. trandolapril |
p.o. 240/4 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.28799999999999998 |
|
|
|
37385 |
|
|
O |
Tarka 240mg/4mg tablety |
tbl flm 28x240mg/4mg |
TPH |
SK |
28 |
17.2 |
8.06 |
S |
9.14 |
0.53139499999999995 |
5.73 |
|
|
|
|
|
C08DA51 |
|
|
|
Verapamil komb. trandolapril |
p.o. 240/4 mg (56 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.28799999999999998 |
|
|
|
37388 |
|
|
O |
Tarka 240mg/4mg tablety |
tbl flm 56x240mg/4mg |
TPH |
SK |
56 |
27.6 |
16.13 |
S |
11.47 |
0.41558 |
11.47 |
|
|
|
|
|
C08DB01 |
|
|
|
Diltiazem |
p.o. predĺžené uvoľňovanie 90 mg (30 ks) |
0.24 |
g |
|
|
|
|
|
|
|
|
0.16930000000000001 |
|
|
|
94314 |
X |
|
G |
DIACORDIN 90 RETARD |
tbl plg 30x90 mg |
ZNT |
CZ |
11.25 |
2.65 |
1.9 |
S |
0.75 |
0.28301900000000002 |
0.75 |
|
|
|
|
|
C08DB01 |
|
|
|
Diltiazem |
p.o. predĺžené uvoľňovanie 120 mg (30 ks) |
0.24 |
g |
|
|
|
|
|
|
|
|
0.16930000000000001 |
|
|
|
76736 |
X |
|
G |
DIACORDIN 120 RETARD |
tbl plg 30x120 mg |
ZNT |
CZ |
15 |
4.3499999999999996 |
2.54 |
S |
1.81 |
0.41609200000000002 |
1.81 |
|
|
|
|
|
C09AA01 |
|
|
|
Kaptopril |
p.o. 12,5 mg (90 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
27808 |
X |
|
G |
TENSIOMIN |
tbl 90x12,5 mg |
EGI |
HU |
22.509 |
5.74 |
0.68 |
S |
5.0599999999999996 |
0.88153300000000001 |
5.0599999999999996 |
|
|
|
|
U7 |
C09AA01 |
|
|
|
Kaptopril |
p.o. 25 mg (90 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
27809 |
X |
|
G |
TENSIOMIN |
tbl 90x25 mg |
EGI |
HU |
45 |
10.99 |
1.35 |
S |
9.64 |
0.87716099999999997 |
9.64 |
|
|
|
|
U7 |
C09AA01 |
|
|
|
Kaptopril |
p.o. 50 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
39862 |
X |
|
G |
Tensiomin |
tbl 30x50 mg |
EGI |
HU |
30 |
8.16 |
0.9 |
S |
7.26 |
0.889706 |
4.0199999999999996 |
|
|
|
|
U7 |
C09AA01 |
|
|
|
Kaptopril |
p.o. 50 mg (90 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
27810 |
X |
|
G |
TENSIOMIN |
tbl 90x50 mg |
EGI |
HU |
90 |
14.76 |
2.7 |
S |
12.06 |
0.81707300000000005 |
12.06 |
|
|
|
|
U7 |
C09AA02 |
|
|
|
Enalapril |
p.o. 2,5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
59976 |
X |
|
G |
ENAP 2,5 |
tbl 30x2,5 mg |
KRK |
SI |
7.5049999999999999 |
2.54 |
0.23 |
S |
2.31 |
0.90944900000000006 |
2.31 |
|
|
|
|
U7 |
C09AA02 |
|
|
|
Enalapril |
p.o. 5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
45273 |
X |
|
G |
ENAP 5 |
tbl 30x5 mg |
KRK |
SI |
15 |
1.23 |
0.45 |
S |
0.78 |
0.63414599999999999 |
0.56000000000000005 |
|
|
|
|
U7 |
68699 |
X |
|
G |
Enalapril Vitabalans 5 mg tablety |
tbl 30x5 mg (blister) |
VTB |
FI |
15 |
1.49 |
0.45 |
S |
1.04 |
0.69798699999999991 |
0.56000000000000005 |
|
|
|
|
U7 |
C09AA02 |
|
|
|
Enalapril |
p.o. 5 mg (100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
68703 |
X |
|
G |
Enalapril Vitabalans 5 mg tablety |
tbl 100x5 mg (blister) |
VTB |
FI |
50 |
3.38 |
1.5 |
S |
1.88 |
0.55621299999999996 |
1.88 |
|
|
|
|
U7 |
C09AA02 |
|
|
|
Enalapril |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
68715 |
X |
|
G |
Enalapril Vitabalans 10 mg tablety |
tbl 30x10 mg (blister) |
VTB |
FI |
30 |
1.76 |
0.9 |
S |
0.86 |
0.48863599999999996 |
0.37 |
|
|
|
|
U7 |
45274 |
X |
|
G |
ENAP 10 |
tbl 30x10 mg |
KRK |
SI |
30 |
1.89 |
0.9 |
S |
0.99 |
0.52381 |
0.37 |
|
|
|
|
U7 |
C09AA02 |
|
|
|
Enalapril |
p.o. 10 mg (100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
68719 |
X |
|
G |
Enalapril Vitabalans 10 mg tablety |
tbl 100x10 mg (blister) |
VTB |
FI |
100 |
4.24 |
3 |
S |
1.24 |
0.29245300000000002 |
1.24 |
|
|
|
|
U7 |
C09AA02 |
|
|
|
Enalapril |
p.o. 20 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
68733 |
X |
|
G |
Enalapril Vitabalans 20 mg tablety |
tbl 30x20 mg (blister) |
VTB |
FI |
60 |
2.1 |
1.8 |
S |
0.3 |
0.14285700000000001 |
0 |
|
|
|
|
U7 |
45275 |
X |
|
G |
ENAP 20 |
tbl 30x20 mg |
KRK |
SI |
60 |
3.23 |
1.8 |
S |
1.43 |
0.44272399999999995 |
0 |
|
|
|
|
U7 |
C09AA02 |
|
|
|
Enalapril |
p.o. 20 mg (100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
68737 |
X |
|
G |
Enalapril Vitabalans 20 mg tablety |
tbl 100x20 mg (blister) |
VTB |
FI |
200 |
5.31 |
5.31 |
I |
0 |
0 |
0 |
|
|
|
|
U7 |
C09AA03 |
|
|
|
Lizinopril |
p.o. 2,5 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
02930 |
X |
|
G |
DIROTON 2,5 MG (BLIS.) |
tbl 28x2,5 mg |
GDN |
HU |
7 |
2.23 |
0.32 |
S |
1.91 |
0.85650199999999999 |
1.91 |
|
|
|
|
U8 |
C09AA03 |
|
|
|
Lizinopril |
p.o. 5 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
33464 |
X |
|
G |
Lisinopril-ratiopharm 5 mg |
tbl 30x5 mg |
MCK |
DE |
15 |
1.28 |
0.68 |
S |
0.6 |
0.46875 |
0.6 |
|
|
|
|
U8 |
52308 |
X |
|
G |
IRUMED 5 |
tbl 30x5 mg |
BLU |
SK |
15 |
1.58 |
0.68 |
S |
0.9 |
0.56962000000000002 |
0.6 |
|
|
|
|
U8 |
67561 |
X |
|
G |
DAPRIL 5 mg |
tbl 30x5 mg |
MOE |
CY |
15 |
2.0099999999999998 |
0.68 |
S |
1.33 |
0.66169200000000006 |
0.6 |
|
|
|
|
U8 |
53641 |
X |
|
G |
DIROTON 5 MG (BLIS.) |
tbl 28x5 mg |
GDN |
HU |
14 |
1.94 |
0.63 |
S |
1.31 |
0.67525800000000002 |
0.56000000000000005 |
|
|
|
|
U8 |
C09AA03 |
|
|
|
Lizinopril |
p.o. 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
33468 |
X |
|
G |
Lisinopril-ratiopharm 10 mg |
tbl 30x10 mg |
MCK |
DE |
30 |
1.89 |
1.35 |
S |
0.54 |
0.28571400000000002 |
0.54 |
|
|
|
|
U8 |
52292 |
X |
|
G |
IRUMED 10 |
tbl 30x10mg |
BLU |
SK |
30 |
2.2999999999999998 |
1.35 |
S |
0.95 |
0.41304299999999999 |
0.54 |
|
|
|
|
U8 |
67562 |
X |
|
G |
DAPRIL 10 mg |
tbl 30x10 mg |
MOE |
CY |
30 |
2.72 |
1.35 |
S |
1.37 |
0.50367600000000001 |
0.54 |
|
|
|
|
U8 |
53642 |
X |
|
G |
DIROTON 10 MG (BLIS.) |
tbl 28x10 mg |
GDN |
HU |
28 |
2.75 |
1.26 |
S |
1.49 |
0.54181800000000002 |
0.5 |
|
|
|
|
U8 |
C09AA03 |
|
|
|
Lizinopril |
p.o. 20 mg (20 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
67563 |
X |
|
G |
DAPRIL 20 mg |
tbl 20x20 mg |
MOE |
CY |
40 |
4.62 |
1.8 |
S |
2.82 |
0.61038999999999999 |
0 |
|
|
|
|
U8 |
C09AA03 |
|
|
|
Lizinopril |
p.o. 20 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
33472 |
X |
|
G |
Lisinopril-ratiopharm 20 mg |
tbl 30x20 mg |
MCK |
DE |
60 |
2.67 |
2.67 |
I |
0 |
0 |
0 |
|
|
|
|
U8 |
52306 |
X |
|
G |
IRUMED 20 |
tbl 30x20mg |
BLU |
SK |
60 |
4.41 |
2.7 |
S |
1.71 |
0.38775500000000002 |
0 |
|
|
|
|
U8 |
53643 |
X |
|
G |
DIROTON 20 MG (BLIS.) |
tbl 28x20 mg |
GDN |
HU |
56 |
4.9800000000000004 |
2.52 |
S |
2.46 |
0.49397599999999997 |
0 |
|
|
|
|
U8 |
C09AA04 |
|
|
|
Perindopril arginín |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
91341 |
X |
|
O |
PRESTARIUM A 5 mg |
tbl flm 30x5 mg |
SVE |
FR |
30 |
7.53 |
2.52 |
S |
5.01 |
0.66533900000000001 |
4.82 |
|
|
|
|
U9 |
C09AA04 |
|
|
|
Perindopril arginín |
p.o. 5 mg (90 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
91344 |
X |
|
O |
PRESTARIUM A 5 mg |
tbl flm 90x5 mg |
SVE |
FR |
90 |
22.02 |
7.56 |
S |
14.46 |
0.65667599999999993 |
14.46 |
|
|
|
|
U9 |
C09AA04 |
|
|
|
Perindopril arginín |
p.o. 10 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
91352 |
X |
|
O |
PRESTARIUM A 10 mg |
tbl flm 30x10 mg |
SVE |
FR |
60 |
10.59 |
3.24 |
S |
7.35 |
0.69405100000000008 |
7.35 |
|
|
|
|
U10 |
C09AA04 |
|
|
|
Perindopril arginín |
p.o. 10 mg (90 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
91355 |
X |
|
O |
PRESTARIUM A 10 mg |
tbl flm 90x10 mg |
SVE |
FR |
180 |
36.119999999999997 |
9.7200000000000006 |
S |
26.4 |
0.73089699999999991 |
22.05 |
|
|
|
|
U10 |
C09AA04 |
|
|
|
Perindopril terc-butylamin |
p.o. 4 mg (30 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
0877A |
X |
|
G |
Perindopril Mylan 4 mg |
tbl 30x4 mg (blis.Al/OPA/PVC/Al) |
GNS |
UK |
30 |
2.52 |
2.52 |
I |
0 |
0 |
0 |
|
|
|
|
U9 |
5537A |
X |
|
G |
Perindopril Saneca 4 mg |
tbl 30x4 mg (blis. Al/Al) |
SNC |
SK |
30 |
2.8 |
2.52 |
S |
0.28000000000000003 |
0.1 |
0 |
|
|
|
|
U9 |
5546A |
X |
|
G |
Perindopril PMCS 4 mg |
tbl 30(3x10)x4 mg (blis.Al/Al) |
PMP |
CZ |
30 |
2.81 |
2.52 |
S |
0.28999999999999998 |
0.10320299999999999 |
0 |
|
|
|
|
U9 |
52271 |
X |
|
G |
Prindex 4 mg |
tbl 30x4 mg |
GLM-CZ |
CZ |
30 |
2.81 |
2.52 |
S |
0.28999999999999998 |
0.10320299999999999 |
0 |
|
|
|
|
U9 |
35321 |
X |
|
G |
Perindopril ratiopharm 4mg |
tbl 30x4 mg |
RAT |
DE |
30 |
2.96 |
2.52 |
S |
0.44 |
0.148649 |
0 |
|
|
|
|
U9 |
35244 |
X |
|
G |
PRENESSA 4mg |
tbl 30x4 mg |
KRK |
SI |
30 |
3.2 |
2.52 |
S |
0.68 |
0.21249999999999999 |
0 |
|
|
|
|
U9 |
C09AA04 |
|
|
|
Perindopril terc-butylamin |
p.o. 4 mg (60 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
52273 |
X |
|
G |
Prindex 4 mg |
tbl 60x4 mg (blis.Al/Al) |
GLM-CZ |
CZ |
60 |
5.65 |
5.04 |
S |
0.61 |
0.10796500000000001 |
0 |
|
|
|
|
U9 |
C09AA04 |
|
|
|
Perindopril terc-butylamin |
p.o. 4 mg (90 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
0879A |
X |
|
G |
Perindopril Mylan 4 mg |
tbl 90x4 mg (blis.Al/OPA/PVC/Al) |
GNS |
UK |
90 |
7.86 |
7.56 |
S |
0.3 |
3.8168000000000001E-2 |
0 |
|
|
|
|
U9 |
35324 |
X |
|
G |
Perindopril ratiopharm 4mg |
tbl 90x4 mg |
RAT |
DE |
90 |
8.41 |
7.56 |
S |
0.85 |
0.10106999999999999 |
0 |
|
|
|
|
U9 |
0699B |
X |
|
G |
Perindopril Saneca 4 mg |
tbl 90x4 mg (blis.Al/Al) |
SNC |
SK |
90 |
8.41 |
7.56 |
S |
0.85 |
0.10106999999999999 |
0 |
|
|
|
|
U9 |
35245 |
X |
|
G |
PRENESSA 4mg |
tbl 90x4 mg |
KRK |
SI |
90 |
8.41 |
7.56 |
S |
0.85 |
0.10106999999999999 |
0 |
|
|
|
|
U9 |
C09AA04 |
|
|
|
Perindopril terc-butylamin |
p.o. 8 mg (30 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
0869A |
X |
|
G |
Perindopril Mylan 8 mg |
tbl 30x8 mg (blis.Al/OPA/PVC/Al) |
GNS |
UK |
60 |
3.2 |
3.2 |
I |
0 |
0 |
0 |
|
|
|
|
U10 |
57288 |
X |
|
G |
Perindopril ratiopharm 8mg |
tbl 30x8 mg |
RAT |
DE |
60 |
4.43 |
3.24 |
S |
1.19 |
0.268623 |
0 |
|
|
|
|
U10 |
5540A |
X |
|
G |
Perindopril Saneca 8 mg |
tbl 30x8 mg (blis.Al/Al) |
SNC |
SK |
60 |
4.43 |
3.24 |
S |
1.19 |
0.268623 |
0 |
|
|
|
|
U10 |
52277 |
X |
|
G |
Prindex 8 mg |
tbl 30x8 mg |
GLM-CZ |
CZ |
60 |
4.43 |
3.24 |
S |
1.19 |
0.268623 |
0 |
|
|
|
|
U10 |
5549A |
X |
|
G |
Perindopril PMCS 8 mg |
tbl 30(3x10)x8 mg (blis.Al/Al) |
PMP |
CZ |
60 |
4.4400000000000004 |
3.24 |
S |
1.2 |
0.27027000000000001 |
0 |
|
|
|
|
U10 |
51328 |
X |
|
G |
Prenessa 8mg |
tbl 30x8 mg |
KRK |
SI |
60 |
4.7300000000000004 |
3.24 |
S |
1.49 |
0.31501099999999999 |
0 |
|
|
|
|
U10 |
2067A |
X |
|
G |
Prenessa Q-Tab 8 mg orodispergovatelné tablety, 8mg |
tbl oro 30x 8 mg (blis. OPA/Al/PVC/PET/Al) |
KRK |
SI |
60 |
5.21 |
3.24 |
S |
1.97 |
0.37811900000000004 |
0 |
|
|
|
|
U10 |
C09AA04 |
|
|
|
Perindopril terc-butylamin |
p.o. 8 mg (60 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
52279 |
X |
|
G |
Prindex 8 mg |
tbl 60x8 mg (blis.Al/Al) |
GLM-CZ |
CZ |
120 |
8.8699999999999992 |
6.48 |
S |
2.39 |
0.26944800000000002 |
0 |
|
|
|
|
U10 |
C09AA04 |
|
|
|
Perindopril terc-butylamin |
p.o. 8 mg (90 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
51331 |
X |
|
G |
Prenessa 8mg |
tbl 90x8 mg |
KRK |
SL |
180 |
12.21 |
9.7200000000000006 |
S |
2.4900000000000002 |
0.203931 |
0 |
|
|
|
|
U10 |
57291 |
X |
|
G |
Perindopril ratiopharm 8mg |
tbl 90x8 mg |
RAT |
DE |
180 |
13.3 |
9.7200000000000006 |
S |
3.58 |
0.269173 |
0 |
|
|
|
|
U10 |
0700B |
X |
|
G |
Perindopril Saneca 8 mg |
tbl 90x8 mg (blis.Al/Al) |
SNC |
SK |
180 |
13.3 |
9.7200000000000006 |
S |
3.58 |
0.269173 |
0 |
|
|
|
|
U10 |
C09AA05 |
|
|
|
Ramipril |
p.o. 1,25 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
06439 |
X |
|
G |
Piramil 1,25 mg |
tbl 30x1,25 mg (blis. OPA/AI/PE//PE/AL) |
SAN |
AT |
7.5 |
1.86 |
0.63 |
S |
1.23 |
0.66129000000000004 |
1.23 |
|
|
|
|
U9 |
25647 |
X |
|
O |
TRITACE 1,25 |
tbl 30x1,25 mg |
HBS |
SK |
7.5 |
2.1800000000000002 |
0.63 |
S |
1.55 |
0.711009 |
1.23 |
|
|
|
|
U9 |
C09AA05 |
|
|
|
Ramipril |
p.o. 2,5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
95216 |
X |
|
G |
Ramipril Actavis 2,5mg |
tbl 30x2,5mg |
ACT |
DK |
15 |
1.57 |
1.26 |
S |
0.31 |
0.19745200000000002 |
0.31 |
|
|
|
|
U9 |
41740 |
X |
|
G |
PIRAMIL 2,5 mg |
tbl 30x2,5 mg (blis.) |
SZK |
AT |
15 |
1.58 |
1.26 |
S |
0.32 |
0.20253199999999999 |
0.31 |
|
|
|
|
U9 |
25651 |
X |
|
O |
TRITACE 2,5 |
tbl 30x2,5 mg |
HBS |
SK |
15 |
3.9 |
1.26 |
S |
2.64 |
0.67692300000000005 |
0.31 |
|
|
|
|
U9 |
C09AA05 |
|
|
|
Ramipril |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
41756 |
X |
|
G |
PIRAMIL 5 mg |
tbl 30x5mg (blis.) |
SZK |
AT |
30 |
2.7 |
2.52 |
S |
0.18 |
6.666699999999999E-2 |
0.18 |
|
|
|
|
U9 |
95217 |
X |
|
G |
Ramipril Actavis 5mg |
tbl 30x5mg |
ACT |
DK |
30 |
2.7 |
2.52 |
S |
0.18 |
6.666699999999999E-2 |
0.18 |
|
|
|
|
U9 |
53522 |
X |
|
G |
Ramimed 5 mg |
tbl 30x5 mg (bli.) |
MOE |
CY |
30 |
3.56 |
2.52 |
S |
1.04 |
0.29213499999999998 |
0.18 |
|
|
|
|
U9 |
25655 |
X |
|
O |
TRITACE 5 |
tbl 30x5 mg |
HBS |
SK |
30 |
3.85 |
2.52 |
S |
1.33 |
0.34545499999999996 |
0.18 |
|
|
|
|
U9 |
C09AA05 |
|
|
|
Ramipril |
p.o. 5 mg (90-100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
09241 |
X |
|
G |
Ramipril Actavis 5 mg |
tbl 98x5 mg (blis.Al/Al) |
ACT-DK-1 |
DK |
98 |
9.1999999999999993 |
8.23 |
S |
0.97 |
0.105435 |
0.59 |
|
|
|
|
U9 |
C09AA05 |
|
|
|
Ramipril |
p.o. 10 mg (28-30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
95215 |
X |
|
G |
Ramipril Actavis 10mg |
tbl 30x10 mg |
ACT |
DK |
60 |
5.28 |
3.24 |
S |
2.04 |
0.38636400000000004 |
0.36 |
|
|
|
|
U10 |
41774 |
X |
|
G |
PIRAMIL 10 mg |
tbl 30x10 mg (blis.) |
SZK |
AT |
60 |
5.41 |
3.24 |
S |
2.17 |
0.40110899999999999 |
0.36 |
|
|
|
|
U10 |
53504 |
X |
|
G |
Ramimed 10 mg |
tbl 30x10 mg (bli.) |
MOE |
CY |
60 |
6.41 |
3.24 |
S |
3.17 |
0.49453999999999998 |
0.36 |
|
|
|
|
U10 |
13314 |
X |
|
O |
TRITACE 10 |
tbl 30x10 mg |
HBS |
SK |
60 |
9.17 |
3.24 |
S |
5.93 |
0.64667399999999997 |
0.36 |
|
|
|
|
U10 |
C09AA05 |
|
|
|
Ramipril |
p.o. 10 mg (90-100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
09292 |
X |
|
G |
Ramipril Actavis 10 mg |
tbl 98x10 mg (blis.Al/Al) |
ACT-DK-1 |
DK |
196 |
11.76 |
10.58 |
S |
1.18 |
0.10034000000000001 |
1.18 |
|
|
|
|
U10 |
C09AA06 |
|
|
|
Quinapril |
p.o. 5 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
42751 |
X |
|
G |
QUINAPRIL-TEVA 5 mg |
tbl flm 30x5 mg |
APP |
GB |
10 |
1.84 |
0.3 |
S |
1.54 |
0.83695700000000006 |
1.54 |
|
|
|
|
U7 |
94958 |
X |
|
O |
ACCUPRO 5 |
tbl flm 30x5 mg |
PFI-GB-1 |
GB |
10 |
2.2599999999999998 |
0.3 |
S |
1.96 |
0.86725700000000006 |
1.54 |
|
|
|
|
U7 |
C09AA06 |
|
|
|
Quinapril |
p.o. 10 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
42768 |
X |
|
G |
QUINAPRIL-TEVA 10 mg |
tbl flm 30x10 mg |
APP |
GB |
20 |
2.91 |
0.6 |
S |
2.31 |
0.79381400000000002 |
2.31 |
|
|
|
|
U7 |
41524 |
X |
|
G |
QUINPRES 10 mg |
tbl flm 30x10 mg (blis.) |
GNS |
GB |
20 |
2.91 |
0.6 |
S |
2.31 |
0.79381400000000002 |
2.31 |
|
|
|
|
U7 |
94959 |
X |
|
O |
ACCUPRO 10 |
tbl flm 30x10 mg |
PFI-GB-1 |
GB |
20 |
3.38 |
0.6 |
S |
2.78 |
0.82248500000000002 |
2.31 |
|
|
|
|
U7 |
C09AA06 |
|
|
|
Quinapril |
p.o. 10 mg (100 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
94967 |
X |
|
O |
ACCUPRO 10 |
tbl flm 100x10 mg |
PFI-GB-1 |
GB |
66.667000000000002 |
9.75 |
2 |
S |
7.75 |
0.79487200000000002 |
7.7 |
|
|
|
|
U7 |
C09AA06 |
|
|
|
Quinapril |
p.o. 20 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
42776 |
X |
|
G |
QUINAPRIL-TEVA 20 mg |
tbl flm 30x20 mg |
APP |
GB |
40 |
4.43 |
1.2 |
S |
3.23 |
0.7291200000000001 |
3.23 |
|
|
|
|
U7 |
94960 |
X |
|
O |
ACCUPRO 20 |
tbl flm 30x20 mg |
PFI-GB-1 |
GB |
40 |
5 |
1.2 |
S |
3.8 |
0.76 |
3.23 |
|
|
|
|
U7 |
41526 |
X |
|
G |
QUINPRES 20 mg |
tbl flm 30x20 mg (blis.) |
GNS |
GB |
40 |
5.71 |
1.2 |
S |
4.51 |
0.78984200000000004 |
3.23 |
|
|
|
|
U7 |
C09AA09 |
|
|
|
Fosinopril |
p.o. 20 mg (28-30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
93597 |
X |
|
G |
Fosinopril-Teva 20 mg |
tbl 30x20mg |
PHM |
NL |
40 |
4.12 |
1.8 |
S |
2.3199999999999998 |
0.56310700000000002 |
2.3199999999999998 |
|
|
|
|
U8 |
C09AA10 |
|
|
|
Trandolapril |
p.o. 0,5 mg (20 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
49450 |
X |
|
O |
GOPTEN 0,5MG (BLIST.) |
cps 20x0,5 mg |
ABB |
DE |
5 |
1.92 |
0.42 |
S |
1.5 |
0.78125 |
1.5 |
|
|
|
|
U9 |
C09AA10 |
|
|
|
Trandolapril |
p.o. 2 mg (28-30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
47143 |
X |
|
G |
Trandolapril Mylan 2mg |
cps dur 30x2 mg |
GNC |
GB |
30 |
2.96 |
2.52 |
S |
0.44 |
0.148649 |
0.44 |
|
|
|
|
U9 |
47244 |
X |
|
G |
Actapril 2 mg |
cps dur 28x2 mg |
ACT |
IS |
28 |
2.77 |
2.35 |
S |
0.42 |
0.15162500000000001 |
0.41 |
|
|
|
|
U9 |
38782 |
X |
|
G |
Trandolapril-ratiopharm 2 mg |
cps dur 28x2 mg |
RAT |
DE |
28 |
2.77 |
2.35 |
S |
0.42 |
0.15162500000000001 |
0.41 |
|
|
|
|
U9 |
48200 |
X |
|
O |
GOPTEN 2MG (BLIST.) |
cps 28x2 mg |
ABB |
DE |
28 |
4.2 |
2.35 |
S |
1.85 |
0.44047600000000003 |
0.41 |
|
|
|
|
U9 |
C09AA10 |
|
|
|
Trandolapril |
p.o. 2 mg (98 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
38786 |
X |
|
G |
Trandolapril ratiopharm 2mg |
cps dur 98x 2mg |
RAT |
DE |
98 |
9.83 |
8.23 |
S |
1.6 |
0.16276700000000002 |
1.44 |
|
|
|
|
U9 |
43229 |
X |
|
O |
Gopten 2 mg |
cps 98x2 mg (blist.) |
ABB |
DE |
98 |
13.43 |
8.23 |
S |
5.2 |
0.38719299999999995 |
1.44 |
|
|
|
|
U9 |
C09AA10 |
|
|
|
Trandolapril |
p.o. 4 mg (28-30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
47252 |
X |
|
G |
Actapril 4 mg |
cps dur 28x4 mg |
ACT |
IS |
56 |
3.65 |
3.02 |
S |
0.63 |
0.17260300000000001 |
0.63 |
|
|
|
|
U10 |
38788 |
X |
|
G |
Trandolapril-ratiopharm 4 mg |
cps dur 28x4 mg |
RAT |
DE |
56 |
4.58 |
3.02 |
S |
1.56 |
0.34061100000000005 |
0.63 |
|
|
|
|
U10 |
41326 |
X |
|
G |
Gopten |
cps 28x4 mg |
ABB |
DE |
56 |
7.58 |
3.02 |
S |
4.5599999999999996 |
0.60158299999999998 |
0.63 |
|
|
|
|
U10 |
C09AA10 |
|
|
|
Trandolapril |
p.o. 4 mg (56 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
47154 |
X |
|
G |
Trandolapril Mylan 4 mg |
cps dur 56x4 mg |
GNS |
GB |
112 |
7.3 |
6.05 |
S |
1.25 |
0.171233 |
1.25 |
|
|
|
|
U10 |
41327 |
X |
|
G |
Gopten |
cps 56x4 mg |
ABB |
DE |
112 |
12.14 |
6.05 |
S |
6.09 |
0.50164700000000007 |
1.25 |
|
|
|
|
U10 |
C09AA10 |
|
|
|
Trandolapril |
p.o. 4 mg (98 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
38792 |
X |
|
G |
Trandolapril ratiopharm 4 mg |
cps dur 98x4 mg |
RAT |
DE |
196 |
13.83 |
10.58 |
S |
3.25 |
0.23499600000000001 |
2.19 |
|
|
|
|
U10 |
C09AA15 |
|
|
|
Zofenopril |
p.o. 30 mg (28 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
40018 |
|
|
O |
Zofaril 30 mg |
tbl flm 28x30 mg (blis.PVDC/PVC/Al) |
BCE |
DE |
28 |
10.119999999999999 |
1.26 |
S |
8.86 |
0.87549400000000011 |
8.86 |
|
|
|
|
|
C09AA15 |
|
|
|
Zofenopril |
p.o. 7,5 mg (28 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
40021 |
|
|
O |
Zofaril 7,5 mg |
tbl flm 28x7,5 mg (blis.PVDC/PVC/Al) |
BCE |
DE |
7 |
4.8 |
0.32 |
S |
4.4800000000000004 |
0.93333299999999997 |
4.4800000000000004 |
|
|
|
|
|
C09AA16 |
|
|
|
Imidapril |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
64703 |
X |
|
O |
Tanatril 5mg |
tbl 30x5 mg |
TPH |
SK |
30 |
8.34 |
1.35 |
S |
6.99 |
0.83812900000000001 |
6.99 |
|
|
|
|
U8 |
C09AA16 |
|
|
|
Imidapril |
p.o. 10 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
64711 |
X |
|
O |
Tanatril 10mg |
tbl 30x10 mg |
TPH |
SK |
60 |
9.94 |
2.7 |
S |
7.24 |
0.72837000000000007 |
7.24 |
|
|
|
|
U8 |
C09AA16 |
|
|
|
Imidapril |
p.o. 20 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
95813 |
X |
|
O |
Tanatril 20mg |
tbl 30x20 mg |
TPH |
SK |
120 |
15.54 |
5.4 |
S |
10.14 |
0.65251000000000003 |
10.14 |
|
|
|
|
U8 |
C09BA02 |
|
|
|
Enalapril a diuretiká |
p.o. 10/12,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
8.2000000000000003E-2 |
|
|
|
55429 |
|
|
G |
ENAP HL |
tbl 30x10/12,5 mg |
KRK |
SI |
30 |
2.4300000000000002 |
2.4300000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09BA02 |
|
|
|
Enalapril a diuretiká |
p.o. 10/25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.13300000000000001 |
|
|
|
66506 |
|
|
O |
ENAP H |
tbl 30x10/25 mg |
KRK |
SI |
30 |
4.8499999999999996 |
3.99 |
S |
0.86 |
0.17732000000000001 |
0.86 |
|
|
|
|
|
C09BA03 |
|
|
|
Lizinopril a diuretiká |
p.o. 10/12,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.7000000000000003E-2 |
|
|
|
52310 |
|
|
G |
IRUZID 10/12,5 |
tbl 30x10mg/12,5mg |
BLU |
SK |
30 |
3.95 |
2.91 |
S |
1.04 |
0.263291 |
1.04 |
|
|
|
|
|
57134 |
|
|
G |
DIROTON plus H 10 mg/12,5 mg tablety |
tbl 30x10 mg/12,5 mg |
GDN |
HU |
30 |
4.29 |
2.91 |
S |
1.38 |
0.32167800000000002 |
1.04 |
|
|
|
|
|
C09BA03 |
|
|
|
Lizinopril a diuretiká |
p.o. 20/12,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.14199999999999999 |
|
|
|
57147 |
|
|
G |
DIROTON plus H 20 mg/12,5 mg tablety |
tbl 30x20/12,5 mg |
GDN |
HU |
30 |
5.56 |
4.26 |
S |
1.3 |
0.23381299999999999 |
1.3 |
|
|
|
|
|
52312 |
|
|
G |
IRUZID 20/12,5 |
tbl 30x20/12,5 mg |
BLU |
SK |
30 |
5.92 |
4.26 |
S |
1.66 |
0.28040500000000002 |
1.3 |
|
|
|
|
|
C09BA03 |
|
|
|
Lizinopril a diuretiká |
p.o. 20/25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.193 |
|
|
|
52314 |
|
|
G |
IRUZID 20/25 |
tbl 30x20/25 mg |
BLU |
SK |
30 |
6.23 |
5.79 |
S |
0.44 |
7.0625999999999994E-2 |
0.44 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril a diuretiká |
p.o. 2/0,625 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
51669 |
|
|
G |
Perindocombi 2mg/0,625mg |
tbl 30x2mg/0,625 mg |
RAT |
DE |
30 |
2.8 |
2.4 |
S |
0.4 |
0.14285700000000001 |
0.31 |
|
|
|
|
|
89109 |
|
|
G |
PERINDASAN 2mg/0,625mg tablety |
tbl 30x2mg/0,625 mg |
SAN |
SI |
30 |
3.01 |
2.4 |
S |
0.61 |
0.20265799999999998 |
0.31 |
|
|
|
|
|
10455 |
|
|
G |
Perindostad Kombi 2 mg/0,625 mg tablety |
tbl 30x2 mg/0,625 mg (blis.PVC/PVDC/Al) |
STD |
DE |
30 |
3.01 |
2.4 |
S |
0.61 |
0.20265799999999998 |
0.31 |
|
|
|
|
|
46255 |
|
|
G |
CO-PRENESSA 2 mg/0,625 mg |
tbl 28x2 mg/0,625 mg(PVC/PE/PVDC/Al) |
KRK-PL |
PL |
28 |
3.72 |
2.2400000000000002 |
S |
1.48 |
0.39784900000000001 |
0.28999999999999998 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril a diuretiká |
p.o. 2/0,625 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
10457 |
|
|
G |
Perindostad Kombi 2 mg/0,625 mg tablety |
tbl 100x2 mg/0,625 mg (blis.PVC/PVDC/Al) |
STD |
DE |
100 |
9.0299999999999994 |
8 |
S |
1.03 |
0.114064 |
1.03 |
|
|
|
|
|
51673 |
|
|
G |
Perindocombi 2mg/0,625mg |
tbl 90x2mg/0,625 mg |
RAT |
DE |
90 |
8.36 |
7.2 |
S |
1.1599999999999999 |
0.13875599999999999 |
0.93 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril a diuretiká |
p.o. 4/1,25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.161 |
|
|
|
58825 |
|
|
G |
Perindopril/Indapamid Actavis 4 mg/1,25 mg |
tbl 30x4 mg/1,25 mg (blis.Al/Al) |
ACT-5 |
IS |
30 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
|
07616 |
|
|
G |
Prindex Combi 4 mg/1,25 mg |
tbl 30x4 mg/1,25 mg (blis.PVC/PVDC/Al) |
GLM |
CZ |
30 |
5.31 |
4.83 |
S |
0.48 |
9.0395000000000003E-2 |
0 |
|
|
|
|
|
89129 |
|
|
G |
PERINDASAN 4 mg/1,25mg tablety |
tbl 30x4 mg/1,25 mg |
SAN |
SI |
30 |
5.33 |
4.83 |
S |
0.5 |
9.3809000000000003E-2 |
0 |
|
|
|
|
|
51658 |
|
|
G |
Perindocombi 4 mg/1,25mg |
tbl 30x4 mg/1,25 mg |
RAT |
DE |
30 |
5.33 |
4.83 |
S |
0.5 |
9.3809000000000003E-2 |
0 |
|
|
|
|
|
10458 |
|
|
G |
Perindostad Kombi 4 mg/1,25 mg tablety |
tbl 30x4 mg/1,25 mg (blis.PVC/PVDC/Al) |
STD |
DE |
30 |
6.17 |
4.83 |
S |
1.34 |
0.21718000000000001 |
0 |
|
|
|
|
|
46276 |
|
|
G |
CO-PRENESSA 4 mg/1,25 mg |
tbl 28x4 mg/1,25 mg(PVC/PE/PVDC/Al) |
KRK-PL |
PL |
28 |
5.99 |
4.51 |
S |
1.48 |
0.24707799999999999 |
0 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril a diuretiká |
p.o. 4/1,25 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.161 |
|
|
|
58829 |
|
|
G |
Perindopril/Indapamid Actavis 4 mg/1,25 mg |
tbl 90x4 mg/1,25 mg (blis.Al/Al) |
ACT-5 |
IS |
90 |
14.48 |
14.48 |
I |
0 |
0 |
0 |
|
|
|
|
|
46281 |
|
|
O |
Co-Prenessa 4mg/1,25mg |
tbl 90x4mg/1,25 mg |
KRK |
SI |
90 |
16.48 |
14.49 |
S |
1.99 |
0.12075200000000001 |
0 |
|
|
|
|
|
07617 |
|
|
G |
Prindex Combi 4 mg/1,25 mg |
tbl 90x4 mg/1,25 mg (blis.PVC/PVDC/Al) |
GLM |
CZ |
90 |
16.48 |
14.49 |
S |
1.99 |
0.12075200000000001 |
0 |
|
|
|
|
|
89132 |
|
|
G |
PERINDASAN 4mg/1,25mg tablety |
tbl 90x4mg/1,25 mg |
SAN |
SI |
90 |
16.649999999999999 |
14.49 |
S |
2.16 |
0.12973000000000001 |
0 |
|
|
|
|
|
51662 |
|
|
G |
Perindocombi 4mg/1,25mg |
tbl 90x4mg/1,25 mg |
RAT |
DE |
90 |
16.649999999999999 |
14.49 |
S |
2.16 |
0.12973000000000001 |
0 |
|
|
|
|
|
10460 |
|
|
G |
Perindostad Kombi 4 mg/1,25 mg tablety |
tbl 100x4 mg/1,25 mg (blis.PVC/PVDC/Al) |
STD |
DE |
100 |
18.5 |
16.100000000000001 |
S |
2.4 |
0.12973000000000001 |
0 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril a diuretiká |
p.o. 8/2,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.253 |
|
|
|
89441 |
|
|
G |
Co-Prenessa 8 mg/2,5 mg |
tbl 30x8 mg/2,5 mg |
KRK |
SI |
30 |
6.73 |
6.73 |
I |
0 |
0 |
0 |
|
|
|
|
|
89440 |
|
|
G |
CO-PRENESSA 8 mg/2,5 mg |
tbl 28x8 mg/2,5 mg(PVC/PE/PVDC/Al) |
KRK-PL |
PL |
28 |
10.36 |
7.08 |
S |
3.28 |
0.31660199999999999 |
0 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril a diuretiká |
p.o. 8/2,5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.253 |
|
|
|
89445 |
|
|
G |
Co-Prenessa 8 mg/2,5 mg |
tbl 90x8 mg/2,5 mg |
KRK |
SI |
90 |
25.26 |
22.77 |
S |
2.4900000000000002 |
9.8574999999999996E-2 |
0 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril arginín a diuretiká |
p.o. 2,5/0,625 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
37193 |
|
|
O |
Noliprel A |
tbl flm 30x2,5mg/0,625 mg |
SVE |
FR |
30 |
8.89 |
2.4 |
S |
6.49 |
0.73003399999999996 |
6.49 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril arginín a diuretiká |
p.o. 2,5/0,625 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
37197 |
|
|
O |
Noliprel A |
tbl flm 90x2,5mg/0,625mg |
SVE |
FR |
90 |
29.46 |
7.2 |
S |
22.26 |
0.75560100000000008 |
19.47 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril arginín a diuretiká |
p.o. 5/1,25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.161 |
|
|
|
37203 |
|
|
O |
Noliprel forte A |
tbl flm 30x5mg/1,25mg |
SVE |
FR |
30 |
9.3000000000000007 |
4.83 |
S |
4.47 |
0.48064500000000004 |
4.47 |
|
|
|
|
|
37173 |
|
|
O |
PRESTARIUM COMBI A |
tbl flm 30x5mg/1,25mg |
SVE |
FR |
30 |
9.3000000000000007 |
4.83 |
S |
4.47 |
0.48064500000000004 |
4.47 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril arginín a diuretiká |
p.o. 5/1,25 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.161 |
|
|
|
37207 |
|
|
O |
Noliprel forte A |
tbl flm 90x5mg/1,25mg |
SVE |
FR |
90 |
30.49 |
14.49 |
S |
16 |
0.52476199999999995 |
13.41 |
|
|
|
|
|
37177 |
|
|
O |
PRESTARIUM COMBI A |
tbl flm 90x5mg/1,25mg |
SVE |
FR |
90 |
30.49 |
14.49 |
S |
16 |
0.52476199999999995 |
13.41 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril arginín a diuretiká |
p.o. 10/2,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.253 |
|
|
|
65603 |
|
|
O |
Noliprel Bi-forte A |
tbl flm 30x10 mg/2,5 mg |
SVE |
FR |
30 |
13.88 |
7.59 |
S |
6.29 |
0.45317000000000002 |
5.38 |
|
|
|
|
|
65593 |
|
|
O |
PRESTARIUM FORTE COMBI A |
tbl flm 30x10 mg/2,5 mg (obal PP) |
SVE |
FR |
30 |
13.88 |
7.59 |
S |
6.29 |
0.45317000000000002 |
5.38 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril arginín a diuretiká |
p.o. 10/2,5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.253 |
|
|
|
65608 |
|
|
O |
Noliprel Bi-forte A |
tbl flm 3x30x10 mg/2,5 mg (obal PP) |
SVE |
FR |
90 |
38.92 |
22.77 |
S |
16.149999999999999 |
0.41495399999999999 |
16.149999999999999 |
|
|
|
|
|
65598 |
|
|
O |
PRESTARIUM FORTE COMBI A |
tbl flm 3x30x10 mg/2,5 mg (obal PP) |
SVE |
FR |
90 |
38.92 |
22.77 |
S |
16.149999999999999 |
0.41495399999999999 |
16.149999999999999 |
|
|
|
|
|
C09BA05 |
|
|
|
Ramipril a diuretiká |
p.o. 2,5/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.9000000000000005E-2 |
|
|
|
95214 |
|
|
G |
Ramipril H 2,5 mg/12,5 mg Actavis |
tbl 30x2,5 mg/12,5 mg |
ACT |
DK |
30 |
2.99 |
2.97 |
S |
0.02 |
6.6890000000000005E-3 |
0.02 |
|
|
|
|
|
56659 |
|
|
O |
TRITAZIDE 2,5 mg/12,5 mg |
tbl 28x2,5 mg/12,5 mg |
HOE |
DE |
28 |
2.8 |
2.77 |
S |
0.03 |
1.0714E-2 |
0.02 |
|
|
|
|
|
94836 |
|
|
G |
AMPRIL HL |
tbl 28x2,5 mg/12,5 mg |
KRK |
SI |
28 |
2.86 |
2.77 |
S |
0.09 |
3.1468999999999997E-2 |
0.02 |
|
|
|
|
|
C09BA05 |
|
|
|
Ramipril a diuretiká |
p.o. 5/25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.19270000000000001 |
|
|
|
09530 |
|
|
G |
Ramipril H 5mg/25 mg Actavis |
tbl 30x5 mg/25 mg (blis.Al/Al) |
ACT-DK-1 |
DK |
30 |
4.4400000000000004 |
4.4400000000000004 |
I |
0 |
0 |
0 |
|
|
|
|
|
94827 |
|
|
G |
AMPRIL HD |
tbl 28x5 mg/25 mg |
KRK |
SI |
28 |
4.17 |
4.17 |
I |
0 |
0 |
0 |
|
|
|
|
|
56661 |
|
|
O |
TRITAZIDE 5 mg/25 mg |
tbl 28x5 mg/25 mg |
HOE |
DE |
28 |
4.53 |
4.53 |
I |
0 |
0 |
0 |
|
|
|
|
|
46311 |
|
|
G |
RAMIMED HCT 5/25 |
tbl 30x5 mg / 25 mg |
MOE |
CY |
30 |
5.19 |
5.19 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09BA06 |
|
|
|
Quinapril a diuretiká |
p.o. 10/12,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.1999999999999995E-2 |
|
|
|
41885 |
|
|
G |
STADAPRESS 10/12,5 mg |
tbl flm 30 |
STD |
DE |
30 |
3.59 |
2.16 |
S |
1.43 |
0.39832900000000004 |
1.43 |
|
|
|
|
|
27549 |
|
|
O |
ACCUZIDE 10 |
tbl flm 30x10 mg/12,5 mg (blis. PVC/PVDC/Al) |
PFI-GB-1 |
GB |
30 |
4.7699999999999996 |
2.16 |
S |
2.61 |
0.54716999999999993 |
1.43 |
|
|
|
|
|
C09BA06 |
|
|
|
Quinapril a diuretiká |
p.o. 10/12,5 mg (100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.1999999999999995E-2 |
|
|
|
41890 |
|
|
G |
STADAPRESS 10/12,5 mg |
tbl flm 100 |
STD |
DE |
100 |
11.97 |
7.2 |
S |
4.7699999999999996 |
0.39849600000000002 |
4.7699999999999996 |
|
|
|
|
|
27551 |
|
|
O |
ACCUZIDE 10 |
tbl flm 100x10 mg/12,5 mg (blis. PVC/PVDC/Al) |
PFI-GB-1 |
GB |
100 |
14.97 |
7.2 |
S |
7.77 |
0.519038 |
4.7699999999999996 |
|
|
|
|
|
C09BA06 |
|
|
|
Quinapril a diuretiká |
p.o. 20/12,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.1999999999999998E-2 |
|
|
|
41896 |
|
|
G |
STADAPRESS 20/12,5 mg |
tbl flm 30 |
STD |
DE |
30 |
6.23 |
2.76 |
S |
3.47 |
0.55698199999999998 |
1.86 |
|
|
|
|
|
64788 |
|
|
O |
ACCUZIDE 20 |
tbl flm 30x20 mg/12,5 mg (blis. PVC/PVDC/Al) |
PFI-GB-1 |
GB |
30 |
6.81 |
2.76 |
S |
4.05 |
0.59471400000000008 |
1.86 |
|
|
|
|
|
C09BA06 |
|
|
|
Quinapril a diuretiká |
p.o. 20/12,5 mg (100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.1999999999999998E-2 |
|
|
|
41901 |
|
|
G |
STADAPRESS 20/12,5 mg |
tbl flm 100 |
STD |
DE |
100 |
15.4 |
9.1999999999999993 |
S |
6.2 |
0.40259700000000004 |
6.2 |
|
|
|
|
|
64790 |
|
|
O |
ACCUZIDE 20 |
tbl flm 100x20 mg/12,5 mg (blis. PVC/PVDC/Al) |
PFI-GB-1 |
GB |
100 |
20 |
9.1999999999999993 |
S |
10.8 |
0.54 |
6.2 |
|
|
|
|
|
C09BA09 |
|
|
|
Fosinopril a hydrochlórotiazid |
p.o. 20/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.112 |
|
|
|
38455 |
|
|
G |
Tevafos 20 mg/12,5 mg tablety |
tbl 30x20 mg/12,5 mg |
TEV |
GB |
30 |
4.5599999999999996 |
3.36 |
S |
1.2 |
0.263158 |
1.2 |
|
|
|
|
|
03692 |
|
|
O |
MONOZIDE |
tbl 28 x20 mg/12,5 mg |
PRW |
CZ |
28 |
7.67 |
3.14 |
S |
4.53 |
0.59061300000000005 |
1.1200000000000001 |
|
|
|
|
|
C09BB03 |
|
|
|
Lizinopril a amlodipín |
p.o. 10/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.2999999999999995E-2 |
|
|
|
52332 |
|
|
O |
DIRONORM tablety |
tbl 30x10 mg/5 mg |
GDN |
HU |
30 |
7.26 |
2.19 |
S |
5.07 |
0.69834699999999994 |
2.88 |
|
|
|
|
|
C09BB03 |
|
|
|
Lizinopril a amlodipín |
p.o. 10/5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.2999999999999995E-2 |
|
|
|
07128 |
|
|
O |
DIRONORM tablety |
tbl 90x 10 mg/5 mg |
GDN |
HU |
90 |
15.21 |
6.57 |
S |
8.64 |
0.56804699999999997 |
8.64 |
|
|
|
|
|
C09BB03 |
|
|
|
Lizinopril a amlodipín |
p.o. 20/5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.11799999999999999 |
|
|
|
32662 |
|
|
O |
Dironorm 20 mg/5 mg tablety |
tbl 90x20 mg/5 mg (blis.PVC/PE/PVDC/Al) |
GDN |
HU |
90 |
16.52 |
10.62 |
S |
5.9 |
0.35714299999999999 |
5.9 |
|
|
|
|
|
C09BB03 |
|
|
|
Lizinopril a amlodipín |
p.o. 20/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.12 |
|
|
|
80296 |
|
|
O |
DIRONORM FORTE 20 mg/10 mg |
tbl 30 x 20 mg/10 mg |
GDN |
HU |
30 |
9.44 |
3.6 |
S |
5.84 |
0.61864400000000008 |
3.03 |
|
|
|
|
|
C09BB03 |
|
|
|
Lizinopril a amlodipín |
p.o. 20/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.12 |
|
|
|
80297 |
|
|
O |
Dironorm Forte 20 mg/10 mg |
tbl 90 x 20 mg/10 mg |
GDN |
HU |
90 |
19.899999999999999 |
10.8 |
S |
9.1 |
0.45728600000000003 |
9.1 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril a amlodipín |
p.o. 4/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
08791 |
|
|
G |
Amlessa 4 mg/5 mg |
tbl 30x4 mg/5 mg |
KRK |
SI |
30 |
4.6399999999999997 |
3.66 |
S |
0.98 |
0.21120700000000001 |
0.38 |
|
|
|
|
|
0271A |
|
|
G |
Vidonorm 4 mg/5 mg tablety |
tbl 30x4 mg/5 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
30 |
4.6500000000000004 |
3.66 |
S |
0.99 |
0.21290299999999998 |
0.38 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril a amlodipín |
p.o. 4/5 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
08798 |
|
|
G |
Amlessa 4 mg/5 mg |
tbl 90x4 mg/5 mg |
KRK |
SI |
90 |
12.13 |
10.98 |
S |
1.1499999999999999 |
9.4806000000000001E-2 |
1.1499999999999999 |
|
|
|
|
|
0272A |
|
|
G |
Vidonorm 4 mg/5 mg tablety |
tbl 90x4 mg/5 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
90 |
12.75 |
10.98 |
S |
1.77 |
0.138824 |
1.1499999999999999 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril a amlodipín |
p.o. 4/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.124 |
|
|
|
0266A |
|
|
G |
Vidonorm 4 mg/10 mg tablety |
tbl 30x4 mg/10 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
30 |
5.72 |
3.72 |
S |
2 |
0.34965000000000002 |
1.5 |
|
|
|
|
|
08774 |
|
|
G |
Amlessa 4 mg/10 mg |
tbl 30x4 mg/10 mg |
KRK |
SI |
30 |
5.86 |
3.72 |
S |
2.14 |
0.36518800000000001 |
1.5 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril a amlodipín |
p.o. 4/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.124 |
|
|
|
08777 |
|
|
G |
Amlessa 4 mg/10 mg |
tbl 90x4 mg/10 mg |
KRK |
SI |
90 |
15.67 |
11.16 |
S |
4.51 |
0.28781099999999998 |
4.51 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril a amlodipín |
p.o. 8/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
08733 |
|
|
G |
Amlessa 8 mg/5 mg |
tbl 30x8 mg/5 mg |
KRK |
SI |
30 |
6.43 |
4.4400000000000004 |
S |
1.99 |
0.30948700000000001 |
1.66 |
|
|
|
|
|
0312A |
|
|
G |
Vidonorm 8 mg/5 mg tablety |
tbl 30x8 mg/5 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
30 |
6.43 |
4.4400000000000004 |
S |
1.99 |
0.30948700000000001 |
1.66 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril a amlodipín |
p.o. 8/5 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
08737 |
|
|
G |
Amlessa 8 mg/5 mg |
tbl 90x8 mg/5 mg |
KRK |
SI |
90 |
18.309999999999999 |
13.32 |
S |
4.99 |
0.27252900000000002 |
4.99 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril a amlodipín |
p.o. 8/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
0309A |
|
|
G |
Vidonorm 8 mg/10 mg tablety |
tbl 30x8 mg/10 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
30 |
7.79 |
4.5 |
S |
3.29 |
0.42233600000000004 |
1.99 |
|
|
|
|
|
08756 |
|
|
G |
Amlessa 8 mg/10 mg |
tbl 30x8 mg/10 mg |
KRK |
SI |
30 |
7.83 |
4.5 |
S |
3.33 |
0.42528700000000003 |
1.99 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril a amlodipín |
p.o. 8/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
0310A |
|
|
G |
Vidonorm 8 mg/10 mg tablety |
tbl 90x8 mg/10 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
90 |
19.46 |
13.5 |
S |
5.96 |
0.30626900000000001 |
5.96 |
|
|
|
|
|
08762 |
|
|
G |
Amlessa 8 mg/10 mg |
tbl 90x8 mg/10 mg |
KRK |
SI |
90 |
19.5 |
13.5 |
S |
6 |
0.30769200000000002 |
5.96 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril arginín a amlodipín |
p.o. 5/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
50971 |
|
|
O |
PRESTANCE 5 mg/5 mg |
tbl 30x5 mg/5 mg |
SVE |
FR |
30 |
10.119999999999999 |
3.66 |
S |
6.46 |
0.63834000000000002 |
6.46 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril arginín a amlodipín |
p.o. 5/5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
50976 |
|
|
O |
PRESTANCE 5 mg/5 mg |
tbl 90x5 mg/5 mg |
SVE |
FR |
90 |
32.200000000000003 |
10.98 |
S |
21.22 |
0.65900599999999998 |
19.38 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril arginín a amlodipín |
p.o. 5/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.124 |
|
|
|
50957 |
|
|
O |
PRESTANCE 5 mg/10 mg |
tbl 30x5 mg/10 mg |
SVE |
FR |
30 |
9.4 |
3.72 |
S |
5.68 |
0.60425499999999999 |
5.68 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril arginín a amlodipín |
p.o. 5/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.124 |
|
|
|
50962 |
|
|
O |
PRESTANCE 5 mg/ 10 mg |
tbl 90x5 mg/10 mg |
SVE |
FR |
90 |
33.89 |
11.16 |
S |
22.73 |
0.67069900000000005 |
17.04 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril arginín a amlodipín |
p.o. 10/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
50943 |
|
|
O |
PRESTANCE 10 mg/5 mg |
tbl 30x10 mg/5 mg |
SVE |
FR |
30 |
12.54 |
4.4400000000000004 |
S |
8.1 |
0.64593299999999998 |
8.1 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril arginín a amlodipín |
p.o. 10/5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
50948 |
|
|
O |
PRESTANCE 10 mg/ 5 mg |
tbl 90x10 mg/5 mg |
SVE |
FR |
90 |
37.74 |
13.32 |
S |
24.42 |
0.64705900000000005 |
24.3 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril arginín a amlodipín |
p.o. 10/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
50926 |
|
|
O |
PRESTANCE 10 mg/10 mg |
tbl 30x10 mg/10 mg |
SVE |
FR |
30 |
13.3 |
4.5 |
S |
8.8000000000000007 |
0.66165400000000008 |
8.16 |
|
|
|
|
|
C09BB04 |
|
|
|
Perindopril arginín a amlodipín |
p.o. 10/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
50931 |
|
|
O |
PRESTANCE 10 mg/10 mg |
tbl 90x10 mg/10 mg |
SVE |
FR |
90 |
37.99 |
13.5 |
S |
24.49 |
0.64464299999999997 |
24.49 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 5/5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
1240B |
|
|
G |
Ramipril/Amlodipin Zentiva 5 mg/5 mg |
cps dur 28x5 mg/5 mg (blis.PA/Al/PVC/Al) |
ZNT |
CZ |
28 |
3.7 |
3.42 |
S |
0.28000000000000003 |
7.5675999999999993E-2 |
0.28000000000000003 |
|
|
|
|
|
0218A |
|
|
G |
AMIRAP 5mg/5mg tvrdé kapsuly |
cps dur 30 x 5mg/5mg |
SAN |
SI |
30 |
3.98 |
3.66 |
S |
0.32 |
8.0402000000000001E-2 |
0.3 |
|
|
|
|
|
0506B |
|
|
G |
Ramomark 5 mg/5 mg tvrdé kapsuly |
cps dur 28x5 mg/5 mg (blis.PA/Al/PVC/Al) |
GLM-CZ |
CZ |
28 |
4.29 |
3.42 |
S |
0.87 |
0.20279699999999998 |
0.28000000000000003 |
|
|
|
|
|
13853 |
|
|
G |
Egiramlon 5 mg/5 mg |
cps dur 30x5 mg/5 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
4.97 |
3.66 |
S |
1.31 |
0.26358100000000001 |
0.3 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 5/5 mg (56 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
1243B |
|
|
G |
Ramipril/Amlodipin Zentiva 5 mg/5 mg |
cps dur 56x5 mg/5 mg (blis.PA/Al/PVC/Al) |
ZNT |
CZ |
56 |
7.42 |
6.83 |
S |
0.59 |
7.9515000000000002E-2 |
0.56000000000000005 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 5/5 mg (90-98 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
0514B |
|
|
G |
Ramomark 5 mg/5 mg tvrdé kapsuly |
cps dur 98x5 mg/5 mg (blis.PA/Al/PVC/Al) |
GLM-CZ |
CZ |
98 |
14.12 |
11.96 |
S |
2.16 |
0.152975 |
0.98 |
|
|
|
|
|
13856 |
|
|
G |
Egiramlon 5 mg/5 mg |
cps dur 90x5 mg/5 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
90 |
13.08 |
10.98 |
S |
2.1 |
0.16055 |
0.9 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 5/10 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.124 |
|
|
|
0208A |
|
|
G |
AMIRAP 5mg/10mg tvrdé kapsuly |
cps dur 30 x 5mg/10mg (blis. OPA/Al/PVC/Al) |
SAN |
SI |
30 |
5.75 |
3.72 |
S |
2.0299999999999998 |
0.353043 |
2.0299999999999998 |
|
|
|
|
|
1250B |
|
|
G |
Ramipril/Amlodipin Zentiva 5 mg/10 mg |
cps dur 28x5 mg/10 mg (blis.PA/Al/PVC/Al) |
ZNT |
CZ |
28 |
5.38 |
3.47 |
S |
1.91 |
0.35501899999999997 |
1.89 |
|
|
|
|
|
0516B |
|
|
G |
Ramomark 5 mg/10 mg tvrdé kapsuly |
cps dur 28x5 mg/10 mg (blis.PA/Al/PVC/Al) |
GLM-CZ |
CZ |
28 |
5.77 |
3.47 |
S |
2.2999999999999998 |
0.39861400000000002 |
1.89 |
|
|
|
|
|
13859 |
|
|
G |
Egiramlon 5 mg/10 mg |
cps dur 30x5 mg/10 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
6.34 |
3.72 |
S |
2.62 |
0.41324899999999998 |
2.0299999999999998 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 5/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.124 |
|
|
|
13863 |
|
|
G |
Egiramlon 5 mg/10 mg |
cps dur 90x5 mg/10 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
90 |
18.760000000000002 |
11.16 |
S |
7.6 |
0.40511699999999995 |
6.09 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 10/5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
0213A |
|
|
G |
AMIRAP 10mg/5mg tvrdé kapsuly |
cps dur 30 x 10mg/5mg (blis. OPA/Al/PVC/Al) |
SAN |
SI |
30 |
6.51 |
4.4400000000000004 |
S |
2.0699999999999998 |
0.31797199999999998 |
1.48 |
|
|
|
|
|
1260B |
|
|
G |
Ramipril/Amlodipin Zentiva 10 mg/5 mg |
cps dur 28x10 mg/5 mg (blis.PA/Al/PVC/Al) |
ZNT |
CZ |
28 |
6.08 |
4.1399999999999997 |
S |
1.94 |
0.319079 |
1.38 |
|
|
|
|
|
0526B |
|
|
G |
Ramomark 10 mg/5 mg tvrdé kapsuly |
cps dur 28x10 mg/5 mg (blis.PA/Al/PVC/Al) |
GLM-CZ |
CZ |
28 |
6.45 |
4.1399999999999997 |
S |
2.31 |
0.35814000000000001 |
1.38 |
|
|
|
|
|
13865 |
|
|
G |
Egiramlon 10 mg/5 mg |
cps dur 30x10 mg/5 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
7.29 |
4.4400000000000004 |
S |
2.85 |
0.39094700000000004 |
1.48 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 10/5 mg (56 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
1263B |
|
|
G |
Ramipril/Amlodipin Zentiva 10 mg/5 mg |
cps dur 56x10 mg/5 mg (blis.PA/Al/PVC/Al) |
ZNT |
CZ |
56 |
12.16 |
8.2899999999999991 |
S |
3.87 |
0.31825700000000001 |
2.76 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 10/5 mg (90-98 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
0534B |
|
|
G |
Ramomark 10 mg/5 mg tvrdé kapsuly |
cps dur 98x10 mg/5 mg (blis.PA/Al/PVC/Al) |
GLM-CZ |
CZ |
98 |
19.329999999999998 |
14.5 |
S |
4.83 |
0.24987100000000001 |
4.83 |
|
|
|
|
|
13869 |
|
|
G |
Egiramlon 10 mg/5 mg |
cps dur 90x10 mg/5 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
90 |
20.64 |
13.32 |
S |
7.32 |
0.35465099999999999 |
4.4400000000000004 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 10/10 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
1270B |
|
|
G |
Ramipril/Amlodipin Zentiva 10 mg/10 mg |
cps dur 28x10 mg/10 mg (blis.PA/Al/PVC/Al) |
ZNT |
CZ |
28 |
7 |
4.2 |
S |
2.8 |
0.4 |
2.8 |
|
|
|
|
|
0148A |
|
|
G |
AMIRAP 10mg/10mg tvrdé kapsuly |
cps dur 30 x 10mg/10mg (blis. OPA/Al/PVC/Al) |
SAN |
SI |
30 |
7.76 |
4.5 |
S |
3.26 |
0.420103 |
3 |
|
|
|
|
|
0536B |
|
|
G |
Ramomark 10 mg/10 mg tvrdé kapsuly |
cps dur 28x10 mg/10 mg (blis.PA/Al/PVC/Al) |
GLM-CZ |
CZ |
28 |
7.35 |
4.2 |
S |
3.15 |
0.42857100000000004 |
2.8 |
|
|
|
|
|
13871 |
|
|
G |
Egiramlon 10 mg/10 mg |
cps dur 30x10 mg/10 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
8.49 |
4.5 |
S |
3.99 |
0.46996499999999997 |
3 |
|
|
|
|
|
C09BB07 |
|
|
|
Ramipril a amlodipín |
p.o. 10/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
13875 |
|
|
G |
Egiramlon 10 mg/10 mg |
cps dur 90x10 mg/10 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
90 |
25.42 |
13.5 |
S |
11.92 |
0.46892200000000001 |
9 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a diuretiká |
p.o. 2/5/0,625 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.1999999999999998E-2 |
|
|
|
7914A |
|
|
G |
Co-Amlessa 2mg/5mg/0,625mg tablety |
tbl 30x2mg/5mg/0,625mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
5.22 |
2.76 |
S |
2.46 |
0.47126399999999996 |
1.33 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a diuretiká |
p.o. 4/5/1,25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.155 |
|
|
|
7923A |
|
|
G |
Co-Amlessa 4mg/5mg/1,25mg tablety |
tbl 30x4mg/5mg/1,25mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
6.64 |
4.6500000000000004 |
S |
1.99 |
0.29969899999999999 |
1.33 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a diuretiká |
p.o. 4/5/1,25 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.155 |
|
|
|
7927A |
|
|
G |
Co-Amlessa 4mg/5mg/1,25mg tablety |
tbl 90x4mg/5mg/1,25mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
90 |
17.93 |
13.95 |
S |
3.98 |
0.22197399999999998 |
3.98 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a diuretiká |
p.o. 4/10/1,25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.157 |
|
|
|
7932A |
|
|
G |
Co-Amlessa 4mg/10mg/1,25mg tablety |
tbl 30x4mg/10mg/1,25mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
6.7 |
4.71 |
S |
1.99 |
0.29701499999999997 |
1.33 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a diuretiká |
p.o. 8/5/2,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.214 |
|
|
|
7941A |
|
|
G |
Co-Amlessa 8mg/5mg/2,5mg tablety |
tbl 30x8mg/5mg/2,5mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
9.75 |
6.42 |
S |
3.33 |
0.34153799999999995 |
1.33 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a diuretiká |
p.o. 8/5/2,5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.214 |
|
|
|
7945A |
|
|
G |
Co-Amlessa 8 mg/5 mg/2,5 mg tablety |
tbl 90x8mg/5mg/2,5mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
90 |
26.28 |
19.260000000000002 |
S |
7.02 |
0.267123 |
3.98 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a diuretiká |
p.o. 8/10/2,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.216 |
|
|
|
7950A |
|
|
G |
Co-Amlessa 8mg/10mg/2,5mg tablety |
tbl 30x8mg/10mg/2,5mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
9.82 |
6.48 |
S |
3.34 |
0.34012199999999998 |
1.33 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a diuretiká |
p.o. 8/10/2,5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.216 |
|
|
|
7954A |
|
|
G |
Co-Amlessa 8 mg/10 mg/2,5 mg tablety |
tbl 90x8mg/10mg/2,5mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
90 |
26.46 |
19.440000000000001 |
S |
7.02 |
0.26530599999999999 |
3.98 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a indapamid |
p.o. 5/1,25/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.155 |
|
|
|
8778A |
|
|
O |
TRIPLIXAM 5 mg/1,25 mg/5 mg |
tbl flm 30x5 mg/1,25 mg/5 mg (obal PP) |
SVE-2 |
FR |
30 |
10.72 |
4.6500000000000004 |
S |
6.07 |
0.56623100000000004 |
1.33 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a indapamid |
p.o. 5/1,25/5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.155 |
|
|
|
8780A |
|
|
O |
TRIPLIXAM 5 mg/1,25 mg/5 mg |
tbl flm 90(3x30)x5 mg/1,25 mg/5 mg (obal PP) |
SVE-2 |
FR |
90 |
28.95 |
13.95 |
S |
15 |
0.51813500000000001 |
3.98 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a indapamid |
p.o. 5/1,25/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.157 |
|
|
|
8783A |
|
|
O |
TRIPLIXAM 5 mg/1,25 mg/10 mg |
tbl flm 30x5 mg/1,25 mg/10 mg (obal PP) |
SVE-2 |
FR |
30 |
11.27 |
4.71 |
S |
6.56 |
0.58207600000000004 |
1.33 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a indapamid |
p.o. 5/1,25/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.157 |
|
|
|
8785A |
|
|
O |
TRIPLIXAM 5 mg/1,25 mg/10 mg |
tbl flm 90(3x30)x5 mg/1,25 mg/10 mg (obal PP) |
SVE-2 |
FR |
90 |
29.9 |
14.13 |
S |
15.77 |
0.52742500000000003 |
3.98 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a indapamid |
p.o. 10/2,5/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.214 |
|
|
|
8788A |
|
|
O |
TRIPLIXAM 10 mg/2,5 mg/5 mg |
tbl flm 30x10 mg/2,5 mg/5 mg (obal PP) |
SVE-2 |
FR |
30 |
14.27 |
6.42 |
S |
7.85 |
0.55010499999999996 |
1.33 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a indapamid |
p.o. 10/2,5/5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.214 |
|
|
|
8790A |
|
|
O |
TRIPLIXAM 10 mg/2,5 mg/5 mg |
tbl flm 90(3x30)x10 mg/2,5 mg/5 mg (obal PP) |
SVE-2 |
FR |
90 |
38.14 |
19.260000000000002 |
S |
18.88 |
0.49501800000000001 |
3.98 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a indapamid |
p.o. 10/2,5/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.216 |
|
|
|
8793A |
|
|
O |
TRIPLIXAM 10 mg/2,5 mg/10 mg |
tbl flm 30x10 mg/2,5 mg/10 mg (obal PP) |
SVE-2 |
FR |
30 |
15.15 |
6.48 |
S |
8.67 |
0.57227700000000004 |
1.33 |
|
|
|
|
|
C09BX01 |
|
|
|
Perindopril, amlodipín a indapamid |
p.o. 10/2,5 /10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.216 |
|
|
|
8795A |
|
|
O |
TRIPLIXAM 10 mg/2,5 mg/10 mg |
tbl flm 90(3x30)x10 mg/2,5 mg/10 mg (obal PP) |
SVE-2 |
FR |
90 |
40.6 |
19.440000000000001 |
S |
21.16 |
0.52118200000000003 |
3.98 |
|
|
|
|
|
C09CA01 |
|
|
|
Losartan |
p.o. 12,5 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
49511 |
X |
|
G |
Losartan Zentiva 12,5 mg filmom obalené tablety |
tbl flm 30x12,5 mg (bli. PVC/PVDC/Al) |
ZNT |
SK |
7.5 |
1.26 |
0.48 |
S |
0.78 |
0.61904800000000004 |
0.78 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 50 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
77878 |
X |
|
G |
Losartan Orion 50 mg |
tbl flm 28x50 mg (blis. PVC/LDPE/PVDC/Al) |
ORN |
FI |
28 |
1.78 |
1.78 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
49527 |
X |
|
G |
Losartan Zentiva 50 mg filmom obalené tablety |
tbl flm 30x50 mg (bli. PVC/PVDC/Al) |
ZNT |
SK |
30 |
1.91 |
1.91 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
44176 |
X |
|
G |
Losartan STADA 50 mg |
tbl flm 30x50 mg |
STD |
DE |
30 |
2.98 |
1.92 |
S |
1.06 |
0.35570500000000005 |
0 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 50 mg (84 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
90145 |
X |
|
G |
Lorista 50 |
tbl flm 84x50 mg |
KRK |
SI |
84 |
5.71 |
5.38 |
S |
0.33 |
5.7793000000000004E-2 |
0 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 50 mg (90-100 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
49530 |
X |
|
G |
Losartan Zentiva 50 mg filmom obalené tablety |
tbl flm 90x50 mg (bli. PVC/PVDC/Al) |
ZNT |
SK |
90 |
5.75 |
5.75 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
77879 |
X |
|
G |
Losartan Orion 50 mg |
tbl flm 98x50 mg (blis. PVC/LDPE/PVDC/Al) |
ORN |
FI |
98 |
6.46 |
6.27 |
S |
0.19 |
2.9411999999999997E-2 |
0 |
|
|
|
|
U11 |
44180 |
X |
|
G |
Losartan STADA 50 mg |
tbl flm 90x50 mg |
STD |
DE |
90 |
8.6300000000000008 |
5.76 |
S |
2.87 |
0.33256100000000005 |
0 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 100 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
49505 |
X |
|
G |
Losartan Zentiva 100 mg filmom obalené tablety |
tbl flm 30x100 mg (bli. PVC/PVDC/Al) |
ZNT |
SK |
60 |
3.54 |
3.54 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
77882 |
X |
|
G |
Losartan Orion 100 mg |
tbl flm 28x100 mg (blis. PVC/LDPE/PVDC/Al) |
ORN |
FI |
56 |
3.31 |
3.31 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 100 mg (84 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
37293 |
X |
|
G |
Lorista 100 |
tbl flm 84x100 mg |
KRK |
SI |
168 |
9.8000000000000007 |
9.8000000000000007 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 100 mg (90-100 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
49507 |
X |
|
G |
Losartan Zentiva 100 mg filmom obalené tablety |
tbl flm 90x100 mg (bli. PVC/PVDC/Al) |
ZNT |
SK |
180 |
11.52 |
11.52 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
C09CA02 |
|
|
|
Eprosartan mesilas |
p.o. 600 mg (28 ks) |
600 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
59551 |
X |
|
O |
NAVITEN 600 |
tbl flm 28x600 mg (blis.PVC/Aclar/Al) |
ABB-NL-3 |
NL |
28 |
14.61 |
3.16 |
S |
11.45 |
0.78370999999999991 |
11.45 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
C09CA03 |
|
|
|
Valsartan |
p.o. 80 mg (28-30 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
51633 |
X |
|
G |
Valsartan Actavis 80 mg |
tbl flm 28x80 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
28 |
3.07 |
2.8 |
S |
0.27 |
8.7947999999999998E-2 |
0.27 |
|
|
|
|
U12 |
82981 |
X |
|
G |
Vasopentol 80 mg |
tbl flm 30x80 mg (blis.PVC/PE/PVDC-Al) |
EGI |
HU |
30 |
4.5 |
3 |
S |
1.5 |
0.33333299999999999 |
0.28999999999999998 |
|
|
|
|
U12 |
39975 |
X |
|
G |
VALSACOR 80 mg |
tbl flm 28x80 mg |
KRK |
SI |
28 |
4.32 |
2.8 |
S |
1.52 |
0.351852 |
0.27 |
|
|
|
|
U12 |
81771 |
X |
|
G |
Valzap 80 mg |
tbl flm 28x80 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
28 |
4.32 |
2.8 |
S |
1.52 |
0.351852 |
0.27 |
|
|
|
|
U12 |
0910A |
X |
|
G |
VAPRESS 80 mg |
tbl flm 28x80 mg |
MOE |
CY |
28 |
4.38 |
2.8 |
S |
1.58 |
0.36073099999999997 |
0.27 |
|
|
|
|
U12 |
C09CA03 |
|
|
|
Valsartan |
p.o. 160 mg (28-30 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
81775 |
X |
|
G |
Valzap 160 mg |
tbl flm 28x160 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
56 |
5.44 |
5.44 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
82997 |
X |
|
G |
Vasopentol 160 mg |
tbl flm 30x160 mg (blis.PVC/PE/PVDC-Al) |
EGI |
HU |
60 |
5.92 |
5.92 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
39980 |
X |
|
G |
VALSACOR 160 mg |
tbl flm 28x160 mg |
KRK |
SI |
56 |
5.59 |
5.59 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
51645 |
X |
|
G |
Valsartan Actavis 160 mg |
tbl flm 28x160 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
56 |
5.6 |
5.6 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
0890A |
X |
|
G |
VAPRESS 160 mg |
tbl flm 28x160 mg |
MOE |
CY |
56 |
6.82 |
5.6 |
S |
1.22 |
0.17888599999999999 |
0 |
|
|
|
|
U12 |
C09CA03 |
|
|
|
Valsartan |
p.o. 160 mg (84-98 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
81777 |
X |
|
G |
Valzap 160 mg |
tbl flm 84x160 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
168 |
16.670000000000002 |
16.670000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
53680 |
X |
|
G |
Vasopentol 160 mg |
tbl flm 98x160 mg (blister) |
EGI |
HU |
196 |
19.45 |
19.45 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
39982 |
X |
|
G |
Valsacor 160 |
tbl flm 98x160 mg |
KRK |
SI |
196 |
19.59 |
19.59 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
51647 |
X |
|
G |
Valsartan Actavis 160 mg |
tbl flm 98x160 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
196 |
19.600000000000001 |
19.600000000000001 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
0894A |
X |
|
G |
VAPRESS 160 mg |
tbl flm 90x160 mg |
MOE |
CY |
180 |
19.22 |
18 |
S |
1.22 |
6.3476000000000005E-2 |
0 |
|
|
|
|
U12 |
C09CA03 |
|
|
|
Valsartan |
p.o. 320 mg (28 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
84984 |
X |
|
G |
Valsacor 320 mg |
tbl flm 28x320 mg |
KRK |
SI |
112 |
12.19 |
12.19 |
I |
0 |
0 |
0 |
|
|
|
|
U13 |
C09CA04 |
|
|
|
Irbesartan |
p.o. 150 mg (28-30 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
59446 |
X |
|
O |
Ifirmasta |
tbl flm 28x150 mg |
KRK |
SI |
28 |
3.78 |
2.8 |
S |
0.98 |
0.25925899999999996 |
0.6 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
79737 |
X |
|
G |
Irbesartan Actavis 150 mg |
tbl flm 28x150 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
28 |
3.78 |
2.8 |
S |
0.98 |
0.25925899999999996 |
0.6 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
38264 |
X |
|
G |
Irbesartan Zentiva 150 mg filmom obalené tablety |
tbl flm 28x150 mg (blis.PVC/PVDC/Al) |
SAV-FR |
FR |
28 |
3.78 |
2.8 |
S |
0.98 |
0.25925899999999996 |
0.6 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
C09CA04 |
|
|
|
Irbesartan |
p.o. 150 mg (84 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
80003 |
X |
|
G |
Irbesartan Actavis 150 mg |
tbl flm 84x150 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
84 |
10.19 |
8.4 |
S |
1.79 |
0.17566199999999998 |
1.79 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
C09CA04 |
|
|
|
Irbesartan |
p.o. 300 mg (28-30 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
11253 |
X |
|
G |
Irbesartan Mylan 300 mg |
tbl 28x300 mg (blis.Aclar/PVC/Al) |
GNC |
UK |
56 |
5.92 |
5.92 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
59453 |
X |
|
O |
Ifirmasta |
tbl flm 28x300mg |
KRK |
SI |
56 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
80013 |
X |
|
G |
Irbesartan Actavis 300 mg |
tbl flm 28x300 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
56 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
76167 |
X |
|
G |
Irbesartan Sandoz 300 mg filmom obalené tablety |
tbl flm 28x300 mg (blis. PVC/PVDC/Al) |
SAN |
SI |
56 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
38270 |
X |
|
G |
Irbesartan Zentiva 300 mg filmom obalené tablety |
tbl flm 28x300 mg (blis.PVC/PVDC/Al) |
SAV-FR |
FR |
56 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
80019 |
X |
|
G |
Irbesartan Actavis 300 mg |
tbl flm 30x300 mg (fl. HDPE)) |
ACT |
IS |
60 |
7.88 |
6.78 |
S |
1.1000000000000001 |
0.139594 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
C09CA04 |
|
|
|
Irbesartan |
p.o. 300 mg (60 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
80020 |
X |
|
G |
Irbesartan Actavis 300 mg |
tbl flm 60x300 mg (fl. HDPE)) |
ACT |
IS |
120 |
13.56 |
13.56 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, NEF |
ind.obm. |
|
|
U13 |
C09CA04 |
|
|
|
Irbesartan |
p.o. 300 mg (84-98 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
80016 |
X |
|
G |
Irbesartan Actavis 300 mg |
tbl flm 84x300 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
168 |
18.98 |
18.98 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
38273 |
X |
|
G |
Irbesartan Zentiva 300 mg filmom obalené tablety |
tbl flm 84x300 mg (blis.PVC/PVDC/Al) |
SAV-FR |
FR |
168 |
18.98 |
18.98 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
C09CA06 |
|
|
|
Candesartan |
p.o. 8 mg (28-30 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
10406 |
X |
|
G |
Carzap 8 mg |
tbl 28x8 mg (blis.PVC/PVDC/Al) |
ZNT |
CZ |
28 |
4.43 |
2.8 |
S |
1.63 |
0.36794600000000005 |
0.77 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U12 |
81064 |
X |
|
G |
Candesartan Sandoz 8 mg tablety |
tbl 28x8 mg (blis. Al/Al) |
SAN |
SI |
28 |
4.82 |
2.8 |
S |
2.02 |
0.41908700000000004 |
0.77 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U12 |
86104 |
X |
|
G |
Karbis 8 mg |
tbl 28x8 mg |
KRK |
SI |
28 |
4.95 |
2.8 |
S |
2.15 |
0.43434299999999998 |
0.77 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U12 |
21683 |
X |
|
G |
Candesartan ratiopharm 8 mg |
tbl 28x8 mg (blis. PVC/PVDC/Al) |
RAT |
DE |
28 |
5 |
2.8 |
S |
2.2000000000000002 |
0.44 |
0.77 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U12 |
10492 |
X |
|
G |
Stadacand 8 mg |
tbl 30x8 mg (blis.PVC/PVDC/Al) |
STD |
DE |
30 |
5.93 |
3 |
S |
2.93 |
0.49409799999999998 |
0.83 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U12 |
53383 |
X |
|
O |
ATACAND 8 mg (blis.) |
tbl 28x8 mg |
AZC |
SE |
28 |
8.91 |
2.8 |
S |
6.11 |
0.68574600000000008 |
0.77 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U12 |
C09CA06 |
|
|
|
Candesartan |
p.o. 8 mg (90-98 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
10496 |
X |
|
G |
Stadacand 8 mg |
tbl 98x8 mg (blis.PVC/PVDC/Al) |
STD |
DE |
98 |
12.5 |
9.8000000000000007 |
S |
2.7 |
0.21600000000000003 |
2.7 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U12 |
C09CA06 |
|
|
|
Candesartan |
p.o. 16 mg (28-30 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
10415 |
X |
|
G |
Carzap 16 mg |
tbl 28x16 mg (blis.PVC/PVDC/Al) |
ZNT |
CZ |
56 |
7.23 |
6.33 |
S |
0.9 |
0.12448100000000001 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
81111 |
X |
|
G |
Candesartan Sandoz 16 mg tablety |
tbl 28x16 mg (blis. Al/Al) |
SAN |
SI |
56 |
7.45 |
6.33 |
S |
1.1200000000000001 |
0.150336 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
21691 |
X |
|
G |
Candesartan ratiopharm 16 mg |
tbl 28x16 mg (blis. PVC/PVDC/Al) |
RAT |
DE |
56 |
7.47 |
6.33 |
S |
1.1399999999999999 |
0.15261 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
86113 |
X |
|
G |
Karbis 16mg |
tbl 28x16mg |
KRK |
SI |
56 |
7.48 |
6.33 |
S |
1.1499999999999999 |
0.15374299999999999 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
10510 |
X |
|
G |
Stadacand 16 mg |
tbl 30x16 mg (blis.PVC/PVDC/Al) |
STD |
DE |
60 |
8.7799999999999994 |
6.78 |
S |
2 |
0.22778999999999999 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
53389 |
X |
|
O |
ATACAND 16 mg (blis.) |
tbl 28x16 mg |
AZC |
SE |
56 |
10.72 |
6.33 |
S |
4.3899999999999997 |
0.40951500000000002 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
C09CA06 |
|
|
|
Candesartan |
p.o. 16 mg (90-98 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
86119 |
X |
|
G |
Karbis 16mg |
tbl 98x16 mg |
KRK |
SI |
196 |
21.3 |
21.3 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
10517 |
X |
|
G |
Stadacand 16 mg |
tbl 98x16 mg (blis.PVC/PVDC/Al) |
STD |
DE |
196 |
21.3 |
21.3 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
81118 |
X |
|
G |
Candesartan Sandoz 16 mg tablety |
tbl 90x16 mg (blis. Al/Al) |
SAN |
SI |
180 |
20.34 |
20.34 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
10419 |
X |
|
G |
Carzap 16 mg |
tbl 90x16 mg (blis.PVC/PVDC/Al) |
ZNT |
CZ |
180 |
20.34 |
20.34 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
C09CA06 |
|
|
|
Candesartan |
p.o. 32 mg (28-30 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
21699 |
X |
|
G |
Candesartan ratiopharm 32 mg |
tbl 28x32 mg (blis. PVC/PVDC/Al) |
RAT |
DE |
112 |
13.53 |
12.66 |
S |
0.87 |
6.4301999999999998E-2 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
10388 |
X |
|
G |
Carzap 32 mg |
tbl 28x32 mg (blis.PVC/PVDC/Al) |
ZNT |
CZ |
112 |
13.53 |
12.66 |
S |
0.87 |
6.4301999999999998E-2 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
86121 |
X |
|
G |
Karbis 32mg |
tbl 28x32 mg |
KRK |
SI |
112 |
13.53 |
12.66 |
S |
0.87 |
6.4301999999999998E-2 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
10533 |
X |
|
G |
Stadacand 32 mg |
tbl 30x32 mg (blis.PVC/PVDC/Al) |
STD |
DE |
120 |
14.67 |
13.56 |
S |
1.1100000000000001 |
7.5664999999999996E-2 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
42384 |
X |
|
O |
ATACAND 32 mg (blis.) |
tbl 28x32 mg |
AZC |
SE |
112 |
16 |
12.66 |
S |
3.34 |
0.20874999999999999 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
C09CA06 |
|
|
|
Candesartan |
p.o. 32 mg (90-98 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
10538 |
X |
|
G |
Stadacand 32 mg |
tbl 98x32 mg (blis.PVC/PVDC/Al) |
STD |
DE |
392 |
41.32 |
41.32 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
C09CA07 |
|
|
|
Telmisartan |
p.o. 40 mg (28-30 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
07032 |
X |
|
G |
Telmark 40 mg |
tbl flm 28x40 mg (blis.Al/Al) |
GLM |
CZ |
28 |
3.95 |
2.8 |
S |
1.1499999999999999 |
0.29113900000000004 |
0.82 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
01585 |
X |
|
G |
Telmisartan Actavis 40 mg tablety |
tbl 28(4x7)x40 mg (blis.Al/Al) |
ACT |
IS |
28 |
3.95 |
2.8 |
S |
1.1499999999999999 |
0.29113900000000004 |
0.82 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
21186 |
X |
|
G |
Telmisartan ratiopharm 40 mg |
tbl 28x40 mg (blis.Al/Al) |
RAT |
DE |
28 |
3.95 |
2.8 |
S |
1.1499999999999999 |
0.29113900000000004 |
0.82 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
20488 |
X |
|
G |
Tolura 40mg |
tbl 28 x 40mg |
KRK |
SI |
28 |
3.95 |
2.8 |
S |
1.1499999999999999 |
0.29113900000000004 |
0.82 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
87164 |
X |
|
G |
Tezeo 40 mg |
tbl 30x40 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
30 |
4.24 |
3 |
S |
1.24 |
0.29245300000000002 |
0.88 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
2339A |
X |
|
G |
Telmisartan EGIS 40mg |
tbl flm 28x40 mg (blis) |
EGI |
HU |
28 |
3.98 |
2.8 |
S |
1.18 |
0.29648199999999997 |
0.82 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
01051 |
X |
|
G |
Telmisartan Sandoz 40 mg tablety |
tbl 28x40 mg |
SAN |
SI |
28 |
3.98 |
2.8 |
S |
1.18 |
0.29648199999999997 |
0.82 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
C09CA07 |
|
|
|
Telmisartan |
p.o. 40 mg (84-98 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
01590 |
X |
|
G |
Telmisartan Actavis 40 mg |
tbl 90(9x10)x40 mg (blis.Al/Al) |
ACT-5 |
IS |
90 |
11.63 |
9 |
S |
2.63 |
0.22613900000000001 |
2.63 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
2345A |
X |
|
G |
Telmisartan Egis 40mg |
tbl flm 98x40mg |
EGI |
HU |
98 |
12.67 |
9.8000000000000007 |
S |
2.87 |
0.22651900000000003 |
2.86 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
87165 |
X |
|
G |
Tezeo 40 mg |
tbl 90x40 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
90 |
11.65 |
9 |
S |
2.65 |
0.227468 |
2.63 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U12 |
C09CA07 |
|
|
|
Telmisartan |
p.o. 80 mg (28-30 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
01096 |
X |
|
G |
Telmisartan Sandoz 80 mg tablety |
tbl 28x80 mg |
SAN |
SI |
56 |
4.6500000000000004 |
4.6500000000000004 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
08879 |
X |
|
G |
Telmizek 80 mg |
tbl 28x80 mg (blis. Al/Al) |
ADD |
PL |
56 |
5.81 |
5.81 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
07040 |
X |
|
G |
Telmark 80 mg |
tbl flm 28x80 mg (blis.Al/Al) |
GLM |
CZ |
56 |
5.95 |
5.95 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
01604 |
X |
|
G |
Telmisartan Actavis 80 mg tablety |
tbl 28(4x7)x80 mg (blis.Al/Al) |
ACT |
IS |
56 |
5.95 |
5.95 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
87161 |
X |
|
G |
Tezeo 80 mg |
tbl 30x80 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
60 |
6.38 |
6.38 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
21205 |
X |
|
G |
Telmisartan ratiopharm 80 mg |
tbl 28x80 mg (blis.Al/Al) |
RAT |
DE |
56 |
6.29 |
6.29 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
20495 |
X |
|
G |
Tolura 80mg |
tbl 28x80mg |
KRK |
SI |
56 |
6.29 |
6.29 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
64050 |
X |
|
O |
MICARDIS 80 MG |
tbl 28x80 mg |
BGP |
DE |
56 |
11.14 |
6.33 |
S |
4.8099999999999996 |
0.43177700000000002 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
C09CA07 |
|
|
|
Telmisartan |
p.o. 80 mg (84-100 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
07045 |
X |
|
G |
Telmark 80 mg |
tbl flm 98x80 mg (blis.Al/Al) |
GLM |
CZ |
196 |
20.34 |
20.34 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
2354A |
X |
|
G |
Telmisartan EGIS 80mg |
tbl flm 98x80mg |
EGI |
HU |
196 |
20.34 |
20.34 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
01609 |
X |
|
G |
Telmisartan Actavis 80 mg |
tbl 90(9x10)x80 mg (blis.Al/Al) |
ACT-5 |
IS |
180 |
19.13 |
19.13 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
01108 |
X |
|
G |
Telmisartan Sandoz 80 mg tablety |
tbl 90x80 mg (blis.Al/Al) |
SAN |
SI |
180 |
19.13 |
19.13 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
87162 |
X |
|
G |
Tezeo 80 mg |
tbl 90x80 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
180 |
19.13 |
19.13 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
20498 |
X |
|
G |
Tolura 80mg |
tbl 84x80mg |
KRK |
SI |
168 |
17.88 |
17.88 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 50/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.11550000000000001 |
|
|
|
51955 |
|
|
G |
Losartan/Hydrochlorothiazid STADA 50 mg/12,5 mg |
tbl flm 30x50 mg/12,5 mg |
STD |
DE |
30 |
3.25 |
3.25 |
I |
0 |
0 |
0 |
|
|
|
|
|
80847 |
|
|
G |
Loscomb 50 mg/12,5 mg |
tbl flm 28x50 mg/12,5 mg (blis. PVC/LDPE/PVDC/Al) |
ORN |
FI |
28 |
3.23 |
3.23 |
I |
0 |
0 |
0 |
|
|
|
|
|
43027 |
|
|
G |
LORISTA H 50 mg/12,5 mg |
tbl flm 28 |
KRK |
SI |
28 |
3.49 |
3.23 |
S |
0.26 |
7.449900000000001E-2 |
0 |
|
|
|
|
|
41863 |
|
|
G |
LOZAP H |
tbl flm 30 |
ZNT |
CZ |
30 |
4.3099999999999996 |
3.47 |
S |
0.84 |
0.19489599999999999 |
0 |
|
|
|
|
|
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 50/12,5 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.11550000000000001 |
|
|
|
44314 |
|
|
G |
Lorista H 50mg/12,5mg |
tbl flm 84 |
KRK |
SI |
84 |
11.27 |
9.6999999999999993 |
S |
1.57 |
0.13930799999999999 |
0 |
|
|
|
|
|
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 50/12,5 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.11550000000000001 |
|
|
|
51958 |
|
|
G |
Losartan/Hydrochlorothiazid STADA 50 mg/12,5 mg |
tbl flm 90x50 mg/12,5 mg |
STD |
DE |
90 |
10.54 |
10.4 |
S |
0.14000000000000001 |
1.3283E-2 |
0 |
|
|
|
|
|
41864 |
|
|
G |
LOZAP H |
tbl flm 90 |
ZNT |
CZ |
90 |
12.08 |
10.4 |
S |
1.68 |
0.139073 |
0 |
|
|
|
|
|
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 100/25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
50047 |
|
|
G |
Lorista H 100mg/25mg |
tbl flm 28x100mg/25mg |
KRK |
SI |
28 |
4.4000000000000004 |
4.4000000000000004 |
I |
0 |
0 |
0 |
|
|
|
|
|
51948 |
|
|
G |
Losartan/Hydrochlorothiazid STADA 100 mg/25 mg |
tbl flm 30x100 mg/25 mg |
STD |
DE |
30 |
6.43 |
6.43 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 100/25 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
50050 |
|
|
G |
Lorista H 100mg/25mg |
tbl flm 84x100mg/25mg |
KRK |
SI |
84 |
13.67 |
13.67 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 100/25 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
51951 |
|
|
G |
Losartan/Hydrochlorothiazid STADA 100 mg/25 mg |
tbl flm 98x100 mg/25 mg |
STD |
DE |
98 |
16.34 |
16.34 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA02 |
|
|
|
Eprosartan a diuretiká |
p.o. 600/12,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.16500000000000001 |
|
|
|
97058 |
|
|
O |
Naviten Combi 600 mg/12,5 mg |
tbl flm 28x600 mg/12,5 mg (blis.PVC/PCTFE/Al) |
TPH |
SK |
28 |
11.52 |
4.62 |
S |
6.9 |
0.59895799999999999 |
6.9 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o. 80/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.152 |
|
|
|
64617 |
|
|
G |
Vasopentol HCT 80/12,5 mg |
tbl flm 30x80/12,5 mg (blis.) |
EGI |
HU |
30 |
6.11 |
4.5599999999999996 |
S |
1.55 |
0.25368200000000002 |
1.55 |
|
|
|
|
|
76739 |
|
|
G |
Co-Valsacor 80mg/12,5mg |
tbl flm 28x80mg/12,5mg |
KRK |
SI |
28 |
6.49 |
4.26 |
S |
2.23 |
0.34360599999999997 |
1.45 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o.160/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.252 |
|
|
|
64632 |
|
|
G |
Vasopentol HCT 160/12,5 mg |
tbl flm 30x160/12,5 mg (blis.) |
EGI |
HU |
30 |
6.85 |
6.85 |
I |
0 |
0 |
0 |
|
|
|
|
|
76751 |
|
|
G |
Co-Valsacor 160mg/12,5mg |
tbl flm 28x160mg/12,5mg |
KRK |
SI |
28 |
6.4 |
6.4 |
I |
0 |
0 |
0 |
|
|
|
|
|
66194 |
|
|
G |
Valsartan HCT Actavis 160/12,5 mg |
tbl flm 28x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
28 |
6.4 |
6.4 |
I |
0 |
0 |
0 |
|
|
|
|
|
81830 |
|
|
G |
Valzap HCT 160 mg/12,5 mg |
tbl flm 28x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
28 |
6.4 |
6.4 |
I |
0 |
0 |
0 |
|
|
|
|
|
64557 |
|
|
G |
Valtan HCT 160/12,5mg |
tbl flm 28x160/12,5mg(blis.) |
RAT |
DE |
28 |
7.24 |
7.06 |
S |
0.18 |
2.4862000000000002E-2 |
0 |
|
|
|
|
|
03881 |
|
|
O |
Co-Diovan 160/12,5mg |
tbl flm 28 |
NPA |
CH |
28 |
11 |
7.06 |
S |
3.94 |
0.358182 |
0 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o.160/12,5 mg (84-98 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.252 |
|
|
|
81833 |
|
|
G |
Valzap HCT 160 mg/12,5 mg |
tbl flm 84x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
84 |
19.170000000000002 |
19.170000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
64634 |
|
|
G |
Vasopentol HCT 160/12,5 mg |
tbl flm 98x160/12,5 mg (blis. ) |
EGI |
HU |
98 |
22.37 |
22.37 |
I |
0 |
0 |
0 |
|
|
|
|
|
66199 |
|
|
G |
Valsartan HCT Actavis 160/12,5 mg |
tbl flm 98x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
98 |
22.39 |
22.39 |
I |
0 |
0 |
0 |
|
|
|
|
|
76757 |
|
|
G |
Co-Valsacor 160mg/12,5mg filmom obalené tablety |
tbl flm 98x160 mg/12,5 mg (blis. PVC/PE/PVDC/Al) |
KRK |
SL |
98 |
22.87 |
22.87 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o.160/25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.30299999999999999 |
|
|
|
64656 |
|
|
G |
Vasopentol HCT 160/25 mg |
tbl flm 30x160/25 mg (blis.) |
EGI |
HU |
30 |
6.94 |
6.94 |
I |
0 |
0 |
0 |
|
|
|
|
|
76772 |
|
|
G |
Co-Valsacor 160mg/25mg |
tbl flm 28x160mg/25mg |
KRK |
SI |
28 |
6.48 |
6.48 |
I |
0 |
0 |
0 |
|
|
|
|
|
66180 |
|
|
G |
Valsartan HCT Actavis 160/25 mg |
tbl flm 28x160 mg/25 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
28 |
6.48 |
6.48 |
I |
0 |
0 |
0 |
|
|
|
|
|
81835 |
|
|
G |
Valzap HCT 160 mg/25 mg |
tbl flm 28x160 mg/25 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
28 |
6.48 |
6.48 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o.160/25 mg (98 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.30299999999999999 |
|
|
|
64658 |
|
|
G |
Vasopentol HCT 160/25 mg |
tbl flm 98x160/25 mg (blis. ) |
EGI |
HU |
98 |
22.68 |
22.68 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o. 320/12,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.44850000000000001 |
|
|
|
02594 |
|
|
G |
Co-Valsacor 320 mg/12,5 mg |
tbl flm 28x320 mg/12,5 mg |
KRK |
SI |
28 |
13.55 |
12.56 |
S |
0.99 |
7.3063000000000003E-2 |
0.99 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o. 320/25 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.505 |
|
|
|
02618 |
|
|
G |
Co-Valsacor 320 mg/25 mg |
tbl flm 28x320 mg/25 mg |
KRK |
SI |
28 |
15.13 |
14.14 |
S |
0.99 |
6.5433000000000005E-2 |
0.99 |
|
|
|
|
|
C09DA04 |
|
|
|
Irbesartan a diuretiká |
p.o. 150/12,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.152 |
|
|
|
38096 |
|
|
O |
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg filmom obalené tablety |
tbl flm 28x150 mg/12,5 mg (blis.PVC/PVDC/Al) |
SAV-FR |
FR |
28 |
5.03 |
4.26 |
S |
0.77 |
0.153082 |
0.77 |
DIA, GER, INT, KAR, KLF, NEF |
ind. obm. |
|
|
|
C09DA04 |
|
|
|
Irbesartan a diuretiká |
p.o. 300/12,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
0332B |
|
|
G |
CONVERIDE 300 mg/12,5 mg |
tbl flm 28x300 mg/12,5 mg (blis.PVC/PVDCAI-nepriehľ.) |
MOE |
CY |
28 |
7.86 |
7.07 |
S |
0.79 |
0.100509 |
0.79 |
DIA, GER, INT, KAR, KLF, NEF |
ind. obm. |
|
|
|
38102 |
|
|
G |
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg filmom obalené tablety |
tbl flm 28x300 mg/12,5 mg (blis.PVC/PVDC/Al) |
SAV-FR |
FR |
28 |
7.86 |
7.07 |
S |
0.79 |
0.100509 |
0.79 |
DIA, GER, INT, KAR, KLF, NEF |
ind. obm. |
|
|
|
C09DA04 |
|
|
|
Irbesartan a diuretiká |
p.o. 300/12,5 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
38105 |
|
|
G |
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg filmom obalené tablety |
tbl flm 84x300 mg/12,5 mg (blis.PVC/PVDC/Al) |
SAV-FR |
FR |
84 |
24.03 |
21.21 |
S |
2.82 |
0.117353 |
2.37 |
DIA, GER, INT, KAR, KLF, NEF |
ind. obm. |
|
|
|
C09DA04 |
|
|
|
Irbesartan a diuretiká |
p.o. 300/25 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.309 |
|
|
|
0350B |
|
|
G |
CONVERIDE 300 mg/25 mg |
tbl flm 28x300 mg/25 mg (blis.PVC/PVDCAI-nepriehľ.) |
MOE |
CY |
28 |
9.4499999999999993 |
8.65 |
S |
0.8 |
8.4656000000000009E-2 |
0.8 |
DIA, GER, INT, KAR, KLF, NEF |
ind. obm. |
|
|
|
38108 |
|
|
G |
Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg filmom obalené tablety |
tbl flm 28x300 mg/25 mg (blis.PVC/PVDC/Al) |
SAV-FR |
FR |
28 |
9.4499999999999993 |
8.65 |
S |
0.8 |
8.4656000000000009E-2 |
0.8 |
DIA, GER, INT, KAR, KLF, NEF |
ind. obm. |
|
|
|
C09DA06 |
|
|
|
Candesartan a diuretiká |
p.o. 16/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
1448A |
|
|
G |
Candesartan HCT Actavis 16 mg/12,5 mg |
tbl 28x16 mg/12,5 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
28 |
7.21 |
7.07 |
S |
0.14000000000000001 |
1.9417E-2 |
0.14000000000000001 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
11604 |
|
|
G |
CARZAP HCT 16 mg/12,5 mg |
tbl 28x16 mg/12,5 mg (blis.PVC/PVDV/Al) |
ZNT |
CZ |
28 |
7.53 |
7.07 |
S |
0.46 |
6.1089000000000004E-2 |
0.14000000000000001 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
87049 |
|
|
G |
Candesartan/Hydrochlorotiazid Sandoz 16 mg/12,5 mg |
tbl 28x16 mg/12,5mg (blis. Al/Al) |
SAN |
SI |
28 |
7.91 |
7.07 |
S |
0.84 |
0.106195 |
0.14000000000000001 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
04786 |
|
|
G |
Candesartan HCT ratiopharm 16 mg/12,5 mg |
tbl 28x16 mg/12,5 mg (blis.PVC/PVDC/Al) |
RAT |
DE |
28 |
7.97 |
7.07 |
S |
0.9 |
0.112923 |
0.14000000000000001 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
06798 |
|
|
G |
Karbicombi 16 mg/12,5 mg |
tbl 28x16 mg/12,5 mg |
KRK |
SI |
28 |
7.97 |
7.07 |
S |
0.9 |
0.112923 |
0.14000000000000001 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
10474 |
|
|
G |
Stadacand Plus |
tbl 30x16 mg/12,5 mg (blis.PVC/PVDC/Al) |
STD |
DE |
30 |
10.47 |
7.58 |
S |
2.89 |
0.27602699999999997 |
0.15 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
58066 |
|
|
O |
ATACAND PLUS 16/12,5 mg |
tbl 28 |
AZC |
SE |
28 |
12.05 |
7.07 |
S |
4.9800000000000004 |
0.41327800000000003 |
0.14000000000000001 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
C09DA06 |
|
|
|
Candesartan a diuretiká |
p.o. 16/12,5 mg (90-98 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
06804 |
|
|
G |
Karbicombi 16mg/12,5mg |
tbl 98x16mg/12,5mg |
KRK |
SI |
98 |
26.25 |
24.75 |
S |
1.5 |
5.7142999999999999E-2 |
0.49 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
87055 |
|
|
G |
Candesartan/Hydrochlorotiazid Sandoz 16 mg/12,5 mg |
tbl 90x16 mg/12,5 mg (blis.Al/Al) |
SAN |
SI |
90 |
24.12 |
22.73 |
S |
1.39 |
5.7629E-2 |
1.39 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
10479 |
|
|
O |
Stadacand Plus |
tbl 98x16 mg/12,5 mg (blis.PVC/PVDC/Al) |
STD |
DE |
98 |
27.65 |
24.75 |
S |
2.9 |
0.104882 |
0.49 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
C09DA06 |
|
|
|
Candesartan a diuretiká |
p.o. 32/12,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.44850000000000001 |
|
|
|
06816 |
|
|
G |
Karbicombi 32 mg/12,5 mg |
tbl 28x32 mg/12,5 mg |
KRK |
SI |
28 |
14.55 |
12.56 |
S |
1.99 |
0.13677 |
1.99 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
C09DA06 |
|
|
|
Candesartan a diuretiká |
p.o. 32/25 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.505 |
|
|
|
89567 |
|
|
O |
Atacand Plus 32 mg/ 25 mg |
tbl 28 |
AZC |
SE |
28 |
15.96 |
14.14 |
S |
1.82 |
0.114035 |
1.82 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
06762 |
|
|
G |
Karbicombi 32mg/25mg |
tbl 28x32mg/25mg |
KRK |
SI |
28 |
16.13 |
14.14 |
S |
1.99 |
0.12337300000000001 |
1.82 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
4634A |
|
|
G |
Actelsar HCT 80 mg/12,5 mg tablety |
tbl 28x80 mg/12,5 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4928A |
|
|
G |
Telmisartan/Hydrochlorotiazid EGIS 80mg/12,5mg |
tbl 28x80mg/12,5mg (blis. Al/Al) |
EGI |
HU |
28 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
6418A |
|
|
G |
Telmizek Combi 80 mg/12,5 mg tablety |
tbl 28x80 mg/12,5 mg (blis. Al/Al) |
ADD |
PL |
28 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
6444A |
|
|
G |
TEZEO HCT 80 mg/12,5 mg |
tbl 28x80 mg/12,5 mg (blis. OPA/Al/PVC/Al) |
ZNT |
CZ |
28 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
7049A |
|
|
G |
Telmark Plus 80 mg/12,5 mg |
tbl 30x80 mg/12,5 mg (blis.Al/Al) |
GLM-CZ |
CZ |
30 |
7.56 |
7.56 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
5431A |
|
|
G |
Telmisartan/Hydrochlorotiazid Sandoz 80 mg/12,5 mg |
tbl obd 28x80 mg/12,5 mg (blis. Al/Al) |
SAN |
SI |
28 |
7.06 |
7.06 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4760A |
|
|
G |
Tolucombi 80mg/12,5mg tablety |
tbl 28x80mg/12,5mg |
KRK |
SL |
28 |
7.06 |
7.06 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
96435 |
|
|
O |
MICARDISPLUS 80/12,5 mg |
tbl 28 |
BOE |
DE |
28 |
12.25 |
7.07 |
S |
5.18 |
0.42285699999999998 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/12,5 mg (56 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
4929A |
|
|
G |
Telmisartan/Hydrochlorotiazid EGIS 80mg/12,5mg |
tbl 56x80mg/12,5mg (blis. Al/Al) |
EGI |
HU |
56 |
14.06 |
14.06 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/12,5 mg (84-90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
4637A |
|
|
G |
Actelsar HCT 80 mg/12,5 mg tablety |
tbl 90x80 mg/12,5 mg (blis.Al/Al) |
ACT-5 |
IS |
90 |
22.6 |
22.6 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4764A |
|
|
G |
Tolucombi 80mg/12,5mg tablety |
tbl 84x80mg/12,5mg |
KRK |
SL |
84 |
21.16 |
21.16 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
7052A |
|
|
G |
Telmark Plus 80 mg/12,5 mg |
tbl 90x80 mg/12,5 mg (blis.Al/Al) |
GLM-CZ |
CZ |
90 |
22.68 |
22.68 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
5437A |
|
|
G |
Telmisartan/Hydrochlorotiazid Sandoz 80 mg/12,5 mg |
tbl obd 90x80 mg/12,5 mg (blis. Al/Al) |
SAN |
SI |
90 |
22.68 |
22.68 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
6448A |
|
|
G |
TEZEO HCT 80 mg/12,5 mg |
tbl 90x80 mg/12,5 mg (blis. OPA/Al/PVC/Al) |
ZNT |
CZ |
90 |
22.68 |
22.68 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.309 |
|
|
|
4648A |
|
|
G |
Actelsar HCT 80 mg/25 mg tablety |
tbl 28x80 mg/25 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4934A |
|
|
G |
Telmisartan/Hydrochlorotiazid EGIS 80mg/25mg |
tbl 28x80mg/25mg (blis. Al/Al) |
EGI |
HU |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
5442A |
|
|
G |
Telmisartan/Hydrochlorotiazid Sandoz 80 mg/25 mg |
tbl obd 28x80 mg/25 mg (blis. Al/Al) |
SAN |
SI |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
6451A |
|
|
G |
TEZEO HCT 80 mg/25 mg |
tbl 28x80 mg/25 mg (blis. OPA/Al/PVC/Al) |
ZNT |
CZ |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4772A |
|
|
G |
Tolucombi 80mg/25mg tablety |
tbl 28x80mg/25mg |
KRK |
SL |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
7056A |
|
|
G |
Telmark Plus 80 mg/25 mg |
tbl 30x80 mg/25 mg (blis.Al/Al) |
GLM-CZ |
CZ |
30 |
9.27 |
9.27 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
50556 |
|
|
O |
MicardisPlus |
tbl 28x80 mg/25 mg |
BOE |
DE |
28 |
12.31 |
8.65 |
S |
3.66 |
0.297319 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/25 mg (56 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.309 |
|
|
|
4935A |
|
|
G |
Telmisartan/Hydrochlorotiazid EGIS 80mg/25mg |
tbl 56x80mg/25mg (blis. Al/Al) |
EGI |
HU |
56 |
17.28 |
17.28 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DB01 |
|
|
|
Valsartan a amlodipín |
p.o. 5/80 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.126 |
|
|
|
38148 |
|
|
O |
EXFORGE 5 mg/80 mg |
tbl flm 28x5 mg/80 mg |
NEH |
GB |
28 |
21.11 |
3.53 |
S |
17.579999999999998 |
0.83278099999999999 |
17.579999999999998 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DB01 |
|
|
|
Valsartan a amlodipín |
p.o. 5/160 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.224 |
|
|
|
38156 |
|
|
O |
EXFORGE 5 mg/160 mg |
tbl flm 28x5 mg/160 mg |
NEH |
GB |
28 |
21.97 |
6.27 |
S |
15.7 |
0.714611 |
15.7 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DB04 |
|
|
|
Telmisartan a amlodipín |
p.o. 80/5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.224 |
|
|
|
01538 |
|
|
O |
Twynsta 80 mg/5 mg tablety |
tbl 28x80 mg/5 mg |
BOE |
DE |
28 |
23.27 |
6.27 |
S |
17 |
0.73055400000000004 |
17 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DB04 |
|
|
|
Telmisartan a amlodipín |
p.o. 80/10 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22600000000000001 |
|
|
|
01545 |
|
|
O |
Twynsta 80 mg/10 mg tablety |
tbl 28x80 mg/10 mg |
BOE |
DE |
28 |
23.16 |
6.33 |
S |
16.829999999999998 |
0.72668400000000011 |
16.829999999999998 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DB06 |
|
|
|
Losartan a amlodipín |
p.o. 50/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.1999999999999998E-2 |
|
|
|
9086A |
|
|
G |
Tenloris 50 mg/5 mg filmom obalené tablety |
tbl flm 30x50mg/5mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
3.25 |
2.76 |
S |
0.49 |
0.15076900000000001 |
0.49 |
|
|
|
|
|
C09DB06 |
|
|
|
Losartan a amlodipín |
p.o. 50/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.4E-2 |
|
|
|
9092A |
|
|
G |
Tenloris 50 mg/10 mg filmom obalené tablety |
tbl flm 30x50mg/10mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
3.31 |
2.82 |
S |
0.49 |
0.148036 |
0.49 |
|
|
|
|
|
C09DB06 |
|
|
|
Losartan a amlodipín |
p.o. 100/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.156 |
|
|
|
9098A |
|
|
G |
Tenloris 100 mg/5 mg filmom obalené tablety |
tbl flm 30x100mg/5mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
5.18 |
4.68 |
S |
0.5 |
9.6525E-2 |
0.5 |
|
|
|
|
|
C09DB06 |
|
|
|
Losartan a amlodipín |
p.o. 100/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.158 |
|
|
|
9104A |
|
|
G |
Tenloris 100 mg/10 mg filmom obalené tablety |
tbl flm 30x100mg/10mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
5.24 |
4.74 |
S |
0.5 |
9.5420000000000005E-2 |
0.5 |
|
|
|
|
|
C09XA02 |
|
|
|
Aliskiren |
p.o. 150 mg (28 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.502 |
|
|
|
85361 |
X |
|
O |
RASILEZ 150 mg |
tbl flm 28x150 mg |
NEH |
GB |
28 |
18.690000000000001 |
14.06 |
S |
4.63 |
0.247726 |
4.63 |
DIA, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09XA02 |
|
|
|
Aliskiren |
p.o. 300 mg (28 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.40500000000000003 |
|
|
|
85372 |
X |
|
O |
RASILEZ 300 mg |
tbl flm 28x300 mg |
NEH |
GB |
56 |
23.55 |
22.68 |
S |
0.87 |
3.6943000000000004E-2 |
0.87 |
DIA, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09XA02 |
|
|
|
Aliskiren |
p.o. 300 mg (98 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.40500000000000003 |
|
|
|
85378 |
X |
|
O |
RASILEZ 300 mg |
tbl flm 98x300 mg |
NEH |
GB |
196 |
92.06 |
79.38 |
S |
12.68 |
0.137736 |
3.05 |
DIA, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09XA52 |
|
|
|
Aliskiren a hydrochlórotiazid |
p.o. 150/12,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.55400000000000005 |
|
|
|
65076 |
|
|
O |
RASILEZ HCT 150 mg/12,5 mg |
tbl flm 28x150 mg/12,5 mg |
NEH |
GB |
28 |
21.33 |
15.51 |
S |
5.82 |
0.27285500000000001 |
5.82 |
DIA, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09XA52 |
|
|
|
Aliskiren a hydrochlórotiazid |
p.o. 300/12,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.86199999999999999 |
|
|
|
65147 |
|
|
O |
RASILEZ HCT 300 mg/12,5 mg |
tbl flm 28x300 mg/12,5 mg |
NEH |
GB |
28 |
26.01 |
24.14 |
S |
1.87 |
7.1895000000000001E-2 |
1.87 |
DIA, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09XA52 |
|
|
|
Aliskiren a hydrochlórotiazid |
p.o. 300/25 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.91300000000000003 |
|
|
|
65212 |
|
|
O |
RASILEZ HCT 300 mg/25 mg |
tbl flm 28x300 mg/25 mg |
NEH |
GB |
28 |
26.38 |
25.56 |
S |
0.82 |
3.1084000000000001E-2 |
0.82 |
DIA, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C10AA01 |
|
|
|
Simvastatín |
p.o. 10 mg (28-30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
66024 |
X |
|
G |
SIMVOR 10 MG |
tbl flm 30x10 mg |
RXY |
IN |
20 |
1.39 |
0.66 |
S |
0.73 |
0.52517999999999998 |
0.73 |
|
|
|
|
U14 |
15011 |
X |
|
G |
SIMVACARD 10 (BLIS.) |
tbl flm 28x10 mg |
ZNT |
CZ |
18.667000000000002 |
1.44 |
0.62 |
S |
0.82 |
0.56944400000000006 |
0.68 |
|
|
|
|
U14 |
13207 |
X |
|
G |
SIMGAL 10 MG (blis.) |
tbl flm 28x10 mg |
IVX |
CZ |
9.3330000000000002 |
1.03 |
0.31 |
S |
0.72 |
0.69902900000000001 |
0.34 |
|
|
|
|
U14 |
58136 |
X |
|
G |
VASILIP 10 |
tbl flm 28x10 mg |
KRK |
SI |
18.667000000000002 |
2.15 |
0.62 |
S |
1.53 |
0.71162800000000004 |
0.68 |
|
|
|
|
U14 |
97921 |
X |
|
O |
ZOCOR 10 mg |
tbl obd 28x10 mg |
MSD |
NL |
18.667000000000002 |
2.67 |
0.62 |
S |
2.0499999999999998 |
0.76778999999999997 |
0.68 |
|
|
|
|
U14 |
C10AA01 |
|
|
|
Simvastatín |
p.o. 20 mg (28-30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
8224A |
X |
|
G |
Medilip 20 mg filmom obalené tablety |
p.o., tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al) |
MRG |
CR |
37.33 |
2.17 |
1.23 |
S |
0.94 |
0.43317999999999995 |
0.94 |
|
|
|
|
U14 |
66026 |
X |
|
G |
SIMVOR 20 MG |
tbl flm 30x20 mg |
RXY |
IN |
40 |
2.33 |
1.32 |
S |
1.01 |
0.43347599999999997 |
1.01 |
|
|
|
|
U14 |
13209 |
X |
|
G |
SIMGAL 20 MG (blis.) |
tbl flm 28x20 mg |
IVX |
CZ |
37.332999999999998 |
2.1800000000000002 |
1.23 |
S |
0.95 |
0.43578000000000006 |
0.94 |
|
|
|
|
U14 |
33681 |
X |
|
G |
Simvastatin-ratiopharm 20 mg |
tbl flm 30x20 mg |
MCK |
DE |
40 |
2.4300000000000002 |
1.32 |
S |
1.1100000000000001 |
0.45679000000000003 |
1.01 |
|
|
|
|
U14 |
15029 |
X |
|
G |
SIMVACARD 20 (BLIS.) |
tbl flm 28x20 mg |
ZNT |
CZ |
37.332999999999998 |
2.31 |
1.23 |
S |
1.08 |
0.467532 |
0.94 |
|
|
|
|
U14 |
14630 |
X |
|
G |
VASILIP 20 |
tbl flm 28x20 mg |
KRK |
SI |
37.332999999999998 |
4.1399999999999997 |
1.23 |
S |
2.91 |
0.70289900000000005 |
0.94 |
|
|
|
|
U14 |
97923 |
X |
|
O |
ZOCOR 20 mg |
tbl obd 28x20 mg |
MSD |
NL |
37.332999999999998 |
4.41 |
1.23 |
S |
3.18 |
0.72108800000000006 |
0.94 |
|
|
|
|
U14 |
C10AA01 |
|
|
|
Simvastatín |
p.o. 20 mg (84 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
47731 |
X |
|
G |
SIMVACARD 20 (blis.) |
tbl flm 84x20 mg |
ZNT |
CZ |
112 |
7.48 |
3.7 |
S |
3.78 |
0.50534800000000002 |
2.82 |
|
|
|
|
U14 |
C10AA01 |
|
|
|
Simvastatín |
p.o. 40 mg (28-30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
66028 |
X |
|
G |
SIMVOR 40 MG |
tbl flm 30x40 mg |
RXY |
IN |
80 |
3.2 |
2.64 |
S |
0.56000000000000005 |
0.17499999999999999 |
0.56000000000000005 |
|
|
|
|
U14 |
13211 |
X |
|
G |
SIMGAL 40 MG (blis.) |
tbl flm 28x40 mg |
IVX |
CZ |
74.674999999999997 |
2.99 |
2.46 |
S |
0.53 |
0.177258 |
0.52 |
|
|
|
|
U14 |
15084 |
X |
|
G |
SIMVACARD 40 (BLIS.) |
tbl flm 28x40 mg |
ZNT |
CZ |
74.674999999999997 |
3.28 |
2.46 |
S |
0.82 |
0.25 |
0.52 |
|
|
|
|
U14 |
42929 |
X |
|
G |
VASILIP 40 |
tbl flm 28x40 mg |
KRK |
SI |
74.674999999999997 |
6.35 |
2.46 |
S |
3.89 |
0.61259799999999998 |
0.52 |
|
|
|
|
U14 |
97925 |
X |
|
O |
ZOCOR 40 mg |
tbl obd 28x40 mg |
MSD |
NL |
74.674999999999997 |
7.06 |
2.46 |
S |
4.5999999999999996 |
0.65155799999999997 |
0.52 |
|
|
|
|
U14 |
C10AA02 |
|
|
|
Lovastatín |
p.o. 40 mg (10 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
36527 |
X |
|
G |
MEDOSTATIN 40 mg |
tbl 10x40 mg |
MOE |
CY |
13.326000000000001 |
2.73 |
0.44 |
S |
2.29 |
0.83882800000000002 |
1.1200000000000001 |
|
ind.obm. |
|
|
U14 |
C10AA02 |
|
|
|
Lovastatín |
p.o. 40 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
36528 |
X |
|
G |
MEDOSTATIN 40 mg |
tbl 30x40 mg |
MOE |
CY |
40 |
7.47 |
1.32 |
S |
6.15 |
0.82329300000000005 |
3.35 |
|
ind.obm. |
|
|
U14 |
C10AA02 |
|
|
|
Lovastatín |
p.o. 40 mg (100 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
36529 |
X |
|
G |
MEDOSTATIN 40 mg |
tbl 100x40 mg |
MOE |
CY |
133.32599999999999 |
15.58 |
4.4000000000000004 |
S |
11.18 |
0.71758700000000009 |
11.18 |
|
ind.obm. |
|
|
U14 |
C10AA04 |
|
|
|
Fluvastatín |
p.o. predĺžené uvoľňovanie 80 mg (28-30 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
02967 |
X |
|
O |
LESCOL XL 80 mg |
tbl plg 28x80 mg |
NPF |
CH |
56 |
6.28 |
1.85 |
S |
4.43 |
0.70541399999999999 |
4.43 |
ANG, DIA, END, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U14 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
21245 |
X |
|
G |
Atorvastatin Teva Pharma 10 mg |
tbl flm 30x10 mg (blis.Al/Al) |
TEV |
SK |
30 |
1.78 |
0.99 |
S |
0.79 |
0.44381999999999999 |
0.63 |
|
|
|
|
U14 |
20884 |
X |
|
G |
Tulip 10 mg filmom obalené tablety |
tbl flm 30x10 mg (blis.Al/Al) |
SAN |
SI |
30 |
1.96 |
0.99 |
S |
0.97 |
0.494898 |
0.63 |
|
|
|
|
U14 |
38821 |
X |
|
G |
Atorvastatin Actavis 10mg |
tbl flm 30x10 mg |
ACT |
IS |
30 |
1.97 |
0.99 |
S |
0.98 |
0.49746200000000002 |
0.63 |
|
|
|
|
U14 |
4269A |
X |
|
G |
Atorvastatin Billev 10 mg filmom obalené tablety |
tbl flm 30x10mg(blis.OPA/Al/PVC/Al) |
BIP |
DK |
30 |
1.97 |
0.99 |
S |
0.98 |
0.49746200000000002 |
0.63 |
|
|
|
|
U14 |
92234 |
X |
|
G |
Torvacard 10 |
tbl flm 30x10 mg |
ZNT-SK-2 |
SK |
30 |
1.97 |
0.99 |
S |
0.98 |
0.49746200000000002 |
0.63 |
|
|
|
|
U14 |
3037B |
X |
|
G |
Torvacard Novum 10 mg |
tbl flm 30x10 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
30 |
1.97 |
0.99 |
S |
0.98 |
0.49746200000000002 |
0.63 |
|
|
|
|
U14 |
82812 |
X |
|
G |
Atorgamma 10 mg |
tbl flm 30x10 mg (blis. OPA-Al-PVC/Al) |
WGP |
DE |
30 |
2.0699999999999998 |
0.99 |
S |
1.08 |
0.52173900000000006 |
0.63 |
|
|
|
|
U14 |
04089 |
X |
|
G |
AMICOR 10 mg |
tbl flm 30x10 mg (blis.Al/Al) |
MOE |
CY |
30 |
2.52 |
0.99 |
S |
1.53 |
0.60714299999999999 |
0.63 |
|
|
|
|
U14 |
38881 |
X |
|
G |
LARUS 10 mg |
tbl flm 30x10 mg (blis.) |
GDN |
HU |
30 |
2.59 |
0.99 |
S |
1.6 |
0.617761 |
0.63 |
|
|
|
|
U14 |
57031 |
X |
|
G |
Pharmastatin 10 mg |
tbl flm 30x10 mg (blister) |
STD |
DE |
30 |
2.59 |
0.99 |
S |
1.6 |
0.617761 |
0.63 |
|
|
|
|
U14 |
40532 |
X |
|
G |
ATORIS 10 |
tbl flm 30x10 mg |
KRK |
SI |
30 |
2.6 |
0.99 |
S |
1.61 |
0.61923099999999998 |
0.63 |
|
|
|
|
U14 |
82507 |
X |
|
G |
Gletor 10 mg |
tbl flm 30x10 mg |
GLM |
CZ |
30 |
3.61 |
0.99 |
S |
2.62 |
0.72576200000000002 |
0.63 |
|
|
|
|
U14 |
88857 |
X |
|
G |
Torvazin 10 mg |
tbl flm 30x10 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
4.8499999999999996 |
0.99 |
S |
3.86 |
0.79587599999999992 |
0.63 |
|
|
|
|
U14 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 10 mg (84-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
38826 |
X |
|
G |
Atorvastatin Actavis 10 mg |
tbl flm 100x10 mg (blis.) |
ACT |
IS |
100 |
5.39 |
3.3 |
S |
2.09 |
0.38775500000000002 |
2.09 |
|
|
|
|
U14 |
40534 |
X |
|
G |
ATORIS 10 |
tbl flm 90x10 mg |
KRK |
SI |
90 |
4.95 |
2.97 |
S |
1.98 |
0.4 |
1.88 |
|
|
|
|
U14 |
21257 |
X |
|
G |
Atorvastatin Teva Pharma 10 mg |
tbl flm 90x10 mg (blis.Al/Al) |
TEV |
SK |
90 |
4.95 |
2.97 |
S |
1.98 |
0.4 |
1.88 |
|
|
|
|
U14 |
57036 |
X |
|
G |
Pharmastatin 10 mg |
tbl flm 100x10 mg (blister) |
STD |
DE |
100 |
5.5 |
3.3 |
S |
2.2000000000000002 |
0.4 |
2.09 |
|
|
|
|
U14 |
92235 |
X |
|
G |
Torvacard 10 |
tbl flm 90x10 mg |
ZNT-SK-2 |
SK |
90 |
4.95 |
2.97 |
S |
1.98 |
0.4 |
1.88 |
|
|
|
|
U14 |
3041B |
X |
|
G |
Torvacard Novum 10 mg |
tbl flm 90x10 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
90 |
4.95 |
2.97 |
S |
1.98 |
0.4 |
1.88 |
|
|
|
|
U14 |
20895 |
X |
|
G |
Tulip 10 mg filmom obalené tablety |
tbl flm 90x10 mg (blis.Al/Al) |
SAN |
SI |
90 |
6.1 |
2.97 |
S |
3.13 |
0.51311499999999999 |
1.88 |
|
|
|
|
U14 |
88867 |
X |
|
G |
Torvazin 10 mg |
tbl flm 90x10 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
90 |
6.6 |
2.97 |
S |
3.63 |
0.55000000000000004 |
1.88 |
|
|
|
|
U14 |
38886 |
X |
|
G |
LARUS 10 mg |
tbl flm 100x10 mg |
GDN |
HU |
100 |
7.83 |
3.3 |
S |
4.53 |
0.57854399999999995 |
2.09 |
|
|
|
|
U14 |
82817 |
X |
|
G |
Atorgamma 10 mg |
tbl flm 100x10 mg (blis. OPA-Al-PVC/Al) |
WGP |
DE |
100 |
8 |
3.3 |
S |
4.7 |
0.58750000000000002 |
2.09 |
|
|
|
|
U14 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 20 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
21270 |
X |
|
G |
Atorvastatin Teva Pharma 20 mg |
tbl flm 30x20 mg (blis.Al/Al) |
TEV |
SK |
60 |
1.55 |
1.55 |
I |
0 |
0 |
0 |
|
|
|
|
U14 |
38841 |
X |
|
G |
Atorvastatin Actavis 20mg |
tbl flm 30x20 mg |
ACT |
IS |
60 |
1.76 |
1.76 |
I |
0 |
0 |
0 |
|
|
|
|
U14 |
4283A |
X |
|
G |
Atorvastatin Billev 20 mg filmom obalené tablety |
tbl flm 30x20mg(blis.OPA/Al/PVC/Al) |
BIP |
DK |
60 |
1.76 |
1.76 |
I |
0 |
0 |
0 |
|
|
|
|
U14 |
40538 |
X |
|
G |
ATORIS 20 |
tbl flm 30x20 |
KRK |
SI |
60 |
2.41 |
1.98 |
S |
0.43 |
0.17842300000000003 |
0 |
|
|
|
|
U14 |
38840 |
X |
|
G |
Atorvastatin Actavis 20 mg |
tbl flm 28x20 mg (blis.) |
ACT-3 |
IS |
56 |
2.46 |
1.85 |
S |
0.61 |
0.24796700000000002 |
0 |
|
|
|
|
U14 |
82555 |
X |
|
G |
Gletor 20 mg |
tbl flm 30x20 mg |
GLM |
CZ |
60 |
2.88 |
1.98 |
S |
0.9 |
0.3125 |
0 |
|
|
|
|
U14 |
92240 |
X |
|
G |
Torvacard 20 |
tbl flm 30x20 mg |
ZNT-SK-2 |
SK |
60 |
2.91 |
1.98 |
S |
0.93 |
0.31958799999999998 |
0 |
|
|
|
|
U14 |
3049B |
X |
|
G |
Torvacard Novum 20 mg |
tbl flm 30x20 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
60 |
2.91 |
1.98 |
S |
0.93 |
0.31958799999999998 |
0 |
|
|
|
|
U14 |
57051 |
X |
|
G |
Pharmastatin 20 mg |
tbl flm 30x20 mg (blister) |
STD |
DE |
60 |
3.14 |
1.98 |
S |
1.1599999999999999 |
0.36942700000000001 |
0 |
|
|
|
|
U14 |
82931 |
X |
|
G |
Atorgamma 20 mg |
tbl flm 30x20 mg (blis. OPA-Al-PVC/Al) |
WGP |
DE |
60 |
3.35 |
1.98 |
S |
1.37 |
0.40895499999999996 |
0 |
|
|
|
|
U14 |
38901 |
X |
|
G |
LARUS 20 mg |
tbl flm 30x20 mg (blis.) |
GDN |
HU |
60 |
3.41 |
1.98 |
S |
1.43 |
0.41935499999999998 |
0 |
|
|
|
|
U14 |
88893 |
X |
|
G |
Torvazin 20 mg |
tbl flm 30x20 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
60 |
3.44 |
1.98 |
S |
1.46 |
0.42441899999999999 |
0 |
|
|
|
|
U14 |
20905 |
X |
|
G |
Tulip 20 mg filmom obalené tablety |
tbl flm 30x20 mg (blis.Al/Al) |
SAN |
SI |
60 |
3.57 |
1.98 |
S |
1.59 |
0.445378 |
0 |
|
|
|
|
U14 |
04134 |
X |
|
G |
AMICOR 20 mg |
tbl flm 30x20 mg (blis.Al/Al) |
MOE |
CY |
60 |
3.83 |
1.98 |
S |
1.85 |
0.48302899999999999 |
0 |
|
|
|
|
U14 |
93016 |
X |
|
O |
SORTIS 20 mg |
tbl flm 30x20 mg (blis.PA/Al/PVC) |
PFI-GB-3 |
GB |
60 |
9.64 |
1.98 |
S |
7.66 |
0.79460600000000003 |
0 |
|
|
|
|
U14 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 20 mg (84-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
82560 |
X |
|
G |
Gletor 20 mg |
tbl flm 100x20 mg |
GLM |
CZ |
200 |
6.6 |
6.6 |
I |
0 |
0 |
0 |
|
|
|
|
U14 |
38846 |
X |
|
G |
Atorvastatin Actavis 20 mg |
tbl flm 100x20 mg (blis.) |
ACT |
IS |
200 |
7.5 |
6.6 |
S |
0.9 |
0.12 |
0 |
|
|
|
|
U14 |
6931A |
X |
|
G |
Atorvastatin Farmax 20 mg |
tbl flm 100x20 mg (blis.Al/Al) |
SVS |
CZ |
200 |
7.5 |
6.6 |
S |
0.9 |
0.12 |
0 |
|
|
|
|
U14 |
92241 |
X |
|
G |
Torvacard 20 |
tbl flm 90x20 mg |
ZNT-SK-2 |
SK |
180 |
6.91 |
5.94 |
S |
0.97 |
0.140376 |
0 |
|
|
|
|
U14 |
3053B |
X |
|
G |
Torvacard Novum 20 mg |
tbl flm 90x20 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
180 |
6.91 |
5.94 |
S |
0.97 |
0.140376 |
0 |
|
|
|
|
U14 |
88894 |
X |
|
G |
Torvazin 20 mg |
tbl flm 90x20 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
180 |
6.91 |
5.94 |
S |
0.97 |
0.140376 |
0 |
|
|
|
|
U14 |
40541 |
X |
|
G |
ATORIS 20 |
tbl flm 90x20 mg |
KRK |
SI |
180 |
7.03 |
5.94 |
S |
1.0900000000000001 |
0.15505000000000002 |
0 |
|
|
|
|
U14 |
21278 |
X |
|
G |
Atorvastatin Teva Pharma 20 mg |
tbl flm 90x20 mg (blis.Al/Al) |
TEV |
SK |
180 |
7.44 |
5.94 |
S |
1.5 |
0.20161300000000001 |
0 |
|
|
|
|
U14 |
00916 |
X |
|
G |
Atorvastatin Mylan 20mg |
tbl flm 90x20mg |
GNC |
GB |
180 |
7.58 |
5.94 |
S |
1.64 |
0.216359 |
0 |
|
|
|
|
U14 |
57056 |
X |
|
G |
Pharmastatin 20 mg |
tbl flm 100x20 mg (blister) |
STD |
DE |
200 |
8.67 |
6.6 |
S |
2.0699999999999998 |
0.23875399999999999 |
0 |
|
|
|
|
U14 |
20916 |
X |
|
G |
Tulip 20 mg filmom obalené tablety |
tbl flm 90x20 mg (blis.Al/Al) |
SAN |
SI |
180 |
7.82 |
5.94 |
S |
1.88 |
0.24040900000000001 |
0 |
|
|
|
|
U14 |
82936 |
X |
|
G |
Atorgamma 20 mg |
tbl flm 100x20 mg (blis. OPA-Al-PVC/Al) |
WGP |
DE |
200 |
11.3 |
6.6 |
S |
4.7 |
0.41592899999999999 |
0 |
|
|
|
|
U14 |
38906 |
X |
|
G |
LARUS 20 mg |
tbl flm 100x20 mg |
GDN |
HU |
200 |
12.5 |
6.6 |
S |
5.9 |
0.47200000000000003 |
0 |
|
|
|
|
U14 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 30 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
04619 |
X |
|
G |
Atoris 30 |
tbl flm 30x30mg |
KRK |
SI |
90 |
4.46 |
2.97 |
S |
1.49 |
0.33408099999999996 |
0.5 |
|
|
|
|
U14 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 30 mg (90 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
04621 |
X |
|
G |
Atoris 30 filmom obalené tablety |
tbl flm 90x30mg(blis.Al/OPA/Al/PVC/Al) |
KRK |
SL |
270 |
10.4 |
8.91 |
S |
1.49 |
0.14326900000000001 |
1.49 |
|
|
|
|
U14 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 40 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
32736 |
X |
|
G |
Atorvastatin Mylan 40 mg |
tbl flm 30x 40 mg (fľ.HDPE) |
GNS |
UK |
120 |
4.49 |
4.49 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
21287 |
X |
|
G |
Atorvastatin Teva Pharma 40 mg |
tbl flm 30x40 mg (blis.Al/Al) |
TEV |
SK |
120 |
4.49 |
4.49 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
82589 |
X |
|
G |
Gletor 40 mg |
tbl flm 30x40 mg |
GLM |
CZ |
120 |
4.49 |
4.49 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
57072 |
X |
|
G |
Pharmastatin 40 mg |
tbl flm 30x40 mg (blister) |
STD |
DE |
120 |
4.49 |
4.49 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
92749 |
X |
|
G |
ATORIS 40 |
tbl flm 30x40 mg |
KRK |
SI |
120 |
4.58 |
4.58 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
38861 |
X |
|
G |
Atorvastatin Actavis 40 mg |
tbl flm 30x40 mg (blis.) |
ACT |
IS |
120 |
4.58 |
4.58 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
20926 |
X |
|
G |
Tulip 40 mg filmom obalené tablety |
tbl flm 30x40 mg (blis.Al/Al) |
SAN-SLO-1 |
SI |
120 |
5.39 |
4.8 |
S |
0.59 |
0.10946199999999999 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
82959 |
X |
|
G |
Atorgamma 40 mg |
tbl flm 30x40 mg (blis. OPA-Al-PVC/Al) |
WGP |
DE |
120 |
6.07 |
4.8 |
S |
1.27 |
0.209226 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
92248 |
X |
|
G |
Torvacard 40 |
tbl flm 30x40 mg |
ZNT-SK-2 |
SK |
120 |
6.07 |
4.8 |
S |
1.27 |
0.209226 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
3061B |
X |
|
G |
Torvacard Novum 40 mg |
tbl flm 30x40 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
120 |
6.07 |
4.8 |
S |
1.27 |
0.209226 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
38921 |
X |
|
G |
LARUS 40 mg |
tbl flm 30x40 mg (blis.) |
GDN |
HU |
120 |
7.65 |
4.8 |
S |
2.85 |
0.37254900000000002 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
04164 |
X |
|
G |
AMICOR 40 mg |
tbl flm 30x40 mg (blis.Al/Al) |
MOE |
CY |
120 |
7.79 |
4.8 |
S |
2.99 |
0.38382500000000003 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
93019 |
X |
|
O |
SORTIS 40 mg |
tbl flm 30x40 mg (blis. PA/Al/PVC) |
PFI-GB-3 |
GB |
120 |
11.37 |
4.8 |
S |
6.57 |
0.57783600000000002 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 40 mg (84-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
00991 |
X |
|
G |
Atorvastatin Mylan 40mg |
tbl flm 90x40mg |
GNC |
GB |
360 |
13.47 |
13.47 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
21293 |
X |
|
G |
Atorvastatin Teva Pharma 40 mg |
tbl flm 90x40 mg (blis.Al/Al) |
TEV |
SK |
360 |
13.47 |
13.47 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
6937A |
X |
|
G |
Atorvastatin Farmax 40 mg |
tbl flm 100x40 mg (blis.Al/Al) |
SVS |
CZ |
400 |
14.97 |
14.97 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
92751 |
X |
|
G |
ATORIS 40 |
tbl flm 90x40 mg |
KRK |
SI |
360 |
13.74 |
13.74 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
38866 |
X |
|
G |
Atorvastatin Actavis 40 mg |
tbl flm 100x40 mg (blis.) |
ACT-3 |
IS |
400 |
15.27 |
15.27 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
57077 |
X |
|
G |
Pharmastatin 40 mg |
tbl flm 100x40 mg (blister) |
STD |
DE |
400 |
15.27 |
15.27 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
82594 |
X |
|
G |
Gletor 40 mg |
tbl flm 100x40 mg (blis.OPA-Al-PVC/Al) |
GLM |
CZ |
400 |
16 |
16 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
88897 |
X |
|
G |
Torvazin 40 mg |
tbl flm 90x40 mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
360 |
15.64 |
14.4 |
S |
1.24 |
7.9283999999999993E-2 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
20937 |
X |
|
G |
Tulip 40 mg filmom obalené tablety |
tbl flm 90x40 mg (blis.Al/Al) |
SAN-SLO-1 |
SI |
360 |
15.9 |
14.4 |
S |
1.5 |
9.4339999999999993E-2 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
92249 |
X |
|
G |
Torvacard 40 |
tbl flm 90x40 mg |
ZNT-SK-2 |
SK |
360 |
17.32 |
14.4 |
S |
2.92 |
0.16859100000000002 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
3065B |
X |
|
G |
Torvacard Novum 40 mg |
tbl flm 90x40 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
360 |
17.32 |
14.4 |
S |
2.92 |
0.16859100000000002 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
82964 |
X |
|
G |
Atorgamma 40 mg |
tbl flm 100x40 mg (blis. OPA-Al-PVC/Al) |
WGP |
DE |
400 |
27.11 |
16 |
S |
11.11 |
0.40981200000000001 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 60 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
04622 |
X |
|
G |
Atoris 60 |
tbl flm 30x60mg |
KRK |
SI |
180 |
7.2 |
7.2 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 80 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.2000000000000003E-2 |
|
|
|
04625 |
X |
|
G |
Atoris 80 |
tbl flm 30x80 mg |
KRK |
SI |
240 |
9.26 |
9.26 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
3436A |
X |
|
G |
Tulip 80 mg filmom obalené tablety |
tbl flm 30x80 mg (blis.Al/Al) |
SAN |
SI |
240 |
9.26 |
9.26 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
34351 |
X |
|
O |
SORTIS 80 mg |
tbl flm 30x80 mg (blis. PA/Al/PVC) |
PFI-GB-3 |
GB |
240 |
9.89 |
9.89 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
0366A |
X |
|
G |
Atorvastatin Actavis 80 mg |
tbl flm 30x80 mg (blis.Al/Al) |
ACT-3 |
IS |
240 |
9.94 |
9.94 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
12486 |
X |
|
G |
TORVACARD 80 mg |
tbl flm 30x80 mg (blis.OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
240 |
9.94 |
9.94 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
3073B |
X |
|
G |
Torvacard Novum 80 mg |
tbl flm 30x80 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
240 |
9.94 |
9.94 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
21302 |
X |
|
G |
Atorvastatin Teva Pharma 80 mg |
tbl flm 28x80 mg (blis.Al/Al) |
TEV |
IL |
224 |
9.2899999999999991 |
9.2899999999999991 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 80 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.2000000000000003E-2 |
|
|
|
04627 |
X |
|
G |
Atoris 80 |
tbl flm 90x80 mg |
KRK |
SI |
720 |
27.78 |
27.78 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
3446A |
X |
|
G |
Tulip 80 mg filmom obalené tablety |
tbl flm 90x80 mg (blis.Al/Al) |
SAN |
SI |
720 |
27.78 |
27.78 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
0371A |
X |
|
G |
Atorvastatin Actavis 80 mg |
tbl flm 100x80 mg (blis.Al/Al) |
ACT-3 |
IS |
800 |
30.87 |
30.87 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
34353 |
X |
|
O |
SORTIS 80 mg |
tbl flm 100x80 mg (blis.PA/Al/PVC) |
PFI-GB-3 |
GB |
800 |
31.2 |
31.2 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
21309 |
X |
|
G |
Atorvastatin Teva Pharma 80 mg |
tbl flm 90x80 mg (blis.Al/Al) |
TEV |
SK |
720 |
29.82 |
29.82 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
12487 |
X |
|
G |
TORVACARD 80 mg |
tbl flm 90x80 mg (blis.OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
720 |
29.82 |
29.82 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
3077B |
X |
|
G |
Torvacard Novum 80 mg |
tbl flm 90x80 mg (blis.OPA/Al/PVC/Al) |
ZNT |
|
720 |
29.82 |
29.82 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
C10AA07 |
|
|
|
Rosuvastatín |
p.o. 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
23301 |
X |
|
G |
Sorvasta 10 mg |
tbl flm 28x10 mg (blis.OPA/Al/PVC/Al) |
KRK-2 |
SI |
28 |
3.1 |
1.1200000000000001 |
S |
1.98 |
0.63871 |
1.21 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
84756 |
X |
|
G |
ROSUCARD 10 mg filmom obalené tablety |
tbl flm 30x10 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
30 |
5.41 |
1.2 |
S |
4.21 |
0.77818900000000002 |
1.3 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
84870 |
X |
|
G |
Rosuvastatin Teva 10 mg filmom obalené tablety |
tbl flm 30x10 mg (blis.PVC/PVAC/Al-OPA/Al/PVC) |
TEV |
IL |
30 |
5.56 |
1.2 |
S |
4.3600000000000003 |
0.78417300000000001 |
1.3 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
85494 |
X |
|
G |
ZARANTA 10 mg |
tbl flm 30x10 mg |
GDN |
HU |
30 |
5.57 |
1.2 |
S |
4.37 |
0.78456000000000004 |
1.3 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
21415 |
X |
|
G |
Zahron 10 mg |
tbl flm 28x10 mg (blis.PA/Al/PVC/Al) |
ZKL |
PL |
28 |
5.42 |
1.1200000000000001 |
S |
4.3 |
0.79335800000000001 |
1.21 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA07 |
|
|
|
Rosuvastatín |
p.o. 10 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
84758 |
X |
|
G |
ROSUCARD 10 mg filmom obalené tablety |
tbl flm 90x10 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
90 |
7.5 |
3.6 |
S |
3.9 |
0.52 |
3.9 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
23306 |
X |
|
G |
Sorvasta 10mg |
tbl flm 90x10 mg |
KRK-2 |
SI |
90 |
7.5 |
3.6 |
S |
3.9 |
0.52 |
3.9 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA07 |
|
|
|
Rosuvastatín |
p.o. 15 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
23315 |
X |
|
G |
Sorvasta 15mg |
tbl flm 28x15mg |
KRK-2 |
SI |
42 |
3.67 |
1.68 |
S |
1.99 |
0.54223399999999999 |
1.99 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA07 |
|
|
|
Rosuvastatín |
p.o. 20 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
23326 |
X |
|
G |
Sorvasta 20mg |
tbl flm 28x20 mg |
KRK-2 |
SI |
56 |
4.7300000000000004 |
2.2400000000000002 |
S |
2.4900000000000002 |
0.52642699999999998 |
1.52 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
84760 |
X |
|
G |
ROSUCARD 20 mg filmom obalené tablety |
tbl flm 30x20 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
60 |
6.08 |
2.4 |
S |
3.68 |
0.605263 |
1.63 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
21408 |
X |
|
G |
Zahron 20 mg |
tbl flm 28x20 mg (blis.PA/Al/PVC/Al) |
ZKL |
PL |
56 |
5.89 |
2.2400000000000002 |
S |
3.65 |
0.61969399999999997 |
1.52 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
85496 |
X |
|
G |
ZARANTA 20 mg |
tbl flm 30x20 mg |
GDN |
HU |
60 |
8.07 |
2.4 |
S |
5.67 |
0.70260199999999995 |
1.63 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA07 |
|
|
|
Rosuvastatín |
p.o. 20 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
84762 |
X |
|
G |
ROSUCARD 20 mg filmom obalené tablety |
tbl flm 90x20 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
180 |
12.1 |
7.2 |
S |
4.9000000000000004 |
0.40495900000000001 |
4.9000000000000004 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
23331 |
X |
|
G |
Sorvasta 20mg |
tbl flm 90x20 mg |
KRK-2 |
SI |
180 |
12.1 |
7.2 |
S |
4.9000000000000004 |
0.40495900000000001 |
4.9000000000000004 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA07 |
|
|
|
Rosuvastatín |
p.o. 30 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
23340 |
X |
|
G |
Sorvasta 30 mg |
tbl flm 28x30 mg (blis. OPA/Al/PVC/Al) |
KRK-2 |
SI |
84 |
5.84 |
3.36 |
S |
2.48 |
0.42465800000000004 |
2.48 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA07 |
|
|
|
Rosuvastatín |
p.o. 40 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.2000000000000003E-2 |
|
|
|
23352 |
X |
|
G |
Sorvasta 40mg |
tbl flm 28x40 mg |
KRK-2 |
SI |
112 |
7.68 |
4.7 |
S |
2.98 |
0.388021 |
2.98 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U16 |
84766 |
X |
|
G |
ROSUCARD 40 mg filmom obalené tablety |
tbl flm 30x40 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
120 |
11.41 |
5.04 |
S |
6.37 |
0.55828200000000006 |
3.19 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U16 |
85498 |
X |
|
G |
ZARANTA 40 mg |
tbl flm 30x40 mg |
GDN |
HU |
120 |
13.22 |
5.04 |
S |
8.18 |
0.61875900000000006 |
3.19 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U16 |
C10AA07 |
|
|
|
Rosuvastatín |
p.o. 40 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.2000000000000003E-2 |
|
|
|
84769 |
X |
|
G |
ROSUCARD 40 mg filmom obalené tablety |
tbl flm 90x40 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
360 |
24.69 |
15.12 |
S |
9.57 |
0.38760599999999995 |
9.57 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U16 |
C10AB05 |
|
|
|
Fenofibrát |
p.o. 200 mg (30 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.19719999999999999 |
|
|
|
85485 |
X |
|
G |
Fenofix 200 |
cps dur 30x200 mg (blis.PVC/PVDC/Al) |
TEV-SK |
SK |
30 |
6.45 |
5.92 |
S |
0.53 |
8.2171000000000008E-2 |
0 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. 200 mg (90 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.19719999999999999 |
|
|
|
85488 |
X |
|
G |
Fenofix 200 |
cps dur 90x200 mg (blis.PVC/PVDC/Al) |
TEV-SK |
SK |
90 |
17.75 |
17.75 |
I |
0 |
0 |
0 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. nanočastice 145 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.18099999999999999 |
|
|
|
95033 |
X |
|
O |
Lipanthyl NT 145 mg |
tbl flm 30x145 mg |
FFR |
FR |
30 |
8.2799999999999994 |
5.43 |
S |
2.85 |
0.34420299999999998 |
1.58 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. nanočastice 145 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.18099999999999999 |
|
|
|
95036 |
X |
|
O |
Lipanthyl NT 145 mg |
tbl flm 90x145 mg |
FFR |
FR |
90 |
21.02 |
16.29 |
S |
4.7300000000000004 |
0.225024 |
4.7300000000000004 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. supra bio 160 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.21099999999999999 |
|
|
|
59503 |
X |
|
O |
LIPANTHYL SUPRA 160 MG (BLIS.) |
tbl mod 30x160 mg |
FFR |
FR |
30 |
8.8699999999999992 |
6.33 |
S |
2.54 |
0.28635899999999997 |
2.08 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. supra bio 160 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.21099999999999999 |
|
|
|
59505 |
X |
|
O |
LIPANTHYL SUPRA 160 MG (BLIS.) |
tbl mod 90x160 mg |
FFR |
FR |
90 |
25.24 |
18.989999999999998 |
S |
6.25 |
0.24762300000000001 |
6.25 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. supra bio 215 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.254 |
|
|
|
95021 |
X |
|
O |
LIPANTHYL SUPRA 215 mg |
tbl flm 30x215 mg |
FFR |
FR |
30 |
9.84 |
7.62 |
S |
2.2200000000000002 |
0.22561 |
2.2200000000000002 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. mikronizované 200 mg (30 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
5.7000000000000002E-2 |
|
|
|
42080 |
X |
|
G |
SUPRELIP |
cps dur 30x200 mg (blis. PVC/Al) |
PRW |
CZ |
30 |
5.93 |
1.71 |
S |
4.22 |
0.71163600000000005 |
0 |
|
|
|
|
|
33291 |
X |
|
G |
FEBIRA 200 |
cps 30x200 mg |
ZNT |
SK |
30 |
7.88 |
1.71 |
S |
6.17 |
0.782995 |
0 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. mikronizované 200 mg (60 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
5.7000000000000002E-2 |
|
|
|
33292 |
X |
|
G |
FEBIRA 200 |
cps 60x200 mg |
ZNT |
SK |
60 |
14.72 |
3.42 |
S |
11.3 |
0.76766299999999998 |
0 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. mikronizované 200 mg (100 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
5.7000000000000002E-2 |
|
|
|
42081 |
X |
|
G |
SUPRELIP |
cps dur 100x200 mg (blis. PVC/Al) |
PRW |
CZ |
100 |
6.29 |
5.7 |
S |
0.59 |
9.3800000000000008E-2 |
0 |
|
|
|
|
|
C10AB05 |
|
|
|
Fenofibrát |
p.o. mikronizované 267 mg (30 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.22900000000000001 |
|
|
|
49623 |
X |
|
G |
Fenofibrate - AS 267 mg |
cps dur 30x267 mg |
TEV |
GB |
40.1 |
11.34 |
9.18 |
S |
2.16 |
0.19047599999999998 |
2.16 |
|
|
|
|
|
C10AX09 |
|
|
|
Ezetimib |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.2529999999999999 |
|
|
|
34410 |
X |
|
O |
EZETROL 10 mg tablety |
tbl 30x10 mg |
MSD |
GB |
30 |
40.64 |
37.590000000000003 |
S |
3.05 |
7.5049000000000005E-2 |
2.91 |
DIA, END, ENP, GER, INT, KAR, KLF |
ind.obm. |
|
|
|
C10AX09 |
|
|
|
Ezetimib |
p.o. 10 mg (84-98 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.2529999999999999 |
|
|
|
34411 |
X |
|
O |
EZETROL |
tbl 98x10 mg (blis. pretl.) |
MSD |
GB |
98 |
132.30000000000001 |
122.79 |
S |
9.51 |
7.1882000000000001E-2 |
9.51 |
DIA, END, GER, INT, KAR, ENP, KLF |
ind.obm. |
|
|
|
C10BA02 |
|
|
|
Simvastatín a ezetimib |
p.o. 10/20 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.2969999999999999 |
|
|
|
35961 |
|
|
O |
INEGY 10 mg/20 mg tablety |
tbl 30x10 mg/20 mg |
MSD-GB-1 |
GB |
30 |
44.2 |
38.909999999999997 |
S |
5.29 |
0.119683 |
3.36 |
DIA, END, GER, INT, KAR, ENP |
ind.obm. |
|
|
|
C10BA02 |
|
|
|
Simvastatín a ezetimib |
p.o. 10/20 mg (98 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.2969999999999999 |
|
|
|
35965 |
|
|
O |
INEGY 10 mg/20 mg tablety |
tbl 98x10 mg/20 mg |
MSD |
GB |
98 |
138.1 |
127.11 |
S |
10.99 |
7.9579999999999998E-2 |
10.99 |
DIA, END, GER, INT, KAR, ENP |
ind.obm. |
|
|
|
C10BA02 |
|
|
|
Simvastatín a ezetimib |
p.o. 10/40 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.341 |
|
|
|
35937 |
|
|
O |
INEGY 10 mg/40 mg tablety |
tbl 30x10 mg/40 mg |
MSD-GB-1 |
GB |
30 |
45.53 |
40.229999999999997 |
S |
5.3 |
0.11640700000000001 |
3.37 |
DIA, END, ENP, GER, INT, KAR |
ind.obm. |
|
|
|
C10BA02 |
|
|
|
Simvastatín a ezetimib |
p.o. 10/40 mg (98 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.341 |
|
|
|
35941 |
|
|
O |
INEGY 10 mg/40 mg tablety |
tbl 98x10 mg/40 mg |
MSD |
GB |
98 |
142.41999999999999 |
131.41999999999999 |
S |
11 |
7.7235999999999999E-2 |
11 |
DIA, END, ENP, GER, INT, KAR |
ind.obm. |
|
|
|
C10BA04 |
|
|
|
Simvastatín a fenofibrát |
p.o. 145/20 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22500000000000001 |
|
|
|
7020A |
|
|
O |
Cholib 145 mg/20 mg filmom obalené tablety |
tbl flm 30x145 mg/20 mg (blis.Al/Al) |
ABB-GB |
GB |
30 |
11.91 |
6.75 |
S |
5.16 |
0.433249 |
5.16 |
|
|
|
|
|
C10BA04 |
|
|
|
Simvastatín a fenofibrát |
p.o. 145/40 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.26900000000000002 |
|
|
|
7022A |
|
|
O |
Cholib 145 mg/40 mg filmom obalené tablety |
tbl flm 30x145 mg/40 mg (blis.Al/Al) |
ABB-GB |
GB |
30 |
14.15 |
8.07 |
S |
6.08 |
0.42968200000000001 |
6.08 |
|
|
|
|
|
C10BX03 |
|
|
|
Atorvastatín a amlodipín |
p.o. 5/10 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
6.0999999999999999E-2 |
|
|
|
0798B |
|
|
G |
AMLOAT 5 mg/10 mg |
tbl flm 28x5 mg/10 mg (blis.OPA/Al/PVC/Al) |
TEV-SK |
SK |
28 |
4.2 |
1.71 |
S |
2.4900000000000002 |
0.59285699999999997 |
1.71 |
|
|
|
|
|
9777A |
|
|
G |
Atordapin 5mg/10mg filmom obalené tablety |
tbl flm 30x5 mg/10mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
4.92 |
1.83 |
S |
3.09 |
0.62804900000000008 |
1.83 |
|
|
|
|
|
07794 |
|
|
O |
DICARTIL 5 mg/10 mg filmom obalené tablety |
tbl flm 28x5 mg/10 mg (blis.PA/Al/PVC) |
PFI-GB-3 |
GB |
28 |
5 |
1.71 |
S |
3.29 |
0.65799999999999992 |
1.71 |
|
|
|
|
|
08396 |
|
|
G |
AMLATOR 10 mg/5 mg |
tbl flm 30x10 mg/5 mg |
GDN |
HU |
30 |
5.38 |
1.83 |
S |
3.55 |
0.65985100000000008 |
1.83 |
|
|
|
|
|
C10BX03 |
|
|
|
Atorvastatín a amlodipín |
p.o. 5/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
6.0999999999999999E-2 |
|
|
|
0800B |
|
|
G |
AMLOAT 5 mg/10 mg |
tbl flm 90x5 mg/10 mg (blis.OPA/Al/PVC/Al) |
TEV-SK |
SK |
90 |
10.99 |
5.49 |
S |
5.5 |
0.50045499999999998 |
5.5 |
|
|
|
|
|
08397 |
|
|
G |
Amlator 10 mg/5 mg filmom obalené tablety |
tbl flm 90 x 10 mg/5 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
90 |
12.36 |
5.49 |
S |
6.87 |
0.55582500000000001 |
5.5 |
|
|
|
|
|
C10BX03 |
|
|
|
Atorvastatín a amlodipín |
p.o. 10/10 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
6.3E-2 |
|
|
|
0802B |
|
|
G |
AMLOAT 10 mg/10 mg |
tbl flm 28x10 mg/10 mg (blis.OPA/Al/PVC/Al) |
TEV-SK |
SK |
28 |
4.37 |
1.76 |
S |
2.61 |
0.59725399999999995 |
1.8 |
|
|
|
|
|
4439A |
|
|
G |
Atordapin 10mg/10mg filmom obalené tablety |
tbl flm 30x10 mg/10mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
30 |
5.04 |
1.89 |
S |
3.15 |
0.625 |
1.92 |
|
|
|
|
|
07778 |
|
|
O |
DICARTIL 10 mg/10 mg filmom obalené tablety |
tbl flm 28x10 mg/10 mg (blis.PA/Al/PVC) |
PFI-GB-3 |
GB |
28 |
5.04 |
1.76 |
S |
3.28 |
0.65079400000000009 |
1.8 |
|
|
|
|
|
08398 |
|
|
G |
AMLATOR 10 mg/10 mg |
tbl flm 30x10 mg/10 mg |
GDN |
HU |
30 |
5.56 |
1.89 |
S |
3.67 |
0.66007199999999999 |
1.92 |
|
|
|
|
|
C10BX03 |
|
|
|
Atorvastatín a amlodipín |
p.o. 10/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
6.3E-2 |
|
|
|
0804B |
|
|
G |
AMLOAT 10 mg/10 mg |
tbl flm 90x10 mg/10 mg (blis.OPA/Al/PVC/Al) |
TEV-SK |
SK |
90 |
11.44 |
5.67 |
S |
5.77 |
0.50437100000000001 |
5.77 |
|
|
|
|
|
08399 |
|
|
G |
Amlator 10 mg/10 mg filmom obalené tablety |
tbl flm 90 x 10 mg/10 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
90 |
12.81 |
5.67 |
S |
7.14 |
0.55737700000000001 |
5.77 |
|
|
|
|
|
C10BX03 |
|
|
|
Atorvastatín a amlodipín |
p.o. 20/5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.4E-2 |
|
|
|
08400 |
|
|
G |
AMLATOR 20 mg/5 mg |
tbl flm 30x20 mg/5 mg |
GDN |
HU |
30 |
8.06 |
2.82 |
S |
5.24 |
0.65012400000000004 |
3.26 |
|
|
|
|
|
C10BX03 |
|
|
|
Atorvastatín a amlodipín |
p.o. 20/5 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.4E-2 |
|
|
|
08401 |
|
|
G |
Amlator 20 mg/5 mg filmom obalené tablety |
tbl flm 90 x 20 mg/5 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
90 |
18.23 |
8.4600000000000009 |
S |
9.77 |
0.53593000000000002 |
9.77 |
|
|
|
|
|
C10BX03 |
|
|
|
Atorvastatín a amlodipín |
p.o. 20/10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.6000000000000002E-2 |
|
|
|
08402 |
|
|
G |
AMLATOR 20 mg/10 mg |
tbl flm 30x20 mg/10 mg |
GDN |
HU |
30 |
8.82 |
2.88 |
S |
5.94 |
0.6734690000000001 |
3.32 |
|
|
|
|
|
C10BX03 |
|
|
|
Atorvastatín a amlodipín |
p.o. 20/10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
9.6000000000000002E-2 |
|
|
|
08404 |
|
|
G |
Amlator 20 mg/10 mg filmom obalené tablety |
tbl flm 90 x 20 mg/10 mg (blis. PA/Al/PVC/Al) |
GDN |
HU |
90 |
18.600000000000001 |
8.64 |
S |
9.9600000000000009 |
0.53548399999999996 |
9.9600000000000009 |
|
|
|
|
|
D01AA01 |
|
|
|
Nystatín |
loc. 100 KU (10 g) |
1 |
g |
|
|
|
|
|
|
|
|
5.3499999999999999E-2 |
|
|
|
01069 |
|
|
G |
FUNGICIDIN LÉČIVA |
ung 10 g |
ZNT |
CZ |
10 |
2.13 |
0.54 |
S |
1.59 |
0.74647900000000011 |
1.59 |
|
|
|
|
|
D01AC01 |
|
|
|
Klotrimazol |
loc. 1% (30 g) |
1 |
g |
|
|
|
|
|
|
|
|
6.6400000000000001E-2 |
|
|
|
97165 |
|
|
O |
IMAZOL CREMEPASTE |
pst der 1x30 g |
SEG |
CH |
30 |
3.12 |
1.99 |
S |
1.1299999999999999 |
0.36217900000000003 |
1.1299999999999999 |
|
|
|
|
|
D01AC01 |
|
|
|
Klotrimazol |
loc. 1 % (30 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
4.8000000000000001E-2 |
|
|
|
71980 |
|
|
G |
CANIFUG-LOSUNG |
liq 1x30 ml |
WOL |
DE |
30 |
4.2699999999999996 |
1.44 |
S |
2.83 |
0.6627630000000001 |
2.83 |
|
|
|
|
|
D01AC11 |
|
|
|
Oxikonazol |
loc. 1% |
1 |
g |
|
|
|
|
|
|
|
|
3.9E-2 |
|
|
|
99248 |
|
|
G |
MYFUNGAR |
crm 1x30 g |
ZNT |
CZ |
30 |
3.72 |
1.17 |
S |
2.5499999999999998 |
0.68548399999999998 |
2.5499999999999998 |
|
|
|
|
|
D01AC16 |
|
|
|
Flutrimazol |
loc. crm 1% |
1 |
g |
|
|
|
|
|
|
|
|
0.16600000000000001 |
|
|
|
53457 |
|
|
O |
MICETAL 1% krém |
crm 1x15 g |
MCI |
CZ |
15 |
5.33 |
2.4900000000000002 |
S |
2.84 |
0.532833 |
2.84 |
DER, ORL |
|
|
|
|
D01AC16 |
|
|
|
Flutrimazol |
loc. sol. 1% |
1 |
g |
|
|
|
|
|
|
|
|
0.1517 |
|
|
|
34278 |
|
|
O |
MICETAL roztok |
sol der 1x30 g (HDPE fľ.) |
MCI |
CZ |
30 |
7.33 |
4.55 |
S |
2.78 |
0.37926299999999996 |
2.78 |
DER, ORL |
|
|
|
|
D01AC20 |
|
|
|
Kombinácie |
loc. 15 g klotrimazol/betametazón crm. |
1 |
g |
|
|
|
|
|
|
|
|
0.23899999999999999 |
|
|
|
56940 |
|
|
O |
LOTRIDERM |
crm 15 g |
MSD-NL |
NL |
15 |
5 |
3.59 |
S |
1.41 |
0.28199999999999997 |
0.47 |
DER, ORL, PED |
|
|
|
|
D01AC20 |
|
|
|
Kombinácie |
loc. crm. |
1 |
g |
|
|
|
|
|
|
|
|
6.9699999999999998E-2 |
|
|
|
97166 |
|
|
O |
IMAZOL PLUS |
crm 1x30 g |
SEG |
CH |
30 |
3.02 |
2.09 |
S |
0.93 |
0.30794699999999997 |
0.93 |
|
|
|
|
|
D01AC20 |
|
|
|
Kombinácie |
loc. Imacort ung. |
1 |
g |
|
|
|
|
|
|
|
|
0.10290000000000001 |
|
|
|
97164 |
|
|
O |
IMACORT |
crm 1x20 g |
SEG |
CH |
20 |
3.07 |
2.06 |
S |
1.01 |
0.32899 |
0.62 |
DER, ORL |
|
|
|
|
D01AE14 |
|
|
|
Ciklopirox |
loc. liečivý lak na nechty |
1 |
ml |
|
|
|
|
|
|
|
|
3.4 |
|
|
|
81341 |
|
|
O |
Polinail |
lum 1x3,3 ml (fľ.skl.) |
ASW |
IT |
3.3 |
16.47 |
11.22 |
S |
5.25 |
0.31876100000000002 |
5.25 |
DER |
|
|
|
|
D01AE16 |
|
|
|
Amorolfín |
loc. lac. 5% |
1 |
ml |
|
|
|
|
|
|
|
|
4.6420000000000003 |
|
|
|
27064 |
|
|
O |
LOCERYL |
lum 2,5 ml |
GAD |
FR |
2.5 |
16.579999999999998 |
11.61 |
S |
4.97 |
0.299759 |
4.97 |
DER |
|
|
|
|
D01BA02 |
|
|
|
Terbinafín |
p.o. 250 mg (28-30 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
0.34639999999999999 |
|
|
|
90378 |
X |
|
G |
Terbinafin Mylan 250 mg |
tbl 28x250 mg |
GNS |
GB |
28 |
6.94 |
6.94 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
D01BA02 |
|
|
|
Terbinafín |
p.o. 250 mg (56 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
0.34639999999999999 |
|
|
|
35837 |
X |
|
G |
Terbinafin Actavis 250 mg |
tbl 56x250 mg (bli.) |
ACT-3 |
IS |
56 |
13.88 |
13.88 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. (200 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.9900000000000001E-2 |
|
|
|
89996 |
|
|
O |
LINOLA-FETT OLBAD |
add bal 1x200 ml |
WOL |
DE |
200 |
6.23 |
3.98 |
S |
2.25 |
0.36115600000000003 |
1.29 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. (225 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.9900000000000001E-2 |
|
|
|
07399 |
|
|
O |
BALMANDOL |
sol der 1x225 ml/300 mg |
SEG |
CH |
225 |
6.78 |
4.4800000000000004 |
S |
2.2999999999999998 |
0.33923299999999995 |
2.2999999999999998 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. (400 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.9900000000000001E-2 |
|
|
|
89997 |
|
|
O |
LINOLA-FETT OLBAD |
add bal 1x400 ml |
WOL |
DE |
400 |
10.54 |
7.96 |
S |
2.58 |
0.244782 |
2.58 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. liq (150 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.7000000000000001E-2 |
|
|
|
44358 |
|
|
O |
OILATUM EMOLLIENT |
add bal 1x150 ml |
STI |
IE |
150 |
5.31 |
2.5499999999999998 |
S |
2.76 |
0.51977400000000007 |
0 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. liq (500 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.7000000000000001E-2 |
|
|
|
44359 |
|
|
O |
OILATUM EMOLLIENT |
add bal 1x500 ml |
STI |
IE |
500 |
8.4499999999999993 |
8.4499999999999993 |
I |
0 |
0 |
0 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. (150 ml) |
1 |
g |
|
|
|
|
|
|
|
|
2.3199999999999998E-2 |
|
|
|
97057 |
|
|
G |
OILATUM GEL |
gel der 150 ml |
STI |
IE |
150 |
9.16 |
3.48 |
S |
5.68 |
0.62008699999999994 |
5.68 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. kombinácie (150 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
46267 |
|
|
O |
OILATUM PLUS |
add bal 1x150 ml |
STI |
IE |
150 |
7.59 |
6.75 |
S |
0.84 |
0.11067199999999999 |
0.36 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. kombinácie (500 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.9E-2 |
|
|
|
56719 |
|
|
O |
OILATUM PLUS |
add bal exn 1x500 ml |
STI |
IE |
500 |
10.7 |
9.5 |
S |
1.2 |
0.11215 |
1.2 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. (50 g) |
1 |
g |
|
|
|
|
|
|
|
|
2.3199999999999998E-2 |
|
|
|
60087 |
|
|
O |
LINOLA |
crm 50 g |
WOL |
DE |
50 |
4.16 |
1.1599999999999999 |
S |
3 |
0.72115399999999996 |
3 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. (100 g ) |
1 |
g |
|
|
|
|
|
|
|
|
2.3199999999999998E-2 |
|
|
|
07397 |
|
|
O |
EXCIPIAL |
crm 1x100 g |
SEG |
CH |
100 |
3.96 |
2.3199999999999998 |
S |
1.64 |
0.41414099999999998 |
1.64 |
DER, PED, PLM |
|
|
|
|
86038 |
|
|
O |
LIPOBASE |
crm 1x100 g |
YEU |
NL |
100 |
4.25 |
2.3199999999999998 |
S |
1.93 |
0.45411800000000002 |
1.64 |
DER, PED, PLM |
|
|
|
|
97155 |
|
|
O |
EXCIPIAL masť s mandľovým olejom |
ung 1x100 g |
SEG |
CH |
100 |
4.6399999999999997 |
2.3199999999999998 |
S |
2.3199999999999998 |
0.5 |
1.64 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. kombinácie (200 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.7299999999999999E-2 |
|
|
|
60412 |
|
|
O |
BALNEUM HERMAL PLUS |
add bal 200 ml |
HEM |
DE |
200 |
5.81 |
3.46 |
S |
2.35 |
0.40447499999999997 |
0.19 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. kombinácie (500 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.7299999999999999E-2 |
|
|
|
60413 |
|
|
O |
BALNEUM HERMAL PLUS |
add bal 500 ml |
HEM |
DE |
500 |
11.58 |
8.65 |
S |
2.93 |
0.25302199999999997 |
0.47 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. kombinácie (1000 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.7299999999999999E-2 |
|
|
|
60414 |
|
|
O |
BALNEUM HERMAL PLUS |
add bal 1000 ml |
HEM |
DE |
1000 |
18.239999999999998 |
17.3 |
S |
0.94 |
5.1535000000000004E-2 |
0.94 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. liq. 84,75% (200 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.26E-2 |
|
|
|
60404 |
|
|
O |
BALNEUM HERMAL |
add bal 200 ml |
HEM |
DE |
200 |
4.41 |
2.52 |
S |
1.89 |
0.42857100000000004 |
1.51 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. liq. 84,75% (500 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.26E-2 |
|
|
|
60405 |
|
|
O |
BALNEUM HERMAL |
add bal 500 ml |
HEM |
DE |
500 |
10.08 |
6.3 |
S |
3.78 |
0.375 |
3.78 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. liq. 46,45% (200 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.26E-2 |
|
|
|
60408 |
|
|
O |
BALNEUM HERMAL F |
add bal 200 ml |
HEM |
DE |
200 |
5.66 |
2.52 |
S |
3.14 |
0.55476999999999999 |
1.1499999999999999 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. liq. 46,45% (500 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.26E-2 |
|
|
|
60409 |
|
|
O |
BALNEUM HERMAL F |
add bal 500 ml |
HEM |
DE |
500 |
9.17 |
6.3 |
S |
2.87 |
0.31297700000000001 |
2.87 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. ung, crm (50 g) |
1 |
g |
|
|
|
|
|
|
|
|
2.3199999999999998E-2 |
|
|
|
60091 |
|
|
O |
LINOLA FETT N |
crm 50 g |
WOL |
DE |
50 |
5.24 |
1.1599999999999999 |
S |
4.08 |
0.77862600000000004 |
4.08 |
DER, PED, PLM |
|
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. ung, crm (100 g) |
1 |
g |
|
|
|
|
|
|
|
|
2.3199999999999998E-2 |
|
|
|
07398 |
|
|
O |
EXCIPIAL mastný krém |
crm 1x100 g |
SEG |
CH |
100 |
3.96 |
2.3199999999999998 |
S |
1.64 |
0.41414099999999998 |
1.64 |
DER, PED, PLM |
|
|
|
|
97154 |
|
|
O |
EXCIPIAL masť |
ung 1x100 g |
SEG |
CH |
100 |
4.6399999999999997 |
2.3199999999999998 |
S |
2.3199999999999998 |
0.5 |
1.64 |
DER, PED, PLM |
|
|
|
|
D02AE01 |
|
|
|
Karbamid |
loc. lot., hydro, lipo |
1 |
ml |
|
|
|
|
|
|
|
|
1.9900000000000001E-2 |
|
|
|
97153 |
|
|
O |
EXCIPIAL U HYDROLOTIO |
lot 200 ml |
SEG |
CH |
200 |
4.4000000000000004 |
3.98 |
S |
0.42 |
9.5455000000000012E-2 |
0.42 |
ALG, DER, PED, PLM |
|
|
|
|
D02AE01 |
|
|
|
Karbamid |
loc. lot. lipo |
1 |
ml |
|
|
|
|
|
|
|
|
0.02 |
|
|
|
97152 |
|
|
O |
EXCIPIAL U LIPOLOTIO |
lot 200 ml |
SEG |
CH |
200 |
5.27 |
4 |
S |
1.27 |
0.24098700000000001 |
1.27 |
ALG, DER, PED, PLM |
|
|
|
|
D02AE51 |
|
|
|
Močovina, kombinácie |
loc. kys. salicylová, 1% |
1 |
g |
|
|
|
|
|
|
|
|
6.1699999999999998E-2 |
|
|
|
27932 |
|
|
O |
KERASAL |
ung 1x50 g |
SEG |
CH |
50 |
3.69 |
3.09 |
S |
0.6 |
0.16260200000000002 |
0.6 |
|
|
|
|
|
D05AX04 |
|
|
|
Takalcitol |
loc. |
1 |
g |
|
|
|
|
|
|
|
|
0.36799999999999999 |
|
|
|
95227 |
|
|
O |
CURATODERM 4ug/g dermálna emulzia |
emu der 1x20ml |
HEM |
DE |
20 |
19.350000000000001 |
7.36 |
S |
11.99 |
0.61963800000000002 |
11.99 |
DER |
|
|
|
|
D05AX04 |
|
|
|
Takalcitol |
loc. ung |
1 |
g |
|
|
|
|
|
|
|
|
0.33189999999999997 |
|
|
|
56582 |
|
|
O |
CURATODERM |
ung 1x60 g |
HEM |
DE |
60 |
30.71 |
19.91 |
S |
10.8 |
0.35167700000000002 |
10.8 |
DER |
|
|
|
|
D05AX04 |
|
|
|
Takalcitol |
loc. ung. 20 g |
1 |
g |
|
|
|
|
|
|
|
|
0.439 |
|
|
|
84566 |
|
|
O |
CURATODERM |
ung 1x20 g |
HEM |
DE |
20 |
15.51 |
8.7799999999999994 |
S |
6.73 |
0.43391399999999997 |
3.6 |
DER |
|
|
|
|
D05AX52 |
|
|
|
Kalcipotriol, kombinácie |
loc. 30 g |
1 |
g |
|
|
|
|
|
|
|
|
0.47099999999999997 |
|
|
|
30768 |
|
|
O |
Daivobet gél |
gel der 1x30 g (fľ.HDPE) |
LEO-2 |
DK |
30 |
23.1 |
14.13 |
S |
8.9700000000000006 |
0.38831200000000005 |
7.65 |
DER |
|
|
|
|
D05AX52 |
|
|
|
Kalcipotriol, kombinácie |
loc. 60 g |
1 |
g |
|
|
|
|
|
|
|
|
0.47099999999999997 |
|
|
|
79381 |
|
|
O |
Xamiol |
gel der 1x60g (fľ. HDPE) |
LEO |
DK |
60 |
43.56 |
28.26 |
S |
15.3 |
0.35124 |
15.3 |
DER |
|
|
|
|
D05BB02 |
|
|
|
Acitretín |
p.o. 10 mg (30 ks) |
35 |
mg |
|
|
|
|
|
|
|
|
1.32 |
|
|
|
76660 |
|
|
O |
NEOTIGASON |
cps 30x10 mg |
ACT-5 |
IS |
8.57 |
11.27 |
11.27 |
I |
0 |
0 |
0 |
DER, REU |
|
|
|
|
D05BB02 |
|
|
|
Acitretín |
p.o. 25 mg (30 ks) |
35 |
mg |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
76661 |
|
|
O |
NEOTIGASON |
cps 30x25 mg |
ACT-5 |
IS |
21.43 |
22.47 |
22.47 |
I |
0 |
0 |
0 |
DER, REU |
|
|
|
|
D06AX |
|
|
|
Ostatné antibiotiká na vonkajšie použitie |
loc. neomycín/bacitracín na prípravu roztoku |
1 |
DF |
|
|
|
|
|
|
|
|
1.724 |
|
|
|
24880 |
|
|
G |
PAMYCON NA PR.KV.(=FRAMYKOIN) |
plv gtt 1x1 fľaš. |
BTA |
SK |
1 |
3.54 |
1.72 |
S |
1.82 |
0.51412400000000003 |
1.82 |
|
|
|
|
|
D06AX |
|
|
|
Ostatné antibiotiká na vonkajšie použitie |
loc. neomycín/bacitracín nad 2 g plv. ads. |
1 |
g |
|
|
|
|
|
|
|
|
6.9699999999999998E-2 |
|
|
|
01063 |
|
|
G |
FRAMYKOIN |
plv ads 20 g |
BCS |
CZ |
20 |
2.52 |
1.39 |
S |
1.1299999999999999 |
0.44841299999999995 |
1.1299999999999999 |
|
|
|
|
|
44894 |
|
|
G |
FRAMYKOIN |
plv ads 5 g |
BCS |
CZ |
5 |
1.99 |
0.35 |
S |
1.64 |
0.82412099999999999 |
1.64 |
|
|
|
|
|
D06AX |
|
|
|
Ostatné antibiotiká na vonkajšie použitie |
loc. neomycín/bacitracín ung. |
1 |
g |
|
|
|
|
|
|
|
|
7.2999999999999995E-2 |
|
|
|
74987 |
|
|
G |
BANEOCIN |
ung der 1x20 g |
SAN-A |
AT |
20 |
1.75 |
1.46 |
S |
0.28999999999999998 |
0.165714 |
0.28999999999999998 |
|
|
|
|
|
01066 |
|
|
G |
FRAMYKOIN |
ung 1x10 g |
ZNT |
CZ |
10 |
2.09 |
0.73 |
S |
1.36 |
0.65071799999999991 |
1.36 |
|
|
|
|
|
D06AX01 |
|
|
|
Kyselina fusidová |
loc. crm 2% |
1 |
g |
|
|
|
|
|
|
|
|
0.11899999999999999 |
|
|
|
84492 |
|
|
O |
FUCIDIN krém |
crm 1x15 g |
LEO |
IE |
15 |
2.75 |
1.79 |
S |
0.96 |
0.34909100000000004 |
0.96 |
|
|
|
|
|
D06AX01 |
|
|
|
Kyselina fusidová |
loc. ung 2% |
1 |
g |
|
|
|
|
|
|
|
|
0.11899999999999999 |
|
|
|
88746 |
|
|
O |
FUCIDIN masť |
ung 1x15 g |
LEO |
IE |
15 |
2.78 |
1.79 |
S |
0.99 |
0.35611500000000001 |
0.96 |
|
|
|
|
|
D06AX09 |
|
|
|
Mupirocín |
loc. 2,2 % |
1 |
g |
|
|
|
|
|
|
|
|
0.187 |
|
|
|
90778 |
|
|
O |
BACTROBAN |
ung 15 g |
SKB |
GB |
15 |
4.03 |
2.81 |
S |
1.22 |
0.30273 |
1.22 |
|
|
|
|
|
D06AX13 |
|
|
|
Retapamulín |
loc. ung 1% |
1 |
g |
|
|
|
|
|
|
|
|
1.585 |
|
|
|
43234 |
|
|
O |
Altargo |
ung der 1 x 5 g (tuba) |
GLA |
GB |
5 |
11.03 |
7.93 |
S |
3.1 |
0.28105200000000002 |
3.1 |
DER |
|
|
|
|
D06BA51 |
|
|
|
Sulfadiazínan strieborný, kombinácie |
loc. hyaluronan sodný crm. |
1 |
g |
|
|
|
|
|
|
|
|
5.8000000000000003E-2 |
|
|
|
55951 |
|
|
O |
IALUGEN PLUS |
crm 20 g |
IBS |
CH |
20 |
4.59 |
1.1599999999999999 |
S |
3.43 |
0.74727699999999997 |
3.43 |
|
|
|
|
|
D06BA51 |
|
|
|
Sulfadiazínan strieborný, kombinácie |
loc. hyaluronan sodný liq. (5 ks) |
1 |
ml |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
55952 |
|
|
O |
IALUGEN PLUS |
lig imp 5 ks 10x10 cm |
IBS |
CH |
20 |
4.1100000000000003 |
2.96 |
S |
1.1499999999999999 |
0.27980499999999997 |
0.91 |
|
|
|
|
|
D06BA51 |
|
|
|
Sulfadiazínan strieborný, kombinácie |
loc. hyaluronan sodný liq. (10 ks) |
1 |
ml |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
76906 |
|
|
O |
IALUGEN PLUS (10x10 cm) |
lig imp 10 ks |
IBS |
CH |
40 |
7.74 |
5.92 |
S |
1.82 |
0.23514199999999999 |
1.82 |
|
|
|
|
|
D06BB04 |
|
|
|
Podophylotoxín |
loc. crm 0,15% |
1 |
g |
|
|
|
|
|
|
|
|
2.8839999999999999 |
|
|
|
03939 |
|
|
O |
WARTEC cream |
crm 1x5 g |
STI |
IE |
5 |
17.920000000000002 |
14.42 |
S |
3.5 |
0.19531199999999999 |
3.5 |
DER,GYN,URO |
|
|
|
|
D06BB10 |
|
|
|
Imikvimod |
loc. crm 5% |
250 |
mg |
|
|
|
|
|
|
|
|
4.62 |
|
|
|
01796 |
|
|
O |
Aldara |
crm 12x250 mg (vrecko PE/Al) |
MPH-S |
SE |
12 |
55.42 |
55.42 |
I |
0 |
0 |
0 |
DER, GYN, ONK |
ind.obm. |
|
|
|
D06BB12 |
|
|
|
Epigalokatechíngalát |
loc. ung. 10% |
750 |
mg |
|
|
|
|
|
|
|
|
2.41 |
|
|
|
2050A |
|
|
O |
Veregen 100 mg/g masť |
ung 1x15 g (tuba Al) |
NRC-CZ |
CZ |
20 |
48.14 |
48.14 |
I |
0 |
0 |
0 |
DER, GYN, URO |
ind.obm. |
|
|
|
D06BX01 |
|
|
|
Metronidazol |
loc. 0,75% |
1 |
g |
|
|
|
|
|
|
|
|
9.9299999999999999E-2 |
|
|
|
46640 |
|
|
G |
ROZEX krém |
crm 1x30 g |
GAD |
FR |
30 |
6.63 |
2.98 |
S |
3.65 |
0.55052800000000002 |
3.65 |
DER |
|
|
|
|
D07AA02 |
|
|
|
Hydrokortizón |
loc. ung. 1% |
1 |
g |
|
|
|
|
|
|
|
|
7.9699999999999993E-2 |
|
|
|
00858 |
|
|
G |
Hydrocortison Léčiva |
ung der 1 x 10 g |
ZNT |
CZ |
10 |
1.88 |
0.8 |
S |
1.08 |
0.57446799999999998 |
1.08 |
|
|
|
|
|
D07AB02 |
|
|
|
Hydrokortizón butyrát |
loc. 0,1% |
1 |
g |
|
|
|
|
|
|
|
|
7.2999999999999995E-2 |
|
|
|
83212 |
|
|
O |
LOCOID CRELO |
emu der 1x30 g |
YEU |
NL |
30 |
2.89 |
2.19 |
S |
0.7 |
0.24221499999999999 |
0.7 |
|
|
|
|
|
09305 |
|
|
O |
LOCOID 0,1% |
crm 1x30 g 0,1% |
YEU |
NL |
30 |
3.04 |
2.19 |
S |
0.85 |
0.27960499999999999 |
0.85 |
|
|
|
|
|
62047 |
|
|
O |
LOCOID LIPOCREAM 0,1% |
crm 1x30 g 0,1% |
YEU |
NL |
30 |
3.07 |
2.19 |
S |
0.88 |
0.28664499999999998 |
0.85 |
|
|
|
|
|
D07AB02 |
|
|
|
Hydrokortizón butyrát |
loc. lot 0,1% |
1 |
ml |
|
|
|
|
|
|
|
|
6.5000000000000002E-2 |
|
|
|
09307 |
|
|
O |
LOCOID LOTION 0,1% |
lot 1x30 ml |
YEU |
NL |
30 |
2.67 |
1.95 |
S |
0.72 |
0.26966299999999999 |
0.72 |
|
|
|
|
|
D07AB02 |
|
|
|
Hydrokortizón butyrát |
loc. ung 0,1% |
1 |
g |
|
|
|
|
|
|
|
|
7.1999999999999995E-2 |
|
|
|
09310 |
|
|
O |
LOCOID 0,1% |
ung 1x30 g 0,1% |
YEU |
NL |
30 |
3.07 |
2.16 |
S |
0.91 |
0.29641699999999999 |
0.91 |
|
|
|
|
|
D07AB09 |
|
|
|
Triamcinolón |
loc. 0,1% ung, crm |
1 |
g |
|
|
|
|
|
|
|
|
9.4899999999999998E-2 |
|
|
|
02829 |
|
|
G |
TRIAMCINOLON LÉČIVA |
ung 10 g 0,1% |
ZNT |
CZ |
10 |
1.42 |
0.95 |
S |
0.47 |
0.330986 |
0.47 |
|
|
|
|
|
02828 |
|
|
G |
TRIAMCINOLON LÉČIVA |
crm 10 g 0,1% |
ZNT |
CZ |
10 |
2.23 |
0.95 |
S |
1.28 |
0.57399099999999992 |
0.47 |
|
|
|
|
|
D07AB10 |
|
|
|
Alclometasone |
loc. ung, crm 0,05% |
1 |
g |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
58308 |
|
|
G |
AFLODERM |
crm 1x20 g |
BLU |
HR |
20 |
4.49 |
3 |
S |
1.49 |
0.33184900000000001 |
1.49 |
ALG, DER |
|
|
|
|
58306 |
|
|
G |
AFLODERM |
UNG 1x20 g |
BLU |
HR |
20 |
4.49 |
3 |
S |
1.49 |
0.33184900000000001 |
1.49 |
ALG, DER |
|
|
|
|
D07AC01 |
|
|
|
Betametazón |
loc. ung, crm, lot der 0,05% |
1 |
ml |
|
|
|
|
|
|
|
|
7.9699999999999993E-2 |
|
|
|
80206 |
|
|
G |
BELODERM |
crm 1x30 g 0,05% |
BLU |
HR |
30 |
2.86 |
2.39 |
S |
0.47 |
0.16433599999999998 |
0.47 |
ALG, DER |
|
|
|
|
80204 |
|
|
G |
BELODERM |
ung 1x30 g 0,05% |
BLU |
HR |
30 |
2.86 |
2.39 |
S |
0.47 |
0.16433599999999998 |
0.47 |
ALG, DER |
|
|
|
|
98034 |
|
|
O |
DIPROSONE |
crm 30 g |
MSD-NL |
NL |
30 |
3.27 |
2.39 |
S |
0.88 |
0.26911299999999999 |
0.47 |
ALG, DER |
|
|
|
|
98032 |
|
|
O |
DIPROSONE |
ung 30 g |
MSD-NL |
NL |
30 |
3.27 |
2.39 |
S |
0.88 |
0.26911299999999999 |
0.47 |
ALG, DER |
|
|
|
|
02284 |
|
|
G |
Beloderm lotión |
lot der 1x50ml/25mg ( fľ.PE) |
BLU |
SK |
50 |
6.28 |
3.99 |
S |
2.29 |
0.36465000000000003 |
2.29 |
ALG, DER |
|
|
|
|
D07AC04 |
|
|
|
Fluocinolón |
loc. gel 0,025% (25 g) |
1 |
g |
|
|
|
|
|
|
|
|
8.3000000000000004E-2 |
|
|
|
04156 |
|
|
G |
GELARGIN |
gel der 1x25 g |
ZNT |
CZ |
25 |
2.99 |
2.08 |
S |
0.91 |
0.30434800000000001 |
0.91 |
DER, GYN |
|
|
|
|
D07AC13 |
|
|
|
Mometazón |
loc. 0,1% (15 g) |
1 |
g |
|
|
|
|
|
|
|
|
0.18 |
|
|
|
81693 |
|
|
O |
ELOCOM krém 0,1 % |
crm 1x15 g 0,1% |
MSD-NL |
NL |
15 |
4.1100000000000003 |
2.7 |
S |
1.41 |
0.34306600000000004 |
1.41 |
ALG, DER, ORL |
|
|
|
|
18418 |
|
|
O |
ELOCOM masť 0,1 % |
ung 1x15 g 0,1% |
MSD-NL |
NL |
15 |
4.1100000000000003 |
2.7 |
S |
1.41 |
0.34306600000000004 |
1.41 |
ALG, DER, ORL |
|
|
|
|
D07AC13 |
|
|
|
Mometazón |
loc. 0,1% (30 g) |
1 |
g |
|
|
|
|
|
|
|
|
0.13200000000000001 |
|
|
|
18600 |
|
|
O |
ELOCOM krém 0,1 % |
crm 1x30 g 0,1 % |
MSD-NL |
NL |
30 |
4.5599999999999996 |
3.96 |
S |
0.6 |
0.131579 |
0.6 |
ALG, DER, ORL |
|
|
|
|
18416 |
|
|
O |
ELOCOM masť 0,1 % |
ung 1 x 30 g 0,1 % |
MSD-NL |
NL |
30 |
4.5599999999999996 |
3.96 |
S |
0.6 |
0.131579 |
0.6 |
ALG, DER, ORL |
|
|
|
|
D07AC13 |
|
|
|
Mometazón |
loc. 0,1% (30 ml) |
1 |
g |
|
|
|
|
|
|
|
|
0.16 |
|
|
|
22282 |
|
|
O |
ELOCOM roztok |
sol der 1x30 ml |
MSD-NL |
NL |
30 |
6.19 |
4.8 |
S |
1.39 |
0.22455600000000001 |
1.39 |
ALG, DER, ORL |
|
|
|
|
D07AC14 |
|
|
|
Metylprednizolón aceponát |
loc. crm.0,1% |
1 |
g |
|
|
|
|
|
|
|
|
0.108 |
|
|
|
72176 |
|
|
O |
ADVANTAN krém (Al tuba) |
crm 1x15 g |
SAG |
IT |
15 |
3.02 |
1.62 |
S |
1.4 |
0.46357599999999999 |
1.4 |
ALG, DER |
|
|
|
|
44046 |
|
|
O |
ADVANTAN mastný krém (Al tuba) |
crm 1x15 g |
SAG |
IT |
15 |
3.06 |
1.62 |
S |
1.44 |
0.47058800000000001 |
1.4 |
ALG, DER |
|
|
|
|
D07AC14 |
|
|
|
Metylprednizolón aceponát |
loc. ung. 0,1% |
1 |
g |
|
|
|
|
|
|
|
|
0.13800000000000001 |
|
|
|
44052 |
|
|
O |
ADVANTAN masť (Al tuba) |
ung der 1x15 g |
SAG |
IT |
15 |
3.15 |
2.0699999999999998 |
S |
1.08 |
0.34285699999999997 |
1.08 |
ALG, DER |
|
|
|
|
D07AD01 |
|
|
|
Klobetazol propionát |
loc.0,05% |
1 |
ml |
|
|
|
|
|
|
|
|
0.105 |
|
|
|
30137 |
|
|
O |
CLARELUX 500 mikrogramov/g dermálna pena |
spm der 1x100 g (fľ. Al) |
PFD |
FR |
100 |
10.45 |
10.45 |
I |
0 |
0 |
0 |
DER |
|
|
|
|
37402 |
|
|
O |
Clobex |
shp 1x125 ml |
GLD |
FR |
125 |
14.37 |
13.13 |
S |
1.24 |
8.6290999999999993E-2 |
1.24 |
DER |
|
|
|
|
D07BB03 |
|
|
|
Triamcinolón a antiseptiká |
loc. ung. 0,1% |
1 |
g |
|
|
|
|
|
|
|
|
8.5199999999999998E-2 |
|
|
|
04178 |
|
|
G |
TRIAMCINOLON E LÉČIVA |
ung 20 g |
ZNT |
CZ |
20 |
2.2799999999999998 |
1.7 |
S |
0.57999999999999996 |
0.254386 |
0.57999999999999996 |
DER |
|
|
|
|
D07CA01 |
|
|
|
Hydrokortizón a antibiotiká |
loc. a kys. fusidová crm. |
1 |
g |
|
|
|
|
|
|
|
|
0.2 |
|
|
|
00707 |
|
|
O |
FUCIDIN H |
crm 15 g |
LEO |
DK |
15 |
5.09 |
3 |
S |
2.09 |
0.41060899999999995 |
1.18 |
|
|
|
|
|
D07CA01 |
|
|
|
Hydrokortizón a antibiotiká |
loc. crm. |
1 |
g |
|
|
|
|
|
|
|
|
0.1273 |
|
|
|
41515 |
|
|
O |
PIMAFUCORT |
crm 15 g |
YEU |
NL |
15 |
3.09 |
1.91 |
S |
1.18 |
0.38187700000000002 |
1.18 |
|
|
|
|
|
D07CC01 |
|
|
|
Betametazón a antibiotiká |
loc. komb. s gentamycínom crm. |
1 |
g |
|
|
|
|
|
|
|
|
9.6299999999999997E-2 |
|
|
|
26375 |
|
|
G |
BELOGENT |
crm 1x30 g |
BLU |
HR |
30 |
3.36 |
2.89 |
S |
0.47 |
0.13988100000000001 |
0.47 |
ALG, DER, ORL |
|
|
|
|
D07CC01 |
|
|
|
Betametazón a antibiotiká |
loc. komb. s gentamycínom ung. |
1 |
g |
|
|
|
|
|
|
|
|
9.6299999999999997E-2 |
|
|
|
26377 |
|
|
G |
BELOGENT |
ung 1x30 g |
BLU |
HR |
30 |
3.36 |
2.89 |
S |
0.47 |
0.13988100000000001 |
0.47 |
ALG, DER, ORL |
|
|
|
|
D07CC01 |
|
|
|
Betametazón a antibiotiká |
loc. komb. s kyselinou fusidovou crm. |
1 |
g |
|
|
|
|
|
|
|
|
0.20200000000000001 |
|
|
|
89014 |
|
|
O |
FUCICORT |
crm 15 g |
LEO |
DK |
15 |
5.07 |
3.03 |
S |
2.04 |
0.40236699999999997 |
2.04 |
DER |
|
|
|
|
D07XA02 |
|
|
|
Prednizolón |
loc. prednizolón/estradiol sol. |
1 |
ml |
|
|
|
|
|
|
|
|
8.5000000000000006E-2 |
|
|
|
92410 |
|
|
G |
ALPICORT F |
liq der 1x100 ml |
WOL |
DE |
100 |
11.31 |
8.5 |
S |
2.81 |
0.24845300000000001 |
2.81 |
DER |
|
|
|
|
D07XA02 |
|
|
|
Prednizolón |
loc. prednizolón/kys. salicylová. sol. |
1 |
ml |
|
|
|
|
|
|
|
|
3.9800000000000002E-2 |
|
|
|
92411 |
|
|
O |
ALPICORT |
liq der 1x100 ml |
WOL |
DE |
100 |
7 |
3.98 |
S |
3.02 |
0.43142899999999995 |
2.81 |
ALG, DER |
|
|
|
|
D07XC01 |
|
|
|
Betametazón |
loc. liq. |
1 |
ml |
|
|
|
|
|
|
|
|
7.5999999999999998E-2 |
|
|
|
18495 |
|
|
G |
BELOSALIC |
liq der 1x50 ml |
BLU |
HR |
50 |
4.58 |
3.8 |
S |
0.78 |
0.17030599999999999 |
0.78 |
ALG, DER |
|
|
|
|
0753A |
|
|
G |
BELOSALIC |
liq der 1x100 ml (fľ.HDPE+rozprašovač) |
BLU |
SK |
100 |
9.9600000000000009 |
7.6 |
S |
2.36 |
0.23694800000000002 |
2.36 |
ALG, DER |
|
|
|
|
31334 |
|
|
O |
DIPROSALIC |
sol der 30 ml |
MSD-NL |
NL |
30 |
3.74 |
2.2799999999999998 |
S |
1.46 |
0.390374 |
0.47 |
ALG, DER |
|
|
|
|
D07XC01 |
|
|
|
Betametazón |
loc. ung. |
1 |
g |
|
|
|
|
|
|
|
|
7.5999999999999998E-2 |
|
|
|
85864 |
|
|
G |
BELOSALIC |
ung 30 g |
BLU |
HR |
30 |
2.8 |
2.2799999999999998 |
S |
0.52 |
0.18571400000000002 |
0.52 |
ALG, DER |
|
|
|
|
98072 |
|
|
O |
DIPROSALIC |
ung 15 g |
MSD-NL |
NL |
15 |
2.62 |
1.1399999999999999 |
S |
1.48 |
0.56488499999999997 |
0.26 |
ALG, DER |
|
|
|
|
D10AD01 |
|
|
|
Tretinoín |
loc. crm. 0,05% |
1 |
g |
|
|
|
|
|
|
|
|
0.108 |
|
|
|
98205 |
|
|
O |
LOCACID |
crm 1x30 g |
PFB |
FR |
30 |
4.04 |
3.24 |
S |
0.8 |
0.19802 |
0.8 |
DER |
|
|
|
U83 |
D10AD03 |
|
|
|
Adapalén |
loc. 0,1% |
1 |
g |
|
|
|
|
|
|
|
|
0.108 |
|
|
|
34670 |
|
|
G |
DIFFERINE 0,1% gél |
gel der 1x30 g |
GAD |
FR |
30 |
5.87 |
3.24 |
S |
2.63 |
0.44804099999999997 |
2.63 |
DER |
|
|
|
U83 |
46643 |
|
|
G |
DIFFERINE 0,1% krém |
crm 1x30 g |
GAD |
FR |
30 |
6.63 |
3.24 |
S |
3.39 |
0.51131199999999999 |
3.39 |
DER |
|
|
|
U83 |
02193 |
|
|
G |
Belakne gél |
gel der 1x30 g (tuba PE) |
BLU |
SK |
30 |
6.99 |
3.24 |
S |
3.75 |
0.53648099999999999 |
2.63 |
DER |
|
|
|
U83 |
02195 |
|
|
G |
Belakne krém |
crm der 1x30 g (tuba Al) |
BLU-SK |
SK |
30 |
6.99 |
3.24 |
S |
3.75 |
0.53648099999999999 |
3.39 |
DER |
|
|
|
U83 |
D10AD54 |
|
|
|
Izotretinoín, kombinacie |
loc. s erytromycínom gel |
1 |
g |
|
|
|
|
|
|
|
|
0.108 |
|
|
|
31220 |
|
|
O |
ISOTREXIN |
gel der 30 g |
STI |
IE |
30 |
9.16 |
3.24 |
S |
5.92 |
0.64628799999999997 |
5.92 |
DER |
|
|
|
U83 |
D10AF02 |
|
|
|
Erytromycín |
loc. liq. 2% (25-30 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
4.8000000000000001E-2 |
|
|
|
97514 |
|
|
O |
AKNEMYCIN |
sol der 1x25 ml |
HEM |
DE |
25 |
4.91 |
1.2 |
S |
3.71 |
0.75560100000000008 |
3.71 |
DER |
|
|
|
|
D10AF02 |
|
|
|
Erytromycín |
loc. liq. 4% (25-30 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
4.3999999999999997E-2 |
|
|
|
98204 |
|
|
O |
ERYFLUID |
sol der 1x30 ml |
PFB |
FR |
30 |
2.0099999999999998 |
1.32 |
S |
0.69 |
0.34328400000000003 |
0.24 |
DER |
|
|
|
|
D10AF02 |
|
|
|
Erytromycín |
loc. liq. 4 % (100 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
4.2999999999999997E-2 |
|
|
|
75285 |
|
|
O |
ERYFLUID |
sol der 1x100 ml |
PFB |
FR |
100 |
5.0999999999999996 |
4.3 |
S |
0.8 |
0.156863 |
0.8 |
DER |
|
|
|
|
D10AF02 |
|
|
|
Erytromycín |
loc. ung. 2% |
1 |
g |
|
|
|
|
|
|
|
|
5.1999999999999998E-2 |
|
|
|
97513 |
|
|
O |
AKNEMYCIN 2000 |
ung 1x25 g |
HEM |
DE |
25 |
3.96 |
1.3 |
S |
2.66 |
0.67171700000000001 |
2.66 |
DER |
|
|
|
|
D10AF51 |
|
|
|
Klindamycín, kombinácie |
loc. tretinoín |
1 |
g |
|
|
|
|
|
|
|
|
0.154 |
|
|
|
8009A |
|
|
O |
Acnatac 10mg/g+0,25mg/g gél |
gel 1x30g (tuba AI) |
MPH |
SK |
30 |
18.47 |
4.62 |
S |
13.85 |
0.74986500000000011 |
13.85 |
DER |
|
|
|
|
D10AF51 |
|
|
|
Klindamycín, kombinácie |
loc. benzoylperoxid |
1 |
g |
|
|
|
|
|
|
|
|
0.154 |
|
|
|
90139 |
|
|
O |
Duac Gel |
gel der 1x25 g (tuba Al) |
GAG |
SK |
25 |
17.559999999999999 |
3.85 |
S |
13.71 |
0.780752 |
11.54 |
DER |
|
|
|
|
91936 |
|
|
O |
DUAC GEL |
gel der 15g |
STI |
GB |
15 |
11.19 |
2.31 |
S |
8.8800000000000008 |
0.79356599999999999 |
6.93 |
DER |
|
|
|
|
D10AF52 |
|
|
|
Erytromycín komb. |
loc. s tretinoínom |
1 |
ml |
|
|
|
|
|
|
|
|
0.1759 |
|
|
|
33163 |
|
|
O |
Aknemycin Plus |
sol der 1x25 ml |
HEM |
DE |
25 |
8.09 |
4.4000000000000004 |
S |
3.69 |
0.456119 |
3.69 |
DER |
|
|
|
|
D10AF52 |
|
|
|
Erytromycín komb. |
loc. zinok (30 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
0.14299999999999999 |
|
|
|
25671 |
|
|
O |
ZINERYT |
plq der 1x30 ml |
YEU |
NL |
30 |
7.12 |
4.29 |
S |
2.83 |
0.39747199999999999 |
2.25 |
DER |
|
|
|
|
D10AF52 |
|
|
|
Erytromycín komb. |
loc. zinok (70 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
0.14299999999999999 |
|
|
|
35900 |
|
|
O |
ZINERYT lotio |
plq der 1x70ml |
AST |
NL |
70 |
15.27 |
10.01 |
S |
5.26 |
0.34446599999999994 |
5.26 |
DER |
|
|
|
|
D10AX03 |
|
|
|
Kyselina azelaová |
loc. crm. 20% |
1 |
g |
|
|
|
|
|
|
|
|
0.11899999999999999 |
|
|
|
97639 |
|
|
O |
SKINOREN krém |
crm 30 g |
INN |
DE |
30 |
7.08 |
3.57 |
S |
3.51 |
0.49576300000000001 |
3.51 |
DER |
|
|
|
|
D10AX03 |
|
|
|
Kyselina azelaová |
loc. gel 15% |
1 |
g |
|
|
|
|
|
|
|
|
0.159 |
|
|
|
66534 |
|
|
O |
Finacea 15 % gél |
gel der 1x30 g |
INN |
DE |
30 |
10.220000000000001 |
4.7699999999999996 |
S |
5.45 |
0.53326799999999996 |
5.45 |
DER |
|
|
|
|
D10BA01 |
|
|
|
Izotretinoín |
p.o. 10 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.9 |
|
|
|
7558A |
|
|
G |
Isotretinoin Actavis 10 mg |
cps mol 30x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
10 |
8.85 |
8.85 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
11685 |
|
|
O |
ROACCUTANE ROCHE |
cps mol 30x10 mg |
HLR |
CH |
10 |
10.98 |
9 |
S |
1.98 |
0.18032800000000002 |
0 |
DER |
ind.obm. |
|
|
|
90429 |
|
|
O |
AKNENORMIN 10 |
cps mol 30x10 mg |
HEM |
DE |
10 |
14.24 |
9 |
S |
5.24 |
0.36797800000000003 |
0 |
DER |
ind.obm. |
|
|
|
D10BA01 |
|
|
|
Izotretinoín |
p.o. 10 mg (60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.9 |
|
|
|
90430 |
|
|
G |
AKNENORMIN 10 |
cps mol 60x10 mg |
HER |
DE |
20 |
21.55 |
18 |
S |
3.55 |
0.16473299999999999 |
0 |
DER |
ind.obm. |
|
|
|
D10BA01 |
|
|
|
Izotretinoín |
p.o. 20 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.7 |
|
|
|
7563A |
|
|
G |
Isotretinoin Actavis 20 mg |
cps mol 30x20 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
20 |
13.8 |
13.8 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
91843 |
|
|
O |
ROACCUTANE ROCHE |
cps mol 30x20 mg |
HLR |
CH |
20 |
15.98 |
14 |
S |
1.98 |
0.12390499999999999 |
0 |
DER |
ind.obm. |
|
|
|
90432 |
|
|
O |
AKNENORMIN 20 |
cps mol 30x20mg |
HEM |
DE |
20 |
20.25 |
14 |
S |
6.25 |
0.30864200000000003 |
0 |
DER |
ind.obm. |
|
|
|
D10BA01 |
|
|
|
Izotretinoín |
p.o. 20 mg (60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.7 |
|
|
|
90433 |
|
|
G |
AKNENORMIN 20 |
cps mol 60x20 mg |
HER |
DE |
40 |
35.78 |
28 |
S |
7.78 |
0.21743999999999999 |
0 |
DER |
ind.obm. |
|
|
|
D10BA01 |
|
|
|
Izotretinoín |
p.o. 40 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.91 |
|
|
|
49915 |
|
|
G |
CURACNÉ 40 mg |
cps mol 30x40 mg |
PAH |
FR |
40 |
36.15 |
36.15 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
D11A |
|
|
|
Iné dermatologiká |
loc. (50 g) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
24720 |
|
|
G |
HOLTOV KRÉM |
crm 1x 50 g |
XGA |
SK |
50 |
1.1299999999999999 |
0.65 |
S |
0.48 |
0.42477899999999996 |
0.48 |
|
|
|
|
U80 |
15568 |
|
|
G |
CREMOR ALUM. ACETICO-TARTARICI |
ung 1x50 g (ČSL4) |
VUL |
SK |
50 |
1.1599999999999999 |
0.65 |
S |
0.51 |
0.43965499999999996 |
0.3 |
|
|
|
|
U80 |
24699 |
|
|
G |
GÁFROVÁ MASŤ S ICHTAMOLOM |
ung der 1x50 g |
XGA |
SK |
50 |
1.44 |
0.65 |
S |
0.79 |
0.54861099999999996 |
0.79 |
|
|
|
|
U80 |
15639 |
|
|
G |
UNG. ACIDI SALICYLICI 5% |
ung 1x50 g |
VUL |
SK |
50 |
2.17 |
0.65 |
S |
1.52 |
0.700461 |
0.86 |
|
|
|
|
U80 |
D11A |
|
|
|
Iné dermatologiká |
loc. (80-100 g) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
24705 |
|
|
G |
TEKUTÝ PÚDER |
sus der 1x100 g |
XGA |
SK |
100 |
1.75 |
1.3 |
S |
0.45 |
0.25714300000000001 |
0.45 |
|
|
|
|
U80 |
24702 |
|
|
G |
TEKUTÝ PÚDER S MENTOLOM |
sus der 1x100 g |
XGA |
SK |
100 |
1.88 |
1.3 |
S |
0.57999999999999996 |
0.30851099999999998 |
0.57999999999999996 |
|
|
|
|
U80 |
24715 |
|
|
G |
PASTA S RYBÍM OLEJOM |
pst der 1x100 g |
XGA |
SK |
100 |
1.89 |
1.3 |
S |
0.59 |
0.31216899999999997 |
0.59 |
|
|
|
|
U80 |
24693 |
|
|
G |
OCTANOVÝ KRÉM |
crm 1x80 g (ČSL4) |
XGA |
SK |
80 |
1.52 |
1.04 |
S |
0.48 |
0.31578899999999999 |
0.48 |
|
|
|
|
U80 |
15620 |
|
|
G |
TEKUTÝ PÚDER S 1% MENTOLU |
sus der 1x100 g |
VUL |
SK |
100 |
1.92 |
1.3 |
S |
0.62 |
0.32291700000000001 |
0.57999999999999996 |
|
|
|
|
U80 |
15574 |
|
|
G |
CREMOR ALUM. ACETICO-TARTARICI |
ung 1x100 g (ČSL4) |
VUL |
SK |
100 |
2.04 |
1.3 |
S |
0.74 |
0.36274500000000004 |
0.6 |
|
|
|
|
U80 |
15602 |
|
|
G |
PASTA CUM OLEI JECORIS ASELLI |
pst der 1x100 g |
VUL |
SK |
100 |
2.04 |
1.3 |
S |
0.74 |
0.36274500000000004 |
0.59 |
|
|
|
|
U80 |
15616 |
|
|
G |
SUSPENSIO ZINCI OXIDATI |
sus der 1x100 g |
VUL |
SK |
100 |
2.62 |
1.3 |
S |
1.32 |
0.50381700000000007 |
0.45 |
|
|
|
|
U80 |
15640 |
|
|
G |
UNG. ACIDI SALICYLICI 5% |
ung 1x100 g |
VUL |
SK |
100 |
3.01 |
1.3 |
S |
1.71 |
0.568106 |
1.71 |
|
|
|
|
U80 |
D11A |
|
|
|
Iné dermatologiká |
loc. 1% (100 g ) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
24439 |
|
|
G |
SOLUTIO ACID. SALIC. SPIRIT.1% |
liq 1x100 g |
VUL |
SK |
100 |
2.36 |
1.3 |
S |
1.06 |
0.44915300000000002 |
1.06 |
|
|
|
|
U80 |
D11A |
|
|
|
Iné dermatologiká |
loc. 2% (100 g ) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
24435 |
|
|
G |
SOLUTIO ACID. SALIC. SPIRIT.2% |
liq 1x100 g |
VUL |
SK |
100 |
2.64 |
1.3 |
S |
1.34 |
0.50757599999999992 |
1.34 |
|
|
|
|
U80 |
D11A |
|
|
|
Iné dermatologiká |
loc. 3% (100 g ) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
24671 |
|
|
G |
SOLUTIO ACIDI BORICI 3% |
liq 1x100 g |
VUL |
SK |
100 |
1.88 |
1.3 |
S |
0.57999999999999996 |
0.30851099999999998 |
0.57999999999999996 |
|
|
|
|
U80 |
D11A |
|
|
|
Iné dermatologiká |
loc. 60% (50 g) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
15663 |
|
|
O |
SPIRITUS DILUTUS |
liq 1x50 g (CSL4) |
VUL |
SK |
50 |
1.46 |
0.65 |
S |
0.81 |
0.55479500000000004 |
0.35 |
|
|
|
|
U80 |
D11A |
|
|
|
Iné dermatologiká |
loc. 60% (100 g ) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
15664 |
|
|
O |
SPIRITUS DILUTUS |
liq 1x100 g (CSL4) |
VUL |
SK |
100 |
1.99 |
1.3 |
S |
0.69 |
0.34673399999999999 |
0.69 |
|
|
|
|
U80 |
D11A |
|
|
|
Iné dermatologiká |
loc. 95 % (75 g) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
24431 |
|
|
O |
SPIRITUS CUM BENZINO DENAT. |
liq 1x75 g |
VUL |
SK |
75 |
1.31 |
0.98 |
S |
0.33 |
0.25190800000000002 |
0 |
|
|
|
|
U80 |
D11A |
|
|
|
Iné dermatologiká |
loc. 95% ( 150 g ) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
24432 |
|
|
O |
SPIRITUS CUM BENZINO DENAT. |
sol der 1x150 g |
VUL |
SK |
150 |
1.83 |
1.83 |
I |
0 |
0 |
0 |
|
|
|
|
U80 |
D11AH01 |
|
|
|
Tacrolimus monohydrát |
loc. 0,03 % |
1 |
g |
|
|
|
|
|
|
|
|
0.68200000000000005 |
|
|
|
23195 |
|
|
O |
PROTOPIC 0,03% masť |
ung der 1x30 g |
FUJ |
IE |
30 |
25.47 |
20.46 |
S |
5.01 |
0.19670200000000002 |
5.01 |
DER, ALG |
ind.obm. |
|
|
|
D11AH01 |
|
|
|
Tacrolimus monohydrát |
loc. 0,1 % |
1 |
g |
|
|
|
|
|
|
|
|
0.73899999999999999 |
|
|
|
23197 |
|
|
O |
PROTOPIC 0,1% masť |
ung der 1x30 g |
FUJ |
DE |
30 |
27.73 |
22.17 |
S |
5.56 |
0.20050499999999999 |
5.56 |
DER, ALG |
ind.obm. |
|
|
|
D11AH02 |
|
|
|
Pimekrolimus |
loc. 1% (15 g) |
2 |
g |
|
|
|
|
|
|
|
|
1.6859999999999999 |
|
|
|
32409 |
|
|
O |
Elidel 10 mg/g krém |
crm 1x15 g (tuba Al) |
MPH |
SK |
7.5010000000000003 |
16.79 |
12.65 |
S |
4.1399999999999997 |
0.24657499999999999 |
4.1399999999999997 |
DER, ALG |
ind.obm. |
|
|
|
G01AA01 |
|
|
|
Nystatín |
vag. sup. |
1 |
DF |
|
|
|
|
|
|
|
|
0.14269999999999999 |
|
|
|
27545 |
|
|
G |
NYSTATIN GALVEX SUPP.VAG. |
sup vag 15 |
XGA |
SK |
15 |
2.5499999999999998 |
2.14 |
S |
0.41 |
0.16078399999999998 |
0.41 |
|
|
|
|
|
G01AA10 |
|
|
|
Klindamycín |
vag. crm. |
0.1 |
g |
|
|
|
|
|
|
|
|
0.05 |
|
|
|
62362 |
|
|
O |
DALACIN V 2% |
crm vag 1x40 g (tuba PE) |
PFI-GB-3 |
GB |
200 |
11.07 |
10 |
S |
1.07 |
9.6658000000000008E-2 |
1.07 |
GYN |
|
|
|
|
G01AA51 |
|
|
|
Nystatin, kombinácie |
vag. nifuratel sup. |
1 |
DF |
|
|
|
|
|
|
|
|
0.51500000000000001 |
|
|
|
41146 |
|
|
O |
MACMIROR COMPLEX 500 |
glo vag 12 |
PIN |
IT |
12 |
9.17 |
6.18 |
S |
2.99 |
0.32606299999999999 |
2.99 |
DER, GYN, URO |
|
|
|
|
G01AA51 |
|
|
|
Nystatin, kombinácie |
vag. nifuratel ung. |
5 |
g |
|
|
|
|
|
|
|
|
1.1651 |
|
|
|
41145 |
|
|
G |
MACMIROR COMPLEX |
ung vag 30 g |
PIN |
IT |
6 |
8.6199999999999992 |
6.99 |
S |
1.63 |
0.18909500000000001 |
1.63 |
DER, GYN, URO |
|
|
|
|
G01AA51 |
|
|
|
Nystatín, kombinácie |
vag. neomycín, polymyxín B cps. vag. |
1 |
DF |
|
|
|
|
|
|
|
|
0.53600000000000003 |
|
|
|
59450 |
|
|
O |
POLYGYNAX |
cps vag 6 |
XIT |
FR |
6 |
4.37 |
3.22 |
S |
1.1499999999999999 |
0.263158 |
1.1499999999999999 |
DER, GYN |
|
|
|
|
G01AC05 |
|
|
|
Dequalínium chlorid |
vag. 10 mg (6 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.0900000000000001 |
|
|
|
23402 |
|
|
G |
Fluomizin 10 mg vaginálne tablety |
tbl vag 6x10 mg (blis. PVC/PE/PVDC/AI) |
HPA |
DE |
6 |
9.3800000000000008 |
6.54 |
S |
2.84 |
0.30277199999999999 |
2.84 |
GYN |
|
|
|
|
G01AF01 |
|
|
|
Metronidazol |
vag. 500 mg (10 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.112 |
|
|
|
02430 |
|
|
G |
ENTIZOL |
tbl vag 10x500 mg |
XPO |
PL |
10 |
1.33 |
1.1200000000000001 |
S |
0.21 |
0.15789500000000001 |
0.21 |
DER, GYN |
|
|
|
|
G01AF02 |
|
|
|
Klotrimazol |
vag. do 100 mg tbl.vag. |
0.1 |
g |
|
|
|
|
|
|
|
|
0.29870000000000002 |
|
|
|
93484 |
|
|
O |
CLOTRIMAZOLUM 100 mg GW |
tbl vag 6x100 mg |
GWP |
PL |
6 |
2.15 |
1.79 |
S |
0.36 |
0.16744199999999998 |
0.36 |
DER, GYN |
|
|
|
U17 |
65483 |
|
|
O |
CLOTRIMAZOL AL 100 |
tbl vag 6x100 mg |
APA |
DE |
6 |
2.1800000000000002 |
1.79 |
S |
0.39 |
0.178899 |
0.36 |
DER, GYN |
|
|
|
U17 |
62862 |
|
|
G |
CANDIBENE /FUNGIZID-RATIOPHARM/ |
tbl vag 6x100 mg |
MCK |
DE |
6 |
2.33 |
1.79 |
S |
0.54 |
0.23175999999999999 |
0.36 |
DER, GYN |
|
|
|
U17 |
G01AF02 |
|
|
|
Klotrimazol |
vag. 200 mg |
0.1 |
g |
|
|
|
|
|
|
|
|
0.29870000000000002 |
|
|
|
58654 |
|
|
G |
CLOTRIMAZOL AL 200 |
tbl vag 3x200 mg |
APA |
DE |
6 |
2.2000000000000002 |
1.79 |
S |
0.41 |
0.18636399999999997 |
0.41 |
DER, GYN |
|
|
|
U17 |
62863 |
|
|
G |
CANDIBENE /FUNGIZID-RATIOPHARM/ |
tbl vag 3x200 mg |
MCK |
DE |
6 |
2.33 |
1.79 |
S |
0.54 |
0.23175999999999999 |
0.41 |
DER, GYN |
|
|
|
U17 |
G01AF05 |
|
|
|
Ekonazol |
vag. glo. 150 mg |
0.1 |
g |
|
|
|
|
|
|
|
|
0.8 |
|
|
|
06096 |
|
|
O |
GYNO-PEVARYL 150 |
glo vag 3x150 mg |
CIL |
CH |
4.5010000000000003 |
3.95 |
3.6 |
S |
0.35 |
8.8607999999999992E-2 |
0.35 |
DER, GYN |
|
|
|
|
06095 |
|
|
O |
GYNO-PEVARYL 50 |
glo vag 15x50 mg |
CIL |
CH |
7.5010000000000003 |
9.7200000000000006 |
6 |
S |
3.72 |
0.382716 |
3.72 |
DER, GYN |
|
|
|
|
G01AF05 |
|
|
|
Ekonazol |
vag. komb. glo. + crm. |
0.1 |
g |
|
|
|
|
|
|
|
|
0.8 |
|
|
|
13350 |
|
|
O |
GYNO-PEVARYL 150 COMBIPACK |
sup vag 3+crm 15 g |
JAC |
PT |
6 |
7.32 |
4.8 |
S |
2.52 |
0.34426200000000001 |
2.52 |
DER, GYN |
|
|
|
|
G01AF12 |
|
|
|
Fenticonazol |
vag. crm. |
0.1 |
g |
|
|
|
|
|
|
|
|
0.22700000000000001 |
|
|
|
76547 |
|
|
G |
LOMEXIN 2 % |
crm vag 78 g |
REC |
IT |
15.596 |
8.5 |
3.54 |
S |
4.96 |
0.58352899999999996 |
4.96 |
DER,GYN |
|
|
|
|
G01AF12 |
|
|
|
Fenticonazol |
vag. obsah balenia 600 mg cps.vag. |
0.1 |
g |
|
|
|
|
|
|
|
|
0.24099999999999999 |
|
|
|
76545 |
|
|
O |
LOMEXIN 600 mg |
cps vag 2x600 mg |
REC |
IT |
12 |
6.96 |
2.89 |
S |
4.07 |
0.58477000000000001 |
4.07 |
DER,GYN |
|
|
|
|
G01AF15 |
|
|
|
Butokonazol |
vag. crem |
0.1 |
g |
|
|
|
|
|
|
|
|
4.6399999999999997 |
|
|
|
82949 |
|
|
O |
GYNAZOL 2 % vaginálny krém |
crm vag 1x5 g (20 mg/1 g) |
GDN |
HU |
1 |
9.48 |
4.6399999999999997 |
S |
4.84 |
0.51054900000000003 |
4.84 |
GYN, DER |
|
|
|
|
G01AF20 |
|
|
|
Kombinácie derivátov imidazolu |
vag. metronid./mikonaz. tbl. vag. |
0.1 |
g |
|
|
|
|
|
|
|
|
0.17 |
|
|
|
31404 |
|
|
O |
KLION D |
tbl vag 10x100 mg |
GDN |
HU |
10 |
3.12 |
1.7 |
S |
1.42 |
0.45512799999999998 |
1.42 |
DER, GYN |
|
|
|
|
G01AX05 |
|
|
|
Nifuratel |
p.o. 200 mg |
0.6 |
g |
|
|
|
|
|
|
|
|
0.93400000000000005 |
|
|
|
70498 |
X |
|
O |
MACMIROR |
tbl obd 20x200 mg |
PIN |
IT |
6.6680000000000001 |
8.99 |
6.23 |
S |
2.76 |
0.307008 |
2.76 |
DER, GYN, URO |
|
|
|
|
G01AX11 |
|
|
|
Polyvidón - jód |
vag. |
0.2 |
g |
|
|
|
|
|
|
|
|
0.13800000000000001 |
|
|
|
62321 |
|
|
G |
BETADINE |
sup vag 14 |
EGI |
HU |
14 |
4.6399999999999997 |
1.93 |
S |
2.71 |
0.58405200000000002 |
2.71 |
|
|
|
|
|
G01AX14 |
|
|
|
Ostatné antinfektíva a antiseptiká |
vag. estriol |
1 |
DF |
|
|
|
|
|
|
|
|
0.73799999999999999 |
|
|
|
45605 |
|
|
G |
GYNOFLOR |
tbl vag 12 |
VVX |
SK |
12 |
12.14 |
8.86 |
S |
3.28 |
0.270181 |
3.28 |
GYN |
|
|
|
|
45604 |
|
|
G |
GYNOFLOR |
tbl vag 6 |
MIA |
CH |
6 |
9.51 |
4.43 |
S |
5.08 |
0.53417499999999996 |
1.64 |
GYN |
|
|
|
|
G02CB01 |
|
|
|
Bromkriptín |
p.o. 2,5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
03747 |
X |
|
O |
PARLODEL |
tbl 30x2,5 mg |
MPH-CZ |
CZ |
15 |
4.91 |
4.91 |
I |
0 |
0 |
0 |
END, GYN, ENP |
|
|
|
|
67512 |
X |
|
G |
MEDOCRIPTINE 2,5MG |
tbl 30x2,5 mg |
MOE |
CY |
15 |
6.81 |
4.95 |
S |
1.86 |
0.27312799999999998 |
0 |
END, GYN, ENP |
|
|
|
|
G02CB03 |
|
|
|
Kabergolín |
p.o. 0,5 mg (8 ks) |
0.14000000000000001 |
mg |
|
|
|
|
|
|
|
|
0.78 |
|
|
|
37256 |
X |
|
G |
Cabest 0,5 mg |
tbl 8x0,5 mg |
IVX |
CZ |
27.97 |
22.53 |
21.82 |
S |
0.71 |
3.1514E-2 |
0.71 |
END, ENP, GYN |
ind.obm. |
|
|
U85 |
G02CB04 |
|
|
|
Quinagolid |
p.o. 25 a 50 µg |
75 |
mcg |
|
|
|
|
|
|
|
|
0.78 |
|
|
|
95561 |
X |
|
O |
Norprolac 25µg+50µg tablety |
tbl 3x25µg+3x50µg |
FEI |
GB |
3 |
3.2 |
2.34 |
S |
0.86 |
0.26874999999999999 |
0.86 |
END, GYN |
ind.obm. |
|
|
U85 |
G02CB04 |
|
|
|
Quinagolid |
p.o. 75 µg |
75 |
mcg |
|
|
|
|
|
|
|
|
0.78 |
|
|
|
95582 |
X |
|
O |
Norprolac 75µg tablety |
tbl 30x75µg |
FEI-CZ |
CZ |
30 |
23.35 |
23.35 |
I |
0 |
0 |
0 |
END, GYN |
ind.obm. |
|
|
U85 |
G02CB04 |
|
|
|
Quinagolid |
p.o. 150 µg |
75 |
mcg |
|
|
|
|
|
|
|
|
0.78 |
|
|
|
95583 |
X |
|
O |
Norprolac 150µg tablety |
tbl 30x150µg |
FEI-CZ |
CZ |
60 |
47.77 |
46.8 |
S |
0.97 |
2.0306000000000001E-2 |
0.97 |
END, GYN |
ind.obm. |
|
|
U85 |
G02CX01 |
|
|
|
Atosiban |
parent. sol. inj. |
165 |
mg |
|
|
|
|
|
|
|
|
349.12 |
|
|
|
14920 |
|
|
O |
TRACTOCILE |
sol inj 1x0,9 ml |
FEG |
SE |
3.9E-2 |
27.67 |
13.62 |
AS |
14.05 |
0.50777000000000005 |
14.05 |
GYN |
ind.obm. |
|
|
|
G03BA03 |
|
|
|
Testosterón |
p.o. 40 mg |
0.12 |
g |
|
|
|
|
|
|
|
|
0.52900000000000003 |
|
|
|
34442 |
X |
|
O |
Undestor Testocaps 40 mg |
cps 60x40 mg |
ORG |
NL |
20 |
11.37 |
10.58 |
S |
0.79 |
6.9481000000000001E-2 |
0.79 |
END, ENP, SEX, URO |
ind.obm. |
|
|
|
G03BA03 |
|
|
|
Testosterón |
parent. |
18 |
mg |
|
|
|
|
|
|
|
|
0.34 |
|
|
|
00373 |
|
|
G |
AGOVIRIN DEPOT |
sus inj 5x2 ml/50 mg |
BTA |
SK |
13.888999999999999 |
4.7 |
4.7 |
I |
0 |
0 |
0 |
END, ENP, SEX, URO |
ind.obm. |
|
|
|
G03BA03 |
|
|
|
Testosterón |
parent. undekanoát |
10.199999999999999 |
mg |
|
|
|
|
|
|
|
|
0.96299999999999997 |
|
|
|
90439 |
|
|
O |
NEBIDO 1000 mg/4 ml injekčný roztok |
sol inj 1x4 ml |
BAS |
DE |
98 |
94.32 |
94.32 |
I |
0 |
0 |
0 |
END, SEX, URO |
ind.obm. |
|
|
|
2633B |
|
|
O |
Nebido 1000 mg/4 ml injekčný roztok |
sol inj 1x4 ml/1000 mg (liek.skl.hnedá.) |
BYE |
DE |
98 |
95 |
94.37 |
S |
0.63 |
6.6319999999999999E-3 |
0.63 |
END, SEX, URO |
ind.obm. |
|
|
|
G03BB01 |
|
|
|
Mesterolón |
p.o. 25 mg (50 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.28899999999999998 |
|
|
|
09592 |
X |
|
O |
PROVIRON-25 |
tbl 50x25 mg |
BAS |
DE |
25 |
9.0500000000000007 |
7.23 |
S |
1.82 |
0.20110499999999998 |
1.82 |
END, SEX, URO |
|
|
|
|
G03CA03 |
|
|
|
Estradiol |
p.o. 1 mg |
2 |
mg |
|
|
|
|
|
|
|
|
0.23219999999999999 |
|
|
|
26704 |
X |
|
O |
ESTROFEM 1 mg |
tbl flm 28x1 mg |
NOO |
DK |
14 |
4.03 |
3.25 |
S |
0.78 |
0.193548 |
0.78 |
END, GYN |
|
|
|
|
G03CA03 |
|
|
|
Estradiol |
p.o. 2 mg |
2 |
mg |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
32810 |
X |
|
G |
ESTRIMAX |
tbl flm 3x28 |
GDN |
HU |
84 |
14.9 |
12.43 |
S |
2.4700000000000002 |
0.165772 |
2.4700000000000002 |
END, GYN |
|
|
|
|
G03CA03 |
|
|
|
Estradiol |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.2 |
|
|
|
00365 |
|
|
G |
AGOFOLLIN-DEPOT |
sus inj 1x2 ml/10 mg |
BTA |
SK |
10 |
1.89 |
1.89 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03CA03 |
|
|
|
Estradiol |
parent. valerát |
1 |
mg |
|
|
|
|
|
|
|
|
5.8999999999999997E-2 |
|
|
|
00529 |
|
|
G |
NEOFOLLIN |
sol inj 5x1 ml/5 mg |
BTA |
SK |
25 |
2.72 |
1.48 |
S |
1.24 |
0.45588200000000001 |
0 |
END, GYN |
|
|
|
|
G03CA03 |
|
|
|
Estradiol |
transd. gel |
1 |
mg |
|
|
|
|
|
|
|
|
4.7E-2 |
|
|
|
53753 |
|
|
O |
ESTREVA GEL |
gel der 1x50 g |
THL |
MC |
50 |
4.22 |
2.35 |
S |
1.87 |
0.44312800000000002 |
1.87 |
END, GYN |
|
|
|
|
G03CA03 |
|
|
|
Estradiol |
transd. nad 25 µg/deň |
50 |
µg |
|
|
|
|
|
|
|
|
0.17330000000000001 |
|
|
|
96053 |
|
|
O |
ESTRAPATCH 60 µg/24 hodín |
emp tdm 4x60 µg/24 hodín |
PFB |
FR |
33.6 |
6.7 |
5.82 |
S |
0.88 |
0.13134299999999999 |
0.88 |
END, GYN |
|
|
|
|
96050 |
|
|
O |
ESTRAPATCH 40 µg/24 hodín |
emp tdm 4x40 µg/24 hodín |
PFB |
FR |
22.4 |
5.21 |
3.88 |
S |
1.33 |
0.255278 |
1.33 |
END, GYN |
|
|
|
|
G03CA04 |
|
|
|
Estriol |
vag. |
0.2 |
mg |
|
|
|
|
|
|
|
|
5.9299999999999999E-2 |
|
|
|
97170 |
|
|
O |
OVESTIN |
crm 15 g+aplikátor |
ORG |
NL |
75 |
5.38 |
4.45 |
S |
0.93 |
0.17286200000000002 |
0.93 |
GYN |
|
|
|
|
G03CX01 |
|
|
|
Tibolón |
p.o. 2,5 mg (28 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
0.42099999999999999 |
|
|
|
36926 |
X |
|
G |
LADYBON |
tbl 28x2,5 mg |
ZNT |
CZ |
28 |
15.75 |
11.79 |
S |
3.96 |
0.25142900000000001 |
3.96 |
END, GYN |
|
|
|
|
96226 |
X |
|
O |
LIVIAL |
tbl 1x28 |
ORG |
NL |
28 |
15.75 |
11.79 |
S |
3.96 |
0.25142900000000001 |
3.96 |
END, GYN |
|
|
|
|
G03CX01 |
|
|
|
Tibolón |
p.o. 2,5 mg (84 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
0.42099999999999999 |
|
|
|
36927 |
X |
|
G |
LADYBON |
tbl 84x2,5 mg |
ZNT |
CZ |
84 |
47.24 |
35.36 |
S |
11.88 |
0.25148199999999998 |
11.88 |
END, GYN |
|
|
|
|
G03D |
|
|
|
Dienogest |
p.o. 2 mg (28 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
1.377 |
|
|
|
85140 |
|
|
O |
Visanne |
tbl 28x2 mg (blis.PVC/Al) |
BAY-SK |
SK |
28 |
39.979999999999997 |
38.56 |
S |
1.42 |
3.5518000000000001E-2 |
1.42 |
END, GYN |
|
|
|
|
G03D |
|
|
|
Dienogest |
p.o. 2 mg (84 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
1.377 |
|
|
|
85141 |
|
|
O |
Visanne |
tbl 84x2 mg (blis.PVC/Al) |
BAY-SK |
SK |
84 |
130.15 |
115.67 |
S |
14.48 |
0.11125600000000001 |
4.26 |
END, GYN |
|
|
|
|
G03DA02 |
|
|
|
Medroxyprogesterón |
p.o. 5 mg (24 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.13550000000000001 |
|
|
|
91231 |
X |
|
O |
PROVERA 5 mg |
tbl 24x5 mg (liek.) |
PFI-GB-3 |
GB |
24 |
3.69 |
3.25 |
S |
0.44 |
0.11924099999999999 |
0.44 |
END, GYN, ONK, URO, ENP |
|
|
|
|
G03DA04 |
|
|
|
Progesterón |
parent. depot. |
5 |
mg |
|
|
|
|
|
|
|
|
0.1162 |
|
|
|
00367 |
|
|
G |
AGOLUTIN-DEPOT |
sus inj 25 mg/1 ml, 1x2 ml |
BTA |
SK |
10 |
1.81 |
1.1599999999999999 |
S |
0.65 |
0.35911599999999999 |
0.65 |
|
|
|
|
|
G03DA04 |
|
|
|
Progesterón |
parent. nedepot. |
5 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
02094 |
|
|
G |
AGOLUTIN |
sol inj 5x2 ml/60 mg |
BTA |
SK |
60 |
2.77 |
1.8 |
S |
0.97 |
0.35018099999999996 |
0.97 |
|
|
|
|
|
G03DA04 |
|
|
|
Progesterón |
vag. |
90 |
mg |
|
|
|
|
|
|
|
|
2.8000000000000001E-2 |
|
|
|
23212 |
|
|
O |
CRINONE 8% |
gel vag 15 aplikátorov (po 1,45 g) |
SEY |
GB |
15 |
43.98 |
0.42 |
S |
43.56 |
0.99045000000000005 |
43.56 |
GYN |
|
|
|
|
G03DB01 |
|
|
|
Dydrogesterón |
p.o. 10 mg (20 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.2 |
|
|
|
15943 |
|
|
O |
DUPHASTON |
tbl flm 20x10 mg |
SYF |
NL |
20 |
5.21 |
4 |
S |
1.21 |
0.23224599999999998 |
1.21 |
END, GYN, ENP |
|
|
|
|
G03DB04 |
|
|
|
Nomegestrol acetát |
p.o. 5 mg (10 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.54 |
|
|
|
47059 |
X |
|
O |
LUTENYL |
tbl 10x5 mg |
THL |
MC |
10 |
5.25 |
5.25 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03DC02 |
|
|
|
Noretisterón |
p.o. 5 mg (45 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.26 |
|
|
|
2015B |
X |
|
G |
Norethisteron Zentiva |
tbl 45x5 mg (blis.Al/PVC) |
ZNT |
SK |
45 |
11.7 |
11.7 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03EA02 |
|
|
|
Testosterón a estrogén |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
0.84640000000000004 |
|
|
|
00464 |
|
|
G |
FOLIVIRIN |
sus inj 5x2 ml |
BTA |
SK |
5 |
10.99 |
4.2300000000000004 |
S |
6.76 |
0.61510500000000001 |
6.76 |
END, GYN, SEX |
|
|
|
|
G03FA01 |
|
|
|
Noretisterón a estrogén |
p.o. 1/0,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.23100000000000001 |
|
|
|
47651 |
|
|
O |
Gynovel 1 mg/ 0,5 mg tablety |
tbl 28x1mg/0,5 mg |
DRK |
DE |
28 |
6.46 |
6.46 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
46645 |
|
|
O |
ACTIVELLE |
tbl flm 1x28 |
NOO |
DK |
28 |
7.8 |
6.47 |
S |
1.33 |
0.17051300000000003 |
0 |
END, GYN |
|
|
|
|
G03FA01 |
|
|
|
Noretisterón a estrogén |
p.o. 1/0,5 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.23100000000000001 |
|
|
|
47653 |
|
|
O |
Gynovel 1 mg/ 0,5 mg tablety |
tbl 84x1mg/0,5 mg |
DRK |
DE |
84 |
19.38 |
19.38 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03FA01 |
|
|
|
Noretisterón a estrogén |
p.o. 1/1 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.23100000000000001 |
|
|
|
34316 |
|
|
O |
Novofem |
tbl flm 1x28 |
NOO |
DK |
28 |
6.84 |
6.47 |
S |
0.37 |
5.4093999999999996E-2 |
0.37 |
END, GYN |
|
|
|
|
G03FA12 |
|
|
|
Medroxyprogesterón a estrogén |
p.o. 1/2,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.23499999999999999 |
|
|
|
66500 |
|
|
O |
INDIVINA 1mg/2,5 mg tablety |
tbl 1x28 |
ORN |
DK |
28 |
9.57 |
6.58 |
S |
2.99 |
0.31243500000000002 |
2.99 |
END, GYN |
|
|
|
|
G03FA12 |
|
|
|
Medroxyprogesterón a estrogén |
p.o. 1/2,5 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.23499999999999999 |
|
|
|
66501 |
|
|
O |
INDIVINA 1mg/2,5 mg tablety |
tbl 3x28 |
ORN |
DK |
84 |
30.06 |
19.739999999999998 |
S |
10.32 |
0.34331299999999998 |
8.9700000000000006 |
END, GYN |
|
|
|
|
G03FA12 |
|
|
|
Medroxyprogesterón a estrogén |
p.o. 1/5 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22900000000000001 |
|
|
|
66293 |
|
|
O |
INDIVINA 1 mg/5 mg tablety |
tbl 3x28 |
ORN |
DK |
84 |
29.66 |
19.239999999999998 |
S |
10.42 |
0.35131500000000004 |
10.42 |
END, GYN |
|
|
|
|
G03FA12 |
|
|
|
Medroxyprogesterón a estrogén |
p.o. 2/5 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22600000000000001 |
|
|
|
66289 |
|
|
O |
INDIVINA 2 mg/5 mg tablety |
tbl 3x28 |
ORN |
DK |
84 |
29.66 |
18.98 |
S |
10.68 |
0.36008099999999998 |
10.68 |
END, GYN |
|
|
|
|
G03FA14 |
|
|
|
Dydrogesterón a estrogén |
p.o. 2,5/0,5 (28 ks) kontinuálne prípravky |
1 |
DF |
|
|
|
|
|
|
|
|
7.2999999999999995E-2 |
|
|
|
21066 |
|
|
O |
Femoston conti 0,5 mg/2,5 mg |
tbl flm 28x0,5 mg/2,5 mg (blis.PVC/Al) |
ABB-DE-2 |
DE |
28 |
7.23 |
2.04 |
S |
5.19 |
0.71784199999999998 |
5.19 |
END, GYN |
|
|
|
|
G03FA14 |
|
|
|
Dydrogesterón a estrogén |
p.o. 5/1 mg (28 ks) kontinuálne prípravky |
1 |
DF |
|
|
|
|
|
|
|
|
0.19700000000000001 |
|
|
|
30109 |
|
|
O |
FEMOSTON CONTI |
tbl flm 1x28 |
SYF |
NL |
28 |
7 |
5.52 |
S |
1.48 |
0.21142900000000001 |
1.48 |
END, GYN |
|
|
|
|
G03FA15 |
|
|
|
Dienogest a estradiol |
p.o. 2/1mg (84 ks) kontinuálne prípravky |
1 |
DF |
|
|
|
|
|
|
|
|
1.5149999999999999 |
|
|
|
2051B |
|
|
G |
VELBIENNE 2 mg/1 mg filmom obalené tablety |
tbl flm 3x28 (blis.PVC/PVDC/Al) |
LDP-SK |
SK |
84 |
127.24 |
127.24 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03FA17 |
|
|
|
Drospirenón, estradiol |
p.o. 2/1 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.248 |
|
|
|
42989 |
|
|
O |
Angeliq |
tbl flm 84 (3x28) |
BAS |
DE |
84 |
38.340000000000003 |
20.83 |
S |
17.510000000000002 |
0.45670299999999997 |
17.510000000000002 |
END, GYN |
|
|
|
|
G03FB08 |
|
|
|
Dydrogesterón a estrogén |
p.o. 10/1 (28 ks) sekvenčné prípravky |
1 |
DF |
|
|
|
|
|
|
|
|
0.19500000000000001 |
|
|
|
10204 |
|
|
O |
FEMOSTON 1/10 |
tbl flm 1x28 |
SYF |
NL |
28 |
8.07 |
5.46 |
S |
2.61 |
0.32341999999999999 |
2.61 |
END, GYN |
|
|
|
|
G03FB08 |
|
|
|
Dydrogesterón a estrogén |
p.o. 10/2 (28 ks) sekvenčné prípravky |
1 |
DF |
|
|
|
|
|
|
|
|
0.19500000000000001 |
|
|
|
01746 |
|
|
O |
FEMOSTON 2/10 |
tbl flm 1x28 |
SYF |
NL |
28 |
6.76 |
5.46 |
S |
1.3 |
0.19230799999999998 |
1.3 |
END, GYN |
|
|
|
|
G03FB09 |
|
|
|
Levonorgestrel a estrogén |
p.o. 0,15/2 mg (63 ks) sekvenčné prípravky |
0.75 |
DF |
|
|
|
|
|
|
|
|
0.14399999999999999 |
|
|
|
89782 |
|
|
O |
KLIMONORM |
tbl obd 3x21 |
VJP |
DE |
84 |
14.83 |
12.1 |
S |
2.73 |
0.184086 |
2.73 |
END, GYN |
|
|
|
|
G03GA02 |
|
|
|
Ľudský menopauzálny gonadotropín |
parent. |
75 |
UT |
|
|
|
|
|
|
|
|
6.66 |
|
|
|
12979 |
|
|
O |
MENOGON |
plv iud 10+10 solv. |
FEI |
DE |
10 |
86.99 |
66.599999999999994 |
S |
20.39 |
0.23439499999999999 |
20.39 |
END, GYN, RPM |
ind.obm., ZP |
|
|
|
43728 |
|
|
O |
MERIONAL 75 UT |
plv iol 10x75 UT+solv |
IBS |
CH |
10 |
97.98 |
66.599999999999994 |
S |
31.38 |
0.32026899999999997 |
20.39 |
END, GYN, RPM |
ind.obm., ZP |
|
|
|
43727 |
|
|
O |
MERIONAL 75 UT |
plv iol 1x75 UT+solv |
IBS |
CH |
1 |
11.98 |
6.66 |
S |
5.32 |
0.444073 |
2.04 |
END, GYN, RPM |
ind.obm., ZP |
|
|
|
G03GA02 |
|
|
|
Ľudský menopauzálny gonadotropín |
parent. plv.inj. + sol. |
30 |
UT |
|
|
|
|
|
|
|
|
4.9450000000000003 |
|
|
|
10672 |
|
|
O |
MENOPUR |
plv iol 10 amp+ solv. |
FEI |
DE |
25 |
185.38 |
123.63 |
S |
61.75 |
0.33310000000000001 |
50.98 |
END, GYN, RPM |
ind.obm., ZP |
|
|
|
85209 |
|
|
O |
MENOPUR 600 IU |
plv iol 1 x 600 IU + 1 ml solv. (liek.inj.skl. + striek.inj.napl. + prisl.) |
FEI |
DE |
20 |
161.41 |
98.9 |
S |
62.51 |
0.38727499999999998 |
62.51 |
END, GYN, RPM |
ind.obm., ZP |
|
|
|
G03GA04 |
|
|
|
Urofolitropín |
parent. vysokopurifikovaný |
75 |
UT |
|
|
|
|
|
|
|
|
8.9600000000000009 |
|
|
|
14587 |
|
|
O |
FOSTIMON HP 75 UT |
plv iol 10x75 UT+solv. |
IBS |
CH |
10 |
125.01 |
89.6 |
S |
35.409999999999997 |
0.28325700000000004 |
35.409999999999997 |
GYN, RPM |
ind.obm., ZP |
|
|
|
7966A |
|
|
O |
Fostimon HP 150IU |
plv iol 10x150 IU + 10x1ml solv.(liek.inj.skl.+striek.inj.napl.) |
IBS-SK |
SK |
20 |
339.17 |
179.2 |
S |
159.97 |
0.47165100000000004 |
159.97 |
GYN, RPM |
ind.obm., ZP |
|
|
|
7963A |
|
|
O |
Fostimon HP 75 IU |
plv iol 10x75 IU + 10x1ml solv. (liek inj.skl.+striek. inj. napl.) |
IBS-SK |
SK |
10 |
171.9 |
89.6 |
S |
82.3 |
0.478767 |
35.409999999999997 |
GYN, RPM |
ind.obm., ZP |
|
|
|
7964A |
|
|
O |
Fostimon HP 150 IU |
plv iol 1x150 IU+1x1 ml solv. (liek.inj.skl.+striek.inj.napl.) |
IBS-SK |
SK |
2 |
37.18 |
17.920000000000002 |
S |
19.260000000000002 |
0.51802000000000004 |
16 |
GYN, RPM |
ind.obm., ZP |
|
|
|
47690 |
|
|
O |
Bravelle 75 IU prášok a rozpúšťadlo na injekčný roztok |
plv iol 10x75 IU+solv. |
FEI |
DE |
10 |
196.72 |
89.6 |
S |
107.12 |
0.54453000000000007 |
35.409999999999997 |
GYN, RPM |
ind.obm., ZP |
|
|
|
7961A |
|
|
O |
FOSTIMON HP 75 IU |
plv iol 1x75 IU+1x1 ml solv. (liek.inj.skl.+striek.inj.napl.) |
IBS-SK |
SK |
1 |
19.98 |
8.9600000000000009 |
S |
11.02 |
0.55155200000000004 |
3.54 |
GYN, RPM |
ind.obm., ZP |
|
|
|
G03GA05 |
|
|
|
Follitropín alfa |
parent. |
75 |
UT |
|
|
|
|
|
|
|
|
17.45 |
|
|
|
40551 |
|
|
O |
GONAL-f 900 IU/1,5 ml |
sol inj, 1 naplnené pero + 14 ihiel |
SEY |
GB |
12 |
334.08 |
209.4 |
S |
124.68 |
0.37320399999999998 |
124.68 |
END, GYN, RPM |
ind.obm., ZP |
|
|
U18 |
40550 |
|
|
O |
GONAL-f 450 IU/0,75 ml |
sol inj, 1 naplnené pero + 7 ihiel |
SEY |
GB |
6 |
171.32 |
104.7 |
S |
66.62 |
0.38886299999999996 |
62.34 |
END, GYN, RPM |
ind.obm., ZP |
|
|
U18 |
G03GA05 |
|
|
|
Follitropín alfa, kombinácie |
parent. lutropín |
1 |
DF |
|
|
|
|
|
|
|
|
57.393000000000001 |
|
|
|
43568 |
|
|
O |
PERGOVERIS |
plv iol 1x11 mcg r-hFSH/3mcg r-hLH + 1x1 ml solv. |
SEY |
GB |
1 |
85.27 |
57.39 |
S |
27.88 |
0.326961 |
27.88 |
GYN, RPM |
ind.obm., ZP |
|
|
U19 |
G03GA06 |
|
|
|
Follitropín beta |
parent. |
75 |
UT |
|
|
|
|
|
|
|
|
17.45 |
|
|
|
42508 |
|
|
O |
PUREGON 600 IU/0,72 ml |
sol inj 833 IU/ ml |
MSD-GB-1 |
GB |
8 |
199.4 |
139.6 |
S |
59.8 |
0.2999 |
59.8 |
END, GYN, RPM |
ind.obm., ZP |
|
|
U18 |
42275 |
|
|
O |
PUREGON 900 IU/1,08 ml |
sol inj 1x1,08 ml |
MSD-GB-1 |
GB |
12 |
304.06 |
209.4 |
S |
94.66 |
0.31132000000000004 |
89.7 |
END, GYN, RPM |
ind.obm., ZP |
|
|
U18 |
42506 |
|
|
O |
PUREGON 300 IU/0,36 ml |
sol inj 833 IU/ ml |
MSD-GB-1 |
GB |
4 |
103.98 |
69.8 |
S |
34.18 |
0.32871699999999998 |
29.9 |
END, GYN, RPM |
ind.obm., ZP |
|
|
U18 |
G03GA07 |
|
|
|
Lutropín alfa |
parent. |
75 |
UT |
|
|
|
|
|
|
|
|
17.45 |
|
|
|
31825 |
|
|
O |
LUVERIS 75 |
plv iol 1x75 ut+solv. |
IFB |
IT |
1 |
31.43 |
17.45 |
S |
13.98 |
0.44479799999999997 |
13.98 |
GYN, RPM |
ind.obm., ZP |
|
|
U18 |
G03GA08 |
|
|
|
Choriogonadotropín alfa |
parent. |
250 |
mcg |
|
|
|
|
|
|
|
|
8.85 |
|
|
|
10378 |
|
|
O |
Ovitrelle |
sol inj 1x0,5 ml/250 µg (napln skl. v napl. pere + ihla) |
MSS-GB |
GB |
1 |
31.39 |
8.85 |
S |
22.54 |
0.7180629999999999 |
22.54 |
GYN, RPM |
ind.obm. |
|
|
|
42192 |
|
|
O |
OVITRELLE 250 mikrogramov |
plv iol 1x250 µg/0,5 ml (napln skl. striek.) |
MSS |
GB |
1 |
31.61 |
8.85 |
S |
22.76 |
0.72002500000000003 |
22.54 |
GYN, RPM |
ind.obm. |
|
|
|
G03GA09 |
|
|
|
Korifolitropín alfa |
parent. |
150 |
mcg |
|
|
|
|
|
|
|
|
341.32400000000001 |
|
|
|
86707 |
|
|
O |
ELONVA |
sol inj 1x0,5 ml/150 µg |
MSD-GB-1 |
GB |
1 |
523.66 |
341.32 |
S |
182.34 |
0.34820300000000004 |
182.34 |
GYN, RPM |
ind.obm., ZP |
|
|
|
86703 |
|
|
O |
ELONVA |
sol inj 1x0,5 ml/100 µg |
MSD-GB-1 |
GB |
0.75 |
456.11 |
255.99 |
S |
200.12 |
0.43875399999999998 |
200.12 |
GYN, RPM |
ind.obm., ZP |
|
|
|
G03GB02 |
|
|
|
Klomifén |
p.o. 50 mg (10 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
2.76E-2 |
|
|
|
10233 |
X |
|
G |
Clostilbegyt |
tbl 10x50 mg (bli.) |
EGI |
HU |
55.5 |
4.2 |
1.53 |
S |
2.67 |
0.635714 |
2.67 |
END, GYN |
|
|
|
|
G03HA01 |
|
|
|
Cyproterón |
p.o. 50 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.84 |
|
|
|
32095 |
X |
|
G |
Cyproplex |
tbl 50x50mg |
PHM |
NL |
25 |
20.98 |
20.98 |
I |
0 |
0 |
0 |
END, GYN, ONK, PSY, SEX, URO, ENP |
|
|
|
|
03783 |
X |
|
O |
ANDROCUR 50 |
tbl 50x50 mg |
BAS |
DE |
25 |
24.29 |
21 |
S |
3.29 |
0.13544700000000001 |
0 |
END, GYN, ONK, PSY, SEX, URO, ENP |
|
|
|
|
G03HA01 |
|
|
|
Cyproterón |
parent. |
0.1 |
g |
|
|
|
|
|
|
|
|
2.7570000000000001 |
|
|
|
23342 |
|
|
O |
ANDROCUR-DEPOT |
sol inj 3x3 ml/300 mg |
BAS |
DE |
9 |
26.71 |
24.81 |
S |
1.9 |
7.1134000000000003E-2 |
1.9 |
END, GYN, ONK, PSY, SEX, URO |
|
|
|
|
G03HB01 |
|
|
|
Cyproterón a estrogén |
p.o. cyproter.ac./estrad.valer. |
0.75 |
DF |
|
|
|
|
|
|
|
|
0.14599999999999999 |
|
|
|
75013 |
|
|
O |
CLIMEN |
tbl obd 1x21 |
BAS |
DE |
28 |
6.43 |
4.09 |
S |
2.34 |
0.36391899999999999 |
2.34 |
END, GER, GYN, INT, KLF |
|
|
|
|
G03XA01 |
|
|
|
Danazol |
p.o. 100 mg (100 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.95 |
|
|
|
67525 |
X |
|
G |
ANARGIL 100 mg |
cps 100x100 mg |
MOE |
CY |
16.667000000000002 |
44.4 |
42.18 |
S |
2.2200000000000002 |
0.05 |
2.2200000000000002 |
ALG, DER, END, GYN, HEM |
|
|
|
|
G03XA01 |
|
|
|
Danazol |
p.o. 200 mg (100 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.95 |
|
|
|
67528 |
X |
|
G |
ANARGIL 200 mg |
cps 100x200 mg |
MOE |
CY |
33.332999999999998 |
77.900000000000006 |
74.010000000000005 |
S |
3.89 |
4.9936000000000001E-2 |
3.89 |
ALG, DER, END, GYN, HEM |
|
|
|
|
G03XB02 |
|
|
|
Ulipristal |
p.o. 5 mg (28 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
4.6100000000000003 |
|
|
|
0086A |
|
|
O |
Esmya 5 mg tablety |
tbl 28x5 mg (blis.PVC/PE/PVDC/Al) |
GDN |
HU |
28 |
141.13 |
129.08000000000001 |
S |
12.05 |
8.5382E-2 |
12.05 |
GYN |
|
|
|
|
G03XC01 |
|
|
|
Raloxifén hydrochlorid |
p.o. 60 mg (28 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.42 |
|
|
|
89226 |
X |
|
G |
Raloxifene Teva |
tbl flm 28x60 mg (blis.PVC/PVDC/Al) |
TEV |
HU |
28 |
13.24 |
11.76 |
S |
1.48 |
0.11178200000000001 |
1.48 |
END, GYN, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
G04BC |
|
|
|
Rozpúšťadlá močových kameňov |
p.o. 3 g (100 ks) |
10 |
g |
|
|
|
|
|
|
|
|
0.73360000000000003 |
|
|
|
06373 |
|
|
O |
Blemaren N |
tbl eff 100 |
EPF-1 |
DE |
30 |
24.95 |
22.01 |
S |
2.94 |
0.117836 |
2.94 |
URO,NEF |
|
|
|
|
G04BD04 |
|
|
|
Oxybutynín |
p.o. 5 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.254 |
|
|
|
26999 |
X |
|
O |
DITROPAN |
tbl 30x5 mg |
LSY |
FR |
10 |
2.86 |
2.54 |
S |
0.32 |
0.111888 |
0 |
GYN, GYU, URO |
|
|
|
|
33012 |
X |
|
G |
Eurin 5mg |
tbl 30x5 mg |
GNS |
GB |
10 |
3.25 |
2.54 |
S |
0.71 |
0.21846199999999999 |
0 |
GYN, GYU, URO |
|
|
|
|
G04BD04 |
|
|
|
Oxybutynín |
p.o. 5 mg (60 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.254 |
|
|
|
33013 |
X |
|
G |
Eurin 5mg |
tbl 60x5 mg |
GNS |
GB |
20 |
5.03 |
5.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
|
|
|
|
13102 |
X |
|
G |
UROXAL 5 MG |
tbl 60x5 mg |
FFR |
FR |
20 |
5.38 |
5.08 |
S |
0.3 |
5.5761999999999999E-2 |
0 |
GYN, GYU, URO |
|
|
|
|
G04BD04 |
|
|
|
Oxybutynín |
p.o. 5 mg (90 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.254 |
|
|
|
33014 |
X |
|
G |
Eurin 5mg |
tbl 90x5 mg |
GNS |
GB |
30 |
7.55 |
7.55 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
|
|
|
|
G04BD04 |
|
|
|
Oxybutynín |
transd. |
15 |
mg |
|
|
|
|
|
|
|
|
1.2130000000000001 |
|
|
|
40835 |
|
|
O |
KENTERA |
emp tdm 8 (3,9 mg/24 hod) |
NCB |
GB |
28 |
33.82 |
33.82 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
40836 |
|
|
O |
KENTERA |
emp tdm 24 (3,9 mg/24 hod) |
NCB |
GB |
84 |
101.88 |
101.88 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD06 |
|
|
|
Propiverín |
p.o. 5 mg (50 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.70699999999999996 |
|
|
|
66819 |
X |
|
O |
MICTONETTEN |
tbl obd 50x5 mg |
APG |
DE |
8.3320000000000007 |
8.89 |
5.89 |
S |
3 |
0.33745800000000004 |
3 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD06 |
|
|
|
Propiverín |
p.o. 15 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.36509999999999998 |
|
|
|
92254 |
X |
|
G |
MICTONORM |
tbl obd 30x15 mg |
APG |
DE |
15 |
7.11 |
5.48 |
S |
1.63 |
0.22925499999999999 |
1.63 |
GYN, GYU, URO |
|
|
|
|
G04BD07 |
|
|
|
Tolterodín |
p.o. predĺžené uvoľňovanie 4 mg (28 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.98199999999999998 |
|
|
|
32641 |
X |
|
O |
DETRUSITOL SR 4 mg |
cps pld 28x4 mg (blist.) |
PFI-GB-3 |
GB |
28 |
29.7 |
27.5 |
S |
2.2000000000000002 |
7.4074000000000001E-2 |
2.2000000000000002 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD08 |
|
|
|
Solifenacín |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
23015 |
X |
|
G |
Asolfena 5mg |
tbl flm 30x5 mg |
KRK |
SI |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30311 |
X |
|
G |
Karesol 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PVC/PVDC/Al) |
STD |
DE |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
9836A |
X |
|
G |
Sentacurin 5mg |
tbl flm 30x5mg (blis.PVC/Al) |
EGI |
HU |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30207 |
X |
|
G |
Solifenacin Teva 5 mg |
tbl flm 30x5 mg (blis.PVC/PVDC/Al) |
TEV |
SK |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30232 |
X |
|
G |
Soliflow 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PVC/PVDC/Al) |
ADD |
PL |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30184 |
X |
|
G |
Zabcare 5 mg |
tbl flm 30x5 mg |
HTN-3 |
CZ |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
04865 |
X |
|
G |
Zevesin 5 mg |
tbl flm 30x5 mg (blis.OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
G04BD08 |
|
|
|
Solifenacín |
p.o. 5 mg (100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
23019 |
X |
|
G |
Asolfena 5mg |
tbl flm 100x5 mg |
KRK |
SI |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30312 |
X |
|
G |
Karesol 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PVC/PVDC/Al) |
STD |
DE |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
9840A |
X |
|
G |
Sentacurin 5mg |
tbl flm 100x5mg (blis.PVC/Al) |
EGI |
HU |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
9381A |
X |
|
G |
Solifenacin PMCS 5 mg |
tbl flm 100x5 mg (blis. OPA/Al/PVC/Al) |
PMP |
CZ |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30738 |
X |
|
G |
Solifenacin Sandoz 5 mg filmom obalené tablety |
tbl flm 100x5mg (blis.PVC/PVDC/Al) |
SAN |
SI |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30208 |
X |
|
G |
Solifenacin Teva 5 mg |
tbl flm 100x5 mg (blis.PVC/PVDC/Al) |
TEV |
SK |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30233 |
X |
|
G |
Soliflow 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PVC/PVDC/Al) |
ADD |
PL |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
0395B |
X |
|
G |
SOLIMED 5 mg |
tbl flm, 100x5 mg (blis.PVC/AI) |
CRR |
SK |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
9273A |
X |
|
G |
Urokur 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.OPA/Al/PVC/Al) |
GLH-2 |
AT |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30185 |
X |
|
G |
Zabcare 5 mg |
tbl flm 100 x 5 mg |
HTN-3 |
CZ |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
04866 |
X |
|
G |
Zevesin 5 mg |
tbl flm 100x5 mg (blis.OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
G04BD08 |
|
|
|
Solifenacín |
p.o. 10 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.54100000000000004 |
|
|
|
04868 |
X |
|
G |
Zevesin 10 mg |
tbl flm 30x10 mg (blis.OPA/Al/PVC/Al) |
ZNT |
SK |
60 |
32.11 |
32.11 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
1558B |
X |
|
G |
Solifenacin Actavis 10 mg |
tbl flm 30x10 mg (blis PVC/Al) |
ACT-5 |
IS |
60 |
32.130000000000003 |
32.130000000000003 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30221 |
X |
|
G |
Solifenacin Teva 10 mg |
tbl flm 30x10 mg (blis.PVC/PVDC/Al) |
TEV |
SK |
60 |
33.46 |
32.46 |
S |
1 |
2.9885999999999999E-2 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
23022 |
X |
|
G |
Asolfena 10mg |
tbl flm 30x10 mg |
KRK |
SI |
60 |
33.950000000000003 |
32.46 |
S |
1.49 |
4.3887999999999996E-2 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30195 |
X |
|
G |
Zabcare 10 mg |
tbl flm 30x10 mg |
HTN-3 |
CZ |
60 |
35.630000000000003 |
32.46 |
S |
3.17 |
8.8970000000000007E-2 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD08 |
|
|
|
Solifenacín |
p.o. 10 mg (100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.54100000000000004 |
|
|
|
30323 |
X |
|
G |
Karesol 10 mg filmom obalené tablety |
tbl flm 100x10 mg (blis.PVC/PVDC/Al) |
STD |
DE |
200 |
107.03 |
107.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
9850A |
X |
|
G |
Sentacurin 10mg |
tbl flm 100x10mg (blis.PVC/Al) |
EGI |
HU |
200 |
107.03 |
107.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30748 |
X |
|
G |
Solifenacin Sandoz 10 mg filmom obalené tablety |
tbl flm 100x10 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
200 |
107.03 |
107.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
0401B |
X |
|
G |
SOLIMED 10 mg |
tbl flm 100x10 mg (blis.PVC/AI) |
CRR |
SK |
200 |
107.03 |
107.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
23026 |
X |
|
G |
Asolfena 10mg |
tbl flm 100x10 mg |
KRK |
SI |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
1560B |
X |
|
G |
Solifenacin Actavis 10 mg |
tbl flm 100x10 mg (blis PVC/Al) |
ACT-5 |
IS |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30222 |
X |
|
G |
Solifenacin Teva 10 mg |
tbl flm 100x10 mg (blis.PVC/PVDC/Al) |
TEV |
SK |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30242 |
X |
|
G |
Soliflow 10 mg filmom obalené tablety |
tbl flm 100x10 mg (blis.PVC/PVDC/Al) |
ADD |
PL |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
9284A |
X |
|
G |
Urokur 10 mg filmom obalené tablety |
tbl flm 100x10 mg (blis.OPA/Al/PVC/Al) |
GLH-2 |
AT |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
04869 |
X |
|
G |
Zevesin 10 mg |
tbl flm 100x10 mg (blis.OPA/Al/PVC/Al) |
ZNT |
SK |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
9388A |
X |
|
G |
Solifenacin PMCS 10 mg |
tbl flm 100x10 mg (blis. OPA/Al/PVC/Al) |
PMP |
CZ |
200 |
108.16 |
108.16 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30196 |
X |
|
G |
Zabcare 10 mg |
flm tbl 100x10 mg |
HTN-3 |
CZ |
200 |
108.16 |
108.16 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
42805 |
X |
|
O |
VESICARE 10 mg |
tbl flm 100x10 mg |
ASL |
NL |
200 |
111.59 |
108.2 |
S |
3.39 |
3.0379E-2 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD09 |
|
|
|
Trospium chlorid |
p.o. 15 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.41099999999999998 |
|
|
|
12528 |
X |
|
O |
SPASMED 15 |
tbl flm 50x15 mg |
PMP |
CZ |
18.754000000000001 |
9.09 |
7.71 |
S |
1.38 |
0.15181500000000001 |
1.38 |
GYN, GYU, URO |
|
|
|
|
G04BD09 |
|
|
|
Trospium chlorid |
p.o. 30 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.39500000000000002 |
|
|
|
04998 |
|
|
O |
Spasmed 30 |
tbl flm 50x30 mg |
PMP |
CZ |
37.5 |
15.95 |
14.81 |
S |
1.1399999999999999 |
7.1473000000000009E-2 |
1.1399999999999999 |
GYN, URO, GYU |
|
|
|
|
G04BD10 |
|
|
|
Darifenacín |
p.o. predĺžené uvoľňovanie 7,5 mg (28 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
1.1200000000000001 |
|
|
|
41980 |
X |
|
O |
EMSELEX 7,5 mg |
tbl plg 28x7,5 mg |
NEH |
GB |
28 |
33.58 |
31.36 |
S |
2.2200000000000002 |
6.6111000000000003E-2 |
2.2200000000000002 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD10 |
|
|
|
Darifenacín |
p.o. predĺžené uvoľňovanie 15 mg (28 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
0.56999999999999995 |
|
|
|
41986 |
X |
|
O |
EMSELEX 15 mg |
tbl plg 28x15 mg |
NEH |
GB |
56 |
33.92 |
31.92 |
S |
2 |
5.8962000000000001E-2 |
2 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD11 |
|
|
|
Fesoterodín |
p.o. predĺžené uvoľňovanie 4 mg (28 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
39621 |
X |
|
O |
TOVIAZ |
tbl plg 28x4 mg (blister Al/Al) |
PFI-GB-1 |
GB |
28 |
32.03 |
27.72 |
S |
4.3099999999999996 |
0.13456099999999999 |
2.37 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD11 |
|
|
|
Fesoterodín |
p.o. predĺžené uvoľňovanie 4 mg (84 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
47958 |
X |
|
O |
TOVIAZ |
tbl plg 84x4 mg (blister Al/Al) |
PFI-GB-1 |
GB |
84 |
90.28 |
83.16 |
S |
7.12 |
7.8865999999999992E-2 |
7.12 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD11 |
|
|
|
Fesoterodín |
p.o.predĺžené uvoľňovanie 8 mg (28 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.58099999999999996 |
|
|
|
39626 |
X |
|
O |
TOVIAZ |
tbl plg 28x8 mg (blister Al/Al) |
PFI-GB-1 |
GB |
56 |
34.57 |
32.54 |
S |
2.0299999999999998 |
5.8720999999999995E-2 |
2.0299999999999998 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD11 |
|
|
|
Fesoterodín |
p.o.predĺžené uvoľňovanie 8 mg (100 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.58099999999999996 |
|
|
|
79328 |
X |
|
O |
TOVIAZ |
tbl plg 100x8 mg (blister Al/Al) |
PFI-GB-1 |
GB |
200 |
125.7 |
116.2 |
S |
9.5 |
7.5576999999999991E-2 |
7.25 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD12 |
|
|
|
Mirabegron |
p.o. 50 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
1.23 |
|
|
|
3862A |
|
|
O |
Betmiga 50mg tablety s predĺženým uvoľnovaním |
tbl plg 30x50mg |
ASL |
NL |
30 |
38.590000000000003 |
36.9 |
S |
1.69 |
4.3794000000000007E-2 |
1.68 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD12 |
|
|
|
Mirabegron |
p.o. 50 mg (90 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
1.23 |
|
|
|
3864A |
|
|
O |
Betmiga 50 mg tablety s predĺženým uvoľnovaním |
tbl plg 90x50mg |
ASL |
NL |
90 |
115.73 |
110.7 |
S |
5.03 |
4.3463000000000002E-2 |
5.03 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BE03 |
|
|
|
Sildenafil |
p.o. 20 mg (90 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
16.22 |
|
|
|
95558 |
|
|
O |
Revatio 20 mg filmom obalené tablety |
tbl flm 90x20 mg (blis.PVC/Al) |
PFI-GB-1 |
GB |
30 |
486.33 |
486.33 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
G04CA01 |
|
|
|
Alfuzosín |
p.o. predĺžené uvoľňovanie 5 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.17100000000000001 |
|
|
|
83093 |
|
|
O |
XATRAL 5-SR |
tbl flm 56x5 mg |
XSB |
FR |
28 |
12.55 |
4.79 |
S |
7.76 |
0.61832700000000007 |
7.76 |
URO |
|
|
|
U20 |
G04CA01 |
|
|
|
Alfuzosín |
p.o. predĺžené uvoľňovanie 10 mg (60 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.17100000000000001 |
|
|
|
35235 |
|
|
G |
Alfuzosin Mylan 10 mg |
tbl plg 60x10 mg |
GNS |
GB |
60 |
10.26 |
10.26 |
I |
0 |
0 |
0 |
URO |
|
|
|
U20 |
98821 |
|
|
G |
Alfuzosin Sandoz 10 mg |
tbl plg 60x10 mg |
SAN |
AT |
60 |
14.25 |
10.26 |
S |
3.99 |
0.28000000000000003 |
0 |
URO |
|
|
|
U20 |
G04CA01 |
|
|
|
Alfuzosín |
p.o. predĺžené uvoľňovanie 10 mg (90 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.17100000000000001 |
|
|
|
35237 |
|
|
G |
Alfuzosín Mylan 10 mg |
tbl plg 90 x 10 mg |
GENERICS |
UK |
90 |
16.18 |
15.39 |
S |
0.79 |
4.8826000000000001E-2 |
0 |
URO |
|
|
|
U20 |
98823 |
|
|
G |
Alfuzosin Sandoz 10 mg tablety s predĺženým uvoľňovaním |
tbl plg 90x10 mg |
SAN |
AT |
90 |
16.18 |
15.39 |
S |
0.79 |
4.8826000000000001E-2 |
0 |
URO |
|
|
|
U20 |
G04CA02 |
|
|
|
Tamsulosín |
p.o. predĺžené uvoľňovanie 0,4 mg (30 ks) |
0.4 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
95369 |
X |
|
G |
Tamsulosin-Teva 0,4 mg |
cps mdd 30x0,4 mg |
SBV |
NL |
30 |
4.03 |
3 |
S |
1.03 |
0.255583 |
0 |
URO |
|
|
|
|
95358 |
X |
|
G |
Tanyz cps mod 30x0,4 mg |
cps mdd 30x0,4 mg |
KRK |
SI |
30 |
4.1399999999999997 |
3 |
S |
1.1399999999999999 |
0.275362 |
0 |
URO |
|
|
|
|
G04CA02 |
|
|
|
Tamsulosín |
p.o. predĺžené uvoľňovanie 0,4 mg (90-100 ks) |
0.4 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
23098 |
X |
|
G |
Solesmin 0,4 mg |
cps mdd 100x0,4 mg (blis.PVC/PVDC/Al) |
CIA-GB-1 |
GB |
100 |
9.86 |
9.86 |
I |
0 |
0 |
0 |
URO |
|
|
|
|
95320 |
X |
|
G |
Tamsulosin HCL Mylan 0,4mg |
cps mdd 100x0,4mg |
GNC |
GB |
100 |
9.86 |
9.86 |
I |
0 |
0 |
0 |
URO |
|
|
|
|
95374 |
X |
|
G |
Tamsulosin-Teva 0,4 mg |
cps mdd 100x0,4 mg |
SBV |
NL |
100 |
9.86 |
9.86 |
I |
0 |
0 |
0 |
URO |
|
|
|
|
02590 |
X |
|
G |
Geroprostan 0,4 mg |
tbl plg 100x0,4 mg (blis.OPA/Al/PVC/Al) |
GLH-2 |
AT |
100 |
13.42 |
10 |
S |
3.42 |
0.25484400000000001 |
0 |
URO |
|
|
|
|
09771 |
X |
|
G |
Tamsulosin Actavis |
cps mdd 100x0,4 mg (blis.PVC/PE/PVDC/Al |
ACT-7 |
IS |
100 |
13.42 |
10 |
S |
3.42 |
0.25484400000000001 |
3.42 |
URO |
|
|
|
|
37233 |
X |
|
G |
Tamurox 0,4 mg kapsuly s predĺženým uvoľňovaním |
cps plg 100x0,4 mg |
RXY |
IN |
100 |
13.42 |
10 |
S |
3.42 |
0.25484400000000001 |
0 |
URO |
|
|
|
|
95363 |
X |
|
G |
Tanyz cps mod 100x0,4 mg |
cps mdd 100x0,4 mg |
KRK |
SI |
100 |
13.42 |
10 |
S |
3.42 |
0.25484400000000001 |
0 |
URO |
|
|
|
|
95887 |
X |
|
G |
Fokusin |
cps mdd 90x0,4 mg |
ZNT-SK-2 |
SK |
90 |
12.08 |
9 |
S |
3.08 |
0.254967 |
0 |
URO |
|
|
|
|
87470 |
X |
|
G |
Urotam 0,4 mg tvrdé kapsuly s predĺženým uvoľňovaním |
cps pld 90x0,4 mg (blis.PVC/PVD/Al) |
PRW |
CZ |
90 |
12.08 |
9 |
S |
3.08 |
0.254967 |
0 |
URO |
|
|
|
|
G04CA02 |
|
|
|
Tamsulosín |
p.o. kontrol. absorp. systém 0,4 mg (90-100 ks) |
0.4 |
mg |
|
|
|
|
|
|
|
|
0.11799999999999999 |
|
|
|
42540 |
X |
|
O |
Omnic TOCAS 0,4 |
tbl flp 100 x 0,4mg |
YEU |
NL |
100 |
31.23 |
11.8 |
S |
19.43 |
0.62215799999999999 |
0 |
URO |
ind.obm. |
|
|
|
G04CA03 |
|
|
|
Terazosín |
p.o. 5 mg (28-30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.17100000000000001 |
|
|
|
76487 |
X |
|
O |
HYTRIN 5MG |
tbl 28x5 mg |
ABB |
GB |
28 |
15.22 |
4.79 |
S |
10.43 |
0.68528299999999998 |
0.9 |
URO |
|
|
|
U20 |
G04CA03 |
|
|
|
Terazosín |
p.o. 5 mg (90 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.17100000000000001 |
|
|
|
53550 |
X |
|
G |
Kornam 5mg |
tbl 90x5mg |
SAN-SLO-1 |
SI |
90 |
18.29 |
15.39 |
S |
2.9 |
0.158557 |
2.9 |
URO |
|
|
|
U20 |
G04CA03 |
|
|
|
Terazosín |
p.o. 10 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.17100000000000001 |
|
|
|
36538 |
X |
|
G |
Kornam 10 mg |
tbl 30x10 mg |
SAN |
SI |
60 |
12.16 |
10.26 |
S |
1.9 |
0.15625 |
1.9 |
URO |
|
|
|
U20 |
G04CA04 |
|
|
|
Silodozín |
p.o. 4 mg (30 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.36 |
|
|
|
86905 |
|
|
G |
Urorec 4 mg tvrdé kapsuly |
cps dur 30x4 mg (blis.PVC/PVDC/Al) |
REC-2 |
IE |
15 |
7.09 |
5.4 |
S |
1.69 |
0.23836400000000002 |
1.69 |
URO |
|
|
|
|
G04CA04 |
|
|
|
Silodozín |
p.o. 8 mg (30 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.36 |
|
|
|
86912 |
|
|
G |
Urorec 8 mg tvrdé kapsuly |
cps dur 30x8 mg (blis.PVC/PVDC/Al) |
REC-2 |
IE |
30 |
13.38 |
10.8 |
S |
2.58 |
0.192825 |
2.58 |
URO |
|
|
|
|
G04CA04 |
|
|
|
Silodozín |
p.o. 8 mg (50 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.36 |
|
|
|
86913 |
|
|
G |
Urorec 8 mg tvrdé kapsuly |
cps dur 50x8 mg (blis.PVC/PVDC/Al) |
REC-2 |
IE |
50 |
22.79 |
18 |
S |
4.79 |
0.21018000000000001 |
4.3 |
URO |
|
|
|
|
G04CA52 |
|
|
|
Tamsulosín a dutasterid |
p.o. 0,5/0,4 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.56000000000000005 |
|
|
|
89416 |
|
|
O |
Duodart 0,5 mg/0,4 mg tvrdé kapsuly |
cps dur 90x0,5 mg/0,4 mg (fľ. HDPE) |
GAG |
SK |
90 |
78.28 |
50.4 |
S |
27.88 |
0.35615699999999995 |
27.88 |
URO |
ind.obm. |
|
|
|
G04CB01 |
|
|
|
Finasterid |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.245 |
|
|
|
04879 |
X |
|
G |
Finasteride Accord 5mg |
tbl flm 30x5 mg (blis.PVC/PVDC/AI) |
ACC |
GB |
30 |
7.35 |
7.35 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
43545 |
X |
|
G |
Finasterid Orion 5 mg |
tbl flm 30x5 mg |
ORN |
FI |
30 |
7.92 |
7.35 |
S |
0.56999999999999995 |
7.1970000000000006E-2 |
0 |
URO |
ind.obm. |
|
|
U86 |
37039 |
X |
|
G |
FINPROS 5 mg |
tbl flm 30x5 mg |
KRK |
SI |
30 |
8.1300000000000008 |
7.35 |
S |
0.78 |
9.5940999999999999E-2 |
0 |
URO |
ind.obm. |
|
|
U86 |
36939 |
X |
|
G |
Androfin 5 mg |
tbl flm 30x5 mg (blis.Al/PVC) |
GLH |
AT |
30 |
8.42 |
7.35 |
S |
1.07 |
0.127078 |
0 |
URO |
ind.obm. |
|
|
U86 |
65988 |
X |
|
O |
PENESTER |
tbl flm 30x5 mg |
ZNT |
CZ |
30 |
9.31 |
7.35 |
S |
1.96 |
0.21052600000000002 |
0 |
URO |
ind.obm. |
|
|
U86 |
G04CB01 |
|
|
|
Finasterid |
p.o. 5 mg (50 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.245 |
|
|
|
76417 |
X |
|
G |
Finanorm 5 mg |
tbl flm 50x5 mg (blis. PVC/PVDC/Al) |
PRW |
CZ |
50 |
12.25 |
12.25 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
G04CB01 |
|
|
|
Finasterid |
p.o. 5 mg (90-100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.245 |
|
|
|
76418 |
X |
|
G |
Finanorm 5 mg |
tbl flm 100x5 mg (blis. PVC/PVDC/Al) |
PRW |
CZ |
100 |
24.5 |
24.5 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
04884 |
X |
|
G |
Finasteride Accord 5 mg filmom obalené tablety |
tbl flm 90x5 mg (blis.PVC/PVDC/Al) |
ACC |
GB |
90 |
22.05 |
22.05 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
37581 |
X |
|
O |
PENESTER |
tbl flm 90x5 mg |
ZNT |
CZ |
90 |
22.05 |
22.05 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
43546 |
X |
|
G |
Finasterid Orion 5 mg |
tbl flm 100x5 mg |
ORN |
FI |
100 |
25.28 |
24.5 |
S |
0.78 |
3.0853999999999999E-2 |
0 |
URO |
ind.obm. |
|
|
U86 |
36943 |
X |
|
G |
Androfin 5 mg |
tbl flm 100x5 mg (blis.Al/PVC) |
GLH-2 |
AT |
100 |
25.84 |
24.5 |
S |
1.34 |
5.1858000000000001E-2 |
0 |
URO |
ind.obm. |
|
|
U86 |
37040 |
X |
|
G |
Finpros 5mg |
tbl flm 100x 5mg |
KRK |
SL |
100 |
26.9 |
24.5 |
S |
2.4 |
8.9219000000000007E-2 |
0 |
URO |
ind.obm. |
|
|
U86 |
G04CB02 |
|
|
|
Dutasterid |
p.o. 0,5 mg (90 ks) |
0.5 |
mg |
|
|
|
|
|
|
|
|
0.46 |
|
|
|
3805B |
X |
|
G |
DUTAMED 0,5 mg |
cps mol 90x0,5 mg (blis.PVC/PVDC/Al) |
CRR |
SK |
90 |
45.58 |
41.4 |
S |
4.18 |
9.1706999999999997E-2 |
4.18 |
URO |
ind.obm. |
|
|
|
1647B |
X |
|
G |
Dutasterid Cipla 0,5 mg mäkké kapsuly |
cps mol 90x0,5 mg (blis.PVC/PVDC/Al) |
CIA-BE |
BE |
90 |
45.58 |
41.4 |
S |
4.18 |
9.1706999999999997E-2 |
4.18 |
URO |
ind.obm. |
|
|
|
49822 |
X |
|
O |
Avodart |
cps mol 90x0,5 mg |
GLA |
FR |
90 |
68.84 |
41.4 |
S |
27.44 |
0.39860500000000004 |
27.44 |
URO |
ind.obm. |
|
|
|
H01AB01 |
|
|
|
Tyrotropín |
parent. |
0.9 |
mg |
|
|
|
|
|
|
|
|
367.6 |
|
|
|
40768 |
|
|
O |
THYROGEN |
plv ino 2x0,9 mg (skl. liek.) |
GZE |
NL |
2 |
735.2 |
735.2 |
I |
0 |
0 |
0 |
END, ONK, RAT |
|
|
|
|
H01AC01 |
|
|
|
Somatotropín |
parent. |
2 |
UT |
|
|
|
|
|
|
|
|
14.34 |
|
|
|
05884 |
|
|
O |
GENOTROPIN 5,3 mg |
plv iol 1x5,3 mg (náplň inj.skl.dvojkom.+pero GoQuick) |
PFI-GB-3 |
GB |
8 |
105.76 |
105.76 |
A |
0 |
0 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
24791 |
|
|
O |
HUMATROPE 36 UT (12 mg) |
plv iol 36 UT+sol. |
LIL |
FR |
18 |
246.85 |
246.85 |
A |
0 |
0 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
05886 |
|
|
O |
GENOTROPIN 12 mg |
plv iol 1x12 mg (náplň inj.skl.dvojkom.+pero GoQuick) |
PFI-GB-3 |
GB |
18 |
254.54 |
254.54 |
A |
0 |
0 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
24788 |
|
|
O |
HUMATROPE 18 UT (6 mg) |
plv iol 18 UT+sol. |
LIL |
FR |
9 |
127.93 |
127.93 |
A |
0 |
0 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
01936 |
|
|
O |
Saizen 8 mg/ ml injekčný roztok |
sol inj 1x1,50 ml/12 mg (náplň.skl.) |
IFB |
IT |
18 |
264.01 |
258.12 |
AS |
5.89 |
2.231E-2 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
40800 |
|
|
O |
NutropinAq |
sol inj 3x2 ml (náplne) |
IPE |
GB |
45 |
662.74 |
645.29999999999995 |
AS |
17.440000000000001 |
2.6314999999999998E-2 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
01932 |
|
|
O |
Saizen 5,83 mg/ ml injekčný roztok |
sol inj 1x1,03 ml/6 mg (náplň.skl.) |
IFB |
IT |
9 |
134.6 |
129.06 |
AS |
5.54 |
4.1159000000000001E-2 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
47687 |
|
|
O |
Zomacton 10 mg |
plv iol 1x10 mg+solv |
FEI |
DE |
15 |
233.39 |
215.1 |
AS |
18.29 |
7.8367000000000006E-2 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
89093 |
|
|
O |
ZOMACTON 4 mg |
plv iol 1x12,96 ut+sol. |
FEI |
DE |
6 |
99.03 |
86.04 |
AS |
12.99 |
0.13117200000000001 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
01165 |
|
|
O |
NORDITROPIN SIMPLEX 10MG/1,5ML |
sol inj 1x1,5 ml/10 mg |
NOO |
DK |
15 |
293.39999999999998 |
215.1 |
AS |
78.3 |
0.26687100000000002 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
H01AX01 |
|
|
|
Pegvisomant |
s.c. |
10 |
mg |
|
|
|
|
|
|
|
|
66.150000000000006 |
|
|
|
40901 |
|
|
O |
Somavert |
plv iol 30x15 mg |
PFI-GB-1 |
GB |
45 |
2976.5 |
2976.5 |
I |
0 |
0 |
0 |
ENP, END |
ind.obm., ZP |
|
|
|
40899 |
|
|
O |
Somavert |
plv iol 30x10 mg |
PFI-GB-1 |
GB |
30 |
1984.35 |
1984.35 |
I |
0 |
0 |
0 |
ENP, END |
ind.obm., ZP |
|
|
|
40902 |
|
|
O |
Somavert |
plv iol 30x20 mg |
PFI-GB-1 |
GB |
60 |
3968.7 |
3968.7 |
I |
0 |
0 |
0 |
ENP, END |
ind.obm., ZP |
|
|
|
H01BA02 |
|
|
|
Dezmopresín |
p.o. sublng. lyofilizát 60 mcg (30 ks) |
240 |
µg |
|
|
|
|
|
|
|
|
2.93 |
|
|
|
92644 |
X |
|
O |
MINIRIN Melt |
lyo por 30 x 60 µg |
FEI |
GB |
7.5 |
21.94 |
21.94 |
I |
0 |
0 |
0 |
|
|
|
|
|
H01BA02 |
|
|
|
Dezmopresín |
p.o. sublng. lyofilizát 60 mcg (100 ks) |
240 |
µg |
|
|
|
|
|
|
|
|
2.93 |
|
|
|
92645 |
X |
|
O |
MINIRIN MELT 60 µg |
lyo por 100 x 60 mcg |
FEI-CZ |
CZ |
25 |
73.75 |
73.25 |
S |
0.5 |
6.7800000000000004E-3 |
0 |
|
|
|
|
|
H01BA02 |
|
|
|
Dezmopresín |
p.o. sublng. lyofilizát 120 mcg (30 ks) |
240 |
µg |
|
|
|
|
|
|
|
|
2.68 |
|
|
|
92650 |
X |
|
O |
MINIRIN Melt |
lyo por 30 x 120µg |
FEI |
GB |
15 |
40.18 |
40.18 |
I |
0 |
0 |
0 |
|
|
|
|
|
H01BA02 |
|
|
|
Dezmopresín |
p.o. sublng. lyofilizát 120 mcg (100 ks) |
240 |
µg |
|
|
|
|
|
|
|
|
2.68 |
|
|
|
92651 |
X |
|
O |
MINIRIN Melt 120 µg |
lyo por 100 x 120 mcg |
FEI-CZ |
CZ |
50 |
134.99 |
134 |
S |
0.99 |
7.3340000000000002E-3 |
0 |
|
|
|
|
|
H01BA02 |
|
|
|
Dezmopresín |
p.o. sublng. lyofilizát 240 mcg (30 ks) |
240 |
µg |
|
|
|
|
|
|
|
|
2.6854 |
|
|
|
92647 |
|
|
O |
MINIRIN MELT 240 µg |
lyo por 30 x 240 µg |
FRL |
ČR |
30 |
80.56 |
80.56 |
I |
0 |
0 |
0 |
|
|
|
|
|
H01BA02 |
|
|
|
Dezmopresín |
nasal. 10 mcg/0,1 ml |
25 |
µg |
|
|
|
|
|
|
|
|
1.6319999999999999 |
|
|
|
34533 |
|
|
O |
MINIRIN spray |
aer nao 1x5 ml |
FEI |
SE |
20 |
32.78 |
32.64 |
S |
0.14000000000000001 |
4.2709999999999996E-3 |
0.14000000000000001 |
|
|
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
72 |
|
|
|
93866 |
|
|
O |
SANDOSTATIN |
sol ijf 5x1 ml/0,5 mg |
NPA |
CH |
2.5 |
179.99 |
179.99 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. inj. |
1 |
mg |
|
|
|
|
|
|
|
|
66.37 |
|
|
|
93865 |
|
|
O |
SANDOSTATIN |
sol ijf 5x1 ml/0,1 mg |
NPA |
CH |
0.5 |
10.59 |
10.59 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
93867 |
|
|
O |
SANDOSTATIN |
sol ijf 1x5 ml/1 mg-fľaš. |
NPA |
CH |
1 |
53.71 |
53.71 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. depot. 10 mg |
1 |
mg |
|
|
|
|
|
|
|
|
61.579700000000003 |
|
|
|
0597A |
|
|
O |
Sandostatin LAR 10 mg |
plv iul 1x10 mg (liek.skl.)+1xstriek.inj.napl.+nástavec+1xbezp.ihla |
NAI |
CZ |
10 |
615.79999999999995 |
615.79999999999995 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. depot. 20 mg |
1 |
mg |
|
|
|
|
|
|
|
|
38.953000000000003 |
|
|
|
0599A |
|
|
O |
Sandostatin LAR 20 mg |
plv iul 1x20 mg (liek.skl.)+1xstriek.inj.napl.+nástavec+1xbezp.ihla |
NAI |
CZ |
20 |
779.06 |
779.06 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. depot. 30 mg |
1 |
mg |
|
|
|
|
|
|
|
|
35.82 |
|
|
|
0601A |
|
|
O |
Sandostatin LAR 30 mg |
plv iul 1x30 mg (liek.skl.)+1xstriek.inj.napl.+nástavec+1xbezp.ihla |
NAI |
CZ |
30 |
1074.5899999999999 |
1074.5899999999999 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB03 |
|
|
|
Lanreotid |
parent. 30 mg |
2.14 |
mg |
|
|
|
|
|
|
|
|
27.193000000000001 |
|
|
|
84701 |
|
|
O |
SOMATULINE P.R. |
plv iud 1x30 mg+solv. |
PBE |
FR |
14.019 |
381.22 |
381.22 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB03 |
|
|
|
Lanreotid |
parent. 60 mg |
2.14 |
mg |
|
|
|
|
|
|
|
|
24.99 |
|
|
|
46342 |
|
|
O |
Somatuline Autogel 60 mg |
sol inj 1x0,5 ml/60 mg (striek. naplnená PP) |
IAA-1 |
FR |
28.036999999999999 |
700.59 |
700.59 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB03 |
|
|
|
Lanreotid |
parent. 120 mg |
2.14 |
mg |
|
|
|
|
|
|
|
|
20.260000000000002 |
|
|
|
46343 |
|
|
O |
Somatuline Autogel 120 mg |
sol inj 1x0,5ml/120mg |
IAA-1 |
FR |
56.075000000000003 |
1135.47 |
1135.47 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CC01 |
|
|
|
Ganirelix |
parent. 0,25 mg |
0.25 |
mg |
|
|
|
|
|
|
|
|
20.91 |
|
|
|
05981 |
|
|
O |
ORGALUTRAN 0,25 mg/0,5 ml |
sol inj 1x0,5 ml |
MSD-GB-1 |
GB |
1 |
33.24 |
20.91 |
S |
12.33 |
0.37093899999999996 |
12.33 |
GYN, RPM |
ind.obm., ZP |
|
|
U87 |
H01CC02 |
|
|
|
Cetrorelix |
parent. 0,25 mg |
0.25 |
mg |
|
|
|
|
|
|
|
|
20.91 |
|
|
|
28604 |
|
|
O |
CETROTIDE 0,25 mg |
plv iol 7x0,25 mg+solv. |
ASD |
DE |
7 |
182.97 |
146.37 |
S |
36.6 |
0.20003299999999999 |
36.6 |
GYN, RPM |
ind.obm., ZP |
|
|
U87 |
28603 |
|
|
O |
CETROTIDE 0,25 mg |
plv iol 1x0,25 mg+solv. |
ASD |
DE |
1 |
32.19 |
20.91 |
S |
11.28 |
0.35041899999999998 |
5.23 |
GYN, RPM |
ind.obm., ZP |
|
|
U87 |
H02AB01 |
|
|
|
Betametazón |
parent. depot. |
0.4 |
mg |
|
|
|
|
|
|
|
|
0.112 |
|
|
|
24865 |
|
|
O |
DIPROPHOS |
sus inj 5x1 ml |
MSD-NL |
NL |
87.5 |
9.9 |
9.8000000000000007 |
S |
0.1 |
1.0101000000000001E-2 |
0.1 |
|
|
|
|
|
H02AB02 |
|
|
|
Dexametazón |
parent. 4 mg/ml |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.32 |
|
|
|
84090 |
|
|
G |
DEXAMED |
inj 10x2 ml/8 mg |
MOE |
CY |
53 |
4.7 |
4.7 |
A |
0 |
0 |
0 |
|
|
|
|
|
27534 |
|
|
G |
DEXA-RATIOPHARM 4 |
inj 3x1 ml/4 mg |
MCK |
DE |
8 |
2.36 |
2.36 |
A |
0 |
0 |
0 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
p.o. 4 mg (100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
9.1999999999999998E-2 |
|
|
|
85506 |
X |
|
G |
Metypred 4 mg |
tbl 100x4 mg (liek.HDPE) |
ORN |
FI |
53.332999999999998 |
4.95 |
4.91 |
S |
0.04 |
8.0809999999999996E-3 |
0.04 |
|
|
|
|
|
86604 |
X |
|
O |
MEDROL 4 mg |
tbl 100x4 mg (bli.) |
PFI-GB-3 |
GB |
53.332999999999998 |
5.34 |
4.91 |
S |
0.43 |
8.0523999999999998E-2 |
0.04 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
p.o. 16 mg (50 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
6.7000000000000004E-2 |
|
|
|
93617 |
X |
|
O |
MEDROL 16 mg |
tbl 50x16 mg (bli.) |
PFI-GB-3 |
GB |
106.672 |
8.1199999999999992 |
7.15 |
S |
0.97 |
0.11945800000000001 |
0.36 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
p.o. 16 mg (100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
6.7000000000000004E-2 |
|
|
|
85512 |
X |
|
G |
Metypred 16 mg |
tbl 100x16 mg (liek.HDPE) |
ORN |
FI |
213.333 |
15 |
14.29 |
S |
0.71 |
4.7333E-2 |
0.71 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
parent. 40 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
0.89 |
|
|
|
40536 |
|
|
O |
DEPO-MEDROL 40 mg/ml |
sus inj 1x5 ml/200 mg (liek.inj.skl.) |
PFI-GB-3 |
GB |
10 |
8.8699999999999992 |
8.8699999999999992 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
parent. 40 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
0.65300000000000002 |
|
|
|
9117A |
|
|
G |
Metylprednizolón Hikma 40 mg |
plv ino 10x40 mg (liek.inj.skl.) |
HKP-P |
PT |
20 |
13.06 |
13.06 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
parent. 125 mg |
20 |
mg |
|
|
|
|
|
|
|
|
0.38500000000000001 |
|
|
|
9119A |
|
|
G |
Metylprednizolón Hikma 125 mg |
plv ino 10x125 mg (liek.inj.skl.) |
HKP-P |
PT |
62.5 |
24.04 |
24.04 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
parent. 250 mg |
20 |
mg |
|
|
|
|
|
|
|
|
0.372 |
|
|
|
9121A |
|
|
G |
Metylprednizolón Hikma 250 mg |
plv ino 10x250 mg (liek.inj.skl.) |
HKP-P |
PT |
125 |
48.36 |
46.5 |
S |
1.86 |
3.8462000000000003E-2 |
0 |
|
|
|
|
|
H02AB07 |
|
|
|
Prednizón |
p.o. riadené uvoľňovanie 2 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.311 |
|
|
|
5353A |
|
|
O |
Lodotra 2 mg tablety s riadeným uvoľňovaním |
tbl mod 30x2 mg (fľ. HDPE) |
MUP |
AT |
6 |
21.17 |
1.87 |
S |
19.3 |
0.91166700000000001 |
19.3 |
|
|
|
|
|
H02AB07 |
|
|
|
Prednizón |
p.o. riadené uvoľňovanie 5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.311 |
|
|
|
5358A |
|
|
O |
Lodotra 5 mg tablety s riadeným uvoľňovaním |
tbl mod 30x5 mg (fľ. HDPE) |
MUP |
AT |
15 |
21.17 |
4.67 |
S |
16.5 |
0.77940500000000001 |
0 |
|
|
|
|
|
H02AB07 |
|
|
|
Prednizón |
p.o. 5 mg (20 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.29799999999999999 |
|
|
|
00269 |
X |
|
G |
PREDNISON 5 LÉČIVA |
tbl 20x5 mg |
ZNT |
CZ |
10 |
2.98 |
2.98 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB07 |
|
|
|
Prednizón |
p.o. 20 mg (20 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.16 |
|
|
|
02963 |
X |
|
G |
PREDNISON 20 LÉČIVA |
tbl 20x20 mg (blis.) |
ZNT |
CZ |
40 |
6.22 |
6.22 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB07 |
|
|
|
Prednizón |
p.rect. 100 mg (4 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.1958 |
|
|
|
42591 |
|
|
G |
RECTODELT 100 mg |
sup 4x100 mg |
TRM |
DE |
40 |
9.4499999999999993 |
7.83 |
S |
1.62 |
0.171429 |
1.62 |
ALG, PED, TRN, URM |
|
|
|
|
H02AB09 |
|
|
|
Hydrokortizón |
parent. |
30 |
mg |
|
|
|
|
|
|
|
|
0.66610000000000003 |
|
|
|
12124 |
|
|
G |
Hydrocortison VUAB 100 mg |
plv ino 1x100 mg (liek.inj.skl.) |
VUA-1 |
CZ |
3.3330000000000002 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
|
|
|
|
|
2410B |
|
|
G |
HYDROCORTISONE MEDOPHARM 100 mg |
plo ijf 1x100 mg (liek.inj.skl.) |
MPM |
CR |
3.3330000000000002 |
2.2200000000000002 |
2.2200000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 25 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
24824 |
|
|
O |
EUTHYROX 25 ug |
tbl 100x25 ug |
MEC |
DE |
16.658000000000001 |
2.31 |
0.75 |
S |
1.56 |
0.67532499999999995 |
1.56 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 50 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
69189 |
|
|
O |
EUTHYROX 50 ug |
tbl 100x50 ug |
MEC |
DE |
33.332999999999998 |
2.1 |
1.5 |
S |
0.6 |
0.28571400000000002 |
0.6 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
15426 |
|
|
G |
L-THYROXIN 50 BERLIN CHEMIE |
tbl 100x50 ug |
BCE |
DE |
33.332999999999998 |
2.39 |
1.5 |
S |
0.89 |
0.37238500000000002 |
0.6 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 75 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
25599 |
|
|
O |
EUTHYROX 75 µg |
tbl 100x75 µg |
MEC |
DE |
50 |
3.12 |
2.25 |
S |
0.87 |
0.27884599999999998 |
0.87 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
46963 |
|
|
G |
L-Thyroxin 75 Berlin-Chemie |
tbl 100x 75 µg |
BCE |
DE |
50 |
3.3 |
2.25 |
S |
1.05 |
0.31818200000000002 |
0.87 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 88 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
02048 |
|
|
O |
Euthyrox 88 µg |
tbl 100 x 88 mcg ( blis.PP/AI ) |
MEC |
DE |
58.67 |
3.54 |
2.64 |
S |
0.9 |
0.25423699999999999 |
0.9 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 100 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
97186 |
|
|
O |
EUTHYROX 100 ug |
tbl 100x100 ug |
MEC |
DE |
66.67 |
2.96 |
2.96 |
I |
0 |
0 |
0 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
15394 |
|
|
G |
L-THYROXIN 100 BERLIN CHEMIE |
tbl 100x100 ug |
BCE |
DE |
66.67 |
3.25 |
3 |
S |
0.25 |
7.6923000000000005E-2 |
0 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 112 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
05254 |
|
|
O |
Euthyrox 112 µg |
tbl 100 x 112 µg |
MEC |
DE |
74.667000000000002 |
4.5 |
3.36 |
S |
1.1399999999999999 |
0.25333300000000003 |
1.1399999999999999 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 125 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
25601 |
|
|
O |
EUTHYROX 125 µg |
tbl 100x125 µg |
MEC |
DE |
83 |
3.96 |
3.74 |
S |
0.22 |
5.5556000000000001E-2 |
0.22 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
46957 |
|
|
G |
L-Thyroxin 125 Berlin-Chemie |
tbl 100x125 µg |
BCE |
DE |
83 |
4.3099999999999996 |
3.74 |
S |
0.56999999999999995 |
0.13225100000000001 |
0.22 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 137 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
05256 |
|
|
O |
Euthyrox 137 µg |
tbl 100 x 137 µg (blis.PVC/Al) |
MEC |
DE |
91.33 |
6.02 |
4.1100000000000003 |
S |
1.91 |
0.317276 |
1.91 |
END, ENP, GER, INT, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 150 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
69191 |
|
|
O |
EUTHYROX 150 ug |
tbl 100x150 ug |
MEC |
DE |
100 |
4.3499999999999996 |
4.3499999999999996 |
I |
0 |
0 |
0 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
46960 |
|
|
G |
L-Thyroxin 150 Berlin-Chemie |
tbl 100x150 ug |
BCE |
DE |
100 |
4.82 |
4.5 |
S |
0.32 |
6.6390000000000005E-2 |
0 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 200 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
91987 |
|
|
O |
EUTHYROX 200 µg |
tbl 100x200 µg (PVC blister) |
MEC |
DE |
133.30000000000001 |
7.27 |
6 |
S |
1.27 |
0.17469100000000001 |
1.27 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03BA02 |
|
|
|
Propyltiouracil |
p.o. 50 mg (100 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
26588 |
X |
|
O |
PROPYCIL 50 |
tbl 100x50 mg |
SYF |
DE |
50 |
10.95 |
10.95 |
I |
0 |
0 |
0 |
END, ENP |
|
|
|
|
H03BB02 |
|
|
|
Tiamazol |
p.o. 10 mg (50 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.112 |
|
|
|
2523A |
|
|
O |
Thyrozol 10 mg |
tbl flm 50 x 10 mg (blis.PVC/Al) |
MEC |
DE |
50 |
5.59 |
5.59 |
I |
0 |
0 |
0 |
END, INT, ENP |
|
|
|
|
H04AA01 |
|
|
|
Glukagón |
parent. hypokit |
1 |
mg |
|
|
|
|
|
|
|
|
13.25 |
|
|
|
83741 |
|
|
O |
GLUCAGEN 1MG HYPOKIT |
plv iol 1 mg+1 ml+syringe |
NOO |
DK |
1 |
16.579999999999998 |
13.25 |
S |
3.33 |
0.20084399999999999 |
3.33 |
DIA, END, ENP, INT, KLF |
ind.obm. |
|
|
|
H05AA02 |
|
|
|
Teriparatid |
parent. |
20 |
mcg |
|
|
|
|
|
|
|
|
11.85 |
|
|
|
40160 |
|
|
O |
FORSTEO 20 mikrogramov/80 mikrolitrov, injekčný roztok naplnený v pere |
sol inj 1x2,4 ml (skl.inj.pero napln.) |
LIL-NL-1 |
NL |
28 |
341.07 |
331.8 |
S |
9.27 |
2.7179000000000002E-2 |
9.27 |
END, KLF, ORT, REU |
ind.obm., ZP |
|
|
|
H05BX01 |
|
|
|
Cinakalcet |
p.o. 30 mg (28 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
12.1 |
|
|
|
41634 |
X |
|
O |
MIMPARA |
tbl flm 28x30 mg (blis.) |
AMG |
NL |
14 |
169.19 |
169.19 |
I |
0 |
0 |
0 |
NEF, END |
ind.obm. |
|
|
|
H05BX01 |
|
|
|
Cinakalcet |
p.o. 60 mg (28 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
11.401999999999999 |
|
|
|
41638 |
X |
|
O |
MIMPARA |
tbl flm 28x60 mg (blis.) |
AMG |
NL |
28 |
319.24 |
319.24 |
I |
0 |
0 |
0 |
NEF, END |
ind.obm. |
|
|
|
H05BX01 |
|
|
|
Cinakalcet |
p.o. 90 mg (28 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
11.233000000000001 |
|
|
|
41642 |
X |
|
O |
MIMPARA |
tbl flm 28x90 mg (blis.) |
AMG |
NL |
42 |
471.76 |
471.76 |
I |
0 |
0 |
0 |
NEF, END |
ind.obm. |
|
|
|
H05BX02 |
|
|
|
Parikalcitol |
p.o. 1 mcg (28 ks) |
2 |
mcg |
|
|
|
|
|
|
|
|
4.9400000000000004 |
|
|
|
46784 |
X |
|
O |
Zemplar 1 µg kapsuly |
cps mol 28x1 µg (blis.PVC/fluóropolymér/Al) |
ABV |
SK |
14 |
69.099999999999994 |
69.099999999999994 |
I |
0 |
0 |
0 |
END, NEF |
|
|
|
|
H05BX02 |
|
|
|
Parikalcitol |
p.o. 2 mcg (28 ks) |
2 |
mcg |
|
|
|
|
|
|
|
|
5.59 |
|
|
|
46788 |
X |
|
O |
Zemplar 2 µg kapsuly |
cps mol 28x2 µg (blis.PVC/fluóropolymér/Al) |
ABV |
SK |
28 |
156.38999999999999 |
156.38999999999999 |
I |
0 |
0 |
0 |
END, NEF |
|
|
|
|
H05BX02 |
|
|
|
Parikalcitol |
parent. |
1.7 |
mcg |
|
|
|
|
|
|
|
|
5.19 |
|
|
|
0310B |
|
|
O |
Zemplar 5 µg/ml |
sol inj 5x1 ml/5 µg (liek.inj.skl.), |
ABV |
SK |
14.706 |
76.2 |
76.2 |
A |
0 |
0 |
0 |
NEF |
|
|
|
|
41787 |
|
|
O |
Zemplar 5 µg/ml |
sol inj 5x2 ml/10 µg (amp.skl.) |
ABV |
SK |
29.411999999999999 |
184.1 |
152.65 |
AS |
31.45 |
0.17083100000000001 |
0 |
NEF |
|
|
|
|
0311B |
|
|
O |
Zemplar 5 µg/ml |
sol inj 5x2 ml/10 µg (liek.inj.skl.), |
ABV |
SK |
29.411999999999999 |
184.1 |
152.65 |
AS |
31.45 |
0.17083100000000001 |
0 |
NEF |
|
|
|
|
J01AA02 |
|
|
|
Doxycyklín |
p.o. 100 mg (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
34980 |
X |
|
G |
Doxybene 100 mg |
tbl 10x100 mg (blis.Al/PVC) |
RAT |
DE |
10 |
1.1299999999999999 |
0.84 |
S |
0.28999999999999998 |
0.256637 |
0.28999999999999998 |
|
|
|
|
S01 |
90986 |
X |
|
G |
DEOXYMYKOIN |
tbl 10x100 mg |
GLM |
CZ |
10 |
1.6 |
0.84 |
S |
0.76 |
0.47499999999999998 |
0.28999999999999998 |
|
|
|
|
S01 |
J01AA02 |
|
|
|
Doxycyklín |
p.o. 100 mg (20 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
12742 |
X |
|
G |
DOXYHEXAL TABS |
tbl 20x100 mg |
HEX |
DE |
20 |
2.8 |
1.68 |
S |
1.1200000000000001 |
0.4 |
0.57999999999999996 |
|
|
|
|
S01 |
J01AA02 |
|
|
|
Doxycyklín |
p.o. 200 mg (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
12735 |
X |
|
G |
DOXYHEXAL 200 TABS |
tbl 10x200 mg |
HEX |
DE |
20 |
3.12 |
1.68 |
S |
1.44 |
0.46153799999999995 |
1.27 |
|
|
|
|
S01 |
J01AA02 |
|
|
|
Doxycyklín |
p.o. 200 mg (20 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
12736 |
X |
|
G |
DOXYHEXAL 200 TABS |
tbl 20x200 mg |
HEX |
DE |
40 |
5.89 |
3.36 |
S |
2.5299999999999998 |
0.42954199999999998 |
2.5299999999999998 |
|
|
|
|
S01 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. 50 mg/ml (60 ml) |
1 |
g |
|
|
|
|
|
|
|
|
0.3 |
|
|
|
66366 |
X |
|
G |
Ospamox 250 mg/5 ml prášok na perorálnu suspenziu |
plu por 60 ml + odmerná lyžička |
SAN-SLO-1 |
SI |
3 |
1.2 |
0.9 |
S |
0.3 |
0.25 |
0.3 |
|
|
|
|
S02 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. 250 mg (20 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
62049 |
X |
|
G |
DUOMOX 250 |
tbl dsp 20x250 mg |
YEU |
NL |
5 |
2.2200000000000002 |
0.94 |
S |
1.28 |
0.57657700000000001 |
1.28 |
|
|
|
|
S03 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. dsp. 375 mg (20 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
62053 |
X |
|
G |
DUOMOX 375 |
tbl dsp 20x375 mg |
YEU |
NL |
7.5 |
2.81 |
1.41 |
S |
1.4 |
0.49822099999999997 |
1.4 |
|
|
|
|
S03 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. 500 mg (14 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
28911 |
X |
|
G |
Ospamox 500 mg filmom obalené tablety |
tbl flm 14x500 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
7 |
1.86 |
1.32 |
S |
0.54 |
0.290323 |
0.54 |
|
|
|
|
S03 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. dsp. 500 mg (20 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
62050 |
X |
|
G |
DUOMOX 500 |
tbl dsp 20x500 mg |
YEU |
NL |
10 |
2.98 |
1.88 |
S |
1.1000000000000001 |
0.36912799999999996 |
0.77 |
|
|
|
|
S03 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. 750 mg (14 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
28912 |
X |
|
G |
Ospamox 750 mg filmom obalené tablety |
tbl flm 14x750 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
10.5 |
2.75 |
1.97 |
S |
0.78 |
0.283636 |
0.78 |
|
|
|
|
S03 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. dsp. 750 mg (20 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
62051 |
X |
|
G |
DUOMOX 750 |
tbl dsp 20x750 mg |
YEU |
NL |
15 |
4.0599999999999996 |
2.82 |
S |
1.24 |
0.305419 |
1.1100000000000001 |
|
|
|
|
S03 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. 1000 mg (14 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
28913 |
X |
|
G |
Ospamox 1000 mg filmom obalené tablety |
tbl flm 14x1000 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
14 |
3.7 |
2.63 |
S |
1.07 |
0.28918900000000003 |
0.83 |
|
|
|
|
S03 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. dsp. 1000 mg (12-14 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
36915 |
X |
|
G |
DUOMOX 1000 |
tbl dsp 14x1000mg |
ASL |
NL |
14 |
3.46 |
2.63 |
S |
0.83 |
0.23988399999999999 |
0.83 |
|
|
|
|
S03 |
J01CA04 |
|
|
|
Amoxicilín |
p.o. dsp. 1000 mg (20 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.188 |
|
|
|
62052 |
X |
|
G |
DUOMOX 1000 |
tbl dsp 20x1000 mg |
YEU |
NL |
20 |
5.04 |
3.76 |
S |
1.28 |
0.25396799999999997 |
1.19 |
|
|
|
|
S03 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 250 mg (20 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
51010 |
X |
|
G |
V PNC 250 filmom obalené tablety |
tbl flm 20x250 mg |
GVP |
SK |
2.5 |
1.08 |
0.62 |
S |
0.46 |
0.42592599999999997 |
0.36 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 250 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
51011 |
X |
|
G |
V PNC 250 filmom obalené tablety |
tbl flm 30x250 mg |
GVP |
SK |
3.75 |
1.46 |
0.92 |
S |
0.54 |
0.369863 |
0.54 |
|
|
|
|
S04 |
84626 |
X |
|
G |
V-PENICILIN 250MG SLOVAKOFARMA |
tbl 30x250 mg (blis.) |
ZNT |
SK |
3.75 |
1.67 |
0.92 |
S |
0.75 |
0.44910200000000006 |
0.54 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 329 mg (12 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
66358 |
X |
|
G |
OSPEN 500 |
tbl flm 12x500 KU |
SAN-A |
AT |
1.974 |
0.92 |
0.49 |
S |
0.43 |
0.467391 |
0.21 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 329 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
45996 |
X |
|
G |
OSPEN 500 |
tbl flm 30x500 KU |
SAN-A |
AT |
4.9349999999999996 |
1.99 |
1.21 |
S |
0.78 |
0.39195999999999998 |
0.52 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 500 mg (20 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
51014 |
X |
|
G |
V PNC 500 filmom obalené tablety |
tbl flm 20x500 mg |
GVP |
SK |
5 |
1.76 |
1.23 |
S |
0.53 |
0.30113600000000001 |
0.53 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 500 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
51015 |
X |
|
G |
V PNC 500 filmom obalené tablety |
tbl flm 30x500 mg |
GVP |
SK |
7.5 |
2.8 |
1.85 |
S |
0.95 |
0.33928600000000003 |
0.8 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 523 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
92435 |
X |
|
G |
V-PENICILIN 0,8MEGA BIOTIKA |
tbl 30x800 ku (3x10) |
BTA |
SK |
7.8449999999999998 |
3.56 |
1.93 |
S |
1.63 |
0.45786499999999997 |
1.63 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 658 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
45997 |
X |
|
G |
OSPEN 1000 |
tbl flm 30x1000 KU |
SAN-A |
AT |
9.8699999999999992 |
3.78 |
2.4300000000000002 |
S |
1.35 |
0.35714299999999999 |
0.81 |
|
|
|
|
S04 |
65357 |
X |
|
G |
PENBENE 1 IU |
tbl flm 30 |
MCK |
DE |
9.8699999999999992 |
3.78 |
2.4300000000000002 |
S |
1.35 |
0.35714299999999999 |
1.35 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 750 mg (20 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
51018 |
X |
|
G |
V PNC 750 filmom obalené tablety |
tbl flm 20x750 mg |
GVP |
SK |
7.5 |
2.73 |
1.85 |
S |
0.88 |
0.32234400000000002 |
0.88 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 750 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
51019 |
X |
|
G |
V PNC 750 filmom obalené tablety |
tbl flm 30x750 mg |
GVP |
SK |
11.25 |
4.1399999999999997 |
2.77 |
S |
1.37 |
0.33091799999999999 |
1.32 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 784 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
92436 |
X |
|
G |
V-PENICILIN 1,2MEGA BIOTIKA |
tbl 30x1,2mu (5x6) |
BTA |
SK |
11.76 |
4.74 |
2.89 |
S |
1.85 |
0.390295 |
1.85 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 987 mg (12 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
66360 |
X |
|
G |
OSPEN 1500 |
tbl flm 12x1500 KU |
SAN-A |
AT |
5.9219999999999997 |
1.99 |
1.46 |
S |
0.53 |
0.26633200000000001 |
0.53 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 987 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
45998 |
X |
|
G |
OSPEN 1500 |
tbl flm 30x1500 KU |
SAN-A |
AT |
14.805 |
5.27 |
3.64 |
S |
1.63 |
0.30929800000000002 |
1.33 |
|
|
|
|
S04 |
57779 |
X |
|
G |
PENBENE 1,5 MU |
tbl flm 30 |
MCK |
DE |
14.805 |
5.27 |
3.64 |
S |
1.63 |
0.30929800000000002 |
1.63 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 1000 mg (20 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
51022 |
X |
|
G |
V PNC 1000 filmom obalené tablety |
tbl flm 20x1000 mg |
GVP |
SK |
10 |
3.65 |
2.46 |
S |
1.19 |
0.32602700000000001 |
0.82 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 1000 mg (30 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.246 |
|
|
|
51023 |
X |
|
G |
V PNC 1000 filmom obalené tablety |
tbl flm 30x1000 mg |
GVP |
SK |
15 |
4.92 |
3.69 |
S |
1.23 |
0.25 |
1.23 |
|
|
|
|
S04 |
J01CE02 |
|
|
|
Fenoxymetylpenicilín |
p.o. 47,2 mg/ml tekuté |
2 |
g |
|
|
|
|
|
|
|
|
0.80400000000000005 |
|
|
|
49549 |
X |
|
G |
OSPEN 400 |
sir 1x150 ml |
SAN-A |
AT |
4.6989999999999998 |
5.04 |
3.78 |
S |
1.26 |
0.25 |
1.26 |
|
|
|
|
S05 |
15377 |
X |
|
G |
PENBENE 400000 IU/5 ml |
gra sir 94 g/150 ml |
MCK |
DE |
4.6989999999999998 |
5.28 |
3.78 |
S |
1.5 |
0.28409099999999998 |
1.26 |
|
|
|
|
S05 |
15421 |
X |
|
G |
PENBENE 400000 IU/5 ml |
gra sir 37,6 g/60 ml |
MCK |
DE |
1.881 |
2.99 |
1.51 |
S |
1.48 |
0.49498300000000001 |
0.5 |
|
|
|
|
S05 |
J01CR02 |
|
|
|
Amoxicilín a inhibítor betalaktamázy |
p.o. 375 mg (20-21 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.32600000000000001 |
|
|
|
33520 |
|
|
G |
MEDOCLAV 375 mg |
tbl flm 21x375 mg |
MOE |
CY |
7.8730000000000002 |
5.41 |
2.57 |
S |
2.84 |
0.52495399999999992 |
2.84 |
|
|
|
|
S06 |
24107 |
|
|
G |
AMOKSIKLAV |
tbl obd 21x375 mg |
LEK |
SI |
7.8730000000000002 |
5.51 |
2.57 |
S |
2.94 |
0.53357500000000002 |
2.84 |
|
|
|
|
S06 |
93709 |
|
|
O |
AUGMENTIN |
tbl obd 21x375 mg |
SKB |
GB |
7.8730000000000002 |
5.51 |
2.57 |
S |
2.94 |
0.53357500000000002 |
2.84 |
|
|
|
|
S06 |
36276 |
|
|
G |
MEGAMOX 375 |
tbl 21x375 mg |
ALM |
PT |
7.875 |
5.56 |
2.57 |
S |
2.99 |
0.53776999999999997 |
2.84 |
|
|
|
|
S06 |
J01CR02 |
|
|
|
Amoxicilín a inhibítor betalaktamázy |
p.o. 625 mg (21 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.32600000000000001 |
|
|
|
18614 |
|
|
G |
AMOKSIKLAV |
tbl obd 21x625 mg |
LEK |
SI |
13.127000000000001 |
7.09 |
4.28 |
S |
2.81 |
0.39633299999999999 |
2.81 |
|
|
|
|
S06 |
33522 |
|
|
G |
MEDOCLAV 625 mg |
tbl flm 21x625 mg |
MOE |
CY |
13.125 |
8.1199999999999992 |
4.28 |
S |
3.84 |
0.47290599999999999 |
2.81 |
|
|
|
|
S06 |
17156 |
|
|
O |
AUGMENTIN |
tbl obd 21x625 mg |
SKB |
GB |
13.127000000000001 |
8.19 |
4.28 |
S |
3.91 |
0.47741100000000003 |
2.81 |
|
|
|
|
S06 |
33406 |
|
|
G |
Tevaklav 625 mg |
tbl flm 21x625 mg (blis.Al/PE) |
RAT |
DE |
13.127000000000001 |
8.6999999999999993 |
4.28 |
S |
4.42 |
0.508046 |
2.81 |
|
|
|
|
S06 |
94425 |
|
|
G |
MEGAMOX 625 FORTE |
tbl 21x625 mg |
HKP |
JO |
13.125 |
9.1999999999999993 |
4.28 |
S |
4.92 |
0.53478300000000001 |
2.81 |
|
|
|
|
S06 |
J01CR02 |
|
|
|
Amoxicilín a inhibítor betalaktamázy |
p.o. 1 g (14 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.32600000000000001 |
|
|
|
34702 |
|
|
G |
MEGAMOX BID 1 G |
tbl ent 14x1 g |
HKP |
PT |
14 |
8.06 |
4.5599999999999996 |
S |
3.5 |
0.43424300000000005 |
1.51 |
|
|
|
|
S06 |
12494 |
|
|
O |
AUGMENTIN 1G |
tbl flm 14x1 g |
SKB |
GB |
14 |
8.09 |
4.5599999999999996 |
S |
3.53 |
0.43634099999999998 |
1.51 |
|
|
|
|
S06 |
39164 |
|
|
G |
Medoclav 1g |
tbl flm 14x1 g |
MOE |
CY |
14 |
8.41 |
4.5599999999999996 |
S |
3.85 |
0.45778799999999997 |
1.51 |
|
|
|
|
S06 |
4942A |
|
|
G |
ENHANCIN 875 mg/125 mg filmom obalené tablety |
tbl flm 14x875 mg/125 mg (blis. PVC/PVDC/Al) |
RXY |
UK |
14 |
8.42 |
4.5599999999999996 |
S |
3.86 |
0.45843200000000001 |
1.51 |
|
|
|
|
S06 |
28856 |
|
|
G |
AMOKSIKLAV 2x1000 mg |
tbl flm 14x1 g |
LEK |
SI |
14 |
8.4600000000000009 |
4.5599999999999996 |
S |
3.9 |
0.46099299999999999 |
1.51 |
|
|
|
|
S06 |
J01CR02 |
|
|
|
Amoxicilín a inhibítor betalaktamázy |
p.o. predĺžené uvoľňovanie 1 g (28 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.32600000000000001 |
|
|
|
10193 |
|
|
O |
Augmentin SR |
tbl plg 28x1 g (Al blis.) |
GAG-SK |
SK |
29.753 |
12.9 |
9.6999999999999993 |
S |
3.2 |
0.248062 |
3.2 |
|
|
|
|
S06 |
J01CR02 |
|
|
|
Amoxicilín a inhibítor betalaktamázy |
p.o. tekuté LF |
1 |
g |
|
|
|
|
|
|
|
|
0.52300000000000002 |
|
|
|
96416 |
|
|
G |
AMOKSIKLAV FORTE |
plu por 1x100 ml |
LEK |
SI |
6.2510000000000003 |
5.18 |
3.27 |
S |
1.91 |
0.368726 |
1.91 |
|
|
|
|
S07 |
74991 |
|
|
G |
AMOKSIKLAV |
plu por 1x100 ml |
LEK |
SI |
3.1230000000000002 |
2.67 |
1.63 |
S |
1.04 |
0.38951300000000005 |
0.95 |
|
|
|
|
S07 |
33219 |
|
|
G |
AMOKSIKLAV 2x457 mg/5 ml |
plu por 1x70 ml |
LEK |
SI |
6.3979999999999997 |
5.47 |
3.35 |
S |
2.12 |
0.387569 |
1.95 |
|
|
|
|
S07 |
14085 |
|
|
O |
AUGMENTIN DUO |
plv sir 1x70 ml |
SKB |
GB |
6.3979999999999997 |
5.62 |
3.35 |
S |
2.27 |
0.40391500000000002 |
1.95 |
|
|
|
|
S07 |
43116 |
|
|
G |
Megamox Duo |
plu por 1x13,51 g (plv)/70 ml |
HKP |
PT |
6.4 |
5.71 |
3.35 |
S |
2.36 |
0.41331000000000001 |
1.96 |
|
|
|
|
S07 |
33218 |
|
|
G |
AMOKSIKLAV 2x457 mg/5 ml |
plu por 1x35 ml |
LEK |
SI |
3.1989999999999998 |
2.96 |
1.67 |
S |
1.29 |
0.435811 |
0.98 |
|
|
|
|
S07 |
41152 |
|
|
G |
MEDOCLAV FORTE 312,5 mg |
plv sus 1x100 ml |
MOE |
CY |
6.2510000000000003 |
5.9 |
3.27 |
S |
2.63 |
0.44576300000000002 |
1.91 |
|
|
|
|
S07 |
43115 |
|
|
G |
Megamox Duo |
plu por 1x6,755 g (plv)/35 ml |
HKP |
PT |
3.2 |
3.1 |
1.67 |
S |
1.43 |
0.46128999999999998 |
0.98 |
|
|
|
|
S07 |
41144 |
|
|
G |
MEDOCLAV 156,25 mg |
plv sus 1x100 ml |
MOE |
CY |
3.1190000000000002 |
3.33 |
1.63 |
S |
1.7 |
0.51051099999999994 |
0.95 |
|
|
|
|
S07 |
J01CR02 |
|
|
|
Amoxicilín a inhibítor betalaktamázy |
p.o. tekuté LF 875/125 mg (12-14 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.52300000000000002 |
|
|
|
02449 |
|
|
G |
Amoksiklav 1000 mg granulát na perorálnu suspenziu |
gru por 14(875 mg+125 mg) |
SAN |
SI |
14 |
9.77 |
7.32 |
S |
2.4500000000000002 |
0.25076799999999999 |
2.4500000000000002 |
|
|
|
|
S07 |
J01CR04 |
|
|
|
Sultamicilín |
p.o. 375 mg (12-14 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
1.8280000000000001 |
|
|
|
8044A |
X |
|
G |
Bitammon 375 |
tbl obd 2x7x375 mg |
BBP-CZ |
CR |
3.5 |
8.5299999999999994 |
6.4 |
S |
2.13 |
0.24970700000000001 |
2.13 |
|
|
|
|
S08 |
34844 |
X |
|
G |
Bitammon 375 |
tbl obd12x375 mg |
BTA |
SK |
3 |
7.98 |
5.48 |
S |
2.5 |
0.31328299999999998 |
1.83 |
|
|
|
|
S08 |
72881 |
X |
|
O |
UNASYN 375 mg |
tbl flm 12x375 mg (blis.) |
PFI-GB-3 |
GB |
3 |
8.1300000000000008 |
5.48 |
S |
2.65 |
0.32595299999999999 |
1.83 |
|
|
|
|
S08 |
J01CR04 |
|
|
|
Sultamicilín |
p.o. 50 mg/ml tekuté |
1.5 |
g |
|
|
|
|
|
|
|
|
2.2000000000000002 |
|
|
|
72568 |
X |
|
O |
UNASYN P.O.S. 250 mg/5 ml |
plu por 1x60 ml (fľa HDPE) |
PFI-GB-3 |
GB |
2.3330000000000002 |
6.87 |
5.13 |
S |
1.74 |
0.25327500000000003 |
1.74 |
|
|
|
|
S09 |
34846 |
X |
|
G |
Bitammon |
plv sus 250 mg/5 ml |
BTA |
SK |
2.3330000000000002 |
7.21 |
5.13 |
S |
2.08 |
0.28848800000000002 |
1.74 |
|
|
|
|
S09 |
J01CR04 |
|
|
|
Sultamicilín |
parent. |
1.5 |
g |
|
|
|
|
|
|
|
|
2.6 |
|
|
|
31791 |
|
|
G |
Ampisulcillin 1,5 g |
plo ijf 10x1,5 g Iliek.inj.) |
ACT-5 |
IS |
10 |
25.74 |
25.74 |
A |
0 |
0 |
0 |
|
|
|
|
|
J01CR05 |
|
|
|
Piperacilin/tazobactam |
parent. |
14 |
g |
|
|
|
|
|
|
|
|
60.09 |
|
|
|
80777 |
|
|
G |
Piperacilin/Tazobactam Mylan 4g/0,5g |
plo jof 1x4g/0,5g |
MLB |
FR |
0.32100000000000001 |
9.26 |
9.26 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
J01DB01 |
|
|
|
Cefalexín |
p.o. 500 mg (12 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.71499999999999997 |
|
|
|
66356 |
X |
|
G |
OSPEXIN 500 mg |
tbl flm 12x500 mg |
SAN-A |
AT |
3 |
2.93 |
2.15 |
S |
0.78 |
0.266212 |
0.78 |
|
|
|
|
S10 |
J01DB01 |
|
|
|
Cefalexín |
p.o. 1000 mg (12 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.71499999999999997 |
|
|
|
66357 |
X |
|
G |
OSPEXIN 1000 mg |
tbl flm 12x1000 mg |
SAN-A |
AT |
6 |
5.72 |
4.29 |
S |
1.43 |
0.25 |
1.43 |
|
|
|
|
S10 |
J01DB01 |
|
|
|
Cefalexín |
p.o. 50 mg/ml tekuté |
2 |
g |
|
|
|
|
|
|
|
|
1.34 |
|
|
|
66354 |
X |
|
G |
OSPEXIN 250 mg/5 ml |
gru por 5 ml/250mg |
SAN-A |
AT |
1.5 |
2.68 |
2.0099999999999998 |
S |
0.67 |
0.25 |
0.67 |
|
|
|
|
S11 |
J01DB05 |
|
|
|
Cefadroxil |
p.o. 500 mg (12 ks) |
2 |
g |
|
|
|
|
|
|
|
|
1.04 |
|
|
|
68580 |
X |
|
G |
CEDROX |
cps 12x500 mg |
HKP |
JO |
3 |
4.16 |
3.12 |
S |
1.04 |
0.25 |
1.04 |
|
|
|
|
S12 |
J01DB05 |
|
|
|
Cefadroxil |
p.o. 1000 mg (12 ks) |
2 |
g |
|
|
|
|
|
|
|
|
1.04 |
|
|
|
15146 |
X |
|
G |
CEDROX |
tbl 12x1000 mg |
HKP |
JO |
6 |
8.6199999999999992 |
6.24 |
S |
2.38 |
0.27610200000000001 |
2.38 |
|
|
|
|
S12 |
J01DB05 |
|
|
|
Cefadroxil |
p.o. 50 mg/ml tekuté |
2 |
g |
|
|
|
|
|
|
|
|
1.9 |
|
|
|
15147 |
X |
|
G |
CEDROX (250 mg/5 ml) |
gru por 60 ml |
HKP |
JO |
1.5 |
3.8 |
2.85 |
S |
0.95 |
0.25 |
0.95 |
|
|
|
|
S13 |
J01DC02 |
|
|
|
Cefuroxim |
p.o. 125 mg (10 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.46300000000000002 |
|
|
|
15868 |
X |
|
O |
ZINNAT 125 mg |
tbl flm 10x125 mg |
GWE |
IT |
2.5 |
3.57 |
1.1599999999999999 |
S |
2.41 |
0.67507000000000006 |
2.41 |
INF, MFC, ORL, PED, TRN, URM |
|
|
|
S14 |
J01DC02 |
|
|
|
Cefuroxim |
p.o. 250 mg (10 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.46300000000000002 |
|
|
|
03355 |
X |
|
G |
Xelacef 250 mg |
tbl flm 10x250 mg (blis. PVC/Aclar) |
ACT-5 |
IS |
5 |
3.3 |
2.3199999999999998 |
S |
0.98 |
0.29697000000000001 |
0.98 |
|
|
|
|
S14 |
91268 |
X |
|
G |
Xorimax 250 mg |
tbl obd 10x250 mg |
SAN |
AT |
5 |
3.3 |
2.3199999999999998 |
S |
0.98 |
0.29697000000000001 |
0.98 |
|
|
|
|
S14 |
33203 |
X |
|
G |
CEROXIM 250 mg |
tbl 10x250 mg |
RXY |
IN |
5 |
3.38 |
2.3199999999999998 |
S |
1.06 |
0.31360900000000003 |
0.98 |
|
|
|
|
S14 |
15869 |
X |
|
O |
ZINNAT 250 mg |
tbl flm 10x250 mg |
GWE |
IT |
5 |
3.98 |
2.3199999999999998 |
S |
1.66 |
0.41708499999999998 |
0.98 |
|
|
|
|
S14 |
J01DC02 |
|
|
|
Cefuroxim |
p.o. 500 mg (10 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.46300000000000002 |
|
|
|
03386 |
X |
|
G |
Xelacef 500 mg |
tbl flm 10x500 mg (blis. PVC/Aclar) |
ACT-5 |
IS |
10 |
6.17 |
4.63 |
S |
1.54 |
0.24959499999999998 |
1.54 |
|
|
|
|
S14 |
91230 |
X |
|
G |
Xorimax 500 mg |
tbl obd 10x500 mg |
SAN |
AT |
10 |
6.17 |
4.63 |
S |
1.54 |
0.24959499999999998 |
1.54 |
|
|
|
|
S14 |
15870 |
X |
|
O |
ZINNAT 500 mg |
tbl flm 10x500 mg |
GWE |
IT |
10 |
6.6 |
4.63 |
S |
1.97 |
0.298485 |
1.54 |
|
|
|
|
S14 |
33205 |
X |
|
G |
CEROXIM 500 mg |
tbl 10x500 mg |
RXY |
IN |
10 |
6.75 |
4.63 |
S |
2.12 |
0.31407399999999996 |
1.54 |
|
|
|
|
S14 |
J01DC02 |
|
|
|
Cefuroxim |
p.o. 25 mg/ml tekuté |
0.5 |
g |
|
|
|
|
|
|
|
|
1.3109999999999999 |
|
|
|
62239 |
X |
|
O |
ZINNAT 125 MG |
gru por 100 ml |
GWE |
GB |
5 |
11.4 |
6.56 |
S |
4.84 |
0.42456099999999997 |
4.84 |
|
|
|
|
S15 |
J01DC02 |
|
|
|
Cefuroxim |
p.o. 50 mg/ml tekuté |
0.5 |
g |
|
|
|
|
|
|
|
|
1.3109999999999999 |
|
|
|
14052 |
X |
|
O |
ZINNAT 250 MG |
gru por 50 ml |
GWE |
GB |
5 |
8.74 |
6.56 |
S |
2.1800000000000002 |
0.24942799999999998 |
2.1800000000000002 |
|
|
|
|
S15 |
J01DC10 |
|
|
|
Cefprozil |
p.o. 250 mg (10 ks) |
1 |
g |
|
|
|
|
|
|
|
|
1.99 |
|
|
|
53129 |
X |
|
O |
CEFZIL 250 mg |
tbl flm 10x250 mg |
BMS |
IT |
2.5 |
8.66 |
4.9800000000000004 |
S |
3.68 |
0.42494199999999999 |
3.68 |
|
|
|
|
S17 |
J01DC10 |
|
|
|
Cefprozil |
p.o. 500 mg (10 ks) |
1 |
g |
|
|
|
|
|
|
|
|
1.99 |
|
|
|
53132 |
X |
|
O |
CEFZIL 500 mg |
tbl flm 10x500 mg |
BMS |
IT |
5 |
13.26 |
9.9499999999999993 |
S |
3.31 |
0.24962299999999998 |
3.31 |
|
|
|
|
S17 |
J01DC10 |
|
|
|
Cefprozil |
p.o. 50 mg/ml tekuté |
1 |
g |
|
|
|
|
|
|
|
|
2.754 |
|
|
|
53128 |
X |
|
O |
CEFZIL 250MG/5 ML |
plv sus 1x60 ml |
BMS |
IT |
3 |
9.2899999999999991 |
8.26 |
S |
1.03 |
0.110872 |
1.03 |
|
|
|
|
S18 |
J01DD01 |
|
|
|
Cefotaxim |
parent. 1 g |
4 |
g |
|
|
|
|
|
|
|
|
12.2531 |
|
|
|
31787 |
|
|
G |
ABRICEF |
plo ijf 10x1 g |
ACT-5 |
IS |
2.5 |
26.16 |
26.16 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01DD01 |
|
|
|
Cefotaxim |
parent. 2 g |
4 |
g |
|
|
|
|
|
|
|
|
10.44 |
|
|
|
89885 |
|
|
G |
Cefotaxim Eberth 2 g |
plo jof 10x2g (liek.sklenená) |
DRF |
DE |
5 |
54.43 |
52.2 |
S |
2.23 |
4.0970000000000006E-2 |
2.23 |
TRN, ALG |
ind.obm. |
|
|
|
J01DD04 |
|
|
|
Ceftriaxon |
parent. 1 g |
2 |
g |
|
|
|
|
|
|
|
|
10.61 |
|
|
|
58563 |
|
|
G |
Ceftriaxon Sandoz 1 g prášok na injekčný a infúzny roztok |
plo ijf 5x1x1,0 g, zbal. (15 ml liek.) |
SAN |
SI |
2.5 |
33.44 |
26.53 |
S |
6.91 |
0.20663900000000002 |
6.91 |
INF |
ind.obm. |
|
|
|
J01DD08 |
|
|
|
Cefixim |
p.o. 20 mg/ml tekuté |
0.4 |
g |
|
|
|
|
|
|
|
|
2.63 |
|
|
|
26460 |
X |
|
G |
SUPRAX (100 mg/5 ml) |
plv sus 1x50 ml/1 g |
GDN |
HU |
2.5 |
8.66 |
6.58 |
S |
2.08 |
0.24018499999999998 |
2.08 |
|
|
|
|
S19 |
J01DD08 |
|
|
|
Cefixim |
p.o. 200 mg (10 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
1.6379999999999999 |
|
|
|
26461 |
X |
|
G |
SUPRAX |
tbl flm 10x200 mg |
GDN |
HU |
5 |
12.45 |
8.19 |
S |
4.26 |
0.342169 |
4.26 |
|
|
|
|
S20 |
J01DD08 |
|
|
|
Cefixim |
p.o. 400 mg (7 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
1.6379999999999999 |
|
|
|
02356 |
X |
|
G |
SUPRAX 400 mg dispergovateľné tablety |
tbl dsp 7x400 mg |
GDN |
HU |
7 |
18.239999999999998 |
11.47 |
S |
6.77 |
0.37116199999999999 |
3.79 |
|
|
|
|
S20 |
J01DD08 |
|
|
|
Cefixim |
p.o. 400 mg (10 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
1.6379999999999999 |
|
|
|
7903A |
X |
|
G |
Cefixime InnFarm 400 mg |
tbl flm 10x400 mg (bli. PVC/PVDC/Al) |
INN |
SI |
10 |
21.8 |
16.38 |
S |
5.42 |
0.24862400000000001 |
5.42 |
|
|
|
|
S20 |
J01DD13 |
|
|
|
Cefpodoxim |
p.o. 8 mg/ml tekuté |
0.4 |
g |
|
|
|
|
|
|
|
|
2.56 |
|
|
|
2861A |
|
|
G |
FOREXO 40 mg/5 ml prášok na perorálnu suspenziu |
plu por 1x108 ml (fľ.HDPE) |
ALK |
SI |
2.16 |
7.38 |
5.53 |
S |
1.85 |
0.25067799999999996 |
1.85 |
|
|
|
|
S50 |
J01DD14 |
|
|
|
Ceftibutén |
p.o. 400 mg (5 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
2.37 |
|
|
|
18576 |
X |
|
O |
CEDAX |
cps 5x400 mg |
XSF |
IT |
5 |
15.8 |
11.85 |
S |
3.95 |
0.25 |
3.95 |
|
|
|
|
S21 |
J01DE01 |
|
|
|
Cefepim |
parent. inj. 1 g |
2 |
g |
|
|
|
|
|
|
|
|
16.14 |
|
|
|
87199 |
|
|
O |
MAXIPIME 1 g |
plv ino 1x1 g |
BMS |
IT |
0.5 |
8.07 |
8.07 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01DH02 |
|
|
|
Meropeném |
parent. |
2 |
g |
|
|
|
|
|
|
|
|
17.559999999999999 |
|
|
|
02112 |
|
|
G |
Meropenem Hospira 500 mg |
plo jof 10x500 mg (liek.inj.skl.) |
HSP |
GB |
2.5 |
43.9 |
43.9 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01EE01 |
|
|
|
Sulfametoxazol a trimetoprim |
p.o. 100/20 mg (20 ks) |
1.92 |
g |
|
|
|
|
|
|
|
|
0.21299999999999999 |
|
|
|
03378 |
|
|
G |
BISEPTOL 120 |
tbl 20x120 mg |
POL |
PL |
1.252 |
0.95 |
0.27 |
S |
0.68 |
0.71578900000000001 |
0.68 |
|
|
|
|
S23 |
J01EE01 |
|
|
|
Sulfametoxazol a trimetoprim |
p.o. 400/80 mg (20 ks) |
1.92 |
g |
|
|
|
|
|
|
|
|
0.21299999999999999 |
|
|
|
03377 |
|
|
G |
BISEPTOL 480 |
tbl 20x480 mg 400/80 mg |
POL |
PL |
5 |
1.42 |
1.07 |
S |
0.35 |
0.246479 |
0.35 |
|
|
|
|
S23 |
J01EE01 |
|
|
|
Sulfametoxazol a trimetoprim |
p.o. 400/80 mg (28 ks) |
1.92 |
g |
|
|
|
|
|
|
|
|
0.21299999999999999 |
|
|
|
2191B |
|
|
G |
BISEPTOL 480 |
tbl 28x480 mg (blis. PVC/Al) |
PBA |
PL |
7 |
3.74 |
1.49 |
S |
2.25 |
0.60160400000000003 |
0.49 |
|
|
|
|
S23 |
J01EE01 |
|
|
|
Sulfametoxazol a trimetoprim |
parent. |
4 |
DF |
|
|
|
|
|
|
|
|
17.920000000000002 |
|
|
|
11706 |
|
|
G |
BISEPTOL 480 |
con inf 10x5 ml |
WZF |
PL |
1 |
17.91 |
17.91 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01FA02 |
|
|
|
Spiramycín |
p.o. 1500 KU (16 ks) |
3 |
g |
|
|
|
|
|
|
|
|
1.052 |
|
|
|
98069 |
X |
|
O |
ROVAMYCINE 1,5 mu |
tbl flm 16x1500 ku |
RRO |
FR |
2.6669999999999998 |
3.75 |
2.81 |
S |
0.94 |
0.25066700000000003 |
0.94 |
|
|
|
|
S24 |
J01FA02 |
|
|
|
Spiramycín |
p.o. 3000 KU (10 ks) |
3 |
g |
|
|
|
|
|
|
|
|
1.052 |
|
|
|
18536 |
X |
|
O |
ROVAMYCINE 3 mu |
tbl flm 10x3000 ku |
RRO |
FR |
3.3319999999999999 |
6.14 |
3.51 |
S |
2.63 |
0.42833900000000003 |
2.63 |
|
|
|
|
S24 |
J01FA06 |
|
|
|
Roxitromycín |
p.o. 150 mg (10 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.629 |
|
|
|
13452 |
X |
|
G |
ROXITHROMYCIN-RATIOPHARM 150 mg |
tbl flm 10x150 mg |
MCK |
DE |
5 |
4.68 |
3.15 |
S |
1.53 |
0.32692300000000002 |
1.49 |
|
|
|
|
S25 |
J01FA06 |
|
|
|
Roxitromycín |
p.o. 150 mg (14 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.629 |
|
|
|
13454 |
X |
|
G |
ROXITHROMYCIN-RATIOPHARM 150 mg |
tbl flm 14x150 mg |
MCK |
DE |
7 |
6.48 |
4.4000000000000004 |
S |
2.08 |
0.320988 |
2.08 |
|
|
|
|
S25 |
J01FA06 |
|
|
|
Roxitromycín |
p.o. 300 mg (10 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.629 |
|
|
|
13461 |
X |
|
G |
ROXITHROMYCIN-RATIOPHARM 300 mg |
tbl flm 10x300 mg |
MCK |
DE |
10 |
8.3800000000000008 |
6.29 |
S |
2.09 |
0.24940300000000001 |
2.09 |
|
|
|
|
S25 |
J01FA09 |
|
|
|
Klaritromycín |
p.o. 250 mg (14 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.33200000000000002 |
|
|
|
40200 |
X |
|
G |
KLERIMED 250 mg |
tbl flm 14x250 mg |
MOE |
CY |
7 |
3.9 |
2.3199999999999998 |
S |
1.58 |
0.40512799999999999 |
1.58 |
|
|
|
|
S26 |
30181 |
X |
|
G |
LEKOKLAR 250 mg filmom obalené tablety |
tbl flm 14x250 mg (blis. PVC/PVDC/Al) |
SAN |
SI |
7 |
3.9 |
2.3199999999999998 |
S |
1.58 |
0.40512799999999999 |
1.58 |
|
|
|
|
S26 |
01944 |
X |
|
G |
KLABAX 250MG |
tbl flm 14x250 mg |
RXY |
IN |
7 |
3.95 |
2.3199999999999998 |
S |
1.63 |
0.41265799999999997 |
1.58 |
|
|
|
|
S26 |
53282 |
X |
|
G |
FROMILID 250 |
tbl flm 14x250 mg |
KRK |
SI |
7 |
4.1100000000000003 |
2.3199999999999998 |
S |
1.79 |
0.43552300000000005 |
1.58 |
|
|
|
|
S26 |
J01FA09 |
|
|
|
Klaritromycín |
p.o. 500 mg (14 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.33200000000000002 |
|
|
|
40203 |
X |
|
G |
KLERIMED 500 mg |
tbl flm 14x500 mg |
MOE |
CY |
14 |
6.2 |
4.6500000000000004 |
S |
1.55 |
0.25 |
1.55 |
|
|
|
|
S26 |
30171 |
X |
|
G |
LEKOKLAR 500 mg filmom obalené tablety |
tbl flm 14x500 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
14 |
6.2 |
4.6500000000000004 |
S |
1.55 |
0.25 |
1.55 |
|
|
|
|
S26 |
53283 |
X |
|
G |
FROMILID 500 |
tbl flm 14x500 mg |
KRK |
SI |
14 |
6.23 |
4.6500000000000004 |
S |
1.58 |
0.253612 |
1.55 |
|
|
|
|
S26 |
01943 |
X |
|
G |
KLABAX 500MG |
tbl flm 14x500 mg |
RXY |
IN |
14 |
7.38 |
4.6500000000000004 |
S |
2.73 |
0.369919 |
1.55 |
|
|
|
|
S26 |
J01FA09 |
|
|
|
Klaritromycín |
p.o. predĺžené uvoľňovanie 500 mg (7 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.33200000000000002 |
|
|
|
45710 |
X |
|
G |
Lekoklar XL 500 mg filmom obalené tablety s riadeným uvoľňovaním |
tbl fmo 7x500 mg |
SAN-SLO-1 |
SI |
7 |
5.66 |
2.3199999999999998 |
S |
3.34 |
0.59010600000000002 |
0.77 |
|
|
|
|
S26 |
40206 |
X |
|
G |
FROMILID UNO |
tbl mod 7x500 mg |
KRK |
SI |
7 |
6.14 |
2.3199999999999998 |
S |
3.82 |
0.62214999999999998 |
0.77 |
|
|
|
|
S26 |
53189 |
X |
|
O |
KLACID SR |
tbl mod 7x500 mg |
ABB |
GB |
7 |
8.0399999999999991 |
2.3199999999999998 |
S |
5.72 |
0.71144300000000005 |
0.77 |
|
|
|
|
S26 |
J01FA09 |
|
|
|
Klaritromycín |
p.o.25 mg/ml |
0.5 |
g |
|
|
|
|
|
|
|
|
0.89800000000000002 |
|
|
|
80481 |
X |
|
G |
KLACID (125 mg/5 ml) |
gru por 1x100 ml |
ABB |
IT |
5 |
7.41 |
4.49 |
S |
2.92 |
0.39406199999999997 |
2.92 |
|
|
|
|
S27 |
58491 |
X |
|
G |
FROMILID 125 mg/5 ml |
gru por 1x60 ml |
KRK |
SI |
3 |
4.88 |
2.69 |
S |
2.19 |
0.44877 |
1.75 |
|
|
|
|
S27 |
75184 |
X |
|
G |
KLACID (125mg/5ml) |
gru por 1x60 ml |
ABB |
IT |
3 |
5.41 |
2.69 |
S |
2.72 |
0.50277299999999991 |
1.75 |
|
|
|
|
S27 |
J01FA09 |
|
|
|
Klaritromycín |
p.o. 50 mg/ml |
0.5 |
g |
|
|
|
|
|
|
|
|
0.89800000000000002 |
|
|
|
30446 |
X |
|
G |
Lekoklar 250 mg/5 ml granulát na perorálnu suspenziu |
gru por 100 ml (68,3 g gran./57,0 ml vody) |
SAN |
SI |
10 |
12.04 |
8.98 |
S |
3.06 |
0.25415299999999996 |
3.06 |
|
|
|
|
S27 |
53800 |
X |
|
O |
KLACID 250 mg/5 ml |
gru por 1x100 ml |
ABB |
IT |
10 |
14.79 |
8.98 |
S |
5.81 |
0.39283299999999999 |
3.06 |
|
|
|
|
S27 |
53199 |
X |
|
O |
KLACID 250 mg/5 ml |
gru por 1x60 ml |
ABB |
IT |
6 |
9.66 |
5.39 |
S |
4.2699999999999996 |
0.44202900000000001 |
1.84 |
|
|
|
|
S27 |
J01FA10 |
|
|
|
Azitromycín |
p.o. 125 mg (6 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.433 |
|
|
|
96819 |
X |
|
O |
SUMAMED |
tbl flm 6x125 mg |
PLI |
HR |
2.5 |
5.86 |
1.08 |
S |
4.78 |
0.81569999999999998 |
4.78 |
|
|
|
|
S28 |
J01FA10 |
|
|
|
Azitromycín |
p.o. 250 mg (6 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.433 |
|
|
|
34350 |
X |
|
G |
Azatril |
cps dur 6x250 mg (blis.PVC/Al) |
ACT-5 |
IS |
5 |
5.16 |
2.17 |
S |
2.99 |
0.579457 |
2.46 |
|
|
|
|
S28 |
0315B |
X |
|
G |
Azithromycin Krka 250 mg filmom obalené tablety |
tbl flm 6x250mg(blis.PVC/PVDC/Al) |
KRK |
SL |
5 |
5.16 |
2.17 |
S |
2.99 |
0.579457 |
2.46 |
|
|
|
|
S28 |
35723 |
X |
|
G |
AZITHROMYCIN SANDOZ 250 mg |
tbl flm 6x250 mg |
SAN |
AT |
5 |
5.16 |
2.17 |
S |
2.99 |
0.579457 |
2.46 |
|
|
|
|
S28 |
10381 |
X |
|
G |
AZITROX 250 |
tbl flm 6X250 mg |
ZNT |
CZ |
5 |
5.71 |
2.17 |
S |
3.54 |
0.61996499999999999 |
2.46 |
|
|
|
|
S28 |
93590 |
X |
|
O |
SUMAMED |
cps 6x250 mg |
PLI |
HR |
5 |
7.21 |
2.17 |
S |
5.04 |
0.69902900000000001 |
2.46 |
|
|
|
|
S28 |
J01FA10 |
|
|
|
Azitromycín |
p.o. 250 mg (8 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.433 |
|
|
|
31785 |
X |
|
G |
Azatril |
cps dur 8x250 mg (blis.PVC/Al) |
ACT-5 |
IS |
6.6669999999999998 |
6.17 |
2.89 |
S |
3.28 |
0.53160499999999999 |
3.28 |
|
|
|
|
S28 |
J01FA10 |
|
|
|
Azitromycín |
p.o. 500 mg (3 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.433 |
|
|
|
35715 |
X |
|
G |
AZITHROMYCIN SANDOZ 500 mg |
tbl flm 3x500 mg |
SAN |
AT |
5 |
2.65 |
2.17 |
S |
0.48 |
0.18113199999999999 |
0.48 |
|
|
|
|
S28 |
3097A |
X |
|
G |
Azithromycin Actavis 500 mg |
tbl flm 3x500 mg (blis.OPA/PVC/Al/Al) |
ACT-5 |
IS |
5 |
2.78 |
2.17 |
S |
0.61 |
0.21942399999999998 |
0.48 |
|
|
|
|
S28 |
86952 |
X |
|
G |
Azitromycin Mylan 500mg |
tbl flm 3x500 mg |
GNC |
GB |
5 |
4.22 |
2.17 |
S |
2.0499999999999998 |
0.48578200000000005 |
0.48 |
|
|
|
|
S28 |
08598 |
X |
|
G |
Zigilex 500 mg filmom obalené tablety |
tbl flm 3x500 mg (blis.PVC/PVDC/Al) |
PRW |
CZ |
5 |
4.5199999999999996 |
2.17 |
S |
2.35 |
0.51991200000000004 |
0.48 |
|
|
|
|
S28 |
45300 |
X |
|
G |
AZIBIOT |
tbl flm 3x500 mg |
KRK |
SI |
5 |
5.16 |
2.17 |
S |
2.99 |
0.579457 |
0.48 |
|
|
|
|
S28 |
10382 |
X |
|
G |
AZITROX 500 |
tbl flm 3X500MG |
ZNT |
CZ |
5 |
5.16 |
2.17 |
S |
2.99 |
0.579457 |
0.48 |
|
|
|
|
S28 |
96813 |
X |
|
O |
SUMAMED |
tbl flm 3x500 mg |
PLI |
HR |
5 |
5.98 |
2.17 |
S |
3.81 |
0.63712400000000002 |
0.48 |
|
|
|
|
S28 |
J01FA10 |
|
|
|
Azitromycín |
p.o. 500 mg (6 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.433 |
|
|
|
35716 |
X |
|
G |
Azithromycin Sandoz 500 mg filmom obalené tablety |
tbl flm 6x500 mg |
SAN |
A |
10 |
8.43 |
4.33 |
S |
4.0999999999999996 |
0.48635800000000001 |
0.96 |
|
|
|
|
S28 |
J01FA10 |
|
|
|
Azitromycín |
p.o. predĺžené uvoľňovanie 2 g |
0.3 |
g |
|
|
|
|
|
|
|
|
0.433 |
|
|
|
66222 |
X |
|
O |
Zmax 2g granulát s predĺženým uvoľňovaním na perorálnu suspenziu |
gra psp 1x2 g (fľaša HDPE) |
PFI-GB-3 |
GB |
6.6669999999999998 |
9.9600000000000009 |
2.89 |
S |
7.07 |
0.70983900000000011 |
7.07 |
|
|
|
|
S28 |
J01FA10 |
|
|
|
Azitromycín |
p.o. 20 mg/ml |
0.3 |
g |
|
|
|
|
|
|
|
|
1.7410000000000001 |
|
|
|
39780 |
X |
|
G |
Azithromycin Sandoz 100 mg/5 ml |
plu por 1x20 ml/400 mg |
SAN |
SI |
1.333 |
4.5599999999999996 |
2.3199999999999998 |
S |
2.2400000000000002 |
0.491228 |
2.2400000000000002 |
|
|
|
|
S29 |
96811 |
X |
|
O |
SUMAMED 100MG/5ML |
plv sir 20 ml |
PLI |
HR |
1.333 |
4.7 |
2.3199999999999998 |
S |
2.38 |
0.50638300000000003 |
2.2400000000000002 |
|
|
|
|
S29 |
J01FA10 |
|
|
|
Azitromycín |
p.o. 40 mg/ml |
0.3 |
g |
|
|
|
|
|
|
|
|
1.7410000000000001 |
|
|
|
26538 |
X |
|
O |
Sumamed forte |
plv sir 30 ml |
PLI |
HR |
4 |
9.2899999999999991 |
6.96 |
S |
2.33 |
0.250807 |
2.33 |
|
|
|
|
S29 |
39782 |
X |
|
G |
Azithromycin Sandoz 200 mg/5 ml |
plu por 1x20 ml/800 mg |
SAN |
SI |
2.6669999999999998 |
6.64 |
4.6399999999999997 |
S |
2 |
0.301205 |
1.55 |
|
|
|
|
S29 |
37070 |
X |
|
O |
SUMAMED FORTE |
plv sir 15 ml |
PLI |
HR |
2 |
5.21 |
3.48 |
S |
1.73 |
0.33205399999999996 |
1.17 |
|
|
|
|
S29 |
37071 |
X |
|
O |
SUMAMED FORTE |
plv sir 37,5 ml |
PLI |
HR |
5 |
13.56 |
8.7100000000000009 |
S |
4.8499999999999996 |
0.35767000000000004 |
2.91 |
|
|
|
|
S29 |
J01FF01 |
|
|
|
Klindamycín |
p.o. 150 mg (16 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
0.96599999999999997 |
|
|
|
03365 |
X |
|
O |
DALACIN C 150 mg |
cps dur 16x150 mg (blis.PVC/Al) |
PFI-GB-3 |
GB |
2 |
3.07 |
1.93 |
S |
1.1399999999999999 |
0.371336 |
1.1399999999999999 |
|
|
|
|
S30 |
J01FF01 |
|
|
|
Klindamycín |
p.o. 300 mg (16 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
0.96599999999999997 |
|
|
|
83458 |
X |
|
O |
DALACIN C 300 mg |
cps dur 16x300 mg (blis.PVC/Al) |
PFI-GB-3 |
GB |
4 |
5.15 |
3.86 |
S |
1.29 |
0.25048500000000001 |
1.29 |
|
|
|
|
S30 |
J01FF01 |
|
|
|
Klindamycín |
parent. |
1.8 |
g |
|
|
|
|
|
|
|
|
17.46 |
|
|
|
27029 |
|
|
G |
KLIMICIN I.V. A I.M. |
sol ijf 10x4 ml/600 mg |
LEK |
SI |
3.3330000000000002 |
58.17 |
58.17 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
97878 |
|
|
G |
KLIMICIN I.V. A I.M. |
sol ijf 10x2 ml/300 mg |
LEK |
SI |
1.667 |
29.11 |
29.11 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01GB01 |
|
|
|
Tobramycín |
inhal. prášok |
224 |
mg |
|
|
|
|
|
|
|
|
63.6 |
|
|
|
10777 |
|
|
O |
TOBI Podhaler 28 mg |
plv icd 224x28 mg |
NEH |
GB |
28 |
2228.6 |
1780.8 |
S |
447.8 |
0.200933 |
447.8 |
ALG, TRN |
ind.obm., ZP |
|
|
|
J01GB01 |
|
|
|
Tobramycín |
inhal. |
600 |
mg |
|
|
|
|
|
|
|
|
53.185000000000002 |
|
|
|
37450 |
|
|
O |
BRAMITOB |
sol neb 56x4 ml/300 mg (obal PE) |
CHS-AT |
AT |
28 |
1489.17 |
1489.17 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm., ZP |
|
|
|
34757 |
|
|
O |
TOBI 300 MG/5 ML |
sol neb 56x5ML/300MG |
CCL |
GB |
28 |
1559.46 |
1489.18 |
S |
70.28 |
4.5067000000000003E-2 |
0 |
TRN, ALG |
ind.obm., ZP |
|
|
|
J01GB03 |
|
|
|
Gentamicín |
parent. |
0.24 |
g |
|
|
|
|
|
|
|
|
0.93 |
|
|
|
96414 |
|
|
G |
GENTAMICIN 80MG LEK |
sol inj 10x2 ml/80 mg |
LEK |
SI |
3.3330000000000002 |
3.09 |
3.09 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01MA01 |
|
|
|
Ofloxacín |
p.o. 200 mg (10 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.42 |
|
|
|
12349 |
X |
|
G |
Zanocin 200 MG |
tbl flm 10x200 mg |
RXY |
IN |
5 |
2.8 |
2.1 |
S |
0.7 |
0.25 |
0.7 |
|
|
|
|
S31 |
34921 |
X |
|
G |
MEDOFLOXINE 200 mg |
tbl flm 10x200 mg |
MOE |
CY |
5 |
3.23 |
2.1 |
S |
1.1299999999999999 |
0.34984499999999996 |
0.7 |
|
|
|
|
S31 |
27321 |
X |
|
O |
TAROFLOX |
tbl flm 10x200 mg |
HBS |
SK |
5 |
4.46 |
2.1 |
S |
2.36 |
0.52914799999999995 |
0.7 |
|
|
|
|
S31 |
55636 |
X |
|
G |
OFLOXIN 200 |
tbl flm 10x200 mg |
ZNT |
CZ |
5 |
4.88 |
2.1 |
S |
2.78 |
0.56967199999999996 |
0.7 |
|
|
|
|
S31 |
J01MA01 |
|
|
|
Ofloxacín |
p.o. 200 mg (20 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.42 |
|
|
|
34922 |
X |
|
G |
MEDOFLOXINE 200 mg |
tbl flm 20x200 mg |
MOE |
CY |
10 |
6.31 |
4.2 |
S |
2.11 |
0.33439000000000002 |
1.4 |
|
|
|
|
S31 |
J01MA02 |
|
|
|
Ciprofloxacín |
p.o. 250 mg (10 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.26300000000000001 |
|
|
|
67517 |
X |
|
G |
MEDOCIPRIN 250 mg |
tbl flm 10x250 mg |
MOE |
CY |
2.5019999999999998 |
1.62 |
0.66 |
S |
0.96 |
0.59259300000000004 |
0.96 |
|
|
|
|
S32 |
94453 |
X |
|
G |
CIPRINOL 250 |
tbl flm 10x250 mg |
KRK |
SI |
2.5019999999999998 |
1.68 |
0.66 |
S |
1.02 |
0.60714299999999999 |
0.96 |
|
|
|
|
S32 |
J01MA02 |
|
|
|
Ciprofloxacín |
p.o. 500 mg (10 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.26300000000000001 |
|
|
|
37942 |
X |
|
G |
Ciprofloxacin-Teva 500 mg filmom obalené tablety |
tbl flm 10x500 mg |
TEV |
GB |
5 |
1.75 |
1.32 |
S |
0.43 |
0.24571400000000002 |
0.43 |
|
|
|
|
S32 |
71854 |
X |
|
G |
CIPROLON 500 |
tbl flm 10x500 mg blister PVC/Alu |
HKP |
PT |
5 |
2.52 |
1.32 |
S |
1.2 |
0.47619 |
0.43 |
|
|
|
|
S32 |
67520 |
X |
|
G |
MEDOCIPRIN 500 mg |
tbl flm 10x500 mg |
MOE |
CY |
5 |
2.78 |
1.32 |
S |
1.46 |
0.52517999999999998 |
0.43 |
|
|
|
|
S32 |
80535 |
X |
|
G |
CIPLOX-500 |
tbl flm 10x500 mg |
CIA |
IN |
5 |
2.8 |
1.32 |
S |
1.48 |
0.52857100000000001 |
0.43 |
|
|
|
|
S32 |
26606 |
X |
|
G |
CIPHIN 500 |
tbl flm 10x500 mg |
ZNT |
SK |
5 |
2.81 |
1.32 |
S |
1.49 |
0.53024899999999997 |
0.43 |
|
|
|
|
S32 |
96039 |
X |
|
G |
CIPRINOL 500 |
tbl flm 10x500 mg |
KRK |
SI |
5 |
2.81 |
1.32 |
S |
1.49 |
0.53024899999999997 |
0.43 |
|
|
|
|
S32 |
99946 |
X |
|
G |
Ciprofloxacín Sandoz 500 mg |
tbl flm 10x500 mg |
SAN |
SI |
5 |
2.81 |
1.32 |
S |
1.49 |
0.53024899999999997 |
0.43 |
|
|
|
|
S32 |
J01MA02 |
|
|
|
Ciprofloxacín |
p.o. 500 mg (20 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.26300000000000001 |
|
|
|
99949 |
X |
|
G |
Ciprofloxacín Sandoz 500 mg |
tbl flm 20x500 mg |
SAN |
SI |
10 |
5.53 |
2.63 |
S |
2.9 |
0.52441199999999999 |
0.86 |
|
|
|
|
S32 |
J01MA03 |
|
|
|
Pefloxacín |
p.o. 400 mg (10 ks) |
0.8 |
g |
|
|
|
|
|
|
|
|
1.2589999999999999 |
|
|
|
94156 |
X |
|
G |
ABAKTAL |
tbl obd 10x400 mg |
LEK |
SI |
5 |
8.39 |
6.3 |
S |
2.09 |
0.24910599999999999 |
2.09 |
|
|
|
|
S33 |
J01MA06 |
|
|
|
Norfloxacín |
p.o. 400 mg (14 ks) |
0.8 |
g |
|
|
|
|
|
|
|
|
0.315 |
|
|
|
67015 |
X |
|
G |
GYRABLOCK |
tbl flm 14x400 mg |
MOE |
CY |
7 |
3.23 |
2.21 |
S |
1.02 |
0.31578899999999999 |
0.74 |
|
|
|
|
S34 |
J01MA06 |
|
|
|
Norfloxacín |
p.o. 400 mg (20 ks) |
0.8 |
g |
|
|
|
|
|
|
|
|
0.315 |
|
|
|
93465 |
X |
|
G |
NOLICIN |
tbl obd 20x400 mg |
KRK |
SI |
10 |
4.2 |
3.15 |
S |
1.05 |
0.25 |
1.05 |
|
|
|
|
S34 |
J01MA06 |
|
|
|
Norfloxacín |
p.o. 400 mg (30 ks) |
0.8 |
g |
|
|
|
|
|
|
|
|
0.315 |
|
|
|
18668 |
X |
|
G |
GYRABLOCK |
tbl flm 30x400 mg |
MOE |
CY |
15 |
6.49 |
4.7300000000000004 |
S |
1.76 |
0.27118599999999998 |
1.58 |
|
|
|
|
S34 |
J01MA12 |
|
|
|
Levofloxacín |
p.o. 500 mg (10 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
0.59499999999999997 |
|
|
|
3980B |
X |
|
G |
Levalox 500 mg filmom obalené tablety |
tbl flm 10x500mg (blis.PVC/PE/PVDC/Al) |
KRK |
SL |
20 |
10.19 |
10.19 |
I |
0 |
0 |
0 |
URO, NEF, TRN, ORL, INF |
ind.obm. |
|
|
S35 |
28798 |
X |
|
O |
TAVANIC 500MG |
tbl flm 10x500 mg |
HMR |
DE |
20 |
15.58 |
11.9 |
S |
3.68 |
0.23620000000000002 |
0 |
URO, NEF, TRN, ORL, INF |
ind.obm. |
|
|
S35 |
J01MA14 |
|
|
|
Moxifloxacín |
p.o. 400 mg (7 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
1.643 |
|
|
|
0471B |
X |
|
G |
Moloxin 400 mg filmom obalené tablety |
tbl flm 7x400mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
7 |
15.33 |
11.5 |
S |
3.83 |
0.24983699999999998 |
3.83 |
INF, TRN |
ind.obm. |
|
|
S36 |
64821 |
X |
|
O |
AVELOX 400 mg |
tbl flm 7x400 mg (blis. PP/Al) |
BAS |
DE |
7 |
19.57 |
11.5 |
S |
8.07 |
0.41236600000000001 |
3.83 |
INF, TRN |
ind.obm. |
|
|
S36 |
J01XA01 |
|
|
|
Vankomycín |
parent. 500 mg (1 ks) |
2 |
g |
|
|
|
|
|
|
|
|
22.17 |
|
|
|
08255 |
|
|
G |
Vancomycin Mylan 500mg |
plv ifo 1 x 500 mg |
MRK |
FR |
0.25 |
5.54 |
5.54 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XA01 |
|
|
|
Vankomycín |
parent. 500 mg (10 ks) |
2 |
g |
|
|
|
|
|
|
|
|
22.17 |
|
|
|
01836 |
|
|
G |
Vancomycin PharmaSwiss 500 mg |
plv ifo 10x500 mg (liek. Inj.skl.) |
PRW |
CZ |
2.5 |
55.41 |
55.41 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XA01 |
|
|
|
Vankomycín |
parent. 1000 mg (1 ks) |
2 |
g |
|
|
|
|
|
|
|
|
25.15 |
|
|
|
08259 |
|
|
G |
Vancomycin Mylan 1g |
plv ifo 1 x 1 g |
MRK |
FR |
0.5 |
12.57 |
12.57 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XA01 |
|
|
|
Vankomycín |
parent. 1000 mg (10 ks) |
2 |
g |
|
|
|
|
|
|
|
|
25.15 |
|
|
|
01840 |
|
|
G |
Vancomycin PharmaSwiss 1000 mg |
plv ifo 10x1000 mg (liek. Inj.skl.) |
PRW |
CZ |
5 |
125.72 |
125.72 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XB01 |
|
|
|
Kolistín |
parent. |
3 |
MU |
|
|
|
|
|
|
|
|
7.8460000000000001 |
|
|
|
61178 |
|
|
O |
COLIMYCINE |
plv ino 50x1 MU |
RDG |
GB |
16.667000000000002 |
130.77000000000001 |
130.77000000000001 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XX01 |
|
|
|
Fosfomycín |
p.o. 3 g (1 ks) |
3 |
g |
|
|
|
|
|
|
|
|
3.09 |
|
|
|
40305 |
X |
|
G |
MONURAL 3G |
gro por 1 vrecko |
ZAM |
IT |
1 |
4.1100000000000003 |
3.09 |
S |
1.02 |
0.24817499999999998 |
1.02 |
|
|
|
|
S38 |
J01XX08 |
|
|
|
Linezolid |
p.o. 600 mg (10 ks) |
1200 |
mg |
|
|
|
|
|
|
|
|
56.99 |
|
|
|
0872B |
X |
|
G |
Linezolid Sandoz 600 mg filmom obalené tablety |
tbl flm 10x600 mg (blis.OPA/Al/PVC/Al) |
SAN |
SI |
5 |
284.93 |
284.93 |
I |
0 |
0 |
0 |
HEM, CHI, INF, INT, NEF, TRN, CCH, KLF |
ind.obm. |
|
|
U56 |
33439 |
X |
|
O |
ZYVOXID 600 mg |
tbl flm 10x600 mg (bli.) |
PFI-GB-3 |
GB |
5 |
430.8 |
284.95 |
S |
145.85 |
0.33855600000000002 |
0 |
HEM, CHI, INF, INT, NEF, TRN, CCH, KLF |
ind.obm. |
|
|
U56 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 50 mg (7-8 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.57599999999999996 |
|
|
|
92018 |
X |
|
G |
Fluco Sandoz 50 mg |
cps dur 7x50 mg |
SAN |
AT |
1.75 |
2.54 |
1.01 |
S |
1.53 |
0.60236199999999995 |
1.53 |
|
ind.obm. |
|
|
S40 |
31783 |
X |
|
G |
Fungolon 50 mg |
cps 8x50 mg (blis.Al/PVC) |
ACT-5 |
IS |
2 |
5.0999999999999996 |
1.1499999999999999 |
S |
3.95 |
0.77450999999999992 |
1.75 |
|
ind.obm. |
|
|
S40 |
67030 |
X |
|
G |
MEDOFLUCON 50mg |
cps 7x50 mg |
MOE |
CY |
1.75 |
5.15 |
1.01 |
S |
4.1399999999999997 |
0.80388300000000001 |
1.53 |
|
ind.obm. |
|
|
S40 |
93859 |
X |
|
O |
DIFLUCAN 50 mg |
cps 7x50 mg (blis.PVC/Al-priehľ.) |
PFI-GB-3 |
GB |
1.75 |
7.64 |
1.01 |
S |
6.63 |
0.86780100000000004 |
1.53 |
|
ind.obm. |
|
|
S40 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 50 mg (100 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.57599999999999996 |
|
|
|
33199 |
X |
|
G |
MEDOFLUCON 50mg |
cps 100x50 mg |
MOE |
CY |
25 |
58.39 |
14.4 |
S |
43.99 |
0.753382 |
21.86 |
|
ind.obm. |
|
|
S40 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 100 mg (7-8 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.57599999999999996 |
|
|
|
33774 |
X |
|
G |
Fungolon 100 mg |
cps 8x100 mg (blis.Al/PVC) |
ACT-5 |
IS |
4 |
8.25 |
2.2999999999999998 |
S |
5.95 |
0.72121199999999996 |
5.95 |
|
ind.obm. |
|
|
S40 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 100 mg (28 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.57599999999999996 |
|
|
|
92006 |
X |
|
G |
Fluco Sandoz 100 mg |
cps dur 28x100 mg |
SAN |
AT |
14 |
29.89 |
8.06 |
S |
21.83 |
0.73034499999999991 |
20.83 |
|
ind.obm. |
|
|
S40 |
14079 |
X |
|
G |
MYCOMAX 100 |
cps 28x100 mg |
ZNT |
CZ |
14 |
29.89 |
8.06 |
S |
21.83 |
0.73034499999999991 |
20.83 |
|
ind.obm. |
|
|
S40 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 150 mg (1 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.57599999999999996 |
|
|
|
92012 |
X |
|
G |
Fluco Sandoz 150 mg |
cps dur 1x150 mg |
SAN |
AT |
1 |
1.71 |
0.57999999999999996 |
S |
1.1299999999999999 |
0.66081900000000005 |
0.19 |
|
ind.obm. |
|
|
S40 |
10107 |
X |
|
G |
Femgin 150 mg |
cps dur 1x150 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
1 |
2.52 |
0.57999999999999996 |
S |
1.94 |
0.769841 |
0.19 |
|
ind.obm. |
|
|
S40 |
14082 |
X |
|
G |
MYCOMAX 150 |
cps dur 1x150 mg (blis. PVC/PE/PVDC/Al) |
ZNT |
CZ |
1 |
3.12 |
0.57999999999999996 |
S |
2.54 |
0.81410300000000002 |
0.19 |
|
ind.obm. |
|
|
S40 |
96084 |
X |
|
G |
MEDOFLUCON 150mg |
cps 1x150 mg |
MOE |
CY |
1 |
3.23 |
0.57999999999999996 |
S |
2.65 |
0.82043299999999997 |
0.19 |
|
ind.obm. |
|
|
S40 |
93860 |
X |
|
O |
DIFLUCAN 150 mg |
cps 1x150 mg (blis.PVC/Al-priehľ.) |
PFI-GB-3 |
GB |
1 |
3.46 |
0.57999999999999996 |
S |
2.88 |
0.83236999999999994 |
0.19 |
|
ind.obm. |
|
|
S40 |
59875 |
X |
|
G |
MYCOSYST 150 mg |
cps 1x150 mg |
GDN |
HU |
1 |
4.62 |
0.57999999999999996 |
S |
4.04 |
0.87445899999999999 |
0.19 |
|
ind.obm. |
|
|
S40 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 150 mg (2 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.57599999999999996 |
|
|
|
92014 |
X |
|
G |
Fluco Sandoz 150 mg |
cps dur 2x150 mg |
SAN |
AT |
2 |
4.1399999999999997 |
1.1499999999999999 |
S |
2.99 |
0.72222200000000003 |
0.39 |
|
ind.obm. |
|
|
S40 |
59876 |
X |
|
G |
MYCOSYST 150 mg |
cps 2x150 mg |
GDN |
HU |
2 |
9.33 |
1.1499999999999999 |
S |
8.18 |
0.87674200000000002 |
0.39 |
|
ind.obm. |
|
|
S40 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 150 mg (3 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.57599999999999996 |
|
|
|
34221 |
X |
|
G |
MYCOMAX 150 |
cps 3x150 mg |
ZNT |
CZ |
3 |
8.56 |
1.73 |
S |
6.83 |
0.79789699999999997 |
0.57999999999999996 |
|
ind.obm. |
|
|
S40 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 150 mg (4 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.57599999999999996 |
|
|
|
92015 |
X |
|
G |
Fluco Sandoz 150 mg |
cps dur 4x150 mg |
SAN |
AT |
4 |
3.07 |
2.2999999999999998 |
S |
0.77 |
0.25081399999999998 |
0.77 |
|
ind.obm. |
|
|
S40 |
10109 |
X |
|
G |
Femgin 150 mg |
cps dur 4x150 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
4 |
6.25 |
2.2999999999999998 |
S |
3.95 |
0.63200000000000001 |
0.77 |
|
ind.obm. |
|
|
S40 |
10743 |
X |
|
G |
MYCOSYST 150 mg |
cps 4x150 mg |
GDN |
HU |
4 |
16.21 |
2.2999999999999998 |
S |
13.91 |
0.85811199999999999 |
0.77 |
|
ind.obm. |
|
|
S40 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 150 mg (10 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.57599999999999996 |
|
|
|
67031 |
X |
|
G |
MEDOFLUCON 150mg |
cps 10x150 mg |
MOE |
CY |
10 |
14.61 |
5.76 |
S |
8.85 |
0.60574899999999998 |
1.93 |
|
ind.obm. |
|
|
S40 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 10 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
5.2729999999999997 |
|
|
|
25313 |
X |
|
O |
DIFLUCAN P.O.S. 10 mg/ml |
plu por 1x24,4 g (fľ.HDPE+odm.lyžička alebo striekačka) |
PFI-GB-3 |
GB |
1.75 |
12.81 |
9.23 |
S |
3.58 |
0.27946899999999997 |
3.58 |
|
ind.obm. |
|
|
U59 |
J02AC01 |
|
|
|
Flukonazol |
p.o. 40 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
5.2729999999999997 |
|
|
|
25314 |
X |
|
O |
DIFLUCAN P.O.S. 40 mg/ml |
plu por 1x24,4 g (fľ.HDPE+odm.lyžička alebo striekačka) |
PFI-GB-3 |
GB |
7 |
38.880000000000003 |
36.909999999999997 |
S |
1.97 |
5.0669000000000006E-2 |
1.97 |
|
ind.obm. |
|
|
U59 |
J02AC02 |
|
|
|
Itrakonazol |
p.o. 100 mg (4 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
1.2250000000000001 |
|
|
|
3558A |
X |
|
G |
Prokanazol 100 mg |
cps dur 4x100 mg (blis.Al/Al) |
LDP-SK |
SK |
2 |
4.0599999999999996 |
2.4500000000000002 |
S |
1.61 |
0.39655200000000002 |
0.68 |
|
ind.obm. |
|
|
S41 |
J02AC02 |
|
|
|
Itrakonazol |
p.o. 100 mg (14 -15 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
1.2250000000000001 |
|
|
|
94897 |
X |
|
O |
SPORANOX (3 BLIS.) |
cps 15x100 mg |
JAG |
IT |
7.5 |
11.74 |
9.19 |
S |
2.5499999999999998 |
0.21720600000000001 |
2.5499999999999998 |
|
ind.obm. |
|
|
S41 |
3559A |
X |
|
G |
Prokanazol 100 mg |
cps dur 14x100 mg (blis.Al/Al) |
LDP-SK |
SK |
7 |
11.54 |
8.58 |
S |
2.96 |
0.25649899999999998 |
2.38 |
|
ind.obm. |
|
|
S41 |
J02AC03 |
|
|
|
Vorikonazol |
p.o. 40 mg/ml |
0.4 |
g |
|
|
|
|
|
|
|
|
79.650000000000006 |
|
|
|
40906 |
X |
|
O |
VFEND 40 mg/ml prášok na perorálnu suspenziu |
plu por 1x45 g (40 mg/ml) (fľ.HDPE) |
PFI-GB-1 |
GB |
7 |
556.38 |
556.38 |
I |
0 |
0 |
0 |
INF, ONK, HEM, TRN |
ind.obm., ZP |
|
|
U57tek |
J02AC03 |
|
|
|
Vorikonazol |
p.o. 200 mg (14 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
80.971000000000004 |
|
|
|
33741 |
X |
|
O |
VFEND 200 mg filmom obalené tablety |
tbl flm 14x200 mg (blis.PVC/Alu) |
PFI-GB-1 |
GB |
7 |
566.79999999999995 |
566.79999999999995 |
I |
0 |
0 |
0 |
INF, ONK, HEM, TRN |
ind.obm., ZP |
|
|
U57pev |
J02AC04 |
|
|
|
Posakonazol |
p.o. 40 mg/ml |
800 |
mg |
|
|
|
|
|
|
|
|
123.13 |
|
|
|
95513 |
X |
|
O |
Noxafil 40 mg/ml perorálna suspenzia |
sus por 1x105 ml (fľa.jant.skl.) |
MSD-GB-1 |
GB |
5.25 |
645.01 |
645.01 |
I |
0 |
0 |
0 |
HEM, INF, ONK, TRN |
ind.obm., ZP |
|
|
U58tek |
J04AB02 |
|
|
|
Rifampicín |
p.o. 150 mg (100 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.52939999999999998 |
|
|
|
93921 |
X |
|
G |
BENEMICIN 150 mg |
cps 100x150 mg |
POL |
PL |
25 |
13.22 |
13.22 |
I |
0 |
0 |
0 |
INF, TRN |
ind.obm. |
|
|
|
J04AB02 |
|
|
|
Rifampicín |
p.o. 300 mg (100 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.41 |
|
|
|
93922 |
X |
|
G |
BENEMICIN 300 mg |
cps 100x300 mg |
POL |
PL |
50 |
20.03 |
20.03 |
I |
0 |
0 |
0 |
INF, TRN |
ind.obm. |
|
|
|
J04AC01 |
|
|
|
Izoniazid |
p.o. 100 mg (250 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.104 |
|
|
|
03303 |
X |
|
G |
NIDRAZID |
tbl 250x100 mg |
ZNT |
CZ |
83.332999999999998 |
8.6199999999999992 |
8.6199999999999992 |
I |
0 |
0 |
0 |
TRN |
ind.obm. |
|
|
|
J04AK02 |
|
|
|
Etambutol |
p.o. 400 mg (100 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
0.38200000000000001 |
|
|
|
03023 |
X |
|
O |
SURAL 400MG |
tbl 100x400 mg |
CHN |
HU |
33.332999999999998 |
12.59 |
12.59 |
I |
0 |
0 |
0 |
TRN |
ind.obm. |
|
|
|
J04BA02 |
|
|
|
Dapson |
p.o. 100 mg (100 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
5.7099999999999998E-2 |
|
|
|
93821 |
X |
|
O |
DISULONE 100 AU PROTOX.DE FER |
tbl 100x100 mg |
SPC |
FR |
200 |
11.26 |
11.26 |
I |
0 |
0 |
0 |
DER, INF,TRN |
|
|
|
|
J05AB01 |
|
|
|
Aciklovir |
p.o. 40 mg/ml tekuté |
4 |
g |
|
|
|
|
|
|
|
|
19.385999999999999 |
|
|
|
93191 |
X |
|
O |
ZOVIRAX (200 mg/5 ml) |
sus por 125 ml |
GWE |
GB |
1.25 |
26.92 |
24.23 |
S |
2.69 |
9.9926000000000001E-2 |
2.69 |
DER, INF, ONK, PED, URM |
ind.obm. |
|
|
U60tek |
J05AB01 |
|
|
|
Aciklovir |
p.o. 200 mg (25-30 ks) |
4 |
g |
|
|
|
|
|
|
|
|
4.17 |
|
|
|
84127 |
X |
|
G |
HERPESIN 200 |
tbl 25x200 mg |
PVL |
CZ |
1.25 |
8.6199999999999992 |
5.21 |
S |
3.41 |
0.39559199999999994 |
3.41 |
DER, HEM, HEP, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U60pev |
14757 |
X |
|
G |
TELVIRAN 200 MG |
tbl 25x200 mg |
EGI |
HU |
1.25 |
9.4700000000000006 |
5.21 |
S |
4.26 |
0.44984200000000002 |
3.41 |
DER, HEM, HEP, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U60pev |
J05AB01 |
|
|
|
Aciklovir |
p.o. 400 mg (25 ks) |
4 |
g |
|
|
|
|
|
|
|
|
4.17 |
|
|
|
84128 |
X |
|
G |
HERPESIN 400 |
tbl 25x400 mg |
PVL |
CZ |
2.5 |
11.58 |
10.43 |
S |
1.1499999999999999 |
9.9308999999999995E-2 |
1.1499999999999999 |
|
ind.obm. |
|
|
U60pev |
J05AB01 |
|
|
|
Aciklovir |
p.o. 400 mg (35 ks) |
4 |
g |
|
|
|
|
|
|
|
|
4.17 |
|
|
|
14758 |
X |
|
G |
TELVIRAN 400 MG |
tbl 35x400 mg |
EGI |
HU |
3.5 |
20.2 |
14.6 |
S |
5.6 |
0.27722799999999997 |
1.61 |
|
ind.obm. |
|
|
U60pev |
J05AB04 |
|
|
|
Ribavirín |
p.o. 200 mg (168 ks) |
1 |
g |
|
|
|
|
|
|
|
|
6.38 |
|
|
|
5025A |
|
|
G |
Ribavirin Mylan 200 mg filmom obalené tablety |
tbl flm 168x200mg(fľ.HDPE) |
GNS |
UK |
33.6 |
214.21 |
214.21 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
23143 |
|
|
O |
COPEGUS 200 mg |
tbl flm 168x200 mg |
HLR |
CH |
33.6 |
313.41000000000003 |
214.37 |
S |
99.04 |
0.31600800000000001 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
58274 |
|
|
O |
Rebetol 200 mg tvrdé kapsuly |
cps dur 168x200 mg (bli.PVC/PE/PVDC) |
MSD-GB-1 |
GB |
33.6 |
313.44 |
214.37 |
S |
99.07 |
0.31607299999999999 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AB09 |
|
|
|
Famciklovir |
p.o. 250 mg (15 ks) |
1500 |
mg |
|
|
|
|
|
|
|
|
9.2070000000000007 |
|
|
|
44367 |
X |
|
G |
Famciclovir-Teva 250 mg |
tbl flm 15x250 mg |
TEV |
GB |
2.5 |
27.01 |
23.02 |
S |
3.99 |
0.14772299999999999 |
3.99 |
DER, GYN, INF, ONK |
ind.obm. |
|
|
U61pev |
J05AB09 |
|
|
|
Famciklovir |
p.o. 500 mg (14 ks) |
1500 |
mg |
|
|
|
|
|
|
|
|
9.2070000000000007 |
|
|
|
44423 |
X |
|
G |
Famciclovir-Teva 500 mg |
tbl flm 14x500 mg |
TEV |
GB |
4.6669999999999998 |
47.74 |
42.97 |
S |
4.7699999999999996 |
9.9916000000000005E-2 |
4.7699999999999996 |
DER, GYN, INF, ONK |
ind.obm. |
|
|
U61pev |
J05AB11 |
|
|
|
Valaciklovir |
p.o. 500 mg (10 ks) |
3 |
g |
|
|
|
|
|
|
|
|
5.25 |
|
|
|
53075 |
X |
|
O |
VALTREX |
tbl flm 10x500 mg |
GOK |
GB |
1.667 |
11.21 |
8.75 |
S |
2.46 |
0.219447 |
0.98 |
|
ind.obm. |
|
|
U62pev |
J05AB11 |
|
|
|
Valaciklovir |
p.o. 500 mg (42 ks) |
3 |
g |
|
|
|
|
|
|
|
|
5.25 |
|
|
|
87205 |
X |
|
O |
VALTREX |
tbl flm 42x500 mg |
GOK |
GB |
7 |
40.85 |
36.75 |
S |
4.0999999999999996 |
0.100367 |
4.0999999999999996 |
|
ind.obm. |
|
|
U62pev |
J05AB14 |
|
|
|
Valganciklovir |
p.o. 450 mg (60 ks) |
0.9 |
g |
|
|
|
|
|
|
|
|
40.619999999999997 |
|
|
|
2711B |
|
|
G |
Valdamin 450mg |
tbl flm 60x450mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
790.66 |
790.66 |
I |
0 |
0 |
0 |
HEM, INF, KAR, NEF, ONK |
ind.obm. |
|
|
|
97249 |
|
|
O |
VALCYTE 450 mg |
tbl flm 60x450 mg |
HLR |
CH |
30 |
1218.52 |
1218.52 |
I |
0 |
0 |
0 |
HEM, INF, KAR, NEF, ONK |
ind.obm. |
|
|
|
J05AB15 |
|
|
|
Brivudin |
p.o. 125 mg (7 ks) |
125 |
mg |
|
|
|
|
|
|
|
|
9.32 |
|
|
|
34059 |
X |
|
O |
Zovudex 125 mg |
tbl 7x125 mg |
BCE |
DE |
7 |
72.52 |
65.239999999999995 |
S |
7.28 |
0.100386 |
7.28 |
|
ind.obm. |
|
|
U63pev |
J05AE |
|
|
|
Boceprevir |
p.o. 200 mg (336 ks) |
2400 |
mg |
|
|
|
|
|
|
|
|
91.653000000000006 |
|
|
|
10913 |
X |
|
O |
VICTRELIS |
cps dur 336(4x84)x200 mg |
MSD |
GB |
28 |
2566.2800000000002 |
2566.2800000000002 |
I |
0 |
0 |
0 |
INF, HEP |
ind.obm., ZP |
|
|
|
J05AE02 |
|
|
|
Indinavír |
p.o. 400 mg (180 ks) |
2.4 |
g |
|
|
|
|
|
|
|
|
7.83 |
|
|
|
26796 |
X |
|
O |
CRIXIVAN 400MG |
cps 180x400 mg |
MSD |
NL |
30 |
234.55 |
234.55 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE03 |
|
|
|
Ritonavir |
p.o. 100 mg (30 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
6.27 |
|
|
|
87018 |
X |
|
O |
Norvir 100 mg filmom obalené tablety |
tbl flm 30x100 mg (fla.HDPE) |
ABV-GB |
GB |
2.5 |
26.23 |
15.68 |
S |
10.55 |
0.40221099999999999 |
10.55 |
INF |
ind.obm., ZP |
|
|
|
J05AE06 |
|
|
|
Lopinavir |
p.o. 200/50 mg (120 ks) |
0.8 |
g |
|
|
|
|
|
|
|
|
12.503 |
|
|
|
35543 |
X |
|
O |
Kaletra 200 mg/50 mg filmom obalené tablety |
tbl flm 120x200 mg/50 mg (fľ.HDPE) |
ABV-GB |
GB |
30 |
375.05 |
375.05 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE07 |
|
|
|
Fosamprenavir |
p.o. 700 mg (60 ks) |
1.4 |
g |
|
|
|
|
|
|
|
|
10.702999999999999 |
|
|
|
41929 |
X |
|
O |
TELZIR |
tbl flm 60x700 mg (fľ. HDPE) |
GLA |
GB |
30 |
321 |
321 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE10 |
|
|
|
Darunavir |
p.o. 400 mg (30 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
13.93 |
|
|
|
4226A |
X |
|
O |
PREZISTA 800 mg filmom obalené tablety |
tbl flm 30x800 mg (fľ.HDPE) |
JNS |
BE |
30 |
417.82 |
417.82 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE10 |
|
|
|
Darunavir |
p.o. 600 mg (60 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
20.8 |
|
|
|
65045 |
X |
|
O |
Prezista |
tbl flm 60x600 mg |
JNS |
BE |
30 |
623.89 |
623.89 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE14 |
|
|
|
Simeprevir |
p.o. 150 mg (28 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
330.93099999999998 |
|
|
|
0252B |
|
|
O |
OLYSIO 150 mg tvrdé kapsuly |
cps dur 28x150 mg (blis.PVC/PE/PVDC/Al) |
JNS |
BE |
28 |
9266.0499999999993 |
9266.0499999999993 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
|
|
|
J05AF01 |
|
|
|
Zidovudin |
p.o. 250 mg (40 ks) |
600 |
mg |
|
|
|
|
|
|
|
|
4.1929999999999996 |
|
|
|
14102 |
|
|
O |
RETROVIR |
cps 40x250 mg |
GWL |
GB |
16.667000000000002 |
69.77 |
69.77 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AF05 |
|
|
|
Lamivudin |
p.o. 100 mg (28 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.33 |
|
|
|
02085 |
X |
|
O |
ZEFFIX 100MG |
tbl flm 28x100 mg |
GOW |
GB |
9.3330000000000002 |
31.08 |
31.08 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF05 |
|
|
|
Lamivudin |
p.o. 100 mg (84 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.33 |
|
|
|
02087 |
X |
|
O |
ZEFFIX 100MG |
tbl flm 84x100 mg |
GOW |
GB |
28 |
93.24 |
93.24 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF05 |
|
|
|
Lamivudin |
p.o. 150 mg (60 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
2.65 |
|
|
|
56452 |
X |
|
O |
EPIVIR |
tbl flm 60x150 mg |
XGO |
GB |
30 |
79.17 |
79.17 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AF06 |
|
|
|
Abakavir |
p.o. 300 mg (60 ks) |
600 |
mg |
|
|
|
|
|
|
|
|
7.29 |
|
|
|
58396 |
X |
|
O |
ZIAGEN 300 mg |
tbl flm 60x300 mg |
GLA |
GB |
30 |
218.57 |
218.57 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AF07 |
|
|
|
Tenofovir |
p.o. 145 mg (30 ks) |
245 |
mg |
|
|
|
|
|
|
|
|
9.6549999999999994 |
|
|
|
40908 |
X |
|
O |
VIREAD |
tbl flm 30x245 mg |
GSA |
GB |
30 |
289.63 |
289.63 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF08 |
|
|
|
Adefovir |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
9.9529999999999994 |
|
|
|
40907 |
X |
|
O |
HEPSERA |
tbl 30x10 mg |
GSA |
GB |
30 |
298.58 |
298.58 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF10 |
|
|
|
Entekavir |
p.o. 0,5 mg (30 ks) |
0.5 |
mg |
|
|
|
|
|
|
|
|
13.693 |
|
|
|
35555 |
X |
|
O |
BARACLUDE |
tbl flm 30x0,5 mg |
BMS |
GB |
30 |
410.78 |
410.78 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF10 |
|
|
|
Entekavir |
p.o. 1 mg (30 ks) |
0.5 |
mg |
|
|
|
|
|
|
|
|
7.36 |
|
|
|
35556 |
X |
|
O |
BARACLUDE |
tbl flm 30x1 mg |
BMS |
GB |
60 |
441.42 |
441.42 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AG01 |
|
|
|
Nevirapin |
p.o. 200 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
4.32 |
|
|
|
64988 |
X |
|
O |
VIRAMUNE 200 mg |
tbl flm 60x200 mg |
BOE |
DE |
30 |
129.46 |
129.46 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AG04 |
|
|
|
Etravirin |
p.o. 200 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
14.37 |
|
|
|
30687 |
X |
|
O |
Intelence 200 mg tablety |
tbl 60x 200 mg (fl. HDPE) |
JNS |
BE |
30 |
431.08 |
431.08 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AG05 |
|
|
|
Rilpivirín |
p.o. 25 mg (30 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
8.69 |
|
|
|
30688 |
|
|
O |
EDURANT 25 mg filmom obalené tablety |
tbl flm 30x25 mg (fl. HDPE) |
JNS |
BE |
30 |
260.55 |
260.55 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AH01 |
|
|
|
Zanamivir |
inhal. |
20 |
mg |
|
|
|
|
|
|
|
|
1.593 |
|
|
|
14114 |
|
|
O |
RELENZA |
plv inh 1x5 blist.+ inh. |
GWE |
FR |
5 |
16.309999999999999 |
7.97 |
S |
8.34 |
0.51134299999999999 |
8.34 |
|
ind.obm. |
|
|
|
J05AR01 |
|
|
|
Lamivudin, zidovudin |
p.o. 150/300 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
4.1900000000000004 |
|
|
|
57852 |
|
|
O |
COMBIVIR |
tbl flm 60 blist. |
GWE |
GB |
30 |
125.63 |
125.63 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR02 |
|
|
|
Lamivudin, abakavir |
p.o. 300/600 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
12.77 |
|
|
|
42714 |
|
|
O |
KIVEXA |
tbl flm 30 (blis.) |
GLA |
GB |
30 |
382.7 |
382.7 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR03 |
|
|
|
Tenofovir disoproxil a emtricitabin |
p.o. 245/200 mg |
1 |
DF |
|
|
|
|
|
|
|
|
16.510999999999999 |
|
|
|
98584 |
|
|
O |
Truvada |
tbl flm 30 |
GSA |
GB |
30 |
495.31 |
495.31 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR08 |
|
|
|
Emtricitabín, tenofovir dizoproxyl a rilpivirín |
p.o. 200/245/25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
26.03 |
|
|
|
31086 |
|
|
O |
Eviplera 200 mg/25 mg/245 mg filmom obalené tablety |
tbl flm 30x200 mg/25 mg/245 mg (fľ.HDPE) |
GSA |
UK |
30 |
780.81 |
780.81 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR09 |
|
|
|
Emtricitabín, tenofovir dizoproxil, elvitegravir a kobicistát |
p.o. 150/150/200/245 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
34.892000000000003 |
|
|
|
6113A |
|
|
O |
Stribild 150 mg/150 mg/200 mg/245 mg filmom obalené tablety |
tbl flm 30x150 mg/150 mg/200 mg/245 mg (fľ.HDPE) |
GSA |
UK |
30 |
1046.75 |
1046.75 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR13 |
|
|
|
Lamivudin, abakavir, dolutegravir |
p.o. 50/600/300 mg (30ks) |
1 |
DF |
|
|
|
|
|
|
|
|
34.834000000000003 |
|
|
|
1459B |
|
|
O |
Triumeq 50mg/600mg/300mg filmom obalené tablety |
tbl flm 30x50mg/600mg/300mg (fľ.HDPE) |
VVH |
GB |
30 |
1045 |
1045 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AX05 |
|
|
|
Inozín pranobex |
p.o. 500 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.51900000000000002 |
|
|
|
88174 |
|
|
O |
ISOPRINOSINE |
tbl 50x500 mg |
EWO |
CH |
25 |
17.239999999999998 |
12.98 |
S |
4.26 |
0.24710000000000001 |
3.89 |
ALG, DER, INF, ONK, TRN |
ind.obm. |
|
|
|
J05AX05 |
|
|
|
Inozín pranobex |
p.o. 500 mg (100 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.51900000000000002 |
|
|
|
81327 |
|
|
O |
Isoprinosine |
tbl 100x500 mg |
EWO |
CH |
50 |
33.72 |
25.95 |
S |
7.77 |
0.23042699999999999 |
7.77 |
ALG, DER, INF, ONK, TRN |
ind.obm. |
|
|
|
J05AX05 |
|
|
|
Inozín pranobex |
p.o. tekuté LF |
1 |
g |
|
|
|
|
|
|
|
|
0.56000000000000005 |
|
|
|
85044 |
|
|
G |
Isoprinosine sirup |
sir 1x150 ml (fľ.skl. hnedá) |
EWO |
CH |
7.5 |
13.56 |
4.2 |
S |
9.36 |
0.69026500000000002 |
9.36 |
ALG, DER, INF, ONK, PED |
ind.obm. |
|
|
|
J05AX08 |
|
|
|
Raltegravír |
p.o. 400 mg (60 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
21.062000000000001 |
|
|
|
47025 |
|
|
O |
ISENTRESS 400mg |
tbl flm 60x400 mg |
MSD |
GB |
30 |
631.85 |
631.85 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AX12 |
|
|
|
Dolutegravir |
p.o. 50 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
21.800999999999998 |
|
|
|
8746A |
|
|
O |
Tivicay 50 mg filmom obalené tablety |
tbl flm 30x50 mg (fľ.HDPE) |
VVH |
GB |
30 |
654.03 |
654.03 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AX15 |
|
|
|
Sofosbuvir |
p.o. 400 mg (28 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
562.93499999999995 |
|
|
|
8996A |
|
|
O |
Sovaldi 400 mg filmom obalené tablety |
tbl flm 28x400 mg (fľ.HDPE) |
GSA |
UK |
28 |
15762.17 |
15762.17 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
2015-01-01T00:00:00.000 |
|
|
J05AX16 |
|
|
|
Dasabuvir |
p.o. 250 mg (56 ks) |
500 |
mg |
|
|
|
|
|
|
|
|
46.96 |
|
|
|
2708B |
|
|
O |
Exviera 250 mg filmom obalené tablety |
tbl flm 56(4x14)x250 mg (blis.PVC/PE/PCTFE/AI-multibal.) |
ABV-GB |
GB |
28 |
1314.86 |
1314.86 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
|
|
|
J05AX65 |
|
|
|
Sofosbuvir a ledipasvir |
p.o. 90mg/400mg ( 28 ks ) |
1 |
DF |
|
|
|
|
|
|
|
|
638.89499999999998 |
|
|
|
2394B |
|
|
O |
Harvoni 90 mg/400 mg filmom obalené tablety |
tbl flm 28x90 mg/400 mg (fľ.HDPE) |
GSA |
UK |
28 |
17889.04 |
17889.04 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
|
|
|
J05AX67 |
|
|
|
Ombitasvir, paritaprevir, ritonavir |
p. o. 12,5/75/50 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
540.03399999999999 |
|
|
|
2709B |
|
|
O |
Viekirax 12,5 mg/75 mg/50 mg filmom obalené tablety |
tbl flm 56(4x14)x12,5 mg/75 mg/50 mg (blis.PVC/PE/PCTFE/AI) |
ABV-GB |
GB |
28 |
15120.93 |
15120.93 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
|
|
|
J06AA06 |
|
|
|
Sérum proti besnote |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
85.73 |
|
|
|
42843 |
|
|
O |
FAVIRAB |
sol inj 1x5 ml |
XAL |
FR |
1 |
85.72 |
85.72 |
A |
0 |
0 |
0 |
INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 1000 mg |
1 |
g |
|
|
|
|
|
|
|
|
50.1 |
|
|
|
07750 |
|
|
O |
Hizentra 200 mg/ml roztok na subkutánnu injekciu |
sol inj 1x5 ml/1 g (liek.inj.skl.) |
CSL |
DE |
1 |
50.1 |
50.1 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 2000 mg |
1 |
g |
|
|
|
|
|
|
|
|
45.65 |
|
|
|
07753 |
|
|
O |
Hizentra 200 mg/ml roztok na subkutánnu injekciu |
sol inj 1x10 ml/2 g (liek.inj.skl.) |
CSL |
DE |
2 |
91.3 |
91.3 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 4000 mg |
1 |
g |
|
|
|
|
|
|
|
|
44.892000000000003 |
|
|
|
07759 |
|
|
O |
Hizentra 200 mg/ml roztok na subkutánnu injekciu |
sol inj 1x20 ml/4 g (liek.inj.skl.) |
CSL |
DE |
4 |
179.57 |
179.57 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 800 mg |
1 |
g |
|
|
|
|
|
|
|
|
49.25 |
|
|
|
91622 |
|
|
O |
SUBCUVIA, 160 g/l |
sol inj 20x5ml/800 mg |
BAX |
AT |
16 |
787.88 |
787.88 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
57670 |
|
|
O |
Igamplia 160 mg/ml |
sol inj 1x5 ml/800 mg |
GFO |
ES |
0.8 |
39.4 |
39.4 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 1600 mg |
1 |
g |
|
|
|
|
|
|
|
|
49.83 |
|
|
|
91623 |
|
|
O |
SUBCUVIA, 160 g/l |
sol inj 20x10ml/1600 mg |
BAX |
AT |
32 |
1594.33 |
1594.33 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 1650 mg |
1 |
DF |
|
|
|
|
|
|
|
|
76.06 |
|
|
|
45894 |
|
|
O |
Gammanorm 165 mg/ ml |
sol inj 1x10ml |
OCP |
GB |
1 |
76.05 |
76.05 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 2,5g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5730A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x25 ml (10 % IG)+1x1,25 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
2.5 |
153.75 |
153.75 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 5 g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5731A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x50 ml (10 % IG)+1x2,5 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
5 |
307.5 |
307.5 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 10 g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5732A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x100 ml (10 % IG)+1x5 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
10 |
615 |
615 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 20 g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5733A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x200 ml (10 % IG)+1x10 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
20 |
1229.99 |
1229.99 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 30 g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5734A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x300 ml (10 % IG)+1x15 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
30 |
1845 |
1845 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 0,5 g |
1 |
g |
|
|
|
|
|
|
|
|
68.760000000000005 |
|
|
|
45080 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x10 ml/0,5 g (liek.skl.) |
GFO |
ES |
0.5 |
34.380000000000003 |
34.380000000000003 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 2 g |
1 |
g |
|
|
|
|
|
|
|
|
51.28 |
|
|
|
83310 |
|
|
O |
Octagam 10% |
sol inf 1x20 ml (liek.inj.skl.) |
OCP-GB-1 |
GB |
2 |
100.87 |
100.87 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 2,5 g |
1 |
g |
|
|
|
|
|
|
|
|
48.62 |
|
|
|
45081 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x50 ml/2,5 g (liek.skl.) |
GFO |
ES |
2.5 |
121.55 |
121.55 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
12691 |
|
|
O |
OCTAGAM |
sol inf 1x50 ml |
OCP |
AT |
2.5 |
121.55 |
121.55 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
80027 |
|
|
O |
Privigen 100 mg/ml infúzny intravenózny roztok |
sol inf 1 x 25 ml (liek.inj.skl.) |
CSL |
DE |
2.5 |
121.55 |
121.55 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
97213 |
|
|
O |
KIOVIG |
sol inf 1x25 ml/2,5 g |
BAX |
AT |
2.5 |
121.95 |
121.55 |
S |
0.4 |
3.2799999999999999E-3 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 5 g |
1 |
g |
|
|
|
|
|
|
|
|
46.67 |
|
|
|
06837 |
|
|
O |
Flebogamma DIF 100 mg/ml infúzny roztok |
sol inf 1x50 ml/5 g (liek.skl.) |
GFO |
ES |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
45082 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x100 ml/5 g (liek.skl.) |
GFO |
ES |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
12692 |
|
|
O |
OCTAGAM |
sol inf 1x100 ml |
OCP |
AT |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
83311 |
|
|
O |
Octagam 10% |
sol inf 1x50 ml (liek.inj.skl.) |
OCP-GB-1 |
GB |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
50934 |
|
|
O |
PRIVIGEN |
sol inf 50 ml/5 g |
CSL |
DE |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
97247 |
|
|
O |
Kiovig |
sol inf 1x50 ml/5 g (liek.inj.skl.) |
BAX-A |
AT |
5 |
234.89 |
233.35 |
S |
1.54 |
6.5559999999999993E-3 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 10 g |
1 |
g |
|
|
|
|
|
|
|
|
46.191000000000003 |
|
|
|
06838 |
|
|
O |
Flebogamma DIF 100 mg/ml infúzny roztok |
sol inf 1x100 ml/10 g (liek.skl.) |
GFO |
ES |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
45083 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x200 ml/10 g (liek.skl.) |
GFO |
ES |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
12693 |
|
|
O |
OCTAGAM |
sol inf 1x200 ml |
OCP |
AT |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
83312 |
|
|
O |
Octagam 10% |
sol inf 1x100 ml (liek.inj.skl.) |
OCP-GB-1 |
GB |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
50935 |
|
|
O |
PRIVIGEN |
sol inf 100 ml/10 g |
CSL |
DE |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
97248 |
|
|
O |
KIOVIG |
sol inf 1x100 ml/10 g |
BAX |
AT |
10 |
465 |
461.91 |
S |
3.09 |
6.6449999999999999E-3 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 20 g |
1 |
g |
|
|
|
|
|
|
|
|
55.11 |
|
|
|
83313 |
|
|
O |
Octagam 10% |
sol inf 1x200 ml (liek.inj.skl.) |
OCP-GB-1 |
GB |
20 |
943.05 |
943.05 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
06839 |
|
|
O |
Flebogamma DIF 100 mg/ml infúzny roztok |
sol inf 1x200 ml/20 g (liek.skl.) |
GFO |
ES |
20 |
961.22 |
961.22 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
45084 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x400 ml/20 g (liek.skl.) |
GFO |
ES |
20 |
961.22 |
961.22 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
50936 |
|
|
O |
PRIVIGEN |
sol inf 200 ml/20 g |
CSL |
DE |
20 |
961.22 |
961.22 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
97250 |
|
|
O |
Kiovig |
sol inf 1x200 ml/20 g (liek.inj.skl.) |
BAX-A |
AT |
20 |
1022.2 |
1022.2 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 30 g |
1 |
g |
|
|
|
|
|
|
|
|
53.715000000000003 |
|
|
|
20049 |
|
|
O |
Kiovig |
sol inf 1x300 ml/30 g ( liek.inj.skl.) |
BAX-A |
AT |
30 |
1611.44 |
1611.44 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
J06BB01 |
|
|
|
Anti-d (rh) imunoglobulín |
parent. |
250 |
mcg |
|
|
|
|
|
|
|
|
42.4 |
|
|
|
50053 |
|
|
O |
Rhesonativ |
sol inj 1x2 ml/1250 |
OCP |
SE |
1 |
39.07 |
39.07 |
A |
0 |
0 |
0 |
|
|
|
|
|
46594 |
|
|
O |
Rhophylac 300 mikrogramov/2 ml |
sol inj 1 x 2 ml/300 ug + ihla |
CSL |
DE |
1.2 |
46.93 |
46.93 |
A |
0 |
0 |
0 |
|
|
|
|
|
91630 |
|
|
O |
IGAMAD 1500 I.U. |
sol inj 1500 I.U./2 ml |
GFO |
ES |
1.2 |
50.87 |
50.87 |
A |
0 |
0 |
0 |
|
|
|
|
|
J06BB02 |
|
|
|
Imonoglobulín proti tetanu |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
13.36 |
|
|
|
57804 |
|
|
O |
Pasteurised Hum.Antitet.Ig.Grifols |
sol inj 250 IU/2 ml+str. |
GFO |
ES |
1 |
12.04 |
12.04 |
A |
0 |
0 |
0 |
|
|
|
|
|
J06BB16 |
|
|
|
Palivizumab |
parent. 50 mg |
50 |
mg |
|
|
|
|
|
|
|
|
484.01 |
|
|
|
02106 |
|
|
O |
Synagis 50 mg prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x50 mg (liek.inj.skl.)+1 ml solv. (amp.skl.) |
ABV-GB |
GB |
1 |
484.01 |
484.01 |
A |
0 |
0 |
0 |
KAR, LRN, TRN |
ind.obm., ZP |
|
|
|
J06BB16 |
|
|
|
Palivizumab |
parent. 100 mg |
50 |
mg |
|
|
|
|
|
|
|
|
409.67 |
|
|
|
02143 |
|
|
O |
Synagis 100 mg prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x100 mg (liek.inj.skl.)+1 ml solv. (amp.skl.) |
ABV-GB |
GB |
2 |
819.33 |
819.33 |
A |
0 |
0 |
0 |
KAR, LRN, TRN |
ind.obm., ZP |
|
|
|
J07AH03 |
|
|
|
Vakcína proti meningokokom, bivalentný purifikovaný polysacharidový antigén |
parent. 1 dávka |
0.5 |
ml |
|
|
|
|
|
|
|
|
1 |
|
|
|
76063 |
|
|
O |
MENINGOCOCCAL POLYS.VACCINE A+C |
plv iul 1x1dávka+str. |
PMX |
FR |
1 |
11.19 |
11.19 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07AH07 |
|
|
|
Vakcína proti Meningococcus C, purifikovaný polysacharidový konjugovaný antigén |
parent. 1 dávka |
0.5 |
ml |
|
|
|
|
|
|
|
|
1 |
|
|
|
32685 |
|
|
O |
NEISVAC-C |
sus inj 1x0,5 ml (striek. inj. skl. naplnená) |
PFI-GB-7 |
GB |
1 |
29.75 |
29.75 |
V |
0 |
0 |
0 |
INF, PED |
ind.obm. |
|
|
|
J07AJ52 |
|
|
|
Vakcína proti pertussis (acelulárna), purifikovaný antigén, kombinácie s toxoidmi |
parent. |
0.5 |
ml |
|
|
|
|
|
|
|
|
4.9400000000000004 |
|
|
|
45368 |
|
|
O |
Boostrix |
sus inj 1x0,5ml |
GLA-SK |
SK |
1 |
16.510000000000002 |
4.9400000000000004 |
S |
11.57 |
0.70078699999999994 |
11.57 |
|
ind.obm. |
|
|
|
J07AL01 |
|
|
|
Vakcína proti pneumokokom, purifikovaný polysacharidový antigén |
parent. |
0.5 |
ml |
|
|
|
|
|
|
|
|
1 |
|
|
|
85534 |
|
|
O |
PNEUMO 23 |
sol inj 1x0,5 ml+striek. |
XAL |
FR |
1 |
12.54 |
12.54 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07AL02 |
|
|
|
Vakcína proti pneumokokom, purifikovaný polysacharidový konjugovaný antigén |
parent. 13-valentná |
0.5 |
ml |
|
|
|
|
|
|
|
|
38.154000000000003 |
|
|
|
85035 |
|
|
O |
Prevenar 13 injekčná suspenzia |
sus inj 10x0,5 ml (striek.skl.napln.+ samost.ihly) |
PFI-GB-1 |
GB |
10 |
508.72 |
381.54 |
V |
127.18 |
0.25 |
127.18 |
PED |
ind.obm. |
|
|
U22 |
85033 |
|
|
O |
Prevenar 13 injekčná suspenzia |
sus inj 1x0,5 ml (striek.skl.napln.+ samost.ihla) |
PFI-GB-1 |
GB |
1 |
54.21 |
38.15 |
V |
16.059999999999999 |
0.29625499999999999 |
12.72 |
PED |
ind.obm. |
|
|
U22 |
J07AL52 |
|
|
|
Vakcína proti pneumokokom, purifikovaný polysacharidový konjugovaný antigén |
parent. 10-valentná |
0.5 |
ml |
|
|
|
|
|
|
|
|
38.154000000000003 |
|
|
|
69867 |
|
|
O |
Synflorix |
sus inj 10x0,5ml +10 ihiel |
GAG |
BE |
10 |
381.54 |
381.54 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
U22 |
J07AM01 |
|
|
|
Tetanový toxoid |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
5.5 |
|
|
|
7207A |
|
|
O |
ALTEANA |
sus inj 1x0,5 ml/40 IU (striek.inj.napl.) |
IMA |
SK |
1 |
5.5 |
5.5 |
A |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07AM51 |
|
|
|
Tetanický toxoid, kombinácie s difterickým toxoidom |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
1 |
|
|
|
33919 |
|
|
O |
IMOVAX D.T. ADULT |
sus inj 1x0,5ml inj.striek. |
XAL |
FR |
1 |
5.86 |
5.86 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07AN01 |
|
|
|
Vakcíny proti tuberkulóze, živé atenuované |
parent. |
0.1 |
ml |
|
|
|
|
|
|
|
|
1.29 |
|
|
|
91324 |
|
|
O |
BCG VACCINE SSI |
plv iul 10+10 solv. |
SST |
DE |
100 |
60.59 |
60.59 |
A |
0 |
0 |
0 |
TRN |
|
|
|
|
91323 |
|
|
O |
BCG VACCINE SSI |
plv iul 5+5 solv. |
SST |
DE |
50 |
64.3 |
64.3 |
A |
0 |
0 |
0 |
TRN |
|
|
|
|
J07BB02 |
|
|
|
Vakcíny proti chrípke, purifikovaný antigén |
parent. |
0.5 |
ml |
|
|
|
|
|
|
|
|
5.72 |
|
|
|
56079 |
|
|
O |
INFLUVAC (INJ.STRIEK.) |
sus inj 1x0,5 ml |
SDU |
NL |
1 |
5.72 |
5.72 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
39136 |
|
|
O |
Vaxigrip |
sus inj 10 x 0,5 ml |
SP |
FR |
10 |
57.8 |
57.2 |
V |
0.6 |
1.0381E-2 |
0.6 |
|
ind.obm. |
|
|
|
14886 |
|
|
O |
VAXIGRIP (inj.striek.) |
sus inj 1x0,5 ml |
XAL |
FR |
1 |
6.54 |
5.72 |
V |
0.82 |
0.12538199999999999 |
0 |
|
ind.obm. |
|
|
|
J07BC01 |
|
|
|
Vakcína proti hepatitíde B, purifikovaný antigén |
parent. adjuvans adsorbovaná |
0.5 |
ml |
|
|
|
|
|
|
|
|
54.9 |
|
|
|
42652 |
|
|
O |
FENDRIX |
sus inj 1x0,5 ml |
GAG |
BE |
1 |
54.89 |
54.89 |
A |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
J07BC01 |
|
|
|
Vakcíny proti hepatitíde B, purifikovaný antigén |
parent. do 10 ug povinné očkovanie |
1 |
DF |
|
|
|
|
|
|
|
|
1 |
|
|
|
28452 |
|
|
O |
EUVAX B 10 mG |
sus inj 1x0,5 ml |
XLG |
PL |
1 |
6.76 |
6.76 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07BC01 |
|
|
|
Vakcíny proti hepatitíde B, purifikovaný antigén |
parent. do 10 ug |
1 |
DF |
|
|
|
|
|
|
|
|
6.375 |
|
|
|
25093 |
|
|
O |
ENGERIX-B 10RG(DOS.PAEDIATR.) |
sus inj 1x0,5 ml (v n.s.) |
GAG |
BE |
1 |
9.4700000000000006 |
6.38 |
S |
3.09 |
0.32629399999999997 |
0 |
PED |
ind.obm. |
|
|
|
J07BC01 |
|
|
|
Vakcíny proti hepatitíde B, purifikovaný antigén |
parent. 20 ug povinné očkovanie |
1 |
ml |
|
|
|
|
|
|
|
|
1 |
|
|
|
28454 |
|
|
O |
EUVAX B 20 mG |
sus inj 1x1 ml |
XLG |
PL |
1 |
12.01 |
12.01 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
25092 |
|
|
O |
ENGERIX-B 20RG(DOS.ADUL) |
sus inj 1x1 ml (v nap.s.) |
SKX |
BE |
1 |
13.57 |
13.57 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07BC02 |
|
|
|
Vakcíny proti hepatitíde A, inaktivovaný celobunkový vírus |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
1 |
|
|
|
25982 |
|
|
O |
HAVRIX 720 Jun.monodose (inj.s.) |
sus inj 1x0,5 ml/720 eu |
SKX |
BE |
1 |
16.36 |
16.36 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
14675 |
|
|
O |
VAQTA 25 U (striek.inj.napl.) |
sus inj 1x0,5 ml/25 U |
MSD |
NL |
1 |
20.91 |
20.91 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
25980 |
|
|
O |
HAVRIX 1440 Dos.adulta (inj.s.) |
sus inj 1x1 ml/1440 eu |
SKX |
BE |
1 |
24.07 |
24.07 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
14677 |
|
|
O |
VAQTA 50 U (striek.inj.napl.) |
sus inj 1x1 ml/50 U |
MSD |
NL |
1 |
27.35 |
27.35 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
92296 |
|
|
O |
AVAXIM 160 |
sus inj 1x0,5 ml |
PMX |
FR |
1 |
29.5 |
29.5 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07BD52 |
|
|
|
Vakcíny proti osýpkam, v kombinácii proti príušniciam, ružienke, živá atenuovaná |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
9.4499999999999993 |
|
|
|
36424 |
|
|
O |
M-M-RVAXPRO |
plv iul 10x liek.+10x solv. |
SNP |
FR |
10 |
94.46 |
94.46 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
28654 |
|
|
O |
PRIORIX (inj.str.) |
plv iol 10x0,5 ml+sol |
GAG |
BE |
10 |
94.46 |
94.46 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07BD54 |
|
|
|
Vakcína proti osýpkam, v kombinácii proti príušniciam, ružienke a ovčím kiahňam, živá atenuovaná |
parent. |
0.5 |
ml |
|
|
|
|
|
|
|
|
7.9989999999999997 |
|
|
|
44439 |
|
|
O |
Priorix-Tetra |
plv iol 1x0,5 ml + 2 ihly |
GAG-SK |
SK |
1 |
69.77 |
8 |
S |
61.77 |
0.88533799999999996 |
61.77 |
PED |
|
|
|
|
J07BG01 |
|
|
|
Vakcíny proti besnote, inaktivovaná, celobunková |
parent. |
2.5 |
UT |
|
|
|
|
|
|
|
|
1 |
|
|
|
93706 |
|
|
O |
IMOVAX RABIES VERO (=VERORAB) |
plv iul 2,5 ut+0,5 ml |
PMX |
FR |
1 |
14.45 |
14.45 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07BH01 |
|
|
|
Vakcína proti rotavírusom, živá, atenuovaná |
p.o. |
1 |
ml |
|
|
|
|
|
|
|
|
12.18 |
|
|
|
52845 |
|
|
O |
Rotarix |
sus por 1x1,5 ml (1xnapl.p.o.aplikátor) |
GAG |
BE |
1 |
55.04 |
12.18 |
S |
42.86 |
0.77870600000000001 |
42.86 |
PED |
ind.obm. |
|
|
|
J07BH02 |
|
|
|
Vakcína proti rotavírusom, pentavalentná, živá, reasortovaná |
p.o. tekuté LF |
2 |
ml |
|
|
|
|
|
|
|
|
7.34 |
|
|
|
35586 |
|
|
O |
ROTATEQ |
sol por 1x2 ml |
SNP |
FR |
1 |
38.64 |
7.34 |
S |
31.3 |
0.8100409999999999 |
31.3 |
PED |
ind.obm. |
|
|
|
J07BM01 |
|
|
|
Vakcína proti papilomavírusom (humánne typy 6, 11, 16, 18) |
parent. |
0.5 |
ml |
|
|
|
|
|
|
|
|
6.2990000000000004 |
|
|
|
36697 |
|
|
O |
Silgard |
sus inj 1 x 0,5 ml |
MSD |
GB |
1 |
106.51 |
6.3 |
S |
100.21 |
0.94085099999999999 |
100.21 |
PED |
ind.obm. |
|
|
U23 |
J07BM02 |
|
|
|
Vakcíny proti papilomavírusom (humánne typy 16, 18) |
parent. |
0.5 |
ml |
|
|
|
|
|
|
|
|
6.2990000000000004 |
|
|
|
45237 |
|
|
O |
Cervarix |
sus inj 1x0,5 ml (1xnapl.inj.striek.+1xihla) |
GAG |
BE |
1 |
62.99 |
6.3 |
S |
56.69 |
0.89998400000000001 |
56.69 |
PED |
ind.obm. |
|
|
U23 |
J07CA02 |
|
|
|
Vakcína proti diftérii, tetanu, pertussis, detskej obrne |
parent. povinné očkovanie |
0.5 |
ml |
|
|
|
|
|
|
|
|
21.792999999999999 |
|
|
|
45411 |
|
|
G |
Boostrix polio |
sus.inj 10x0,5ml+10 ihiel |
GLA-SK |
SK |
10 |
217.93 |
217.93 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07CA02 |
|
|
|
Vakcína proti diftérii, tetanu, pertussis, detskej obrne |
parent. povinné očkovanie |
1 |
DF |
|
|
|
|
|
|
|
|
1 |
|
|
|
52280 |
|
|
O |
Infanrix Polio |
sus inj 1x0,5ml |
GAG |
BE |
1 |
24.01 |
24.01 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07CA06 |
|
|
|
Vakcíny proti diftérii, tetanu, pertussis, Haemophilus influenzae b, detskej obrne |
parent. povinné očkovanie |
1 |
DF |
|
|
|
|
|
|
|
|
25.61 |
|
|
|
43006 |
|
|
O |
INFANRIX-IPV+Hib (inj. liek.+ napln.inj.str. s ihlou) |
plu inu 1x0,5 ml |
GLA |
GB |
1 |
25.61 |
25.61 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07CA09 |
|
|
|
Vakcína proti diftérii, tetanu, pertussis, Haemophilus influenzae b, detskej obrne, hepatitíde B |
parent. povinné očkovanie sus. inj. |
1 |
DF |
|
|
|
|
|
|
|
|
42.9 |
|
|
|
34905 |
|
|
O |
Infanrix hexa |
plv iul 10x0,5 ml, str.+2i. |
GAG |
BE |
10 |
428.99 |
428.99 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
L01AA01 |
|
|
|
Cyklofosfamid |
parent. |
10 |
mg |
|
|
|
|
|
|
|
|
0.23499999999999999 |
|
|
|
0384B |
|
|
O |
Endoxan 200 mg prášok na infúzny roztok |
plv ino 50x200 mg (liek.inj.skl) |
XBT-1 |
DE |
1000 |
234.09 |
234.09 |
A |
0 |
0 |
0 |
|
|
|
|
|
0385B |
|
|
O |
Endoxan 500 mg prášok na infúzny roztok |
plv ino 6x500 mg (liek.inj.skl) |
XBT-1 |
DE |
300 |
70.23 |
70.23 |
A |
0 |
0 |
0 |
|
|
|
|
|
0387B |
|
|
O |
Endoxan 1000 mg prášok na infúzny roztok |
plv ino 5x1g (liek.inj.skl) |
XBT-1 |
DE |
500 |
117.06 |
117.06 |
A |
0 |
0 |
0 |
|
|
|
|
|
L01AA06 |
|
|
|
Ifosfamid |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.06 |
|
|
|
0389B |
|
|
O |
Holoxan 1000mg prášok na infúzny roztok |
plv ifo 5x1g (liek.inj.) |
XBT-1 |
DE |
5000 |
299.08999999999997 |
299.08999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
0391B |
|
|
O |
Holoxan 2000mg prášok na infúzny roztok |
plv ifo 5x2g (liek.inj.) |
XBT-1 |
DE |
10000 |
598.17999999999995 |
598.17999999999995 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01AA09 |
|
|
|
Bendamustín |
parent. 25 mg |
58.3 |
mg |
|
|
|
|
|
|
|
|
179.52 |
|
|
|
2723B |
|
|
G |
Bendamustine Accord 2,5 mg/ml prášok na infúzny koncentrát |
plc ifo 20x25 mg (liek.skl.jantárová) |
ACC |
GB |
8.5760000000000005 |
1522.24 |
1522.24 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
2721B |
|
|
G |
Bendamustine Accord 2,5 mg/ml prášok na infúzny koncentrát |
plc ifo 5x25 mg (liek.skl.jantárová) |
ACC |
GB |
2.1440000000000001 |
380.56 |
380.56 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4324B |
|
|
G |
Bendamustine Actavis 2,5 mg/ml |
plc ifo 20x25 mg (liek.skl.inj.jantárová) |
ACT-5 |
IS |
8.5760000000000005 |
1522.24 |
1522.24 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4322B |
|
|
G |
Bendamustine Actavis 2,5 mg/ml |
plc ifo 5x25 mg (liek.skl.inj.jantárová) |
ACT-5 |
IS |
2.1440000000000001 |
380.56 |
380.56 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
9763A |
|
|
G |
Lynetoril 2,5 mg/ml |
plc ifo 5x25 mg (liek.inj.skl.) |
CHS-AT |
AT |
2.1440000000000001 |
384.6 |
384.6 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
08143 |
|
|
G |
Levact 2,5 mg/ml |
plc ifo 20x25 mg (liek.inj.skl.hnedá) |
ASL-D |
DE |
8.5760000000000005 |
1539.53 |
1539.53 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
08141 |
|
|
G |
Levact 2,5 mg/ml |
plc ifo 5x25 mg (liek.inj.skl.hnedá) |
ASL-D |
DE |
2.1440000000000001 |
386.21 |
384.89 |
AS |
1.32 |
3.418E-3 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01AA09 |
|
|
|
Bendamustín |
parent. 100 mg |
58.3 |
mg |
|
|
|
|
|
|
|
|
162.25 |
|
|
|
2725B |
|
|
G |
Bendamustine Accord 2,5 mg/ml prášok na infúzny koncentrát |
plc ifo 5x100 mg (liek.skl.jantárová) |
ACC |
GB |
8.5760000000000005 |
1391.43 |
1391.43 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4326B |
|
|
G |
Bendamustine Actavis 2,5 mg/ml |
plc ifo 5x100 mg (liek.skl.inj.jantárová) |
ACT-5 |
IS |
8.5760000000000005 |
1391.43 |
1391.43 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
9767A |
|
|
G |
Lynetoril 2,5 mg/ml |
plc ifo 5x100 mg (liek.inj.skl.) |
CHS-AT |
AT |
8.5760000000000005 |
1391.43 |
1391.43 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
08144 |
|
|
G |
Levact 2,5 mg/ml |
plc ifo 5x100 mg (liek.inj.skl.hnedá) |
ASL-D |
DE |
8.5760000000000005 |
1536 |
1391.46 |
AS |
144.54 |
9.4101999999999991E-2 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
9766A |
|
|
G |
Lynetoril 2,5 mg/ml |
plc ifo 1x100 mg (liek.inj.skl.) |
CHS-AT |
AT |
1.7150000000000001 |
307.39 |
278.26 |
AS |
29.13 |
9.4765999999999989E-2 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01AD02 |
|
|
|
Lomustín |
p.o. 40 mg (20 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.185 |
|
|
|
60271 |
|
|
O |
CEENU LOMUSTINE (CCNU) |
cps 20x40 mg |
BMS |
IT |
800 |
145.44 |
145.44 |
I |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01AD05 |
|
|
|
Fotemustín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
1.3 |
|
|
|
55407 |
|
|
O |
MUSTOPHORAN |
plv fol 1x208 mg+4 ml |
THN |
BE |
208 |
268.67 |
268.67 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 20 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
60.8 |
|
|
|
6893A |
X |
|
G |
Nogron 20mg |
cps dur 5x20mg |
EGI |
HU |
0.28599999999999998 |
17.39 |
17.39 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
65579 |
X |
|
O |
TEMODAL 20 mg |
cps dur 5x20 mg (jedn.vrecko) |
MSD-GB-1 |
GB |
0.28599999999999998 |
17.39 |
17.39 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
88980 |
X |
|
G |
TEMOSTAD 20 mg |
cps dur 5x20 mg (fľ.sklo, jantár) |
STD |
DE |
0.28599999999999998 |
17.39 |
17.39 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
86630 |
X |
|
O |
Temomedac |
cps dur 5x20 mg (fľa. skl.) |
MED |
DE |
0.28599999999999998 |
36.42 |
17.39 |
S |
19.03 |
0.52251499999999995 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 100 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
51.5 |
|
|
|
6896A |
|
|
G |
Nogron 100mg |
cps dur 5x100mg (liek.PE) |
EGI |
HU |
1.429 |
73.59 |
73.59 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
65581 |
|
|
O |
TEMODAL 100 mg |
cps dur 5x100 mg (jedn.vrecko) |
MSD-GB-1 |
GB |
1.429 |
73.59 |
73.59 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
88982 |
|
|
G |
TEMOSTAD 100 mg |
cps dur 5x100 mg (fľ.sklo, jantár) |
STD |
DE |
1.429 |
73.59 |
73.59 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
86562 |
|
|
G |
Temozolomide Teva |
cps dur 5x100 mg (fľa.skl.) |
TEV |
FR |
1.429 |
73.59 |
73.59 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
86632 |
|
|
O |
Temomedac |
cps dur 5x100 mg (fľa. skl.) |
MED |
DE |
1.429 |
150.86000000000001 |
73.59 |
S |
77.27 |
0.51219700000000001 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 140 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
74.680000000000007 |
|
|
|
6899A |
|
|
G |
Nogron 140mg |
cps dur 5x140mg (liek.PE) |
EGI |
HU |
2 |
149.35 |
149.35 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
65583 |
|
|
O |
TEMODAL 140 mg |
cps dur 5x140 mg (jedn.vrecko) |
MSD-GB-1 |
GB |
2 |
149.35 |
149.35 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
88984 |
|
|
G |
TEMOSTAD 140 mg |
cps dur 5x140 mg (fľ.sklo, jantár) |
STD |
DE |
2 |
149.35 |
149.35 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
86564 |
|
|
G |
Temozolomide Teva |
cps dur 5x140 mg (fľa.skl.) |
TEV |
FR |
2 |
149.35 |
149.35 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
86635 |
|
|
O |
Temomedac |
cps dur 5x140mg (fľa. skl.) |
MED |
DE |
2 |
247.17 |
149.36000000000001 |
S |
97.81 |
0.39572000000000002 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 180 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
75 |
|
|
|
6902A |
|
|
G |
Nogron 180mg |
cps dur 5x180mg (liek.PE) |
EGI |
HU |
2.5710000000000002 |
192.83 |
192.83 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
65585 |
|
|
O |
TEMODAL 180 mg |
cps dur 5x180 mg (jedn.vrecko) |
MSD-GB-1 |
GB |
2.5710000000000002 |
192.83 |
192.83 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
86644 |
|
|
O |
Temomedac |
cps dur 5x180mg (fľa. skl.) |
MED |
DE |
2.5710000000000002 |
298.68 |
192.83 |
S |
105.85 |
0.35439300000000001 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 250 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
122.41 |
|
|
|
65587 |
|
|
O |
TEMODAL 250 mg |
cps dur 5x250 mg (jedn.vrecko) |
SCH-B-2 |
BE |
3.5710000000000002 |
437.11 |
437.11 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
88988 |
|
|
G |
TEMOSTAD 250 mg |
cps dur 5x250 mg (fľ.sklo, jantár) |
STD |
DE |
3.5710000000000002 |
437.11 |
437.11 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
86646 |
|
|
O |
Temomedac |
cps dur 5x250 mg (fľa. skl.) |
MED |
DE |
3.5710000000000002 |
511.55 |
437.13 |
S |
74.42 |
0.145479 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01BA01 |
|
|
|
Metotrexát |
parent. |
10 |
mg |
|
|
|
|
|
|
|
|
0.19 |
|
|
|
69166 |
|
|
G |
METHOTREXAT-EBEWE 5000MG |
sol inj 1x50 ml/5000 mg |
EBW |
AT |
500 |
85.11 |
85.11 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01BA01 |
|
|
|
Metotrexát |
parent. napl. striekačka s ihlou |
15 |
mg |
|
|
|
|
|
|
|
|
20.8 |
|
|
|
82673 |
|
|
G |
Methotrexat Ebewe 20 mg/ml |
sol inj 1x1 ml/20 mg (striek.skl.napl.) |
EBW |
AT |
1.333 |
23.84 |
23.84 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
60935 |
|
|
G |
Metoject 50 mg/ml injekčný roztok |
sol inj 1x0,50 ml/ 25 mg (vsadená ihla) |
MED |
DE |
1.67 |
30.25 |
30.25 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
60769 |
|
|
G |
Metoject 50 mg/ml injekčný roztok |
sol inj 1x0,40 ml/ 20 mg (vsadená ihla) |
MED |
DE |
1.33 |
27.65 |
27.65 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
8928A |
|
|
G |
Metoject PEN 20 mg injekčný roztok naplnený v injekčnom pere |
sol ira 1x0,40 ml/20 mg (pero napl.) |
MED |
DE |
1.33 |
27.65 |
27.65 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
8950A |
|
|
G |
Metoject PEN 25 mg injekčný roztok naplnený v injekčnom pere |
sol ira 1x0,5 ml/25 mg (pero napl.) |
MED |
DE |
1.67 |
34.729999999999997 |
34.729999999999997 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
5573A |
|
|
G |
Methotrexat Ebewe 20 mg/ml |
sol inj 1x0,75 ml/15 mg (striek.skl.napl.) |
EBW |
AT |
1 |
20.8 |
20.8 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
5567A |
|
|
G |
Methotrexat Ebewe 20 mg/ml |
sol inj 1x0,5 ml/10 mg (striek.skl.napl.) |
EBW |
AT |
0.67 |
14.94 |
13.94 |
S |
1 |
6.6933999999999994E-2 |
1 |
DER, REU |
ind.obm. |
|
|
|
60759 |
|
|
G |
Metoject 50 mg/ml injekčný roztok |
sol inj 1x0,30 ml/15 mg (striek.napl.skl. so vsad.ihl.) |
MED |
DE |
1 |
22.44 |
20.8 |
S |
1.64 |
7.3083999999999996E-2 |
0 |
DER, REU |
ind.obm. |
|
|
|
8906A |
|
|
G |
Metoject PEN 15 mg injekčný roztok naplnený v injekčnom pere |
sol ira 1x0,30 ml/15 mg (pero napl.) |
MED |
DE |
1 |
22.52 |
20.8 |
S |
1.72 |
7.6377E-2 |
0 |
DER, REU |
ind.obm. |
|
|
|
08962 |
|
|
G |
Metoject 50 mg/ml injekčný roztok |
sol inj 1x0,25 ml/12,5 mg (striek.napl.skl.zo vsad.ihl.) |
MED |
DE |
0.83299999999999996 |
20.95 |
17.329999999999998 |
S |
3.62 |
0.172792 |
3.62 |
DER, REU |
ind.obm. |
|
|
|
8895A |
|
|
G |
Metoject PEN 12,5 mg injekčný roztok naplnený v injekčnom pere |
sol ira 1x0,25 ml/12,5 mg (pero napl.) |
MED |
DE |
0.83299999999999996 |
20.95 |
17.329999999999998 |
S |
3.62 |
0.172792 |
3.62 |
DER, REU |
ind.obm. |
|
|
|
60554 |
|
|
G |
Metoject 50 mg/ml injekčný roztok |
sol inj 1x0,20 ml/10 mg (striek.napl.skl. so vsad.ihl.) |
MED |
DE |
0.67 |
17.190000000000001 |
13.94 |
S |
3.25 |
0.18906300000000001 |
1 |
DER, REU |
ind.obm. |
|
|
|
8884A |
|
|
G |
Metoject PEN 10 mg injekčný roztok naplnený v injekčnom pere |
sol ira 1x0,2 ml/10 mg (pero napl.) |
MED |
DE |
0.67 |
17.190000000000001 |
13.94 |
S |
3.25 |
0.18906300000000001 |
1 |
DER, REU |
ind.obm. |
|
|
|
5561A |
|
|
G |
Methotrexat Ebewe 20 mg/ml |
sol inj 1x0,375 ml/7,5 mg (striek.skl.napl.) |
EBW |
AT |
0.5 |
13.19 |
10.4 |
S |
2.79 |
0.21152399999999999 |
2.79 |
DER, REU |
ind.obm. |
|
|
|
60540 |
|
|
G |
Metoject 50 mg/ml injekčný roztok |
sol inj 1x0,15 ml/ 7,5 mg (vsadená ihla) |
MED |
DE |
0.5 |
15.9 |
10.4 |
S |
5.5 |
0.345912 |
5.5 |
DER, REU |
ind.obm. |
|
|
|
8873A |
|
|
G |
Metoject PEN 7,5 mg injekčný roztok naplnený v injekčnom pere |
sol ira 1x0,15 ml/7,5 mg (pero napl.) |
MED |
DE |
0.5 |
15.9 |
10.4 |
S |
5.5 |
0.345912 |
2.79 |
DER, REU |
ind.obm. |
|
|
|
L01BA04 |
|
|
|
Pemetrexed |
parent. 100 mg |
500 |
mg |
|
|
|
|
|
|
|
|
1103.96 |
|
|
|
46538 |
|
|
O |
ALIMTA 100 mg prášok na infúzny koncentrát |
pls ifo 1 x 100 mg |
LIL |
NL |
0.2 |
220.79 |
220.79 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01BA04 |
|
|
|
Pemetrexed |
parent. 500 mg |
500 |
mg/m2 |
|
|
|
|
|
|
|
|
1050.1300000000001 |
|
|
|
41437 |
|
|
O |
ALIMTA |
plc ifo 1x500 mg |
LIL |
NL |
1 |
1050.1300000000001 |
1050.1300000000001 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01BB04 |
|
|
|
Kladribin |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
32.71 |
|
|
|
31741 |
|
|
O |
LITAK 10 Solution |
sol inj 5x5 ml |
LMG-D |
DE |
50 |
1635.06 |
1635.06 |
A |
0 |
0 |
0 |
|
|
|
|
|
31740 |
|
|
O |
LITAK 10 Solution |
sol inj 1x5 ml |
LMG-D |
DE |
10 |
352.43 |
327.10000000000002 |
AS |
25.33 |
7.1871999999999991E-2 |
0 |
|
|
|
|
|
L01BB05 |
|
|
|
Fludarabín |
p.o. 10 mg (15 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
196.72 |
|
|
|
58897 |
|
|
O |
FLUDARA ORAL |
tbl flm 15x10 mg |
GZE |
NL |
1.875 |
368.84 |
368.84 |
I |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01BB05 |
|
|
|
Fludarabín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
2.87 |
|
|
|
52466 |
|
|
G |
Fludarabin Ebewe 25 mg/ ml |
con ijf 1x2 ml/50 mg |
EBW |
AT |
50 |
98.7 |
98.7 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01BC02 |
|
|
|
Fluorouracil |
loc. ung. |
1 |
g |
|
|
|
|
|
|
|
|
1.0149999999999999 |
|
|
|
03739 |
|
|
G |
EFUDIX |
ung 20 g 5% |
MPH |
SK |
20 |
20.29 |
20.29 |
I |
0 |
0 |
0 |
DER, ONK |
|
|
|
|
L01BC02 |
|
|
|
Fluorouracil |
parent. |
10 |
mg |
|
|
|
|
|
|
|
|
4.3999999999999997E-2 |
|
|
|
05194 |
|
|
G |
Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok |
sol ijf 1x100 ml/5 g (liek.inj.skl.) |
ACC |
GB |
500 |
16.12 |
16.12 |
A |
0 |
0 |
0 |
DER, GER, INT, KLF, ONK, OPH |
|
|
|
|
05193 |
|
|
G |
Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok |
sol ijf 1x20 ml/1000 mg (liek.inj.skl.) |
ACC |
GB |
100 |
4.4000000000000004 |
4.4000000000000004 |
A |
0 |
0 |
0 |
DER, GER, INT, KLF, ONK, OPH |
|
|
|
|
05192 |
|
|
G |
Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok |
sol ijf 1x10 ml/500 mg (liek.inj.skl.) |
ACC |
GB |
50 |
3.35 |
2.2000000000000002 |
AS |
1.1499999999999999 |
0.34328400000000003 |
0 |
DER, GER, INT, KLF, ONK, OPH |
|
|
|
|
L01BC05 |
|
|
|
Gemcitabín |
parent. 200 mg |
1 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
51255 |
|
|
G |
CITEGIN |
plv ifo 1x200mg |
EGI |
HU |
200 |
7.36 |
7.36 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
2494A |
|
|
G |
Gemcitabine Accord 100 mg/ml infúzny koncentrát |
con inf 1x200 mg/2 ml (liek.inj.skl.) |
ACC |
GB |
200 |
7.36 |
7.36 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
82623 |
|
|
G |
GEMSTAD |
con inf 1x5,26 ml/200 mg |
STD |
DE |
200 |
7.36 |
7.36 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
79324 |
|
|
G |
Gemcirena 38 mg/ml |
plv ifo 1x200 mg |
FRK |
DE |
200 |
8 |
8 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
76528 |
|
|
G |
Gemcitabin Actavis 38 mg/ml |
plv ifo 1x200 mg (liek.inj.skl.) |
ACT-5 |
IS |
200 |
8 |
8 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
85883 |
|
|
G |
Gemliquid 10 mg/ml |
con inf x20 ml/200 mg (liek.inj.skl.) |
EBW |
AT |
200 |
8 |
8 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
02113 |
|
|
G |
Gemliquid 40 mg/ml con inf |
con inf 1x5 ml/200 mg (liek.inj.skl.) |
EBW |
AT |
200 |
8 |
8 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
00534 |
|
|
G |
Gemcitabin Mylan 40 mg/ml infúzny koncentrát |
con inf 1x5 ml/200 mg (liek.inj.skl.) |
MLB-F |
FR |
200 |
9.1999999999999993 |
8 |
AS |
1.2 |
0.130435 |
0 |
HEM, ONK |
|
|
|
U24 |
75989 |
|
|
G |
Gemcitabine medac 38 mg/ml prášok na infúzny roztok |
plv ifo 1x200 mg (liek.inj.skl.) |
MED |
DE |
200 |
12.7 |
8 |
AS |
4.7 |
0.37007899999999999 |
0 |
HEM, ONK |
|
|
|
U24 |
L01BC05 |
|
|
|
Gemcitabín |
parent. 1000 mg |
1 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
51256 |
|
|
G |
CITEGIN 1 g |
plv ifo 1x1 g |
EGI |
HU |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
89447 |
|
|
G |
Gemcitabin Actavis 38 mg/ml |
plv ifo 1x1 g (liek.inj.skl.) |
ACT |
IS |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
00538 |
|
|
G |
Gemcitabin Mylan 40 mg/ml infúzny koncentrát |
con inf 1x25 ml/1 g (liek.inj.skl.) |
MLB-F |
FR |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
2495A |
|
|
G |
Gemcitabine Accord 100 mg/ml infúzny koncentrát |
con inf 1x1000 mg/10 ml (liek.inj.skl.) |
ACC |
GB |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
82624 |
|
|
G |
GEMSTAD |
con inf 1x26,3 ml/1000 mg |
STD |
DE |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
79325 |
|
|
G |
Gemcirena 38 mg/ml |
plv ifo 1 x 1000 mg |
FRK |
DE |
1000 |
37.76 |
37.76 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
85896 |
|
|
G |
Gemliquid 10 mg/ml |
con inf 1x100 ml/1000 mg (liek.inj.skl.) |
EBW |
AT |
1000 |
40 |
40 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
02131 |
|
|
G |
Gemliquid 40 mg/ml con inf |
con inf 1x25 ml/1000 mg (liek.inj.skl.+ochr.viečko Onco-Safe) |
EBW |
AT |
1000 |
40 |
40 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
75996 |
|
|
G |
Gemcitabine medac 38 mg/ml prášok na infúzny roztok |
plv ifo 1x1000 mg (liek.inj.skl.) |
MED |
DE |
1000 |
58.51 |
40 |
AS |
18.510000000000002 |
0.31635600000000003 |
0 |
HEM, ONK |
|
|
|
U24 |
L01BC05 |
|
|
|
Gemcitabín |
parent. 2000 mg |
1 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
03852 |
|
|
G |
Gemcirena 38 mg/ml prášok na infúzny roztok |
plv ifo 1x2000 mg (liek. inj. skl.) |
FRK |
CZ |
2000 |
79.61 |
79.61 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
L01BC06 |
|
|
|
Kapecitabin |
p.o. 500 mg (120 ks) |
4 |
g |
|
|
|
|
|
|
|
|
6.625 |
|
|
|
8077A |
|
|
G |
Capecitabin Sandoz 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis.Al/Al) |
SAN |
SI |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1211A |
|
|
G |
Capecitabine Accord 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis.PVC/PVDC/Al) |
ACC |
GB |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2003A |
|
|
G |
Capecitabine Actavis 500 mg |
tbl flm 120x500 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4156A |
|
|
G |
Capecitabine CANDE 500 mg |
tbl flm 120x500 mg (blis.PVC/PE/PVDC/Al) |
CRR-SK |
SK |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4138A |
|
|
G |
Capecitabine Fresenius Kabi 500 mg filmom obalené tablety |
tbl flm(12x10) x500 mg (blis.PVC/PVDC/AL) |
FSN |
UK |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2854A |
|
|
G |
Capecitabine Glenmark 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis.PVC/PVDC/Al) |
GLM-CZ |
CZ |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4199A |
|
|
G |
Capecitabine Pharmacenter 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2398A |
|
|
G |
Capecitabine STADA |
tbl flm 120x500 mg (blis.PVC/PVDC/Al) |
STD |
DE |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1228A |
|
|
G |
Capecitabine Teva 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis.PVC/PE/PVDC/Al) |
TVP-2 |
NL |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4823A |
|
|
G |
Capecitalox 500 mg |
tbl flm 120 x 500 mg (blis Al/PVC/PE/PVDC) |
GNS |
UK |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
3464A |
|
|
G |
Coloxet 500mg |
tbl flm 120x500mg (blis. PVC/PVDC/AL |
EGI |
HU |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1184A |
|
|
G |
Ecansya 500mg filmom obalené tablety |
tbl flm120x500mg(blis.PVC/PVDC/Al) |
KRK |
SL |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
3843A |
|
|
G |
Capecitabine medac 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis.Al/Al) |
MED |
DE |
15 |
115.2 |
99.38 |
S |
15.82 |
0.137326 |
0 |
ONK |
ind.obm. |
|
|
|
3742A |
|
|
G |
Xalvobin 500 mg filmom obalené tablety |
tbl flm 120x500mg (blis.Al/PVC/PE/PVDC) |
ALV-1 |
LU |
15 |
115.2 |
99.38 |
S |
15.82 |
0.137326 |
0 |
ONK |
ind.obm. |
|
|
|
L01BC07 |
|
|
|
Azacitidín |
parent. |
33.75 |
mg |
|
|
|
|
|
|
|
|
128.41999999999999 |
|
|
|
64369 |
|
|
O |
Vidaza |
plv inu 1x100 mg |
CLG-1 |
GB |
2.96 |
380.11 |
380.11 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01BC53 |
|
|
|
Tegafur. kombinácie |
p.o. 15/4,35/11,8 mg (126 ks) |
90 |
mg |
|
|
|
|
|
|
|
|
18.010000000000002 |
|
|
|
07499 |
|
|
O |
TEYSUNO 15 mg/4,35 mg/11,8 mg tvrdé kapsuly |
cps dur 126x15 mg/4,35 mg/11,8 mg (blis.PCTFE/PVC/Al) |
NRC-1 |
NL |
21 |
378.17 |
378.17 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01BC53 |
|
|
|
Tegafur. kombinácie |
p.o. 20/5,8/15,8 mg (84 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
15.644 |
|
|
|
07501 |
|
|
O |
Teysuno 20 mg/5,8 mg/15,8 mg tvrdé kapsuly |
cps dur 84x20 mg/5,8 mg/15,8 mg (blis.PCTFE/PVC/Al) |
NRC-1 |
NL |
21 |
328.51 |
328.51 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01CA01 |
|
|
|
Vinblastin |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
1.153 |
|
|
|
31134 |
|
|
G |
VINBLASTIN RICHTER 5 mg |
plv iol 10x5 mg+5 ml sol. |
GDN |
HU |
50 |
57.6 |
57.6 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01CA02 |
|
|
|
Vinkristin |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
9.1929999999999996 |
|
|
|
31251 |
|
|
G |
VINCRISTIN LIQUID-RICHTER 1MG |
sol inj 5x1 ml/1 mg |
GDN |
HU |
5 |
47.26 |
45.97 |
AS |
1.29 |
2.7296000000000001E-2 |
1.29 |
HEM, ONK |
|
|
|
|
L01CA04 |
|
|
|
Vinorelbin |
p.o. 20 mg (1 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
2.5409999999999999 |
|
|
|
05924 |
|
|
O |
Navelbine Oral |
cps1x20mg |
PFB |
FR |
20 |
50.81 |
50.81 |
I |
0 |
0 |
0 |
ONK |
|
|
|
|
L01CA04 |
|
|
|
Vinorelbin |
p.o. 30 mg (1 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
2.46 |
|
|
|
05925 |
|
|
O |
Navelbine Oral |
cps1x30mg |
PFB |
FR |
30 |
73.58 |
73.58 |
I |
0 |
0 |
0 |
ONK |
|
|
|
|
L01CA04 |
|
|
|
Vinorelbin |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
1.1100000000000001 |
|
|
|
36467 |
|
|
G |
Vinorelbin "EBEWE" 10 mg/ml |
con inf 1x5 ml/50 mg |
EBW |
AT |
50 |
54.85 |
54.85 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
50573 |
|
|
G |
Visera 10 mg/ml |
con inf 1x5 ml/50 mg (liek.inj.skl.) |
ACT |
IS |
50 |
55.49 |
55.49 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
36466 |
|
|
G |
Vinorelbin "EBEWE" 10 mg/ml |
con inf 1x1 ml/10 mg |
EBW |
AT |
10 |
11.1 |
11.1 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
50570 |
|
|
G |
Visera 10 mg/ml |
con inf 1x1 ml/10 mg (liek.inj.skl.) |
ACT-5 |
IS |
10 |
11.1 |
11.1 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
35253 |
|
|
O |
Navelbine 50mg |
con inf 1x5ml/50mg |
PFB |
FR |
50 |
59.5 |
55.5 |
AS |
4 |
6.7226999999999995E-2 |
0 |
HEM, ONK |
|
|
|
|
98203 |
|
|
O |
NAVELBINE |
con inf 10x5 ml/50 mg |
PFB |
FR |
500 |
717.46 |
555 |
AS |
162.46 |
0.226438 |
0 |
HEM, ONK |
|
|
|
|
35252 |
|
|
O |
Navelbine 10mg |
con inf 1x1ml/10mg |
PFB |
FR |
10 |
14.81 |
11.1 |
AS |
3.71 |
0.25050600000000001 |
0 |
HEM, ONK |
|
|
|
|
98197 |
|
|
O |
NAVELBINE |
con inf 10x1 ml/10 mg |
PFB |
FR |
100 |
155.61000000000001 |
111 |
AS |
44.61 |
0.28667799999999999 |
0 |
HEM, ONK |
|
|
|
|
23978 |
|
|
G |
Navirel |
con inf 1x1 ml/10 mg (liek.inj.skl.) |
MCW |
DE |
10 |
17.93 |
11.1 |
AS |
6.83 |
0.38092599999999999 |
0 |
HEM, ONK |
|
|
|
|
23977 |
|
|
G |
Navirel |
con inf 1x5 ml/50 mg (liek.inj.skl.) |
MCW |
DE |
50 |
89.71 |
55.5 |
AS |
34.21 |
0.38134000000000001 |
0 |
HEM, ONK |
|
|
|
|
L01CB01 |
|
|
|
Etopozid |
parent. sol. |
1 |
mg |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
12670 |
|
|
G |
Etoposid "Ebewe" 200 mg |
sol inf 1x200 mg/10 ml |
EBW |
AT |
200 |
19.04 |
19.04 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
12669 |
|
|
G |
Etoposid "Ebewe" 100 mg |
sol inf 1x100 mg/5 ml |
EBW |
AT |
100 |
10.11 |
10.11 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
12668 |
|
|
G |
Etoposid "Ebewe" 50 mg |
sol inf 1x50 mg/2,5 ml |
EBW |
AT |
50 |
5.0599999999999996 |
5.0599999999999996 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01CD01 |
|
|
|
Paklitaxel |
parent. nanočastice viazané na albumín |
1 |
mg |
|
|
|
|
|
|
|
|
2.9039999999999999 |
|
|
|
47858 |
|
|
O |
Abraxane 5 mg/ml prášok na infúznu suspenziu |
plv ins 1x100 mg (liek.inj.skl.) |
CLG |
GB |
100 |
290.31 |
290.31 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01CD01 |
|
|
|
Paklitaxel |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.32 |
|
|
|
32938 |
|
|
G |
PACLITAXEL "Ebewe" 6 mg/ ml |
con inf 1x5 ml/30 mg |
EBW |
AT |
30 |
9.59 |
9.59 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
20362 |
|
|
G |
Paclitaxel Accord 6mg/ml |
con inf 1x5ml/30mg |
ACC |
GB |
30 |
9.59 |
9.59 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
92125 |
|
|
G |
Paclitaxel Hospira 6 mg/ml |
con inf 1x5 ml/30 mg (inj.liek.) |
HSP |
GB |
30 |
9.59 |
9.59 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
38518 |
|
|
G |
Paclitaxel Mylan 6mg/ml |
con inf 1x5ml/30mg |
MRK |
FR |
30 |
9.59 |
9.59 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
20363 |
|
|
G |
Paclitaxel Accord 6mg/ml |
con inf 1x16,7ml/100mg |
ACC |
GB |
100 |
31.98 |
31.98 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
92126 |
|
|
G |
Paclitaxel Hospira 6 mg/ml |
con inf 1x16,7 ml/100mg (inj.liek.) |
HSP |
GB |
100 |
31.98 |
31.98 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
38519 |
|
|
G |
Paclitaxel Mylan 6mg/ml |
con inf 1x16,7ml/100mg |
MRK |
FR |
100 |
31.98 |
31.98 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
32939 |
|
|
G |
PACLITAXEL "Ebewe" 6 mg/ ml |
con inf 1x16,6 ml/100 mg |
EBW |
AT |
100 |
31.99 |
31.99 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
32941 |
|
|
G |
PACLITAXEL "Ebewe" 6 mg/ ml |
con inf 1x50 ml/300 mg |
EBW |
AT |
300 |
96 |
96 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
04401 |
|
|
G |
Paclitaxel Kabi 6 mg/ml |
con inf 1x100ml/600 mg (liek.inj.skl.) |
FRK |
CZ |
600 |
198 |
192 |
AS |
6 |
3.0303E-2 |
0 |
ONK |
|
|
|
|
76882 |
|
|
G |
Paclitaxel Kabi 6 mg/ml |
con inf 1x16,7 ml/100 mg |
FRK |
CZ |
100 |
33 |
32 |
AS |
1 |
3.0303E-2 |
0 |
ONK |
|
|
|
|
76881 |
|
|
G |
Paclitaxel Kabi 6 mg/ml |
con inf 1x5 ml/30 mg |
FRK |
CZ |
30 |
9.9 |
9.6 |
AS |
0.3 |
3.0303E-2 |
0 |
ONK |
|
|
|
|
76883 |
|
|
G |
Paclitaxel Kabi 6 mg/ml |
con inf 1x50 ml/300 mg |
FRK |
CZ |
300 |
99 |
96 |
AS |
3 |
3.0303E-2 |
0 |
ONK |
|
|
|
|
99423 |
|
|
G |
SINDAXEL |
con inf 1x100 mg/16,7 ml |
ACT-5 |
IS |
100 |
33 |
32 |
AS |
1 |
3.0303E-2 |
0 |
ONK |
|
|
|
|
99422 |
|
|
G |
SINDAXEL |
con inf 1x30 mg/5 ml |
ACT-5 |
IS |
30 |
9.9 |
9.6 |
AS |
0.3 |
3.0303E-2 |
0 |
ONK |
|
|
|
|
46795 |
|
|
G |
Sindaxel |
con inf 1x50 ml/300 mg (liek.inj.skl.) |
ACT-5 |
IS |
300 |
99 |
96 |
AS |
3 |
3.0303E-2 |
0 |
ONK |
|
|
|
|
51228 |
|
|
G |
Paclimedac 6mg/ml infúzny koncentrát |
con inf 1x5 ml/30 mg |
MCW |
DE |
30 |
13.4 |
9.6 |
AS |
3.8 |
0.283582 |
0 |
ONK |
|
|
|
|
51229 |
|
|
G |
Paclimedac 6mg/ml infúzny koncentrát |
con inf 1x16,7 ml/100 mg |
MCW |
DE |
100 |
44.67 |
32 |
AS |
12.67 |
0.283636 |
0 |
ONK |
|
|
|
|
L01CD02 |
|
|
|
Docetaxel |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.75 |
|
|
|
1564A |
|
|
G |
Docetaxel Kabi 160 mg/8 ml infúzny koncentrát |
con inf 1x8 ml/160 mg (liek.inj.skl.) |
FSN |
GB |
160 |
119.87 |
119.87 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1559A |
|
|
G |
Docetaxel Accord 20 mg/1 ml infúzny koncentrát |
con inf 1x1 ml/20 mg (liek.inj.skl.) |
ACC |
GB |
20 |
15 |
15 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1560A |
|
|
G |
Docetaxel Accord 80 mg/4 ml infúzny koncentrát |
con inf 1x4 ml/80 mg (liek.inj.skl.) |
ACC |
GB |
80 |
60 |
60 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
83294 |
|
|
G |
Docetaxel Hospira 10 mg/ ml |
con inf 1x2 ml/20 mg (liek.inj.skl.) |
HSP |
GB |
20 |
15 |
15 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
3342A |
|
|
G |
Docetaxel Egis 20mg/1ml |
con inf 1x1 ml/20mg |
EGI |
HU |
20 |
15.13 |
15 |
AS |
0.13 |
8.5919999999999989E-3 |
0 |
ONK |
ind.obm. |
|
|
|
5603A |
|
|
G |
Tolnexa 20 mg/ml infúzny koncentrát |
con inf 1x1ml/20mg (liek. inj.skl.) |
KRK |
SL |
20 |
15.13 |
15 |
AS |
0.13 |
8.5919999999999989E-3 |
0 |
ONK |
ind.obm. |
|
|
|
4373A |
|
|
G |
Docetaxel Egis 20mg/1ml |
con inf 1x4 ml/80mg |
EGI |
HU |
80 |
60.54 |
60 |
AS |
0.54 |
8.9200000000000008E-3 |
0 |
ONK |
ind.obm. |
|
|
|
83295 |
|
|
G |
Docetaxel Hospira 10 mg/ ml |
con inf 1x8 ml/80 mg (liek.inj.skl.) |
HSP |
GB |
80 |
60.54 |
60 |
AS |
0.54 |
8.9200000000000008E-3 |
0 |
ONK |
ind.obm. |
|
|
|
5604A |
|
|
G |
Tolnexa 20 mg/ml infúzny koncentrát |
con inf 1x4ml/80mg (liek. inj.skl.) |
KRK |
SL |
80 |
60.54 |
60 |
AS |
0.54 |
8.9200000000000008E-3 |
0 |
ONK |
ind.obm. |
|
|
|
01168 |
|
|
G |
Camitotic 20 mg/ml |
con inf 1x4 ml/80 mg (liek.inj.skl.+ochr.plast.obal) |
ACT-5 |
IS |
80 |
98.63 |
60 |
AS |
38.630000000000003 |
0.39166600000000001 |
0 |
ONK |
ind.obm. |
|
|
|
01167 |
|
|
G |
Camitotic 20 mg/ml |
con inf 1x1 ml/20 mg (liek.inj.skl.+ochr.plast.obal) |
ACT-5 |
IS |
20 |
26.36 |
15 |
AS |
11.36 |
0.43095599999999995 |
0 |
ONK |
ind.obm. |
|
|
|
1562A |
|
|
G |
Docetaxel Kabi 80 mg/4 ml infúzny koncentrát |
con inf 1x4 ml/80 mg (liek.inj.skl.) |
FSN |
GB |
80 |
105.44 |
60 |
AS |
45.44 |
0.43095599999999995 |
0 |
ONK |
ind.obm. |
|
|
|
3270A |
|
|
G |
Docetaxel Kabi 20 mg/1 ml infúzny koncentrát |
con inf 1x1 ml/20 mg (liek.inj.skl.) |
FSN |
GB |
20 |
26.97 |
15 |
AS |
11.97 |
0.44382599999999994 |
0 |
ONK |
ind.obm. |
|
|
|
86434 |
|
|
G |
Docetaxel Ebewe 10 mg/ml infúzny koncentrát |
con inf 1x8 ml/80 mg (liek.inj.skl) |
EBW |
A |
80 |
217.51 |
60 |
AS |
157.51 |
0.72415099999999999 |
0 |
ONK |
ind.obm. |
|
|
|
86431 |
|
|
G |
Docetaxel Ebewe 10 mg/ml infúzny koncentrát |
con inf 1x2 ml/20 mg (liek.inj.skl) |
EBW |
A |
20 |
59.3 |
15 |
AS |
44.3 |
0.74704899999999996 |
0 |
ONK |
ind.obm. |
|
|
|
L01DB01 |
|
|
|
Doxorubicín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
12663 |
|
|
G |
DOXORUBICIN |
sol ijf 1x5ml/10 mg |
EBW |
AT |
10 |
2.65 |
2.65 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
12664 |
|
|
G |
DOXORUBICIN |
sol ijf 1x25ml/50 mg |
EBW |
AT |
50 |
13.26 |
13.26 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
0082A |
|
|
G |
Doxorubicin Actavis 2 mg/ml |
con inf 1x25 ml/50 mg (liek.inj.skl.) |
ACT-5 |
IS |
50 |
22.11 |
13.5 |
AS |
8.61 |
0.38941699999999996 |
0 |
HEM, ONK |
|
|
|
|
0078A |
|
|
G |
Doxorubicin Actavis 2 mg/ml |
con inf 1x5 ml/10 mg (liek.inj.skl.) |
ACT-5 |
IS |
10 |
4.5 |
2.7 |
AS |
1.8 |
0.4 |
0 |
HEM, ONK |
|
|
|
|
87494 |
|
|
G |
Doxorubicin medac 2mg/ml infúzny roztok |
sol inf 1x25 ml/50 mg (liek.skl.) |
MED |
DE |
50 |
31.15 |
13.5 |
AS |
17.649999999999999 |
0.56661299999999992 |
0 |
HEM, ONK |
|
|
|
|
87490 |
|
|
G |
Doxorubicin medac 2mg/ml infúzny roztok |
sol inf 1x5 ml/10 mg (liek.skl.) |
MED |
DE |
10 |
6.23 |
2.7 |
AS |
3.53 |
0.56661299999999992 |
0 |
HEM, ONK |
|
|
|
|
L01DB01 |
|
|
|
Doxorubicín |
parent. lipozomálny, nepegylovaný |
1 |
mg |
|
|
|
|
|
|
|
|
10.79 |
|
|
|
42120 |
|
|
O |
Myocet 50 mg prášok, disperzia a rozpúšťadlo na koncentrát pre infúznu disperziu |
plv dct 2xset (50 mg prášok+1,9 ml lip.+3 ml tlm.roztoku) (liek.inj.skl.) |
TVP-2 |
NL |
100 |
1078.17 |
1078.17 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01DB01 |
|
|
|
Doxorubicín |
parent. pegylovaný, lipozomálny |
1 |
mg |
|
|
|
|
|
|
|
|
19 |
|
|
|
53712 |
|
|
O |
CAELYX 2 mg/ml infúzny koncentrát |
con inf 1x10 ml (liek.inj.skl.) |
JNS |
BE |
20 |
379.92 |
379.92 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L01DB02 |
|
|
|
Daunorubicín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
96122 |
|
|
O |
DAUNOBLASTINA |
plv iol 1x20 mg + 1x10 ml solv. |
PFI-GB-3 |
GB |
20 |
13.06 |
13.06 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01DB03 |
|
|
|
Epirubicín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.69 |
|
|
|
20076 |
|
|
G |
Epirubicin Accord 2 mg/ml |
sol ijf 1x25ml/50mg (liek.skl.) |
ACC |
GB |
50 |
34.49 |
34.49 |
A |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
52549 |
|
|
G |
Epirubicin Mylan 2mg/ml |
sol inj 1 x 25 ml / 50mg |
MLB-F |
FR |
50 |
34.49 |
34.49 |
A |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
20074 |
|
|
G |
Epirubicin Accord 2 mg/ml |
sol ijf 1x5 ml/10 mg (liek.skl.) |
ACC |
GB |
10 |
6.9 |
6.9 |
A |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
52547 |
|
|
G |
Epirubicin Mylan 2mg/ml |
sol inj 1 x 5 ml /10 mg |
MLB-F |
FR |
10 |
6.9 |
6.9 |
A |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
50133 |
|
|
G |
Epirubicin Actavis 2mg/ml |
sol inj 1x25ml/50mg |
ACT |
IS |
50 |
38.1 |
34.5 |
AS |
3.6 |
9.4488000000000003E-2 |
0 |
HEM, ONK, URO |
|
|
|
|
50131 |
|
|
G |
Epirubicin Actavis 2mg/ml |
sol inj 1x5ml/10mg |
ACT |
IS |
10 |
7.62 |
6.9 |
AS |
0.72 |
9.4488000000000003E-2 |
0 |
HEM, ONK, URO |
|
|
|
|
47346 |
|
|
G |
Epimedac 2 mg/ml |
sol inj 1x25 ml/50 mg |
MCW |
DE |
50 |
38.11 |
34.5 |
AS |
3.61 |
9.4726000000000005E-2 |
0 |
HEM, ONK, URO |
|
|
|
|
34010 |
|
|
O |
FARMORUBICIN PFS |
sol inj 1x25 ml/50 mg (liek.PP) |
PFI-GB-3 |
GB |
50 |
38.79 |
34.5 |
AS |
4.29 |
0.110596 |
0 |
HEM, ONK, URO |
|
|
|
|
47344 |
|
|
G |
Epimedac 2 mg/ml |
sol inj 1x5 ml/10 mg |
MCW |
DE |
10 |
7.83 |
6.9 |
AS |
0.93 |
0.11877399999999999 |
0 |
HEM, ONK, URO |
|
|
|
|
34009 |
|
|
O |
FARMORUBICIN PFS |
sol inj 1x5 ml/10 mg (liek.PP) |
PFI-GB-3 |
GB |
10 |
7.89 |
6.9 |
AS |
0.99 |
0.125475 |
0 |
HEM, ONK, URO |
|
|
|
|
L01DB06 |
|
|
|
Idarubicín |
p.o. 10 mg (1 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
4.92 |
|
|
|
78813 |
|
|
O |
ZAVEDOS 10 mg |
cps dur 1x10 mg (skl.fl.) |
PFI-GB-3 |
GB |
10 |
54.18 |
49.2 |
S |
4.9800000000000004 |
9.1915999999999998E-2 |
4.9800000000000004 |
HEM, ONK |
|
|
|
|
L01DB06 |
|
|
|
Idarubicín |
parent. 10 mg |
1 |
mg |
|
|
|
|
|
|
|
|
11.1 |
|
|
|
01181 |
|
|
O |
ZAVEDOS 10 mg |
plv ino 1x10 mg (liek.inj.skl.) |
PFI-GB-3 |
GB |
10 |
110.91 |
110.91 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01DB07 |
|
|
|
Mitoxantrón |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
7.4930000000000003 |
|
|
|
56073 |
|
|
O |
ONKOTRONE |
inj 1x10,0 ml/20 mg |
XBT-1 |
DE |
20 |
149.85 |
149.85 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01DC03 |
|
|
|
Mitomycín C |
parent. |
20 |
mg |
|
|
|
|
|
|
|
|
30.710999999999999 |
|
|
|
44076 |
|
|
O |
Mitomycin C Kyowa |
plv iio 5x20 mg |
KWH |
JP |
5 |
153.56 |
153.56 |
A |
0 |
0 |
0 |
ONK, URO |
|
|
|
|
L01XA01 |
|
|
|
Cisplatina |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
2042B |
|
|
G |
Cisplatin Kabi 1 mg/1 ml |
con inf 1x50 ml/50 mg ( liek. inj. jantárová) |
FSN |
UK |
50 |
13.25 |
13.25 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
95273 |
|
|
G |
Cisplatina Hospira 1 mg/ml |
con inf 1x10 ml/10 mg (liek.inj.skl.) |
HSP-GB |
GB |
10 |
2.65 |
2.65 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
95274 |
|
|
G |
Cisplatina Hospira 1 mg/ml |
con inf 1x50 ml/50 mg (liek.inj.skl.) |
HSP-GB |
GB |
50 |
13.25 |
13.25 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
2043B |
|
|
G |
Cisplatin Kabi 1 mg/ml |
con inf 1x100 ml/100 mg( liek. inj.jantárová) |
FSN |
UK |
100 |
26.51 |
26.51 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
95275 |
|
|
G |
Cisplatina Hospira 1 mg/ml |
con inf 1x100 ml/100 mg (liek.inj.skl.) |
HSP-GB |
GB |
100 |
26.51 |
26.51 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
L01XA02 |
|
|
|
Karboplatina |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
9.2999999999999999E-2 |
|
|
|
0071A |
|
|
G |
Carboplatin Kabi 10 mg/ml |
con inf 1x45 ml/450 mg (liek.inj.skl.) |
FSN |
UK |
450 |
41.51 |
41.51 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
22426 |
|
|
G |
Carboplatin Accord 10mg/ml infúzny koncentrát |
con inf 1x15ml/150mg (liek.skl.hnedá) |
ACC |
GB |
150 |
13.94 |
13.94 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
0070A |
|
|
G |
Carboplatin Kabi 10 mg/ml |
con inf 1x15 ml/150 mg (liek.inj.skl.) |
FSN |
UK |
150 |
13.94 |
13.94 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
22427 |
|
|
G |
Carboplatin Accord 10mg/ml infúzny koncentrát |
con inf 1x45ml/450mg (liek.skl.hnedá) |
ACC |
GB |
450 |
41.85 |
41.85 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
0072A |
|
|
G |
Carboplatin Kabi 10 mg/ml |
con inf 1x60 ml/600 mg (liek.inj.skl.) |
FSN |
UK |
600 |
55.8 |
55.8 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
22389 |
|
|
G |
Bopacatin 10 mg/ml |
con inf 1x45 ml/450 mg (liek.inj.skl.) |
ACT |
IS |
450 |
51.49 |
41.85 |
AS |
9.64 |
0.187221 |
0 |
ONK |
|
|
|
|
22390 |
|
|
G |
Bopacatin 10 mg/ml |
con inf 1x60 ml/600 mg (liek.inj.skl.) |
ACT-5 |
IS |
600 |
69.709999999999994 |
55.8 |
AS |
13.91 |
0.199541 |
0 |
ONK |
|
|
|
|
22388 |
|
|
G |
Bopacatin 10 mg/ml |
con inf 1x15 ml/150 mg (liek.inj.skl.) |
ACT |
IS |
150 |
17.43 |
13.95 |
AS |
3.48 |
0.19965599999999997 |
0 |
ONK |
|
|
|
|
66509 |
|
|
G |
Carbomedac 10 mg/ml infúzny koncentrát |
con inf 1x15 ml/150 mg |
MED |
DE |
150 |
17.46 |
13.95 |
AS |
3.51 |
0.20103100000000002 |
0 |
ONK |
|
|
|
|
66510 |
|
|
G |
Carbomedac 10 mg/ml infúzny koncentrát |
con inf 1x45 ml/450 mg |
MED |
DE |
450 |
52.39 |
41.85 |
AS |
10.54 |
0.201183 |
0 |
ONK |
|
|
|
|
22425 |
|
|
G |
Carboplatin Accord 10 mg/ml infúzny koncentrát |
con inf 1x5 ml/50 mg (liek.skl.hnedá) |
ACC |
GB |
50 |
5.86 |
4.6500000000000004 |
AS |
1.21 |
0.20648499999999997 |
0 |
ONK |
|
|
|
|
0069A |
|
|
G |
Carboplatin Kabi 10 mg/ml |
con inf 1x5 ml/50 mg (liek.inj.skl.) |
FSN |
UK |
50 |
6.31 |
4.6500000000000004 |
AS |
1.66 |
0.26307400000000003 |
0 |
ONK |
|
|
|
|
66504 |
|
|
G |
Carbomedac 10 mg/ml infúzny koncentrát |
con inf 1x5 ml/50 mg |
MED |
DE |
50 |
6.46 |
4.6500000000000004 |
AS |
1.81 |
0.28018599999999999 |
0 |
ONK |
|
|
|
|
L01XA03 |
|
|
|
Oxaliplatina |
parent. |
80 |
mg/m2 |
|
|
|
|
|
|
|
|
2.2530000000000001 |
|
|
|
80761 |
|
|
G |
Oxaliplatin Kabi 5 mg/ml |
con inf 1x20 ml/100 mg (liek.inj.skl.) |
FSN |
GB |
9.3000000000000007 |
20.95 |
20.95 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
44922 |
|
|
G |
Oxaliplatina Mylan 5mg/ml |
plv ifo 1 x 100 mg + 20 ml solv. |
MRK |
FR |
9.41 |
21.2 |
21.2 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
80760 |
|
|
G |
Oxaliplatin Kabi 5 mg/ml |
con inf 1x10 ml/50 mg (liek.inj.skl.) |
FSN |
GB |
4.7 |
10.59 |
10.59 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
44916 |
|
|
G |
Oxaliplatina Mylan 5mg/ml |
plv ifo 1x50mg + 10ml solv. |
MRK |
FR |
4.7 |
10.59 |
10.59 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
47321 |
|
|
G |
Oxaliplatina Hospira 5 mg/ml infúzny koncentrát |
con inf 1x10 ml |
HSP |
GB |
4.71 |
30.27 |
10.61 |
AS |
19.66 |
0.64948800000000007 |
0 |
ONK |
ind.obm. |
|
|
|
47322 |
|
|
G |
Oxaliplatina Hospira 5 mg/ml infúzny koncentrát |
con inf 1x20 ml |
HSP |
GB |
9.41 |
60.6 |
21.2 |
AS |
39.4 |
0.65016499999999988 |
0 |
ONK |
ind.obm. |
|
|
|
02014 |
|
|
G |
Oxaliplatin Sandoz 5 mg/ml infúzny koncentrát |
con inf 1x10 ml/50 mg (liek.skl.) |
SAN-SLO-1 |
SI |
4.71 |
30.39 |
10.61 |
AS |
19.78 |
0.65087200000000001 |
0 |
ONK |
ind.obm. |
|
|
|
02019 |
|
|
G |
Oxaliplatin Sandoz 5 mg/ml infúzny koncentrát |
con inf 1x20 ml/100 mg (liek.skl.) |
SAN-SLO-1 |
SI |
9.41 |
60.77 |
21.2 |
AS |
39.57 |
0.65114400000000006 |
0 |
ONK |
ind.obm. |
|
|
|
49687 |
|
|
G |
Oxaliplatina Actavis 5mg/ml |
plv ifo 1x100mg |
ACT |
IS |
9.4 |
60.77 |
21.18 |
AS |
39.590000000000003 |
0.65147299999999997 |
0 |
ONK |
ind.obm. |
|
|
|
49686 |
|
|
G |
Oxaliplatina Actavis 5mg/ml |
plv ifo 1x50mg |
ACT |
IS |
4.7 |
30.39 |
10.59 |
AS |
19.8 |
0.65153000000000005 |
0 |
ONK |
ind.obm. |
|
|
|
31458 |
|
|
G |
Sinoxal 5 mg/ml |
con inf 1x10 ml/50 mg (liek.inj.skl.) |
ACT-5 |
IS |
4.71 |
37.380000000000003 |
10.61 |
AS |
26.77 |
0.71615799999999996 |
0 |
ONK |
ind.obm. |
|
|
|
31459 |
|
|
G |
Sinoxal 5 mg/ml |
con inf 1x20 ml/100 mg (liek.inj.skl.) |
ACT-5 |
IS |
9.41 |
74.84 |
21.2 |
AS |
53.64 |
0.71672899999999995 |
0 |
ONK |
ind.obm. |
|
|
|
37600 |
|
|
G |
Oxaliplatin medac 5mg/ml |
plv ifo 1x50 mg |
MDW |
DE |
4.7 |
40.07 |
10.59 |
AS |
29.48 |
0.73571299999999995 |
0 |
ONK |
ind.obm. |
|
|
|
37601 |
|
|
G |
Oxaliplatin medac 5mg/ml |
plv ifo 1x100 mg |
MDW |
DE |
9.41 |
80.25 |
21.2 |
AS |
59.05 |
0.73582599999999998 |
0 |
ONK |
ind.obm. |
|
|
|
L01XC02 |
|
|
|
Rituximab |
s.c.1400 mg |
1 |
DF |
|
|
|
|
|
|
|
|
1739.78 |
|
|
|
9687A |
|
|
O |
Mabthera 1400 mg roztok na subkutánnu injekciu |
sol icu 1x11,7 ml/1400 mg (liek.inj.skl.) |
HLR-GB |
GB |
1 |
1739.78 |
1739.78 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XC02 |
|
|
|
Rituximab |
parent. 100 mg |
86 |
mg |
|
|
|
|
|
|
|
|
213.08 |
|
|
|
59839 |
|
|
O |
MABTHERA 100MG |
con inf 2x100 mg |
HLR |
DE |
2.3260000000000001 |
495.6 |
495.6 |
A |
0 |
0 |
0 |
HEM, ONK, REU |
ind.obm., ZP |
|
|
|
L01XC02 |
|
|
|
Rituximab |
parent. 500 mg |
86 |
mg |
|
|
|
|
|
|
|
|
210.91 |
|
|
|
46130 |
|
|
O |
MABTHERA 500MG |
con inf 1x500 mg |
HLR |
DE |
5.8140000000000001 |
1226.1600000000001 |
1226.1600000000001 |
A |
0 |
0 |
0 |
HEM, ONK, REU |
ind.obm., ZP |
|
|
|
L01XC03 |
|
|
|
Trastuzumab |
parent. 150 mg |
1 |
DF |
|
|
|
|
|
|
|
|
576.05999999999995 |
|
|
|
05959 |
|
|
O |
HERCEPTIN 150 mg |
plc ifo 1x150 mg |
HLR |
DE |
1 |
576.05999999999995 |
576.05999999999995 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC03 |
|
|
|
Trastuzumab |
s.c. 600 mg |
28.571999999999999 |
mg |
|
|
|
|
|
|
|
|
81.34 |
|
|
|
6957A |
|
|
O |
Herceptin 600 mg/5 ml injekčný roztok |
sol inj 1x5 ml (liek.inj.skl.) |
HLR-GB |
GB |
21 |
1708.12 |
1708.12 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC06 |
|
|
|
Cetuximab |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
206.33 |
|
|
|
40890 |
|
|
O |
ERBITUX |
sol inf 1x20 ml (5 mg/ml) (skl. liek.) |
MEC |
DE |
1 |
206.33 |
206.33 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC07 |
|
|
|
Bevacizumab |
parent. 100 mg |
5 |
mg/kg |
|
|
|
|
|
|
|
|
15.801 |
|
|
|
42389 |
|
|
O |
Avastin 25 mg/ml |
con inf 1x4ml/100 mg |
HLR |
DE |
20 |
316.01 |
316.01 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC07 |
|
|
|
Bevacizumab |
parent. 400 mg |
5 |
mg/kg |
|
|
|
|
|
|
|
|
14.49 |
|
|
|
42415 |
|
|
O |
Avastin 25 mg/ml |
con inf 1x16ml/400 mg |
HLR |
DE |
80 |
1159.0999999999999 |
1159.0999999999999 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC08 |
|
|
|
Panitumumab |
parent. |
400 |
mg |
|
|
|
|
|
|
|
|
1675.68 |
|
|
|
47011 |
|
|
O |
VECTIBIX |
con inf 1x5 ml (20 mg/ ml) |
AMG |
NL |
0.25 |
418.92 |
418.92 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
47013 |
|
|
O |
VECTIBIX |
con inf 1x20 ml (20 mg/ ml) |
AMG |
NL |
1 |
1689.97 |
1675.68 |
AS |
14.29 |
8.456E-3 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC15 |
|
|
|
Obinutuzumab |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
4400.3599999999997 |
|
|
|
1191B |
|
|
O |
Gazyvaro 1 000 mg infúzny koncentrát |
con inf 1x40 ml (liek inj.skl.) |
HLR-GB |
GB |
1 |
4400.3599999999997 |
4400.3599999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XD03 |
|
|
|
Metylaminolevulonát |
loc. |
2 |
g |
|
|
|
|
|
|
|
|
204.81 |
|
|
|
41469 |
|
|
O |
METVIX |
crm 1x2 g |
GAD |
FR |
1 |
204.81 |
204.81 |
A |
0 |
0 |
0 |
DER, ONK |
ind.obm. |
|
|
|
L01XE01 |
|
|
|
Imatinib |
p.o. 100 mg (60 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
12.8 |
|
|
|
4391A |
|
|
G |
Imatinib Fresenius Kabi 100 mg |
tbl flm,p.o. 60x100 mg |
FRK-1 |
D |
60 |
671.53 |
671.53 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4026A |
|
|
G |
Meaxin 100mg filmom obalené tablety |
tbl flm 60x100mg(blis.PVC/PE/PVDC/Al) |
KRK |
SL |
60 |
671.53 |
671.53 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
41160 |
|
|
O |
Glivec 100mg |
tbl flm 60x100 mg |
NEH |
GB |
60 |
1154.6600000000001 |
768 |
S |
386.66 |
0.33486899999999997 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE01 |
|
|
|
Imatinib |
p.o. 400 mg (30 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
12.71 |
|
|
|
4397A |
|
|
G |
Imatinib Fresenius Kabi 400 mg |
tbl flm,p.o. 30x400 mg |
FRK-1 |
D |
120 |
1389.83 |
1389.83 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4035A |
|
|
G |
Meaxin 400mg filmom obalené tablety |
tbl flm 30x400mg(blis.PVC/PE/PVDC/Al) |
KRK |
SL |
120 |
1389.83 |
1389.83 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
41162 |
|
|
O |
Glivec 400mg |
tbl flm 30x400 mg |
NEH |
GB |
120 |
2215.42 |
1525.2 |
S |
690.22 |
0.31155300000000002 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE02 |
|
|
|
Gefitinib |
p.o. 250 mg (30 ks) |
250 |
mg |
|
|
|
|
|
|
|
|
72.52 |
|
|
|
87371 |
|
|
O |
IRESSA |
tbl flm 30(3x10) x 250 mg (blis.PVC/Al neperfor.) |
AZC |
SE |
30 |
2175.5300000000002 |
2175.5300000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
78264 |
|
|
O |
IRESSA |
tbl flm 30x250 mg |
AZC |
SE |
30 |
2175.5300000000002 |
2175.5300000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE03 |
|
|
|
Erlotinib |
p.o. 100 mg (30 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
77.373000000000005 |
|
|
|
94488 |
|
|
O |
Tarceva 100 mg |
tbl flm 30x100 mg |
HLR |
DE |
20 |
1547.39 |
1547.39 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE03 |
|
|
|
Erlotinib |
p.o. 150 mg (30 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
65.23 |
|
|
|
94490 |
|
|
O |
Tarceva 150 mg |
tbl flm 30x150 mg |
HLR |
DE |
30 |
1956.8 |
1956.8 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE04 |
|
|
|
Sunitinib |
p.o. 12,5 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
161.56399999999999 |
|
|
|
35915 |
|
|
O |
SUTENT |
cps dur 30x12,5 mg (fľaša HDPE) |
PFI-GB-1 |
GB |
7.5 |
1211.73 |
1211.73 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE04 |
|
|
|
Sunitinib |
p.o. 25 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
160.785 |
|
|
|
35916 |
|
|
O |
SUTENT |
cps dur 30x25 mg (fľaša HDPE) |
PFI-GB-1 |
GB |
15 |
2411.77 |
2411.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE04 |
|
|
|
Sunitinib |
p.o. 50 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
160.065 |
|
|
|
35917 |
|
|
O |
SUTENT |
cps dur 30x50 mg (fľaša HDPE) |
PFI-GB-1 |
GB |
30 |
4801.9399999999996 |
4801.9399999999996 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE05 |
|
|
|
Sorafenib |
p.o. 200 mg (112 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
123.605 |
|
|
|
36227 |
|
|
O |
NEXAVAR |
tbl flm 112 x 200 mg |
BAS |
DE |
28 |
3460.93 |
3460.93 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE06 |
|
|
|
Dasatinib |
p.o. 70 mg (60 ks) |
140 |
mg |
|
|
|
|
|
|
|
|
119.42 |
|
|
|
37369 |
|
|
O |
SPRYCEL 70 mg |
tbl flm 60x70 mg |
BMS |
GB |
30 |
3582.57 |
3582.57 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE07 |
|
|
|
Lapatinib |
p.o. 250 mg (70 ks) |
1250 |
mg |
|
|
|
|
|
|
|
|
79.180000000000007 |
|
|
|
07339 |
|
|
O |
Tyverb |
tbl flm 70x250 mg (fľaša HDPE) |
GLA |
GB |
14 |
1108.43 |
1108.43 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE08 |
|
|
|
Nilotinib |
p.o. 150 mg (112-120 ks) |
600 |
mg |
|
|
|
|
|
|
|
|
103.3552 |
|
|
|
11645 |
|
|
O |
TASIGNA 150 mg |
cps dur 120 (3x40)x 150 mg (blis. PVC/PVDC/Al) |
NEH |
GB |
30 |
3100.65 |
3100.65 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE08 |
|
|
|
Nilotinib |
p.o. 200 mg (112-120 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
127.36 |
|
|
|
11647 |
|
|
O |
TASIGNA 200 mg |
cps dur 120 (3x40)x 200 mg (lis. PVC/PVDC/Al) |
NEH |
GB |
30 |
3820.39 |
3820.39 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE09 |
|
|
|
Temsirolimus |
parent. |
25 |
mg |
|
|
|
|
|
|
|
|
834.16 |
|
|
|
46872 |
|
|
O |
TORISEL 30 mg koncentrát a rozpúšťadlo na infúzny roztok |
cif fol 1x1,2 ml/30 mg + 1x2,2 ml solv. (liek.inj.skl.) |
PFI-GB-1 |
GB |
1 |
834.16 |
834.16 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE10 |
|
|
|
Everolimus |
p.o. 5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
164.83 |
|
|
|
79395 |
|
|
O |
AFINITOR 5 mg |
tbl 30x5 mg |
NEH |
GB |
15 |
2472.34 |
2472.34 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE10 |
|
|
|
Everolimus |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
116.66 |
|
|
|
79398 |
|
|
O |
AFINITOR 10 mg |
tbl 30x10 mg |
NEH |
GB |
30 |
3499.66 |
3499.66 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE11 |
|
|
|
Pazopanib |
p.o. 200 mg (90 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
98.123999999999995 |
|
|
|
20582 |
|
|
O |
Votrient |
tbl flm 90x200 mg |
NEH-1 |
GB |
22.5 |
2207.7800000000002 |
2207.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE11 |
|
|
|
Pazopanib |
p.o. 400 mg (30 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
101.8 |
|
|
|
20584 |
|
|
O |
Votrient |
tbl flm 30x400 mg |
NEH-1 |
GB |
15 |
1527 |
1527 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE13 |
|
|
|
Afatinib |
p.o. 20 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
75.099999999999994 |
|
|
|
7594A |
|
|
O |
GIOTRIF 20 mg filmom obalené tablety |
tbl flm 28x1x20 mg (blis.PVC/PVDC-perf.) |
BOE |
DE |
28 |
2102.7800000000002 |
2102.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE13 |
|
|
|
Afatinib |
p.o. 30 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
75.099999999999994 |
|
|
|
7597A |
|
|
O |
GIOTRIF 30 mg filmom obalené tablety |
tbl flm 28x1x30 mg (blis.PVC/PVDC-perf.) |
BOE |
DE |
28 |
2102.7800000000002 |
2102.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE13 |
|
|
|
Afatinib |
p.o. 40 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
75.099999999999994 |
|
|
|
7600A |
|
|
O |
GIOTRIF 40 mg filmom obalené tablety |
tbl flm 28x1x40 mg (blis.PVC/PVDC-perf.) |
BOE |
DE |
28 |
2102.7800000000002 |
2102.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE13 |
|
|
|
Afatinib |
p.o. 50 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
75.099999999999994 |
|
|
|
7603A |
|
|
O |
GIOTRIF 50 mg filmom obalené tablety |
tbl flm 28x1x50 mg (blis.PVC/PVDC-perf.) |
BOE |
DE |
28 |
2102.7800000000002 |
2102.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XX02 |
|
|
|
Asparagináza |
parent. 5000 U |
1 |
mg |
|
|
|
|
|
|
|
|
384.47 |
|
|
|
40588 |
|
|
O |
Asparaginase medac 5000 |
plv iol 5x5000 U |
MED |
DE |
1 |
384.46 |
384.46 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L01XX02 |
|
|
|
Asparagináza |
parent. 10000 U |
2 |
mg |
|
|
|
|
|
|
|
|
537.51 |
|
|
|
40589 |
|
|
O |
Asparaginase medac 10000 |
plv iol 5x10000 U |
MED |
DE |
1 |
537.5 |
537.5 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L01XX11 |
|
|
|
Estramustin |
p.o. 140 mg (100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
58742 |
X |
|
O |
ESTRACYT 140 mg |
cps dur 100x140 mg |
PFI-GB-3 |
GB |
1400 |
92.37 |
92.37 |
I |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
L01XX17 |
|
|
|
Topotekan |
p.o. 0,25 mg (10 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
31.73 |
|
|
|
49736 |
X |
|
O |
Hycamtin |
cps dur 10x0,25 mg |
NEH-1 |
GB |
2.5 |
79.33 |
79.33 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX17 |
|
|
|
Topotekan |
p.o. 1 mg (10 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
30.51 |
|
|
|
49737 |
X |
|
O |
Hycamtin |
cps dur 10x1,0 mg |
SKB |
GB |
10 |
305.08 |
305.08 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX17 |
|
|
|
Topotekan |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
24.22 |
|
|
|
03463 |
|
|
G |
Topotecan Kabi 4 mg |
plc ifo 1x4 mg (liek.inj.skl.) |
FSN |
GB |
4 |
59.39 |
59.39 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
20666 |
|
|
G |
Topotecan Hospira |
con inf 5x4 ml/4 mg (liek.inj.skl.) |
HSP |
GB |
20 |
369 |
369 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2773A |
|
|
G |
Topotecan Accord 1 mg/ml infúzny koncentrát |
con inf 1x1 ml/1 mg (liek.inj.skl.jantárová) |
ACC |
UK |
1 |
19.27 |
19.27 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2774A |
|
|
G |
Topotecan Accord 1 mg/ml infúzny koncentrát |
con inf 1x4 ml/4 mg (liek.inj.skl.jantárová) |
ACC |
GB |
4 |
77.08 |
77.08 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
06609 |
|
|
G |
Topotecan medac 1 mg/ml infúzny koncentrát |
con inf 1x1 ml/1 mg (liek.inj.skl.) |
MED |
DE |
1 |
34.76 |
24.22 |
AS |
10.54 |
0.30322199999999999 |
0 |
ONK |
ind.obm. |
|
|
|
06613 |
|
|
G |
Topotecan medac 1 mg/ml infúzny koncentrát |
con inf 1x4 ml/4 mg (liek.inj.skl.) |
MED |
DE |
4 |
139.04 |
96.88 |
AS |
42.16 |
0.30322199999999999 |
0 |
ONK |
ind.obm. |
|
|
|
56649 |
|
|
O |
HYCAMTIN |
plv ifo 5x4 mg |
NEH-1 |
GB |
20 |
749.01 |
484.4 |
AS |
264.61 |
0.35328000000000004 |
0 |
ONK |
ind.obm. |
|
|
|
15917 |
|
|
O |
HYCAMTIN |
plv ifo 1x1 mg |
NEH-1 |
GB |
1 |
57.03 |
24.22 |
AS |
32.81 |
0.57531100000000002 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX19 |
|
|
|
Irinotekan |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.17199999999999999 |
|
|
|
86627 |
|
|
G |
Irinotecan Fresenius 20 mg/ml infúzny koncentrát |
con inf 1x5 ml/100 mg (liek.skl.hnedá) |
FSN |
GB |
100 |
17.2 |
17.2 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
58653 |
|
|
G |
Irinotecan Mylan 20mg/ml |
con inf 1 x 2 ml / 40mg |
MLB-F |
FR |
40 |
6.88 |
6.88 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
58658 |
|
|
G |
Irinotecan Mylan 20mg/ml |
con inf 1 x 5 ml / 100mg |
MLB-F |
FR |
100 |
17.2 |
17.2 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
82012 |
|
|
G |
Irinotecan STADA 20 mg/ml |
con inf 1x2 ml/40 mg |
STD |
DE |
40 |
6.88 |
6.88 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
82013 |
|
|
G |
Irinotecan STADA 20 mg/ml |
con inf 1x5 ml/100 mg |
STD |
DE |
100 |
17.2 |
17.2 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
86626 |
|
|
G |
Irinotecan Fresenius 20 mg/ml infúzny koncentrát |
con inf 1x2 ml/40 mg (liek.skl.hnedá) |
FSN |
GB |
40 |
6.94 |
6.88 |
AS |
0.06 |
8.6460000000000009E-3 |
0 |
ONK |
ind.obm. |
|
|
|
46844 |
|
|
G |
Irinotecan HCL Actavis 20mg/ml |
con inf 1x2xml/40mg |
ACT |
IS |
40 |
16.559999999999999 |
6.88 |
AS |
9.68 |
0.58454099999999998 |
0 |
ONK |
ind.obm. |
|
|
|
78210 |
|
|
G |
Irinotecan medac 20 mg/ml |
con inf 1x40 mg/2 ml (liek.skl.hnedá) |
MED |
DE |
40 |
16.559999999999999 |
6.88 |
AS |
9.68 |
0.58454099999999998 |
0 |
ONK |
ind.obm. |
|
|
|
46845 |
|
|
G |
Irinotecan HCL Actavis 20mg/ml |
con inf 1x5ml/100mg |
ACT |
IS |
100 |
41.41 |
17.2 |
AS |
24.21 |
0.58464099999999997 |
0 |
ONK |
ind.obm. |
|
|
|
41350 |
|
|
G |
Irinotecan Hospira 20 mg/ml infúzny koncentrát |
con inf 1x5ml/100 mg |
HSP |
GB |
100 |
41.41 |
17.2 |
AS |
24.21 |
0.58464099999999997 |
0 |
ONK |
ind.obm. |
|
|
|
78211 |
|
|
G |
Irinotecan medac 20 mg/ml |
con inf 1x100 mg/5 ml (liek.skl.hnedá) |
MED |
DE |
100 |
41.41 |
17.2 |
AS |
24.21 |
0.58464099999999997 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX23 |
|
|
|
Mitotan |
p.o. 500 mg (100 ks) |
3 |
g |
|
|
|
|
|
|
|
|
36.71 |
|
|
|
40828 |
X |
|
O |
LYSODREN |
tbl 100x500 mg |
BMS |
IT |
16.5 |
605.64 |
605.64 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX25 |
|
|
|
Bexaroten |
p.o. 75 mg (100 ks) |
300 |
mg/m2 |
|
|
|
|
|
|
|
|
39.170999999999999 |
|
|
|
98994 |
X |
|
O |
TARGRETIN |
cps mol 100x75 mg |
LGD |
GB |
25 |
979.26 |
979.26 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XX32 |
|
|
|
Bortezomib |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
199.55 |
|
|
|
5046B |
|
|
G |
Bortega 3,5 mg |
plv ino 1x3,5 mg (liek.inj.skl.) |
HTN |
CZ |
5.25 |
684.32 |
684.32 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4562B |
|
|
G |
Bortezomib Glenmark 3,5 mg |
plv ino 1x3,5 mg (liek.inj.skl.) |
GLM-CZ |
CZ |
5.25 |
684.32 |
684.32 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4973B |
|
|
G |
Bortezomib Pharmevid 3,5 mg prašok na injekčný roztok |
plv ino 1x3,5 mg (liek.inj.skl.) |
PEV |
SK |
5.25 |
684.32 |
684.32 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4443B |
|
|
G |
Zegomib 3,5mg |
plv ino 1x3,5mg (liek.inj.skl.) |
EGI |
HU |
5.25 |
684.32 |
684.32 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
40531 |
|
|
O |
VELCADE |
plv ino 1x3,5 mg |
JNS |
BE |
5.25 |
1047.6199999999999 |
1047.6199999999999 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XX35 |
|
|
|
Anagrelid |
p.o. 0,5 mg (100 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
14.54 |
|
|
|
47614 |
|
|
O |
THROMBOREDUCTIN 0,5 mg |
cps 100x0,5 mg |
ORV |
AT |
25 |
363.35 |
363.35 |
I |
0 |
0 |
0 |
HEM |
ind.obm., ZP |
|
|
|
L01XX44 |
|
|
|
Aflibercept |
parent. 100 mg |
4 |
mg/kg |
|
|
|
|
|
|
|
|
14.752000000000001 |
|
|
|
4323A |
|
|
O |
ZALTRAP 25 mg/ml infúzny koncentrát |
con inf 1x4 ml/100 mg (liek.inj.skl.) |
SOI |
FR |
25 |
368.8 |
368.8 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XX44 |
|
|
|
Aflibercept |
parent. 200 mg |
4 |
mg/kg |
|
|
|
|
|
|
|
|
14.624000000000001 |
|
|
|
4325A |
|
|
O |
ZALTRAP 25 mg/ml infúzny koncentrát |
con inf 1x8 ml/200 mg (liek.inj.skl.) |
SOI |
FR |
50 |
731.12 |
731.12 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L02AB01 |
|
|
|
Megestrol |
p.o. 160 mg (100 ks) |
0.16 |
g |
|
|
|
|
|
|
|
|
0.73470000000000002 |
|
|
|
34950 |
X |
|
G |
MEGESIN 160mg |
tbl 100x160 mg |
ACT-5 |
IS |
100 |
71.69 |
71.69 |
I |
0 |
0 |
0 |
GYN, HEM, ONK, TRN, URO, INF |
|
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 3,75 mg inj. |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.0699999999999998 |
|
|
|
2722A |
|
|
O |
Lutrate Depot 3,75 mg |
plu igf 1x3,75 mg+1x2ml solv.(liek.inj.skl.+striek.inj.napl.+adaptér HDPE+ihla) |
XCC |
AT |
28.846 |
99.96 |
59.71 |
S |
40.25 |
0.40266099999999999 |
40.25 |
GYN, ONK, URO |
ind.obm. |
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 5 mg imp. |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.2029999999999998 |
|
|
|
80448 |
|
|
G |
Leuprorelin Sandoz 5 mg implantát |
imp 1x5 mg ( striek. inj. napl. plast. ) |
SAN |
SI |
84 |
184.86 |
184.86 |
I |
0 |
0 |
0 |
ONK, URO |
|
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 7,5 mg plv. iol. |
0.25 |
mg |
|
|
|
|
|
|
|
|
2.5009999999999999 |
|
|
|
42281 |
|
|
O |
ELIGARD 7,5 mg |
plv iol 1x 7,5mg + 1x sol. |
YEU |
NL |
30 |
75.03 |
75.03 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 22,5 mg plv. iol. |
0.25 |
mg |
|
|
|
|
|
|
|
|
2.29 |
|
|
|
42283 |
|
|
O |
ELIGARD 22,5 mg |
plv iol 1x 22,5mg + 1x sol. |
YEU |
NL |
90 |
204.8 |
204.8 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 45 mg plv. iol. |
0.25 |
mg |
|
|
|
|
|
|
|
|
2.34 |
|
|
|
46793 |
|
|
O |
Eligard 45 mg |
plv iol 1x 45 mg + 1 solv. (vanička) |
ASL-CZ |
CZ |
180 |
420.6 |
420.6 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
U25 |
L02AE03 |
|
|
|
Goserelin |
parent. depot. 3,6 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.5649999999999999 |
|
|
|
99174 |
|
|
O |
ZOLADEX DEPOT 3,6 mg |
imp 1x3,6 mg |
AZC |
GB |
27.907 |
71.52 |
71.52 |
I |
0 |
0 |
0 |
GYN, ONK, RPM, URO |
ind.obm. |
|
|
|
L02AE03 |
|
|
|
Goserelin |
parent. depot. 10,8 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.72 |
|
|
|
12320 |
|
|
O |
ZOLADEX LA DEPOT 10,8MG |
imp 1x10,8 mg |
AZC |
GB |
83.721000000000004 |
227.32 |
227.32 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02AE04 |
|
|
|
Triptorelín |
parent. 0,1 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
4.8 |
|
|
|
58623 |
|
|
O |
DIPHERELINE 0,1 mg |
plv iol 7x0,1 mg + sol. |
IPE |
FR |
5.2240000000000002 |
26.73 |
25.08 |
S |
1.65 |
6.1727999999999998E-2 |
1.65 |
GYN, ONK, RPM, URO |
ind.obm. |
|
|
|
62707 |
|
|
O |
DECAPEPTYL |
sol inj 7x0,1 mg/1 ml |
FEI |
DE |
5.2240000000000002 |
40.04 |
25.08 |
S |
14.96 |
0.37362600000000001 |
1.65 |
GYN, ONK, RPM, URO |
ind.obm. |
|
|
|
L02AE04 |
|
|
|
Triptorelín |
parent. 3,75 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
3.0750000000000002 |
|
|
|
01656 |
|
|
O |
DIPHERELINE S.R. 3.75 mg |
plv iud 1x3,75 mg+ sol. |
IPE |
FR |
27.984999999999999 |
86.01 |
86.01 |
I |
0 |
0 |
0 |
END, ENP, GYN, ONK, RPM, URO |
ind.obm. |
|
|
|
L02AE04 |
|
|
|
Triptorelín |
parent. 11,25 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.83 |
|
|
|
06215 |
|
|
O |
DIPHERELINE S.R. 11.25 mg |
plv iud 1x11,25 mg+ sol. |
IPE |
FR |
83.954999999999998 |
236.97 |
236.97 |
I |
0 |
0 |
0 |
END, ENP, GYN, ONK, URO |
ind.obm. |
|
|
|
L02AE04 |
|
|
|
Triptorelín |
parent. depot. |
0.13 |
mg |
|
|
|
|
|
|
|
|
3.0049999999999999 |
|
|
|
96107 |
|
|
O |
DECAPEPTYL DEPOT |
plv iul 1x3,75 mg |
FEI |
DE |
27.984999999999999 |
84.03 |
84.03 |
I |
0 |
0 |
0 |
END, ENP, GYN, ONK, RPM, URO |
ind.obm. |
|
|
|
L02BA01 |
|
|
|
Tamoxifén |
p.o. 10 mg (100 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.19739999999999999 |
|
|
|
58701 |
X |
|
G |
TAMOXIFEN |
tbl 100x10 mg |
EBW |
AT |
50 |
10.14 |
9.8699999999999992 |
S |
0.27 |
2.6627000000000001E-2 |
0.27 |
ONK, URO, |
|
|
|
|
L02BA01 |
|
|
|
Tamoxifén |
p.o. 20 mg (100 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.18590000000000001 |
|
|
|
58702 |
X |
|
G |
TAMOXIFEN |
tbl 100x20 mg |
EBW |
AT |
100 |
18.82 |
18.59 |
S |
0.23 |
1.2220999999999999E-2 |
0.23 |
ONK, URO, |
|
|
|
|
L02BA03 |
|
|
|
Fulvestrant |
parent. |
16.600000000000001 |
mg |
|
|
|
|
|
|
|
|
21.01 |
|
|
|
40812 |
|
|
O |
FASLODEX |
sol inj 1x5 ml (250 mg/5 ml) |
AZC |
GB |
15.06 |
316.33 |
316.33 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BB01 |
|
|
|
Flutamid |
p.o. 250 mg (90-100 ks) |
0.75 |
g |
|
|
|
|
|
|
|
|
1 |
|
|
|
40460 |
X |
|
G |
FLUTASIN250mg |
tbl 90x250 mg |
ACT-5 |
IS |
30 |
29.99 |
29.99 |
I |
0 |
0 |
0 |
ONK, URO |
|
|
|
|
L02BB03 |
|
|
|
Bikalutamid |
p.o. 50 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
58677 |
X |
|
G |
Binabic 50 mg filmom obalené tablety |
tbl flm 28x50 mg |
VIH |
PL |
28 |
14.16 |
4.2 |
S |
9.9600000000000009 |
0.70338999999999996 |
9.9600000000000009 |
ONK, URO |
ind.obm. |
|
|
|
L02BB03 |
|
|
|
Bikalutamid |
p.o. 150 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.5 |
|
|
|
58679 |
X |
|
G |
Binabic 150 mg |
tbl flm 28x150 mg (blis. PVC/PVDC/Al) |
VIH |
PL |
84 |
41.6 |
41.6 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
22291 |
X |
|
G |
Bicacel 150 mg |
tbl flm 30x150 mg (blis.PVC/PE/PVDC/Al) |
GLM-CZ |
CZ |
90 |
44.58 |
44.58 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
54433 |
X |
|
G |
Bicusan 150 mg |
tbl flm 30x150 mg |
ACT |
IS |
90 |
44.58 |
44.58 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
2473B |
X |
|
G |
Brectasa 150 mg |
tbl flm 30x150 mg (blis.PVC/Al) |
ACT-5 |
IS |
90 |
44.58 |
44.58 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02BB03 |
|
|
|
Bikalutamid |
p.o. 150 mg (90-98 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.5 |
|
|
|
0806B |
X |
|
G |
Binabic 150 mg |
tbl flm 98x150 mg (blis.PVC/PVDC/Al) |
VIH |
PL |
294 |
145.61000000000001 |
145.61000000000001 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
46903 |
X |
|
G |
Bicalutamid - Teva 150 mg |
tbl flm 90x150 mg |
TEV |
SK |
270 |
133.72999999999999 |
133.72999999999999 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
22315 |
X |
|
G |
Bicalutamide Pharmevid 150 mg |
tbl flm 90x150 mg (blis. PVC/PE/PVDC/Al) |
PMT-SK |
SK |
270 |
133.72999999999999 |
133.72999999999999 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
54439 |
X |
|
G |
Bicusan 150 mg |
tbl flm 90x150 mg |
ACT-5 |
IS |
270 |
133.72999999999999 |
133.72999999999999 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
2478B |
X |
|
G |
Brectasa 150 mg |
tbl flm 90x150 mg (blis.PVC/Al) |
ACT-5 |
IS |
270 |
133.72999999999999 |
133.72999999999999 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02BB04 |
|
|
|
Enzalutamid |
p.o. 40 mg (112 cps.) |
0.16 |
g |
|
|
|
|
|
|
|
|
127.26300000000001 |
|
|
|
6336A |
|
|
O |
Xtandi 40 mg mäkké kapsuly |
cps mol 112x40 mg (blis.PVC/PCTFE/Al) |
ASL-2 |
NL |
28 |
3563.36 |
3563.36 |
I |
0 |
0 |
0 |
ONK, URK |
ind.obm., ZP |
|
|
|
L02BG03 |
|
|
|
Anastrozol |
p.o. 1 mg (28-30 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
64313 |
X |
|
G |
Anastrozole Pharmacenter |
tbl flm 30x1 mg (blister PVC/PE/PVDC/Al) |
PMT-SK |
SK |
30 |
7.82 |
7.82 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
52361 |
X |
|
G |
Anaprex 1mg |
tbl flm 28x1 mg |
NVN |
CZ |
28 |
7.3 |
7.3 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
39818 |
X |
|
G |
Anastrozol Sandoz 1mg filmom obalené tablety |
tbl flm 28x1 mg |
SAN |
SI |
28 |
7.3 |
7.3 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
39799 |
X |
|
G |
Anastrozol-ratiopharm 1mg |
tbl flm 28x1mg |
RAT |
DE |
28 |
7.3 |
7.3 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
78626 |
X |
|
G |
Ozolan 1 mg filmom obalené tablety |
tbl flm 28x1 mg (blis.PVC/Al) |
GLM |
CZ |
28 |
7.3 |
7.3 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
39842 |
X |
|
G |
Ansyn |
tbl flm 28x1 mg |
ACT |
IS |
28 |
9.3800000000000008 |
7.56 |
S |
1.82 |
0.19402999999999998 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG03 |
|
|
|
Anastrozol |
p.o. 1 mg (90-100 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
39805 |
X |
|
G |
Anastrozol ratiopharm 1mg |
tbl flm 90x1mg |
RAT |
DE |
90 |
23.46 |
23.46 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
64318 |
X |
|
G |
Anastrozole Pharmacenter |
tbl flm 90x1 mg (blister PVC/PE/PVDC/Al) |
PMT-SK |
SK |
90 |
23.46 |
23.46 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
43378 |
X |
|
G |
Egistrozol |
tbl flm 90x1 mg (blis.) |
EGI |
HU |
90 |
82.93 |
24.3 |
S |
58.63 |
0.706982 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG04 |
|
|
|
Letrozol |
p.o. 2,5 mg (28-30 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
0.65 |
|
|
|
88592 |
X |
|
G |
Clarzole |
tbl flm 30x2,5 mg |
ACT |
IS |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
07338 |
X |
|
G |
Letrovena 2,5 mg filmom obalené tablety |
tbl flm 30x2,5 mg (blis.PVC/Al) |
ONC |
PL |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
51831 |
X |
|
G |
Letrozol STADA 2,5 mg filmom obalené tablety |
tbl flm 30x2,5 mg (blis. PVC/Al) |
STD |
DE |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
75535 |
X |
|
G |
Letrozole Pharmacenter 2,5 mg |
tbl flm 30x2,5 mg |
PMT-SK |
SK |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4008A |
X |
|
G |
Lortanda 2,5mg filmom obalené tablety |
tbl flm 30x2,5mg |
KRK |
SL |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
83880 |
X |
|
G |
Trozel 2,5 mg |
tbl flm 30x2,5 mg (blis.PVC/PVdC/Al) |
GLM-CZ |
CZ |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
80313 |
X |
|
G |
Aletro 2,5 mg filmom obalené tablety |
tbl flm 30x2,5 mg |
NVN |
CZ |
30 |
21.53 |
19.5 |
S |
2.0299999999999998 |
9.4286999999999996E-2 |
0 |
ONK |
ind.obm. |
|
|
|
56509 |
X |
|
O |
FEMARA 2,5 mg |
tbl flm 30x2,5 mg |
NPF |
CH |
30 |
49.61 |
19.5 |
S |
30.11 |
0.60693399999999997 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG04 |
|
|
|
Letrozol |
p.o. 2,5 mg (90-100 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
0.65 |
|
|
|
75539 |
X |
|
G |
Letrozole Pharmacenter 2,5 mg |
tbl flm 90x2,5 mg |
PMT-SK |
SK |
90 |
58.1 |
58.1 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
54673 |
X |
|
G |
ETRUZIL |
tbl flm 90x2,5 mg |
EGI |
HU |
90 |
58.11 |
58.11 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
07348 |
X |
|
G |
Letrovena 2,5 mg filmom obalené tablety |
tbl flm 100x2,5 mg (blis.PVC/Al) |
ONC |
PL |
100 |
64.569999999999993 |
64.569999999999993 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
54211 |
X |
|
G |
Letrozol Sandoz 2,5mg filmom obalené tablety |
tbl flm 100x2,5 mg |
SAN |
SI |
100 |
64.569999999999993 |
64.569999999999993 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
51832 |
X |
|
G |
Letrozol STADA 2,5 mg filmom obalené tablety |
tbl flm 100 (10x10)x2,5 mg (blis. PVC/Al) |
STD |
DE |
100 |
64.569999999999993 |
64.569999999999993 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
88596 |
X |
|
G |
Clarzole |
tbl flm 100x2,5 mg (blis.Al/PVC) |
ACT-5 |
IS |
100 |
65 |
65 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG06 |
|
|
|
Exemestan |
p.o. 25 mg (30 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
04235 |
X |
|
G |
Cotamox 25 mg |
tbl flm 30x25 mg (blis. Al/PVC) |
ACT |
IS |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
89864 |
X |
|
G |
Escepran 25mg filmom obalené tablety |
tbl flm 30x25mg |
KRK |
SL |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
05310 |
X |
|
G |
Exemestan Mylan 25 mg |
tbl flm 30 x 25 mg |
GNC |
GB |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
20635 |
X |
|
G |
Exemestane Accord 25mg |
tbl flm 30x25 mg |
ACC |
GB |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
20333 |
X |
|
G |
Exemestane Pharmacenter 25 mg filmom obalené tablety |
tbl flm 30x25 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG06 |
|
|
|
Exemestan |
p.o. 25 mg (90-100 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
20334 |
X |
|
G |
Exemestane Pharmacenter 25 mg filmom obalené tablety |
tbl flm 90x25 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
90 |
59.31 |
59.31 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
22724 |
X |
|
G |
Astexana 25 mg |
tbl flm 100x25 mg |
VIH |
PL |
100 |
66 |
66 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
78792 |
X |
|
O |
AROMASIN |
tbl obd 100x25 mg (blis. PVC/PVDC/Al) |
PFI-GB-3 |
GB |
100 |
67.989999999999995 |
66 |
S |
1.99 |
2.9269E-2 |
0 |
ONK |
ind.obm. |
|
|
|
04240 |
X |
|
G |
Cotamox 25 mg |
tbl flm 100x25 mg (blis.Al/PVC) |
ACT-5 |
IS |
100 |
118.23 |
66 |
S |
52.23 |
0.44176599999999999 |
0 |
ONK |
ind.obm. |
|
|
|
L02BX02 |
|
|
|
Degarelix |
parent. 80 mg |
2.7 |
mg |
|
|
|
|
|
|
|
|
4.66 |
|
|
|
03856 |
|
|
O |
FIRMAGON |
plv iol 3x80 mg + 3x6 ml solv. |
FEI |
DK |
90 |
419.4 |
419.4 |
I |
0 |
0 |
0 |
ONK, URK, URO |
ind.obm. |
|
|
|
L02BX02 |
|
|
|
Degarelix |
parent. 120 mg |
2.7 |
mg |
|
|
|
|
|
|
|
|
2.84 |
|
|
|
65736 |
|
|
O |
FIRMAGON |
plv iol 2x120 mg + 2x6 ml solv |
FEI |
DK |
88 |
249.75 |
249.75 |
I |
0 |
0 |
0 |
ONK, URK, URO |
ind.obm. |
|
|
|
L02BX03 |
|
|
|
Abiraterón |
p.o. 250 mg (120 ks) |
1 |
g |
|
|
|
|
|
|
|
|
119.85 |
|
|
|
10799 |
|
|
O |
Zytiga 250 mg tablety |
tbl 120x250 mg (fľ.HDPE) |
JNS |
BE |
30 |
3595.38 |
3595.38 |
I |
0 |
0 |
0 |
ONK, URK |
ind.obm., ZP |
2014-10-01T00:00:00.000 |
|
|
L03AA02 |
|
|
|
Filgrastim |
parent. 300 mcg |
0.35 |
mg |
|
|
|
|
|
|
|
|
31.122 |
|
|
|
65482 |
|
|
O |
Zarzio |
sol ijf 1x0,5 ml/30 MU |
SAN |
AT |
0.85699999999999998 |
26.67 |
26.67 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
2231B |
|
|
B |
Accofil 30 MU/0,5 ml injekčný alebo infúzny roztok v naplnenej injekčnej striekačke |
sol ijf 5x0,5 ml (striek.inj.napl.skl.) |
ACC |
GB |
4.2859999999999996 |
133.38999999999999 |
133.38999999999999 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
7809A |
|
|
B |
Grastofil 30 MU/0,5 ml |
sol ijf 5x0,5 ml/30 MU (striek.inj.napl.skl.) |
AEL |
NL |
4.2859999999999996 |
133.38999999999999 |
133.38999999999999 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
20505 |
|
|
B |
Nivestim |
sol ijf 5x0,5 ml/300 µg (striek.inj.napl.skl.+ochr.kryt ihly) |
HSP |
GB |
4.2859999999999996 |
133.38999999999999 |
133.38999999999999 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
85145 |
|
|
G |
Ratiograstim 30 MIU/0,5ml injekčný alebo infúzny roztok |
sol ijf 5x0,5 ml/300 ug(30 MIU) (striek.skl.napln. s bezp. zar.) |
RAT |
DE |
4.2859999999999996 |
133.38999999999999 |
133.38999999999999 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L03AA02 |
|
|
|
Filgrastim |
parent. 480 mcg |
0.35 |
mg |
|
|
|
|
|
|
|
|
29.93 |
|
|
|
65487 |
|
|
O |
Zarzio |
sol ijf 1x0,5 ml/48 MU |
SAN |
AT |
1.371 |
41.03 |
41.03 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
2233B |
|
|
B |
Accofil 48 MU/0,5 ml injekčný alebo infúzny roztok v naplnenej injekčnej striekačke |
sol ijf 5x0,5 ml (striek.inj.napl.skl.) |
ACC |
GB |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
7811A |
|
|
B |
Grastofil 48 MU/0,5 ml |
sol ijf 5x0,5 ml/48 MU (striek.inj.napl.skl.) |
AEL |
NL |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
20508 |
|
|
B |
Nivestim |
sol ijf 5x0,5 ml/480 µg (striek.inj.napl.skl.+ochr.kryt ihly) |
HSP |
GB |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
85147 |
|
|
G |
Ratiograstim 48 MIU/0,8 ml injekčný alebo infúzny roztok |
sol ijf 5x0,8 ml/480 ug(48 MIU) (striek.skl.napln. s bezp. zar.) |
RAT |
DE |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
65489 |
|
|
O |
Zarzio |
sol ijf 5x0,5 ml/48 MU |
SAN |
AT |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L03AA13 |
|
|
|
Pegfilgrastím |
parent. |
0.3 |
mg |
|
|
|
|
|
|
|
|
42.57 |
|
|
|
76081 |
|
|
O |
Neulasta |
sol inj 1x0,6 ml/6 mg (napln.skl.inj.striek.- blistr.bal.+ chránič ihly) |
AMG |
NL |
20 |
851.36 |
851.36 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L03AA14 |
|
|
|
Lipegfilgrastim |
s.c. 6 mg |
0.3 |
mg |
|
|
|
|
|
|
|
|
41.911999999999999 |
|
|
|
6781A |
|
|
O |
Lonquex 6 mg injekčný roztok |
sol inj 1x0,6 ml/6 mg (striek.inj.skl.napl. s bezp.zar.) |
UAS |
LT |
20 |
838.23 |
838.23 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L03AB01 |
|
|
|
Interferón-alfa z ľudských leukocytov |
parent. |
2 |
MU |
|
|
|
|
|
|
|
|
33.53 |
|
|
|
78288 |
|
|
O |
Multiferon |
sol iru 6x0,5 ml |
SWO |
SE |
15 |
502.91 |
502.91 |
I |
0 |
0 |
0 |
HEP, INF, ONK |
ind.obm., ZP |
|
|
|
L03AB04 |
|
|
|
Interferón alfa-2a |
parent. |
2 |
MU |
|
|
|
|
|
|
|
|
9.3729999999999993 |
|
|
|
26779 |
|
|
O |
ROFERON-A (inj.striek.) |
sol inj 1x3 MU/0,5 ml |
HLR |
CH |
1.5 |
14.12 |
14.06 |
S |
0.06 |
4.2490000000000002E-3 |
0.06 |
GIT, HEM, HEP, INF, ONK, URO |
ind.obm., ZP |
|
|
|
L03AB05 |
|
|
|
Interferón alfa-2b |
parent. REDIPEN |
2 |
MU |
|
|
|
|
|
|
|
|
10.5 |
|
|
|
28929 |
|
|
O |
IntronA 18 miliónov IU injekčný roztok vo viacdávkovom pere |
sol inj 1x1,2 ml/18 MU (1x náplň vo viacdávk.pere+ 12x inj.set) |
MSD-GB-1 |
GB |
9 |
94.48 |
94.48 |
I |
0 |
0 |
0 |
GIT, HEM, HEP, INF, ONK, URO |
ind.obm., ZP |
|
|
|
28930 |
|
|
O |
IntronA 30 miliónov IU injekčný roztok vo viacdávkovom pere |
sol inj 1x1,2 ml/30 MU (1x náplň vo viacdávk.pere+ 12x inj.set) |
MSD-GB-1 |
GB |
15 |
157.47 |
157.47 |
I |
0 |
0 |
0 |
GIT, HEM, HEP, INF, ONK, URO |
ind.obm., ZP |
|
|
|
28931 |
|
|
O |
IntronA 60 miliónov IU injekčný roztok vo viacdávkovom pere |
sol inj 1x1,2 ml/60 MU (1x náplň vo viacdávk.pere+ 12x inj.set) |
MSD-GB-1 |
GB |
30 |
314.94 |
314.94 |
I |
0 |
0 |
0 |
GIT, HEM, HEP, INF, ONK, URO |
ind.obm., ZP |
|
|
|
L03AB07 |
|
|
|
Interferón beta-1a |
parent. |
4.3 |
µg |
|
|
|
|
|
|
|
|
7.1619999999999999 |
|
|
|
64994 |
|
|
O |
REBIF 44 mcg / 0,5 ml |
sol inj 4 x 1,5 ml ( 24 MU/ml ) |
SEY |
GB |
122.8 |
911.16 |
879.49 |
AS |
31.67 |
3.4757999999999997E-2 |
31.67 |
NEU |
ind.obm., ZP |
|
|
|
02731 |
|
|
O |
Rebif 44 µg |
sol inj 12x0,5ml / 44µg ( 12 MU ) (pero napln ) |
MSS-GB |
GB |
122.8 |
982.98 |
879.49 |
AS |
103.49 |
0.105282 |
103.49 |
NEU |
ind.obm., ZP |
|
|
|
64995 |
|
|
O |
REBIF 8,8 mcg / 0,1 ml a 22 mcg/0,25ml |
sol inj 2 x 1,5 ml ( 24 MU/ml ) |
MSS-GB |
GB |
42.98 |
565.16999999999996 |
307.82 |
AS |
257.35000000000002 |
0.45534999999999998 |
257.35000000000002 |
NEU |
ind.obm., ZP |
|
|
|
02735 |
|
|
O |
Rebif 8,8 µg + 22µg |
sol inj 6x0,2ml / 8,8µg ( 2,4 MU ) + 6x0,5ml / 22µg ( 6 MU )(pero napln ) |
MSS-GB |
GB |
42.98 |
796.13 |
307.82 |
AS |
488.31 |
0.61335499999999998 |
36.22 |
NEU |
ind.obm., ZP |
|
|
|
L03AB07 |
|
|
|
Interferón beta-1a |
parent. sol. inj. |
4.3 |
µg |
|
|
|
|
|
|
|
|
19.91 |
|
|
|
08662 |
|
|
O |
Avonex |
sol inj 4x0,5 ml/30 µg (napln. inj. striek. v inj. pere) |
BGI-GB |
GB |
40 |
796.39 |
796.39 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L03AB08 |
|
|
|
Interferón beta-1b |
parent. 300 mcg |
4 |
MU |
|
|
|
|
|
|
|
|
20.45 |
|
|
|
5283A |
|
|
O |
EXTAVIA 250 µg/ml |
plv iol (15x skl.liek.-prášok + 15x napl.inj.striek.-solvent) |
NEH |
GB |
30 |
613.33000000000004 |
613.33000000000004 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
36545 |
|
|
O |
Betaferon |
plv iol 15x (1 skl.liek.+1x1,2 ml napl.skl.striek.+1adapt. s ih.+ 2 alk.tamp.) (0,25 mg/ml) |
BAS |
DE |
30 |
742.31 |
613.5 |
AS |
128.81 |
0.17352599999999999 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L03AB10 |
|
|
|
Peginterferón alfa-2b |
parent. PERO |
7.5 |
µg |
|
|
|
|
|
|
|
|
13.032 |
|
|
|
95710 |
|
|
O |
PegIntron 120 mikrogramov, prášok a rozp. na inj. roztok naplnené v injekčnom pere |
plv ipl 4x120 ug (4x napl.skl.pero+ 4x ihla+ 8x čist.tampon) |
MSD-GB-1 |
GB |
64 |
833.97 |
833.97 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
95706 |
|
|
O |
PegIntron 100 mikrogramov, prášok a rozp. na inj. roztok naplnené v injekčnom pere |
plv ipl 4x 100 ug (4x napl.skl.pero+ 4x ihla+ 8x čist.tampon) |
MSD-GB-1 |
GB |
53.332999999999998 |
694.98 |
694.98 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
95708 |
|
|
O |
PegIntron 150 mikrogramov, prášok a rozp. na inj. roztok naplnené v injekčnom pere |
plv ipl 4x150 ug (4x napl.skl.pero+ 4x ihla+ 8x čist.tampon) |
MSD-GB-1 |
GB |
80 |
1042.48 |
1042.48 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
L03AB11 |
|
|
|
Peginterferón alfa-2a |
parent. sol. inj. |
26 |
µg |
|
|
|
|
|
|
|
|
24.92 |
|
|
|
09725 |
|
|
O |
Pegasys 180 mcg/0,5 ml |
sol inj 1x0,5 ml (pero napln.) |
HLR |
GB |
6.923 |
172.49 |
172.49 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
20237 |
|
|
O |
Pegasys 180 mcg/0,5 ml |
sol inj 1x180 mcg/0,5 ml |
HLR |
DE |
6.923 |
172.49 |
172.49 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
20305 |
|
|
O |
Pegasys 135 mcg/0.5 ml |
sol inj 1x135 mcg/0.5 ml |
HLR |
DE |
5.1920000000000002 |
146.38 |
129.38 |
S |
17 |
0.116136 |
17 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
L03AB13 |
|
|
|
Peginterferón beta-1a |
s.c. 63 mcg a 94 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
429.61 |
|
|
|
1538B |
|
|
O |
Plegridy 63 mikrogramov injekčný roztok naplnený v injekčnom pere, Plegridy 94 mikrogramov injekčný roztok naplnený v injekčnom pere |
sol inj 1x0,5 ml/63 µg + 1x0,5 ml/94 µg (pero.inj.napl. Plegridy Pen) |
BGI |
GB |
2 |
859.22 |
859.22 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L03AB13 |
|
|
|
Peginterferón beta-1a |
s.c. 125 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
429.61 |
|
|
|
1541B |
|
|
O |
Plegridy 125 mikrogramov injekčný roztok naplnený v injekčnom pere |
sol inj 2x125 µg/0,5 ml (pero inj.napl. Plegridy Pen) |
BGI |
GB |
2 |
859.22 |
859.22 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L03AX |
|
|
|
Ostatné imunostimulanciá |
p.o. |
1 |
DF |
|
|
|
|
|
|
|
|
0.75 |
|
|
|
88471 |
|
|
O |
BRONCHO-VAXOM PRE DETI |
cps 30x3,5 mg |
OAA-2 |
PT |
30 |
13.65 |
10.24 |
S |
3.41 |
0.24981700000000001 |
3.41 |
|
|
|
|
|
84101 |
|
|
O |
LUIVAC |
tbl 28 |
SAK |
DE |
28 |
14.68 |
11.01 |
S |
3.67 |
0.25 |
3.67 |
|
|
|
|
|
37443 |
|
|
O |
BRONCHO-VAXOM pre deti |
plv por 1x30 vreciek |
OAA-2 |
PT |
30 |
16.600000000000001 |
12.45 |
S |
4.1500000000000004 |
0.25 |
4.1500000000000004 |
|
|
|
|
|
88472 |
|
|
O |
BRONCHO-VAXOM PRE DOSPELÝCH |
cps 30x7 mg |
OAA-2 |
PT |
30 |
18.739999999999998 |
14.06 |
S |
4.68 |
0.24973299999999998 |
4.68 |
|
|
|
|
|
98189 |
|
|
O |
RIBOMUNYL |
gro por 20x500 mg (vrecká) |
PFB |
FR |
20 |
19.43 |
14.57 |
S |
4.8600000000000003 |
0.25012899999999999 |
4.8600000000000003 |
|
|
|
|
|
55676 |
|
|
O |
RIBOMUNYL |
tbl 20 (trojnás.) |
PFB |
FR |
20 |
19.43 |
14.57 |
S |
4.8600000000000003 |
0.25012899999999999 |
4.8600000000000003 |
|
|
|
|
|
98187 |
|
|
O |
RIBOMUNYL |
gro por 4x500 mg (vrecká) |
PFB |
FR |
4 |
4.4400000000000004 |
3.33 |
S |
1.1100000000000001 |
0.25 |
0.97 |
|
|
|
|
|
55675 |
|
|
O |
RIBOMUNYL |
tbl 4 (trojnás.) |
PFB |
FR |
4 |
4.4400000000000004 |
3.33 |
S |
1.1100000000000001 |
0.25 |
0.97 |
|
|
|
|
|
L03AX |
|
|
|
Ostatné imunostimulanciá |
parent. lyofil. dialyzát leukocytov |
1 |
DF |
|
|
|
|
|
|
|
|
0.8 |
|
|
|
97146 |
|
|
O |
IMMODIN |
plv iol 5x1 dáv.+ sol. |
SVF |
CZ |
5 |
226.82 |
181.46 |
S |
45.36 |
0.19998199999999999 |
45.36 |
ALG, DER, INF, REU, TRN |
ind.obm. |
|
|
|
56930 |
|
|
O |
IMMODIN |
plv iol 1x1 dáv. + sol. |
SVF |
CZ |
1 |
49.89 |
39.909999999999997 |
S |
9.98 |
0.20004000000000002 |
9.07 |
ALG, DER, INF, REU, TRN |
ind.obm. |
|
|
|
L03AX |
|
|
|
Ostatné imunostimulanciá |
p.o. extr. lyof. escherichiae c. |
6 |
mg |
|
|
|
|
|
|
|
|
0.75 |
|
|
|
93993 |
|
|
O |
URO-VAXOM |
cps 90x6 mg |
OAA-2 |
PT |
90 |
55.68 |
41.76 |
S |
13.92 |
0.25 |
13.92 |
|
|
|
|
|
93992 |
|
|
O |
URO-VAXOM |
cps 30x6 mg |
OAA-2 |
PT |
30 |
21.59 |
16.190000000000001 |
S |
5.4 |
0.250116 |
4.6399999999999997 |
|
|
|
|
|
L03AX |
|
|
|
Ostatné imunostimulanciá |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
0.8 |
|
|
|
34045 |
|
|
O |
POLYOXIDONIUM 6 mg |
lyo ijo 5x6 mg |
IMF |
SK |
5 |
95 |
76 |
S |
19 |
0.2 |
19 |
ALG, DER, INF, ONK, REU |
|
|
|
|
51567 |
|
|
O |
POLYOXIDONIUM 6 mg |
lyo ijo 5x6 mg (amp.) |
NPO |
SK |
5 |
95 |
76 |
S |
19 |
0.2 |
19 |
ALG, DER, INF, ONK, REU |
|
|
|
|
L03AX03 |
|
|
|
BCG vakcína |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
92.67 |
|
|
|
40197 |
|
|
O |
BCG-medac |
plv iul 1x1 set (1 inj. liek.+ 50 ml disp. prostr.+ adapt. Luer-Lock) |
MED |
DE |
1 |
92.67 |
92.67 |
A |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L03AX13 |
|
|
|
Glatirameracetát |
parent. |
20 |
mg |
|
|
|
|
|
|
|
|
23.706099999999999 |
|
|
|
50503 |
|
|
O |
Copaxone 20 mg/ml |
sol inj 7x1 ml/20 mg (striek.skl.napl.) |
TEV |
CZ |
7 |
224.34 |
165.94 |
AS |
58.4 |
0.26031900000000002 |
58.4 |
NEU |
ind.obm., ZP |
|
|
|
3584B |
|
|
O |
Copaxone 40 mg/ml |
sol iru 3x1 ml/40mg (striek.inj.skl.) |
TEV |
CZ |
6 |
262.66000000000003 |
142.24 |
AS |
120.42 |
0.45846300000000001 |
120.42 |
NEU |
ind.obm., ZP |
|
|
|
L03AX93 |
|
|
|
Ostatné imunostimulanciá |
p.o. plv. por. |
10 |
mg |
|
|
|
|
|
|
|
|
0.8 |
|
|
|
87299 |
|
|
O |
IMUNOR |
lyo por 4x10mg |
IMU |
CZ |
4 |
42.7 |
34.159999999999997 |
S |
8.5399999999999991 |
0.2 |
8.5399999999999991 |
ALG,REU |
|
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát |
p.o. 250 mg (100 ks) |
2 |
g |
|
|
|
|
|
|
|
|
3.62 |
|
|
|
47859 |
|
|
G |
Myfenax 250 mg tvrdé kapsuly |
cps dur 100x250 mg (blis.PVC/PVDC/Al) |
TEV-NL-4 |
NL |
12.5 |
45.21 |
45.21 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
3572A |
|
|
G |
Mygref 250 mg |
cps dur 100x250 mg (blis.PVC/PVDC/Al) |
MDS |
CZ |
12.5 |
45.21 |
45.21 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
25560 |
|
|
O |
CELLCEPT 250 |
cps dur 100x250 mg |
HLR |
DE |
12.5 |
45.22 |
45.22 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát |
p.o. 500 mg (50 ks) |
2 |
g |
|
|
|
|
|
|
|
|
3.4359999999999999 |
|
|
|
47861 |
|
|
G |
Myfenax 500 mg filmom obalené tablety |
tbl flm 50x500 mg (blis.PVC/PVDC/Al) |
TEV-NL-4 |
NL |
12.5 |
42.93 |
42.93 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
3574A |
|
|
G |
Mygref 500 mg |
tbl flm 50x500 mg (blis.PVC/PVDC/Al) |
MDS |
CZ |
12.5 |
42.93 |
42.93 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
52089 |
|
|
G |
Mykofenolát mofetil Sandoz 500mg filmom obalené tablety |
tbl flm 50x500 mg |
SAN |
SI |
12.5 |
42.93 |
42.93 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
44077 |
|
|
O |
CELLCEPT 500 |
tbl flm 50x500 mg |
HLR |
DE |
12.5 |
42.94 |
42.94 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát |
parent. |
2 |
g |
|
|
|
|
|
|
|
|
48 |
|
|
|
55295 |
|
|
O |
CELLCEPT 500 |
plc ifo 4x500 mg |
HLR |
DE |
1 |
48 |
48 |
A |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát, sodná soľ |
p.o. 180 mg (120 ks) |
1440 |
mg |
|
|
|
|
|
|
|
|
6.66 |
|
|
|
43041 |
|
|
O |
Myfortic 180 mg |
tbl fle 120x180 mg |
NAI |
CZ |
15 |
99.83 |
99.83 |
I |
0 |
0 |
0 |
INT, KLF, NEF |
ind.obm. |
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát, sodná soľ |
p.o. 360 mg (120 ks) |
1440 |
mg |
|
|
|
|
|
|
|
|
6.6550000000000002 |
|
|
|
43036 |
|
|
O |
Myfortic 360 mg |
tbl fle 120x360 mg |
NAI |
CZ |
30 |
199.64 |
199.64 |
I |
0 |
0 |
0 |
INT, KLF, NEF |
ind.obm. |
|
|
|
L04AA10 |
|
|
|
Sirolimus |
p.o. 1 mg (100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
18.3 |
|
|
|
34341 |
|
|
O |
Rapamune 1 mg obalené tablety |
tbl obd 100x1 mg (blis.PVC/PE/Aclar/Al) |
PFI-GB-1 |
GB |
20 |
365.91 |
365.91 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
L04AA13 |
|
|
|
Leflunomid |
p.o. 10 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
1.28 |
|
|
|
21708 |
X |
|
G |
Leflunomide medac 10 mg filmom obalené tablety |
tbl flm 30x10 mg (fľaša HDPE) |
MED |
DE |
20 |
25.59 |
25.59 |
I |
0 |
0 |
0 |
REU |
ind.obm. |
|
|
|
L04AA13 |
|
|
|
Leflunomid |
p.o. 20 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.64 |
|
|
|
86931 |
X |
|
G |
Leflunomide Winthrop |
tbl flm 30x20 mg (fľaša HDPE) |
SAV-D |
DE |
40 |
25.29 |
25.29 |
I |
0 |
0 |
0 |
REU |
ind.obm. |
|
|
|
21714 |
X |
|
G |
Leflunomide medac 20 mg filmom obalené tablety |
tbl flm 30x20 mg (fľaša HDPE) |
MED |
DE |
40 |
27.67 |
25.6 |
S |
2.0699999999999998 |
7.4810000000000001E-2 |
0 |
REU |
ind.obm. |
|
|
|
L04AA13 |
|
|
|
Leflunomid |
p.o. 20 mg (50 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.64 |
|
|
|
86932 |
X |
|
G |
Leflunomide Winthrop |
tbl flm 50x20 mg (fľaša HDPE) |
SAV-D |
DE |
66.665999999999997 |
42.15 |
42.15 |
I |
0 |
0 |
0 |
REU |
ind.obm. |
|
|
|
L04AA18 |
|
|
|
Everolimus |
p.o. 0,25 mg (60 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
11.07 |
|
|
|
42169 |
|
|
O |
Certican 0,25mg tablety |
tbl 60x0,25 mg |
NAI |
CZ |
10 |
110.65 |
110.65 |
I |
0 |
0 |
0 |
ALG, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
L04AA18 |
|
|
|
Everolimus |
p.o. 0,75 mg (60 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
10.993 |
|
|
|
42178 |
|
|
O |
Certican 0,75mg tablety |
tbl 60x0,75 mg |
NAI |
CZ |
30 |
329.78 |
329.78 |
I |
0 |
0 |
0 |
ALG, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
L04AA23 |
|
|
|
Natalizumab |
parent. |
10.71 |
mg |
|
|
|
|
|
|
|
|
53.01 |
|
|
|
35677 |
|
|
O |
Tysabri 300 mg |
con inf 1x15 ml/300mg |
Bio |
NL |
28 |
1484.15 |
1484.15 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L04AA24 |
|
|
|
Abatacept |
parent. |
27 |
mg |
|
|
|
|
|
|
|
|
36.590000000000003 |
|
|
|
43230 |
|
|
O |
ORENCIA 250 mg |
plc ifo 1x250 mg(1xliek+1xstriek.) |
BMS |
GB |
9.25 |
338.42 |
338.42 |
A |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AA26 |
|
|
|
Belimumab |
parent. 120 mg |
25.64 |
mg |
|
|
|
|
|
|
|
|
33.75 |
|
|
|
09504 |
|
|
O |
Benlysta 120 mg prášok na infúzny koncentrát |
plc ifo 1x120 mg (liek.inj.skl.) |
GLA |
GB |
4.68 |
157.93 |
157.93 |
A |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AA26 |
|
|
|
Belimumab |
parent. 400 mg |
25.64 |
mg |
|
|
|
|
|
|
|
|
33.03 |
|
|
|
09505 |
|
|
O |
Benlysta 400 mg prášok na infúzny koncentrát |
plc ifo 1x400 mg (liek.inj.skl.) |
GLA |
GB |
15.601000000000001 |
515.16 |
515.16 |
A |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AA27 |
|
|
|
Fingolimod |
p.o. 0,5 mg |
0.5 |
mg |
|
|
|
|
|
|
|
|
60.99 |
|
|
|
08294 |
|
|
O |
GILENYA 0,5 mg |
cps dur 28x0,5 mg |
NEH |
GB |
28 |
1707.54 |
1707.54 |
I |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L04AA31 |
|
|
|
Teriflunomid |
p.o. 14 mg (28 ks) |
14 |
mg |
|
|
|
|
|
|
|
|
30.792000000000002 |
|
|
|
7010A |
|
|
O |
Aubagio 14 mg filmom obalené tablety |
tbl flm 28x14 mg (blisAI/AI) |
SOI |
FR |
28 |
862.16 |
862.16 |
I |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L04AA34 |
|
|
|
Alemtuzumab |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
8152.55 |
|
|
|
7211A |
|
|
O |
LEMTRADA 12 mg infúzny koncentrát |
con inf 1x1,2 ml/12 mg (liek.inj.skl.) |
GZE |
GB |
1 |
8152.55 |
8152.55 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L04AB01 |
|
|
|
Etanercept |
parent. |
7 |
mg |
|
|
|
|
|
|
|
|
32.83 |
|
|
|
36757 |
|
|
O |
Enbrel 50 mg injekčný roztok naplnený v injekčnej striekačke |
sol iru 4x1 ml/50 mg (4x striek.skl.napln.+8x tamp.) |
PFI-GB-1 |
GB |
28.57 |
937.85 |
937.85 |
I |
0 |
0 |
0 |
REU, DER |
ind.obm., ZP |
|
|
|
78432 |
|
|
O |
Enbrel 50 mg injekčný roztok v naplnenom pere |
sol ira 4x1 ml/50 mg (4x napl. pero+ 8x tamp.) |
PFI-GB-1 |
GB |
28.57 |
937.85 |
937.85 |
I |
0 |
0 |
0 |
REU, DER |
ind.obm., ZP |
|
|
|
36753 |
|
|
O |
Enbrel 25 mg injekčný roztok naplnený v injekčnej striekačke |
sol iru 4x0,5 ml/25 mg (4x striek.skl.napln.+8x tamp.) |
PFI-GB-1 |
GB |
14.29 |
469.14 |
469.14 |
I |
0 |
0 |
0 |
REU, DER |
ind.obm., ZP |
|
|
|
03260 |
|
|
O |
Enbrel 25 mg prášok a rozpúšťadlo na injekčný roztok |
plv iol 4x25 mg + 4x1 ml (4x liek.skl.+4xstriek.skl.napln.+4x ih.+4x adapt.+8x tamp.) |
PFI-GB-1 |
GB |
14.29 |
480.11 |
469.14 |
S |
10.97 |
2.2848999999999998E-2 |
0 |
REU, DER |
ind.obm., ZP |
|
|
|
09337 |
|
|
O |
Enbrel 10 mg prášok a rozpúšťadlo na injekčný roztok pre pediatrické použitie |
plv iol 4x10 mg +4x1 ml (4x liek.skl.+4x striek.skl.+4x ih.+4x adapt.+8x tamp.) |
PFI-GB-1 |
GB |
5.71 |
195.27 |
187.46 |
S |
7.81 |
3.9996000000000004E-2 |
7.81 |
REU, DER |
ind.obm., ZP |
|
|
|
L04AB02 |
|
|
|
Infliximab |
parent. |
3.75 |
mg |
|
|
|
|
|
|
|
|
14.57 |
|
|
|
7169A |
|
|
B |
Inflectra 100 mg prášok na prípravu infúzneho koncentrátu |
plc ifo, 1x100 mg (liek.inj.skl.) |
HSP |
GB |
26.667000000000002 |
388.48 |
388.48 |
A |
0 |
0 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
7044A |
|
|
B |
Remsima 100mg prášok na prípravu infúzneho koncentrátu |
plc.ifo.1x100mg (liek.inj.skl.) |
CLO |
HU |
26.667000000000002 |
388.48 |
388.48 |
A |
0 |
0 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
02578 |
|
|
O |
REMICADE 100 mg |
plc ifo 1x100 mg |
CEO |
NL |
26.667000000000002 |
540.66999999999996 |
388.54 |
AS |
152.13 |
0.28137299999999998 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
L04AB04 |
|
|
|
Adalimumab |
parent. |
2.85 |
mg |
|
|
|
|
|
|
|
|
34.942 |
|
|
|
40795 |
|
|
O |
Humira 40 mg injekčný roztok naplnený v striekačke |
sol inj 2x0,8 ml/40 mg (striek.skl.napln.) |
ABV-GB |
GB |
28 |
978.37 |
978.37 |
I |
0 |
0 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
37218 |
|
|
O |
Humira 40 mg injekčný roztok v naplnenom pere |
sol inj 2x0,8 ml/40 mg (napl.skl.pero) |
ABV-GB |
GB |
28 |
978.37 |
978.37 |
I |
0 |
0 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
40793 |
|
|
O |
Humira 40 mg injekčný roztok na pediatrické použitie |
sol inj 2x0,8 ml/40 mg (liek.inj.skl.) |
ABV-GB |
GB |
28.07 |
1013.62 |
980.82 |
S |
32.799999999999997 |
3.2358999999999999E-2 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
L04AB05 |
|
|
|
Certolizumab |
parent. |
14 |
mg |
|
|
|
|
|
|
|
|
31.343 |
|
|
|
81325 |
|
|
O |
Cimzia |
sol inj 2x200 mg/1 ml (striek.inj.napl. + lieh.tamp.) |
UCP |
BE |
28.571000000000002 |
895.49 |
895.49 |
I |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AB06 |
|
|
|
Golimumab |
parent. |
1.64 |
mg |
|
|
|
|
|
|
|
|
31.95 |
|
|
|
83300 |
|
|
O |
Simponi |
sol inj 1x0,5 ml/50 mg (pero napl.sklo) |
CEO |
NL |
30.488 |
974.02 |
974.02 |
I |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
83302 |
|
|
O |
SIMPONI |
sol inj 1x0,5 ml/50 mg (striek.napl.skl.) |
JAN |
NL |
30.488 |
974.02 |
974.02 |
I |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AC05 |
|
|
|
Ustekinumab |
parent. |
0.53420000000000001 |
mg |
|
|
|
|
|
|
|
|
36.362000000000002 |
|
|
|
87597 |
|
|
O |
Stelara |
sol iru 1x0,5 ml/45 mg (striek.skl.napln.) |
JNS |
BE |
84.238 |
3063.05 |
3063.05 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm., ZP |
|
|
|
L04AC07 |
|
|
|
Tocilizumab |
s.c. 162 mg |
20 |
mg |
|
|
|
|
|
|
|
|
32.604999999999997 |
|
|
|
9954A |
|
|
O |
RoActemra 162 mg injekčný roztok v naplnenej injekčnej striekačke |
sol inj 4x0,9 ml/162 mg (striek.inj.napl.skl.) |
HLR-GB |
GB |
32.4 |
1056.3800000000001 |
1056.3800000000001 |
I |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AC07 |
|
|
|
Tocilizumab |
parent. |
20 |
mg |
|
|
|
|
|
|
|
|
35.042000000000002 |
|
|
|
64991 |
|
|
O |
RoActemra |
con inf 1x20 ml/400 mg |
HLR |
GB |
20 |
700.83 |
700.83 |
A |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
64989 |
|
|
O |
RoActemra |
con inf 1x10 ml/200 mg |
HLR |
GB |
10 |
358.24 |
350.42 |
AS |
7.82 |
2.1829000000000001E-2 |
0 |
REU |
ind.obm., ZP |
|
|
|
64984 |
|
|
O |
RoActemra |
con inf 1x4 ml/80 mg |
HLR |
GB |
4 |
146.58000000000001 |
140.16999999999999 |
AS |
6.41 |
4.3730000000000005E-2 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AC10 |
|
|
|
Sekukinumab |
s.c. 150 mg |
9.8629999999999995 |
mg |
|
|
|
|
|
|
|
|
40.204999999999998 |
|
|
|
2817B |
|
|
O |
Cosentyx 150 mg injekčný roztok v naplnenom pere |
sol ira 2x1 ml/150 mg (striek.inj.skl. v pere SensoReady) |
NEH-1 |
GB |
30.417000000000002 |
1222.9000000000001 |
1222.9000000000001 |
I |
0 |
0 |
0 |
DER |
ind.obm., ZP |
|
|
|
L04AD01 |
|
|
|
Cyklosporín |
p.o. mikroemulgované 25 mg (50 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
3.36 |
|
|
|
50490 |
|
|
G |
Ciclosporin Mylan 25 mg |
cps mol 50x25 mg (blis. Al/Al) |
GNC |
GB |
5 |
16.8 |
16.8 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
10183 |
|
|
G |
EQUORAL 25 mg |
cps 50x25 mg |
IVX |
CZ |
5 |
16.8 |
16.8 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
84044 |
|
|
O |
SANDIMMUN NEORAL 25 mg |
cps 50x25 mg |
RPS |
DE |
5 |
28.38 |
16.8 |
S |
11.58 |
0.40803400000000001 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
L04AD01 |
|
|
|
Cyklosporín |
p.o. mikroemulgované 50 mg (50 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
3.181 |
|
|
|
50495 |
|
|
G |
Ciclosporin Mylan 50 mg |
cps mol 50x50 mg (blis. Al/Al) |
GNC |
GB |
10 |
31.81 |
31.81 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
10184 |
|
|
G |
EQUORAL 50 mg |
cps 50x50 mg |
IVX |
CZ |
10 |
31.81 |
31.81 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
84045 |
|
|
O |
SANDIMMUN NEORAL 50 mg |
cps 50x50 mg |
RPS |
DE |
10 |
45.22 |
31.81 |
S |
13.41 |
0.29655000000000004 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
L04AD01 |
|
|
|
Cyklosporín |
p.o. mikroemulgované 100 mg (50 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
2.72 |
|
|
|
50500 |
|
|
G |
Ciclosporin Mylan 100 mg |
cps mol 50x100 mg (blis. Al/Al) |
GNC |
GB |
20 |
54.26 |
54.26 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
10185 |
|
|
G |
EQUORAL 100 mg |
cps 50x100 mg |
IVX |
CZ |
20 |
54.26 |
54.26 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
L04AD01 |
|
|
|
Cyklosporín |
p.o. 100 mg/ml tekuté |
0.25 |
g |
|
|
|
|
|
|
|
|
2.83 |
|
|
|
06408 |
|
|
G |
EQUORAL |
sol por 1x50 ml |
IVX |
CZ |
20 |
56.49 |
56.49 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
84047 |
|
|
O |
SANDIMMUN NEORAL 100 mg/ ml |
sol por 1x50 ml |
XNU |
FR |
20 |
100.16 |
56.6 |
S |
43.56 |
0.43490400000000001 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. 1 mg (60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
5.76 |
|
|
|
01914 |
|
|
G |
GECROL 1 mg |
cps dur 60x1 mg (blis. PVC/PVDC/Al) |
HTN |
CZ |
12 |
69.05 |
69.05 |
I |
0 |
0 |
0 |
HEP, KAR, NEF |
ind.obm. |
|
|
|
57628 |
|
|
O |
PROGRAF 1MG |
cps dur 60x1 mg |
FUJ |
IE |
12 |
69.05 |
69.05 |
I |
0 |
0 |
0 |
HEP, KAR, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
4.68 |
|
|
|
01922 |
|
|
G |
GECROL 5 mg |
cps dur 30x5 mg (blis. PVC/PVDC/Al) |
HTN |
CZ |
30 |
139.94999999999999 |
139.94999999999999 |
I |
0 |
0 |
0 |
HEP, KAR, NEF |
ind.obm. |
|
|
|
57629 |
|
|
O |
PROGRAF 5MG |
cps 30x5mg |
FUJ |
IE |
30 |
147.28 |
140.4 |
S |
6.88 |
4.6714000000000006E-2 |
0 |
HEP, KAR, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. predĺžené uvoľňovanie 0,5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.7100000000000009 |
|
|
|
39629 |
|
|
O |
Advagraf |
cps pld 30x0,5 mg |
ASL |
IE |
3 |
26.11 |
26.11 |
I |
0 |
0 |
0 |
HEP, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. predĺžené uvoľňovanie 1 mg (60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
9.1199999999999992 |
|
|
|
39633 |
|
|
O |
Advagraf |
cps pld 60x1 mg |
ASL |
IE |
12 |
109.38 |
109.38 |
I |
0 |
0 |
0 |
HEP, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. predĺžené uvoľňovanie 3 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
6.7119999999999997 |
|
|
|
76887 |
|
|
O |
Advagraf |
cps pld 30x3 mg |
ASL |
NL |
18 |
120.8 |
120.8 |
I |
0 |
0 |
0 |
HEP, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. predĺžené uvoľňovanie 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
7.1219999999999999 |
|
|
|
39635 |
|
|
O |
Advagraf |
cps pld 30x5 mg |
ASL |
IE |
30 |
213.65 |
213.65 |
I |
0 |
0 |
0 |
HEP, NEF |
ind.obm. |
|
|
|
L04AX01 |
|
|
|
Azatioprin |
p.o. 25 mg (100 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.52800000000000002 |
|
|
|
31396 |
|
|
O |
IMURAN |
tbl obd 100x25 mg |
GWE |
GB |
16.7 |
12.8 |
8.82 |
S |
3.98 |
0.31093799999999999 |
3.98 |
|
|
|
|
|
L04AX01 |
|
|
|
Azatioprin |
p.o. 50 mg (100 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.47 |
|
|
|
02418 |
|
|
O |
IMURAN |
tbl obd 100x50 mg |
GWE |
GB |
33.332999999999998 |
15.54 |
15.54 |
I |
0 |
0 |
0 |
|
|
|
|
|
98732 |
|
|
G |
Immunoprin 50 mg |
tbl flm 100x50 mg |
EBW |
AT |
33.33 |
15.67 |
15.67 |
I |
0 |
0 |
0 |
|
|
|
|
|
L04AX01 |
|
|
|
Azatioprin |
p.o. 100 mg (100 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.70809999999999995 |
|
|
|
23376 |
|
|
G |
Immunoprin 100mg |
tbl flm 100x100 mg |
EBW |
AT |
66.667000000000002 |
38.49 |
38.49 |
I |
0 |
0 |
0 |
|
|
|
|
|
L04AX03 |
|
|
|
Metotrexát |
p.o. 2,5 mg (100 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
4.8500000000000001E-2 |
|
|
|
43180 |
X |
|
O |
Methotrexate-Teva 2,5 mg |
tbl 100x2,5 mg |
PHM |
NL |
250 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DER, HEM, ONK, PED, REU |
|
|
|
|
64424 |
X |
|
G |
Trexan 2,5 mg |
tbl 100x2,5 mg |
ORN |
FI |
250 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DER, HEM, ONK, PED, REU |
|
|
|
|
L04AX03 |
|
|
|
Metotrexát |
p.o. 10 mg (10 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
4.8500000000000001E-2 |
|
|
|
64425 |
X |
|
G |
Trexan 10 mg |
tbl 10x10 mg |
ORN |
FI |
100 |
5.03 |
4.8499999999999996 |
S |
0.18 |
3.5784999999999997E-2 |
0.18 |
DER, HEM, ONK, PED, REU |
|
|
|
|
L04AX04 |
|
|
|
Lenalidomid |
p.o. 10 mg (21 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
596.08000000000004 |
|
|
|
43534 |
|
|
O |
Revlimid 10 mg tvrdé kapsuly |
cps dur 21x10 mg |
CLG |
GB |
8.4 |
5007.05 |
5007.05 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L04AX04 |
|
|
|
Lenalidomid |
p.o. 15 mg (21 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
418.50200000000001 |
|
|
|
43535 |
|
|
O |
Revlimid 15 mg tvrdé kapsuly |
cps dur 21x15 mg |
CLG |
GB |
12.6 |
5273.12 |
5273.12 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L04AX04 |
|
|
|
Lenalidomid |
p.o. 25 mg (21 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
269.17 |
|
|
|
43536 |
|
|
O |
Revlimid 25 mg tvrdé kapsuly |
cps dur 21x25 mg |
CLG |
GB |
21 |
5652.56 |
5652.56 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
M01AB01 |
|
|
|
Indometacín |
p.rect. 50 mg (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.10290000000000001 |
|
|
|
93723 |
|
|
O |
Indometacin 50 Berlin-Chemie |
sup 10x50 mg (fólia PVC/PE) |
BCE |
DE |
5 |
2.2599999999999998 |
0.51 |
S |
1.75 |
0.77433600000000002 |
1.75 |
|
|
|
|
|
M01AB01 |
|
|
|
Indometacín |
p.rect. 100 mg (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.10290000000000001 |
|
|
|
89611 |
|
|
G |
Indometacin 100 Galvex |
sup 10x100 mg (strip PVC/LDPE) |
GVX |
SK |
10 |
1.37 |
1.03 |
S |
0.34 |
0.24817499999999998 |
0.34 |
|
|
|
|
|
93724 |
|
|
O |
INDOMETACIN 100 BERLIN-CHEMIE |
sup 10x100 mg |
BCE |
DE |
10 |
3.4 |
1.03 |
S |
2.37 |
0.69705899999999998 |
0.34 |
|
|
|
|
|
M01AB05 |
|
|
|
Diklofenak |
p.o. 50 mg (20 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
14130 |
X |
|
G |
DICLOBENE 50 MG |
tbl flm 20x50 mg |
MCK |
DE |
10 |
0.94 |
0.7 |
S |
0.24 |
0.25531900000000002 |
7.0000000000000007E-2 |
|
|
|
|
U26 |
67541 |
X |
|
G |
ALMIRAL 50 MG |
tbl ent 20x50 mg |
MOE |
CY |
10 |
1.44 |
0.7 |
S |
0.74 |
0.51388900000000004 |
7.0000000000000007E-2 |
|
|
|
|
U26 |
15886 |
X |
|
G |
VERAL 50MG |
tbl ent 20x50 mg (b.) |
SLO |
SK |
10 |
1.7 |
0.7 |
S |
1 |
0.58823500000000006 |
7.0000000000000007E-2 |
|
|
|
|
U26 |
89024 |
X |
|
G |
DICLOFENAC AL 50 |
tbl flm 20x50 mg |
APA |
DE |
10 |
2.09 |
0.7 |
S |
1.39 |
0.665072 |
7.0000000000000007E-2 |
|
|
|
|
U26 |
97518 |
X |
|
O |
VOLTAREN 50 |
tbl obd 20x50 mg |
XNT |
IT |
10 |
3.69 |
0.7 |
S |
2.99 |
0.81029799999999996 |
7.0000000000000007E-2 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. 50 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
07454 |
X |
|
G |
Dicuno 50 mg filmom obalené tablety |
tbl flm 30x50 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
15 |
3.07 |
1.05 |
S |
2.02 |
0.65798000000000001 |
0.1 |
|
|
|
|
U26 |
97599 |
X |
|
G |
DICLOREUM |
tbl ent 30x50 mg |
ASW |
IT |
15 |
3.33 |
1.05 |
S |
2.2799999999999998 |
0.6846850000000001 |
0.1 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. 50 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
14131 |
X |
|
G |
DICLOBENE 50 MG |
tbl flm 50x50 mg |
MCK |
DE |
25 |
1.92 |
1.75 |
S |
0.17 |
8.854200000000001E-2 |
0.17 |
|
|
|
|
U26 |
15887 |
X |
|
G |
VERAL 50MG |
tbl ent 50x50 mg (b.) |
SLO |
SK |
25 |
4.3499999999999996 |
1.75 |
S |
2.6 |
0.59770100000000004 |
0.17 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. 100 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
75632 |
X |
|
G |
DICLOFENAC AL RETARD |
tbl obd 50x100 mg |
APA |
DE |
50 |
6.37 |
3.5 |
S |
2.87 |
0.45054900000000003 |
2.87 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. 150 mg (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
14133 |
X |
|
G |
DICLOBENE 150 MG RETARD |
tbl mod 10x150 mg |
MCK |
DE |
15 |
1.28 |
1.05 |
S |
0.23 |
0.17968800000000001 |
0 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. 150 mg (20 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
14134 |
X |
|
G |
DICLOBENE 150 MG RETARD |
tbl mod 20x150 mg |
MCK |
DE |
30 |
2.52 |
2.1 |
S |
0.42 |
0.16666699999999998 |
0 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. 150 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
14135 |
X |
|
G |
DICLOBENE 150 MG RETARD |
tbl mod 50x150 mg |
MCK |
DE |
75 |
5 |
5 |
I |
0 |
0 |
0 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. predĺžené uvoľňovanie 75 mg (20 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
28302 |
X |
|
G |
VERAL 75 RETARD |
tbl flp 20x75 mg |
SLO |
SK |
15 |
2.67 |
1.05 |
S |
1.62 |
0.606742 |
1.62 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. predĺžené uvoľňovanie 75 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
89136 |
X |
|
G |
Diclofenac Duo PharmaSwiss 75 mg |
cps mod 30x75 mg |
PRW |
CZ |
22.515999999999998 |
4.1399999999999997 |
1.58 |
S |
2.56 |
0.61835700000000005 |
2.4300000000000002 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. predĺžené uvoľňovanie 100 mg (20 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
68631 |
X |
|
G |
DICLAC RETARD |
tbl plg 20x100 mg |
HEX |
DE |
20 |
3.19 |
1.4 |
S |
1.79 |
0.56112899999999999 |
1.1499999999999999 |
|
|
|
|
U26 |
75631 |
X |
|
G |
DICLOFENAC AL RETARD |
tbl plg 20x100 mg |
APA |
DE |
20 |
3.25 |
1.4 |
S |
1.85 |
0.56923099999999993 |
1.1499999999999999 |
|
|
|
|
U26 |
97596 |
X |
|
G |
DICLOREUM |
tbl plg 20x100 mg |
ASW |
IT |
20 |
4.53 |
1.4 |
S |
3.13 |
0.69094899999999992 |
1.1499999999999999 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. predĺžené uvoľňovanie 100 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
28303 |
X |
|
G |
VERAL 100 RETARD |
tbl plg 30x100 mg |
SLO |
SK |
30 |
4.95 |
2.1 |
S |
2.85 |
0.57575799999999999 |
1.72 |
|
|
|
|
U26 |
87521 |
X |
|
O |
VOLTAREN RETARD 100 |
tbl plg 30x100 mg |
NPF |
CH |
30 |
7.61 |
2.1 |
S |
5.51 |
0.72404700000000011 |
1.72 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
p.o. draselná soľ 50 mg (20 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.25800000000000001 |
|
|
|
27802 |
X |
|
O |
VOLTAREN RAPID 50 MG |
tbl obd 20x50 mg |
NPF |
CH |
10 |
3.2 |
2.58 |
S |
0.62 |
0.19375000000000001 |
7.0000000000000007E-2 |
|
|
|
|
U27 |
M01AB05 |
|
|
|
Diklofenak |
p.o. epolamín 50 mg (10 ks) tekuté |
0.1 |
g |
|
|
|
|
|
|
|
|
9.8599999999999993E-2 |
|
|
|
55700 |
X |
|
O |
FLECTOR EP RAPID 50MG |
gra 10x50 mg |
IBS |
CH |
5 |
2.81 |
0.49 |
S |
2.3199999999999998 |
0.82562299999999988 |
2.19 |
|
|
|
|
|
M01AB05 |
|
|
|
Diklofenak |
p.o. epolamín 50 mg (20 ks) tekuté |
0.1 |
g |
|
|
|
|
|
|
|
|
9.8599999999999993E-2 |
|
|
|
55701 |
X |
|
O |
FLECTOR EP RAPID 50MG |
gra 20x50 mg |
IBS |
CH |
10 |
5.36 |
0.99 |
S |
4.37 |
0.815299 |
4.37 |
|
|
|
|
|
M01AB05 |
|
|
|
Diklofenak |
p.rect. 50 mg (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.32200000000000001 |
|
|
|
97631 |
|
|
G |
DICLOREUM 50MG |
sup 10x50 mg |
ASW |
IT |
5 |
2.1 |
1.61 |
S |
0.49 |
0.23333300000000001 |
0.49 |
|
|
|
|
|
M01AB05 |
|
|
|
Diklofenak |
p.rect. 100 mg (5 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.32200000000000001 |
|
|
|
66747 |
|
|
O |
VOLTAREN 100 |
sup 5x100 mg |
XNU |
FR |
5 |
2.57 |
1.61 |
S |
0.96 |
0.37354100000000001 |
0.49 |
|
|
|
|
|
M01AB05 |
|
|
|
Diklofenak |
p.rect. 100 mg (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.32200000000000001 |
|
|
|
18553 |
|
|
G |
VERAL 100MG |
sup 10x100 mg |
SLO |
SK |
10 |
4.1900000000000004 |
3.22 |
S |
0.97 |
0.23150400000000002 |
0.97 |
|
|
|
|
|
97632 |
|
|
G |
DICLOREUM 100MG |
sup 10x100 mg |
ASW |
IT |
10 |
4.2 |
3.22 |
S |
0.98 |
0.23333300000000001 |
0.97 |
|
|
|
|
|
M01AB05 |
|
|
|
Diklofenak |
parent. 25 mg/ml (5 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.30499999999999999 |
|
|
|
27910 |
|
|
G |
VERAL 75 |
inj 5x3 ml |
HEO |
CZ |
3.7519999999999998 |
1.1299999999999999 |
1.1299999999999999 |
I |
0 |
0 |
0 |
|
|
|
|
|
87523 |
|
|
O |
VOLTAREN 75 MG/3 ML |
inj 5x3 ml/75 mg |
NPF |
CH |
3.7519999999999998 |
2.13 |
1.1399999999999999 |
S |
0.99 |
0.46478900000000001 |
0 |
|
|
|
|
|
M01AB05 |
|
|
|
Diklofenak |
parent. 25 mg/ml (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.30499999999999999 |
|
|
|
67547 |
|
|
G |
ALMIRAL |
inj 10x3 ml/75 mg |
MOE |
CY |
7.5 |
3.07 |
2.29 |
S |
0.78 |
0.25407200000000002 |
0 |
|
|
|
|
|
M01AB16 |
|
|
|
Aceklofenak |
p.o. 100 mg (20 ks) |
200 |
mg |
|
|
|
|
|
|
|
|
6.6000000000000003E-2 |
|
|
|
40339 |
X |
|
O |
AFLAMIL |
tbl flm 20x100 mg |
GDN |
HU |
10 |
5.5 |
0.66 |
S |
4.84 |
0.88 |
0.99 |
GER, NEU, ORT, REU |
|
|
|
|
M01AB16 |
|
|
|
Aceklofenak |
p.o. 100 mg (30 ks) |
200 |
mg |
|
|
|
|
|
|
|
|
6.6000000000000003E-2 |
|
|
|
10884 |
X |
|
G |
Aceclofenac Accord 100 mg filmom obalené tablety |
tbl flm 30x100 mg (blis.Al/Al) |
ACC |
GB |
15 |
2.4700000000000002 |
0.99 |
S |
1.48 |
0.59919 |
1.48 |
GER, NEU, ORT, REU |
|
|
|
|
98368 |
X |
|
O |
AFLAMIL |
tbl flm 30x100 mg (blis. PAD/Al/PVC/Al) |
GDN |
HU |
15 |
5.09 |
0.99 |
S |
4.0999999999999996 |
0.80550100000000002 |
1.48 |
GER, NEU, ORT, REU |
|
|
|
|
M01AB16 |
|
|
|
Aceklofenak |
p.o. 100 mg (60 ks) |
200 |
mg |
|
|
|
|
|
|
|
|
6.6000000000000003E-2 |
|
|
|
10886 |
X |
|
G |
Aceclofenac Accord 100 mg filmom obalené tablety |
tbl flm 60x100 mg (blis.Al/Al) |
ACC |
GB |
30 |
4.95 |
1.98 |
S |
2.97 |
0.6 |
2.96 |
GER, NEU, ORT, REU |
|
|
|
|
40340 |
X |
|
O |
AFLAMIL |
tbl flm 60x100 mg |
GDN |
HU |
30 |
11.73 |
1.98 |
S |
9.75 |
0.831202 |
2.96 |
GER, NEU, ORT, REU |
|
|
|
|
M01AB55 |
|
|
|
Diklofenak, kombinácie s misoprostolom |
p.o. 75 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.40799999999999997 |
|
|
|
53239 |
|
|
O |
ARTHROTEC FORTE |
tbl flm 30x75 mg (blis.PA/Al/PVC) |
PFI-GB-3 |
GB |
22.5 |
14.1 |
9.18 |
S |
4.92 |
0.34893599999999997 |
4.92 |
NEU, ORT, REU, UCH |
|
|
|
|
M01AC01 |
|
|
|
Piroxikam |
p.o. betacyklodextrín 20 mg (30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.10299999999999999 |
|
|
|
49522 |
X |
|
G |
FLAMEXIN 20 mg |
tbl 30x191,2 mg |
CHS |
IT |
30 |
8.2100000000000009 |
3.09 |
S |
5.12 |
0.62363000000000002 |
5.12 |
|
|
|
|
|
M01AC01 |
|
|
|
Piroxikam |
p.o. 20 mg (20 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
6.9699999999999998E-2 |
|
|
|
84717 |
X |
|
G |
HOTEMIN |
cps 20x20 mg |
EGI |
HU |
20 |
2.23 |
1.39 |
S |
0.84 |
0.37668199999999996 |
0.84 |
|
|
|
|
|
M01AC01 |
|
|
|
Piroxikam |
p.o. betacyklodextrín 20 mg (20 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.10299999999999999 |
|
|
|
49503 |
X |
|
G |
FLAMEXIN 20 mg |
tbl 20x191,2 mg |
CHS |
IT |
20 |
5.59 |
2.06 |
S |
3.53 |
0.63148499999999996 |
3.41 |
|
|
|
|
|
M01AC01 |
|
|
|
Piroxikam |
p.o. betacyklodextrín 20 mg (20 ks) tekuté |
20 |
mg |
|
|
|
|
|
|
|
|
0.10299999999999999 |
|
|
|
49504 |
X |
|
G |
FLAMEXIN 20 mg |
gra 20x191,2 mg |
CHS |
IT |
20 |
6.28 |
2.06 |
S |
4.22 |
0.6719750000000001 |
4.22 |
|
|
|
|
|
M01AC01 |
|
|
|
Piroxikam |
parent. 20 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
0.35830000000000001 |
|
|
|
68649 |
|
|
G |
HOTEMIN 20MG |
sol inj 5x1 ml |
EGI |
HU |
5 |
2.93 |
1.79 |
S |
1.1399999999999999 |
0.38907800000000003 |
1.1399999999999999 |
|
|
|
|
|
M01AC05 |
|
|
|
Lornoxikam |
p.o. 4 mg (50 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
55582 |
X |
|
O |
Xefo 4 mg filmom obalené tablety |
tbl flm 50 x 4 mg ( blister) |
NCD |
DK |
12.5 |
6.23 |
0.88 |
S |
5.35 |
0.85874799999999996 |
5.35 |
|
|
|
|
U26 |
M01AC05 |
|
|
|
Lornoxikam |
p.o. 8 mg (50 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
55560 |
X |
|
O |
Xefo 8 mg filmom obalené tablety |
tbl flm 50 x 8 mg |
NCD |
DK |
25 |
6.31 |
1.75 |
S |
4.5599999999999996 |
0.72266200000000003 |
4.5599999999999996 |
|
|
|
|
U26 |
M01AC05 |
|
|
|
Lornoxikam |
p.o. rapid 8 mg (10 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
55458 |
X |
|
G |
Xefo Rapid |
tbl flm 10 x 8 mg |
NCD |
DK |
5 |
4.01 |
0.35 |
S |
3.66 |
0.91271800000000003 |
0.91 |
|
|
|
|
U26 |
M01AC05 |
|
|
|
Lornoxikam |
parent. 4 mg/ml |
8 |
mg |
|
|
|
|
|
|
|
|
1.216 |
|
|
|
55590 |
|
|
O |
Xefo 4mg/ml prášok a rozpúšťadlo na injekčný roztok |
plv iol 1 x 8mg + 1 x 2 ml solv. |
NCD |
DK |
1 |
2.94 |
1.22 |
S |
1.72 |
0.58503399999999994 |
1.72 |
AGG, CCH, CHI, NEU, ORT, REU |
|
|
|
|
M01AC06 |
|
|
|
Meloxikam |
p.o. 15 mg (20 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
89417 |
X |
|
G |
Meloxikam Saneca 15 mg |
tbl 20x15 mg (blis. OPA/Al/PVC/Al) |
SEP |
SK |
20 |
2.2000000000000002 |
1.4 |
S |
0.8 |
0.36363599999999996 |
0.64 |
|
|
|
|
U26 |
91547 |
X |
|
G |
Recoxa 15 |
tbl 20x15 mg |
ZNT-SK-2 |
SK |
20 |
2.34 |
1.4 |
S |
0.94 |
0.40170900000000004 |
0.64 |
|
|
|
|
U26 |
95046 |
X |
|
G |
Meloxicam Mylan 15mg |
tbl 20x15mg |
GNS |
GB |
20 |
2.59 |
1.4 |
S |
1.19 |
0.45945900000000001 |
0.64 |
|
|
|
|
U26 |
95795 |
X |
|
G |
Meloxistad 15 |
tbl 20x15 mg |
STD |
DE |
20 |
2.73 |
1.4 |
S |
1.33 |
0.48717900000000003 |
0.64 |
|
|
|
|
U26 |
95841 |
X |
|
G |
LORMED 15 |
tbl 20x15 mg |
PMP |
CZ |
20 |
2.77 |
1.4 |
S |
1.37 |
0.494585 |
0.64 |
|
|
|
|
U26 |
40317 |
X |
|
G |
MELOXAN 15 mg |
tbl 20x15 mg |
PRW |
CZ |
20 |
3.22 |
1.4 |
S |
1.82 |
0.56521700000000008 |
0.64 |
|
|
|
|
U26 |
25931 |
X |
|
O |
MOVALIS |
tbl 20x15 mg |
BOE |
DE |
20 |
3.44 |
1.4 |
S |
2.04 |
0.59302300000000008 |
0.64 |
|
|
|
|
U26 |
M01AC06 |
|
|
|
Meloxikam |
p.o. 15 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
98782 |
X |
|
G |
MELOBAX 15 mg tablety |
tbl 30x15 mg |
RXY |
IE |
30 |
3.67 |
2.1 |
S |
1.57 |
0.42779299999999998 |
0.96 |
|
|
|
|
U26 |
3599B |
X |
|
G |
Meloxikam Saneca 15 mg |
tbl 30x15 mg (blis.OPA/Al/PVC/Al) |
SNC |
SK |
30 |
3.67 |
2.1 |
S |
1.57 |
0.42779299999999998 |
0.96 |
|
|
|
|
U26 |
95797 |
X |
|
G |
Meloxistad 15 |
tbl 30x15 mg |
STD |
DE |
30 |
3.69 |
2.1 |
S |
1.59 |
0.430894 |
0.96 |
|
|
|
|
U26 |
96029 |
X |
|
G |
MELOXAN 15 mg |
tbl 30x15 mg |
PRW |
CZ |
30 |
4.79 |
2.1 |
S |
2.69 |
0.56158700000000006 |
0.96 |
|
|
|
|
U26 |
M01AC06 |
|
|
|
Meloxikam |
p.o. oro 15 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
00115 |
X |
|
G |
Oramellox 15mg |
tbl oro 3x10x15 mg (blis.Al/PA/Al/PVC) |
SBO |
IT |
30 |
4.8 |
2.1 |
S |
2.7 |
0.5625 |
0.96 |
|
|
|
|
U26 |
M01AC06 |
|
|
|
Meloxikam |
p.o. 15 mg (50 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
95842 |
X |
|
G |
LORMED 15 |
tbl 50x15 mg |
PMP |
CZ |
50 |
5.12 |
3.5 |
S |
1.62 |
0.31640599999999997 |
1.6 |
|
|
|
|
U26 |
M01AC06 |
|
|
|
Meloxikam |
p.o. 15 mg (60 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
96030 |
X |
|
G |
MELOXAN 15 mg |
tbl 60x15 mg |
PRW |
CZ |
60 |
7.15 |
4.2 |
S |
2.95 |
0.41258699999999998 |
1.91 |
|
|
|
|
U26 |
95051 |
X |
|
G |
Meloxicam MYLAN 15mg |
tbl 60x15mg |
GNS |
GB |
60 |
7.15 |
4.2 |
S |
2.95 |
0.41258699999999998 |
1.91 |
|
|
|
|
U26 |
3600B |
X |
|
G |
Meloxikam Saneca 15 mg |
tbl 60x15 mg (blis.OPA/Al/PVC/Al) |
SNC |
SK |
60 |
7.15 |
4.2 |
S |
2.95 |
0.41258699999999998 |
1.91 |
|
|
|
|
U26 |
35033 |
X |
|
G |
Recoxa 15 |
tbl 60x15 mg |
ZNT-SK-2 |
SK |
60 |
8.91 |
4.2 |
S |
4.71 |
0.52861999999999998 |
1.91 |
|
|
|
|
U26 |
M01AC06 |
|
|
|
Meloxikam |
p.o. 15 mg (100 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
95052 |
X |
|
G |
Meloxicam MYLAN 15mg |
tbl 100x15mg |
GNS |
GB |
100 |
10.19 |
7 |
S |
3.19 |
0.313052 |
3.19 |
|
|
|
|
U26 |
M01AC06 |
|
|
|
Meloxikam |
parent. 10mg/ml |
15 |
mg |
|
|
|
|
|
|
|
|
0.63700000000000001 |
|
|
|
34418 |
|
|
O |
MOVALIS 15 mg/1,5 ml |
sol inj 5x1,5 ml |
BOE |
DE |
5 |
3.65 |
3.19 |
S |
0.46 |
0.126027 |
0.46 |
CCH, CHI, NEU, ORT, REU |
|
|
|
|
M01AE01 |
|
|
|
Ibuprofén |
p.o. 600 mg (30 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
56035 |
X |
|
G |
IBALGIN 600 |
tbl flm 30x600 mg |
ZNT |
CZ |
15 |
2.68 |
1.07 |
S |
1.61 |
0.600746 |
1.61 |
|
|
|
|
U28 |
30478 |
X |
|
G |
Ibutabs 600 mg |
tbl flm 30x600 mg (fľ.HDPE) |
VTB |
FI |
15 |
2.75 |
1.07 |
S |
1.68 |
0.61090899999999992 |
1.61 |
|
|
|
|
U28 |
M01AE01 |
|
|
|
Ibuprofén |
p.o. granulát 600 mg (20 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
52929 |
X |
|
O |
BRUFEN 600 |
gra eff 20x600mg |
ABB |
IT |
10 |
3.77 |
0.71 |
S |
3.06 |
0.81167100000000003 |
3.06 |
|
|
|
|
U28 |
M01AE01 |
|
|
|
Ibuprofén |
p.o. predĺžené uvoľňovanie 800 mg (30 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
23089 |
X |
|
G |
Brufen retard 800 |
tbl flp 30x800 mg (blis. PVC/PVDC) |
ABB |
DE |
20 |
4.7699999999999996 |
1.42 |
S |
3.35 |
0.70230599999999999 |
3.35 |
|
|
|
|
U28 |
M01AE02 |
|
|
|
Naproxén |
p.o. 250 mg (30 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.05 |
|
|
|
80207 |
X |
|
G |
NAPSYN |
tbl 30x250 mg |
PRW |
CZ |
15 |
3.82 |
0.75 |
S |
3.07 |
0.80366500000000007 |
3.07 |
|
|
|
|
U84 |
M01AE02 |
|
|
|
Naproxén |
p.o. 500 mg (30 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.05 |
|
|
|
3316A |
|
|
G |
Nalgesin FORTE 550 mg |
tbl flm 30x550 mg (blis.Al/PVC) |
KRK-2 |
SI |
30 |
3.72 |
1.5 |
S |
2.2200000000000002 |
0.59677400000000003 |
1.99 |
|
|
|
|
U84 |
M01AE02 |
|
|
|
Naproxén |
p.o. 500 mg (60 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.05 |
|
|
|
3318A |
|
|
G |
Nalgesin FORTE 550 mg |
tbl flm 60x550 mg (blis.Al/PVC) |
KRK-2 |
SI |
60 |
6.97 |
3 |
S |
3.97 |
0.56958399999999998 |
3.97 |
|
|
|
|
U84 |
M01AE03 |
|
|
|
Ketoprofén |
p.o. 50 mg (25 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.1394 |
|
|
|
76655 |
X |
|
G |
KETONAL |
cps 25x50 mg |
LEK |
SI |
8.3420000000000005 |
1.7 |
1.1599999999999999 |
S |
0.54 |
0.31764700000000001 |
0.54 |
|
|
|
|
U29 |
M01AE03 |
|
|
|
Ketoprofén |
p.o. 100 mg (20 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.1394 |
|
|
|
76653 |
X |
|
G |
KETONAL FORTE |
tbl flm 20x100 mg |
LEK |
SI |
13.342000000000001 |
2.72 |
1.86 |
S |
0.86 |
0.31617600000000001 |
0.86 |
|
|
|
|
U29 |
M01AE03 |
|
|
|
Ketoprofén |
p.o. predĺžené uvoľňovanie 150 mg (20 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.1394 |
|
|
|
76654 |
X |
|
G |
KETONAL RETARD |
tbl plg 20x150 mg |
LEK |
SI |
20 |
3.7 |
2.79 |
S |
0.91 |
0.245946 |
0.91 |
|
|
|
|
U29 |
45254 |
X |
|
G |
Ketonal DUO 150mg |
cps mdd 20x150 mg |
SAN |
SI |
20 |
4.38 |
2.79 |
S |
1.59 |
0.363014 |
0.91 |
|
|
|
|
U29 |
M01AE03 |
|
|
|
Ketoprofén |
parent. 50 mg/ml |
0.15 |
g |
|
|
|
|
|
|
|
|
0.45 |
|
|
|
25993 |
|
|
G |
KETONAL |
inj 5x2 ml/100 mg |
LEK |
SI |
3.331 |
2.0099999999999998 |
1.5 |
S |
0.51 |
0.25373099999999998 |
0.51 |
|
|
|
|
|
M01AE09 |
|
|
|
Flurbiprofén |
p.o. 50 mg (30 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.1062 |
|
|
|
25110 |
X |
|
G |
FLUGALIN |
tbl obd 30x50 mg |
KNO |
GB |
7.5 |
2.94 |
0.8 |
S |
2.14 |
0.72789100000000007 |
2.14 |
|
|
|
|
U30 |
M01AE11 |
|
|
|
Kyselina tiaprofénová |
p.o. 300 mg (20 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.1062 |
|
|
|
96484 |
X |
|
G |
SURGAM |
tbl 20x300 mg |
ZNT |
CZ |
10 |
4.07 |
1.06 |
S |
3.01 |
0.73955799999999994 |
3.01 |
|
|
|
|
U30 |
M01AE17 |
|
|
|
Dexketoprofen |
p.o. 25 mg (10 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
0.13 |
|
|
|
07226 |
|
|
O |
Dexadol 25 mg gro por |
gro por 10x25 mg (vre. Al/PE) |
MNR |
LU |
3.3330000000000002 |
3.74 |
0.43 |
S |
3.31 |
0.88502700000000001 |
2.46 |
|
|
|
|
|
M01AE17 |
|
|
|
Dexketoprofen |
p.o. 25 mg (20 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
0.13 |
|
|
|
07227 |
|
|
O |
Dexadol 25 mg gro por |
gro por 20x25 mg (vre. Al/PE) |
MNR |
LU |
6.6669999999999998 |
5.8 |
0.87 |
S |
4.93 |
0.85 |
4.93 |
|
|
|
|
|
M01AE52 |
|
|
|
Naproxén a ezomeprazol |
p.o. predĺžené uvoľňovanie 500/20 mg |
2 |
DF |
|
|
|
|
|
|
|
|
0.19400000000000001 |
|
|
|
01648 |
|
|
O |
Vimovo 500 mg/20 mg tablety s riadeným uvoľňovaním |
tbl mod 60x500 mg/20 mg (liek.HDPE+bezp.uzáver) |
AZC |
SE |
30 |
21.45 |
5.82 |
S |
15.63 |
0.72867099999999996 |
15.63 |
|
|
|
|
|
M01AH01 |
|
|
|
Celekoxib |
p.o. 100 mg (30 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.28699999999999998 |
|
|
|
9614A |
X |
|
G |
Lectazib 100 mg |
cps dur 30x100 mg (blis.PVC/Al-priehľ.) |
ACT-5 |
IS |
15 |
8.34 |
4.3099999999999996 |
S |
4.03 |
0.483213 |
4.03 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
7836A |
X |
|
G |
Aclexa 100 mg tvrdé kapsuly |
cps dur 30x100 mg(blis.PVC/Al) |
KRK |
SL |
15 |
8.9600000000000009 |
4.3099999999999996 |
S |
4.6500000000000004 |
0.51897300000000002 |
4.03 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
57817 |
X |
|
O |
CELEBREX 100 mg |
cps dur 30x100 mg |
PFI-GB-3 |
GB |
15 |
9.86 |
4.3099999999999996 |
S |
5.55 |
0.56287999999999994 |
4.03 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
M01AH01 |
|
|
|
Celekoxib |
p.o. 200 mg (10 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.28699999999999998 |
|
|
|
9627A |
X |
|
G |
Lectazib 200 mg |
cps dur 10x200 mg (blis.PVC/Al-priehľ.) |
ACT-5 |
IS |
10 |
4.12 |
2.87 |
S |
1.25 |
0.303398 |
0.32 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
57809 |
X |
|
O |
CELEBREX 200 mg |
cps dur 10x200 mg (blis.PVC/Al) |
PFI-GB-3 |
GB |
10 |
7.38 |
2.87 |
S |
4.51 |
0.61111099999999996 |
0.32 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
M01AH01 |
|
|
|
Celekoxib |
p.o. 200 mg (20 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.28699999999999998 |
|
|
|
9628A |
X |
|
G |
Lectazib 200 mg |
cps dur 20x200 mg (blis.PVC/Al-priehľ.) |
ACT-5 |
IS |
20 |
7.15 |
5.74 |
S |
1.41 |
0.19720300000000002 |
0.63 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
7843A |
X |
|
G |
Aclexa 200mg tvrdé kapsuly |
cps dur 20x200mg(blis.PVC/Al) |
KRK |
SL |
20 |
7.59 |
5.74 |
S |
1.85 |
0.24374199999999999 |
0.63 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
57810 |
X |
|
O |
CELEBREX 200 mg |
cps dur 20x200 mg (blis.PVC/Al) |
PFI-GB-3 |
GB |
20 |
13.87 |
5.74 |
S |
8.1300000000000008 |
0.58615699999999993 |
0.63 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
M01AH01 |
|
|
|
Celekoxib |
p.o. 200 mg (100 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.28699999999999998 |
|
|
|
9633A |
X |
|
G |
Lectazib 200 mg |
cps dur 100x200 mg (blis.PVC/Al-priehľ.) |
ACT-5 |
IS |
100 |
31.85 |
28.7 |
S |
3.15 |
9.8901000000000003E-2 |
3.15 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
7848A |
X |
|
G |
Aclexa 200mg tvrdé kapsuly |
cps dur 90x200mg(blis.PVC/Al) |
KRK |
SL |
90 |
35.1 |
25.83 |
S |
9.27 |
0.26410299999999998 |
9.27 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
57814 |
X |
|
O |
CELEBREX 200 mg |
cps dur 100x200 mg (blis.PVC/Al) |
PFI-GB-3 |
GB |
100 |
60.7 |
28.7 |
S |
32 |
0.52718299999999996 |
3.15 |
ORT,REU, NEU |
ind.obm. |
|
|
U31 |
M01AH05 |
|
|
|
Etorikoxib |
p.o. 90 mg (28 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.28699999999999998 |
|
|
|
34334 |
X |
|
O |
ARCOXIA 90mg |
tbl 28x90 mg |
MSD |
NL |
42 |
23.63 |
12.05 |
S |
11.58 |
0.49005499999999996 |
11.58 |
NEU, ORT, REU, UCH |
ind.obm. |
|
|
U31 |
M01AH05 |
|
|
|
Etorikoxib |
p.o. 120 mg (7 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.28699999999999998 |
|
|
|
34335 |
X |
|
O |
ARCOXIA 120MG |
tbl 7x120 mg |
MSD |
NL |
14 |
8.43 |
4.0199999999999996 |
S |
4.41 |
0.52313200000000004 |
4.41 |
GER, INT, KLF, NEU, ORT, REU, UCH |
ind.obm. |
|
|
U31 |
M01AX17 |
|
|
|
Nimesulid |
p.o. 100 mg (15 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.1062 |
|
|
|
12891 |
X |
|
O |
AULIN |
tbl 15x100 mg |
MCI |
CZ |
7.5 |
2.5499999999999998 |
0.8 |
S |
1.75 |
0.68627499999999997 |
1.5 |
|
|
|
|
U30 |
M01AX17 |
|
|
|
Nimesulid |
p.o. 100 mg (30 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.1062 |
|
|
|
12892 |
X |
|
O |
AULIN |
tbl 30x100 mg |
MCI |
CZ |
15 |
4.59 |
1.59 |
S |
3 |
0.65359499999999993 |
3 |
|
|
|
|
U30 |
M01AX17 |
|
|
|
Nimesulid |
p.o. 100 mg (15 ks) tekuté |
0.2 |
g |
|
|
|
|
|
|
|
|
0.1062 |
|
|
|
12894 |
X |
|
G |
AULIN 100 mg granulát |
gro por 15 x 100 mg |
MCI |
CZ |
7.5 |
2.93 |
0.8 |
S |
2.13 |
0.726962 |
1.94 |
|
|
|
|
U30 |
M01AX17 |
|
|
|
Nimesulid |
p.o. 100 mg (30 ks) tekuté |
0.2 |
g |
|
|
|
|
|
|
|
|
0.1062 |
|
|
|
12895 |
X |
|
G |
AULIN 100 mg granulát |
gro por 30 x 100 mg |
MCI |
CZ |
15 |
5.47 |
1.59 |
S |
3.88 |
0.70932400000000007 |
3.88 |
|
|
|
|
U30 |
59626 |
X |
|
G |
NIMESIL |
gru por 30x100 mg /vrecko/ |
GUI |
IT |
15 |
7.67 |
1.59 |
S |
6.08 |
0.79269900000000004 |
3.88 |
|
|
|
|
U30 |
M01CC01 |
|
|
|
Penicilamín |
p.o. 150 mg (50 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
1.01 |
|
|
|
66755 |
X |
|
G |
METALCAPTASE 150 |
tbl flm 50x150 mg |
KNO |
DE |
15 |
15.06 |
15.06 |
I |
0 |
0 |
0 |
DER, DIA, GER, GIT, INT, KLF, REU |
|
|
|
|
M01CC01 |
|
|
|
Penicilamín |
p.o. 300 mg (50 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.79 |
|
|
|
66753 |
X |
|
G |
METALCAPTASE 300 |
tbl flm 50x300 mg |
KNO |
DE |
30 |
23.31 |
23.31 |
I |
0 |
0 |
0 |
DER, DIA, GER, GIT, INT, KLF, REU |
|
|
|
|
M03AX01 |
|
|
|
Botulotoxín |
parent. 100 UT |
100 |
UT |
|
|
|
|
|
|
|
|
160.9 |
|
|
|
75241 |
|
|
O |
BOTOX |
plv ino 1x100 U |
ALL |
IE |
1 |
160.9 |
160.9 |
A |
0 |
0 |
0 |
NEU, OPH, URO |
ind.obm. |
|
|
|
0186B |
|
|
O |
XEOMIN 100 LD50 jednotiek prášok na injekčný roztok |
plv ino 1x100 LD50 (liek.inj.skl.) |
MEZ |
DE |
1 |
185.26 |
160.9 |
AS |
24.36 |
0.131491 |
0 |
NEU, OPH, URO |
ind.obm. |
|
|
|
M03AX01 |
|
|
|
Botulotoxín |
parent. 500 UT |
100 |
UT |
|
|
|
|
|
|
|
|
40.799999999999997 |
|
|
|
28992 |
|
|
O |
DYSPORT 500 U |
plv ino 1x500 U (liek. inj. skl.) |
IAA-1 |
FR |
5 |
230.59 |
204 |
AS |
26.59 |
0.115313 |
26.59 |
NEU, OPH |
ind.obm. |
|
|
|
M03AX01 |
|
|
|
Botulotoxín typu B |
parent. 5000 IU/ml (2 ml) |
10000 |
U |
|
|
|
|
|
|
|
|
247.09 |
|
|
|
42394 |
|
|
O |
NEUROBLOC |
sol inj 1x2 ml (5000 IU/ml) (skl. liek.) |
XEI-GB |
GB |
1 |
247.09 |
247.09 |
A |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
M03BX01 |
|
|
|
Baklofén |
p.o. 10 mg (50 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
40274 |
X |
|
G |
BACLOFEN POLPHARMA |
tbl 50x10 mg |
XPO |
PL |
10 |
2.85 |
1.48 |
S |
1.37 |
0.48070200000000002 |
1.37 |
|
|
|
|
|
M03BX01 |
|
|
|
Baklofén |
p.o. 25 mg (50 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.14799999999999999 |
|
|
|
40275 |
X |
|
G |
BACLOFEN POLPHARMA |
tbl 50x25 mg |
XPO |
PL |
25 |
5.19 |
3.7 |
S |
1.49 |
0.28709099999999999 |
1.49 |
|
|
|
|
|
M03BX02 |
|
|
|
Tizanidín |
p.o. 2 mg (30 ks) |
12 |
mg |
|
|
|
|
|
|
|
|
0.249 |
|
|
|
27245 |
X |
|
O |
SIRDALUD |
tbl 30x2 mg |
NPA |
CH |
5 |
4.4400000000000004 |
1.25 |
S |
3.19 |
0.718468 |
3.19 |
|
|
|
|
|
M03BX02 |
|
|
|
Tizanidín |
p.o. 4 mg (30 ks) |
12 |
mg |
|
|
|
|
|
|
|
|
0.249 |
|
|
|
91284 |
X |
|
O |
SIRDALUD |
tbl 30x4 mg |
NPA |
CH |
10 |
6.87 |
2.4900000000000002 |
S |
4.38 |
0.63755499999999998 |
4.38 |
|
|
|
|
|
M04AA01 |
|
|
|
Allopurinol |
p.o. 300 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
01710 |
X |
|
G |
MILURIT |
tbl 30x300 mg |
EGI |
HU |
22.5 |
3.3 |
3.3 |
I |
0 |
0 |
0 |
|
|
|
|
|
M04AA03 |
|
|
|
Febuxostat |
p.o. 80 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.0840000000000001 |
|
|
|
50513 |
|
|
O |
ADENURIC 80 mg filmom obalené tablety |
tbl flm 28x80 mg (blis.Aclar/PVC/Al) |
MNR |
LU |
28 |
31.24 |
30.35 |
S |
0.89 |
2.8489E-2 |
0.89 |
REU |
ind.obm. |
|
|
|
M04AA03 |
|
|
|
Febuxostat |
p.o. 120 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.1259999999999999 |
|
|
|
50515 |
|
|
O |
ADENURIC 120 mg filmom obalené tablety |
tbl flm 28x120 mg (blis.Aclar/PVC/Al) |
MNR |
LU |
28 |
32.44 |
31.53 |
S |
0.91 |
2.8052000000000001E-2 |
0.91 |
REU |
ind.obm. |
|
|
|
M04AC01 |
|
|
|
Kolchicín |
p.o. 0,5 mg (20 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.4 |
|
|
|
26600 |
X |
|
O |
COLCHICUM DISPERT |
tbl obd 20x0,5 mg |
PLM |
AT |
10 |
6.61 |
4 |
S |
2.61 |
0.39485599999999998 |
2.61 |
|
|
|
|
|
M05BA02 |
|
|
|
Kyselina klodrónová |
p.o. 400 mg (120 ks) |
1.6 |
g |
|
|
|
|
|
|
|
|
2.91 |
|
|
|
34954 |
X |
|
G |
SINDRONAT 400 mg |
cps 120x400 mg |
ACT-5 |
IS |
30 |
87.2 |
87.2 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
M05BA02 |
|
|
|
Kyselina klodrónová |
p.o. 800 mg (60 ks) |
1.6 |
g |
|
|
|
|
|
|
|
|
4.6399999999999997 |
|
|
|
56638 |
X |
|
O |
BONEFOS 800 MG |
tbl flm 60x800 mg |
BAY |
FI |
30 |
139.05000000000001 |
139.05000000000001 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 3mg/ml (časová dávka) (10 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
86.68 |
|
|
|
99827 |
|
|
O |
Pamifos |
con inf 1x10 ml/30 mg |
MCW |
DE |
0.5 |
43.34 |
43.34 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 3 mg/ml (časová dávka) (20 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
86.64 |
|
|
|
99838 |
|
|
O |
Pamifos |
con inf 1x20 ml/60 mg |
MCW |
DE |
1 |
86.64 |
86.64 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 3 mg/ml (časová dávka) (30 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
86.653300000000002 |
|
|
|
99845 |
|
|
O |
Pamifos |
con inf 1x30 ml/90 mg |
MCW |
DE |
1.5 |
129.97999999999999 |
129.97999999999999 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 15mg/ml (časová dávka) (2 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
80.98 |
|
|
|
91528 |
|
|
O |
PAMITOR 15 mg/ml |
con inf 1x2 ml/30 mg (PE) |
CHS-AT |
AT |
0.5 |
40.49 |
40.49 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 15 mg/ml (časová dávka) (6 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
70.05 |
|
|
|
91533 |
|
|
O |
PAMITOR 15 mg/ml |
con inf 1x6 ml/90 mg (PE) |
CHS-AT |
AT |
1.5 |
105.08 |
105.08 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
p.o. 50 mg (28-30 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.315 |
|
|
|
04857 |
X |
|
G |
Phacebonate 50 mg filmom obalené tablety |
tbl flm 30x50 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
375 |
118 |
118 |
I |
0 |
0 |
0 |
ONK, PLM |
ind.obm. |
|
|
|
41491 |
X |
|
O |
BONDRONAT 50 mg |
tbl flm 28x50 mg (blis. PVC/Alu) |
HLR |
GB |
350 |
110.14 |
110.14 |
I |
0 |
0 |
0 |
ONK, PLM |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
p.o. 50 mg (90 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.315 |
|
|
|
04859 |
X |
|
G |
Phacebonate 50 mg filmom obalené tablety |
tbl flm 90x50 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
1125 |
354 |
354 |
I |
0 |
0 |
0 |
ONK, PLM |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
p.o. 150 mg (1 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.27400000000000002 |
|
|
|
23998 |
X |
|
G |
Flastin 150mg |
tbl flm 1x150mg (blis.Al/Al) |
EGI |
HU |
30 |
8.19 |
8.19 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
80851 |
X |
|
G |
Ibandronic Acid Mylan 150mg |
tbl flm 1x150mg |
GNC |
GB |
30 |
8.19 |
8.19 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
21935 |
X |
|
G |
Kyselina ibandrónová Sandoz 150mg filmom obalené tablety |
tbl flm 1x150mg (blis.PA/Al/PVC/Al) |
SAN |
SI |
30 |
8.19 |
8.19 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
23383 |
X |
|
G |
Kyselina ibandronová Teva |
tbl flm 1x150 mg (blister PVC/Aclar/PVC-Al) |
TVP-2 |
NL |
30 |
8.19 |
8.19 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
04586 |
X |
|
G |
Ikametin 150 mg |
tbl flm 1x150 mg (blis.PVC/PVDC/Al) |
GLM-CZ |
CZ |
30 |
8.9600000000000009 |
8.2200000000000006 |
S |
0.74 |
8.258900000000001E-2 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
12438 |
X |
|
G |
Osagrand 150 mg filmom obalené tablety |
tbl flm 1x150 mg (blis.PVC/PVDC/Al) |
ZNT-1 |
CZ |
30 |
9.59 |
8.2200000000000006 |
S |
1.37 |
0.14285700000000001 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
86921 |
X |
|
G |
OSSICA 150 mg |
tbl flm 1 X 150 mg |
GDN |
HU |
30 |
11.19 |
8.2200000000000006 |
S |
2.97 |
0.26541599999999999 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
p.o. 150 mg (3 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.27400000000000002 |
|
|
|
80852 |
X |
|
G |
Ibandronic Acid Mylan 150mg |
tbl flm 3x150mg |
GNC |
GB |
90 |
24.57 |
24.57 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
21936 |
X |
|
G |
Kyselina ibandrónová Sandoz 150mg filmom obalené tablety |
tbl flm 3x150mg (blis.PA/Al/PVC/Al) |
SAN |
SI |
90 |
24.57 |
24.57 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
23999 |
X |
|
G |
Flastin 150mg |
tbl flm 3x150mg (blis.Al/Al) |
EGI |
HU |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
04917 |
X |
|
G |
Ibandronat Actavis 150 mg |
tbl flm 3x150 mg (blis. PVC/PVDC/Al) |
ACT-5 |
IS |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
04652 |
X |
|
G |
Ibandronic acid STADA |
tbl flm 3x150 mg (blis.PVC/PVDC/Al) |
STD |
DE |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
04587 |
X |
|
G |
Ikametin 150 mg |
tbl flm 3x150 mg (blis. PVC/PVDC/Al) |
GLM-CZ |
CZ |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
23384 |
X |
|
G |
Kyselina ibandrónová Teva |
tbl flm 3x150 mg (blister PVC/Aclar/PVC-Al) |
TVP |
NL |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
12439 |
X |
|
G |
Osagrand 150 mg filmom obalené tablety |
tbl flm 3x150 mg (blis.PVC/PVDC/Al) |
ZNT-1 |
CZ |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
86922 |
X |
|
G |
OSSICA 150 mg |
tbl flm 3x150 mg |
GDN |
HU |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
00142 |
X |
|
G |
Licobondrat 150 mg |
tbl flm 3x150 mg (blis.Al/Al) |
GNN |
CZ |
90 |
26.77 |
24.66 |
S |
2.11 |
7.8820000000000001E-2 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
94509 |
X |
|
O |
Bonviva 150 mg |
tbl flm 3x150 mg |
HLR |
DE |
90 |
38.86 |
24.66 |
S |
14.2 |
0.36541400000000002 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
parent. sol inj 3 mg |
4 |
mg |
|
|
|
|
|
|
|
|
46.89 |
|
|
|
35459 |
|
|
O |
Bonviva 3 mg/3 ml |
sol inj 1x3 ml |
HLR |
DE |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
0498A |
|
|
G |
Ibandronic acid Actavis 3 mg |
sol inj 1x3 ml/3 mg (striek.inj.napl.+1x inj.ihla) |
ACT-5 |
IS |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
2198A |
|
|
G |
Ibandronic acid STADA 3 mg |
sol inj 1x3 ml/3 mg (striek.inj.napl.skl.+1x inj.ihla) |
STD |
DE |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
2195A |
|
|
G |
Kyselina ibandrónová Sandoz 3 mg/3 ml |
sol inj 1x3 ml/3 mg (striek.inj.napl.skl.+1x inj. ihla) |
SAN |
SI |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
12444 |
|
|
G |
Osagrand 3 mg/3 ml injekčný roztok |
sol inj 1x3 ml (liek.skl.) |
ZNT-1 |
CZ |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
31552 |
|
|
G |
Ossica 3 mg injekčný roztok naplnený v injekčnej striekačke |
sol iru 1x3 ml/3 mg (striek.inj.napln.)+1x inj.ihla |
GDN |
HU |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
parent. con inf 1mg/ml |
4 |
mg |
|
|
|
|
|
|
|
|
73.05 |
|
|
|
41493 |
|
|
O |
BONDRONAT 6 mg/6 ml |
con inf 1x6 ml (liek.skl.) |
HLR |
GB |
1.5 |
109.58 |
109.58 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA07 |
|
|
|
Kyselina risedrónová |
p.o. 35 mg (4 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
64147 |
X |
|
G |
Norifaz 35 mg |
tbl flm 4x35 mg |
ADD |
PL |
28 |
1.96 |
1.96 |
I |
0 |
0 |
0 |
END, GYN, INT, ORT, REU, KLF |
ind.obm. |
|
|
|
44300 |
X |
|
G |
RISENDROS 35 mg |
tbl flm 4x35 mg |
ZNT-SK-2 |
SK |
28 |
3.53 |
1.96 |
S |
1.57 |
0.44475900000000002 |
0 |
END, GYN, INT, ORT, REU, KLF |
ind.obm. |
|
|
|
M05BA07 |
|
|
|
Kyselina risedrónová |
p.o. 35 mg (12 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
64148 |
X |
|
G |
Norifaz 35 mg |
tbl flm 12(3x4)x35 mg |
ADD |
PL |
84 |
5 |
5 |
I |
0 |
0 |
0 |
END, GYN, INT, ORT, REU, KLF |
ind.obm. |
|
|
|
44310 |
X |
|
G |
RISENDROS 35 mg |
tbl flm 12x35 mg |
ZNT-SK-2 |
SK |
84 |
9.0500000000000007 |
5.88 |
S |
3.17 |
0.35027599999999998 |
0 |
END, GYN, INT, ORT, REU, KLF |
ind.obm. |
|
|
|
M05BA08 |
|
|
|
Kyselina zoledrónová |
parent. 0,05 mg/ml |
5 |
mg |
|
|
|
|
|
|
|
|
236.31 |
|
|
|
90197 |
|
|
O |
Aclasta 5 mg |
sol inf 1x 100 ml/5mg |
NEH |
GB |
1 |
236.31 |
236.31 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
M05BA08 |
|
|
|
Kyselina zoledrónová |
parent. |
4 |
mg |
|
|
|
|
|
|
|
|
68.62 |
|
|
|
6835A |
|
|
G |
Fayton 4 mg/100 ml infúzny roztok |
sol inf 1x100 ml/4 mg (liek.inj.plast.) |
GLM-CZ |
CZ |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
1837A |
|
|
G |
FAYTON 4 mg/5 ml |
con inf 1x5 ml/4 mg (liek.inj.plast.) |
GLM |
CR |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
1488A |
|
|
G |
Kyselina zoledrónová Sandoz 4 mg/100 ml infúzny roztok |
sol inf 1x4 mg/100 ml (fľ.inf.plast.) |
SAN |
SI |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
1485A |
|
|
G |
Kyselina zoledrónová Sandoz 4 mg/5 ml infúzny koncentrát |
con inf 1x4 mg/5 ml (liek.inj.plast.) |
SAN |
SI |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
2363A |
|
|
G |
Osporil 4mg/5ml infúzny koncentrát |
con inf 1x5ml/4mg (liek.inj.skl.) |
EGI |
HU |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
2361A |
|
|
G |
Zoledronat STADA |
con inf 1x5 ml/4 mg (liek.inj.plast.) |
STD |
DE |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
1224A |
|
|
G |
Zoledronic acid Actavis 4 mg/5 ml infúzny koncentrát |
con inf 1x5 ml/4 mg (liek.inj.plast) |
ACT-5 |
IS |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
3723A |
|
|
G |
Zoledronic acid Hospira 4 mg/100 ml infúzny roztok |
sol inf 1x100 ml/4 mg (vak PP/PP) |
HSP |
GB |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
7005A |
|
|
G |
Zoledronic acid Mylan 4 mg/100ml infúzny roztok |
sol inf 1 x 100ml/4mg(liek.inj.skl.), parent |
MYL |
FR |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
2540A |
|
|
G |
Zoledronic acid Mylan 4mg/5ml infúzny koncentrát |
con inf 1 x 5 ml/4 mg (liek.inj.skl.) |
MLB-F |
FR |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
3583A |
|
|
G |
Zoledronic acid Pharmacenter 4 mg/5 ml infúzny koncentrát |
con inf 1x5 ml/4 mg (liek.inj.plast.) |
PMT-SK |
SK |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
6034A |
|
|
G |
ZOLEMED 4 mg/5 ml |
con. Inf. 1 x 5 ml/4 mg (liek.inj.polymér) |
CRR |
SK |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
2358A |
|
|
G |
Kyselina zoledrónová medac 4 mg/100 ml infúzny roztok |
sol inf 1x100 ml/4 mg (fľ.skl.) |
MED-2 |
DE |
1 |
71.290000000000006 |
68.62 |
S |
2.67 |
3.7453E-2 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
2355A |
|
|
G |
Kyselina zoledrónová medac 4 mg/5 ml infúzny koncentrát |
con inf 1x5 ml/4 mg (liek.inj.plast.) |
MED-2 |
DE |
1 |
71.290000000000006 |
68.62 |
S |
2.67 |
3.7453E-2 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
3238A |
|
|
G |
Zoledronic Acid Fresenius Kabi 4 mg/5 ml infúzny koncentrát |
con inf 1x5ml/4 mg (liek.inj.plast) |
FRK-CZ1 |
CZ |
1 |
71.290000000000006 |
68.62 |
S |
2.67 |
3.7453E-2 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
1978A |
|
|
G |
Zomikos 4 mg/5 ml infúzny koncentrát |
con inf 1x5 ml/4 mg (liek.inj.plast.) |
VIH |
PL |
1 |
71.44 |
68.62 |
S |
2.82 |
3.9474000000000002E-2 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
3413A |
|
|
G |
ZOLEDRONIC ACID RANBAXY 4 mg/5 ml infúzny koncentrát |
sol inf 1x5 ml/4 mg (liek.inj.skl.) |
RNB-1 |
GB |
1 |
119.02 |
68.62 |
S |
50.4 |
0.42345799999999995 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
41224 |
|
|
O |
ZOMETA 4 mg |
con inf 1x4 mg/5 ml |
NEH |
GB |
1 |
119.02 |
68.62 |
S |
50.4 |
0.42345799999999995 |
50.4 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
M05BX03 |
|
|
|
Stroncium ranelát |
p.o. 2 g (28 ks) |
2 |
g |
|
|
|
|
|
|
|
|
1.1100000000000001 |
|
|
|
41508 |
X |
|
O |
PROTELOS |
gru por 28x2 g (vrec. papier/PE/Alu) |
SVE |
FR |
28 |
32.840000000000003 |
31.08 |
S |
1.76 |
5.3593000000000002E-2 |
1.76 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
U32 |
M05BX03 |
|
|
|
Stroncium ranelát |
p.o. 2 g (84 ks) |
2 |
g |
|
|
|
|
|
|
|
|
1.1100000000000001 |
|
|
|
41510 |
X |
|
O |
PROTELOS |
gru por 84x2 g (vrec. papier/PE/Alu) |
SVE |
FR |
84 |
100.47 |
93.24 |
S |
7.23 |
7.1961999999999998E-2 |
5.28 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
U32 |
M05BX04 |
|
|
|
Denosumab |
parent. 60 mg/ml |
0.33 |
mg |
|
|
|
|
|
|
|
|
1.1100000000000001 |
|
|
|
20097 |
|
|
O |
Prolia |
sol inj 1x1 ml/60 mg (striek.inj.napl.skl.+chránič ihly v blistri) |
AMG |
NL |
181.81800000000001 |
205.93 |
201.82 |
S |
4.1100000000000003 |
1.9958E-2 |
4.1100000000000003 |
END, INT, KLF, ORT, REU, URK |
ind.obm. |
|
|
U32 |
M05BX04 |
|
|
|
Denosumab |
parent. 70 mg/ml |
4.2859999999999996 |
mg |
|
|
|
|
|
|
|
|
10.4 |
|
|
|
09502 |
|
|
O |
XGEVA |
sol inj 1x1,7 ml/120 mg (liek.inj.skl.) |
AMG |
NL |
27.998000000000001 |
335.62 |
291.18 |
S |
44.44 |
0.132412 |
44.44 |
ONK, PLM, URK |
ind.obm. |
|
|
|
M09AX01 |
|
|
|
Kyselina hyalurónová |
parent.10 mg/ml vnútrokĺbová |
3.6 |
mg |
|
|
|
|
|
|
|
|
4.5599999999999996 |
|
|
|
59840 |
|
|
O |
HYALGAN (INJ.STRIEK.) |
inj 1x2 ml/20 mg |
FID |
IT |
5.56 |
30.93 |
25.35 |
S |
5.58 |
0.18040700000000001 |
5.58 |
MFC, ORT, REU, UCH |
ind.obm. |
|
|
|
N01AB06 |
|
|
|
Isofluran |
inhal. 100% (100 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
17.906500000000001 |
|
|
|
93632 |
|
|
O |
FORANE |
sol inh 100 ml |
ABB |
GB |
1 |
20.59 |
17.91 |
AS |
2.68 |
0.13016 |
2.68 |
ANS |
ind.obm. |
|
|
|
N01AB08 |
|
|
|
Sevofluran |
inhal. 100% |
100 |
ml |
|
|
|
|
|
|
|
|
44.05 |
|
|
|
13024 |
|
|
O |
SEVORANE |
vap inl 1x250 ml (PEN fľa.) |
ABV |
SK |
2.5 |
110.13 |
110.13 |
A |
0 |
0 |
0 |
ANS |
ind.obm. |
|
|
|
N01AX03 |
|
|
|
Ketamin |
parent. 50 mg/ml |
100 |
mg |
|
|
|
|
|
|
|
|
0.97 |
|
|
|
87814 |
|
|
G |
CALYPSOL |
inj 5x10 ml/500 mg |
GDN |
HU |
25 |
24.15 |
24.15 |
A |
0 |
0 |
0 |
ANS |
ind.obm. |
|
|
|
N01AX10 |
|
|
|
Propofol |
parent. 10 mg/ml (50 ml) |
10 |
ml |
|
|
|
|
|
|
|
|
1.159 |
|
|
|
49676 |
|
|
G |
Propofol - Lipuro 1% (10 mg/ ml) |
emu ifj 1x50 ml/500 mg |
BME |
DE |
5 |
6.75 |
5.8 |
AS |
0.95 |
0.140741 |
0.27 |
ANS |
ind.obm. |
|
|
|
N01AX10 |
|
|
|
Propofol |
parent. 10 mg/ml (100 ml) |
10 |
ml |
|
|
|
|
|
|
|
|
1.159 |
|
|
|
49678 |
|
|
G |
Propofol - Lipuro 1% (10 mg/ ml) |
emu ifj 1x100 ml/1000 mg |
BME |
DE |
10 |
12.12 |
11.59 |
AS |
0.53 |
4.3728999999999997E-2 |
0.53 |
ANS |
ind.obm. |
|
|
|
N01BB |
|
|
|
Amidy a anilidy |
parent. trimekain 10 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.125 |
|
|
|
00502 |
|
|
G |
MESOCAIN |
inj 10x10 ml 1% |
ZNT |
CZ |
100 |
11.76 |
11.76 |
A |
0 |
0 |
0 |
|
|
|
|
U33 |
N01BB01 |
|
|
|
Bupivakaín |
parent. 5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.125 |
|
|
|
25043 |
|
|
O |
MARCAINE 0,5% |
inj 5x20 ml 0,5% |
AZC |
SE |
100 |
12.08 |
12.08 |
A |
0 |
0 |
0 |
|
|
|
|
U33 |
N01BB02 |
|
|
|
Lidokaín |
transd. 700 mg (6ks) |
700 |
mg |
|
|
|
|
|
|
|
|
1.9590000000000001 |
|
|
|
86430 |
|
|
O |
Versatis 5% liečivá náplasť |
emp med 6x(5x700 mg) (vre.ppa) |
GNG |
DE |
30 |
93.95 |
58.77 |
S |
35.18 |
0.37445400000000001 |
35.18 |
AGG, NEU |
ind.obm. |
|
|
|
N01BX04 |
|
|
|
Kapsaicín 8% |
transd. 179 mg (1 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
244.95 |
|
|
|
76786 |
|
|
O |
Qutenza |
emp der 1x179 mg |
ASL |
NL |
1 |
244.95 |
244.95 |
A |
0 |
0 |
0 |
AGG, NEU |
ind.obm. |
|
|
|
N02AA01 |
|
§ |
|
Morfín |
p.o. 10 mg (60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
2.66 |
|
|
|
92282 |
|
|
O |
Sevredol 10 mg |
tbl flm 60x10 mg |
MUP |
DE |
6 |
15.9 |
15.9 |
I |
0 |
0 |
0 |
|
|
|
|
U90 |
N02AA01 |
|
§ |
|
Morfín |
p.o. 30 mg (60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.81200000000000006 |
|
|
|
94310 |
|
|
O |
MST CONTINUS 30 MG |
tbl mod 60x30 mg |
MUP |
AT |
18 |
16.7 |
14.62 |
S |
2.08 |
0.124551 |
2.08 |
|
|
|
|
U34 |
N02AA01 |
|
§ |
|
Morfín |
p.o. 60 mg (60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.81200000000000006 |
|
|
|
94311 |
|
|
O |
MST CONTINUS 60 MG |
tbl mod 60x60 mg |
MUP |
AT |
36 |
31.96 |
29.23 |
S |
2.73 |
8.5418999999999995E-2 |
2.73 |
|
|
|
|
U34 |
N02AA01 |
|
§ |
|
Morfín |
p.o. 100 mg (60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.81200000000000006 |
|
|
|
94312 |
|
|
O |
MST CONTINUS 100 MG |
tbl mod 60x100 mg |
MUP |
AT |
60 |
48.67 |
48.67 |
I |
0 |
0 |
0 |
|
|
|
|
U34 |
N02AA01 |
|
§ |
|
Morfín |
parent. 10 mg/ml (1 ml) |
30 |
mg |
|
|
|
|
|
|
|
|
1.0788 |
|
|
|
01125 |
|
|
G |
MORPHIN BIOTIKA 1% |
inj 10x1 ml/10 mg |
HBS |
SK |
3.3330000000000002 |
3.59 |
3.59 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02AA01 |
|
§ |
|
Morfín |
parent. 10 mg/ml (2 ml) |
30 |
mg |
|
|
|
|
|
|
|
|
0.624 |
|
|
|
01127 |
|
|
G |
MORPHIN BIOTIKA 1% |
inj 10x2 ml/20 mg |
HBS |
SK |
6.6669999999999998 |
4.16 |
4.16 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02AA03 |
|
§ |
|
Hydromorfón |
p.o. 2 mg (60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
4.6349999999999998 |
|
|
|
92278 |
|
|
O |
Palladone-SR capsules 2 mg |
cps pld 60x2 mg |
MUP |
DE |
6 |
30.82 |
27.81 |
S |
3.01 |
9.7664000000000015E-2 |
3.01 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA03 |
|
§ |
|
Hydromorfón |
p.o. 4 mg (60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.74 |
|
|
|
92283 |
|
|
O |
Palladone-SR capsules 4 mg |
cps pld 60x4 mg |
MUP |
DE |
12 |
44.85 |
44.85 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA03 |
|
§ |
|
Hydromorfón |
p.o. 8 mg (60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.8 |
|
|
|
92284 |
|
|
O |
Palladone-SR capsules 8 mg |
cps pld 60x8 mg |
MUP |
DE |
24 |
91.16 |
91.16 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA03 |
|
§ |
|
Hydromorfón |
p.o. 16 mg (60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.2250000000000001 |
|
|
|
92285 |
|
|
O |
Palladone-SR capsules 16 mg |
cps pld 60x16 mg |
MUP |
DE |
48 |
154.74 |
154.74 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA05 |
|
§ |
|
Oxykodón |
p.o. 10 mg (56-60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
51288 |
|
|
G |
Contiroxil 10 mg tablety s predĺženým uvoľňovaním |
tbl plg 56x10 mg (blister) |
SAN |
SI |
18.666 |
15.81 |
15.81 |
I |
0 |
0 |
0 |
|
|
|
|
U35 |
89756 |
|
|
G |
Oxypro 10 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x10 mg (blis.PVC/PVDC/Al) |
GLH |
AT |
20 |
16.940000000000001 |
16.940000000000001 |
I |
0 |
0 |
0 |
|
|
|
|
U35 |
N02AA05 |
|
§ |
|
Oxykodón |
p.o. 20 mg (56-60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
51317 |
|
|
G |
Contiroxil 20mg tablety s predĺženým uvoľňovaním |
tbl plg 56x20mg (blister) |
SAN |
SI |
37.332999999999998 |
31.63 |
31.63 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
89786 |
|
|
G |
Oxypro 20 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x20 mg (blis.PVC/PVDC/Al) |
GLH |
AT |
40 |
33.89 |
33.89 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
N02AA05 |
|
§ |
|
Oxykodón |
p.o. 40 mg (56-60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
2422A |
|
|
G |
Contiroxil 40mg tablety s predĺženým uvoľňovaním |
tbl plg 56x40mg (blisPVC/PE/PVDC) |
SAN |
SI |
74.665999999999997 |
63.25 |
63.25 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
89839 |
|
|
G |
Oxypro 40 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x40 mg (blis.PVC/PVDC/Al) |
GLH |
AT |
80 |
67.77 |
67.77 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
N02AA05 |
|
§ |
|
Oxykodón |
p.o. 80 mg (56-60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
2440A |
|
|
G |
Contiroxil 80mg tablety s predĺženým uvoľňovaním |
tbl plg 56x80mg (blisPVC/PE/PVDC) |
SAN |
SI |
149.333 |
126.5 |
126.5 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
89806 |
|
|
G |
Oxypro 80 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x80 mg (blis. PVC/PVDC/Al) |
GLH |
AT |
160 |
135.54 |
135.54 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
N02AA08 |
|
|
|
Dihydrokodeín |
p.o. 60 mg (20 ks) |
0.24 |
g |
|
|
|
|
|
|
|
|
0.91 |
|
|
|
56873 |
|
|
O |
DHC CONTINUS 60 (BLIS.) |
tbl mod 20x60 mg |
MUP |
DE |
5 |
5.71 |
4.55 |
S |
1.1599999999999999 |
0.203152 |
0.22 |
|
|
|
|
|
N02AA08 |
|
|
|
Dihydrokodeín |
p.o. 60 mg (60 ks) |
0.24 |
g |
|
|
|
|
|
|
|
|
0.91 |
|
|
|
92310 |
|
|
O |
DHC Continus 60 mg |
tbl mod 60x60 mg |
MUP |
DE |
15 |
14.3 |
13.65 |
S |
0.65 |
4.5454999999999995E-2 |
0.65 |
|
|
|
|
|
N02AA08 |
|
|
|
Dihydrokodeín |
p.o. 90 mg (60 ks) |
0.24 |
g |
|
|
|
|
|
|
|
|
1.123 |
|
|
|
92313 |
|
|
O |
DHC Continus 90 mg |
tbl mod 60x90 mg |
MUP |
DE |
22.5 |
27.3 |
25.27 |
S |
2.0299999999999998 |
7.4359000000000008E-2 |
2.0299999999999998 |
|
|
|
|
|
N02AA08 |
|
|
|
Dihydrokodeín |
p.o. 120 mg (60 ks) |
0.24 |
g |
|
|
|
|
|
|
|
|
1.0853999999999999 |
|
|
|
92315 |
|
|
O |
DHC Continus 120 mg |
tbl mod 60x120 mg |
MUP |
DE |
30 |
33.840000000000003 |
32.56 |
S |
1.28 |
3.7825000000000004E-2 |
1.28 |
|
|
|
|
|
N02AA55 |
|
§ |
|
Oxykodón, kombinácie |
p.o. oxykodón/naloxón 5/2,5 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.4 |
|
|
|
22802 |
|
|
O |
Targin 5 mg/2,5 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x5 mg/2,5 mg |
MUP |
DE |
30 |
43.67 |
42 |
S |
1.67 |
3.8240999999999997E-2 |
1.67 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA55 |
|
§ |
|
Oxykodón, kombinácie |
p.o. oxykodón/naloxón 10/5 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.97 |
|
|
|
22813 |
|
|
O |
Targin 10 mg/5 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x10 mg/5 mg |
MUP |
DE |
30 |
61.62 |
59.1 |
S |
2.52 |
4.0896000000000002E-2 |
2.52 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA55 |
|
§ |
|
Oxykodón, kombinácie |
p.o. oxykodón/naloxón 20/10 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
3.38 |
|
|
|
22824 |
|
|
O |
Targin 20 mg/10 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x20 mg/10 mg |
MUP |
DE |
30 |
103.97 |
101.4 |
S |
2.57 |
2.4719000000000001E-2 |
2.57 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA55 |
|
§ |
|
Oxykodón, kombinácie |
p.o. oxykodón/naloxón 40/20 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
5.23766 |
|
|
|
22835 |
|
|
O |
Targin 40 mg/20 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x40 mg/20 mg |
MUP |
DE |
30 |
160 |
157.13 |
S |
2.87 |
1.7937999999999999E-2 |
2.87 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AB02 |
|
§ |
|
Petidín |
parent. 50mg/ ml (1 ml) |
0.4 |
g |
|
|
|
|
|
|
|
|
2.8879000000000001 |
|
|
|
02715 |
|
|
G |
DOLSIN |
inj 10x1 ml 5% |
HBS |
SK |
1.25 |
3.61 |
3.61 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02AB02 |
|
§ |
|
Petidín |
parent. 50 mg/ ml (2 ml) |
0.4 |
g |
|
|
|
|
|
|
|
|
1.8355999999999999 |
|
|
|
02716 |
|
|
G |
DOLSIN |
inj 10x2 ml 5% |
HBS |
SK |
2.5 |
4.58 |
4.58 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
p.o. flm. buc. 200 mcg (10 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
02492 |
|
|
G |
Breakyl 200 mikrogramov |
flm buc 10x200 µg (vrecko PAN/Al/PA/lamin.pap.) |
MDM |
DE |
10 |
55.38 |
55.38 |
I |
0 |
0 |
0 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. flm. buc. 200 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
12514 |
|
|
G |
Breakyl 200 mikrogramov |
flm buc 28x200 µg (vrecko PAN/Al/PA/lamin.pap.) |
MDM |
DE |
28 |
155.35 |
155.12 |
S |
0.23 |
1.4810000000000001E-3 |
0 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. flm. buc. 400 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
12517 |
|
|
G |
Breakyl 400 mikrogramov |
flm buc 28x400 µg (vrecko PAN/Al/PA/lamin.pap.) |
MDM |
DE |
28 |
155.35 |
155.12 |
S |
0.23 |
1.4810000000000001E-3 |
0.23 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. flm. buc. 800 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
12573 |
|
|
G |
Breakyl 800 mikrogramov |
flm buc 28x800 µg (vrecko PAN/Al/PA/lamin.pap.) |
MDM |
DE |
28 |
155.35 |
155.12 |
S |
0.23 |
1.4810000000000001E-3 |
0.23 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 100 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
50478 |
|
|
O |
Effentora 100 mikrogramov bukálne tablety |
tbl buc 28x100 µg (blis.PVC/Al/PA/PVC) |
TVP-2 |
NL |
28 |
155.06 |
155.06 |
I |
0 |
0 |
0 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 200 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
50480 |
|
|
O |
Effentora 200 mikrogramov bukálne tablety |
tbl buc 28x200 µg (blis.PVC/Al/PA/PVC) |
TVP-2 |
NL |
28 |
169.29 |
155.12 |
S |
14.17 |
8.3703E-2 |
0 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 400 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
50482 |
|
|
O |
Effentora 400 mikrogramov bukálne tablety |
tbl buc 28x400 µg (blis.PVC/Al/PA/PVC) |
TVP-2 |
NL |
28 |
190.99 |
155.12 |
S |
35.869999999999997 |
0.18781099999999998 |
0.23 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 600 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
50484 |
|
|
O |
Effentora 600 mikrogramov bukálne tablety |
tbl buc 28x600 µg (blis.PVC/Al/PA/PVC) |
TVP-2 |
NL |
28 |
190.99 |
155.12 |
S |
35.869999999999997 |
0.18781099999999998 |
35.869999999999997 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 800 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
50486 |
|
|
O |
Effentora 800 mikrogramov bukálne tablety |
tbl buc 28x800 µg (blis.PVC/Al/PA/PVC) |
TVP-2 |
NL |
28 |
190.99 |
155.12 |
S |
35.869999999999997 |
0.18781099999999998 |
0.23 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 100 mcg (4 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
71895 |
|
|
O |
LUNALDIN 100 mikrogramov |
tbl slg 30 x 100 ug |
GDN |
HU |
30 |
166.14 |
166.14 |
I |
0 |
0 |
0 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 200 mcg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
71897 |
|
|
O |
LUNALDIN 200 mikrogramov |
tbl slg 30 x 200 ug |
GDN |
HU |
30 |
167.63 |
166.2 |
S |
1.43 |
8.5310000000000004E-3 |
1.43 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 300 mcg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
71899 |
|
|
O |
LUNALDIN 300 mikrogramov |
tbl slg 30 x 300 ug |
GDN |
HU |
30 |
171.14 |
166.2 |
S |
4.9400000000000004 |
2.8864999999999998E-2 |
4.9400000000000004 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 400 mcg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
71901 |
|
|
O |
LUNALDIN 400 mikrogramov |
tbl slg 30 x 400 ug |
GDN |
HU |
30 |
171.14 |
166.2 |
S |
4.9400000000000004 |
2.8864999999999998E-2 |
4.9400000000000004 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 600 mcg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
71903 |
|
|
O |
LUNALDIN 600 mikrogramov |
tbl slg 30 x 600 ug |
GDN |
HU |
30 |
171.14 |
166.2 |
S |
4.9400000000000004 |
2.8864999999999998E-2 |
4.9400000000000004 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 800 mcg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
71905 |
|
|
O |
LUNALDIN 800 mikrogramov |
tbl slg 30 x 800 ug |
GDN |
HU |
30 |
171.14 |
166.2 |
S |
4.9400000000000004 |
2.8864999999999998E-2 |
4.9400000000000004 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
loc. nosový sprej 50 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
78714 |
|
|
O |
Instanyl |
aer nao 1x1,8 ml/0,90 mg (10 dávok - 50 µg/1 dávka) |
NCD |
DK |
10 |
57.76 |
55.4 |
S |
2.36 |
4.0858999999999999E-2 |
2.36 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
loc. nosový sprej 100 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
78719 |
|
|
O |
Instanyl |
aer.nao 1x5 ml/5,0 mg ( 40 dávok-100 µg/1 dávka) |
NCD |
DK |
40 |
242 |
221.6 |
S |
20.399999999999999 |
8.4297999999999998E-2 |
20.399999999999999 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
loc. nosový sprej 200 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
78722 |
|
|
O |
Instanyl |
aer.nao 1x5 ml/10,0 mg ( 40 dávok-200 µg/1 dávka) |
NCD |
DK |
40 |
240.91 |
221.6 |
S |
19.309999999999999 |
8.0154000000000003E-2 |
19.309999999999999 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
transd. 12 mcg/h |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.9 |
|
|
|
44195 |
|
|
G |
Fentanyl-ratiopharm 12µg/h, |
emp tdm 5x12µg/h, |
RAT |
DE |
7.5 |
6.72 |
6.72 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU, URK |
ind.obm. |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
transd. 25 mcg/h (5 ks) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.89 |
|
|
|
36318 |
|
|
G |
Fentanyl Actavis 25 µg/h transdermálna náplasť |
emp tdm 5x25 µg/h |
ACT-5 |
IS |
15 |
13.24 |
13.24 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
38291 |
|
|
G |
Fentanyl Sandoz 25 µg/h matrix transdermálna náplasť |
emp tdm 5x25 µg/ 1h |
SAN |
SI |
15 |
13.24 |
13.24 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
36302 |
|
|
G |
Fentanyl-ratiopharm 25 mcg/h |
emp tdm 5x25 mcg/h |
RAT |
DE |
15 |
13.24 |
13.24 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
transd. 50 mcg/h (5 ks) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.621 |
|
|
|
36322 |
|
|
G |
Fentanyl Actavis 50 µg/h transdermálna náplasť |
emp tdm 5x50 µg/h |
ACT-5 |
IS |
30 |
18.63 |
18.63 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
38295 |
|
|
G |
Fentanyl Sandoz 50 µg/h matrix transdermálna náplasť |
emp tdm 5 x 50 µg/ 1h |
SAN |
SI |
30 |
18.63 |
18.63 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
36306 |
|
|
G |
Fentanyl-ratiopharm 50 mcg/h |
emp tdm 5x50 mcg/h |
RAT |
DE |
30 |
18.63 |
18.63 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
transd. 75 mcg/h (5 ks) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.755 |
|
|
|
36310 |
|
|
G |
Fentanyl ratiopharm 75 ug/h |
emp tdm 5x75 ug/1h |
RAT |
DE |
45 |
33.97 |
33.97 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU, URK |
ind.obm. |
|
|
|
38299 |
|
|
G |
Fentanyl Sandoz 75 µg/h matrix transdermálna náplasť |
emp tdm 5x75 µg/ 1h |
SAN |
SI |
45 |
33.97 |
33.97 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU, URK |
ind.obm. |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
transd. 100 mcg/h (5 ks) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.63 |
|
|
|
36330 |
|
|
G |
Fentanyl Actavis 100 µg/h transdermálna náplasť |
emp tdm 5x100 µg/h |
ACT-5 |
IS |
60 |
37.39 |
37.39 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
38303 |
|
|
G |
Fentanyl Sandoz 100 µg/h matrix transdermálna náplasť |
emp tdm 5x100 µg/ 1h |
SAN |
SI |
60 |
37.409999999999997 |
37.409999999999997 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
36314 |
|
|
G |
Fentanyl-ratiopharm 100 mcg/h |
emp tdm 5x100 mcg/h |
RAT |
DE |
60 |
37.409999999999997 |
37.409999999999997 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
N02AE01 |
|
§ |
|
Buprenorfín |
transd. nápl.35 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
5.3810000000000002 |
|
|
|
42755 |
|
|
O |
TRANSTEC 35MCG/H |
emp tdm 5X20MG |
GNG |
DE |
5 |
26.91 |
26.91 |
I |
0 |
0 |
0 |
AGG,NEU,ONK,REU,ORT |
ind.obm. |
|
|
|
N02AE01 |
|
§ |
|
Buprenorfín |
transd. nápl. 52,5 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
7.56 |
|
|
|
42758 |
|
|
O |
TRANSTEC 52.5MCG/H |
emp tdm 5X30MG |
GNG |
DE |
5 |
37.76 |
37.76 |
I |
0 |
0 |
0 |
AGG,NEU,ONK,REU,ORT |
ind.obm. |
|
|
|
N02AE01 |
|
§ |
|
Buprenorfín |
transd. nápl. 70 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
9.69 |
|
|
|
42761 |
|
|
O |
TRANSTEC 70MCG/H |
emp tdm 5X40MG |
GNG |
DE |
5 |
48.41 |
48.41 |
I |
0 |
0 |
0 |
AGG,NEU,ONK,REU,ORT |
ind.obm. |
|
|
|
N02AX02 |
|
|
|
Tramadol |
p.o. 100 mg/ml |
0.3 |
g |
|
|
|
|
|
|
|
|
0.47799999999999998 |
|
|
|
26675 |
X |
|
G |
NOAX Drops |
gto por 1x50 ml (fľ.skl.hnedá s kvapkadlom) |
APA |
DE |
16.667000000000002 |
8.2200000000000006 |
7.97 |
S |
0.25 |
3.0414E-2 |
0.25 |
|
|
|
|
|
26674 |
X |
|
G |
NOAX Drops |
gto por 1x20 ml (fľ.skl.hnedá s kvapkadlom) |
APA |
DE |
6.6669999999999998 |
3.46 |
3.19 |
S |
0.27 |
7.8034999999999993E-2 |
0.1 |
|
|
|
|
|
90412 |
X |
|
G |
Tralgit gtt |
gto por 1x96 ml |
ZNT |
SK |
32 |
16.98 |
15.3 |
S |
1.68 |
9.894E-2 |
0.48 |
|
|
|
|
|
14680 |
X |
|
G |
TRAMABENE |
gtt por 100 ml (s dávkov. pumpou) |
MCK |
DE |
33.335000000000001 |
17.88 |
15.93 |
S |
1.95 |
0.10906 |
0.5 |
|
|
|
|
|
27805 |
X |
|
O |
TRAMAL kvapky 100 mg/ml |
gtt por 1x96 ml/9,6 g |
GRU |
DE |
32 |
17.170000000000002 |
15.3 |
S |
1.87 |
0.10891099999999999 |
0.48 |
|
|
|
|
|
04311 |
X |
|
O |
TRAMAL |
gto por 1x10 ml/1 g |
GRU |
DE |
3.3330000000000002 |
1.84 |
1.59 |
S |
0.25 |
0.13586999999999999 |
0.05 |
|
|
|
|
|
28360 |
X |
|
G |
TRAMABENE |
gtt 30 ml |
MCK |
DE |
10 |
6.43 |
4.78 |
S |
1.65 |
0.25661 |
0.15 |
|
|
|
|
|
34542 |
X |
|
G |
TRALGIT gtt. |
gto por 1x10 ml |
ZNT |
SK |
3.3330000000000002 |
3.23 |
1.59 |
S |
1.64 |
0.50773999999999997 |
0.05 |
|
|
|
|
|
28359 |
X |
|
G |
TRAMABENE |
gtt por 10 ml |
MCK |
DE |
3.3330000000000002 |
3.23 |
1.59 |
S |
1.64 |
0.50773999999999997 |
0.05 |
|
|
|
|
|
N02AX02 |
|
|
|
Tramadol |
p.o. oro 50 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
20631 |
X |
|
G |
TRALGIT Sprint 50 mg |
tbl oro 30x50 mg (blis.PVC/PVDC/Al) |
ZNT |
SK |
5 |
5.25 |
2.42 |
S |
2.83 |
0.53904799999999997 |
0.47 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. 50 mg (20 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
32086 |
X |
|
G |
TRALGIT |
cps 20x50 mg |
ZNT |
SK |
3.3330000000000002 |
1.92 |
1.61 |
S |
0.31 |
0.16145800000000002 |
0.31 |
|
|
|
|
U37 |
84376 |
X |
|
G |
Tramadol Saneca 50 mg |
cps 20x50 mg (blis.PVC/Al) |
SNC |
SK |
3.3330000000000002 |
1.92 |
1.61 |
S |
0.31 |
0.16145800000000002 |
0.31 |
|
|
|
|
U37 |
67569 |
X |
|
G |
MABRON 50 MG |
cps 20x50 mg |
MOE |
CY |
3.3330000000000002 |
2.2599999999999998 |
1.61 |
S |
0.65 |
0.28761100000000001 |
0.31 |
|
|
|
|
U37 |
04306 |
X |
|
O |
TRAMAL |
cps 20x50 mg |
GRU |
DE |
3.3330000000000002 |
2.31 |
1.61 |
S |
0.7 |
0.30303000000000002 |
0.31 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. 50 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
67570 |
X |
|
G |
MABRON 50 MG |
cps 30x50 mg |
MOE |
CY |
5 |
3.48 |
2.42 |
S |
1.06 |
0.30459800000000004 |
0.47 |
|
|
|
|
U37 |
4881B |
X |
|
G |
Tramadol Saneca 50 mg |
cps 30x50 mg (blis.PVC/Al) |
SNC |
SK |
5 |
3.48 |
2.42 |
S |
1.06 |
0.30459800000000004 |
0.47 |
|
|
|
|
U37 |
7361A |
X |
|
G |
Tramadol Vitabalans 50 mg tablety |
tbl 30x50 mg (blis.PVC/Al) |
VTB |
FI |
5 |
3.48 |
2.42 |
S |
1.06 |
0.30459800000000004 |
0.47 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. 50 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
28049 |
X |
|
G |
Tramabene 50 mg |
cps 50x50 mg (blis.PVC/Al) |
RAT |
DE |
8.3330000000000002 |
5.22 |
4.0199999999999996 |
S |
1.2 |
0.22988499999999998 |
0.78 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 50 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
99503 |
X |
|
G |
Adamon SR 50 mg |
cps pld 30x50 mg |
MDM |
DE |
5 |
4.95 |
2.42 |
S |
2.5299999999999998 |
0.51111099999999998 |
0.47 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 100 mg (10 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
26882 |
X |
|
O |
TRAMAL RETARD 100 |
tbl plg 10x100 mg |
GRU |
DE |
3.3319999999999999 |
2.25 |
1.61 |
S |
0.64 |
0.28444400000000003 |
0 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 100 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
93330 |
X |
|
G |
Mabron Retard 100 |
tbl plg 30x100 mg |
MOE |
CY |
10 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
3606A |
X |
|
G |
Tramadol Mylan 100 mg |
tbl plg 30x100 mg blis(Al/PVC/PE/PVDC) |
GNS |
GB |
10 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
43087 |
X |
|
G |
Tramadol Retard Actavis 100 mg |
tbl plg 30 x 100 mg |
ACT |
IS |
10 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
26883 |
X |
|
O |
TRAMAL RETARD 100 |
tbl plg 30x100 mg |
GRU |
DE |
10 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
59672 |
X |
|
G |
Tralgit SR 100 |
tbl plg 30x100 mg |
ZNT |
SK |
10 |
5.53 |
4.83 |
S |
0.7 |
0.126582 |
0 |
|
|
|
|
U37 |
95104 |
X |
|
G |
Noax Uno 100 mg |
tbl plg 30x100 mg |
XCC |
AT |
10 |
8.15 |
4.83 |
S |
3.32 |
0.40736199999999995 |
0 |
|
|
|
|
U37 |
99554 |
X |
|
G |
Adamon SR 100 mg |
cps pld 30x100 mg |
MDM |
DE |
10 |
8.8000000000000007 |
4.83 |
S |
3.97 |
0.45113599999999998 |
0 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 100 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
59673 |
X |
|
G |
Tralgit SR 100 |
tbl plg 50x100 mg |
ZNT |
SK |
16.667999999999999 |
10.68 |
8.0500000000000007 |
S |
2.63 |
0.246255 |
0 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 150 mg (10 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
56843 |
X |
|
O |
TRAMAL RETARD 150 |
tbl plg 10x150 mg |
GRU |
DE |
5 |
3.75 |
2.42 |
S |
1.33 |
0.35466700000000001 |
0 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 150 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
93335 |
X |
|
G |
Mabron Retard 150 |
tbl plg 30x150 mg |
MOE |
CY |
15 |
7.24 |
7.24 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
3627A |
X |
|
G |
Tramadol Mylan 150 mg |
tbl plg 30x150 mg(blis. Al/PVC/PE/PVDC) |
GNS |
GB |
15 |
7.24 |
7.24 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
43119 |
X |
|
G |
Tramadol Retard Actavis 150 mg |
tbl plg 30 x 150 mg |
ACT |
IS |
15 |
7.24 |
7.24 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
56844 |
X |
|
O |
TRAMAL RETARD 150 |
tbl plg 30x150 mg |
GRU |
DE |
15 |
7.24 |
7.24 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
34188 |
X |
|
G |
Tralgit SR 150 |
tbl plg 30x150 mg |
ZNT |
SK |
15 |
7.95 |
7.25 |
S |
0.7 |
8.8050000000000003E-2 |
0 |
|
|
|
|
U37 |
99452 |
X |
|
G |
Adamon SR 150 mg |
cps pld 30x150 mg |
MDM |
DE |
15 |
12.26 |
7.25 |
S |
5.01 |
0.40864600000000001 |
0 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 200 mg (10 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
56846 |
X |
|
O |
TRAMAL RETARD 200 |
tbl plg 10x200 mg |
GRU |
DE |
6.6680000000000001 |
4.5 |
3.22 |
S |
1.28 |
0.28444400000000003 |
0 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 200 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
43149 |
X |
|
G |
Tramadol Retard Actavis 200mg |
tbl plg 30 x 200 mg |
ACT |
IS |
20 |
9.65 |
9.65 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
93336 |
X |
|
G |
Mabron Retard 200 |
tbl plg 30x200 mg |
MOE |
CY |
20 |
9.66 |
9.66 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
3648A |
X |
|
G |
Tramadol Mylan 200mg |
tbl plg 30x200 mg (blis.Al/PVC/PE/PVDC) |
GNS |
GB |
20 |
9.66 |
9.66 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
56847 |
X |
|
O |
TRAMAL RETARD 200 |
tbl plg 30x200 mg |
GRU |
DE |
20 |
9.66 |
9.66 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
34192 |
X |
|
G |
Tralgit SR 200 |
tbl plg 30x200 mg |
ZNT |
SK |
20 |
10.36 |
9.66 |
S |
0.7 |
6.7568000000000003E-2 |
0 |
|
|
|
|
U37 |
95098 |
X |
|
G |
Noax Uno 200mg |
tbl plg 30x200 mg |
XCC |
AT |
20 |
12.3 |
9.66 |
S |
2.64 |
0.21463399999999999 |
0 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie300 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
92443 |
X |
|
G |
Noax Uno 300 mg |
tbl plg 30x300 mg |
XCC |
AT |
30 |
18.440000000000001 |
14.49 |
S |
3.95 |
0.21420800000000001 |
3.95 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
parent. 50 mg |
0.3 |
g |
|
|
|
|
|
|
|
|
1.68 |
|
|
|
06200 |
|
|
O |
TRAMAL 50 |
inj 5x1 ml/50 mg |
GRU |
DE |
0.83299999999999996 |
1.79 |
1.4 |
S |
0.39 |
0.21787700000000002 |
0.03 |
|
|
|
|
|
N02AX02 |
|
|
|
Tramadol |
parent. 100 mg |
0.3 |
g |
|
|
|
|
|
|
|
|
1.2361 |
|
|
|
90719 |
|
|
O |
TRAMAL 100 |
sol inj 5x2 ml/100 mg |
GRU |
DE |
1.667 |
2.13 |
2.06 |
S |
7.0000000000000007E-2 |
3.2863999999999997E-2 |
7.0000000000000007E-2 |
|
|
|
|
|
67558 |
|
|
G |
MABRON |
sol inj 5x2 mlx100 mg |
MOE |
CY |
1.667 |
2.38 |
2.06 |
S |
0.32 |
0.13445399999999999 |
7.0000000000000007E-2 |
|
|
|
|
|
67559 |
|
|
G |
MABRON |
sol inj 10x2 mlx100 mg |
MOE |
CY |
3.3330000000000002 |
4.76 |
4.12 |
S |
0.64 |
0.13445399999999999 |
0.14000000000000001 |
|
|
|
|
|
34546 |
|
|
G |
TRALGIT 100 inj. |
sol inj 5x2 ml/100 mg |
ZNT |
SK |
1.667 |
3.07 |
2.06 |
S |
1.01 |
0.32899 |
7.0000000000000007E-2 |
|
|
|
|
|
N02AX06 |
|
§ |
|
Tapentadol |
p.o. 50 mg (50 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
4.641 |
|
|
|
23508 |
|
|
O |
PALEXIA 50 mg filmom obalené tablety |
tbl flm 50x(1x50 mg) (blis.PVC/PVDC/Al-perf.) |
GNG |
DE |
6.25 |
32.270000000000003 |
29.01 |
S |
3.26 |
0.101023 |
0.97 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AX06 |
|
§ |
|
Tapentadol |
p.o. predĺžené uvoľňovanie 50 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.2270000000000001 |
|
|
|
23609 |
|
|
O |
PALEXIA retard 50 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x50 mg (blis.PVC/PVDC/Al/papier/PET) |
GRU |
DE |
30 |
41.48 |
36.81 |
S |
4.67 |
0.112584 |
4.67 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AX06 |
|
§ |
|
Tapentadol |
p.o. predĺžené uvoľňovanie 100 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.4020000000000001 |
|
|
|
23641 |
|
|
O |
PALEXIA retard 100 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x100 mg (blis.PVC/PVDC/Al/papier/PET) |
GRU |
DE |
30 |
77.75 |
72.06 |
S |
5.69 |
7.3182999999999998E-2 |
5.69 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AX06 |
|
§ |
|
Tapentadol |
p.o. predĺžené uvoľňovanie 150 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
3.3290000000000002 |
|
|
|
23690 |
|
|
O |
PALEXIA retard 150 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x150 mg (blis.PVC/PVDC/Al/papier/PET) |
GRU |
DE |
30 |
112.51 |
99.87 |
S |
12.64 |
0.112346 |
12.64 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AX06 |
|
§ |
|
Tapentadol |
p.o. predĺžené uvoľňovanie 200 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
4.6280000000000001 |
|
|
|
23713 |
|
|
O |
PALEXIA retard 200 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x200 mg (blis.PVC/PVDC/Al/papier/PET) |
GRU |
DE |
30 |
138.97999999999999 |
138.84 |
S |
0.14000000000000001 |
1.0070000000000001E-3 |
0.14000000000000001 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AX06 |
|
§ |
|
Tapentadol |
p.o. predĺžené uvoľňovanie 250 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
5.49 |
|
|
|
23752 |
|
|
O |
PALEXIA retard 250 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x250 mg (blis.PVC/PVDC/Al/papier/PET) |
GRU |
DE |
30 |
164.46 |
164.46 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AX52 |
|
|
|
Tramadol, kombinácie |
p.o. 37,5/325 mg (10 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.191 |
|
|
|
88675 |
|
|
G |
Paratramol 37,5 mg/325 mg filmom obalené tablety |
tbl flm 10x37,5 mg/325 mg (blis.Al/PVC) |
PHC-2 |
PL |
5 |
1.91 |
0.96 |
S |
0.95 |
0.49738199999999999 |
0 |
|
|
|
|
U38 |
40429 |
|
|
O |
ZALDIAR |
tbl flm 10 (=1x10) |
GNG |
DE |
5 |
2.04 |
0.96 |
S |
1.08 |
0.52941199999999999 |
0 |
|
|
|
|
U38 |
76191 |
|
|
G |
Doreta 37,5 mg/325 mg |
tbl flm 10x37,5 mg/325 mg |
KRK |
SI |
5 |
2.5099999999999998 |
0.96 |
S |
1.55 |
0.61753000000000002 |
0 |
|
|
|
|
U38 |
N02AX52 |
|
|
|
Tramadol, kombinácie |
p.o. 37,5/325 mg (20 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.191 |
|
|
|
76193 |
|
|
G |
Doreta 37,5 mg/325 mg |
tbl flm 20x37,5 mg/325 mg |
KRK |
SI |
10 |
2.8 |
1.91 |
S |
0.89 |
0.317857 |
0 |
|
|
|
|
U38 |
00109 |
|
|
G |
Zaracet |
tbl flm 20x37,5 mg/325mg |
BLU |
SR |
10 |
3.06 |
1.91 |
S |
1.1499999999999999 |
0.37581699999999996 |
0 |
|
|
|
|
U38 |
1026A |
|
|
G |
Tramadol/Paracetamol Saneca 37,5 mg/325 mg |
tbl 20x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al) |
SNC |
SK |
10 |
3.67 |
1.91 |
S |
1.76 |
0.47956400000000005 |
0 |
|
|
|
|
U38 |
40430 |
|
|
O |
ZALDIAR |
tbl flm 20 (=2x10) |
GNG |
DE |
10 |
4.09 |
1.91 |
S |
2.1800000000000002 |
0.53300700000000001 |
0 |
|
|
|
|
U38 |
06238 |
|
|
O |
ZALDIAR EFFERVESCENS |
tbl eff 20x37,5 mg/325 mg (strip PET/Al/PE) |
GNG |
DE |
10 |
4.09 |
1.91 |
S |
2.1800000000000002 |
0.53300700000000001 |
2.1800000000000002 |
|
|
|
|
U38 |
N02AX52 |
|
|
|
Tramadol, kombinácie |
p.o. 37,5/325 mg (30 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.191 |
|
|
|
2239B |
|
|
G |
Doletam 37,5 mg/325 mg |
tbl flm 30x37,5 mg/325 mg (blis.PVC/PVDC/Al) |
GLM-CZ |
CZ |
15 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
U38 |
31960 |
|
|
G |
Tramcet 37,5 mg/325 mg tablety |
tbl 30x37,5 mg/325 mg (blis.PVC/PVDC/Al) |
ICN-PL |
PL |
15 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
U38 |
31872 |
|
|
G |
Tramylpa 37,5 mg/325 mg |
tbl flm 30x37,5 mg/325 mg (blis.PVC/PVDC/Al) |
GNS |
UK |
15 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
U38 |
00112 |
|
|
G |
Zaracet |
tbl flm 30x37,5 mg/325 mg |
BLU |
SR |
15 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
U38 |
1027A |
|
|
G |
Tramadol/Paracetamol Saneca 37,5 mg/325 mg |
tbl 30x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al) |
SNC |
SK |
15 |
2.96 |
2.87 |
S |
0.09 |
3.0405000000000001E-2 |
0 |
|
|
|
|
U38 |
1030A |
|
|
G |
Tramapran 37,5 mg/325 mg |
tbl 30x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al) |
ZNT |
CZ |
15 |
2.96 |
2.87 |
S |
0.09 |
3.0405000000000001E-2 |
0 |
|
|
|
|
U38 |
1046A |
|
|
G |
Tradocomp 37,5 mg/325 mg |
tbl 30x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al) |
GLH-2 |
AT |
15 |
3.01 |
2.87 |
S |
0.14000000000000001 |
4.6512000000000005E-2 |
0 |
|
|
|
|
U38 |
88677 |
|
|
G |
Paratramol 37,5 mg/325 mg filmom obalené tablety |
tbl flm 30x37,5 mg/325 mg (blis.Al/PVC) |
PHC-2 |
PL |
15 |
5.53 |
2.87 |
S |
2.66 |
0.48101300000000002 |
0 |
|
|
|
|
U38 |
40431 |
|
|
O |
Zaldiar |
tbl flm 30 /=3x10/ |
GNG |
DE |
15 |
5.53 |
2.87 |
S |
2.66 |
0.48101300000000002 |
0 |
|
|
|
|
U38 |
N02AX52 |
|
|
|
Tramadol, kombinácie |
p.o. 37,5/325 mg (50-60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.191 |
|
|
|
2242B |
|
|
G |
Doletam 37,5 mg/325 mg |
tbl flm 60x37,5 mg/325 mg (blis.PVC/PVDC/Al) |
GLM-CZ |
CZ |
30 |
5.99 |
5.73 |
S |
0.26 |
4.3406E-2 |
0 |
|
|
|
|
U38 |
1033A |
|
|
G |
Tramadol/Paracetamol Saneca 37,5 mg/325 mg |
tbl 60x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al) |
SNC |
SK |
30 |
5.99 |
5.73 |
S |
0.26 |
4.3406E-2 |
0 |
|
|
|
|
U38 |
1035A |
|
|
G |
Tramapran 37,5 mg/325 mg |
tbl 60x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al) |
ZNT |
CZ |
30 |
5.99 |
5.73 |
S |
0.26 |
4.3406E-2 |
0 |
|
|
|
|
U38 |
31963 |
|
|
G |
Tramcet 37,5 mg/325 mg tablety |
tbl 60x37,5 mg/325 mg (blis.PVC/PVDC/Al) |
ICN-PL |
PL |
30 |
5.99 |
5.73 |
S |
0.26 |
4.3406E-2 |
0 |
|
|
|
|
U38 |
8798A |
|
|
G |
ZARACET |
tbl flm 60x37,5 mg/325 mg (blis.PVC/Al) |
BLU-SK |
SK |
30 |
5.99 |
5.73 |
S |
0.26 |
4.3406E-2 |
0 |
|
|
|
|
U38 |
1048A |
|
|
G |
Tradocomp 37,5 mg/325 mg |
tbl 50x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al) |
GLH-2 |
AT |
25 |
5.54 |
4.78 |
S |
0.76 |
0.137184 |
0 |
|
|
|
|
U38 |
76199 |
|
|
G |
Doreta 37,5 mg/325 mg filmom obalené tablety, |
tbl flm 60x37,5 mg/325 mg (blis.nepriehľ. PVC/PVDC/Al) |
KRK |
SL |
30 |
7.2 |
5.73 |
S |
1.47 |
0.20416699999999999 |
0 |
|
|
|
|
U38 |
1031A |
|
|
G |
Tramadol/Paracetamol Saneca 37,5 mg/325 mg |
tbl 50x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al) |
SNC |
SK |
25 |
7.83 |
4.78 |
S |
3.05 |
0.38952700000000001 |
0 |
|
|
|
|
U38 |
40432 |
|
|
O |
ZALDIAR |
tbl flm 50 (= 5x10) |
GNG |
DE |
25 |
7.83 |
4.78 |
S |
3.05 |
0.38952700000000001 |
0 |
|
|
|
|
U38 |
06241 |
|
|
O |
Zaldiar effervescens 37,5 mg/325 mg šumivé tablety |
tbl eff 50x37,5 mg/325 mg (strip PET/Al/PE) |
STD |
DE |
25 |
9.86 |
4.78 |
S |
5.08 |
0.51521299999999992 |
5.08 |
|
|
|
|
U38 |
N02AX52 |
|
|
|
Tramadol, kombinácie |
p.o. 37,5/325 mg (90-100 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.191 |
|
|
|
76204 |
|
|
G |
Doreta 37,5 mg/325 mg |
tbl flm 90x37,5 mg/325 mg |
KRK |
SI |
45 |
9.98 |
8.6 |
S |
1.38 |
0.13827700000000001 |
1.38 |
|
|
|
|
U38 |
N02AX52 |
|
|
|
Tramadol, kombinácie |
p.o. 75/650 mg (10 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.191 |
|
|
|
0373B |
|
|
G |
Tramadol/Paracetamol Zentiva 75 mg/650 mg |
tbl flm 10x75 mg/650 mg (blis.PVC/PVDC/Al) |
ZNT |
CZ |
10 |
2.2999999999999998 |
1.91 |
S |
0.39 |
0.16956499999999999 |
0.09 |
|
|
|
|
U38 |
30026 |
|
|
G |
Doreta 75mg/650mg |
tbl flm 10x75 mg/650 mg |
KRK |
SI |
10 |
3.99 |
1.91 |
S |
2.08 |
0.52130299999999996 |
0.09 |
|
|
|
|
U38 |
N02AX52 |
|
|
|
Tramadol, kombinácie |
p.o. 75/650 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.191 |
|
|
|
30028 |
|
|
G |
Doreta 75mg/650mg |
tbl flm 30x75 mg/650 mg |
KRK |
SI |
30 |
5.99 |
5.73 |
S |
0.26 |
4.3406E-2 |
0.26 |
|
|
|
|
U38 |
0375B |
|
|
G |
Tramadol/Paracetamol Zentiva 75 mg/650 mg |
tbl flm 30x75 mg/650 mg (blis.PVC/PVDC/Al) |
ZNT |
CZ |
30 |
5.99 |
5.73 |
S |
0.26 |
4.3406E-2 |
0.26 |
|
|
|
|
U38 |
N02BA04 |
|
|
|
Salicylát sodný |
parent.100 mg/ml |
3 |
g |
|
|
|
|
|
|
|
|
1.0888 |
|
|
|
00527 |
|
|
G |
NATRIUM SALICYLICUM BIOTIKA |
inj 10x10 ml 10% |
HBS |
SK |
3.3340000000000001 |
5.39 |
3.63 |
S |
1.76 |
0.32653100000000002 |
1.76 |
|
|
|
|
|
N02BB02 |
|
|
|
Metamizol, sodná soľ |
p.o. 500 mg (20 ks) |
3 |
g |
|
|
|
|
|
|
|
|
0.74350000000000005 |
|
|
|
24857 |
X |
|
O |
NOVALGIN |
tbl flm 20x500 mg |
HBS |
SK |
3.3359999999999999 |
2.83 |
2.48 |
S |
0.35 |
0.12367499999999999 |
0.35 |
|
|
|
|
|
N02BB02 |
|
|
|
Metamizol, sodná soľ |
p.o. 500 mg/ml (20 ml) |
3 |
g |
|
|
|
|
|
|
|
|
0.74399999999999999 |
|
|
|
7519A |
|
|
G |
Metamizol Stada 500 mg/ml perorálne roztokové kvapky |
gto por 1x20 ml (fľ.skl.jantár.s kvap.aplikátorom) |
STD |
DE |
3.3359999999999999 |
2.83 |
2.48 |
S |
0.35 |
0.12367499999999999 |
0.34 |
|
|
|
|
|
N02BB02 |
|
|
|
Metamizol, sodná soľ |
p.o. 500 mg/ml (50 ml) |
3 |
g |
|
|
|
|
|
|
|
|
0.74399999999999999 |
|
|
|
7520A |
|
|
G |
Metamizol Stada 500 mg/ml perorálne roztokové kvapky |
gto por 1x50 ml (fľ.skl.jantár.s kvap.aplikátorom) |
STD |
DE |
8.3330000000000002 |
7.06 |
6.2 |
S |
0.86 |
0.121813 |
0.86 |
|
|
|
|
|
N02BB02 |
|
|
|
Metamizol, sodná soľ |
parent. 500 mg/ml (2 ml) |
3 |
g |
|
|
|
|
|
|
|
|
1.33 |
|
|
|
24459 |
|
|
O |
NOVALGIN |
inj 10x2 ml 500 mg/ ml |
HBS |
SK |
3.331 |
5.71 |
4.43 |
S |
1.28 |
0.22416799999999998 |
0 |
|
|
|
|
|
N02BB02 |
|
|
|
Metamizol, sodná soľ |
parent. 500 mg/ml (5 ml) |
3 |
g |
|
|
|
|
|
|
|
|
0.72499999999999998 |
|
|
|
24530 |
|
|
O |
NOVALGIN |
inj 5x5 ml 500 mg/ ml |
HBS |
SK |
4.1689999999999996 |
2.99 |
2.99 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02BG07 |
|
|
|
Maleinát flupirtínu |
p.o. 100 mg (30 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
0.85970000000000002 |
|
|
|
98601 |
X |
|
O |
KATADOLON |
cps 30x100 mg |
AWD |
DE |
8.57 |
9.9700000000000006 |
7.37 |
S |
2.6 |
0.26078200000000001 |
1.74 |
AGG, NEU, ORT |
|
|
|
|
N02BG07 |
|
|
|
Maleinát flupirtínu |
p.o. 100 mg (50 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
0.85970000000000002 |
|
|
|
98602 |
X |
|
O |
KATADOLON |
cps 50x100 mg |
AWD |
DE |
14.287000000000001 |
15.18 |
12.28 |
S |
2.9 |
0.19104099999999999 |
2.9 |
AGG, NEU, ORT |
|
|
|
|
N02CC01 |
|
|
|
Sumatriptan |
p.o. 50 mg (6 ks) |
0.05 |
g |
|
|
|
|
|
|
|
|
0.316 |
|
|
|
96168 |
X |
|
G |
SUMATRIPTAN SANDOZ 50 mg tablety |
tbl 6x50mg |
SAN |
SI |
6 |
3.93 |
1.9 |
S |
2.0299999999999998 |
0.51653899999999997 |
1.26 |
|
|
|
|
U40 |
45912 |
X |
|
G |
Sumamigren 50 mg |
tbl flm 6x50mg |
PHK |
PL |
6 |
5.34 |
1.9 |
S |
3.44 |
0.64419499999999996 |
1.26 |
|
|
|
|
U40 |
36243 |
X |
|
G |
Cinie 50 |
tbl 6x50 mg |
ZNT-SK-2 |
SK |
6 |
6.49 |
1.9 |
S |
4.59 |
0.70724199999999993 |
1.26 |
|
|
|
|
U40 |
N02CC01 |
|
|
|
Sumatriptan |
p.o. 50 mg (12 ks) |
0.05 |
g |
|
|
|
|
|
|
|
|
0.316 |
|
|
|
96170 |
X |
|
G |
SUMATRIPTAN SANDOZ 50 mg tablety |
tbl 12x50mg |
SAN |
SI |
12 |
6.31 |
3.79 |
S |
2.52 |
0.399366 |
2.52 |
|
|
|
|
U40 |
N02CC01 |
|
|
|
Sumatriptan |
p.o. 100 mg (4 ks) |
0.05 |
g |
|
|
|
|
|
|
|
|
0.316 |
|
|
|
96249 |
X |
|
G |
SUMATRIPTAN SANDOZ 100 mg tablety |
tbl 4x100mg |
SAN |
SI |
8 |
8.56 |
2.5299999999999998 |
S |
6.03 |
0.70443900000000004 |
4.3499999999999996 |
|
|
|
|
U40 |
N02CC01 |
|
|
|
Sumatriptan |
p.o. 100 mg (6 ks) |
0.05 |
g |
|
|
|
|
|
|
|
|
0.316 |
|
|
|
45918 |
X |
|
G |
Sumamigren 100 mg |
tbl flm 6x100mg |
PHK |
PL |
12 |
10.31 |
3.79 |
S |
6.52 |
0.63239600000000007 |
6.52 |
|
|
|
|
U40 |
36249 |
X |
|
G |
Cinie 100 |
tbl 6x100 mg |
ZNT-SK-2 |
SK |
12 |
12 |
3.79 |
S |
8.2100000000000009 |
0.68416700000000008 |
6.52 |
|
|
|
|
U40 |
N02CC01 |
|
|
|
Sumatriptan |
loc. 200 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
2.35 |
|
|
|
93079 |
|
|
O |
IMIGRAN 20 MG |
aer nas 2x0,1 ml |
GWE |
IT |
2 |
11.69 |
4.7 |
S |
6.99 |
0.59794700000000001 |
6.99 |
NEU |
|
|
|
|
N02CC01 |
|
|
|
Sumatriptan |
parent. 12 mg/ml |
6 |
mg |
|
|
|
|
|
|
|
|
14.55 |
|
|
|
96535 |
|
|
O |
IMIGRAN |
inj 2x0,5 ml |
GWE |
GB |
2 |
29.1 |
29.1 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N02CC03 |
|
|
|
Zolmitriptan |
p.o. 2,5 mg (6 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
1.9810000000000001 |
|
|
|
32910 |
X |
|
O |
ZOMIG RAPIMELT |
tbl dsp 6x2,5 mg |
AZC |
GB |
6 |
16.98 |
11.89 |
S |
5.09 |
0.29976400000000003 |
5.09 |
NEU |
|
|
|
U41 |
N02CC04 |
|
|
|
Rizatriptan |
p.o. 10 mg (6 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.9810000000000001 |
|
|
|
05617 |
X |
|
G |
Rizatriptan Mylan |
tbl oro 6 x 10 mg (blis. OPA/Al/PVC) |
GNS |
UK |
6 |
18.78 |
11.89 |
S |
6.89 |
0.36688000000000004 |
6.89 |
NEU |
|
|
|
U41 |
81549 |
X |
|
G |
Rizatriptan Sandoz 10 mg orodispergovateľné tablety |
tbl oro 6x10 mg (blis. Al/Al) |
SAN |
SI |
6 |
18.78 |
11.89 |
S |
6.89 |
0.36688000000000004 |
6.89 |
NEU |
|
|
|
U41 |
N02CC04 |
|
|
|
Rizatriptan |
p.o. lyo por 10 mg (2 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.9810000000000001 |
|
|
|
13174 |
X |
|
O |
MAXALT RPD 10 mg |
lyo por 2 |
XFR |
ES |
2 |
6.78 |
3.96 |
S |
2.82 |
0.41592899999999999 |
2.42 |
NEU |
|
|
|
U41 |
N02CC04 |
|
|
|
Rizatriptan |
p.o. lyo por 10 mg (6 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.9810000000000001 |
|
|
|
13175 |
X |
|
O |
MAXALT RPD 10 mg |
lyo por 6 |
XFR |
ES |
6 |
20.04 |
11.89 |
S |
8.15 |
0.40668700000000002 |
7.26 |
NEU |
|
|
|
U41 |
N02CC04 |
|
|
|
Rizatriptan |
p.o. lyo por 10 mg (18 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.9810000000000001 |
|
|
|
89959 |
X |
|
O |
MAXALT RPD 10 mg |
lyo por 18x10 mg |
MSD |
NL |
18 |
57.43 |
35.659999999999997 |
S |
21.77 |
0.37906999999999996 |
21.77 |
NEU |
|
|
|
U41 |
N02CC06 |
|
|
|
Eletriptan |
p.o. 40 mg (4 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
1.9810000000000001 |
|
|
|
13753 |
X |
|
O |
RELPAX 40 mg |
tbl flm 4x40 mg |
PFI-GB-3 |
GB |
4 |
17.7 |
7.92 |
S |
9.7799999999999994 |
0.55254199999999998 |
9.7799999999999994 |
NEU |
|
|
|
U41 |
N02CC06 |
|
|
|
Eletriptan |
p.o. 80 mg (2 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
1.9810000000000001 |
|
|
|
13754 |
X |
|
O |
RELPAX 80 mg |
tbl flm 2x80 mg |
PFI-GB-3 |
GB |
4 |
16.53 |
7.92 |
S |
8.61 |
0.52087099999999997 |
8.61 |
NEU |
|
|
|
U41 |
N02CC07 |
|
|
|
Frovatriptan |
p.o. 2,5 mg (6 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
1.9810000000000001 |
|
|
|
40032 |
X |
|
O |
FROVAMEN |
tbl flm 6x2,5 mg |
MNR |
GB |
6 |
22.68 |
11.89 |
S |
10.79 |
0.47575000000000001 |
10.79 |
NEU |
|
|
|
U41 |
N02CX01 |
|
|
|
Pizotifén |
p.o. 0,5 mg (30 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.61080000000000001 |
|
|
|
02761 |
X |
|
O |
SANDOMIGRAN |
tbl obd 30x0,5 mg |
XNT |
IT |
10 |
7.82 |
6.11 |
S |
1.71 |
0.21867 |
1.71 |
NEU |
|
|
|
|
N03AA02 |
|
|
|
Fenobarbital |
p.o. 15 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.66820000000000002 |
|
|
|
2469B |
|
|
G |
Phenaemaletten |
tbl 50x15 mg (obal PE biely) |
DET |
DE |
7.5 |
8.0299999999999994 |
5.01 |
S |
3.02 |
0.37609000000000004 |
3.02 |
|
|
|
|
|
N03AA02 |
|
|
|
Fenobarbital |
p.o. 100 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
9.6000000000000002E-2 |
|
|
|
2468B |
|
|
G |
Phenaemal 0,1 |
tbl 50x100 mg (obal PE biely) |
DET |
DE |
50 |
6.31 |
4.8 |
S |
1.51 |
0.23930299999999999 |
1.51 |
NEU |
|
|
|
|
N03AA02 |
|
|
|
Fenobarbital |
parent. 200 mg/ml |
0.1 |
g |
|
|
|
|
|
|
|
|
0.47139999999999999 |
|
|
|
84449 |
|
|
O |
LUMINAL |
inj 5x1 ml/200 mg |
DET |
DE |
10 |
4.91 |
4.71 |
S |
0.2 |
4.0732999999999998E-2 |
0.2 |
AGG, NEU |
|
|
|
|
N03AB02 |
|
|
|
Fenytoín |
p.o. 100 mg (100 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
62234 |
|
|
O |
EPILAN D GEROT |
tbl 100x100 mg |
GER |
AT |
33.347999999999999 |
3.19 |
3.19 |
I |
0 |
0 |
0 |
|
|
|
|
|
N03AD01 |
|
|
|
Etosuximid |
p.o. 250 mg (50 ks) |
1.25 |
g |
|
|
|
|
|
|
|
|
0.56999999999999995 |
|
|
|
15450 |
|
|
G |
PETNIDAN |
cps 50x250 mg |
DET |
DE |
10 |
7.38 |
5.7 |
S |
1.68 |
0.22764199999999998 |
1.68 |
|
|
|
|
|
N03AD01 |
|
|
|
Etosuximid |
p.o. 250 mg (100 ks) |
1.25 |
g |
|
|
|
|
|
|
|
|
0.56999999999999995 |
|
|
|
92041 |
|
|
O |
PETINIMID 250 mg |
cps 100x250 mg |
GER |
AT |
20 |
14.78 |
11.4 |
S |
3.38 |
0.228687 |
3.36 |
|
|
|
|
|
N03AE01 |
|
|
|
Klonazepam |
p.o. 0,5 mg (50 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.51700000000000002 |
|
|
|
03031 |
|
|
O |
Rivotril 0,5 mg |
tbl 50x0,5 mg |
HLR |
CH |
3.125 |
1.68 |
1.62 |
S |
0.06 |
3.5714000000000003E-2 |
0.06 |
NEU, PSY, AGG |
|
|
|
|
N03AE01 |
|
|
|
Klonazepam |
p.o. 2 mg (30 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.32 |
|
|
|
03032 |
|
|
O |
Rivotril 2 mg |
tbl 30x2 mg |
HLR |
CH |
7.5 |
1.6 |
1.6 |
I |
0 |
0 |
0 |
NEU, PSY, AGG |
|
|
|
|
N03AE01 |
|
|
|
Klonazepam |
p.o. 2,5 mg/ml |
8 |
mg |
|
|
|
|
|
|
|
|
0.46 |
|
|
|
03029 |
|
|
O |
Rivotril 2,5 mg/ml |
gtt por 1x10 ml/25 mg |
HLR |
CH |
3.1259999999999999 |
1.68 |
1.44 |
S |
0.24 |
0.14285700000000001 |
0.24 |
NEU, PSY, AGG |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. 200 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.39 |
|
|
|
03417 |
|
|
O |
BISTON |
tbl 50x200 mg |
ZNT |
SK |
10 |
5.18 |
3.9 |
S |
1.28 |
0.24710399999999999 |
0 |
|
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 150 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.92610000000000003 |
|
|
|
71954 |
|
|
G |
TIMONIL RETARD |
tbl plg 50x150 mg |
DET |
DE |
7.5 |
3.61 |
3.61 |
I |
0 |
0 |
0 |
AGG, NEU, PSY |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 200 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.45 |
|
|
|
92039 |
|
|
O |
TEGRETOL CR 200 |
tbl mod 50x200 mg |
XNT |
IT |
10 |
4.5 |
4.5 |
I |
0 |
0 |
0 |
DIA, NEU, PSY |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 300 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.30499999999999999 |
|
|
|
60164 |
|
|
G |
TIMONIL RETARD |
tbl plg 50x300 mg |
DET |
DE |
15 |
4.8499999999999996 |
4.58 |
S |
0.27 |
5.5670000000000004E-2 |
0.27 |
DIA, NEU, PSY |
|
|
|
|
96305 |
|
|
O |
NEUROTOP RET |
tbl plg 50x300MG |
GER |
AT |
15 |
5.22 |
4.58 |
S |
0.64 |
0.12260500000000001 |
0.27 |
DIA, NEU, PSY |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 300 mg (100 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.30499999999999999 |
|
|
|
60165 |
|
|
G |
TIMONIL RETARD |
tbl plg 100x300 mg |
DET |
DE |
30 |
18.59 |
9.15 |
S |
9.44 |
0.50780000000000003 |
0.54 |
DIA, NEU, PSY |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 400 mg (30 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.45 |
|
|
|
93619 |
|
|
O |
TEGRETOL CR 400 |
tbl mod 30x400 mg |
XNT |
IT |
12 |
5.39 |
5.39 |
I |
0 |
0 |
0 |
DIA, NEU, PSY |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 600 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.31 |
|
|
|
60166 |
|
|
G |
TIMONIL RETARD |
tbl plg 50x600 mg |
DET |
DE |
30 |
8.6300000000000008 |
8.6300000000000008 |
I |
0 |
0 |
0 |
DIA, NEU, PSY |
|
|
|
|
96306 |
|
|
O |
NEUROTOP RET |
tbl plg 50x600MG |
GER |
AT |
30 |
9.75 |
9.3000000000000007 |
S |
0.45 |
4.6154000000000001E-2 |
0 |
DIA, NEU, PSY |
|
|
|
|
N03AF02 |
|
|
|
Oxkarbazepín |
p.o. 300 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.88 |
|
|
|
14922 |
|
|
O |
TRILEPTAL 300 |
tbl flm 50x300 mg |
NPF |
CH |
15 |
14.85 |
13.2 |
S |
1.65 |
0.111111 |
1.65 |
NEU, PSY |
ind.obm. |
|
|
|
N03AF03 |
|
|
|
Rufinamid |
p.o. 200 mg (50 ks) |
1600 |
mg |
|
|
|
|
|
|
|
|
8.7319999999999993 |
|
|
|
37873 |
|
|
O |
Inovelon 200 mg filmom obalené tablety |
tbl flm 50x200 mg |
XEI-GB |
GB |
6.25 |
54.58 |
54.58 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AF03 |
|
|
|
Rufinamid |
p.o. 400 mg (50 ks) |
1600 |
mg |
|
|
|
|
|
|
|
|
8.3450000000000006 |
|
|
|
37878 |
|
|
O |
Inovelon 400 mg filmom obalené tablety |
tbl flm 50x400 mg |
XEI-GB |
GB |
12.5 |
104.31 |
104.31 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AF04 |
|
|
|
Eslikarbazepín acetát |
p.o. 800 mg (30 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
3.1749999999999998 |
|
|
|
75833 |
|
|
O |
Zebinix 800 mg |
tbl 30x800 mg (blister PVC/Al) |
BIAL |
PT |
30 |
95.24 |
95.24 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. 300 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.39 |
|
|
|
08769 |
|
|
G |
Convulex 300 mg kapsuly |
cps 100x300 mg |
GER |
AT |
20 |
7.56 |
7.56 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. 500 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.27800000000000002 |
|
|
|
75296 |
|
|
G |
Convulex 500 mg kapsuly |
cps 100x500 mg |
GER |
AT |
33.332999999999998 |
10 |
9.27 |
S |
0.73 |
7.2999999999999995E-2 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. predĺžené uvoľňovanie 500 mg (30 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.39 |
|
|
|
11853 |
|
|
O |
DEPAKINE CHRONO 500MG |
tbl flp 30x500 mg |
SWA |
FR |
10 |
3.88 |
3.88 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. predĺžené uvoľňovanie 500 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.39 |
|
|
|
36737 |
|
|
G |
Valpro-ratiopharm Chrono 500 mg |
tbl plg 100x500mg |
RAT |
DE |
33.332999999999998 |
13 |
13 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
20587 |
|
|
G |
Convulex CR 500 mg |
tbl plg 100x500 mg (fľ.skl.hnedá) |
GLH |
AT |
33.332999999999998 |
16.670000000000002 |
13 |
S |
3.67 |
0.22015599999999999 |
0 |
NEU, PSY |
|
|
|
|
35378 |
|
|
G |
Valproát CHrono Sandoz 500mg tablety s predĺženým uvoľňovaním |
tbl plg 100x500mg |
SAN |
SI |
33.332999999999998 |
16.670000000000002 |
13 |
S |
3.67 |
0.22015599999999999 |
0 |
NEU, PSY |
|
|
|
|
26560 |
|
|
O |
DEPAKINE CHRONO 500 mg |
tbl flp 100x500 mg |
SWA |
FR |
33.332999999999998 |
18.260000000000002 |
13 |
S |
5.26 |
0.28806100000000001 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. SR predĺžené uvoľňovanie 150 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.67 |
|
|
|
57710 |
|
|
G |
ORFIRIL LONG 150MG |
cps plg 100x150 mg |
DET |
DE |
10 |
8.8699999999999992 |
6.7 |
S |
2.17 |
0.244645 |
2.17 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. SR predĺžené uvoľňovanie 300 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.67 |
|
|
|
57713 |
|
|
G |
ORFIRIL LONG 300MG |
cps plg 100x300 mg |
DET |
DE |
20 |
15.4 |
13.4 |
S |
2 |
0.12987000000000001 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. SR predĺžené uvoľňovanie 500 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.66800000000000004 |
|
|
|
57716 |
|
|
G |
ORFIRIL LONG 500 mg |
tbl plg 100x500 mg |
DET |
DE |
33.334000000000003 |
24.59 |
22.27 |
S |
2.3199999999999998 |
9.4347E-2 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. SR predĺžené uvoľňovanie 1000 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.58899999999999997 |
|
|
|
57719 |
|
|
G |
ORFIRIL LONG 1000 mg |
tbl plg 100x1000 mg |
DET |
DE |
66.665999999999997 |
41.59 |
39.270000000000003 |
S |
2.3199999999999998 |
5.5782999999999999E-2 |
2.3199999999999998 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o.50 mg/ml |
1.5 |
g |
|
|
|
|
|
|
|
|
0.94 |
|
|
|
80202 |
|
|
G |
CONVULEX |
sir 1x100 ml |
GER |
AT |
3.3330000000000002 |
3.65 |
3.13 |
S |
0.52 |
0.14246600000000001 |
0.52 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o.57,64 mg/ml |
1.5 |
g |
|
|
|
|
|
|
|
|
0.77 |
|
|
|
15412 |
|
|
O |
DEPAKINE |
sir 1x150 ml |
SNW |
FR |
5.76 |
4.37 |
4.37 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. 300 mg/ml |
1.5 |
g |
|
|
|
|
|
|
|
|
0.77010000000000001 |
|
|
|
08770 |
|
|
G |
Convulex 300 mg/ml kvapky |
gtt por 100 ml |
GER |
AT |
20 |
15.37 |
15.37 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N03AG04 |
|
|
|
Vigabatrín |
p.o. 500 mg (100 ks) |
2 |
g |
|
|
|
|
|
|
|
|
1.5580000000000001 |
|
|
|
71990 |
|
|
O |
SABRIL |
tbl flm 100x500 mg |
MDD |
GB |
25 |
44.34 |
38.950000000000003 |
S |
5.39 |
0.121561 |
5.39 |
NEU |
ind.obm. |
|
|
|
N03AX03 |
|
|
|
Sultiam |
p.o. 200 mg (50 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.46800000000000003 |
|
|
|
2401B |
|
|
O |
Ospolot |
tbl flm 50x200 mg (obal PE) |
DET |
DE |
25 |
15.69 |
11.7 |
S |
3.99 |
0.25430199999999997 |
3.99 |
NEU, PSY |
|
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 5 mg (56 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
5.77 |
|
|
|
52426 |
|
|
G |
Lamictal 5 mg |
tbl dsp 56x5 mg |
GAG |
SK |
0.9 |
5.54 |
5.19 |
S |
0.35 |
6.3176999999999997E-2 |
0.35 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 25 mg (28-30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.8 |
|
|
|
46235 |
|
|
G |
MEDOTRIGIN 25 mg |
tbl 30x25 mg |
MOE |
CY |
2.5 |
1.99 |
1.99 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
92667 |
|
|
G |
Lamotrigin Actavis 25mg |
tbl dsp 30x25mg |
ACT |
DK |
2.5 |
2.33 |
2 |
S |
0.33 |
0.14163100000000001 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
78346 |
|
|
G |
Lamictal 25 mg tablety |
tbl 28x25 mg (blis.PVC/Al) |
GAG |
SK |
2.3330000000000002 |
2.5099999999999998 |
1.87 |
S |
0.64 |
0.25497999999999998 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
33836 |
|
|
G |
Plexxo 25 mg |
tbl 30x25 mg |
DET |
DE |
2.5 |
3.43 |
2 |
S |
1.43 |
0.41691 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 50 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.73 |
|
|
|
46239 |
|
|
G |
MEDOTRIGIN 50 mg |
tbl 30x50 mg |
MOE |
CY |
5 |
3.62 |
3.62 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
92684 |
|
|
G |
Lamotrigin Actavis 50mg |
tbl dsp 30 x 50mg |
ACT |
IS |
5 |
3.65 |
3.65 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
33841 |
|
|
G |
Plexxo 50 mg |
tbl 30x50 mg |
DET |
DE |
5 |
5.41 |
3.65 |
S |
1.76 |
0.32532299999999997 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 50 mg (98 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.73 |
|
|
|
78350 |
|
|
G |
Lamictal 50 mg tablety |
tbl 98x50 mg (blis.PVC/Al) |
GAG |
SK |
16.332999999999998 |
10.68 |
10.68 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 100 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.61499999999999999 |
|
|
|
92706 |
|
|
G |
Lamotrigin Actavis 100mg |
tbl dsp 30x100mg |
ACT |
DK |
10 |
6.14 |
6.14 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
46243 |
|
|
G |
MEDOTRIGIN 100 mg |
tbl 30x100 mg |
MOE |
CY |
10 |
6.61 |
6.15 |
S |
0.46 |
6.9592000000000001E-2 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
33846 |
|
|
G |
Plexxo 100 mg |
tbl 30x100 mg |
DET |
DE |
10 |
7.8 |
6.15 |
S |
1.65 |
0.211538 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 100 mg (42 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.61499999999999999 |
|
|
|
78188 |
|
|
G |
Lamictal 100 mg dispergovateľné/žuvacie tablety |
tbl mcp 42x100 mg (blis.PVC/PVDC/Al) |
GAG |
SK |
14 |
18.559999999999999 |
8.61 |
S |
9.9499999999999993 |
0.53609899999999999 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 100 mg (98-100 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.61499999999999999 |
|
|
|
92713 |
|
|
G |
Lamotrigin Actavis 100mg |
tbl dsp 100 x 100mg |
ACT |
IS |
33.33 |
20.47 |
20.47 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
46245 |
|
|
G |
MEDOTRIGIN 100 mg |
tbl 100x100 mg |
MOE |
CY |
33.332999999999998 |
20.49 |
20.49 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
33850 |
|
|
G |
Plexxo 100 mg |
tbl 100x100 mg |
DET |
DE |
33.332999999999998 |
22.24 |
20.5 |
S |
1.74 |
7.8237000000000001E-2 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
78189 |
|
|
G |
Lamictal 100 mg dispergovateľné/žuvacie tablety |
tbl mcp 98x100 mg (blis.PVC/PVDC/Al) |
GAG |
SK |
32.667000000000002 |
27.44 |
20.09 |
S |
7.35 |
0.26785700000000001 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX11 |
|
|
|
Topiramát |
p.o. 25 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.288 |
|
|
|
53359 |
|
|
G |
Erravia 25 mg |
tbl flm 60X25 mg(blister) |
PRW |
CZ |
5 |
6.43 |
6.43 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
83244 |
|
|
G |
Talopam 25 mg |
tbl flm 60x25 mg (blis.Al/Al) |
ACT |
IS |
5 |
6.43 |
6.43 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
52033 |
|
|
G |
Topilex 25 mg |
tbl flm 60x 25 mg (bli.ppd) |
LAR |
AT |
5 |
6.43 |
6.43 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
50784 |
|
|
G |
Topimark 25 mg |
tbl flm 60x25 mg (blis.Al/Al) |
GLM-CZ |
CZ |
5 |
7.44 |
6.44 |
S |
1 |
0.134409 |
0 |
NEU |
ind.obm. |
|
|
|
41190 |
|
|
O |
TOPAMAX 25 |
tbl flm 60x25 mg (blister alu/alu) |
JNS |
BE |
5 |
8.42 |
6.44 |
S |
1.98 |
0.235154 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX11 |
|
|
|
Topiramát |
p.o. 50 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.88400000000000001 |
|
|
|
53362 |
|
|
G |
Erravia 50 mg |
tbl flm 60X50 mg (blister) |
PRW |
CZ |
10 |
8.84 |
8.84 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
83256 |
|
|
G |
Talopam 50 mg |
tbl flm 60x50 mg (blis.Al/Al) |
ACT |
IS |
10 |
8.84 |
8.84 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
52014 |
|
|
G |
Topilex 50 mg |
tbl flm 60x 50 mg (bli.ppd) |
LAR |
AT |
10 |
8.84 |
8.84 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
50805 |
|
|
G |
Topimark 50 mg |
tbl flm 60x50 mg (blis.Al/Al) |
GLM-CZ |
CZ |
10 |
8.84 |
8.84 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
41194 |
|
|
O |
TOPAMAX 50 |
tbl flm 60x50 mg (blister alu/alu) |
JHN-SK |
SK |
10 |
17.02 |
8.84 |
S |
8.18 |
0.48061100000000001 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX11 |
|
|
|
Topiramát |
p.o. 100 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
53345 |
|
|
G |
Erravia 100 mg |
tbl flm 60X100 mg (blister) |
PRW |
CZ |
20 |
20.94 |
20.94 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
83271 |
|
|
G |
Talopam 100 mg |
tbl flm 60x100 mg (blis.Al/Al) |
ACT |
IS |
20 |
20.94 |
20.94 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
52027 |
|
|
G |
Topilex 100 mg |
tbl flm 60x 100 mg (bli.ppd) |
LAR |
AT |
20 |
20.94 |
20.94 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
50826 |
|
|
G |
Topimark 100 mg |
tbl flm 60x100 mg (blis.Al/Al) |
GLM-CZ |
CZ |
20 |
20.94 |
20.94 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
41198 |
|
|
G |
TOPAMAX 100 |
tbl flm 60x100 mg (blister alu/alu) |
JHN-SK |
SK |
20 |
28.3 |
21 |
S |
7.3 |
0.25795100000000004 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX11 |
|
|
|
Topiramát |
p.o. 100 mg (120 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
50830 |
|
|
G |
Topimark 100 mg |
tbl flm 120x100 mg (blis.Al/Al) |
GLM-CZ |
CZ |
40 |
42 |
42 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 100 mg (100 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.26 |
|
|
|
91364 |
|
|
G |
Gabapentin-Teva 100mg |
cps dur 100x100mg |
PHM |
NL |
5.556 |
6.93 |
6.93 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
84398 |
|
|
O |
NEURONTIN 100 mg tvrdé kapsuly |
cps dur 100x100 mg (blis.PVC/PVDC/Al) |
PFI-GB-1 |
GB |
5.556 |
9.01 |
7 |
S |
2.0099999999999998 |
0.22308499999999998 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 300 mg (50-60 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
0.82 |
|
|
|
68687 |
|
|
G |
Grimodin 300 mg tvrdé kapsuly |
cps dur 60x300 mg |
EGI |
HU |
10 |
8.18 |
8.18 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
91373 |
|
|
G |
Gabapentin-Teva 300mg |
cps dur 50x300mg |
PHM |
NL |
8.3330000000000002 |
6.82 |
6.82 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
84399 |
|
|
O |
NEURONTIN 300 mg tvrde kapsuly |
cps dur 50x300 mg (blis.PVC/PVDC/Al) |
PFI-GB-1 |
GB |
8.3330000000000002 |
6.91 |
6.83 |
S |
0.08 |
1.1576999999999999E-2 |
0 |
AGG, DIA, NEU |
|
|
|
|
47414 |
|
|
G |
Gabagamma 300 |
cps dur 50x300mg (blis.) |
WGP |
DE |
8.3330000000000002 |
9.31 |
6.83 |
S |
2.48 |
0.26638000000000001 |
0 |
AGG, DIA, NEU |
|
|
|
|
49788 |
|
|
G |
GORDIUS 300 mg |
cps 50x300 mg |
GDN |
HU |
8.3330000000000002 |
11.16 |
6.83 |
S |
4.33 |
0.38799300000000003 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 300 mg (100-120 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
0.82 |
|
|
|
76928 |
|
|
G |
Grimodin 300 mg tvrdé kapsuly |
cps dur 120x300 mg (blis.PVCI/PVDC/AI) |
EGI |
HU |
20 |
16.36 |
16.36 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 300 mg (200 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
0.82 |
|
|
|
47416 |
|
|
G |
Gabagamma 300 |
cps dur 200x300mg (blis.) |
WGP |
DE |
33.332999999999998 |
27.67 |
27.33 |
S |
0.34 |
1.2287999999999999E-2 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 400 mg (50-60 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
68686 |
|
|
G |
Grimodin 400 mg tvrdé kapsuly |
cps dur 60x400 mg |
EGI |
HU |
13.333 |
13.8 |
13.8 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
91383 |
|
|
G |
Gabapentin-Teva 400mg |
cps dur 50x400mg |
PHM |
NL |
11.111000000000001 |
11.51 |
11.51 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
84401 |
|
|
O |
NEURONTIN 400 mg tvrdé kapsuly |
cps dur 50x400 mg (blis.PVC/PVDC/Al) |
PFI-GB-1 |
GB |
11.111000000000001 |
11.67 |
11.67 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
47420 |
|
|
G |
Gabagamma 400 |
cps dur 50x400mg (blis.) |
WGP |
DE |
11.111000000000001 |
14.01 |
11.67 |
S |
2.34 |
0.16702400000000001 |
0 |
AGG, DIA, NEU |
|
|
|
|
49790 |
|
|
G |
GORDIUS 400 mg |
cps 50x400 mg |
GDN |
HU |
11.111000000000001 |
14.19 |
11.67 |
S |
2.52 |
0.17759 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 400 mg (200 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
47422 |
|
|
G |
Gabagamma 400 |
cps dur 200x400mg (blis.) |
WGP |
DE |
44.444000000000003 |
46.67 |
46.67 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 600 mg (50-60 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.2410000000000001 |
|
|
|
91407 |
|
|
G |
Gabapentin-Teva 600mg |
tbl flm 50x600mg |
PHM |
NL |
16.667000000000002 |
20.67 |
20.67 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
65365 |
|
|
G |
Gabagamma 600 mg filmom obalené tablety |
tbl flm 50x600 mg |
WGP |
DE |
16.667000000000002 |
21.56 |
20.68 |
S |
0.88 |
4.0815999999999998E-2 |
0 |
AGG, DIA, NEU |
|
|
|
|
69540 |
|
|
G |
Grimodin 600 mg filmom obalené tablety |
tbl flm 60x600 mg |
EGI |
HU |
20 |
26.3 |
24.82 |
S |
1.48 |
5.6273999999999998E-2 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 800 mg (50 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.2 |
|
|
|
65370 |
|
|
G |
Gabagamma 800 mg filmom obalené tablety |
tbl flm 50x800 mg |
WGP |
DE |
22.222000000000001 |
26.42 |
26.42 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 250 mg (30 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.79900000000000004 |
|
|
|
11477 |
|
|
G |
TRUND 250 mg |
tbl flm 30x250 mg (blis.Al/PVC/PE/PVDC) |
GLM |
CZ |
5 |
5.04 |
4 |
S |
1.04 |
0.20634899999999998 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 250 mg (50-60 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.79900000000000004 |
|
|
|
10908 |
|
|
G |
Epiletam 250 mg |
tbl flm 60x250 mg (blis.Al/PVC/PE/PVDC) |
EGI |
HU |
10 |
7.98 |
7.98 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
07343 |
|
|
G |
LEVEMED 250 mg |
tbl flm 50x250 mg (blis.PVC/PE/PVDC/Al) |
CRR |
SK |
8.3330000000000002 |
6.66 |
6.66 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12357 |
|
|
G |
Levetiracetam Accord 250 mg filmom obalené tablety |
tbl flm 50x250 mg (blis.PVC/Al) |
ACC |
GB |
8.3330000000000002 |
6.66 |
6.66 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
32383 |
|
|
G |
Levetiracetam STADA 250 mg |
tbl flm 50x250 mg (blis.PVC/Al) |
STD |
DE |
8.3330000000000002 |
6.66 |
6.66 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3769A |
|
|
G |
PTEROCYN 250 mg |
tbl flm 50x250 mg (blis.Al/PVC/PE/PVDC) |
SVS |
CZ |
8.3330000000000002 |
6.66 |
6.66 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3283A |
|
|
G |
Levetiracetam UCB 250 mg filmom obalené tablety |
tbl flm 50x250 mg (blis.PVC/Al) |
UCB |
CZ |
8.3330000000000002 |
8.32 |
6.66 |
S |
1.66 |
0.19951899999999997 |
0 |
NEU |
ind.obm. |
|
|
|
11620 |
|
|
G |
Repitend 250 mg |
tbl flm 50x250 mg (blis.Al/PVC) |
PHC-3 |
PL |
8.3330000000000002 |
10.78 |
6.66 |
S |
4.12 |
0.382189 |
0 |
NEU |
ind.obm. |
|
|
|
12266 |
|
|
G |
Matever 250 mg |
tbl flm 50x250 mg (PVC/PE/PVDC/Al) |
PMT |
GR |
8.3330000000000002 |
11.05 |
6.66 |
S |
4.3899999999999997 |
0.39728499999999994 |
0 |
NEU |
ind.obm. |
|
|
|
10508 |
|
|
O |
KEPPRA 250 mg |
tbl flm 50x250 mg |
UCB |
BE |
8.3330000000000002 |
16.22 |
6.66 |
S |
9.56 |
0.58939600000000003 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 250 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.79900000000000004 |
|
|
|
12085 |
|
|
G |
Levetiracetam Actavis 250 mg filmom obalené tablety |
tbl flm 100x250 mg (blis.Al/PVC) |
ACT-5 |
IS |
16.667000000000002 |
13.3 |
13.3 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 500 mg (50-60 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
3777A |
|
|
G |
PTEROCYN 500 mg |
tbl flm 50x500 mg (blis.Al/PVC/PE/PVDC) |
SVS |
CZ |
16.667000000000002 |
14.12 |
14.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12301 |
|
|
G |
Matever 500 mg |
tbl flm 50x500 mg (PVC/PE/PVDC/Al) |
PMT |
GR |
16.667000000000002 |
19.07 |
14.17 |
S |
4.9000000000000004 |
0.25694800000000001 |
0 |
NEU |
ind.obm. |
|
|
|
11613 |
|
|
G |
Repitend 500 mg |
tbl flm 50x500 mg (blis.Al/PVC) |
PHC-3 |
PL |
16.667000000000002 |
20.079999999999998 |
14.17 |
S |
5.91 |
0.294323 |
0 |
NEU |
ind.obm. |
|
|
|
10515 |
|
|
O |
KEPPRA 500 mg |
tbl flm 50x500 mg |
UCB |
BE |
16.667000000000002 |
30.11 |
14.17 |
S |
15.94 |
0.52939199999999997 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 500 mg (100-120 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
07359 |
|
|
G |
LEVEMED 500 mg |
tbl flm 100x500 mg (blis.PVC/PE/PVDC/Al) |
CRR |
SK |
33.332999999999998 |
28.24 |
28.24 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
32396 |
|
|
G |
Levetiracetam STADA 500 mg |
tbl flm 100x500 mg (blis.PVC/Al) |
STD |
DE |
33.332999999999998 |
28.24 |
28.24 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
10925 |
|
|
G |
Epiletam 500 mg |
tbl flm 120x500 mg (blis.Al/PVC/PE/PVDC) |
EGI |
HU |
40 |
33.89 |
33.89 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3780A |
|
|
G |
PTEROCYN 500 mg |
tbl flm 120x500 mg (blis.Al/PVC/PE/PVDC) |
SVS |
CZ |
40 |
33.89 |
33.89 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12368 |
|
|
G |
Levetiracetam Accord 500 mg filmom obalené tablety |
tbl flm 100x500 mg (blis.PVC/Al) |
ACC |
GB |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12098 |
|
|
G |
Levetiracetam Actavis 500 mg filmom obalené tablety |
tbl flm 100x500 mg (blis.Al/PVC) |
ACT-5 |
IS |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3288A |
|
|
G |
Levetiracetam UCB 500 mg filmom obalené tablety |
tbl flm 100x500 mg (blis.PVC/Al) |
UCB |
CZ |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12303 |
|
|
G |
Matever 500 mg |
tbl flm 100x500 mg (PVC/PE/PVDC/Al) |
PMT |
GR |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
11485 |
|
|
G |
TRUND 500 mg |
tbl flm 100x500 mg (blis.Al/PVC/PE/PVDC) |
GLM |
CZ |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
13894 |
|
|
G |
Levetiracetam Sandoz 500 mg filmom obalené tablety |
tbl flm 100x500 mg (blis.OPA/Al/PVC/Al) |
SAN |
SI |
33.332999999999998 |
28.33 |
28.33 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
11616 |
|
|
G |
Repitend 500 mg |
tbl flm 100x500 mg (blis.Al/PVC) |
PHC-3 |
PL |
33.332999999999998 |
39.770000000000003 |
28.33 |
S |
11.44 |
0.28765400000000002 |
0 |
NEU |
ind.obm. |
|
|
|
10516 |
|
|
O |
KEPPRA 500 mg |
tbl flm 100x500 mg |
UCB |
BE |
33.332999999999998 |
55.44 |
28.33 |
S |
27.11 |
0.48899700000000001 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 1000 mg (100-120 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.70699999999999996 |
|
|
|
10947 |
|
|
G |
Epiletam 1000 mg |
tbl flm 120x1000 mg (blis.Al/PVC/PE/PVDC) |
EGI |
HU |
80 |
56.54 |
56.54 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3796A |
|
|
G |
PTEROCYN 1000 mg |
tbl flm 120x1000 mg (blis.Al/PVC/PE/PVDC) |
SVS |
CZ |
80 |
56.54 |
56.54 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
07353 |
|
|
G |
LEVEMED 1000 mg |
tbl flm 100x1000 mg (blis.PVC/PE/PVDC/Al) |
CRR |
SK |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12386 |
|
|
G |
Levetiracetam Accord 1000 mg filmom obalené tablety |
tbl flm 100x1000 mg (blis.PVC/Al) |
ACC |
GB |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12118 |
|
|
G |
Levetiracetam Actavis 1000 mg filmom obalené tablety |
tbl flm 100x1000 mg (blis.Al/PVC) |
ACT-5 |
IS |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
13906 |
|
|
G |
Levetiracetam Sandoz 1000 mg filmom obalené tablety |
tbl flm 100x1000 mg (blis.OPA/Al/PVC/Al) |
SAN |
SI |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
32406 |
|
|
G |
Levetiracetam STADA 1000 mg |
tbl flm 100x1000 mg (blis.PCV/Al) |
STD |
DE |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12322 |
|
|
G |
Matever 1000 mg |
tbl flm 100x1000 mg (PVC/PE/PVDC/Al) |
PMT |
GR |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
11500 |
|
|
G |
TRUND 1000 mg |
tbl flm 100x1000 mg (blis.Al/PVC/PE/PVDC) |
GLM |
CZ |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3294A |
|
|
G |
Levetiracetam UCB 1000 mg filmom obalené tablety |
tbl flm 100x1000 mg (blis.PVC/Al) |
UCB |
CZ |
66.667000000000002 |
56.25 |
47.13 |
S |
9.1199999999999992 |
0.162133 |
0 |
NEU |
ind.obm. |
|
|
|
11640 |
|
|
G |
Repitend 1000 mg |
tbl flm 100x1000 mg (blis.Al/PVC) |
PHC-3 |
PL |
66.667000000000002 |
78.900000000000006 |
47.13 |
S |
31.77 |
0.40266199999999996 |
0 |
NEU |
ind.obm. |
|
|
|
10520 |
|
|
O |
KEPPRA 1000 mg |
tbl flm 100x1000 mg |
UCB |
BE |
66.667000000000002 |
107.87 |
47.13 |
S |
60.74 |
0.56308500000000006 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 100 mg/ml sol. por. |
1.5 |
g |
|
|
|
|
|
|
|
|
1.8759999999999999 |
|
|
|
81542 |
|
|
O |
Keppra |
sol por 1x150 ml (100 mg/1 ml) (skl.fľa. + 1 ml peror.str.) |
UCB-1 |
BE |
10 |
19.73 |
18.760000000000002 |
S |
0.97 |
4.9164000000000006E-2 |
0.97 |
NEU |
ind.obm. |
|
|
|
81541 |
|
|
O |
Keppra |
sol por 1x150 ml (100 mg/1 ml) (skl.fľa. + 3 ml peror.str.) |
UCB-1 |
BE |
10 |
19.73 |
18.760000000000002 |
S |
0.97 |
4.9164000000000006E-2 |
0.97 |
NEU |
ind.obm. |
|
|
|
N03AX15 |
|
|
|
Zonisamid |
p.o. 25 mg (28 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.8376000000000001 |
|
|
|
92656 |
|
|
O |
Zonegran 25 mg tvrdé kapsuly |
cps dur 28x25 mg |
XEI-GB |
GB |
2.33 |
15 |
8.94 |
S |
6.06 |
0.40399999999999997 |
6.06 |
NEU |
ind.obm. |
|
|
|
N03AX15 |
|
|
|
Zonisamid |
p.o. 50 mg (56 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
4.0999999999999996 |
|
|
|
92654 |
|
|
O |
Zonegran 50 mg tvrdé kapsuly |
cps dur 56x50 mg |
XEI-GB |
GB |
9.33 |
49.5 |
38.25 |
S |
11.25 |
0.227273 |
11.25 |
NEU |
ind.obm. |
|
|
|
N03AX15 |
|
|
|
Zonisamid |
p.o. 100 mg (98 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.81 |
|
|
|
92658 |
|
|
O |
Zonegran 100 mg tvrdé kapsuly |
cps dur 98x100 mg |
XEI-GB |
GB |
32.67 |
124.36 |
124.36 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX16 |
|
|
|
Pregabalín |
p.o. 75 mg (56 - 60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.55 |
|
|
|
3858B |
|
|
G |
Pragiola 75mg tvrdé kapsuly |
cps dur 60x75mg(blis.PVC/PVDC/Al) |
KRK |
SL |
15 |
23.25 |
23.25 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4705B |
|
|
G |
Pregabalin Mylan Pharma 75 mg tvrdé kapsuly |
cps dur 56 x 75 mg (blis.PVC/PVDC/Al) |
GNS |
UK |
14 |
21.7 |
21.7 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4594B |
|
|
G |
Pregabalin Sandoz 75 mg tvrdé kapsuly |
cps dur 56x1x75 mg (blis.PVC/PVDC/Al-perf.) |
SAN |
AT |
14 |
21.7 |
21.7 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4910B |
|
|
G |
Pregabalin Teva 75 mg |
cps dur 56x75 mg (blis.PVC/Al) |
TEV |
SK |
14 |
21.7 |
21.7 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
5183B |
|
|
G |
Preglenix 75 mg tvrdé kapsuly |
cps dur 56x75 mg (blis.PVC/Al) |
GLM-CZ |
CZ |
14 |
21.7 |
21.7 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
40926 |
|
|
O |
Lyrica |
cps dur 56x75 mg (blister PVC/Alu) |
PFI-GB-1 |
GB |
14 |
21.91 |
21.7 |
S |
0.21 |
9.5849999999999998E-3 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX16 |
|
|
|
Pregabalín |
p.o. 150 mg (56 - 60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.0900000000000001 |
|
|
|
4717B |
|
|
G |
Pregabalin Mylan Pharma 150 mg tvrdé kapsuly |
cps dur 56 x150mg (blis.PVC/PVDC/Al) |
GNS |
UK |
28 |
30.51 |
30.51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4625B |
|
|
G |
Pregabalin Sandoz 150 mg tvrdé kapsuly |
cps dur 56x1x150 mg (blis.PVC/PVDC/Al-perf.) |
SAN |
AT |
28 |
30.51 |
30.51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4921B |
|
|
G |
Pregabalin Teva 150 mg |
cps dur 56x150 mg (blis.PVC/Al) |
TEV |
SK |
28 |
30.51 |
30.51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
5191B |
|
|
G |
Preglenix 150 mg tvrdé kapsuly |
cps dur 56x150 mg (blis.PVC/Al) |
GLM-CZ |
CZ |
28 |
30.51 |
30.51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4029B |
|
|
G |
Pragiola 150mg tvrdé kapsuly |
cps dur 60x150mg(blis.PVC/PVDC/Al) |
KRK |
SL |
30 |
32.700000000000003 |
32.700000000000003 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
40932 |
|
|
O |
Lyrica |
cps dur 56x150 mg (blister PVC/Alu) |
PFI-GB-1 |
GB |
28 |
30.69 |
30.52 |
S |
0.17 |
5.5389999999999997E-3 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX16 |
|
|
|
Pregabalín |
p.o. 300 mg (56 - 60ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
3901B |
|
|
G |
Pragiola 300mg tvrdé kapsuly |
cps dur 60x300mg(blis.PVC/PVDC/Al) |
KRK |
SL |
60 |
51 |
51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4734B |
|
|
G |
Pregabalin Mylan Pharma 300 mg tvrdé kapsuly |
cps dur 56 x 300 mg (blis.PVC/PVDC/Al) |
GNS |
UK |
56 |
47.6 |
47.6 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4652B |
|
|
G |
Pregabalin Sandoz 300 mg tvrdé kapsuly |
cps dur 56x1x300 mg (blis.PVC/PVDC/Al-perf.) |
SAN |
AT |
56 |
47.6 |
47.6 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4934B |
|
|
G |
Pregabalin Teva 300 mg |
cps dur 56x300 mg (blis.PVC/Al) |
TEV |
SK |
56 |
47.6 |
47.6 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
5199B |
|
|
G |
Preglenix 300 mg tvrdé kapsuly |
cps dur 56x300 mg (blis.PVC/Al) |
GLM-CZ |
CZ |
56 |
47.6 |
47.6 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
40938 |
|
|
O |
Lyrica |
cps dur 56x300 mg (blister PVC/Alu) |
PFI-GB-1 |
GB |
56 |
48.01 |
47.6 |
S |
0.41 |
8.539999999999999E-3 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX18 |
|
|
|
Lakosamid |
p.o. 50 mg (56 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
4.34 |
|
|
|
52856 |
|
|
O |
Vimpat 50 mg |
tbl flm 56 x 50 mg |
SWP |
DE |
9.3330000000000002 |
44.01 |
40.51 |
S |
3.5 |
7.9527E-2 |
3.5 |
NEU |
ind.obm. |
|
|
|
N03AX18 |
|
|
|
Lakosamid |
p.o. 50 mg (168 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
4.34 |
|
|
|
52857 |
|
|
O |
Vimpat 50 mg filmom obalené tablety |
tbl flm 168x50 mg (blis.PVC/PVDC/Al) |
UCP |
BE |
27.998999999999999 |
132.01 |
121.52 |
S |
10.49 |
7.9463999999999993E-2 |
10.49 |
NEU |
ind.obm. |
|
|
|
N03AX18 |
|
|
|
Lakosamid |
p.o. 100 mg (56 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.9969999999999999 |
|
|
|
52859 |
|
|
O |
Vimpat 100 mg |
tbl flm 56 x 100 mg |
SWP |
DE |
18.667000000000002 |
77.73 |
74.61 |
S |
3.12 |
4.0138999999999994E-2 |
3.12 |
NEU |
ind.obm. |
|
|
|
N03AX18 |
|
|
|
Lakosamid |
p.o. 100 mg (168 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.9969999999999999 |
|
|
|
52860 |
|
|
O |
Vimpat 100 mg filmom obalené tablety |
tbl flm 168x100 mg (blis.PVC/PVDC/Al) |
UCP |
BE |
56.000999999999998 |
247.52 |
223.84 |
S |
23.68 |
9.5669000000000004E-2 |
9.36 |
NEU |
ind.obm. |
|
|
|
N03AX18 |
|
|
|
Lakosamid |
p.o. 150 mg (56 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.9729999999999999 |
|
|
|
52862 |
|
|
O |
Vimpat 150 mg |
tbl flm 56 x 150 mg |
SWP |
DE |
28 |
114.36 |
111.24 |
S |
3.12 |
2.7282000000000001E-2 |
3.12 |
NEU |
ind.obm. |
|
|
|
N03AX18 |
|
|
|
Lakosamid |
p.o. 150 mg (168 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.9729999999999999 |
|
|
|
52863 |
|
|
O |
Vimpat 150 mg filmom obalené tablety |
tbl flm 168x150 mg (blis.PVC/PVDC/Al) |
UCP |
BE |
84 |
365.4 |
333.73 |
S |
31.67 |
8.6671999999999999E-2 |
9.36 |
NEU |
ind.obm. |
|
|
|
N03AX18 |
|
|
|
Lakosamid |
p.o. 200 mg (56 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.9729999999999999 |
|
|
|
52865 |
|
|
O |
Vimpat 200 mg |
tbl flm 56 x 200 mg |
SWP |
DE |
37.332999999999998 |
151.32 |
148.32 |
S |
3 |
1.9826E-2 |
3 |
NEU |
ind.obm. |
|
|
|
N03AX18 |
|
|
|
Lakosamid |
p.o. 200 mg (168 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.9729999999999999 |
|
|
|
52866 |
|
|
O |
Vimpat 200 mg filmom obalené tablety |
tbl flm 168x200 mg (blis.PVC/PVDC/Al) |
UCP |
BE |
111.999 |
483.2 |
444.97 |
S |
38.229999999999997 |
7.9118000000000008E-2 |
9 |
NEU |
ind.obm. |
|
|
|
N03AX21 |
|
|
|
Retigabín |
p.o. 50 mg (21 ks) |
900 |
mg |
|
|
|
|
|
|
|
|
3.47 |
|
|
|
06116 |
|
|
O |
Trobalt 50mg filmom obalené tablety |
tbl film 21x50 mg (blis.PVC/PVD/Al) |
GLA |
GB |
1.167 |
5.33 |
4.05 |
S |
1.28 |
0.24015 |
1.28 |
NEU |
ind.obm. |
|
|
U42 |
N03AX21 |
|
|
|
Retigabín |
p.o. 100 mg (84 ks) |
900 |
mg |
|
|
|
|
|
|
|
|
3.47 |
|
|
|
06121 |
|
|
O |
Trobalt 100mg filmom obalené tablety |
tbl flm 84x100 mg (blis. PVDC/PE/PVC/Al) |
GLA |
GB |
9.3330000000000002 |
34.89 |
32.39 |
S |
2.5 |
7.1653999999999995E-2 |
2.5 |
NEU |
ind.obm. |
|
|
U42 |
N03AX21 |
|
|
|
Retigabín |
p.o. 200 mg (84 ks) |
900 |
mg |
|
|
|
|
|
|
|
|
3.47 |
|
|
|
06133 |
|
|
O |
Trobalt 200mg filmom obalené tablety |
tbl flm 84x200 mg (blis. PVDC/PE/PVC/Al) |
GLA |
GB |
18.667000000000002 |
65.95 |
64.77 |
S |
1.18 |
1.7891999999999998E-2 |
1.18 |
NEU |
ind.obm. |
|
|
U42 |
N03AX21 |
|
|
|
Retigabín |
p.o. 300 mg (84 ks) |
900 |
mg |
|
|
|
|
|
|
|
|
3.47 |
|
|
|
06138 |
|
|
O |
Trobalt 300mg filmom obalené tablety |
tbl flm 84x300 mg (blis. PVDC/PE/PVC/Al) |
GLA |
GB |
28 |
97.11 |
97.11 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
U42 |
N03AX21 |
|
|
|
Retigabín |
p.o. 400 mg (84 ks) |
900 |
mg |
|
|
|
|
|
|
|
|
3.47 |
|
|
|
06140 |
|
|
O |
Trobalt 400mg filmom obalené tablety |
tbl flm 84x400 mg (blis. PVDC/PE/PVC/Al) |
GLA |
GB |
37.332999999999998 |
130.61000000000001 |
129.55000000000001 |
S |
1.06 |
8.116E-3 |
1.06 |
NEU |
ind.obm. |
|
|
U42 |
N04AA02 |
|
|
|
Biperidén |
p.o. 2 mg (50 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
20054 |
|
|
O |
AKINETON |
tbl 50x2 mg |
KNO |
DE |
10 |
2.77 |
2.77 |
I |
0 |
0 |
0 |
NEU,PSY |
|
|
|
|
N04AA02 |
|
|
|
Biperidén |
parent. 5 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
2.0579999999999998 |
|
|
|
15515 |
|
|
O |
AKINETON |
sol inj 5x1 ml/5 mg |
KNO |
DE |
2.5 |
5.47 |
5.15 |
S |
0.32 |
5.8501000000000004E-2 |
0.32 |
NEU, PSY |
|
|
|
|
N04BA02 |
|
|
|
Levodopa a inhibítory dekarboxylázy |
p.o. 100/25 mg (100 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.86 |
|
|
|
88498 |
|
|
G |
NAKOM MITE |
tbl 100x125 mg |
LEK |
SI |
16 |
13.76 |
13.76 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
45241 |
|
|
G |
ISICOM 100 mg |
tbl 100 |
DET |
DE |
16.667000000000002 |
15.98 |
14.33 |
S |
1.65 |
0.103254 |
0 |
NEU, PSY |
|
|
|
|
N04BA02 |
|
|
|
Levodopa a inhibítory dekarboxylázy |
p.o. 250/25 mg (100 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.38100000000000001 |
|
|
|
45244 |
|
|
G |
ISICOM 250 mg |
tbl 100 |
DET |
DE |
41.667000000000002 |
17.649999999999999 |
15.88 |
S |
1.77 |
0.100283 |
1.77 |
NEU, PSY |
|
|
|
|
N04BA02 |
|
|
|
Levodopa a inhibítory dekarboxylázy |
p.o. predĺžené uvoľňovanie 100/25 mg (30 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.49 |
|
|
|
12073 |
|
|
O |
MADOPAR HBS |
cps mod 30x125 mg |
HLR |
CH |
6.25 |
4.92 |
3.06 |
S |
1.86 |
0.37804900000000002 |
0 |
NEU, PSY |
|
|
|
|
N04BA02 |
|
|
|
Levodopa a inhibítory dekarboxylázy |
p.o. dispersible 100/25 mg |
0.6 |
g |
|
|
|
|
|
|
|
|
0.49 |
|
|
|
14607 |
|
|
O |
MADOPAR DISPERSIBLE 125 MG (F.) |
tbl dsp 100x125 mg |
HLR |
CH |
20.832999999999998 |
11.8 |
10.210000000000001 |
S |
1.59 |
0.134746 |
0 |
NEU, PSY |
|
|
|
|
N04BA03 |
|
|
|
Levodopa/karbidopa/entakapon |
p.o. levodopa 50 mg |
600 |
mg |
|
|
|
|
|
|
|
|
1.603 |
|
|
|
8250A |
|
|
G |
Corbilta 50 mg/12,5 mg/200 mg filmom obalené tablety |
tbl flm 100x50 mg/12,5 mg/200 mg (fľ.HDPE) |
ORN |
FI |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1493B |
|
|
G |
Levodopa/Carbidopa/Entacapone Stada 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (nád.HDPE) |
STD |
DE |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1320B |
|
|
G |
Levodopa/Carbidopa/Entacapone Teva 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (fľ.HDPE) |
TEV-SK |
SK |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1210B |
|
|
G |
Sastravi 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (obal HDPE) |
ACT-5 |
IS |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1965B |
|
|
G |
STALEMED 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (fľ. HDPE) |
CRR |
SK |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3931B |
|
|
G |
Padovel 50 mg/12,5 mg/200 mg filmom obalené tablety |
tbl flm 100x50 mg/12,5 mg/200 mg (blis. Al/Al) |
SVS |
CZ |
33.332999999999998 |
53.42 |
53.42 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3907B |
|
|
G |
TADOGLEN 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (fl. HDPE) |
GLM-CZ |
CZ |
33.332999999999998 |
53.42 |
53.42 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
40858 |
|
|
O |
STALEVO 50/12,5/200 mg tbl flm |
tbl flm 100 |
ORN |
FI |
33.332999999999998 |
66.02 |
53.43 |
S |
12.59 |
0.19070000000000001 |
0 |
NEU |
|
|
|
|
N04BA03 |
|
|
|
Levodopa/karbidopa/entakapon |
p.o. levodopa 100 mg |
600 |
mg |
|
|
|
|
|
|
|
|
1.603 |
|
|
|
8261A |
|
|
G |
Corbilta 100 mg/25 mg/200 mg filmom obalené tablety |
tbl flm 100x100 mg/25 mg/200 mg (fľ.HDPE) |
ORN |
FI |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1501B |
|
|
G |
Levodopa/Carbidopa/Entacapone Stada 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (nád.HDPE) |
STD |
DE |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1346B |
|
|
G |
Levodopa/Carbidopa/Entacapone Teva 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (fľ.HDPE) |
TEV-SK |
SK |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3941B |
|
|
G |
Padovel 100 mg/25 mg/200 mg filmom obalené tablety |
tbl flm 100x100 mg/25 mg/200 mg (blis. Al/Al) |
SVS |
CZ |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1215B |
|
|
G |
Sastravi 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (obal HDPE) |
ACT-5 |
IS |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1970B |
|
|
G |
STALEMED 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (fľ. HDPE) |
CRR |
SK |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3913B |
|
|
G |
TADOGLEN 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (fl. HDPE) |
GLM-CZ |
CZ |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
40862 |
|
|
O |
STALEVO 100/25/200 mg tbl flm |
tbl flm 100 |
ORN |
FI |
33.332999999999998 |
68.67 |
53.43 |
S |
15.24 |
0.22193100000000002 |
0 |
NEU |
|
|
|
|
N04BA03 |
|
|
|
Levodopa/karbidopa/entakapon |
p.o. levodopa 150 mg |
600 |
mg |
|
|
|
|
|
|
|
|
1.643 |
|
|
|
8272A |
|
|
G |
Corbilta 150 mg/37,5 mg/200 mg filmom obalené tablety |
tbl flm 100x150 mg/37,5 mg/200 mg (fľ.HDPE) |
ORN |
FI |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1509B |
|
|
G |
Levodopa/Carbidopa/Entacapone Stada 150 mg/37,5 mg/200 mg |
tbl flm 100x150 mg/37,5 mg/200 mg (nád.HDPE) |
STD |
DE |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1372B |
|
|
G |
Levodopa/Carbidopa/Entacapone Teva 150 mg/37,5 mg/200 mg |
tbl flm 100x150 mg/37,5 mg/200 mg (fľ.HDPE) |
TEV-SK |
SK |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1220B |
|
|
G |
Sastravi 150 mg/37,5 mg/200 mg |
tbl flm 100x150 mg/37,5 mg/200 mg (obal HDPE) |
ACT-5 |
IS |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1975B |
|
|
G |
STALEMED 150 mg/37,5 mg/200 mg |
tbl flm 100x150 mg/37,5 mg/200 mg (fľ. HDPE) |
CRR |
SK |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3953B |
|
|
G |
Padovel 150 mg/37,5 mg/200 mg filmom obalené tablety |
tbl flm 100x150 mg/37,5 mg/200 mg (blis. Al/Al) |
SVS |
CZ |
33.332999999999998 |
55.3 |
54.77 |
S |
0.53 |
9.5840000000000005E-3 |
0 |
NEU |
|
|
|
|
3919B |
|
|
G |
TADOGLEN 150 mg/37,5 mg/200 mg |
tbl flm 100x150 mg/37,5 mg/200 mg (fl. HDPE) |
GLM-CZ |
CZ |
33.332999999999998 |
55.3 |
54.77 |
S |
0.53 |
9.5840000000000005E-3 |
0 |
NEU |
|
|
|
|
40866 |
|
|
O |
STALEVO 150/37,5/200 mg tbl flm |
tbl flm 100 |
ORN |
FI |
33.332999999999998 |
70.58 |
54.77 |
S |
15.81 |
0.22400099999999998 |
0 |
NEU |
|
|
|
|
N04BA03 |
|
|
|
Levodopa/karbidopa/entakapon |
p.o. levodopa 200 mg |
600 |
mg |
|
|
|
|
|
|
|
|
1.75 |
|
|
|
8283A |
|
|
G |
Corbilta 200 mg/50 mg/200 mg filmom obalené tablety |
tbl flm 100x200 mg/50 mg/200 mg (fľ.HDPE) |
ORN |
FI |
33.332999999999998 |
58.31 |
58.31 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1398B |
|
|
G |
Levodopa/Carbidopa/Entacapone Teva 200 mg/50 mg/200 mg |
tbl flm 100x200 mg/50 mg/200 mg (fľ.HDPE) |
TEV-SK |
SK |
33.332999999999998 |
58.31 |
58.31 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1225B |
|
|
G |
Sastravi 200 mg/50 mg/200 mg |
tbl flm 100x200 mg/50 mg/200 mg (obal HDPE) |
ACT-5 |
IS |
33.299999999999997 |
58.26 |
58.26 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1525B |
|
|
G |
Levodopa/Carbidopa/Entacapone Stada 200 mg/50 mg/200 mg |
tbl flm 100x200 mg/50 mg/200 mg (nád.HDPE) |
STD |
DE |
33.332999999999998 |
58.32 |
58.32 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1980B |
|
|
G |
STALEMED 200 mg/50 mg/200 mg |
tbl flm 100x200 mg/50 mg/200 mg (fľ. HDPE) |
CRR |
SK |
33.299999999999997 |
58.31 |
58.28 |
S |
0.03 |
5.1400000000000003E-4 |
0 |
NEU |
|
|
|
|
3925B |
|
|
G |
TADOGLEN 200 mg/50 mg/200 mg |
tbl flm 100x200 mg/50 mg/200 mg (fl. HDPE) |
GLM-CZ |
CZ |
33.332999999999998 |
60.44 |
58.33 |
S |
2.11 |
3.4910999999999998E-2 |
0 |
NEU |
|
|
|
|
3964B |
|
|
G |
Padovel 200 mg/50 mg/200 mg filmom obalené tablety |
tbl flm 100x200 mg/50 mg/200 mg (blis. Al/Al) |
SVS |
CZ |
33.332999999999998 |
60.5 |
58.33 |
S |
2.17 |
3.5868000000000004E-2 |
0 |
NEU |
|
|
|
|
50472 |
|
|
O |
STALEVO 200/50/200 mg |
tbl flm 100 |
ORN |
FI |
33.299999999999997 |
76.52 |
58.28 |
S |
18.239999999999998 |
0.238369 |
0 |
NEU |
|
|
|
|
N04BB01 |
|
|
|
Amantadín |
p.o. 100 mg (50 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
02871 |
|
|
G |
VIREGYT-K |
cps 50x100 mg |
EGI |
HU |
25 |
4.5599999999999996 |
4.5599999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
|
N04BB01 |
|
|
|
Amantadín |
p.o. sulfát 100 mg (90 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.20699999999999999 |
|
|
|
30073 |
|
|
O |
PK-MERZ |
tbl flm 90x100 mg |
MEZ |
DE |
45 |
10.01 |
9.32 |
S |
0.69 |
6.8930999999999992E-2 |
0 |
NEU, PSY |
|
|
|
|
N04BB01 |
|
|
|
Amantadín |
parent. 0,5 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
17.22 |
|
|
|
76218 |
|
|
O |
PK-MERZ |
sol inf 2x500 ml |
MEZ |
DE |
2 |
34.44 |
34.44 |
A |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. 0,25 mg (12 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
2.61 |
|
|
|
35021 |
|
|
O |
ADARTREL 0,25 mg |
tbl flm 12x0,25 mg |
GLA |
GB |
0.5 |
2.25 |
1.31 |
S |
0.94 |
0.41777799999999998 |
0.94 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. 0,5 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
2.391 |
|
|
|
35023 |
|
|
O |
ADARTREL 0,50 mg |
tbl flm 84x0,50 mg |
GLA |
GB |
7 |
19.11 |
16.739999999999998 |
S |
2.37 |
0.12401899999999999 |
2.37 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. 1 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
0.93 |
|
|
|
47775 |
|
|
G |
Ropinirol Mylan 1mg |
tbl flm 84 x 1 mg |
GNS |
GB |
14 |
12.91 |
12.91 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. 2 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
0.55000000000000004 |
|
|
|
47776 |
|
|
G |
Ropinirol Mylan 2 mg |
tbl flm 84 x 2 mg |
GNS |
GB |
28 |
15.33 |
15.33 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. predĺžené uvoľňovanie 2 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
1.22 |
|
|
|
1250A |
|
|
G |
Raponer 2 mg |
tbl plg 84x2 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
34.07 |
34.07 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
02276 |
|
|
G |
Rolpryna SR 2mg |
tbl plg 84x2mg |
KRK |
SI |
28 |
34.07 |
34.07 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
4049A |
|
|
G |
ROPINSTAD retard 2 mg |
tbl plg 84x2 mg (blis.PVC/PCTFE/Al) |
STD |
DE |
28 |
34.07 |
34.07 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
31200 |
|
|
G |
Sindranol 2mg |
tbl plg 84x2mg |
EGI |
HU |
28 |
34.07 |
34.07 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
36027 |
|
|
O |
REQUIP-MODUTAB 2 mg |
tbl plg 84x2 mg |
GAG |
SK |
28 |
37.14 |
34.159999999999997 |
S |
2.98 |
8.0237000000000003E-2 |
0 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. predĺžené uvoľňovanie 4 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
0.92100000000000004 |
|
|
|
1236A |
|
|
G |
Raponer 4 mg |
tbl plg 84x4 mg (blis.Al/Al) |
ACT-5 |
IS |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
36093 |
|
|
O |
REQUIP-MODUTAB 4 mg |
tbl plg 84x4 mg |
GAG |
SK |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
02282 |
|
|
G |
Rolpryna SR 4mg |
tbl plg 84x4mg |
KRK |
SI |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
4072A |
|
|
G |
ROPINSTAD retard 4 mg |
tbl plg 84x4 mg (blis.PVC/PCTFE/Al) |
STD |
DE |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
31238 |
|
|
G |
Sindranol 4mg |
tbl plg 84x4mg |
EGI |
HU |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. predĺžené uvoľňovanie 8 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
0.77100000000000002 |
|
|
|
1243A |
|
|
G |
Raponer 8 mg |
tbl plg 84x8 mg (blis.Al/Al) |
ACT-5 |
IS |
112 |
86.28 |
86.28 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
02288 |
|
|
G |
Rolpryna SR 8mg |
tbl plg 84x8mg |
KRK |
SI |
112 |
86.28 |
86.28 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
4094A |
|
|
G |
ROPINSTAD retard 8 mg |
tbl plg 84x8 mg (blis.PVC/PCTFE/Al) |
STD |
DE |
112 |
86.28 |
86.28 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
31259 |
|
|
G |
Sindranol 8mg |
tbl plg 84x8mg (blis.PVC/PCTFE/Al) |
EGI |
HU |
112 |
86.28 |
86.28 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
36095 |
|
|
O |
REQUIP-MODUTAB 8 mg |
tbl plg 84x8 mg |
GAG |
SK |
112 |
88.44 |
86.35 |
S |
2.09 |
2.3632E-2 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
Pramipexol p.o. predĺžené uvoľňovanie 3,15 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.367 |
|
|
|
3210B |
|
|
G |
Oprymea 3,15 mg tablety s predĺženým uvoľňovaním |
tbl plg 30x3,15 mg (blis.OPA/Al/vysušovadlo/PE/Al) |
KRK |
SL |
54 |
73.75 |
73.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. prepoč. na bázu 0,18 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
53273 |
|
|
G |
Oprymea |
tbl 30x0,18 mg |
KRK |
SI |
3.0859999999999999 |
3.04 |
3.04 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
64435 |
|
|
G |
Pramipexol STADA 0,18 mg tablety |
tbl 3x10x0,18 mg (blis. OPA/Al/PVC/Al) |
STD |
DE |
3.0859999999999999 |
3.06 |
3.06 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. prepoč. na bázu 0,18 mg (100 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
66853 |
|
|
G |
Glepark 0,18 mg |
tbl 100x0,18 mg (blis.Al/Al) |
GLM-CZ |
CZ |
10.285 |
10.18 |
10.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
64437 |
|
|
G |
Pramipexol STADA 0,18 mg tablety |
tbl 10x10x0,18 mg |
STD |
DE |
10.285 |
10.18 |
10.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. prepoč. na bázu 0,7 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.1399999999999999 |
|
|
|
53286 |
|
|
G |
Oprymea |
tbl 30x0,7 mg |
KRK |
SI |
12 |
13.62 |
13.62 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
64431 |
|
|
G |
Pramipexol STADA 0,7 mg tablety |
tbl 3x10x0,7 mg (blis. OPA/Al/PVC/Al) |
STD |
DE |
12 |
13.62 |
13.62 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
12456 |
|
|
G |
Pramipexole Accord 0,7 mg tablety |
tbl 30x0,7 mg (blis.Al/PVC/Al) |
ACC |
GB |
12 |
13.62 |
13.62 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. prepoč. na bázu 0,7 mg (100 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.1399999999999999 |
|
|
|
64433 |
|
|
G |
Pramipexol STADA 0,7 mg tablety |
tbl 10x10x0,7 mg |
STD |
DE |
40 |
45.4 |
45.4 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
12458 |
|
|
G |
Pramipexole Accord 0,7 mg tablety |
tbl 100x0,7 mg (blis.Al/PVC/Al) |
ACC |
GB |
40 |
45.4 |
45.4 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
66876 |
|
|
G |
Glepark 0,7 mg |
tbl 100x0,7 mg (blis.Al/Al) |
GLM-CZ |
CZ |
40 |
45.6 |
45.6 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 0,26 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.75 |
|
|
|
8025A |
|
|
G |
Oprymea 0,26 tablety s predĺženým uvoľňovaním |
tbl plg 30x0,26mg (blis.OPA/Al/vysušovadlo/PE/Al |
KRK |
SL |
4.4569999999999999 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3267B |
|
|
G |
Pramipexol Teva Pharma 0,26 mg |
tbl plg 30x0,26 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
4.4569999999999999 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
81590 |
|
|
O |
Mirapexin 0,26 mg tablety s predĺženým uvoľňovaním |
tbl plg 30x(3x10)x0,26 mg |
BOE |
DE |
4.4569999999999999 |
10.28 |
7.8 |
S |
2.48 |
0.24124500000000001 |
2.48 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 0,52 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.62 |
|
|
|
81593 |
|
|
O |
Mirapexin 0,52 mg tablety s predĺženým uvoľňovaním |
tbl plg 30x(3x10)x0,52 mg |
BOE |
DE |
8.9139999999999997 |
14.36 |
14.36 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
8029A |
|
|
G |
Oprymea 0,52 tablety s predĺženým uvoľňovaním |
tbl plg 30x0,52mg (blis.OPA/Al/vysušovadlo/PE/Al) |
KRK |
SL |
8.9139999999999997 |
14.36 |
14.36 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3270B |
|
|
G |
Pramipexol Teva Pharma 0,52 mg |
tbl plg 30x0,52 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
8.9139999999999997 |
14.36 |
14.36 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 1,05 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.2 |
|
|
|
8032A |
|
|
G |
Oprymea 1,05 tablety s predĺženým uvoľňovaním |
tbl plg 30x1,05mg (blis.OPA/Al/vysušovadlo/PE/Al) |
KRK |
SL |
18 |
21.52 |
21.52 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3273B |
|
|
G |
Pramipexol Teva Pharma 1,05 mg |
tbl plg 30x1,05 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
18 |
21.52 |
21.52 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
81596 |
|
|
O |
Mirapexin 1,05 mg tablety s predĺženým uvoľňovaním |
tbl plg 30x(3x10)x1,05 mg |
BOE |
DE |
18 |
26.64 |
21.6 |
S |
5.04 |
0.189189 |
5.04 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 2,1 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.1200000000000001 |
|
|
|
8041A |
|
|
G |
Oprymea 2,1 tablety s predĺženým uvoľňovaním |
tbl plg 30x2,1mg (blis.OPA/Al/vysušovadlo/PE/Al) |
KRK |
SL |
36 |
40.19 |
40.19 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3276B |
|
|
G |
Pramipexol Teva Pharma 2,1 mg |
tbl plg 30x2,1 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
36 |
40.19 |
40.19 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
81605 |
|
|
O |
Mirapexin 2,1 mg tablety s predĺženým uvoľňovaním |
tbl plg 30x(3x10)x2,1 mg |
BOE |
DE |
36 |
47.16 |
40.32 |
S |
6.84 |
0.145038 |
6.84 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 2,62 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
2.8639999999999999 |
|
|
|
3206B |
|
|
G |
Oprymea 2,62 tablety s predĺženým uvoľňovaním |
tbl plg 30x2,62mg (blis.OPA/Al/vysušovadlo/PE/Al |
KRK |
SL |
44.914000000000001 |
83.09 |
83.09 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3279B |
|
|
G |
Pramipexol Teva Pharma 2,62 mg |
tbl plg 30x2,62 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
44.914000000000001 |
83.09 |
83.09 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
21429 |
|
|
O |
Mirapexin 2,62 mg tablety s predĺženým uvoľňovaním |
tbl plg 30x(3x10)x2,62 mg |
BOE |
DE |
44.914000000000001 |
86.66 |
86.66 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC07 |
|
|
|
Apomorfín |
parent. subkutánna infúzia, injekčný a infúzny roztok 10 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
9.36 |
|
|
|
08468 |
|
|
G |
Dacepton 10 mg/ml injekčný a infúzny roztok |
sol ijf 2x(5x5 ml) (amp.skl.) |
HML |
DE |
25 |
233.99 |
233.99 |
A |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N04BC09 |
|
|
|
Rotigotín |
transd. emp. 2 mg |
6 |
mg |
|
|
|
|
|
|
|
|
3.0150000000000001 |
|
|
|
98647 |
|
|
O |
Neupro 2 mg/24 h transdermálna náplasť |
emp tdm 7x2 mg/24 hodín |
SWP |
IE |
2.3330000000000002 |
15.27 |
7.03 |
S |
8.24 |
0.53961999999999999 |
8.24 |
NEU |
|
|
|
U43 |
N04BC09 |
|
|
|
Rotigotín |
transd. emp. 4 mg |
6 |
mg |
|
|
|
|
|
|
|
|
3.0150000000000001 |
|
|
|
98651 |
|
|
O |
Neupro 4 mg/24 h transdermálna náplasť |
emp tdm 28x4 mg/24 hodín |
SWP |
IE |
18.667000000000002 |
73.09 |
56.28 |
S |
16.809999999999999 |
0.22999 |
16.809999999999999 |
NEU |
|
|
|
U43 |
98650 |
|
|
O |
Neupro 4 mg/24 h transdermálna náplasť |
emp tdm 7x4 mg/24 hodín |
SWP |
IE |
4.6669999999999998 |
20.76 |
14.07 |
S |
6.69 |
0.32225399999999998 |
4.2 |
NEU |
|
|
|
U43 |
N04BC09 |
|
|
|
Rotigotín |
transd. emp. 6 mg |
6 |
mg |
|
|
|
|
|
|
|
|
3.0150000000000001 |
|
|
|
98654 |
|
|
O |
Neupro 6 mg/24 h transdermálna náplasť |
emp tdm 28x6 mg/24 hodín |
SWP |
IE |
28 |
91.93 |
84.42 |
S |
7.51 |
8.1693000000000002E-2 |
7.51 |
NEU |
|
|
|
U43 |
N04BC09 |
|
|
|
Rotigotín |
transd. emp. 8 mg |
6 |
mg |
|
|
|
|
|
|
|
|
3.0150000000000001 |
|
|
|
98657 |
|
|
O |
Neupro 8 mg/24 h transdermálna náplasť |
emp tdm 28x8 mg/24 hodín |
SWP |
IE |
37.332999999999998 |
112.14 |
112.14 |
I |
0 |
0 |
0 |
NEU |
|
|
|
U43 |
N04BD01 |
|
|
|
Selegilín |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.19 |
|
|
|
14115 |
|
|
G |
SELEGIL 5 MG |
tbl 30x5 mg |
MCK |
DE |
30 |
6.55 |
5.7 |
S |
0.85 |
0.129771 |
0.62 |
GER, NEU, PSY |
|
|
|
|
N04BD01 |
|
|
|
Selegilín |
p.o. 5 mg (50 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.19 |
|
|
|
14116 |
|
|
G |
SELEGIL 5 MG |
tbl 50x5 mg |
MCK |
DE |
50 |
10.54 |
9.5 |
S |
1.04 |
9.867200000000001E-2 |
1.04 |
GER, NEU, PSY |
|
|
|
|
N04BD02 |
|
|
|
Rasagilín |
p.o. 1 mg (28 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
3.14 |
|
|
|
90126 |
|
|
O |
Azilect |
tbl. 28x1mg |
TEV |
NL |
28 |
90.37 |
87.92 |
S |
2.4500000000000002 |
2.7111E-2 |
2.4500000000000002 |
NEU |
|
|
|
|
N04BX01 |
|
|
|
Tolkapon |
p.o. 100 mg (100 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.274 |
|
|
|
56174 |
|
|
O |
TASMAR 100 mg |
tbl flm 100x100 mg (fľa.skl.) |
MPH-S |
SE |
33.332999999999998 |
112.14 |
109.13 |
S |
3.01 |
2.6841E-2 |
3.01 |
NEU, PSY |
ind.obm. |
|
|
|
N04BX02 |
|
|
|
Entakapon |
p.o. 200 mg (60 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
2.19 |
|
|
|
28632 |
|
|
O |
COMTAN 200 mg |
tbl flm 60x200 mg |
XNW |
DE |
20 |
44.49 |
43.8 |
S |
0.69 |
1.5509E-2 |
0.69 |
NEU, PSY |
|
|
|
|
N05AA01 |
|
|
|
Chlórpromazín |
parent. 5 mg/ml |
0.1 |
g |
|
|
|
|
|
|
|
|
2.0099999999999998 |
|
|
|
00560 |
|
|
G |
PLEGOMAZIN |
inj 10x5 ml 25 mg |
EGI |
HU |
2.5 |
5.03 |
5.03 |
A |
0 |
0 |
0 |
|
|
|
|
|
N05AA02 |
|
|
|
Levomepromazín |
p.o. 25 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.65200000000000002 |
|
|
|
02429 |
X |
|
G |
TISERCIN |
tbl flm 50x25 mg |
EGI |
HU |
4.1660000000000004 |
2.72 |
2.72 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AB02 |
|
|
|
Flufenazín |
parent. 25 mg/ml |
1 |
mg |
|
|
|
|
|
|
|
|
0.13 |
|
|
|
03514 |
|
|
O |
AFLUDITEN 25 mg/ml |
sol inj 5x1 ml/25 mg |
BTA |
SK |
125 |
15.96 |
15.96 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AD01 |
|
|
|
Haloperidol |
p.o. 1,5 mg (50 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.20499999999999999 |
|
|
|
02537 |
X |
|
O |
HALOPERIDOL-RICHTER 1,5 MG |
tbl 50x1,5 mg |
GDN |
HU |
9.375 |
1.92 |
1.92 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AD01 |
|
|
|
Haloperidol |
p.o. 2 mg/ml |
8 |
mg |
|
|
|
|
|
|
|
|
0.4481 |
|
|
|
02539 |
X |
|
O |
HALOPERIDOL-RICHTER |
gtt por 1x10 ml/20 mg |
GDN |
HU |
2.504 |
1.76 |
1.1200000000000001 |
S |
0.64 |
0.36363599999999996 |
0.64 |
|
|
|
|
|
N05AD01 |
|
|
|
Haloperidol |
parent. depot. 50 mg/ml |
3.3 |
mg |
|
|
|
|
|
|
|
|
0.14000000000000001 |
|
|
|
12061 |
|
|
O |
HALOPERIDOL DECANOAT-RICHTER |
sol inj 5x1 ml/50 mg |
GDN |
HU |
75.757999999999996 |
10.26 |
10.26 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AD01 |
|
|
|
Haloperidol |
parent. nedepot. 5 mg/ml |
8 |
mg |
|
|
|
|
|
|
|
|
0.9 |
|
|
|
02538 |
|
|
O |
HALOPERIDOL-RICHTER |
inj 5x1 ml/5 mg |
GDN |
HU |
3.125 |
2.8 |
2.8 |
A |
0 |
0 |
0 |
|
|
|
|
|
N05AE03 |
|
|
|
Sertindol |
p.o. 4 mg (30 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
3.1840000000000002 |
|
|
|
13039 |
X |
|
O |
SERDOLECT 4 mg |
tbl flm 30x4 mg |
LUN |
DK |
7.5 |
24.91 |
23.88 |
S |
1.03 |
4.1348999999999997E-2 |
1.03 |
PSY |
ind.obm. |
|
|
|
N05AE03 |
|
|
|
Sertindol |
p.o. 12 mg (28 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
3.29 |
|
|
|
13052 |
X |
|
O |
SERDOLECT 12 mg |
tbl flm 28x12 mg |
LUN |
DK |
21 |
69.069999999999993 |
69.069999999999993 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE03 |
|
|
|
Sertindol |
p.o. 16 mg (28 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
3.18 |
|
|
|
13059 |
X |
|
O |
SERDOLECT 16 mg |
tbl flm 28x16 mg |
LUN |
DK |
28 |
90.38 |
89.04 |
S |
1.34 |
1.4825999999999999E-2 |
1.34 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 40 mg (30 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.91 |
|
|
|
12406 |
X |
|
G |
Ziprasidon Mylan 40 mg |
cps 30 x 40 mg (blis.OPA/Al/PVC) |
GNS |
UK |
15 |
28.5 |
28.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
81935 |
X |
|
G |
Zipwell 40 mg |
cps dur 30x40 mg |
ACT |
IS |
15 |
28.5 |
28.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
52515 |
X |
|
G |
Zypsilan |
cps dur 30x40 mg |
KRK |
SI |
15 |
28.5 |
28.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 40 mg (56-60 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.91 |
|
|
|
52518 |
X |
|
G |
Zypsilan 40mg |
cps dur 60x40mg |
KRK |
SI |
30 |
57 |
57 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
33898 |
X |
|
O |
ZELDOX 40 mg |
cps dur 56x40 mg (blis.) |
PFI-GB-3 |
GB |
28 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 60 mg (30 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.69 |
|
|
|
12339 |
X |
|
G |
Ziprasidon Mylan 60 mg |
cps 30 x 60 mg (blis.OPA/Al/PVC) |
GNS |
UK |
22.5 |
38.020000000000003 |
38.020000000000003 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
82130 |
X |
|
G |
Zipwell 60 mg |
cps dur 30x60 mg |
ACT |
IS |
22.5 |
38.020000000000003 |
38.020000000000003 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
52524 |
X |
|
G |
Zypsilan |
cps dur 30x60 mg |
KRK |
SI |
22.5 |
38.020000000000003 |
38.020000000000003 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 60 mg (56-60 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.69 |
|
|
|
33906 |
X |
|
O |
ZELDOX 60 mg |
cps dur 56x60 mg (blis.) |
PFI-GB-3 |
GB |
42 |
70.97 |
70.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
52527 |
X |
|
G |
Zypsilan 60mg |
cps dur 60x60mg |
KRK |
SI |
45 |
76.06 |
76.05 |
S |
0.01 |
1.3100000000000001E-4 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 80 mg (30 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.57 |
|
|
|
12392 |
X |
|
G |
Ziprasidon Mylan 80 mg |
cps 30 x 80 mg (blis.OPA/Al/PVC |
GNS |
UK |
30 |
47.05 |
47.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
82158 |
X |
|
G |
Zipwell 80 mg |
cps dur 30x80 mg |
ACT |
IS |
30 |
47.05 |
47.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
52533 |
X |
|
G |
Zypsilan |
cps dur 30x80 mg |
KRK |
SI |
30 |
47.05 |
47.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 80 mg (56-60 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.57 |
|
|
|
33914 |
X |
|
O |
ZELDOX 80 mg |
cps dur 56x80 mg (blis.) |
PFI-GB-3 |
GB |
56 |
87.83 |
87.83 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AF01 |
|
|
|
Flupentixol |
parent. 20 mg/ml |
4 |
mg |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
31298 |
|
|
O |
FLUANXOL DEPOT |
inj 10x1 ml |
LUN |
DK |
50 |
16.3 |
16.3 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AF03 |
|
|
|
Chlórprotixén |
p.o. 15 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.17 |
|
|
|
75433 |
X |
|
G |
CHLORPROTHIXEN 15 LÉČIVA |
tbl obd 30x15 mg |
ZNT |
CZ |
1.5 |
1.75 |
1.75 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AF03 |
|
|
|
Chlórprotixén |
p.o. 50 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.7 |
|
|
|
75428 |
X |
|
G |
CHLORPROTHIXEN 50 LÉČIVA |
tbl obd 30x50 mg |
ZNT |
CZ |
5 |
3.49 |
3.49 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AF05 |
|
|
|
Zuklopentixol |
p.o. 10 mg (50 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.3 |
|
|
|
88480 |
X |
|
O |
CISORDINOL 10 mg |
tbl flm 50x10 mg |
LUN |
DK |
16.667000000000002 |
4.9800000000000004 |
4.9800000000000004 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AF05 |
|
|
|
Zuklopentixol |
parent. 200 mg/ml depot. |
15 |
mg |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
86901 |
|
|
O |
CISORDINOL DEPOT 200 mg |
sol inj 10x1 ml/200 mg |
LUN |
DK |
133.333 |
28.29 |
28.29 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AH02 |
|
|
|
Klozapín |
p.o. 25 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.5 |
|
|
|
03617 |
X |
|
O |
LEPONEX |
tbl 50x25 mg |
NHW |
GB |
4.1669999999999998 |
6.25 |
6.25 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH02 |
|
|
|
Klozapín |
p.o. 100 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
02970 |
X |
|
O |
LEPONEX |
tbl 50x100 mg |
NHW |
GB |
16.667999999999999 |
16.440000000000001 |
16.440000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Monohydrát olanzapín pamoátu |
parent. 150 mg/ml (1,4ml) |
10 |
mg |
|
|
|
|
|
|
|
|
7.0149999999999997 |
|
|
|
64306 |
|
|
O |
ZYPADHERA 210 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním |
plu igf 1 x 210 mg (inj.liek.) +solv.(inj.liek.) |
LIL |
FR |
21 |
147.30000000000001 |
147.30000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Monohydrát olanzapín pamoátu |
parent. 150 mg/ml ( 2,0 ml) |
10 |
mg |
|
|
|
|
|
|
|
|
7.14 |
|
|
|
64307 |
|
|
O |
ZYPADHERA 300 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním |
plu igf 1 x 300 mg (inj.liek.) +solv.(inj.liek.) |
LIL |
FR |
30 |
214.05 |
214.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Monohydrát olanzapín pamoátu |
parent. 150 mg/ml (2,7 ml) |
10 |
mg |
|
|
|
|
|
|
|
|
7.05 |
|
|
|
64308 |
|
|
O |
ZYPADHERA 405 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním |
plu igf 1 x 405 mg (inj.liek.) +solv.(inj.liek.) |
LIL |
FR |
40.5 |
285.51 |
285.51 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 5 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.18 |
|
|
|
05158 |
X |
|
G |
Olanzapin Actavis 5 mg filmom obalené tablety |
tbl flm 28x5 mg (blis.Al/Al) |
ACT-5 |
IS |
14 |
2.4700000000000002 |
2.4700000000000002 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
85084 |
X |
|
O |
Olazax |
tbl 28x5 mg (blis. Al/Al) |
GLM |
CZ |
14 |
2.4700000000000002 |
2.4700000000000002 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
0438A |
X |
|
G |
Olanzapine Accord 5 mg filmom obalené tablety |
tbl flm 28x5 mg (bli.Al/Al) |
ACC |
GB |
14 |
2.52 |
2.52 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
89075 |
X |
|
G |
OLPINAT 5 mg |
tbl flm 28x5mg |
VIH |
PL |
14 |
9.26 |
2.52 |
S |
6.74 |
0.7278619999999999 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 5 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.18 |
|
|
|
88717 |
X |
|
G |
Nykob 5 mg filmom obalené tablety |
tbl flm 56x5 mg (blis. PA/Al/PVC/Al) |
SVS |
CZ |
28 |
4.9400000000000004 |
4.9400000000000004 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
05161 |
X |
|
G |
Olanzapin Actavis 5 mg filmom obalené tablety |
tbl flm 56x5 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
5.04 |
5.04 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
89076 |
X |
|
G |
OLPINAT 5 MG |
tbl flm 56(8x7)x5 mg (blis.OPA/Al/PVC/Al) |
VIH |
PL |
28 |
6.04 |
5.04 |
S |
1 |
0.16556300000000002 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13400000000000001 |
|
|
|
88682 |
X |
|
G |
Nykob 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis. PA/Al/PVC/Al) |
SVS |
CZ |
28 |
3.75 |
3.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
05172 |
X |
|
G |
Olanzapin Actavis 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
3.75 |
3.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
0454A |
X |
|
O |
Olanzapine Accord 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.Al/Al) |
ACC |
GB |
28 |
3.75 |
3.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
85086 |
X |
|
O |
Olazax |
tbl 28x10 mg (blis.Al/Al) |
GLM |
CZ |
28 |
3.75 |
3.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
89077 |
X |
|
G |
OLPINAT 10 mg |
tbl flm 28x10mg |
VIH |
PL |
28 |
5.98 |
3.75 |
S |
2.23 |
0.37290999999999996 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 10 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13400000000000001 |
|
|
|
88684 |
X |
|
G |
Nykob 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis. PA/Al/PVC/Al) |
SVS |
CZ |
56 |
7.5 |
7.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
05175 |
X |
|
G |
Olanzapin Actavis 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.Al/Al) |
ACT-5 |
IS |
56 |
7.5 |
7.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
89078 |
X |
|
G |
OLPINAT 10 MG |
tbl flm 56(8x7)x10 mg (blis.OPA/Al/PVC/Al) |
VIH |
PL |
56 |
8.5 |
7.5 |
S |
1 |
0.117647 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 15 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.96 |
|
|
|
05182 |
X |
|
G |
Olanzapin Actavis 15 mg filmom obalené tablety |
tbl flm 56x15 mg (blis.Al/Al) |
ACT-5 |
IS |
84 |
79.959999999999994 |
79.959999999999994 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 5 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
89247 |
X |
|
G |
Bloonis 5 mg |
tbl oro 28x5 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
14 |
3.07 |
3.07 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
53188 |
X |
|
G |
Olanzapin Actavis 5 mg |
tbl oro 28x5 mg(blister s odlep.fól) |
ACT |
IS |
14 |
3.07 |
3.07 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
0240A |
X |
|
G |
Olanzapin Mylan 5 mg orodispergovateľné tablety |
tbl oro 28 x 5 mg (blis. OPA/Al/PVC/Al) |
GNS |
GB |
14 |
3.07 |
3.07 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 5 mg (50-56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
89249 |
X |
|
G |
Bloonis 5 mg |
tbl oro 56x5 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
28 |
6.14 |
6.14 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
53193 |
X |
|
G |
Olanzapin Actavis 5 mg |
tbl oro 56x5 mg (blister s odlep.fól.) |
ACT-5 |
IS |
28 |
6.14 |
6.14 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 5 mg (70 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
45753 |
X |
|
G |
Zalasta 5 mg |
tbl oro 70x5 mg |
KRK |
SI |
35 |
7.68 |
7.68 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13300000000000001 |
|
|
|
53216 |
X |
|
G |
Olanzapin Actavis 10 mg |
tbl oro 28x10 mg(blister s odlep.fól) |
ACT |
IS |
28 |
3.72 |
3.72 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
0276A |
X |
|
G |
Olanzapin Mylan 10 mg orodispergovateľné tablety |
tbl oro 28 x 10 mg (blis. OPA/Al/PVC/Al) |
GNS |
GB |
28 |
3.72 |
3.72 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
89295 |
X |
|
G |
Bloonis 10 mg |
tbl oro 28x10 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
28 |
5.62 |
3.72 |
S |
1.9 |
0.33807799999999999 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 10 mg (50-56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13300000000000001 |
|
|
|
89297 |
X |
|
G |
Bloonis 10 mg |
tbl oro 56x10 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
56 |
7.44 |
7.44 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
53219 |
X |
|
G |
Olanzapin Actavis 10 mg |
tbl oro 56x10 mg (blister s odlep.fól.) |
ACT-5 |
IS |
56 |
7.44 |
7.44 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 10 mg (70 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13300000000000001 |
|
|
|
45763 |
X |
|
G |
Zalasta 10 mg |
tbl oro 70x10 mg |
KRK |
SI |
70 |
9.3000000000000007 |
9.3000000000000007 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 15 mg (70 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.32 |
|
|
|
45768 |
X |
|
G |
Zalasta 15 mg |
tbl oro 70x15 mg |
KRK |
SI |
105 |
29.01 |
29.01 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 20 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.63200000000000001 |
|
|
|
89309 |
X |
|
G |
Bloonis 20 mg |
tbl oro 28x20 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
56 |
35.35 |
35.35 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 20 mg (56ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.63200000000000001 |
|
|
|
89311 |
X |
|
G |
Bloonis 20 mg |
tbl oro 56x20 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
112 |
70.7 |
70.7 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 20 mg (70 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.63200000000000001 |
|
|
|
45773 |
X |
|
G |
Zalasta 20 mg |
tbl oro 70x20 mg |
KRK |
SI |
140 |
88.38 |
88.38 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 25 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
59968 |
X |
|
G |
Equeta 25 mg |
tbl flm 30X25 mg |
PRW |
CZ |
1.875 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
46013 |
X |
|
G |
Questax 25 mg |
tbl flm 30x25 mg |
SVS |
CZ |
1.875 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
03867 |
X |
|
G |
Quetiapin Saneca 25 mg |
tbl flm 30x25 mg (blis.PVC/PVDC/Al) |
SNC |
SK |
1.875 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
07813 |
X |
|
G |
Quetiapine Accord 25 mg filmom obalené tablety |
tbl flm 30x25 mg (blis.PVC/Al) |
ACC |
GB |
1.875 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
43962 |
X |
|
G |
KVENTIAX |
tbl flm 30x25 mg |
KRK |
SI |
1.875 |
2.33 |
1.97 |
S |
0.36 |
0.154506 |
0 |
PSY |
ind.obm. |
|
|
|
66651 |
X |
|
G |
Derin 25 mg filmom obalené tablety |
tbl flm 30 (10x3)x25 mg |
VIH |
PL |
1.875 |
3.23 |
1.97 |
S |
1.26 |
0.39009300000000002 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 100 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.38100000000000001 |
|
|
|
46051 |
X |
|
G |
Questax 100 mg |
tbl flm 30x100 mg |
SVS |
CZ |
7.5 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
|
54111 |
X |
|
G |
Quetiapin Teva 100 mg filmom obalené tablety |
tbl flm 30x100 mg |
TEV |
GB |
7.5 |
2.99 |
2.86 |
S |
0.13 |
4.3478000000000003E-2 |
0 |
|
|
|
|
|
43974 |
X |
|
G |
KVENTIAX |
tbl flm 30x100 mg |
KRK |
SI |
7.5 |
4.37 |
2.86 |
S |
1.51 |
0.34553800000000001 |
0 |
|
|
|
|
|
66661 |
X |
|
G |
Derin 100 mg filmom obalené tablety |
tbl flm 30 (10x3)x100 mg |
VIH |
PL |
7.5 |
5.25 |
2.86 |
S |
2.39 |
0.45523800000000003 |
0 |
|
|
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 100 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.38100000000000001 |
|
|
|
46053 |
X |
|
G |
Questax 100 mg |
tbl flm 60x100 mg (blis.) |
SVS |
CZ |
15 |
5.71 |
5.71 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
07859 |
X |
|
G |
Quetiapine Accord 100 mg filmom obalené tablety |
tbl flm 60x100 mg |
ACC |
GB |
15 |
5.71 |
5.71 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
69175 |
X |
|
G |
Setinin 100 mg |
tbl flm 60x100 mg (blister PVC/Alu) |
ACT |
IS |
15 |
5.71 |
5.71 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
59949 |
X |
|
G |
Equeta 100 mg |
tbl flm 60X100 mg |
PRW |
CZ |
15 |
6.38 |
5.72 |
S |
0.66 |
0.103448 |
0 |
PSY |
ind.obm. |
|
|
|
03890 |
X |
|
G |
Quetiapin Saneca 100 mg |
tbl flm 60x100 mg (blis.PVC/PVDC/Al) |
SNC |
SK |
15 |
6.38 |
5.72 |
S |
0.66 |
0.103448 |
0 |
PSY |
ind.obm. |
|
|
|
43981 |
X |
|
G |
Kventiax 100 mg |
tbl flm 60x100 mg |
KRK |
SI |
15 |
7.74 |
5.72 |
S |
2.02 |
0.26098199999999999 |
0 |
PSY |
ind.obm. |
|
|
|
39908 |
X |
|
G |
Quetiapin Mylan 100 mg |
tbl flm 60x100 mg |
GNS |
GB |
15 |
8.48 |
5.72 |
S |
2.76 |
0.32547199999999998 |
0 |
PSY |
ind.obm. |
|
|
|
39410 |
X |
|
G |
Ketilept 100 mg |
tbl flm 60x100 mg (blis.) |
EGI |
HU |
15 |
14.7 |
5.72 |
S |
8.98 |
0.61088399999999998 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 150 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.53 |
|
|
|
59956 |
X |
|
G |
Equeta 150 mg |
tbl flm 60x150 mg |
PRW |
CZ |
22.5 |
11.88 |
11.88 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 200 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.37 |
|
|
|
46077 |
X |
|
G |
Questax 200 mg |
tbl flm 30x200 mg |
SVS |
CZ |
15 |
5.51 |
5.51 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 200 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.37 |
|
|
|
44012 |
X |
|
G |
KVENTIAX |
tbl flm 60x200 mg |
KRK |
SI |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
46079 |
X |
|
G |
Questax 200 mg |
tbl flm 60x200 mg (blis.) |
SVS |
CZ |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
54060 |
X |
|
G |
Quetiapin Teva 200 mg filmom obalené tablety |
tbl flm 60x200 mg |
TEV |
GB |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
07962 |
X |
|
G |
Quetiapine Accord 200 mg filmom obalené tablety |
tbl flm 60x200 mg |
ACC |
GB |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
69506 |
X |
|
G |
Setinin 200 mg |
tbl flm 60x200 mg (blister PVC/Alu) |
ACT |
IS |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
66683 |
X |
|
G |
Derin 200 mg filmom obalené tablety |
tbl flm 60 (10x6)x200 mg |
VIH |
PL |
30 |
12.04 |
11.1 |
S |
0.94 |
7.8073000000000004E-2 |
0 |
PSY |
ind.obm. |
|
|
|
39932 |
X |
|
G |
Quetiapin Mylan 200 mg |
tbl flm 60x200 mg |
GNS |
GB |
30 |
12.67 |
11.1 |
S |
1.57 |
0.12391500000000001 |
0 |
PSY |
ind.obm. |
|
|
|
03898 |
X |
|
G |
Quetiapin Saneca 200 mg |
tbl flm 60x200 mg (blis.PVC/PVDC/Al) |
SNC |
SK |
30 |
12.71 |
11.1 |
S |
1.61 |
0.12667200000000001 |
0 |
PSY |
ind.obm. |
|
|
|
39419 |
X |
|
G |
Ketilept 200mg |
tbl flm 60x200 mg (blis.) |
EGI |
HU |
30 |
12.88 |
11.1 |
S |
1.78 |
0.13819900000000002 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 300 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.46 |
|
|
|
66693 |
X |
|
G |
Derin 300 mg filmom obalené tablety |
tbl flm 60 (10x6)x300 mg |
VIH |
PL |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
39955 |
X |
|
G |
Quetiapin Mylan 300 mg |
tbl flm 60x300mg |
GNS |
GB |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
54019 |
X |
|
G |
Quetiapin Teva 300 mg filmom obalené tablety |
tbl flm 60x300 mg |
TEV |
GB |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
07976 |
X |
|
G |
Quetiapine Accord 300 mg filmom obalené tablety |
tbl flm 60x300 mg |
ACC |
GB |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
69514 |
X |
|
G |
Setinin 300 mg |
tbl flm 60x300 mg (blister PVC/Alu) |
ACT |
IS |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
44043 |
X |
|
G |
KVENTIAX |
tbl flm 60x300 mg |
KRK |
SI |
45 |
20.6 |
20.6 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
03922 |
X |
|
G |
Quetiapin Saneca 300 mg |
tbl flm 60x300 mg (blis.PVC/PVDC/Al) |
SNC |
SK |
45 |
20.6 |
20.6 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
39423 |
X |
|
G |
Ketilept 300 mg |
tbl flm 60x300 mg (blis.) |
EGI |
HU |
45 |
21.48 |
20.7 |
S |
0.78 |
3.6312999999999998E-2 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. predĺžené uvoľňovanie 50 mg (30 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
0.98499999999999999 |
|
|
|
43537 |
X |
|
O |
Seroquel XR 50 mg |
tbl flp 30 x 50 mg |
AZC |
GB |
3.75 |
21.15 |
3.69 |
S |
17.46 |
0.82553200000000004 |
5.15 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. predĺžené uvoľňovanie 50 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
0.98499999999999999 |
|
|
|
2791B |
X |
|
G |
Ketilept Prolong 50mg tablety s predĺženým uvoľňovaním |
tbl plg 60x50mg (bils.PVC/PCTFE/Al) |
EGI |
HU |
7.5 |
17.68 |
7.39 |
S |
10.29 |
0.58201400000000003 |
10.29 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. predĺžené uvoľňovanie 200 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
1.734 |
|
|
|
3023B |
X |
|
G |
Kventiax SR 200 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x200mg(blis. OPA/Al/PVC/Al) |
KRK |
SL |
30 |
52 |
52 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
30411 |
X |
|
G |
Quetiapine Accord 200 mg filmom obalené tablety s predĺženým uvoľňovaním |
tbl plg 60x200 mg (blis.PVC/PVDC/Al) |
ACC |
GB |
30 |
52 |
52 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
43540 |
X |
|
O |
Seroquel XR 200 mg |
tbl flp 60 x 200 mg |
AZC |
GB |
30 |
52.52 |
52.02 |
S |
0.5 |
9.5199999999999989E-3 |
0 |
PSY |
ind.obm. |
|
|
|
2801B |
X |
|
G |
Ketilept Prolong 200mg tablety s predĺženým uvoľňovaním |
tbl plg 60x200mg (bils.PVC/PCTFE/Al) |
EGI |
HU |
30 |
57.98 |
52.02 |
S |
5.96 |
0.10279400000000001 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. predĺžené uvoľňovanie 300 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
1.464 |
|
|
|
3029B |
X |
|
G |
Kventiax SR 300 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x300mg(blis. OPA/Al/PVC/Al) |
KRK |
SL |
45 |
65.849999999999994 |
65.849999999999994 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
30416 |
X |
|
G |
Quetiapine Accord 300 mg filmom obalené tablety s predĺženým uvoľňovaním |
tbl plg 60x300 mg (blis.PVC/PVDC/Al) |
ACC |
GB |
45 |
65.849999999999994 |
65.849999999999994 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
2806B |
X |
|
G |
Ketilept Prolong 300mg tablety s predĺženým uvoľňovaním |
tbl plg 60x300mg (bils.PVC/PCTFE/Al) |
EGI |
HU |
45 |
65.98 |
65.88 |
S |
0.1 |
1.5160000000000002E-3 |
0 |
PSY |
ind.obm. |
|
|
|
43542 |
X |
|
O |
Seroquel XR 300 mg |
tbl flp 60 x 300 mg |
AZC |
GB |
45 |
72.67 |
65.88 |
S |
6.79 |
9.3436000000000005E-2 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH05 |
|
|
|
Azenapín |
sublng. 5 mg (60 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.3010000000000002 |
|
|
|
22840 |
|
|
O |
Sycrest |
tbl slg 60x5 mg |
ORG |
NL |
30 |
101.04 |
99.03 |
S |
2.0099999999999998 |
1.9893000000000001E-2 |
2.0099999999999998 |
PSY |
ind.obm. |
|
|
|
N05AH05 |
|
|
|
Azenapín |
sublng. 10 mg (60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.294 |
|
|
|
22843 |
|
|
O |
Sycrest |
tbl slg 60x10 mg |
ORG |
NL |
30 |
100.84 |
98.82 |
S |
2.02 |
2.0032000000000001E-2 |
2.02 |
PSY |
ind.obm. |
|
|
|
N05AL01 |
|
|
|
Sulpirid |
p.o. 50 mg (30 ks) |
0.8 |
g |
|
|
|
|
|
|
|
|
1.5966 |
|
|
|
15274 |
X |
|
G |
SULPIRID BELUPO 50 mg |
cps 30x50 mg /blis./ |
BLU |
HR |
1.8740000000000001 |
3.17 |
2.99 |
S |
0.18 |
5.6782000000000006E-2 |
0.18 |
PSY |
|
|
|
|
N05AL01 |
|
|
|
Sulpirid |
p.o. 200 mg (24 ks) |
0.8 |
g |
|
|
|
|
|
|
|
|
1.0921000000000001 |
|
|
|
33145 |
X |
|
G |
SULPIRID BELUPO 200 mg |
cps 24x200 mg/pl.l./ |
BLU |
HR |
6 |
6.7 |
6.55 |
S |
0.15 |
2.2387999999999998E-2 |
0.15 |
PSY |
|
|
|
|
N05AL03 |
|
|
|
Tiaprid |
p.o. 100 mg (20 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.434 |
|
|
|
91116 |
X |
|
O |
TIAPRIDAL tbl |
tbl 20x100 mg |
SSJ |
FR |
5 |
2.4900000000000002 |
2.17 |
S |
0.32 |
0.12851399999999999 |
0.23 |
|
|
|
|
|
N05AL03 |
|
|
|
Tiaprid |
p.o. 100 mg (50 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.434 |
|
|
|
44133 |
X |
|
O |
TIAPRIDAL tbl |
tbl 50x100 mg |
SSJ |
FR |
12.503 |
6.01 |
5.43 |
S |
0.57999999999999996 |
9.6506000000000008E-2 |
0.57999999999999996 |
|
|
|
|
|
N05AL03 |
|
|
|
Tiaprid |
p.o. 137,9 mg/ml |
0.4 |
g |
|
|
|
|
|
|
|
|
1.1051 |
|
|
|
13265 |
X |
|
O |
TIAPRIDAL |
gtt por 1x30 ml |
SYB |
FR |
10.5 |
12.84 |
11.6 |
S |
1.24 |
9.6572999999999992E-2 |
1.24 |
|
|
|
|
|
N05AL03 |
|
|
|
Tiaprid |
parent. 50 mg/ml |
0.4 |
g |
|
|
|
|
|
|
|
|
0.79 |
|
|
|
91117 |
|
|
O |
TIAPRIDAL |
inj 12x2 ml/100 mg |
LSY |
FR |
3 |
2.34 |
2.34 |
A |
0 |
0 |
0 |
GER, INT, KLF, NEU, PSY |
|
|
|
|
N05AL05 |
|
|
|
Amisulprid |
p.o. 100 mg (30 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
1.339 |
|
|
|
64875 |
X |
|
G |
SOLIAN 100MG |
tbl 30x100 mg |
SSJ |
RO |
7.5 |
10.039999999999999 |
10.039999999999999 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AL05 |
|
|
|
Amisulprid |
p.o. 200 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
0.96 |
|
|
|
4778B |
X |
|
G |
AKTIPROL 200 mg |
tbl 60x200 mg |
MOE |
CY |
30 |
28.78 |
28.78 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
79388 |
X |
|
G |
Amisulprid Mylan 200 mg |
tbl 60 x 200 mg |
GNC |
GB |
30 |
28.78 |
28.78 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
14655 |
X |
|
G |
SOLIAN 200MG |
tbl 60x200 mg |
SSJ |
FR |
30 |
38.340000000000003 |
28.8 |
S |
9.5399999999999991 |
0.24882599999999999 |
0 |
PSY |
ind.obm. |
|
|
|
N05AL05 |
|
|
|
Amisulprid |
p.o. 400 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
1.1000000000000001 |
|
|
|
4784B |
X |
|
G |
AKTIPROL 400 mg |
tbl 60x400 mg |
MOE |
CY |
60 |
42.86 |
42.86 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
14657 |
X |
|
O |
SOLIAN 400MG |
tbl 60x400 mg |
SSJ |
FR |
60 |
65.95 |
65.95 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AN01 |
|
|
|
Lítium |
p.o. 300 mg (100 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.28560000000000002 |
|
|
|
02481 |
X |
|
G |
LITHIUM CARBONICUM SLOVAKOFARMA |
tbl 100x300 mg |
ZNT |
SK |
30 |
8.4499999999999993 |
8.4499999999999993 |
I |
0 |
0 |
0 |
END, PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 1 mg (20 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.36099999999999999 |
|
|
|
2719B |
X |
|
G |
Risperidon Farmax 1 mg filmom obalené tablety |
tbl flm 20x1 mg (blis.PVC/LDPE/PVDC/A) |
SVS |
CZ |
4 |
1.99 |
1.44 |
S |
0.55000000000000004 |
0.27638200000000002 |
0.22 |
NEU, PSY |
|
|
|
|
44699 |
X |
|
G |
Risepro 1 mg |
tbl flm 20x1mg |
PRW |
CZ |
4 |
2.0099999999999998 |
1.44 |
S |
0.56999999999999995 |
0.283582 |
0.22 |
NEU, PSY |
|
|
|
|
39264 |
X |
|
G |
MEDORISPER 1 mg |
tbl flm 20x1 mg |
SPC-2 |
GR |
4 |
2.2200000000000002 |
1.44 |
S |
0.78 |
0.35135100000000002 |
0.22 |
NEU, PSY |
|
|
|
|
34740 |
X |
|
G |
RISPEN 1 |
tbl flm 20X1MG |
ZNT |
CZ |
4 |
2.33 |
1.44 |
S |
0.89 |
0.38197400000000004 |
0.22 |
NEU, PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 1 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.36099999999999999 |
|
|
|
44701 |
X |
|
G |
Risepro 1 mg |
tbl flm 60x1 mg |
PRW |
CZ |
12 |
4.9800000000000004 |
4.33 |
S |
0.65 |
0.130522 |
0.65 |
NEU, PSY |
|
|
|
|
2720B |
X |
|
G |
Risperidon Farmax 1 mg filmom obalené tablety |
tbl flm 60x1 mg (blis.PVC/LDPE/PVDC/A) |
SVS |
CZ |
12 |
4.9800000000000004 |
4.33 |
S |
0.65 |
0.130522 |
0.65 |
NEU, PSY |
|
|
|
|
39266 |
X |
|
G |
MEDORISPER 1 mg |
tbl flm 50x1 mg |
SPC-2 |
GR |
10 |
4.2 |
3.61 |
S |
0.59 |
0.14047599999999999 |
0.54 |
NEU, PSY |
|
|
|
|
34742 |
X |
|
G |
RISPEN 1 |
tbl flm 50X1MG |
ZNT |
CZ |
10 |
4.2699999999999996 |
3.61 |
S |
0.66 |
0.15456700000000001 |
0.54 |
NEU, PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 2 mg (20 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.24199999999999999 |
|
|
|
34743 |
X |
|
G |
RISPEN 2 |
tbl flm 20X2MG |
ZNT |
CZ |
8 |
2.44 |
1.94 |
S |
0.5 |
0.20491800000000002 |
0 |
PSY |
|
|
|
|
2713B |
X |
|
G |
Risperidon Farmax 2 mg filmom obalené tablety |
tbl flm 20x2 mg (blis.PVC/LDPE/PVDC/A) |
SVS |
CZ |
8 |
2.44 |
1.94 |
S |
0.5 |
0.20491800000000002 |
0 |
PSY |
|
|
|
|
44707 |
X |
|
G |
Risepro 2 mg |
tbl flm 20x2mg |
PRW |
CZ |
8 |
2.73 |
1.94 |
S |
0.79 |
0.289377 |
0 |
PSY |
|
|
|
|
39272 |
X |
|
G |
MEDORISPER 2 mg |
tbl flm 20x2 mg |
SPC-2 |
GR |
8 |
2.94 |
1.94 |
S |
1 |
0.34013599999999999 |
0 |
PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 2 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.24199999999999999 |
|
|
|
34745 |
X |
|
G |
RISPEN 2 |
tbl flm 50X2MG |
ZNT |
CZ |
20 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
44708 |
X |
|
G |
Risepro 2 mg |
tbl flm 60x2 mg |
PRW |
CZ |
24 |
5.8 |
5.8 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
81563 |
X |
|
G |
Risperidon Orion 2 mg |
tbl flm 60(6x10)x2 mg (blis.PVC/LDPE/PVDC/Al) |
ORN |
FI |
24 |
5.8 |
5.8 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
2714B |
X |
|
G |
Risperidon Farmax 2 mg filmom obalené tablety |
tbl flm 60x2 mg (blis.PVC/LDPE/PVDC/A) |
SVS |
CZ |
24 |
6.51 |
5.81 |
S |
0.7 |
0.10752700000000001 |
0 |
PSY |
|
|
|
|
39274 |
X |
|
G |
MEDORISPER 2 mg |
tbl flm 50x2 mg |
SPC-2 |
GR |
20 |
5.84 |
4.84 |
S |
1 |
0.171233 |
0 |
PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 3 mg (20 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.26200000000000001 |
|
|
|
2715B |
X |
|
G |
Risperidon Farmax 3 mg filmom obalené tablety |
tbl flm 20x3 mg (blis.PVC/LDPE/PVDC/A) |
SVS |
CZ |
12 |
5.89 |
3.14 |
S |
2.75 |
0.466893 |
0 |
PSY |
|
|
|
|
44713 |
X |
|
G |
Risepro 3 mg |
tbl flm 20x3 mg |
PRW |
CZ |
12 |
6.01 |
3.14 |
S |
2.87 |
0.47753700000000004 |
0 |
PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 3 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.26200000000000001 |
|
|
|
2716B |
X |
|
G |
Risperidon Farmax 3 mg filmom obalené tablety |
tbl flm 60x3 mg (blis.PVC/LDPE/PVDC/A) |
SVS |
CZ |
36 |
9.43 |
9.43 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
81564 |
X |
|
G |
Risperidon Orion 3 mg |
tbl flm 60(6x10)x3 mg (blis.PVC/LDPE/PVDC/Al) |
ORN |
FI |
36 |
9.43 |
9.43 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
34748 |
X |
|
G |
RISPEN 3 |
tbl flm 50X3MG |
ZNT |
CZ |
30 |
8.1 |
7.86 |
S |
0.24 |
2.963E-2 |
0 |
PSY |
|
|
|
|
44714 |
X |
|
G |
Risepro 3 mg |
tbl flm 60x3 mg |
PRW |
CZ |
36 |
9.93 |
9.43 |
S |
0.5 |
5.0351999999999994E-2 |
0 |
PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 4 mg (20 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.44479999999999997 |
|
|
|
44719 |
X |
|
G |
Risepro 4 mg |
tbl flm 20x4 mg |
PRW |
CZ |
16 |
7.74 |
7.12 |
S |
0.62 |
8.0103000000000008E-2 |
0.55000000000000004 |
PSY |
|
|
|
|
34749 |
X |
|
G |
RISPEN 4 |
tbl flm 20X4MG |
ZNT |
CZ |
16 |
7.74 |
7.12 |
S |
0.62 |
8.0103000000000008E-2 |
0.55000000000000004 |
PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 4 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.44479999999999997 |
|
|
|
44721 |
X |
|
G |
Risepro 4 mg |
tbl flm 60x4 mg |
PRW |
CZ |
48 |
23.01 |
21.35 |
S |
1.66 |
7.2142999999999999E-2 |
1.66 |
PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o.1 mg/ml (60 ml) |
5 |
mg |
|
|
|
|
|
|
|
|
3.1829999999999998 |
|
|
|
50853 |
X |
|
G |
RISPERIDON ORION 1 mg/ml perorálny roztok |
sol por 1x60 ml |
ORN |
FI |
12 |
38.19 |
38.19 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX08 |
|
|
|
Risperidón |
parent.12,5 mg/ml depot. |
2.7 |
mg |
|
|
|
|
|
|
|
|
9.0399999999999991 |
|
|
|
97605 |
|
|
O |
RISPERDAL CONSTA 25 mg |
plv iul 1x25 mg + solv.+ Alaris SmartSite systém |
JAN |
BE |
9.2590000000000003 |
83.67 |
83.67 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX08 |
|
|
|
Risperidón |
parent. 18,75 mg/ml depot. |
2.7 |
mg |
|
|
|
|
|
|
|
|
8.452 |
|
|
|
97606 |
|
|
O |
RISPERDAL CONSTA 37,5 mg |
plv iul 1x37,5 mg + solv.+ Alaris SmartSite systém |
JAN |
BE |
13.888999999999999 |
117.39 |
117.39 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX08 |
|
|
|
Risperidón |
parent. 25 mg/ml depot. |
2.7 |
mg |
|
|
|
|
|
|
|
|
7.8730000000000002 |
|
|
|
97607 |
|
|
O |
RISPERDAL CONSTA 50 mg |
plv iul 1x50 mg + solv.+ Alaris SmartSite systém |
JAN |
BE |
18.518999999999998 |
145.80000000000001 |
145.80000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX11 |
|
|
|
Zotepín |
p.o. 25 mg (30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
2.62 |
|
|
|
28784 |
X |
|
G |
ZOLEPTIL 25 MG (BLIST.) |
tbl obd 30x25 mg |
ACT-CZ |
CZ |
5 |
13.57 |
13.1 |
S |
0.47 |
3.4634999999999999E-2 |
0.47 |
PSY |
ind.obm. |
|
|
|
N05AX11 |
|
|
|
Zotepín |
p.o. 50 mg (30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
2.282 |
|
|
|
28788 |
X |
|
G |
ZOLEPTIL 50 MG (BLIST.) |
tbl obd 30x50 mg |
ACT-CZ |
CZ |
10 |
23.69 |
22.82 |
S |
0.87 |
3.6724E-2 |
0.87 |
PSY |
ind.obm. |
|
|
|
N05AX11 |
|
|
|
Zotepín |
p.o. 100 mg (30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
2.1459999999999999 |
|
|
|
28792 |
X |
|
G |
ZOLEPTIL 100 MG (BLIST.) |
tbl obd 30x100 mg |
ACT-CZ |
CZ |
20 |
44.46 |
42.92 |
S |
1.54 |
3.4638000000000002E-2 |
1.54 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. 10 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
4.5730000000000004 |
|
|
|
3494B |
|
|
G |
Arisppa 10mg tablety |
tbl 30x10mg (blis.OPA/Al/PVC/Al) |
FCC-NL |
NL |
20 |
93.59 |
91.46 |
S |
2.13 |
2.2759000000000001E-2 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. 15 mg (28-30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
2.0819999999999999 |
|
|
|
4535B |
X |
|
G |
Aripiprazol Glenmark 15 mg tablety |
tbl 28x1x15 mg (blis. OPA/Al/PVC/Al-perfor.) |
GLM-CZ |
CZ |
28 |
58.29 |
58.29 |
I |
0 |
0 |
0 |
PSY |
ind. obm. |
|
|
|
4863B |
X |
|
G |
Aripiprazole Zentiva 15 mg tablety |
tbl 28x15 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
28 |
58.29 |
58.29 |
I |
0 |
0 |
0 |
PSY |
ind. obm. |
|
|
|
5156B |
X |
|
G |
Asduter 15 mg tablety |
tbl 28x15 mg (fľ.HDPE) |
VIH |
PL |
28 |
58.29 |
58.29 |
I |
0 |
0 |
0 |
PSY |
ind. obm. |
|
|
|
3484B |
X |
|
G |
Arisppa 15mg tablety |
tbl 30x15mg (blis. OPA/Al/PVC/Al) |
FCC-NL |
NL |
30 |
64.5 |
62.46 |
S |
2.04 |
3.1627999999999996E-2 |
0 |
PSY |
ind. obm. |
|
|
|
40783 |
X |
|
O |
ABILIFY-15 mg |
tbl 28 |
OTS |
GB |
28 |
60.44 |
58.3 |
S |
2.14 |
3.5407000000000001E-2 |
0 |
PSY |
ind. obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. 15 mg (90 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
2.0819999999999999 |
|
|
|
3489B |
X |
|
G |
Arisppa 15mg tablety |
tbl 90x15mg (blis. OPA/Al/PVC/Al) |
FCC-NL |
NL |
90 |
193.5 |
187.38 |
S |
6.12 |
3.1627999999999996E-2 |
0 |
PSY |
ind. obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. oro 10 mg (28 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
4.5730000000000004 |
|
|
|
5059B |
X |
|
G |
Explemed Rapid 10mg |
tbl oro 28x10mg (blis. OPA/Al/PVC/PET/Al) |
EGI |
HU |
18.667000000000002 |
65.7 |
65.7 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
92340 |
X |
|
O |
ABILIFY 10 mg tbl oro |
tbl oro 28 x 10 mg |
OTS |
GB |
18.667000000000002 |
88.94 |
85.36 |
S |
3.58 |
4.0251999999999996E-2 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. oro 10 mg (56 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
4.5730000000000004 |
|
|
|
5060B |
X |
|
G |
Explemed Rapid 10mg |
tbl oro 56x10mg (blis. OPA/Al/PVC/PET/Al) |
EGI |
HU |
37.334000000000003 |
131.30000000000001 |
131.30000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. oro 15 mg (28 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
3.0459999999999998 |
|
|
|
5062B |
X |
|
G |
Explemed Rapid 15mg |
tbl oro 28x15mg (blis. OPA/Al/PVC/PET/Al) |
EGI |
HU |
28 |
65.7 |
65.7 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
92343 |
X |
|
O |
ABILIFY 15 mg tbl oro |
tbl oro 28x15 mg |
OTS |
GB |
28 |
88.31 |
85.29 |
S |
3.02 |
3.4197999999999999E-2 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. oro 15 mg (56 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
3.0459999999999998 |
|
|
|
5063B |
X |
|
G |
Explemed Rapid 15mg |
tbl oro 56x15mg (blis. OPA/Al/PVC/PET/Al) |
EGI |
HU |
56 |
131.30000000000001 |
131.30000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
parent. predĺžené uvoľňovanie 400 mg |
15 |
mg |
|
|
|
|
|
|
|
|
12 |
|
|
|
8419A |
|
|
O |
Abilify Maintena 400 mg |
plu igf 1x400 mg+1x2 ml+samost.bal.(liek.inj.skl.) |
OTS-2 |
GB |
26.667000000000002 |
319.98 |
319.98 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón |
p.o. predĺžené uvoľňovanie 3 mg (28 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
6.6379999999999999 |
|
|
|
43592 |
X |
|
O |
Invega 3mg |
tbl plg 28x3 mg (bli.PCTFE/PVC/Alu) |
JNS |
BE |
14 |
96.57 |
92.93 |
S |
3.64 |
3.7692999999999997E-2 |
3.64 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón |
p.o. predĺžené uvoľňovanie 6 mg (28 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
3.52 |
|
|
|
43597 |
X |
|
O |
Invega 6mg |
tbl plg 28x6 mg (bli.PCTFE/PVC/Alu) |
JNS |
BE |
28 |
100.16 |
98.56 |
S |
1.6 |
1.5973999999999999E-2 |
1.6 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón |
p.o. predĺžené uvoľňovanie 9 mg (28 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
2.54 |
|
|
|
43602 |
X |
|
O |
Invega 9mg |
tbl plg 28x9 mg (bli.PCTFE/PVC/Alu) |
JNS |
BE |
42 |
107.91 |
106.68 |
S |
1.23 |
1.1397999999999998E-2 |
1.23 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón palmitát |
parent. predĺžené uvoľňovanie 50 mg (1 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
10.522 |
|
|
|
06231 |
|
|
O |
XEPLION 50 mg injekčná suspenzia s predĺženým uvoľňovaním |
sus ijp 1x50 mg (striek.napln.skl.+2 ihly) |
JNS |
BE |
20 |
210.43 |
210.43 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón palmitát |
parent. predĺžené uvoľňovanie 75 mg (1 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
9.07 |
|
|
|
06232 |
|
|
O |
XEPLION 75 mg injekčná suspenzia s predĺženým uvoľňovaním |
sus ijp 1x75 mg (striek.napln.skl.+2 ihly |
JNS |
BE |
30 |
272.06 |
272.06 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón palmitát |
parent. predĺžené uvoľňovanie 100 mg (1 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
8.3450000000000006 |
|
|
|
06233 |
|
|
O |
XEPLION 100 mg injekčná suspenzia s predĺženým uvoľňovaním |
sus ijp 1x100 mg (striek.napln.skl.+2 ihly |
JNS |
BE |
40 |
333.75 |
333.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón palmitát |
parent. predĺžené uvoľňovanie 150 mg (1 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
8.1050000000000004 |
|
|
|
06234 |
|
|
O |
XEPLION 150 mg injekčná suspenzia s predĺženým uvoľňovaním |
sus ijp 1x150 mg (striek.napln.skl.+2 ihly |
JNS |
BE |
60 |
486.24 |
486.24 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05BA01 |
|
|
|
Diazepam |
p.rect. 2 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
2.0819999999999999 |
|
|
|
69417 |
|
|
G |
DIAZEPAM DESITIN RECTAL TUBE |
sol rec 5x2,5 ml/5 mg |
DET |
DE |
2.5 |
5.41 |
5.21 |
S |
0.2 |
3.6969000000000002E-2 |
0.2 |
NEU, PED, PLM, PSY, URM |
|
|
|
|
N05BA01 |
|
|
|
Diazepam |
p.rect. 4 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
1.2190000000000001 |
|
|
|
69418 |
|
|
G |
DIAZEPAM DESITIN RECTAL TUBE |
sol rec 5x2,5 ml/10 mg |
DET |
DE |
5 |
6.28 |
6.1 |
S |
0.18 |
2.8662E-2 |
0.18 |
NEU, PED, PLM, PSY, URM |
|
|
|
|
N05BA01 |
|
|
|
Diazepam |
parent. 5 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
0.24399999999999999 |
|
|
|
96610 |
|
|
G |
APAURIN |
sol inj 10x2 ml/10 mg |
KRK |
SI |
10 |
2.44 |
2.44 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05BA04 |
|
|
|
Oxazepam |
p.o. 10 mg (20 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.18260000000000001 |
|
|
|
01940 |
X |
|
G |
OXAZEPAM LÉCIVA |
tbl 20x10 mg (blist.) |
ZNT |
CZ |
4 |
1.41 |
0.73 |
S |
0.68 |
0.48226999999999998 |
0.68 |
|
|
|
|
|
N05BA08 |
|
|
|
Bromazepam |
p.o. 1,5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.9800000000000002E-2 |
|
|
|
0488A |
X |
|
G |
LEXOPAM 1,5 mg |
cps dur 30x1,5 mg (blis.PVC/Al) |
SVS |
CZ |
4.5 |
1.31 |
0.18 |
S |
1.1299999999999999 |
0.862595 |
1.1299999999999999 |
|
|
|
|
|
N05BA08 |
|
|
|
Bromazepam |
p.o. 3 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.6999999999999998E-2 |
|
|
|
2271B |
X |
|
G |
BROMAZEPAM MEDOPHARM 3 mg |
tbl 28x3 mg (blis.Al/PVC) |
MPM |
CR |
8.4 |
1.57 |
0.31 |
S |
1.26 |
0.80254800000000004 |
1.26 |
|
|
|
|
|
0489A |
X |
|
G |
LEXOPAM 3 mg |
cps dur 30x3 mg (blis.PVC/Al) |
SVS |
CZ |
9 |
1.71 |
0.33 |
S |
1.38 |
0.80701800000000001 |
1.35 |
|
|
|
|
|
N05BA12 |
|
|
|
Alprazolam |
p.o. predĺžené uvoľňovanie 0,5 mg (30 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
23103 |
X |
|
G |
Helex SR 0,5 mg |
tbl mod 30x0,5mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
15 |
1.71 |
1.2 |
S |
0.51 |
0.29824600000000001 |
0.51 |
NEU, PSY |
|
|
|
U44 |
83099 |
X |
|
O |
XANAX SR 0,5 mg |
tbl plg 30x0,5 mg (blis.) |
PFI-GB-3 |
GB |
15 |
2.46 |
1.2 |
S |
1.26 |
0.51219499999999996 |
1.26 |
NEU, PSY |
|
|
|
U44 |
N05BA12 |
|
|
|
Alprazolam |
p.o. predĺžené uvoľňovanie 1 mg (30 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
23104 |
X |
|
G |
Helex SR 1 mg |
tbl mod 30x1mg |
KRK |
SL |
30 |
3.28 |
2.4 |
S |
0.88 |
0.268293 |
0.88 |
NEU, PSY |
|
|
|
U44 |
83100 |
X |
|
O |
XANAX SR 1 mg |
tbl plg 30x1 mg (blis.) |
PFI-GB-3 |
GB |
30 |
4.7 |
2.4 |
S |
2.2999999999999998 |
0.48936200000000002 |
0.88 |
NEU, PSY |
|
|
|
U44 |
N05BA12 |
|
|
|
Alprazolam |
p.o. predĺžené uvoľňovanie 2 mg (30 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
23105 |
X |
|
G |
Helex SR 2 mg |
tbl mod 30x2mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
60 |
6.35 |
4.8 |
S |
1.55 |
0.24409400000000001 |
1.55 |
NEU, PSY |
|
|
|
U44 |
83101 |
X |
|
O |
XANAX SR 2 mg |
tbl plg 30x2 mg (blis.) |
PFI-GB-3 |
GB |
60 |
7.48 |
4.8 |
S |
2.68 |
0.35828899999999997 |
1.55 |
NEU, PSY |
|
|
|
U44 |
N05BA12 |
|
|
|
Alprazolam |
p.o. 0,25 mg (30 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
2.9899999999999999E-2 |
|
|
|
07391 |
X |
|
G |
HELEX 0,25MG |
tbl 30x0,25 mg |
KRK |
SI |
7.5 |
0.97 |
0.22 |
S |
0.75 |
0.77319599999999999 |
0.75 |
|
|
|
|
U45 |
14594 |
X |
|
G |
FRONTIN 0,25MG |
tbl 30x0,25 mg |
EGI |
HU |
7.5 |
1.21 |
0.22 |
S |
0.99 |
0.81818200000000008 |
0.75 |
|
|
|
|
U45 |
91788 |
X |
|
G |
NEUROL 0,25 |
tbl 30x0,25 mg (bli.) |
ZNT |
CZ |
7.5 |
1.26 |
0.22 |
S |
1.04 |
0.82539699999999994 |
0.75 |
|
|
|
|
U45 |
90957 |
X |
|
O |
XANAX 0,25 mg |
tbl 30x0,25 mg (bli.PVC/Al) |
PFI-GB-3 |
GB |
7.5 |
1.37 |
0.22 |
S |
1.1499999999999999 |
0.83941599999999994 |
0.75 |
|
|
|
|
U45 |
N05BA12 |
|
|
|
Alprazolam |
p.o. 0,5 mg (30 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
2.9899999999999999E-2 |
|
|
|
33494 |
X |
|
G |
NEUROL 0,5 |
tbl 30x0,5 mg |
ZNT |
CZ |
15 |
1.78 |
0.45 |
S |
1.33 |
0.74719099999999994 |
1.26 |
|
|
|
|
U45 |
14596 |
X |
|
G |
FRONTIN 0,5MG |
tbl 30x0,5 mg |
EGI |
HU |
15 |
1.83 |
0.45 |
S |
1.38 |
0.75409800000000005 |
1.26 |
|
|
|
|
U45 |
07392 |
X |
|
G |
HELEX 0,5MG |
tbl 30x0,5 mg |
KRK |
SI |
15 |
1.83 |
0.45 |
S |
1.38 |
0.75409800000000005 |
1.26 |
|
|
|
|
U45 |
90959 |
X |
|
O |
XANAX 0,5 mg |
tbl 30x0,5 mg (bli.PVC/Al) |
PFI-GB-3 |
GB |
15 |
2.2000000000000002 |
0.45 |
S |
1.75 |
0.79545500000000002 |
1.26 |
|
|
|
|
U45 |
N05BA12 |
|
|
|
Alprazolam |
p.o. 1 mg (30 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
2.9899999999999999E-2 |
|
|
|
07393 |
X |
|
G |
HELEX 1MG |
tbl 30x1 mg |
KRK |
SI |
30 |
2.78 |
0.9 |
S |
1.88 |
0.67625900000000005 |
0.88 |
|
|
|
|
U45 |
86656 |
X |
|
G |
NEUROL 1,0 |
tbl 30x1 mg (bli.) |
ZNT |
CZ |
30 |
2.8 |
0.9 |
S |
1.9 |
0.67857100000000004 |
0.88 |
|
|
|
|
U45 |
96977 |
X |
|
O |
XANAX 1 mg |
tbl 30x1 mg (bli.PVC/Al) |
PFI-GB-3 |
GB |
30 |
3.07 |
0.9 |
S |
2.17 |
0.70684000000000002 |
0.88 |
|
|
|
|
U45 |
14598 |
X |
|
G |
FRONTIN 1MG |
tbl 30x1 mg |
EGI |
HU |
30 |
3.09 |
0.9 |
S |
2.19 |
0.70873799999999998 |
0.88 |
|
|
|
|
U45 |
N05BB01 |
|
|
|
Hydroxyzín |
p.o. 25 mg (25 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
0.17860000000000001 |
|
|
|
85060 |
X |
|
O |
ATARAX |
tbl obd 25x25 mg |
UCB |
BE |
8.33 |
2.0099999999999998 |
1.49 |
S |
0.52 |
0.25870599999999999 |
0.52 |
|
|
|
|
|
N05BE01 |
|
|
|
Buspiron |
p.o. 5 mg (60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.14180000000000001 |
|
|
|
14968 |
X |
|
G |
SPITOMIN 5 MG (BLIS.) |
tbl 60x5 mg |
EGI |
HU |
10 |
2.65 |
1.42 |
S |
1.23 |
0.46415100000000004 |
1.23 |
NEU, PSY |
|
|
|
|
N05BE01 |
|
|
|
Buspiron |
p.o. 10 mg (50-60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.14180000000000001 |
|
|
|
14967 |
|
|
G |
SPITOMIN 10 MG (BLIS.) |
tbl 60x10 mg |
EGI |
HU |
20 |
4.32 |
2.84 |
S |
1.48 |
0.34259300000000004 |
1.48 |
NEU, PSY |
|
|
|
|
N05BX01 |
|
|
|
Mefenoxalón |
p.o. 200 mg (30 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
0.27439999999999998 |
|
|
|
85656 |
X |
|
G |
DORSIFLEX |
tbl 30x200 mg |
LEK |
SI |
5 |
3.82 |
1.37 |
S |
2.4500000000000002 |
0.64136099999999996 |
2.4500000000000002 |
|
|
|
|
|
N05CD13 |
|
|
|
Cinolazepam |
p.o. 40 mg (10 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.107 |
|
|
|
68602 |
X |
|
G |
GERODORM |
tbl 10x40 mg |
GER |
AT |
10 |
2.73 |
1.07 |
S |
1.66 |
0.60805900000000002 |
0.71 |
|
|
|
|
|
N05CD13 |
|
|
|
Cinolazepam |
p.o. 40 mg (30 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.107 |
|
|
|
68603 |
X |
|
G |
GERODORM |
tbl 30x40 mg |
GER |
AT |
30 |
5.34 |
3.21 |
S |
2.13 |
0.39887600000000001 |
2.13 |
|
|
|
|
|
N05CF01 |
|
|
|
Zopiklón |
p.o. 7,5 mg (10 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
5.0999999999999997E-2 |
|
|
|
36435 |
X |
|
G |
ZOPITIN 7,5 mg |
tbl flm 10x7,5 mg |
VTB |
FR |
10 |
1.92 |
0.51 |
S |
1.41 |
0.734375 |
0.41 |
|
|
|
|
|
28311 |
X |
|
G |
ZOPICLON 7,5-SL |
tbl flm 10x7,5 mg |
ZNT |
SK |
10 |
2.7 |
0.51 |
S |
2.19 |
0.81111099999999992 |
0.41 |
|
|
|
|
|
N05CF01 |
|
|
|
Zopiklón |
p.o. 7,5 mg (20 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
5.0999999999999997E-2 |
|
|
|
38044 |
X |
|
G |
ZOPITIN 7,5 mg |
tbl flm 20x7,5 mg |
VTB |
FR |
20 |
3.85 |
1.02 |
S |
2.83 |
0.73506500000000008 |
0.82 |
|
|
|
|
|
28312 |
X |
|
G |
ZOPICLON 7,5-SL |
tbl flm 20x7,5 mg |
ZNT |
SK |
20 |
4.83 |
1.02 |
S |
3.81 |
0.78882000000000008 |
0.82 |
|
|
|
|
|
N05CF01 |
|
|
|
Zopiklón |
p.o. 7,5 mg (30 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
5.0999999999999997E-2 |
|
|
|
10981 |
X |
|
G |
Sonlax 7,5mg filmom obalené tablety |
tbl flm 30x7,5mg (PVC/PVDC/Al) |
JSG |
LV |
30 |
6.1 |
1.53 |
S |
4.57 |
0.74918000000000007 |
4.57 |
|
|
|
|
|
N05CF01 |
|
|
|
Zopiklón |
p.o. 7,5 mg (100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
5.0999999999999997E-2 |
|
|
|
36437 |
X |
|
G |
ZOPITIN 7,5 mg |
tbl flm 100x7,5 mg |
VTB |
FR |
100 |
9.19 |
5.0999999999999996 |
S |
4.09 |
0.44504899999999997 |
4.09 |
|
|
|
|
|
N05CF02 |
|
|
|
Zolpidem |
p.o. 10 mg (7 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
5.8999999999999997E-2 |
|
|
|
42309 |
|
|
G |
HYPNOGEN |
tbl flm 7X10 mg (blis. PVC/Al) |
NCD-1 |
DE |
7 |
1.18 |
0.41 |
S |
0.77 |
0.65254199999999996 |
0.21 |
|
|
|
|
|
N05CF02 |
|
|
|
Zolpidem |
p.o. 10 mg (10 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
5.8999999999999997E-2 |
|
|
|
00046 |
|
|
O |
ZOLPINOX |
tbl flm 10x10 mg (blis.PVC/Al) |
SVS |
CZ |
10 |
0.97 |
0.59 |
S |
0.38 |
0.39175300000000002 |
0.3 |
|
|
|
|
|
31913 |
|
|
G |
ADORMA 10 mg |
tbl flm 10x10 mg(blis.PVC/Al) |
ALK |
SI |
10 |
1.03 |
0.59 |
S |
0.44 |
0.42718400000000001 |
0.3 |
|
|
|
|
|
14609 |
|
|
G |
SANVAL 10 MG |
tbl flm 10x10 mg |
LEK |
SI |
10 |
1.29 |
0.59 |
S |
0.7 |
0.54263600000000001 |
0.3 |
|
|
|
|
|
10898 |
|
|
G |
Zolpidem Vitabalans 10 mg filmom obalené tablety |
tbl flm 10x10 mg (blis.PVC/Al) |
VTB |
FI |
10 |
1.5 |
0.59 |
S |
0.91 |
0.60666699999999996 |
0.3 |
|
|
|
|
|
83373 |
|
|
O |
STILNOX 10 mg |
tbl obd 10x10 mg |
SSN |
FR |
10 |
1.62 |
0.59 |
S |
1.03 |
0.63580199999999998 |
0.3 |
|
|
|
|
|
N05CF02 |
|
|
|
Zolpidem |
p.o. 10 mg (14-15 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
5.8999999999999997E-2 |
|
|
|
46861 |
|
|
G |
HYPNOGEN |
tbl flm 15x10 mg (blis. PVC/Al) |
NCD-1 |
DE |
15 |
2.4700000000000002 |
0.89 |
S |
1.58 |
0.63967600000000002 |
0.46 |
|
|
|
|
|
N05CF02 |
|
|
|
Zolpidem |
p.o. 10 mg (20 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
5.8999999999999997E-2 |
|
|
|
00049 |
|
|
O |
ZOLPINOX |
tbl flm 20x10 mg (blis.PVC/Al) |
SVS |
CZ |
20 |
1.91 |
1.18 |
S |
0.73 |
0.38219900000000001 |
0.61 |
|
|
|
|
|
58923 |
|
|
G |
Zolpidem Orion 10 mg |
tbl flm 20x10 mg (blister) |
ORN |
FI |
20 |
1.94 |
1.18 |
S |
0.76 |
0.39175300000000002 |
0.61 |
|
|
|
|
|
31914 |
|
|
G |
ADORMA 10 mg |
tbl flm 20x10 mg(blis.PVC/Al) |
ALK |
SI |
20 |
2.0099999999999998 |
1.18 |
S |
0.83 |
0.412935 |
0.61 |
|
|
|
|
|
14610 |
|
|
G |
SANVAL 10 MG |
tbl flm 20x10 mg |
LEK |
SI |
20 |
2.15 |
1.18 |
S |
0.97 |
0.45116300000000004 |
0.61 |
|
|
|
|
|
10899 |
|
|
G |
Zolpidem Vitabalans 10 mg filmom obalené tablety |
tbl flm 20x10 mg (blis.PVC/Al) |
VTB |
FI |
20 |
2.59 |
1.18 |
S |
1.41 |
0.54440199999999994 |
0.61 |
|
|
|
|
|
92955 |
|
|
G |
Zolpidem Mylan 10 mg |
tbl flm 20x10 mg |
GNC |
GB |
20 |
2.67 |
1.18 |
S |
1.49 |
0.55805199999999999 |
0.61 |
|
|
|
|
|
68902 |
|
|
O |
STILNOX 10MG |
tbl obd 20x10 mg |
SSN |
FR |
20 |
3.38 |
1.18 |
S |
2.2000000000000002 |
0.65088800000000002 |
0.61 |
|
|
|
|
|
N05CF02 |
|
|
|
Zolpidem |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
5.8999999999999997E-2 |
|
|
|
00050 |
|
|
O |
ZOLPINOX |
tbl flm 30x10 mg (blis.PVC/Al) |
SVS |
CZ |
30 |
2.75 |
1.77 |
S |
0.98 |
0.35636400000000001 |
0.91 |
|
|
|
|
|
N05CF02 |
|
|
|
Zolpidem |
p.o. 10 mg (50 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
5.8999999999999997E-2 |
|
|
|
00051 |
|
|
O |
ZOLPINOX |
tbl flm 50x10 mg (blis.PVC/Al) |
SVS |
CZ |
50 |
5.45 |
2.95 |
S |
2.5 |
0.45871600000000001 |
1.52 |
|
|
|
|
|
N05CF02 |
|
|
|
Zolpidem |
p.o. 10 mg (100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
5.8999999999999997E-2 |
|
|
|
10902 |
|
|
G |
Zolpidem Vitabalans 10 mg filmom obalené tablety |
tbl flm 100x10 mg (blis.PVC/Al) |
VTB |
FI |
100 |
8.94 |
5.9 |
S |
3.04 |
0.34004499999999999 |
3.04 |
|
|
|
|
|
58927 |
|
|
G |
Zolpidem Orion 10 mg |
tbl flm 100x10 mg (blister) |
ORN |
FI |
100 |
10.38 |
5.9 |
S |
4.4800000000000004 |
0.43159900000000001 |
3.04 |
|
|
|
|
|
94851 |
|
|
G |
Hypnogen |
tbl flm 100x10 mg (blis. PVC/Al) |
NCD-1 |
DE |
100 |
15.59 |
5.9 |
S |
9.69 |
0.62155199999999999 |
3.04 |
|
|
|
|
|
N06AA02 |
|
|
|
Imipramín |
p.o. 25 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.158 |
|
|
|
00200 |
X |
|
G |
MELIPRAMIN |
tbl obd 50x25 mg |
EGI |
HU |
12.505000000000001 |
2.77 |
1.98 |
S |
0.79 |
0.28519899999999998 |
0.79 |
NEU, PSY |
|
|
|
|
N06AA04 |
|
|
|
Klomipramín |
p.o. 25 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.45 |
|
|
|
08557 |
X |
|
O |
ANAFRANIL |
tbl obd 30x25 mg |
XNT |
IT |
7.5 |
3.28 |
3.28 |
I |
0 |
0 |
0 |
AGG, NEU, PSY |
|
|
|
|
N06AA04 |
|
|
|
Klomipramín |
p.o. predĺžené uvoľňovanie 75 mg (20 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.4 |
|
|
|
93828 |
X |
|
O |
ANAFRANIL SR 75 |
tbl flp 20x75 mg |
XNT |
IT |
15 |
5.98 |
5.98 |
I |
0 |
0 |
0 |
AGG, NEU, PSY |
|
|
|
|
N06AA09 |
|
|
|
Amitriptylín |
p.o. 25 mg (50 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
0.1195 |
|
|
|
49447 |
X |
|
G |
AMITRIPTYLIN SLOVAKOFARMA |
tbl flm 50x25 mg |
ZNT |
SK |
16.667000000000002 |
2.17 |
1.99 |
S |
0.18 |
8.2948999999999995E-2 |
0.18 |
|
|
|
|
|
N06AA16 |
|
|
|
Dosulepín |
p.o. 25 mg (30 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.29870000000000002 |
|
|
|
25749 |
X |
|
G |
PROTHIADEN 25 |
tbl obd 30x25 mg |
ZNT |
CZ |
5 |
2.17 |
1.49 |
S |
0.68 |
0.31336400000000003 |
0.68 |
|
|
|
|
|
N06AA16 |
|
|
|
Dosulepín |
p.o. 75 mg (30 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.29870000000000002 |
|
|
|
15849 |
X |
|
G |
PROTHIADEN 75 |
tbl obd 30x75 mg |
ZNT |
CZ |
15 |
6.28 |
4.4800000000000004 |
S |
1.8 |
0.28662399999999999 |
1.8 |
|
|
|
|
|
N06AA21 |
|
|
|
Maprotilín |
p.o. 10 mg (50 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
0.42099999999999999 |
|
|
|
03791 |
X |
|
O |
Ludiomil 10 |
tbl flm 50x10 mg (blis.PVC/PVDC) |
AMD |
IR |
5 |
3.46 |
2.11 |
S |
1.35 |
0.39017299999999999 |
1.35 |
|
|
|
|
|
N06AA21 |
|
|
|
Maprotilín |
p.o. 25 mg (30 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
0.42099999999999999 |
|
|
|
03792 |
X |
|
O |
Ludiomil 25 |
tbl flm 30x25 mg (blis.PVC/PVDC) |
AMD |
IR |
7.5 |
3.44 |
3.16 |
S |
0.28000000000000003 |
8.1394999999999995E-2 |
0.28000000000000003 |
|
|
|
|
|
N06AA21 |
|
|
|
Maprotilín |
p.o. 50 mg (30 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
0.42099999999999999 |
|
|
|
03793 |
X |
|
O |
Ludiomil 50 |
tbl flm 30x50 mg (blis.PVC/PVDC) |
AMD |
IR |
15 |
10.35 |
6.32 |
S |
4.03 |
0.389372 |
4.03 |
|
|
|
|
|
N06AA21 |
|
|
|
Maprotilín |
p.o. 75 mg (20 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
0.42099999999999999 |
|
|
|
04257 |
X |
|
O |
Ludiomil 75 |
tbl flm 20x75 mg (blis.PVC/PVDC) |
AMD |
IR |
15 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
|
|
|
|
|
N06AB03 |
|
|
|
Fluoxetín |
p.o. 20 mg (10 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
08202 |
X |
|
G |
Fluoxetine Vitabalans 20 mg filmom obalené tablety |
tbl flm 10x20 mg (blis.PVC/Al) |
VTB |
FI |
10 |
1.89 |
0.34 |
S |
1.55 |
0.820106 |
0.63 |
|
|
|
|
U46 |
N06AB03 |
|
|
|
Fluoxetín |
p.o. 20 mg (30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
08204 |
X |
|
G |
Fluoxetine Vitabalans 20 mg filmom obalené tablety |
tbl flm 30x20 mg (blis.PVC/Al) |
VTB |
FI |
30 |
2.91 |
1.02 |
S |
1.89 |
0.64948499999999998 |
1.89 |
|
|
|
|
U46 |
54423 |
X |
|
G |
MAGRILAN 20mg |
cps. 30x20mg |
MOE |
CY |
30 |
3.01 |
1.02 |
S |
1.99 |
0.66113 |
1.89 |
|
|
|
|
U46 |
N06AB04 |
|
|
|
Citalopram |
p.o. 10 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
36130 |
X |
|
G |
Citalec 10 Zentiva |
tbl flm 30x10 mg |
ZNT |
SK |
15 |
1.5 |
0.51 |
S |
0.99 |
0.66 |
0.99 |
|
|
|
|
U46 |
N06AB04 |
|
|
|
Citalopram |
p.o. 20 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
98954 |
X |
|
G |
Citalopram - Teva 20 mg |
tbl flm 30x20 mg |
TPW |
HU |
30 |
1.1599999999999999 |
1.02 |
S |
0.14000000000000001 |
0.12069000000000001 |
0 |
|
|
|
|
U46 |
40353 |
X |
|
G |
ZYLORAM tablety 20 mg |
tbl flm 28x20 mg |
RNB |
IE |
28 |
1.29 |
0.95 |
S |
0.34 |
0.26356600000000002 |
0 |
|
|
|
|
U46 |
07465 |
X |
|
G |
Citalopram Vitabalans 20 mg filmom obalené tablety |
tbl flm 30x20 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
30 |
1.83 |
1.02 |
S |
0.81 |
0.44262300000000004 |
0 |
|
|
|
|
U46 |
36136 |
X |
|
G |
Citalec 20 Zentiva |
tbl flm 30x20 mg |
ZNT |
SK |
30 |
2.02 |
1.02 |
S |
1 |
0.49505000000000005 |
0 |
|
|
|
|
U46 |
N06AB04 |
|
|
|
Citalopram |
p.o. 20 mg (56-60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
36138 |
X |
|
G |
CITALEC 20 ZENTIVA |
tbl flm 60x20 mg |
ZNT |
SK |
60 |
4.04 |
2.04 |
S |
2 |
0.49505000000000005 |
0 |
|
|
|
|
U46 |
N06AB04 |
|
|
|
Citalopram |
p.o. 20 mg (98-100 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
98958 |
X |
|
G |
Citalopram - Teva 20 mg |
tbl flm 100x20 mg |
PHM |
NL |
100 |
3.3 |
3.3 |
I |
0 |
0 |
0 |
|
|
|
|
U46 |
07467 |
X |
|
G |
Citalopram Vitabalans 20 mg filmom obalené tablety |
tbl flm 100x20 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
100 |
4.6500000000000004 |
3.4 |
S |
1.25 |
0.26881699999999997 |
0 |
|
|
|
|
U46 |
N06AB04 |
|
|
|
Citalopram |
p.o. 40 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
07471 |
X |
|
G |
Citalopram Vitabalans 40 mg filmom obalené tablety |
tbl flm 30x40 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
60 |
6.85 |
2.04 |
S |
4.8099999999999996 |
0.70218999999999998 |
4.8099999999999996 |
|
|
|
|
U46 |
N06AB05 |
|
|
|
Paroxetin |
p.o. 20 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
40322 |
X |
|
G |
PARETIN 20 mg |
tbl flm 28x20 mg |
GNS |
GB |
28 |
3.44 |
0.95 |
S |
2.4900000000000002 |
0.72383700000000006 |
2.4 |
|
|
|
|
U46 |
37099 |
X |
|
G |
ARKETIS 20 mg |
tbl 30 x 20 mg |
MOE |
CY |
30 |
3.7 |
1.02 |
S |
2.68 |
0.72432399999999997 |
2.57 |
|
|
|
|
U46 |
66157 |
X |
|
G |
Paroxetin G.L. Pharma 20 mg |
tbl flm 30x20 mg (blis. Al/Al) |
GLH-2 |
AT |
30 |
3.7 |
1.02 |
S |
2.68 |
0.72432399999999997 |
2.57 |
|
|
|
|
U46 |
25090 |
X |
|
O |
SEROXAT 20 MG |
tbl flm 30x20 mg |
SKB |
GB |
30 |
6.79 |
1.02 |
S |
5.77 |
0.84977900000000006 |
2.57 |
|
|
|
|
U46 |
N06AB05 |
|
|
|
Paroxetin |
p.o. 20 mg (60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
37101 |
X |
|
G |
ARKETIS 20 mg |
tbl 60 x 20 mg |
MOE |
CY |
60 |
7.18 |
2.04 |
S |
5.14 |
0.71587699999999999 |
5.14 |
|
|
|
|
U46 |
N06AB05 |
|
|
|
Paroxetin |
p.o. 30 mg (30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
37109 |
X |
|
G |
ARKETIS 30 mg |
tbl 30 x 30 mg |
MOE |
CY |
45 |
6.61 |
1.53 |
S |
5.08 |
0.76853300000000002 |
5.08 |
|
|
|
|
U46 |
25091 |
X |
|
O |
SEROXAT 30 MG |
tbl flm 30x30 mg |
SKB |
GB |
45 |
12.17 |
1.53 |
S |
10.64 |
0.87428099999999997 |
5.08 |
|
|
|
|
U46 |
N06AB06 |
|
|
|
Sertralin |
p.o. 50 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
33577 |
X |
|
G |
Serlift 50 MG |
tbl flm 30 x 50 mg |
RXY |
IN |
30 |
2.54 |
1.02 |
S |
1.52 |
0.59842499999999998 |
1.52 |
|
|
|
|
U46 |
95232 |
X |
|
G |
SERTRALIN ACTAVIS 50mg |
tbl flm 30x50mg |
ACT |
IS |
30 |
2.54 |
1.02 |
S |
1.52 |
0.59842499999999998 |
1.52 |
|
|
|
|
U46 |
31866 |
X |
|
G |
ASENTRA 50 mg |
tbl flm 28x50 mg |
KRK |
SI |
28 |
4.2699999999999996 |
0.95 |
S |
3.32 |
0.77751800000000004 |
1.42 |
|
|
|
|
U46 |
33559 |
X |
|
G |
STIMULOTON 50MG |
tbl flm 30x50mg |
EGI |
HU |
30 |
5.15 |
1.02 |
S |
4.13 |
0.80194199999999993 |
1.52 |
|
|
|
|
U46 |
83540 |
X |
|
O |
ZOLOFT 50 mg |
tbl flm 28x50 mg |
PFI-GB-3 |
GB |
28 |
8.49 |
0.95 |
S |
7.54 |
0.888104 |
1.42 |
|
|
|
|
U46 |
N06AB06 |
|
|
|
Sertralin |
p.o. 100 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
33579 |
X |
|
G |
Serlift 100 MG |
tbl flm 30 x 100 mg |
RXY |
IN |
60 |
5.07 |
2.04 |
S |
3.03 |
0.59763299999999997 |
3.03 |
|
|
|
|
U46 |
95236 |
X |
|
G |
SERTRALIN ACTAVIS 100mg |
tbl flm 30x100mg |
ACT |
IS |
60 |
5.07 |
2.04 |
S |
3.03 |
0.59763299999999997 |
3.03 |
|
|
|
|
U46 |
31867 |
X |
|
G |
ASENTRA 100 mg |
tbl flm 28x100 mg |
KRK |
SI |
56 |
7.44 |
1.9 |
S |
5.54 |
0.74462400000000006 |
2.83 |
|
|
|
|
U46 |
83541 |
X |
|
O |
ZOLOFT 100 mg |
tbl flm 28x100 mg |
PFI-GB-3 |
GB |
56 |
14.67 |
1.9 |
S |
12.77 |
0.87048400000000004 |
2.83 |
|
|
|
|
U46 |
N06AB06 |
|
|
|
Sertralin |
p.o. 20 mg/ml |
50 |
mg |
|
|
|
|
|
|
|
|
0.54730000000000001 |
|
|
|
13980 |
X |
|
O |
ZOLOFT OC 20 mg/ml |
con por 1x60 ml |
PFI-GB-3 |
GB |
24 |
15.4 |
13.14 |
S |
2.2599999999999998 |
0.14675299999999999 |
2.2599999999999998 |
NEU,PSY |
|
|
|
|
N06AB08 |
|
|
|
Fluvoxamin |
p.o. 50 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.22600000000000001 |
|
|
|
26440 |
|
|
O |
FEVARIN |
tbl flm 30x50 mg |
SDU |
NL |
15 |
5.59 |
3.39 |
S |
2.2000000000000002 |
0.39356000000000002 |
2.2000000000000002 |
NEU, PSY |
|
|
|
|
N06AB08 |
|
|
|
Fluvoxamin |
p.o. 100 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.28399999999999997 |
|
|
|
26443 |
|
|
O |
FEVARIN |
tbl flm 30x100 mg |
SDU |
NL |
30 |
11.62 |
8.52 |
S |
3.1 |
0.26678099999999999 |
3.1 |
NEU, PSY |
|
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 5 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
6262A |
|
|
G |
Elicea Q-Tab 5 mg orodispergovateľné tablety |
tbl oro 28x5 mg(blis.OPA/Al/PVC s odlup. fóliou PET/Al) |
KRK |
SL |
14 |
2.5499999999999998 |
2.5499999999999998 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
08705 |
X |
|
G |
Escitalopram FARMAX 10 mg |
tbl flm 30x10 mg (blis. PVC-PE-PVdC-PE-PVC/Al) |
SVS |
CZ |
30 |
5.45 |
5.45 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
80861 |
X |
|
G |
Escitalopram Mylan 10mg |
tbl flm 28x10 mg |
GNC |
GB |
28 |
5.09 |
5.09 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
68670 |
X |
|
G |
Escitalopram Teva 10 mg |
tbl flm 28x10 mg |
TEV |
NL |
28 |
5.09 |
5.09 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
89315 |
X |
|
G |
Isozyloram 10 mg |
tbl flm 28x10 mg (blis.PAD/PVC/Al) |
RNB |
GB |
28 |
5.09 |
5.09 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
23112 |
X |
|
G |
Despra 10 mg |
tbl flm 28x10 mg (blis.PVC/PE/PVDC/Al) |
GLM |
CZ |
28 |
5.0999999999999996 |
5.0999999999999996 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
21992 |
X |
|
G |
Solatcit 10 mg |
tbl flm 28x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
28 |
5.0999999999999996 |
5.0999999999999996 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
8404A |
X |
|
G |
Escitalopram Zentiva 10 mg orodispergovateľné tablety |
tbl oro 30x10 mg (blis.papier/PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
30 |
5.47 |
5.47 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
76818 |
X |
|
G |
Esoprex 10 mg |
tbl flm 30x10 mg (blis. OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
30 |
5.48 |
5.48 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
79133 |
X |
|
G |
Elicea 10mg |
tbl flm 28x10 mg |
KRK |
SI |
28 |
5.12 |
5.12 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
6286A |
X |
|
G |
Elicea Q-Tab 10 mg orodispergovateľné tablety |
tbl oro 28x10 mg (blis.OPA/Al/PVC s odlup.fóliou PET/Al) |
KRK |
SL |
28 |
5.12 |
5.12 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
22489 |
X |
|
G |
Miraklide 10 mg |
tbl flm 28x10 mg |
GNT |
NL |
28 |
5.56 |
5.12 |
S |
0.44 |
7.9136999999999999E-2 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
76975 |
X |
|
G |
Escitil 10 mg |
tbl flm 28x10 mg (blis. OPA/AI/PVC/AI) |
EGI |
HU |
28 |
6.02 |
5.12 |
S |
0.9 |
0.149502 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
78367 |
X |
|
G |
LENUXIN 10 mg |
tbl flm 28x10 mg |
GDN |
HU |
28 |
6.61 |
5.12 |
S |
1.49 |
0.22541599999999998 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 10 mg (56-60 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
08706 |
X |
|
G |
Escitalopram FARMAX 10 mg |
tbl flm 60x10 mg (blis. PVC-PE-PVdC-PE-PVC/Al) |
SVS |
CZ |
60 |
10.89 |
10.89 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
76979 |
X |
|
G |
Escitil 10 mg |
tbl flm 56x10 mg (blis. OPA/AI/PVC/AI) |
EGI |
HU |
56 |
10.17 |
10.17 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
22492 |
X |
|
G |
Miraklide 10 mg |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al) |
VIH |
PL |
56 |
10.17 |
10.17 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
21995 |
X |
|
G |
Solatcit 10 mg |
tbl flm 56x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
56 |
10.17 |
10.17 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
68674 |
X |
|
G |
Escitalopram Teva 10 mg |
tbl flm 56x10 mg (blis. PVC/PVDC/Al) |
TEV |
NL |
56 |
10.18 |
10.18 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
79137 |
X |
|
G |
Elicea 10mg |
tbl flm 60x10 mg |
KRK |
SI |
60 |
10.98 |
10.98 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
8406A |
X |
|
G |
Escitalopram Zentiva 10 mg orodispergovateľné tablety |
tbl oro 60x10 mg (blis.papier/PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
60 |
10.98 |
10.98 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
76819 |
X |
|
G |
Esoprex 10 mg |
tbl flm 60x10 mg (blis. OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
60 |
10.98 |
10.98 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 10 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
79138 |
X |
|
G |
Elicea 10mg |
tbl flm 90x10mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
90 |
16.34 |
16.34 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
08711 |
X |
|
G |
Escitalopram FARMAX 10 mg |
tbl flm 90x10 mg (blis.PVC-PE-PVdC-PE-PVC/Al) |
SVS |
CZ |
90 |
16.34 |
16.34 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
21997 |
X |
|
G |
Solatcit 10 mg |
tbl flm 98x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
98 |
17.84 |
17.84 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 15 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
6230A |
X |
|
G |
Elicea Q-Tab 15 mg orodispergovateľné tablety |
tbl oro 28x15 mg(blis.OPA/Al/PVC s odlup. fóliou PET/Al) |
KRK |
SL |
42 |
11.55 |
11.55 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 15 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
77012 |
X |
|
G |
Escitil 15mg |
tbl flm 56x15mg |
EGI |
HU |
84 |
23.1 |
23.1 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 20 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.19 |
|
|
|
6274A |
X |
|
G |
Elicea Q-Tab 20 mg orodispergovateľné tablety |
tbl oro 28x20 mg (blis.OPA/Al/PVC s odlup.fóliou PET/Al) |
KRK |
SL |
56 |
10.24 |
10.24 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
22015 |
X |
|
G |
Solatcit 20 mg |
tbl flm 28x20 mg (bli.PVC/PVDC/Al) |
ACT-5 |
IS |
56 |
10.24 |
10.24 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
23200 |
X |
|
G |
Despra 20 mg |
tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al) |
GLM |
CZ |
56 |
10.25 |
10.25 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
77051 |
X |
|
G |
Escitil 20 mg |
tbl flm 28x20 mg (blis. OPA/AI/PVC/AI) |
EGI |
HU |
56 |
10.25 |
10.25 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AG02 |
|
|
|
Moklobemid |
p.o. 300 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.318 |
|
|
|
85901 |
X |
|
O |
AURORIX 300MG |
tbl flm 30x300 mg |
MPH |
SK |
30 |
11.93 |
9.5399999999999991 |
S |
2.39 |
0.20033500000000001 |
2.39 |
NEU, PSY |
|
|
|
|
N06AX03 |
|
|
|
Mianserin |
p.o. 10 mg (30 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.45 |
|
|
|
85809 |
X |
|
O |
LERIVON |
tbl 30x10 mg |
ORG |
NL |
5 |
3.44 |
2.25 |
S |
1.19 |
0.34593000000000002 |
1.19 |
PSY |
|
|
|
|
N06AX03 |
|
|
|
Mianserin |
p.o. 30 mg (20 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.4 |
|
|
|
85810 |
X |
|
O |
LERIVON |
tbl 20x30 mg |
ORG |
NL |
10 |
7.62 |
4 |
S |
3.62 |
0.47506599999999999 |
3.62 |
PSY |
|
|
|
|
N06AX03 |
|
|
|
Mianserin |
p.o. 60 mg (30 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.39500000000000002 |
|
|
|
85811 |
X |
|
O |
LERIVON |
tbl 30x60 mg |
ORG |
NL |
30 |
13.2 |
11.85 |
S |
1.35 |
0.102273 |
1.35 |
PSY |
|
|
|
|
N06AX05 |
|
|
|
Trazodon |
p.o. 150 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.49199999999999999 |
|
|
|
15915 |
X |
|
O |
TRITTICO AC 150 |
tbl flm 60x150 mg |
XCC-2 |
AT |
30 |
15.14 |
14.76 |
S |
0.38 |
2.5099E-2 |
0.38 |
PSY,NEU |
|
|
|
|
N06AX11 |
|
|
|
Mirtazapín |
p.o. 15 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
42584 |
X |
|
G |
MIRZATEN 15 mg |
tbl flm 30x15 mg |
KRK |
SI |
15 |
2.4300000000000002 |
0.51 |
S |
1.92 |
0.79012299999999991 |
1.92 |
|
|
|
|
U46 |
47698 |
X |
|
G |
Mirzaten Q-Tab 15mg |
tbl oro 30x15 mg |
KRK |
SI |
15 |
2.4300000000000002 |
0.51 |
S |
1.92 |
0.79012299999999991 |
1.92 |
|
|
|
|
U46 |
23120 |
X |
|
O |
REMERON Soltab 15 mg |
tbl oro 30x15 mg |
ORG |
NL |
15 |
11.16 |
0.51 |
S |
10.65 |
0.95430099999999995 |
1.92 |
|
|
|
|
U46 |
N06AX11 |
|
|
|
Mirtazapín |
p.o. 30 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
90134 |
X |
|
G |
Esprital 30 |
tbl flm 30x30 mg |
ZNT |
CZ |
30 |
3.43 |
1.02 |
S |
2.41 |
0.70262400000000003 |
2.41 |
|
|
|
|
U46 |
42603 |
X |
|
G |
MIRZATEN 30 mg |
tbl flm 30x30 mg |
KRK |
SI |
30 |
3.53 |
1.02 |
S |
2.5099999999999998 |
0.71104800000000001 |
2.41 |
|
|
|
|
U46 |
47718 |
X |
|
G |
Mirzaten Q-Tab 30mg |
tbl oro 30x30 mg |
KRK |
SI |
30 |
3.62 |
1.02 |
S |
2.6 |
0.71823199999999998 |
2.41 |
|
|
|
|
U46 |
23126 |
X |
|
O |
REMERON Soltab 30 mg |
tbl oro 30x30 mg |
ORG |
NL |
30 |
14.99 |
1.02 |
S |
13.97 |
0.93195499999999998 |
2.41 |
|
|
|
|
U46 |
N06AX11 |
|
|
|
Mirtazapín |
p.o. 45 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
90135 |
X |
|
G |
Esprital 45 |
tbl flm 30x45 mg |
ZNT |
CZ |
45 |
4.8600000000000003 |
1.53 |
S |
3.33 |
0.68518500000000004 |
3.33 |
|
|
|
|
U46 |
47739 |
X |
|
G |
Mirzaten Q-Tab 45 mg |
tbl oro 30x45 mg |
KRK |
SI |
45 |
5 |
1.53 |
S |
3.47 |
0.69400000000000006 |
3.33 |
|
|
|
|
U46 |
42622 |
X |
|
G |
MIRZATEN 45 mg |
tbl flm 30x45 mg |
KRK |
SI |
45 |
5.13 |
1.53 |
S |
3.6 |
0.70175399999999999 |
3.33 |
|
|
|
|
U46 |
23132 |
X |
|
O |
REMERON Soltab 45 mg |
tbl oro 30x45 mg |
ORG |
NL |
45 |
21.76 |
1.53 |
S |
20.23 |
0.92968800000000007 |
3.33 |
|
|
|
|
U46 |
N06AX12 |
|
|
|
Bupropión |
p.o. predĺžené uvoľňovanie 150 mg (30 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
0.83399999999999996 |
|
|
|
38038 |
X |
|
O |
Elontril 150 mg |
tbl mod 30x150 mg |
GAG |
SK |
15 |
14.6 |
12.51 |
S |
2.09 |
0.143151 |
2.09 |
NEU, PSY |
ind.obm. |
|
|
|
N06AX12 |
|
|
|
Bupropión |
p.o. predĺžené uvoľňovanie 150 mg (60 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
0.83399999999999996 |
|
|
|
01173 |
X |
|
O |
WELLBUTRIN SR |
tbl plg 60x150 mg |
GWE |
PL |
30 |
30.72 |
25.02 |
S |
5.7 |
0.18554700000000002 |
4.18 |
PSY,NEU |
ind.obm. |
|
|
|
N06AX12 |
|
|
|
Bupropión |
p.o. predĺžené uvoľňovanie 300 mg (30 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
0.88600000000000001 |
|
|
|
38041 |
X |
|
O |
Elontril 300 mg |
tbl mod 30x300 mg |
GAG |
SK |
30 |
29.64 |
26.58 |
S |
3.06 |
0.103239 |
3.06 |
NEU, PSY |
ind.obm. |
|
|
|
N06AX12 |
|
|
|
Bupropión |
p.o. predĺžené uvoľňovanie 300 mg (90 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
0.88600000000000001 |
|
|
|
38042 |
X |
|
O |
Elontril 300 mg |
tbl mod 90 (3x30) 300 mg |
GAG |
SK |
90 |
92.67 |
79.739999999999995 |
S |
12.93 |
0.13952700000000001 |
9.18 |
NEU, PSY |
ind.obm. |
|
|
|
N06AX14 |
|
|
|
Tianeptín |
p.o. 12,5 mg (30 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.40300000000000002 |
|
|
|
67436 |
X |
|
O |
COAXIL |
tbl obd 30x12,5 mg |
LLG |
FR |
10 |
7.67 |
4.03 |
S |
3.64 |
0.474576 |
0.41 |
NEU, PSY |
|
|
|
|
N06AX14 |
|
|
|
Tianeptín |
p.o. 12,5 mg (90 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.40300000000000002 |
|
|
|
08235 |
X |
|
G |
Aneptinex 12,5 mg |
tbl flm 90x12,5 mg (blis.PVC/PVDC/Al) |
PRW |
CZ |
30 |
13.24 |
12.09 |
S |
1.1499999999999999 |
8.6858000000000005E-2 |
1.1499999999999999 |
NEU, PSY |
|
|
|
|
12424 |
X |
|
G |
Tianeptin Mylan 12,5 mg |
tbl flm 90x12,5 mg (blis.PVC/PVDC/Al) |
GNC |
UK |
30 |
13.24 |
12.09 |
S |
1.1499999999999999 |
8.6858000000000005E-2 |
1.1499999999999999 |
NEU, PSY |
|
|
|
|
09866 |
X |
|
G |
Lyxit 12,5 mg |
tbl flm 90x12,5 mg (blis. PVC/PVDC/Al) |
GLM-CZ |
CZ |
30 |
13.31 |
12.09 |
S |
1.22 |
9.1660000000000005E-2 |
1.1499999999999999 |
NEU, PSY |
|
|
|
|
08811 |
X |
|
G |
Tianeptin Sandoz 12,5mg filmom obalené tablety |
tbl flm 90 x 12,5 mg (blis. PVC/PVDC/Al) |
SAN |
SI |
30 |
13.31 |
12.09 |
S |
1.22 |
9.1660000000000005E-2 |
1.22 |
NEU, PSY |
|
|
|
|
40511 |
X |
|
O |
Coaxil |
tbl obd 90x12,5 mg |
SVE |
FR |
30 |
16.059999999999999 |
12.09 |
S |
3.97 |
0.247198 |
1.22 |
NEU, PSY |
|
|
|
|
N06AX16 |
|
|
|
Venlafaxín |
p.o.50 mg (60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.34399999999999997 |
|
|
|
95519 |
X |
|
G |
Velaxin 50mg tablety |
tbl 60x50mg |
EGI |
HU |
30 |
17.899999999999999 |
10.32 |
S |
7.58 |
0.42346400000000001 |
7.58 |
NEU, PSY |
|
|
|
|
N06AX16 |
|
|
|
Venlafaxín |
p.o. predĺžené uvoľňovanie 37,5 mg (28-30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.26500000000000001 |
|
|
|
38616 |
X |
|
G |
Alventa 37,5mg |
cps pld 28x37,5mg |
KRK |
SI |
10.5 |
2.86 |
2.78 |
S |
0.08 |
2.7972E-2 |
0.08 |
NEU, PSY |
|
|
|
|
N06AX16 |
|
|
|
Venlafaxín |
p.o. predĺžené uvoľňovanie 75 mg (28-30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
38629 |
X |
|
G |
ALVENTA 75mg |
cps pld 30x75mg |
KRK |
SI |
22.5 |
2.41 |
2.41 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
50405 |
X |
|
G |
ARGOFAN 75 SR |
tbl plg 30x75 mg |
ZNT |
SK |
22.5 |
4.04 |
2.48 |
S |
1.56 |
0.38613900000000001 |
0 |
NEU, PSY |
|
|
|
|
50564 |
X |
|
G |
Depant prolong 75 mg |
cps pld 28x75 mg |
VLN |
CZ |
21 |
4.47 |
2.31 |
S |
2.16 |
0.48322100000000001 |
0 |
NEU, PSY |
|
|
|
|
43685 |
X |
|
G |
Velaxin 75 mg |
cps pld 28x75 mg |
EGI |
HU |
21 |
7.7 |
2.31 |
S |
5.39 |
0.7 |
0 |
NEU, PSY |
|
|
|
|
N06AX16 |
|
|
|
Venlafaxín |
p.o. predĺžené uvoľňovanie 75 mg (50-60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
38631 |
X |
|
G |
Alventa 75mg |
cps pld 60x75 mg |
KRK |
SI |
45 |
4.7 |
4.7 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
21724 |
X |
|
G |
Velaxin 75 mg tvrdé kapsuly s predĺženým uvoľňovaním |
cps pld 56x75 mg (blis.PVC/PVDC/Al) |
EGI |
HU |
42 |
9.9600000000000009 |
4.62 |
S |
5.34 |
0.53614499999999998 |
0 |
NEU, PSY |
|
|
|
|
N06AX16 |
|
|
|
Venlafaxín |
p.o. predĺžené uvoľňovanie 150 mg (28-30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.09 |
|
|
|
38641 |
X |
|
O |
ALVENTA 150mg |
cps pld 30x150mg |
KRK |
SI |
45 |
4.1399999999999997 |
4.05 |
S |
0.09 |
2.1739000000000001E-2 |
0 |
NEU, PSY |
|
|
|
|
50402 |
X |
|
G |
ARGOFAN 150 SR |
tbl plg 30x150 mg |
ZNT |
SK |
45 |
5.04 |
4.05 |
S |
0.99 |
0.19642900000000002 |
0 |
NEU, PSY |
|
|
|
|
43687 |
X |
|
G |
Velaxin 150 mg |
cps pld 28x150 mg |
EGI |
HU |
42 |
9.77 |
3.78 |
S |
5.99 |
0.61310100000000001 |
0 |
NEU, PSY |
|
|
|
|
N06AX16 |
|
|
|
Venlafaxín |
p.o. predĺžené uvoľňovanie 150 mg (50-60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.09 |
|
|
|
38643 |
X |
|
G |
Alventa 150mg |
cps pld 60x150 mg |
KRK |
SI |
90 |
8.06 |
8.06 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
21722 |
X |
|
G |
Velaxin 150 mg tvrdé kapsuly s predĺženým uvoľňovaním |
cps pld 56x150 mg (blis.PVC/PVDC/Al) |
EGI |
HU |
84 |
16.059999999999999 |
7.56 |
S |
8.5 |
0.52926499999999999 |
0 |
NEU, PSY |
|
|
|
|
N06AX21 |
|
|
|
Duloxetín |
p.o. 20 mg (56 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
3.1720000000000002 |
|
|
|
4377B |
X |
|
G |
Loxentia 20 mg tvrdé gastrorezistentné kapsuly |
cps end 56x20 mg (blis.OPA/Al/(HDPE/PE+DES z CaO/HDPE)/Al/PE) |
KRK |
SL |
14 |
31.63 |
31.63 |
I |
0 |
0 |
0 |
URO, GYN |
ind.obm. |
|
|
|
41290 |
X |
|
O |
YENTREVE |
cps end 56x20 mg |
LIL |
NL |
14 |
48.84 |
44.41 |
S |
4.43 |
9.0703999999999993E-2 |
0 |
URO, GYN |
ind.obm. |
|
|
|
N06AX21 |
|
|
|
Duloxetín |
p.o. 30 mg (7 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.55500000000000005 |
|
|
|
92950 |
X |
|
O |
Cymbalta 30 mg tvrdé gastrorezistentné kapsuly |
cps end 7 x 30 mg |
LIL |
NL |
3.5 |
5.19 |
1.94 |
S |
3.25 |
0.62620399999999998 |
3.25 |
AGG, DIA, NEU, PSY |
ind.obm. |
|
|
|
N06AX21 |
|
|
|
Duloxetín |
p.o. 30 mg (30 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.55500000000000005 |
|
|
|
4011B |
X |
|
G |
Dulsevia 30 mg tvrdé gastrorezistentné kapsuly |
cps end 30x30mg (blis.OPA/Al/(HDPE/PE+DES z CaO/HDPE)/Al/PE) |
KRK |
SL |
15 |
14.39 |
8.33 |
S |
6.06 |
0.421126 |
6.06 |
AGG, DIA, NEU, PSY |
ind.obm. |
|
|
|
N06AX21 |
|
|
|
Duloxetín |
p.o. 40 mg (56 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.5649999999999999 |
|
|
|
4386B |
X |
|
G |
Loxentia 40 mg tvrdé gastrorezistentné kapsuly |
cps end 56x40 mg (blis.OPA/Al/(HDPE/PE+DES z CaO/HDPE)/Al/PE) |
KRK |
SL |
28 |
31.36 |
31.36 |
I |
0 |
0 |
0 |
URO, GYN |
ind.obm. |
|
|
|
41292 |
X |
|
O |
YENTREVE |
cps end 56x40 mg |
LIL |
NL |
28 |
47.75 |
43.82 |
S |
3.93 |
8.2303999999999988E-2 |
0 |
URO, GYN |
ind.obm. |
|
|
|
N06AX21 |
|
|
|
Duloxetín |
p.o. 60 mg (28 - 30 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.59399999999999997 |
|
|
|
4677B |
X |
|
G |
Duloxetin Mylan 60 mg tvrdé gastrorezistentné tablety |
cps end 28 x 60 mg (blis.PVC/PCTFE/Al) |
GNS |
UK |
28 |
18.2 |
16.63 |
S |
1.57 |
8.6264000000000007E-2 |
1.57 |
AGG, DIA, NEU, PSY |
ind.obm. |
|
|
|
4020B |
X |
|
G |
Dulsevia 60 mg tvrdé gastrorezistentné kapsuly |
cps end 30x60mg (blis.OPA/Al/(HDPE/PE+DES z CaO/HDPE)/Al/PE) |
KRK |
SL |
30 |
19.5 |
17.82 |
S |
1.68 |
8.6153999999999994E-2 |
1.68 |
AGG, DIA, NEU, PSY |
ind.obm. |
|
|
|
42669 |
X |
|
O |
CYMBALTA |
cps end 28x60 mg |
LIL |
NL |
28 |
26.68 |
16.63 |
S |
10.050000000000001 |
0.37668699999999999 |
1.57 |
AGG, DIA, NEU, PSY |
ind.obm. |
|
|
|
N06AX22 |
|
|
|
Agomelatín |
p.o. 25 mg (28 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
1.27 |
|
|
|
66540 |
X |
|
O |
Valdoxan |
tbl flm 28x25 mg |
SVE |
FR |
28 |
39.33 |
35.56 |
S |
3.77 |
9.5855999999999997E-2 |
3.77 |
PSY |
ind.obm. |
|
|
|
N06AX26 |
|
|
|
Vortioxetín |
p.o. 10 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.28 |
|
|
|
8551A |
|
|
O |
Brintellix 10 mg |
tbl flm 28 x 10 mg |
LUN-1 |
DK |
28 |
41.2 |
35.840000000000003 |
S |
5.36 |
0.13009700000000002 |
5.36 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA04 |
|
§ |
|
Metylfenidát |
p.o. predĺžené uvoľňovanie 18 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
1.254 |
|
|
|
49919 |
|
|
O |
Concerta 18mg tablety s predĺženým uvoľňovaním |
tbl plg 30x18mg |
JAN |
BE |
18 |
22.8 |
22.57 |
S |
0.23 |
1.0088E-2 |
0.23 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA04 |
|
§ |
|
Metylfenidát |
p.o. predĺžené uvoľňovanie 36 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
1 |
|
|
|
49924 |
|
|
O |
Concerta 36mg tablety s predĺženým uvoľňovaním |
tbl plg 30x36mg |
JAN |
BE |
36 |
35.869999999999997 |
35.869999999999997 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA04 |
|
§ |
|
Metylfenidát |
p.o. predĺžené uvoľňovanie 54 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.92 |
|
|
|
49926 |
|
|
O |
Concerta 54mg tablety s predĺženým uvoľňovaním |
tbl plg 30x54mg |
JAN |
BE |
54 |
49.31 |
49.31 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA07 |
|
|
|
Modafinil |
p.o. 100 mg (30 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
6.19 |
|
|
|
01689 |
X |
|
G |
ASPENDOS 100 mg |
tbl 30x100 mg (blis.PVC/Al) |
MOE |
CY |
10 |
61.83 |
61.83 |
I |
0 |
0 |
0 |
NEU, PSY, TRN |
|
|
|
|
N06BA09 |
|
|
|
Atomoxetín |
p.o. 10 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.64 |
|
|
|
95257 |
X |
|
O |
Strattera 10mg |
cps dur 28x10 mg |
LIL |
GB |
28 |
76.430000000000007 |
73.92 |
S |
2.5099999999999998 |
3.2841000000000002E-2 |
2.5099999999999998 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA09 |
|
|
|
Atomoxetín |
p.o. 18 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.645 |
|
|
|
95244 |
X |
|
O |
Strattera 18mg |
cps dur 28x18 mg |
LIL |
GB |
28 |
76.58 |
74.06 |
S |
2.52 |
3.2906999999999999E-2 |
2.52 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA09 |
|
|
|
Atomoxetín |
p.o. 25 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.665 |
|
|
|
95253 |
X |
|
O |
Strattera 25mg |
cps dur 28x25 mg |
LIL |
GB |
28 |
77.010000000000005 |
74.62 |
S |
2.39 |
3.1035E-2 |
2.39 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA09 |
|
|
|
Atomoxetín |
p.o. 40 mg (7 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.665 |
|
|
|
95260 |
X |
|
O |
Strattera 40 mg |
cps dur 7x40mg |
LIL |
CZ |
7 |
22.66 |
18.66 |
S |
4 |
0.17652300000000001 |
0.6 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA09 |
|
|
|
Atomoxetín |
p.o. 40 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.665 |
|
|
|
95262 |
X |
|
O |
Strattera 40mg |
cps dur 28x40 mg |
LIL |
GB |
28 |
77.010000000000005 |
74.62 |
S |
2.39 |
3.1035E-2 |
2.39 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA09 |
|
|
|
Atomoxetín |
p.o. 60 mg (7 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.73 |
|
|
|
95265 |
X |
|
O |
Strattera 60 mg |
cps dur 7 x 60mg |
LIL |
CZ |
7 |
25.79 |
19.11 |
S |
6.68 |
0.259015 |
0.71 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA09 |
|
|
|
Atomoxetín |
p.o. 60 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.73 |
|
|
|
95267 |
X |
|
O |
Strattera 60mg |
cps dur 28x60 mg |
LIL |
GB |
28 |
79.28 |
76.44 |
S |
2.84 |
3.5822E-2 |
2.84 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA09 |
|
|
|
Atomoxetín |
p.o. 80 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
3.415 |
|
|
|
50127 |
|
|
O |
Strattera 80 mg |
cps dur 28 x 80 mg |
LIL |
CZ |
28 |
99.6 |
95.62 |
S |
3.98 |
3.9960000000000002E-2 |
3.98 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA02 |
|
|
|
Donepezil |
p.o. 5 mg (28-30 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
66855 |
X |
|
G |
Adonep 5 mg filmom obalené tablety |
tbl flm 28 (14x2)x5 mg (blis.PVC/PE/PVDC/Al) |
STD |
DE |
18.667000000000002 |
5.22 |
5.22 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
22767 |
X |
|
G |
Donepezil Accord 5 mg |
tbl flm 28x5 mg (blis. PVC/AI) |
ACC |
GB |
18.667000000000002 |
5.22 |
5.22 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
88925 |
X |
|
G |
Donepezil Mylan 5 mg orodispergovateľné tablety |
tbl oro 28 x 5mg(blis. OPA/Al/PVC/Al) |
GNC |
UK |
18.667000000000002 |
5.22 |
5.22 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
40542 |
X |
|
G |
YASNAL 5 |
tbl flm 28x5 mg |
KRK |
SI |
18.667000000000002 |
8.16 |
5.23 |
S |
2.93 |
0.35906900000000003 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
04976 |
X |
|
G |
Yasnal Q-Tab 5mg |
tbl oro 28x5mg |
KRK |
SI |
18.667000000000002 |
8.16 |
5.23 |
S |
2.93 |
0.35906900000000003 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
47808 |
X |
|
G |
Donesyn 5mg |
tbl flm 28x5 mg |
VIP |
PL |
18.667000000000002 |
12.3 |
5.23 |
S |
7.07 |
0.574797 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA02 |
|
|
|
Donepezil |
p.o. 5 mg (84-100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
09329 |
X |
|
G |
Yasnal 5 mg |
tbl flm 84x5mg (blis.Al/OPA/Al/PVC) |
KRK |
SL |
56 |
15.68 |
15.68 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
47814 |
X |
|
G |
Donesyn 5 mg |
tbl flm 98x5 mg |
VIH |
PL |
65.332999999999998 |
19.12 |
18.29 |
S |
0.83 |
4.3410000000000004E-2 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA02 |
|
|
|
Donepezil |
p.o. 10 mg (28-30 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
0.36499999999999999 |
|
|
|
66868 |
X |
|
G |
Adonep 10 mg filmom obalené tablety |
tbl flm 28 (14x2)x10 mg (blis.PVC/PE/PVDC/Al) |
STD |
DE |
37.332999999999998 |
13.29 |
13.29 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
47822 |
X |
|
G |
Cognezil 10 mg |
tbl flm 28x10 mg (blis. PVC/Alu) |
GLM |
CZ |
37.332999999999998 |
13.29 |
13.29 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
22757 |
X |
|
G |
Donepezil Accord 10 mg |
tbl flm 28x10 mg |
ACC |
GB |
37.332999999999998 |
13.29 |
13.29 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
88952 |
X |
|
G |
Donepezil Mylan 10 mg orodispergovateľné tablety |
tbl oro 28 x 10mg(blis. OPA/Al/PVC/Al) |
GNC |
UK |
37.332999999999998 |
13.29 |
13.29 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
09129 |
X |
|
G |
PROMEMORE 10 mg |
tbl flm 30x10 mg (blis. PVC/PVDC/Al) |
SVS |
CZ |
40 |
14.24 |
14.24 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
04986 |
X |
|
G |
Yasnal Q-Tab 10mg |
tbl oro 28x10mg |
KRK |
SI |
37.332999999999998 |
13.6 |
13.6 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
40543 |
X |
|
G |
YASNAL 10 |
tbl flm 28x10 mg |
KRK |
SI |
37.332999999999998 |
13.61 |
13.61 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
47797 |
X |
|
G |
Donesyn 10mg |
tbl flm 28x10mg |
VIP |
PL |
37.332999999999998 |
14.61 |
13.63 |
S |
0.98 |
6.7076999999999998E-2 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
75691 |
X |
|
G |
Landex 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis. PVC/PVDC/AI) |
EGI |
HU |
37.332999999999998 |
24.26 |
13.63 |
S |
10.63 |
0.43817 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA02 |
|
|
|
Donepezil |
p.o. 10 mg (84-100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
0.36499999999999999 |
|
|
|
09131 |
X |
|
G |
PROMEMORE 10 mg |
tbl flm 90x10 mg (blis. PVC/PVDC/Al) |
SVS |
CZ |
120 |
42.71 |
42.71 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
47803 |
X |
|
G |
Donesyn 10 mg |
tbl flm 98x10 mg |
VIH |
PL |
130.667 |
46.51 |
46.51 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
09317 |
X |
|
G |
Yasnal 10 mg |
tbl flm 84x10mg (blis.Al/OPA/Al/PVC) |
KRK |
SL |
112 |
39.869999999999997 |
39.869999999999997 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 1,5 mg (28-30 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
3.93 |
|
|
|
76506 |
X |
|
O |
Nimvastid |
tbl oro 28x1,5 mg |
KRK |
SI |
4.6669999999999998 |
18.329999999999998 |
18.329999999999998 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 1,5 mg (56 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
3.93 |
|
|
|
85734 |
X |
|
G |
RISTIDIC 1,5 mg |
cps dur 56x1,5 mg (blis.PVC/Al) |
PRW |
CZ |
9.3330000000000002 |
7.86 |
7.86 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 3 mg (28-30 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.92 |
|
|
|
76511 |
X |
|
O |
Nimvastid |
tbl oro 28x3 mg |
KRK |
SI |
9.3330000000000002 |
8.57 |
8.57 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 3 mg (56 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.92 |
|
|
|
85737 |
X |
|
G |
RISTIDIC 3 mg |
cps dur 56x3 mg (blis.PVC/Al) |
PRW |
CZ |
18.667000000000002 |
17.059999999999999 |
17.059999999999999 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 4,5 mg (28-30 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.87 |
|
|
|
76516 |
X |
|
O |
Nimvastid |
tbl oro 28x4,5 mg |
KRK |
SI |
14 |
12.17 |
12.17 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 4,5 mg (56 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.87 |
|
|
|
85972 |
X |
|
G |
RISTIDIC 4,5 mg |
cps dur 56x4,5 mg (blis.PVC/Al) |
PRW |
CZ |
28 |
24.34 |
24.34 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 6,0 mg (28-30 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
76521 |
X |
|
O |
Nimvastid |
tbl oro 28x6 mg |
KRK |
SI |
18.667000000000002 |
15.86 |
15.86 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 6,0 mg (56 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
85975 |
X |
|
G |
RISTIDIC 6 mg |
cps dur 56x6 mg (blis.PVC/Al) |
PRW |
CZ |
37.332999999999998 |
31.67 |
31.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
transd. emp. tdm. 4,6 mg |
9.5 |
mg |
|
|
|
|
|
|
|
|
3.32 |
|
|
|
45204 |
|
|
O |
EXELON 4,6 mg/24h |
emp tdm 30 x 4,6 mg/24h |
NEH |
GB |
14.526 |
48.16 |
48.16 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
transd. emp. tdm. 9,5 mg |
9.5 |
mg |
|
|
|
|
|
|
|
|
1.9930000000000001 |
|
|
|
45208 |
|
|
O |
EXELON 9,5 mg/24h |
emp tdm 30 x 9,5 mg/24h |
NEH |
GB |
30 |
59.78 |
59.78 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
transd. emp. tdm. 13,3 mg |
9.5 |
mg |
|
|
|
|
|
|
|
|
1.7470000000000001 |
|
|
|
3977A |
|
|
O |
Exelon 13,3 mg/24 h transdermálna náplasť |
emp tdm 30x13,3 mg/24 hodín |
NEH |
GB |
42 |
74.31 |
73.37 |
S |
0.94 |
1.265E-2 |
0.94 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA04 |
|
|
|
Galantamín |
p.o. predĺžené uvoľňovanie 8 mg (7 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
2.89 |
|
|
|
31370 |
X |
|
G |
Galantamin Mylan 8 mg |
cps pld 7x8 mg (blis.Al/Al) |
GNS |
UK |
3.5 |
10.08 |
10.08 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA04 |
|
|
|
Galantamín |
p.o. predĺžené uvoľňovanie 8 mg (14 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
2.89 |
|
|
|
06926 |
X |
|
G |
Galsya SR 8mg |
cps pld 14x8mg |
KRK |
SI |
7 |
20.16 |
20.16 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA04 |
|
|
|
Galantamín |
p.o. predĺžené uvoľňovanie 16 mg (28 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
0.84499999999999997 |
|
|
|
06945 |
X |
|
G |
Galsya SR 16 mg |
cps pld 28x16 mg |
KRK |
SI |
28 |
23.62 |
23.62 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
31393 |
X |
|
G |
Galantamin Mylan 16 mg |
cps pld 28x16 mg (blis.Al/Al) |
GNS |
UK |
28 |
25.14 |
23.66 |
S |
1.48 |
5.8869999999999999E-2 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 10 mg/ml (50 ml) |
20 |
mg |
|
|
|
|
|
|
|
|
1.72 |
|
|
|
7580A |
|
|
G |
Memantin Mylan 10 mg/ml perorálny roztok |
sol por 1x50 ml (fľ.skl.hnedá s pumpou) |
GNS |
UK |
25 |
43 |
43 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 5 mg (7 ks), 10 mg (7 ks), 15 mg (7 ks), 20 mg (7 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.1299999999999999 |
|
|
|
8023A |
|
|
G |
Zenmem 5 mg orodispergovateľné tablety, Zenmem 10 mg orodispergovateľné tablety, Zenmem 15 mg orodispergovateľné tablety, Zenmem 20 mg orodispergovateľné tablety |
tbl oro 28(7x5mg+7x10 mg+7x15 mg+7x20 mg) (blis.PET/Al/PVC/Al/OPA-initiation pack) |
ZNT |
CZ |
17.5 |
19.73 |
19.73 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 10 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.1000000000000001 |
|
|
|
5289A |
X |
|
G |
Marixino 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.PVC/PVDC/Al) |
CNK-IE |
IE |
14 |
15.33 |
15.33 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7853A |
X |
|
G |
Memolan 10 mg filmom obalené tablety |
tbl flm 30x10 mg (blis.PVC/PE/PVDC/Al) |
GLH-2 |
AT |
15 |
16.43 |
16.43 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
0992B |
X |
|
G |
MORYSA 10 mg filmom obalené tablety |
tbl flm 30x10 mg (fľ.HDPE) |
SVS |
CZ |
15 |
16.43 |
16.43 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8012A |
X |
|
G |
Zenmem 10 mg orodispergovateľné tablety |
tbl oro 30x10 mg (blis.PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
15 |
16.43 |
16.43 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6722A |
X |
|
G |
Polmatine 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis. Al/PVC/PVDC) |
MDL-2 |
PL |
14 |
23.87 |
15.4 |
S |
8.4700000000000006 |
0.35483899999999996 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 10 mg (56-60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.1000000000000001 |
|
|
|
2834B |
X |
|
G |
MANTOMED 10 mg |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al) |
MOE |
CY |
28 |
30.66 |
30.66 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6790A |
X |
|
G |
Memigmin 10mg |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/AL) |
EGI |
HU |
28 |
30.66 |
30.66 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5969A |
X |
|
G |
Xapimant 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
28 |
30.66 |
30.66 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8014A |
X |
|
G |
Zenmem 10 mg orodispergovateľné tablety |
tbl oro 60x10 mg (blis.PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
30 |
32.86 |
32.86 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
95452 |
X |
|
O |
EBIXA 10 mg |
tbl flm 56x10 mg |
LUN |
DK |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7546A |
X |
|
G |
Memabix 10 mg |
tbl oro 56x10 mg (blis. papier/PET/Al/PVC/Al/oPA) |
ADD |
PL |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
4667A |
X |
|
G |
MEMAMED 10 mg |
tbl flm 56x10 mg (blis.PVDC/AI) |
CRR |
SK |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5222A |
X |
|
G |
Memantin Mylan 10 mg filmom obalené tablety |
tbl flm 56x10mg(blis. PVC/PVDC/Al) |
GENERICS |
UK |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7668A |
X |
|
G |
Memantin Stada 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al) |
STD |
DE |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8426A |
X |
|
G |
Memantine Accord 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al) |
ACC |
GB |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7998A |
X |
|
G |
Memantine Glenmark 10 mg |
tbl flm 56x10 mg (blis. PVC/Al) |
GLM - CZ |
CZ |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6299A |
X |
|
G |
Memantine ratiopharm 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PVDC/Al) |
RAT |
DE |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8171A |
X |
|
G |
Memantine Vipharm 10 mg |
tbl flm 56x10 mg (blis.PVC/Al) |
VIH |
PL |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5266A |
X |
|
G |
Nemdatine 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6727A |
X |
|
G |
Polmatine 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis. Al/PVC/PVDC) |
MDL-2 |
PL |
28 |
47.74 |
30.8 |
S |
16.940000000000001 |
0.35483899999999996 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 10 mg (84-98 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.1000000000000001 |
|
|
|
5296A |
X |
|
G |
Marixino 10 mg filmom obalené tablety |
tbl flm 84x10 mg (blis.PVC/PVDC/Al) |
CNK-IE |
IE |
42 |
46 |
46 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5268A |
X |
|
G |
Nemdatine 10 mg filmom obalené tablety |
tbl flm 98x10 mg (blis PVC/PVDC/Al) |
ACT-5 |
IS |
49 |
53.67 |
53.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 20 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.161 |
|
|
|
0999B |
X |
|
G |
MORYSA 20 mg filmom obalené tablety |
tbl flm 30x20 mg (fľ.HDPE) |
SVS |
CZ |
30 |
34.82 |
34.82 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
2849B |
X |
|
G |
MANTOMED 20 mg |
tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al) |
MOE |
CY |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5302A |
X |
|
G |
Marixino 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PVDC/Al) |
CNK-IE |
IE |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7554A |
X |
|
G |
Memabix 20 mg |
tbl oro 28x20 mg (blis. papier/PET/Al/PVC/Al/oPA) |
ADD |
PL |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
4679A |
X |
|
G |
MEMAMED 20 mg |
tbl flm 28x20 mg (blis.PVDC/Al) |
CRR |
SK |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5235A |
X |
|
G |
Memantin Mylan 20 mg filmom obalené tablety |
tbl flm 28x20mg(blis. PVC/PVDC/Al) |
GNC |
UK |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7677A |
X |
|
G |
Memantin Stada 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al) |
STD |
DE |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8430A |
X |
|
G |
Memantine Accord 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al) |
ACC |
GB |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8005A |
X |
|
G |
Memantine Glenmark 20 mg |
tbl flm 28x20 mg (blis. PVC/Al) |
GLM |
CZ |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6307A |
X |
|
G |
Memantine ratiopharm 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PVDC/Al) |
RAT |
DE |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8182A |
X |
|
G |
Memantine Vipharm 20 mg |
tbl flm 28x20 mg (blis.PVC/Al) |
VIH |
PL |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5273A |
X |
|
G |
Nemdatine 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6007A |
X |
|
G |
Xapimant 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7866A |
X |
|
G |
Memolan 20 mg filmom obalené tablety |
tbl flm 30x20 mg (blis.PVC/PE/PVDC/Al) |
GLH-2 |
AT |
30 |
34.83 |
34.83 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8018A |
X |
|
G |
Zenmem 20 mg orodispergovateľné tablety |
tbl oro 30x20 mg (blis.PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
30 |
34.83 |
34.83 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
51159 |
X |
|
O |
Ebixa 20 mg |
tbl flm 28x20 mg |
LUN |
DK |
28 |
34.700000000000003 |
32.51 |
S |
2.19 |
6.3112000000000001E-2 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6710A |
X |
|
G |
Polmatine 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis. Al/PVC/PVDC) |
MDL-2 |
PL |
28 |
48.4 |
32.51 |
S |
15.89 |
0.32830599999999999 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 20 mg (56-60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.161 |
|
|
|
5275A |
X |
|
G |
Nemdatine 20 mg filmom obalené tablety |
tbl flm 56x20 mg (blis PVC/PVDC/Al) |
ACT-5 |
IS |
56 |
65 |
65 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8186A |
X |
|
G |
Memantine Vipharm 20 mg |
tbl flm 56x20 mg (blis.PVC/Al) |
VIH |
PL |
56 |
65.010000000000005 |
65.010000000000005 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8020A |
X |
|
G |
Zenmem 20 mg orodispergovateľné tablety |
tbl oro 60x20 mg (blis.PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
60 |
69.66 |
69.66 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6713A |
X |
|
G |
Polmatine 20 mg filmom obalené tablety |
tbl flm 56x20 mg (blis. Al/PVC/PVDC) |
MDL-2 |
PL |
56 |
97.44 |
65.02 |
S |
32.42 |
0.33271800000000001 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 20 mg (84-98 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.161 |
|
|
|
8189A |
X |
|
G |
Memantine Vipharm 20 mg |
tbl flm 98x20 mg (blis.PVC/Al) |
VIH |
PL |
98 |
113.76 |
113.76 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5309A |
X |
|
G |
Marixino 20 mg filmom obalené tablety |
tbl flm 84x20 mg (blis.PVC/PVDC/Al) |
CNK-IE |
IE |
84 |
97.51 |
97.51 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N07AA01 |
|
|
|
Neostigmín |
p.o. 15 mg (20 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.55279999999999996 |
|
|
|
25037 |
X |
|
G |
SYNTOSTIGMIN |
tbl 20x15 mg (blist.) |
ZNT |
SK |
5 |
3.56 |
2.76 |
S |
0.8 |
0.224719 |
0.8 |
|
|
|
|
|
N07AA01 |
|
|
|
Neostigmín |
parent. 0,5 mg/ml |
2 |
mg |
|
|
|
|
|
|
|
|
1.208 |
|
|
|
00612 |
|
|
G |
SYNTOSTIGMIN |
inj 10x1 ml/0,5 mg |
HBS |
SK |
2.5 |
3.02 |
3.02 |
A |
0 |
0 |
0 |
|
|
|
|
|
N07AA02 |
|
|
|
Pyridostigmín |
p.o. 60 mg (150 ks) |
180 |
mg |
|
|
|
|
|
|
|
|
0.52200000000000002 |
|
|
|
91983 |
X |
|
G |
MESTINON |
tbl obd 150x60 mg |
MPH |
SK |
50 |
26.01 |
26.01 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N07AA03 |
|
|
|
Distigmín |
p.o. 5 mg (50 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.1726 |
|
|
|
02130 |
X |
|
G |
UBRETID 5 mg |
tbl 50x5 mg |
NYC |
AT |
50 |
8.52 |
8.52 |
I |
0 |
0 |
0 |
NEU, URO |
|
|
|
|
N07BB03 |
|
|
|
Akamprosat |
p.o. 300 mg (84 ks) |
2 |
g |
|
|
|
|
|
|
|
|
1.573 |
|
|
|
56150 |
X |
|
O |
CAMPRAL |
tbl obd 84x300 mg |
LIP |
FR |
12.6 |
21.17 |
19.82 |
S |
1.35 |
6.3769000000000006E-2 |
1.35 |
PSY |
|
|
|
|
N07BB04 |
|
|
|
Naltrexón |
p.o. 50 mg (28 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
1.4379999999999999 |
|
|
|
20342 |
|
|
G |
Adepend 50 mg filmom obalené tablety |
tbl flm 28x50 mg (blis. PVC/PVDC/Al) |
ORV |
AT |
28 |
46.72 |
40.26 |
S |
6.46 |
0.13827100000000001 |
6.46 |
PSY |
|
|
|
|
N07BB05 |
|
|
|
Nalmefén |
p.o. 18 mg (14 ks) |
18 |
mg |
|
|
|
|
|
|
|
|
2.089 |
|
|
|
4476A |
|
|
O |
Selincro 18 mg |
tbl flm 14 x 18 mg |
LUN-1 |
DK |
14 |
53.37 |
29.25 |
S |
24.12 |
0.45193899999999998 |
24.12 |
PSY |
ind.obm. |
|
|
|
N07BB05 |
|
|
|
Nalmefén |
p.o. 18 mg (28 ks) |
18 |
mg |
|
|
|
|
|
|
|
|
2.089 |
|
|
|
4477A |
|
|
O |
Selincro 18 mg |
tbl flm 28 x 18 mg |
LUN-1 |
DK |
28 |
114.95 |
58.49 |
S |
56.46 |
0.49117 |
48.24 |
PSY |
ind.obm. |
|
|
|
N07CA01 |
|
|
|
Betahistín |
p.o. 8 mg (90-100 ks) |
24 |
mg |
|
|
|
|
|
|
|
|
6.7000000000000004E-2 |
|
|
|
35950 |
X |
|
G |
Betahistin Actavis 8mg |
tbl 100x8 mg |
ACT-5 |
IS |
33.332999999999998 |
4.24 |
2.23 |
S |
2.0099999999999998 |
0.47405700000000001 |
2.0099999999999998 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
33513 |
X |
|
G |
Avertin 8 mg |
tbl 90x8 mg |
XDE |
IE |
30 |
4.22 |
2.0099999999999998 |
S |
2.21 |
0.52369699999999997 |
1.81 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
79362 |
X |
|
G |
Emperin 8 mg |
tbl 100x8 mg (blis. PVC/PVDC/AI) |
EGI |
HU |
33.332999999999998 |
4.83 |
2.23 |
S |
2.6 |
0.53830199999999995 |
2.0099999999999998 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
38083 |
X |
|
G |
URUTAL 8mg |
tbl 100x8 mg |
BLU |
SK |
33.332999999999998 |
5.6 |
2.23 |
S |
3.37 |
0.60178600000000004 |
2.0099999999999998 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
N07CA01 |
|
|
|
Betahistín |
p.o. 16 mg (60 ks) |
24 |
mg |
|
|
|
|
|
|
|
|
6.7000000000000004E-2 |
|
|
|
35947 |
X |
|
G |
Betahistin Actavis 16mg |
tbl 60x16 mg |
ACT-5 |
IS |
40 |
3.23 |
2.68 |
S |
0.55000000000000004 |
0.17027899999999999 |
0.55000000000000004 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
52924 |
X |
|
G |
Betahistin Mylan 16 mg |
tbl 60 x 16 mg |
GENERICS |
UK |
40 |
4.1100000000000003 |
2.68 |
S |
1.43 |
0.34793199999999996 |
0.55000000000000004 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
38084 |
X |
|
G |
URUTAL 16 mg |
tbl 60x16 mg (blis.PVC/PVDC/Al) |
BLU |
SK |
40 |
4.1100000000000003 |
2.68 |
S |
1.43 |
0.34793199999999996 |
0.55000000000000004 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
79368 |
X |
|
G |
Emperin 16 mg |
tbl 60x16 mg (blis. PVC/PVDC/AI) |
EGI |
HU |
40 |
5.38 |
2.68 |
S |
2.7 |
0.50185899999999994 |
0.55000000000000004 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
44342 |
X |
|
G |
Polvertic 16 mg |
tbl 60x16 mg |
MDL |
PL |
40 |
5.63 |
2.68 |
S |
2.95 |
0.52397899999999997 |
0.55000000000000004 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
02680 |
X |
|
O |
MeniSerc 16 |
tbl 60x16 mg (blis.PVC/PVDC/Al) |
TPH |
SK |
40 |
9.31 |
2.68 |
S |
6.63 |
0.71213700000000002 |
0.55000000000000004 |
GER, INT, KLF, NEU, ORL |
|
|
|
U39 |
N07CA01 |
|
|
|
Betahistín |
p.o. 24 mg (50-60 ks) |
24 |
mg |
|
|
|
|
|
|
|
|
0.10100000000000001 |
|
|
|
79375 |
X |
|
G |
Emperin 24 mg |
tbl 60x24 mg (blis. PVC/PVDC/AI) |
EGI |
HU |
60 |
6.02 |
6.02 |
I |
0 |
0 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
53741 |
X |
|
G |
Betahistin Mylan 24mg |
tbl 50x24 mg |
GNC |
GB |
50 |
5.03 |
5.03 |
I |
0 |
0 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
20379 |
X |
|
G |
Urutal 24 mg |
tbl 50x24 mg |
BLU |
SR |
50 |
5.04 |
5.04 |
I |
0 |
0 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
59461 |
X |
|
G |
Betahistin Actavis 24 mg |
tbl 50x24 mg |
ACT-5 |
IS |
50 |
5.75 |
5.05 |
S |
0.7 |
0.121739 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
46979 |
X |
|
G |
Polvertic 24 mg |
tbl 50x24 mg |
MDL |
PL |
50 |
5.75 |
5.05 |
S |
0.7 |
0.121739 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
41784 |
X |
|
O |
MeniSerc 24 |
tbl 50x24 mg (blis.PVC/PVDC/Al) |
TPH |
SK |
50 |
8.56 |
5.05 |
S |
3.51 |
0.41004699999999999 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
N07CA01 |
|
|
|
Betahistín |
p.o. 24 mg (100 ks) |
24 |
mg |
|
|
|
|
|
|
|
|
0.10100000000000001 |
|
|
|
59465 |
X |
|
G |
Betahistin Actavis 24 mg |
tbl 100x24 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
100 |
10.029999999999999 |
10.029999999999999 |
I |
0 |
0 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
83346 |
X |
|
G |
Vertibetis 24 mg tablety |
tbl 100x24 mg (blis PVC/PVDC/AL) |
XJE |
PL |
100 |
12.16 |
10.1 |
S |
2.06 |
0.169408 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
46981 |
X |
|
G |
Polvertic 24 mg |
tbl 100x24 mg |
MDL |
PL |
100 |
12.19 |
10.1 |
S |
2.09 |
0.17145199999999999 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
N07CA01 |
|
|
|
Betahistín |
p.o. 10 mg/ml (60 ml) |
24 |
mg |
|
|
|
|
|
|
|
|
0.13200000000000001 |
|
|
|
65718 |
X |
|
G |
Acuver 8 mg |
sol ora 1x60 ml |
CTX |
AT |
25 |
6.73 |
3.3 |
S |
3.43 |
0.50965800000000006 |
2.34 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
N07CA01 |
|
|
|
Betahistín |
p.o. 10 mg/ml (120 ml) |
24 |
mg |
|
|
|
|
|
|
|
|
0.13200000000000001 |
|
|
|
65720 |
X |
|
G |
Acuver 8 mg |
sol ora 1x120 ml |
CTX |
AT |
50 |
11.27 |
6.6 |
S |
4.67 |
0.41437399999999996 |
4.67 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
N07X |
|
|
|
Iné liečivá CNS |
parent. 215,2 mg/ml (hydrolyzát z mozgového tkaniva ) |
10 |
ml |
|
|
|
|
|
|
|
|
7.1420000000000003 |
|
|
|
01433 |
|
|
O |
CEREBROLYSIN |
inj 10x1 ml |
EBW |
AT |
1 |
9.51 |
7.14 |
S |
2.37 |
0.24921099999999999 |
2.37 |
NEU |
ind.obm. |
|
|
|
N07X |
|
|
|
Iné liečivá CNS |
parent. 215,2 mg/ml ( hydrolyzát z mozgového tkaniva ) |
10 |
ml |
|
|
|
|
|
|
|
|
4.0179999999999998 |
|
|
|
69058 |
|
|
O |
CEREBROLYSIN |
inj 5x5 ml |
EBW |
AT |
2.5 |
19.93 |
10.050000000000001 |
S |
9.8800000000000008 |
0.49573500000000004 |
9.8800000000000008 |
NEU |
ind.obm. |
|
|
|
N07X |
|
|
|
Iné liečivá CNS |
parent. 215,2 mg/ml (hydrolyzát z mozgového tkaniva) |
10 |
ml |
|
|
|
|
|
|
|
|
2.7639999999999998 |
|
|
|
69059 |
|
|
O |
CEREBROLYSIN |
inj 5x10 ml |
EBW |
AT |
5 |
29.28 |
13.82 |
S |
15.46 |
0.52800499999999995 |
15.46 |
NEU |
ind.obm. |
|
|
|
N07XX09 |
|
|
|
Dimetylfumarát |
p.o. 120 mg (14 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
24.62 |
|
|
|
9681A |
|
|
O |
Tecfidera 120 mg tvrdé gastrorezistentné kapsuly. |
cps end 14x120 mg blis.PVC/PE/PVDC-PVC/alu |
BGI |
GB |
7 |
172.34 |
172.34 |
I |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
N07XX09 |
|
|
|
Dimetylfumarát |
p.o. 240 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
46.01 |
|
|
|
9682A |
|
|
O |
Tecfidera 240 mg tvrdé gastrorezistentné kapsuly. |
cps end 56x240 mg (blis.PVC/PE/PVDC-PVC/alu) |
BGI |
GB |
28 |
1288.28 |
1288.28 |
I |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
P01AB01 |
|
|
|
Metronidazol |
p.o. 250 mg (20 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.435 |
|
|
|
02427 |
X |
|
G |
ENTIZOL |
tbl 20x250 mg |
XPO |
PL |
2.5 |
1.46 |
1.0900000000000001 |
S |
0.37 |
0.25342500000000001 |
0.37 |
|
|
|
|
U64 |
P01BA02 |
|
|
|
Hydroxychlorochin |
p.o. 200 mg (60 ks) |
0.51 |
g |
|
|
|
|
|
|
|
|
0.26 |
|
|
|
14682 |
X |
|
O |
PLAQUENIL 200MG (BLIS.) |
tbl flm 60x200 mg |
SFW |
GB |
23.257000000000001 |
8.06 |
6.05 |
S |
2.0099999999999998 |
0.24937999999999999 |
2.0099999999999998 |
DER, GER, INF, INT, KLF, NEU, REU |
|
|
|
U66 |
P01BB51 |
|
|
|
Atovakvon/progvanilium chlorid |
p.o. 250/100 mg (12 ks) |
4 |
DF |
|
|
|
|
|
|
|
|
5.1890000000000001 |
|
|
|
97767 |
|
|
O |
Malarone |
tbl flm 12 |
GWE |
GB |
3 |
20.76 |
15.57 |
S |
5.19 |
0.25 |
5.19 |
INF |
ind.obm. |
|
|
U67 |
P01BC02 |
|
|
|
Meflochin |
p.o. 250 mg (8 ks) |
1 |
g |
|
|
|
|
|
|
|
|
6.3170000000000002 |
|
|
|
49430 |
X |
|
O |
LARIAM 250 mg |
tbl 8x250 mg (blis.) |
HLR |
CH |
2 |
16.84 |
12.63 |
S |
4.21 |
0.25 |
4.21 |
INF |
ind.obm. |
|
|
U68 |
P02CA01 |
|
|
|
Mebendazol |
p.o. 100 mg (6 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.28499999999999998 |
|
|
|
59238 |
X |
|
O |
VERMOX |
tbl 6x100 mg |
JAG |
IT |
3 |
1.1299999999999999 |
0.86 |
S |
0.27 |
0.23893799999999998 |
0.27 |
|
|
|
|
U69 |
P02CA03 |
|
|
|
Albendazol |
p.o. 400 mg (1 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
1.4650000000000001 |
|
|
|
3798A |
|
|
O |
ZENTEL 400 mg |
tbl 1x400 mg (blis.PVDC/PVC/Al) |
GAG-SK |
SK |
1 |
1.96 |
1.47 |
S |
0.49 |
0.25 |
0.49 |
|
|
|
|
U70 |
P02CA03 |
|
|
|
Albendazol |
p.o. 20 mg/ml |
0.4 |
g |
|
|
|
|
|
|
|
|
2.1225000000000001 |
|
|
|
88300 |
X |
|
O |
ZENTEL |
sus por 20 ml/400 mg |
SKF |
FR |
1 |
2.83 |
2.12 |
S |
0.71 |
0.25088300000000002 |
0.71 |
|
|
|
|
|
P03AC04 |
|
|
|
Permethrin |
loc. 5% |
1 |
g |
|
|
|
|
|
|
|
|
0.35499999999999998 |
|
|
|
35381 |
|
|
O |
Infectoscab 5% krém |
crm 1x30 g |
INF |
DE |
30 |
14.21 |
10.65 |
S |
3.56 |
0.25052800000000003 |
3.56 |
|
|
|
|
U71 |
R01AC03 |
|
|
|
Azelastín |
loc. aer. nas. 0,1% |
0.56000000000000005 |
mg |
|
|
|
|
|
|
|
|
0.252 |
|
|
|
87130 |
|
|
O |
ALLERGODIL |
aer nas 1x10 ml/10 mg |
MDM |
DE |
17.856000000000002 |
6.43 |
4.5 |
S |
1.93 |
0.30015599999999998 |
1.93 |
|
|
|
|
U47 |
R01AD01 |
|
|
|
Beklometazón |
loc. aer. nas. 50 mcg v 1 dávke |
0.4 |
mg |
|
|
|
|
|
|
|
|
9.5000000000000001E-2 |
|
|
|
35676 |
|
|
G |
BECLOMET NASAL AQUA 50 µg |
aer nau 1x23ml/200 dávok |
ORN |
FI |
25 |
5.28 |
2.38 |
S |
2.9 |
0.54924200000000001 |
2.48 |
ALG, ORL, TRN |
|
|
|
U48 |
35674 |
|
|
G |
BECLOMET NASAL AQUA 50 µg |
aer nau 1x9ml/70 dávok |
ORN |
FI |
8.7590000000000003 |
3.06 |
0.83 |
S |
2.23 |
0.72875800000000002 |
0.87 |
ALG, ORL, TRN |
|
|
|
U48 |
R01AD01 |
|
|
|
Beklometazón |
loc. aer. nas. 100 mcg v 1 dávke |
0.4 |
mg |
|
|
|
|
|
|
|
|
9.5000000000000001E-2 |
|
|
|
99860 |
|
|
O |
BECLOMET NASAL AQUA 100 |
aer nas 23 ml/200df |
ORN |
FI |
50 |
9.6999999999999993 |
4.75 |
S |
4.95 |
0.51030900000000001 |
4.95 |
ALG, ORL, TRN |
|
|
|
U48 |
R01AD05 |
|
|
|
Budezonid |
loc. aer. nas. 32 mcg |
0.2 |
mg |
|
|
|
|
|
|
|
|
9.5000000000000001E-2 |
|
|
|
27023 |
|
|
O |
RHINOCORT AQUA 32 ug/dávka |
aer nas 120x32 ug |
AZC |
SE |
19.204000000000001 |
6.08 |
1.82 |
S |
4.26 |
0.700658 |
4.26 |
ALG, ORL, TRN |
|
|
|
U48 |
R01AD05 |
|
|
|
Budezonid |
loc. aer. nas. 64 mcg |
0.2 |
mg |
|
|
|
|
|
|
|
|
9.5000000000000001E-2 |
|
|
|
27025 |
|
|
O |
RHINOCORT AQUA 64 ug/dávka |
aer nas 120x64 ug |
AZC |
SE |
38.396999999999998 |
4.47 |
3.65 |
S |
0.82 |
0.183445 |
0.82 |
ALG, ORL, TRN |
|
|
|
U48 |
R01AD05 |
|
|
|
Budezonid |
loc. aer. nas. 50 mcg |
0.2 |
mg |
|
|
|
|
|
|
|
|
9.5000000000000001E-2 |
|
|
|
14514 |
|
|
G |
TAFEN NASAL 50 ug |
aer nau 1x200 dávok |
LEK |
SI |
50 |
5.3 |
4.75 |
S |
0.55000000000000004 |
0.10377399999999999 |
0.55000000000000004 |
ALG, ORL, TRN |
|
|
|
U48 |
R01AD08 |
|
|
|
Flutikazón |
loc. ins. nas. 400 mcg |
0.2 |
mg |
|
|
|
|
|
|
|
|
0.157 |
|
|
|
06513 |
|
|
O |
FLIXONASE NASAL DROPS |
int nas 4x7 cps |
GWE |
GB |
56 |
13.22 |
8.7899999999999991 |
S |
4.43 |
0.33509800000000001 |
4.43 |
ORL |
|
|
|
U49 |
R01AD08 |
|
|
|
Flutikazón |
loc. aer. nas. 50 mcg |
0.2 |
mg |
|
|
|
|
|
|
|
|
0.157 |
|
|
|
95234 |
|
|
G |
Nasofan 50 mikrogramová nosová aerodisperzia |
aer nas 1x120 dávok/600 mcg |
IVX |
CZ |
30 |
5.72 |
4.71 |
S |
1.01 |
0.17657299999999998 |
1.01 |
ALG, ORL, TRN |
|
|
|
U49 |
18411 |
|
|
O |
Flixonase Aqueous Nasal Spray |
aer nas 1x120 dávok |
GLA |
ES |
30 |
6.55 |
4.71 |
S |
1.84 |
0.280916 |
1.01 |
ALG, ORL, TRN |
|
|
|
U49 |
R01AD09 |
|
|
|
Mometazón |
loc. aer. nas. 50 mcg |
0.2 |
mg |
|
|
|
|
|
|
|
|
0.157 |
|
|
|
1004B |
|
|
G |
Mometasone Actavis |
aer nau 1x140 dávok (fľ.HDPE) |
ACT-5 |
IS |
35 |
6.11 |
5.5 |
S |
0.61 |
9.9835999999999994E-2 |
0.61 |
ALG, ORL, TRN |
|
|
|
U49 |
8832A |
|
|
G |
Mometasone furoate Cipla 50 mikrogramov nosová suspenzná aerodisperzia |
aer nau 1x18 g/140 dávok (fľ.PE s ručným PP dávkovačom) |
CIA-23 |
GB |
35 |
6.11 |
5.5 |
S |
0.61 |
9.9835999999999994E-2 |
0.61 |
ALG, ORL, TRN |
|
|
|
U49 |
3076A |
|
|
G |
Mometasone Sandoz 50 mikrogramov |
aer nau 1x18g/140 dávok (fľ.HDPE s rozpr.) |
SAN |
SI |
35 |
6.11 |
5.5 |
S |
0.61 |
9.9835999999999994E-2 |
0.61 |
ALG, ORL, TRN |
|
|
|
U49 |
6457A |
|
|
G |
Mometasone Sandoz 50 mikrogramov |
aer nau 3x18g/140 dávok (fľ.HDPE s rozpr.) |
SAN |
SI |
105 |
18.329999999999998 |
16.489999999999998 |
S |
1.84 |
0.100382 |
1.83 |
ALG, ORL, TRN |
|
|
|
U49 |
7409A |
|
|
G |
Mometazon Teva |
aer nau 3x18 g/140 vstrekov (fľ.HDPE s rozpraš.-multibalenie) |
TEV-SK |
SK |
105 |
18.329999999999998 |
16.489999999999998 |
S |
1.84 |
0.100382 |
1.83 |
ALG, ORL, TRN |
|
|
|
U49 |
86057 |
|
|
O |
NASONEX |
aer nau 3x18 g |
MSD-NL |
NL |
105 |
23.48 |
16.489999999999998 |
S |
6.99 |
0.29770000000000002 |
1.83 |
ALG, ORL, TRN |
|
|
|
U49 |
34008 |
|
|
O |
NASONEX |
aer nas 140x50 rg |
MSD-NL |
NL |
35 |
8.5299999999999994 |
5.5 |
S |
3.03 |
0.355217 |
0.61 |
ALG, ORL, TRN |
|
|
|
U49 |
R01AD12 |
|
|
|
Flutikazónfuroát |
loc. aer. nas. 27,5 mcg |
110 |
mcg |
|
|
|
|
|
|
|
|
0.157 |
|
|
|
47314 |
|
|
O |
AVAMYS |
aer nau 1x120 dávok/3300 µg |
GLA |
GB |
30 |
9.1300000000000008 |
4.71 |
S |
4.42 |
0.48411799999999999 |
4.42 |
ALG, ORL, TRN |
|
|
|
U49 |
R01AD58 |
|
|
|
Flutikazón, kombinácie |
loc. azelastín aer nau 137/50 mcg |
4 |
DF |
|
|
|
|
|
|
|
|
0.40400000000000003 |
|
|
|
4172A |
|
|
O |
Dymista nosová aerodisperzia |
aer nau 1x23 g (fľ.skl.hnedá s pumpou a aplik.) |
MPH |
SK |
30 |
21.65 |
12.12 |
S |
9.5299999999999994 |
0.44018500000000005 |
9.5299999999999994 |
ALG, ORL, TRN |
|
|
|
|
R03AC02 |
|
|
|
Salbutamol |
inhal. plv. inh. 100 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.128 |
|
|
|
86081 |
|
|
G |
Ventilastin Novolizer |
plv inh 1x200 dávok (min.2,308 g) (náplň PS/PP) orig.bal. |
MPH |
SK |
25 |
4.7300000000000004 |
3.2 |
S |
1.53 |
0.323467 |
0 |
|
|
|
|
|
86078 |
|
|
G |
Ventilastin Novolizer |
plv inh 1x200 dávok (min.2,308 g) (náplň PS/PP + 1 prášk.inhal.) orig.bal. |
MPH |
SK |
25 |
6.37 |
3.2 |
S |
3.17 |
0.497645 |
0 |
|
|
|
|
|
R03AC02 |
|
|
|
Salbutamol |
inhal. sol. 5 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
0.38100000000000001 |
|
|
|
94814 |
|
|
O |
Ventolin |
sol neb 20 ml/100 mg |
GWB |
GB |
12 |
3.7 |
3.7 |
A |
0 |
0 |
0 |
|
|
|
|
|
R03AC02 |
|
|
|
Salbutamol |
inhal. 100 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.111 |
|
|
|
15939 |
|
|
O |
Ventolin Inhaler N |
sus inh 1x200 ug/1 dávka |
GWP |
PL |
25 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
|
R03AC04 |
|
|
|
Fenoterol |
inhal. aerosol 100 mcg |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.115 |
|
|
|
15723 |
|
|
O |
BEROTEC N 100 |
sol inh 1x200DF/ 10 ml |
BOE |
DE |
33.338999999999999 |
4.29 |
3.83 |
S |
0.46 |
0.107226 |
0.46 |
ALG,TRN |
|
|
|
|
R03AC12 |
|
|
|
Salmeterol |
inhal. aerosol 25 mcg |
0.1 |
mg |
|
|
|
|
|
|
|
|
0.60799999999999998 |
|
|
|
36556 |
|
|
O |
SEREVENT INHALER N |
sus inh 1x120 dávok |
GLX |
PL |
30 |
18.89 |
18.239999999999998 |
S |
0.65 |
3.4409999999999996E-2 |
0.65 |
ALG, TRN |
|
|
|
|
R03AC12 |
|
|
|
Salmeterol |
inhal. plv. 50 mcg |
0.1 |
mg |
|
|
|
|
|
|
|
|
0.66900000000000004 |
|
|
|
27962 |
|
|
O |
SEREVENT DISKUS |
plv inh 60x50 ug |
GWE |
FR |
30 |
21.14 |
20.07 |
S |
1.07 |
5.0614999999999993E-2 |
1.07 |
ALG, TRN |
|
|
|
|
R03AC13 |
|
|
|
Formoterol |
inhal. plv. inh. 6 mcg |
24 |
µg |
|
|
|
|
|
|
|
|
0.8 |
|
|
|
15946 |
|
|
G |
OXIS TURBUHALER 6 ug |
plv inh 60x6 ug |
AZC |
SE |
15 |
14 |
12 |
S |
2 |
0.14285700000000001 |
2 |
ALG, TRN |
|
|
|
|
R03AC13 |
|
|
|
Formoterol |
inhal. plv.12 mcg (60 dávok) |
24 |
µg |
|
|
|
|
|
|
|
|
0.47 |
|
|
|
97305 |
|
|
G |
FORMANO |
plv icd 60 x 12 µg + 1 x inhalátor |
TMP |
PL |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
1566A |
|
|
G |
Formostad 12 mikrogramov inhalačný prášok v tvrdej kapsule |
plv icd 60x12µg (fľ.HDPE+inhalátor) |
STD |
DE |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
41312 |
|
|
G |
Formoterol -ratiopharm 12 µg |
plv icd 60x12µg + inhalátor |
RAT |
DE |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
3261A |
|
|
G |
Formoterol Sandoz 12 mikrogramov inhalačný prášok v tvrdej kapsule |
plv icd 1x60 (obal HDPE+inhalátor) |
SAN |
SI |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
42979 |
|
|
G |
FORMOVENT 12µg |
plv icd 60x12 µg+inhalátor |
ITL |
IT |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
64935 |
|
|
O |
FORADIL |
plv inh 60x12 rg+inhal. |
NHW |
GB |
30 |
17.52 |
14.1 |
S |
3.42 |
0.19520499999999999 |
0 |
ALG, TRN |
|
|
|
|
R03AC13 |
|
|
|
Formoterol |
inhal. plv.12 mcg (120 dávok) |
24 |
µg |
|
|
|
|
|
|
|
|
0.47 |
|
|
|
1567A |
|
|
G |
Formostad 12 mikrogramov inhalačný prášok v tvrdej kapsule |
plv icd 120(2x60)x12µg (fľ.HDPE+2xinhalátor) |
STD |
DE |
60 |
27.69 |
27.69 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
95077 |
|
|
G |
FORMOTEROL EASYHALER |
plv inh 1x120 dávok |
ORN |
FI |
60 |
39.5 |
28.2 |
S |
11.3 |
0.286076 |
0 |
ALG, TRN |
|
|
|
|
R03AC13 |
|
|
|
Formoterol |
inhal. sol. 12 mcg |
24 |
µg |
|
|
|
|
|
|
|
|
0.54300000000000004 |
|
|
|
91631 |
|
|
G |
ATIMOS 12 µg inhalačný roztok v tlakovom obale |
sol inh 1x100 dávok/1200 µg +aplikátor |
CHS-AT |
AT |
50 |
28.3 |
27.15 |
S |
1.1499999999999999 |
4.0635999999999999E-2 |
0 |
ALG, TRN |
|
|
|
|
9817A |
|
|
G |
Formoterol Cipla 12 mikrogramov |
sus inh 1x120 dávok (nád.Al tlak.) |
CIA-BE |
BE |
60 |
33.96 |
32.58 |
S |
1.38 |
4.0635999999999999E-2 |
0 |
ALG, TRN |
|
|
|
|
R03AC18 |
|
|
|
Indakaterol |
inhal. 150 mcg |
150 |
mcg |
|
|
|
|
|
|
|
|
0.93700000000000006 |
|
|
|
85159 |
|
|
O |
Onbrez Breezhaler 150 mcg |
plv icd 30x150 mcg |
NEH |
GB |
30 |
29.33 |
28.11 |
S |
1.22 |
4.1596000000000001E-2 |
1.22 |
TRN |
ind.obm. |
|
|
|
R03AC19 |
|
|
|
Olodaterol |
inhal. sol. 2,5 mcg (60 dávok) |
5 |
mcg |
|
|
|
|
|
|
|
|
0.90200000000000002 |
|
|
|
7576A |
|
|
O |
Striverdi Respimat |
sol ihl 1x(1 inh.+1 náplň/60 vstrekov) (náplň PE/PP) |
BOE |
DE |
30 |
28.28 |
27.06 |
S |
1.22 |
4.3139999999999998E-2 |
1.22 |
TRN |
ind.obm. |
|
|
|
R03AK03 |
|
|
|
Fenoterol a iné antiastmatiká |
inhal. s ipratrópiom 50/20 mcg |
6 |
DF |
|
|
|
|
|
|
|
|
0.217 |
|
|
|
15722 |
|
|
O |
BERODUAL N |
sol inh 1x200DF/10 ml |
BOE |
DE |
33.332999999999998 |
8.07 |
7.23 |
S |
0.84 |
0.10408899999999999 |
0.84 |
ALG, TRN |
|
|
|
|
R03AK06 |
|
|
|
Salmeterol a ostatné antiastmatiká |
inhal. 25/50 plv. inh. |
4 |
DF |
|
|
|
|
|
|
|
|
0.76600000000000001 |
|
|
|
13426 |
|
|
O |
SERETIDE 50 INHALER N |
sus inh 120x25/50 ug |
GWL |
GB |
30 |
25.03 |
22.98 |
S |
2.0499999999999998 |
8.1902000000000003E-2 |
2.0499999999999998 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK06 |
|
|
|
Salmeterol a ostatné antiastmatiká |
inhal. 25/125 plv. inh. |
4 |
DF |
|
|
|
|
|
|
|
|
0.66700000000000004 |
|
|
|
9683A |
|
|
G |
FULLHALE 25 mikrogramov/125 mikrogramov/dávka inhalačná suspenzia v tlakovom obale |
sus inh 1x120 dávok (nád.tlak.Al) |
CIA-BE |
BE |
30 |
21.86 |
20.010000000000002 |
S |
1.85 |
8.4628999999999996E-2 |
1.85 |
ALG, TRN |
ind.obm. |
|
|
|
13427 |
|
|
O |
SERETIDE 125 INHALER N |
sus inh 120x25/125 ug |
GWL |
GB |
30 |
33.18 |
20.010000000000002 |
S |
13.17 |
0.396926 |
1.85 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK06 |
|
|
|
Salmeterol a ostatné antiastmatiká |
inhal. 50/100 plv. inh. |
2 |
DF |
|
|
|
|
|
|
|
|
0.74299999999999999 |
|
|
|
45961 |
|
|
O |
SERETIDE DISKUS 50/100 |
plv inh 60x50 µg/100 µg (blis.PVC) |
GLA |
GB |
30 |
23.79 |
22.29 |
S |
1.5 |
6.3051999999999997E-2 |
1.5 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK06 |
|
|
|
Salmeterol a ostatné antiastmatiká |
inhal. 50/100 plv. inh. Combopack |
2 |
DF |
|
|
|
|
|
|
|
|
0.74299999999999999 |
|
|
|
45962 |
|
|
O |
SERETIDE DISKUS 50/100 |
plv inh 180x50/100 |
GLA |
GB |
90 |
83.2 |
66.87 |
S |
16.329999999999998 |
0.196274 |
4.5 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK06 |
|
|
|
Salmeterol a ostatné antiastmatiká |
inhal. 50/250 plv. inh. |
2 |
DF |
|
|
|
|
|
|
|
|
0.92500000000000004 |
|
|
|
45964 |
|
|
O |
SERETIDE DISKUS 50/250 |
plv inh 60x50/250 |
GOW |
GB |
30 |
30.73 |
27.75 |
S |
2.98 |
9.6974000000000005E-2 |
2.98 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK06 |
|
|
|
Salmeterol a ostatné antiastmatiká |
inhal. 50/250 plv. inh. Combopack |
2 |
DF |
|
|
|
|
|
|
|
|
1.17 |
|
|
|
45965 |
|
|
O |
SERETIDE DISKUS 50/250 |
plv inh 180x50/250 |
GLA |
GB |
90 |
115.09 |
105.3 |
S |
9.7899999999999991 |
8.5063999999999987E-2 |
8.94 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK06 |
|
|
|
Salmeterol a ostatné antiastmatiká |
inhal. 25/250 plv. inh. |
4 |
DF |
|
|
|
|
|
|
|
|
0.86199999999999999 |
|
|
|
9684A |
|
|
G |
FULLHALE 25 mikrogramov/250 mikrogramov/dávka inhalačná suspenzia v tlakovom obale |
sus inh 1x120 dávok (nád.tlak.Al) |
CIA-BE |
BE |
30 |
28.3 |
25.86 |
S |
2.44 |
8.6219000000000004E-2 |
2.44 |
ALG, TRN |
ind.obm. |
|
|
|
13428 |
|
|
O |
SERETIDE 250 INHALER N |
sus inh 120x25/250 ug |
GWL |
GB |
30 |
43.55 |
25.86 |
S |
17.690000000000001 |
0.40619999999999995 |
2.44 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK06 |
|
|
|
Salmeterol a ostatné antiastmatiká |
inhal. 50/500 plv. inh. |
2 |
DF |
|
|
|
|
|
|
|
|
1.1990000000000001 |
|
|
|
45958 |
|
|
O |
SERETIDE DISKUS 50/500 |
plv inh 60x50/500 |
GOW |
GB |
30 |
40.58 |
35.97 |
S |
4.6100000000000003 |
0.11360300000000001 |
4.6100000000000003 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK06 |
|
|
|
Salmeterol a ostatné antiastmatiká |
inhal. 50/500 plv. inh. Combopack |
2 |
DF |
|
|
|
|
|
|
|
|
1.43 |
|
|
|
45959 |
|
|
O |
SERETIDE DISKUS 50/500 |
plv inh 180x50/500 |
GLA |
GB |
90 |
144.79 |
128.69999999999999 |
S |
16.09 |
0.111126 |
13.83 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK07 |
|
|
|
Formoterol a iné antiastmatiká |
inhal. s beklometazónom 100/6 mcg |
4 |
DF |
|
|
|
|
|
|
|
|
1.0549999999999999 |
|
|
|
38996 |
|
|
O |
FOSTER |
sol inh 1x180 dávok |
CHS-AT |
AT |
45 |
47.47 |
47.47 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
38995 |
|
|
O |
FOSTER |
sol inh 1x120 dávok |
CHS-AT |
AT |
30 |
37.03 |
31.65 |
S |
5.38 |
0.145288 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK07 |
|
|
|
Formoterol a iné antiastmatiká |
inhal. s beklometazónom 100/6 mcg plv. inh. |
3 |
DF |
|
|
|
|
|
|
|
|
0.89800000000000002 |
|
|
|
3311A |
|
|
O |
Foster Nexthaler |
plv inh, 120x100µg/6 µg (inhalátor PET/Al/PE viacdávkový) |
CHS |
AT |
40 |
38.47 |
35.92 |
S |
2.5499999999999998 |
6.6284999999999997E-2 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK07 |
|
|
|
Formoterol a iné antiastmatiká |
inhal. s budezonidom 100/6 mcg plv. inh. |
3 |
DF |
|
|
|
|
|
|
|
|
0.68899999999999995 |
|
|
|
13225 |
|
|
O |
SYMBICORT TURBUHALER 100/6 ug |
plv inh 1x120 |
AZC |
SE |
40 |
34.880000000000003 |
27.56 |
S |
7.32 |
0.20986199999999999 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK07 |
|
|
|
Formoterol a iné antiastmatiká |
inhal. s budezonidom 200/6 mcg plv. inh. |
3 |
DF |
|
|
|
|
|
|
|
|
0.84599999999999997 |
|
|
|
13227 |
|
|
O |
SYMBICORT TURBUHALER 200/6 ug |
plv inh 1x120 |
AZC |
SE |
40 |
38.200000000000003 |
33.840000000000003 |
S |
4.3600000000000003 |
0.114136 |
4.3600000000000003 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK07 |
|
|
|
Formoterol a iné antiastmatiká |
inhal. s budezonidom 400/12 mcg plv. inh. |
2 |
DF |
|
|
|
|
|
|
|
|
1.1659999999999999 |
|
|
|
33770 |
|
|
O |
SYMBICORT TURBUHALER FORTE 400/12 mcg |
plv inh 1x60 |
AZC |
SE |
30 |
37.64 |
34.979999999999997 |
S |
2.66 |
7.0669999999999997E-2 |
2.66 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK07 |
|
|
|
Formoterol a iné antiastmatiká |
inhal. s flutikazónom 125/5 mcg sus. inh. |
4 |
DF |
|
|
|
|
|
|
|
|
1.222 |
|
|
|
2174A |
|
|
O |
Flutiform 125 µg/5 µg |
sus inh 120 x 125/5 µg (nád.Al tlak.) |
MUP |
AT |
30 |
38.880000000000003 |
36.659999999999997 |
S |
2.2200000000000002 |
5.7099000000000004E-2 |
2.2200000000000002 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK07 |
|
|
|
Formoterol a iné antiastmatiká |
inhal. s flutikazónom 250/10 mcg sus. inh. |
4 |
DF |
|
|
|
|
|
|
|
|
1.7749999999999999 |
|
|
|
2175A |
|
|
O |
Flutiform 250 µg/10 µg |
sus inh 120 x 250/10 µg (nád.Al tlak.) |
MUP |
AT |
30 |
57.85 |
53.25 |
S |
4.5999999999999996 |
7.9516000000000003E-2 |
4.5999999999999996 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK10 |
|
|
|
Vilanterol a flutikazónfuroát |
inhal. 92/22 mcg (30 dávok) |
1 |
DF |
|
|
|
|
|
|
|
|
0.91500000000000004 |
|
|
|
7905A |
|
|
O |
Relvar Ellipta 92 mikrogramov/22 mikrogramov dávkovaný inhalačný prášok |
plv ido 1x30 dávk.inhalátor (strip Al) |
GLA-7 |
GB |
30 |
37.08 |
27.45 |
S |
9.6300000000000008 |
0.25970900000000002 |
9.6300000000000008 |
ALG, TRN |
ind.obm. |
|
|
|
R03AK10 |
|
|
|
Vilanterol a flutikazónfuroát |
inhal. 184/22 mcg (30 dávok) |
1 |
DF |
|
|
|
|
|
|
|
|
1.2230000000000001 |
|
|
|
7908A |
|
|
O |
Relvar Ellipta 184 mikrogramov/22 mikrogramov dávkovaný inhalačný prášok |
plv ido 1x30 dávk.inhalátor (strip Al) |
GLA-7 |
GB |
30 |
45.1 |
36.69 |
S |
8.41 |
0.186475 |
8.41 |
ALG, TRN |
ind.obm. |
|
|
|
R03AL03 |
|
|
|
Vilanterol a umeklidíniumbromid |
inhal. 55/22 mcg (30 dávok) |
1 |
DF |
|
|
|
|
|
|
|
|
1.6619999999999999 |
|
|
|
0320B |
|
|
O |
Anoro 55 mikrogramov/22 mikrogramov dávkovaný inhalačný prášok |
plv ido 1 inhalátor (30 dávok) (blis.Al) |
GLA-7 |
GB |
30 |
51.94 |
49.86 |
S |
2.08 |
4.0045999999999998E-2 |
2.08 |
TRN |
ind.obm. |
|
|
|
R03AL04 |
|
|
|
Indakaterol a glykopyróniumbromid |
inhal. 85/43 mcg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.157 |
|
|
|
7412A |
|
|
O |
Ultibro Breezhaler 85 mikrogramov/43 mikrogramov inhalačný prášok v tvrdých kapsulách |
plv icd 30x1+1 inhalátor (blis.PA/Al/PVC-Al-perf.) |
NEH |
GB |
30 |
65.180000000000007 |
64.709999999999994 |
S |
0.47 |
7.2109999999999995E-3 |
0.47 |
TRN |
ind.obm. |
|
|
|
R03AL04 |
|
|
|
Indakaterol a glykopyróniumbromid |
inhal. 85/43 mcg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.157 |
|
|
|
7413A |
|
|
O |
Ultibro Breezhaler |
plv icd 90 [3(30x1)] + 3 inhalátory |
NEH |
GB |
90 |
195.55 |
194.13 |
S |
1.42 |
7.2619999999999994E-3 |
1.41 |
TRN |
ind.obm. |
|
|
|
R03AL05 |
|
|
|
Formoterol a aklidínium |
inhal. 340/12 mcg (60 dávok) |
2 |
DF |
|
|
|
|
|
|
|
|
1.6379999999999999 |
|
|
|
3426B |
|
|
O |
Brimica Genuair 340 mikrogramov /12 mikrogramov inhalačný prášok |
plv inh 1x60 dávok (inh.plast./nehrdz.oceľ) |
AZC |
SE |
30 |
55.42 |
49.14 |
S |
6.28 |
0.113316 |
6.28 |
TRN |
ind.obm. |
|
|
|
3313B |
|
|
O |
Duaklir Genuair 340 mikrogramov/12 mikrogramov inhalačný prášok |
plv inh 1x60 dávok (inh.plast/nehrdz.oceľ) |
AZC |
SE |
30 |
55.42 |
49.14 |
S |
6.28 |
0.113316 |
6.28 |
TRN |
ind.obm. |
|
|
|
R03BA01 |
|
|
|
Beklometazón |
inhal. plv. 200 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.54849999999999999 |
|
|
|
53876 |
|
|
O |
BECLOMET EASYHALER 200 |
plv inh 1x200 dáv. |
ORN |
FI |
50 |
29.07 |
27.43 |
S |
1.64 |
5.6416000000000001E-2 |
1.64 |
ALG, ORL, TRN |
|
|
|
|
R03BA01 |
|
|
|
Beklometazón |
inhal. aerosol 100 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.377 |
|
|
|
58792 |
|
|
O |
Ecobec 100 µg |
aer ora 200x100 µg |
IVX |
CZ |
25 |
10.64 |
9.43 |
S |
1.21 |
0.11372199999999999 |
1.21 |
ALG, ORL, TRN |
|
|
|
|
R03BA01 |
|
|
|
Beklometazón |
inhal. aerosol 250 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.20910000000000001 |
|
|
|
58793 |
|
|
O |
Ecobec 250 µg |
aer ora 200x250 µg |
IVX |
CZ |
62.5 |
13.7 |
13.07 |
S |
0.63 |
4.5984999999999998E-2 |
0.63 |
ALG, ORL, TRN |
|
|
|
|
R03BA01 |
|
|
|
Beklometazón |
inhal. easi-breathe aerosol. 100 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.56499999999999995 |
|
|
|
58780 |
|
|
G |
Ecobec 100 µg Easi-Breathe |
aer ora 200x100 µg |
IVX |
CZ |
25 |
15.35 |
14.13 |
S |
1.22 |
7.9478999999999994E-2 |
1.21 |
ALG, ORL, TRN |
|
|
|
|
R03BA01 |
|
|
|
Beklometazón |
inhal. easi-breathe aerosol. 250 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.36399999999999999 |
|
|
|
58782 |
|
|
G |
Ecobec 250 µg Easi-Breathe |
aer ora 200x250 µg |
IVX |
CZ |
62.500999999999998 |
23.69 |
22.75 |
S |
0.94 |
3.9678999999999999E-2 |
0.63 |
ALG, ORL, TRN |
|
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 100 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.46 |
|
|
|
62697 |
|
|
O |
PULMICORT TURBUHALER |
plv inh 200x100 ug |
AZC |
SE |
25 |
11.48 |
11.48 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
93502 |
|
|
O |
GIONA EASYHALER 100 |
plv inh 1x200 dávok |
ORN |
FI |
25 |
18.54 |
11.5 |
S |
7.04 |
0.37972 |
0 |
ALG, TRN |
|
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 200 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.4 |
|
|
|
40585 |
|
|
O |
Budelin Novolizer 200 µg |
plv inh 200 dávok/2,18 g + aplikátor |
MPH |
SK |
50 |
19.28 |
19.28 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
93516 |
|
|
O |
GIONA EASYHALER 200 |
plv inh 1x200 dávok |
ORN |
FI |
50 |
21.69 |
20 |
S |
1.69 |
7.7915999999999999E-2 |
0 |
ALG, TRN |
|
|
|
|
33315 |
|
|
O |
MIFLONID 200 (BLIS.) |
plv inh 1x120x200ug |
PHM |
NL |
30 |
13.16 |
12 |
S |
1.1599999999999999 |
8.8146000000000002E-2 |
0 |
ALG, TRN |
|
|
|
|
69242 |
|
|
O |
PULMICORT TURBUHALER |
plv inh 200x200 ug |
AZC |
SE |
50 |
24.5 |
20 |
S |
4.5 |
0.183673 |
0 |
ALG, TRN |
|
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 200 mcg ( bezfreónový) |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.27800000000000002 |
|
|
|
64765 |
|
|
O |
BUDIAIR 0,2 MG |
sol inh 11,2 ml(200 dávok) |
CHS |
IT |
50 |
15.78 |
13.9 |
S |
1.88 |
0.11913800000000001 |
0 |
ALG, TRN |
|
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 200 mcg náplň |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.34300000000000003 |
|
|
|
40268 |
|
|
O |
Budelin Novolizer 200 µg |
plv inh 200 dávok/2,18 g |
MPH |
SK |
50 |
17.14 |
17.14 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 400 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.38 |
|
|
|
33318 |
|
|
O |
MIFLONID 400 (BLIS.) |
plv inh 1x60x400ug |
PHM |
NL |
30 |
11.1 |
11.1 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
93519 |
|
|
O |
GIONA EASYHALER 400 |
plv inh 1x100 dávok |
ORN |
FI |
50 |
22.13 |
19 |
S |
3.13 |
0.14143700000000001 |
0 |
ALG, TRN |
|
|
|
|
R03BA05 |
|
|
|
Flutikazón |
inhal. 50 mcg (bezfreónové) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.87 |
|
|
|
13971 |
|
|
O |
Flixotide 50 Inhaler N |
sus inh 120x50 ug |
GWE |
FR |
10 |
8.56 |
8.56 |
I |
0 |
0 |
0 |
ALG,TRN |
|
|
|
|
R03BA05 |
|
|
|
Flutikazón |
inhal. 125 mcg (bezfreónové) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.61299999999999999 |
|
|
|
13973 |
|
|
O |
Flixotide 125 Inhaler N |
sus inh 120x125 ug |
GWE |
FR |
25 |
17.7 |
15.33 |
S |
2.37 |
0.13389799999999999 |
2.37 |
ALG,TRN |
|
|
|
|
R03BA05 |
|
|
|
Flutikazón |
inhal. 250 mcg (bezfreónové) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.58299999999999996 |
|
|
|
13975 |
|
|
O |
Flixotide 250 Inhaler N |
sus inh 120x250 ug |
GWE |
FR |
50 |
29.99 |
29.15 |
S |
0.84 |
2.8008999999999999E-2 |
0.26 |
ALG,TRN |
|
|
|
|
R03BA05 |
|
|
|
Flutikazón |
inhal. 100 mcg |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.83199999999999996 |
|
|
|
27957 |
|
|
O |
Flixotide Diskus 100 ug |
plv inh 1x60 dávok |
GWE |
FR |
10 |
8.43 |
8.32 |
S |
0.11 |
1.3049E-2 |
0.11 |
ALG, TRN |
|
|
|
|
R03BA05 |
|
|
|
Flutikazón |
inhal. 250 mcg |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.66800000000000004 |
|
|
|
27959 |
|
|
O |
Flixotide Diskus 250 ug |
plv inh 1x60 dávok |
GWE |
FR |
25 |
16.829999999999998 |
16.7 |
S |
0.13 |
7.724E-3 |
0.13 |
ALG, TRN |
|
|
|
|
R03BA05 |
|
|
|
Flutikazón |
inhal. 500 mcg |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.57499999999999996 |
|
|
|
27961 |
|
|
O |
Flixotide Diskus 500 ug |
plv inh 1x60 dávok |
GWE |
FR |
50 |
28.73 |
28.73 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03BA07 |
|
|
|
Mometazón |
inhal. 200 mcg |
0.4 |
mg |
|
|
|
|
|
|
|
|
0.60899999999999999 |
|
|
|
33370 |
|
|
O |
ASMANEX 200 µg |
plv inh 1x60 dávok |
MSD-NL |
NL |
30 |
19.71 |
18.27 |
S |
1.44 |
7.3058999999999999E-2 |
1.44 |
ALG, TRN |
|
|
|
|
R03BA07 |
|
|
|
Mometazón |
inhal. 400 mcg |
0.4 |
mg |
|
|
|
|
|
|
|
|
0.55500000000000005 |
|
|
|
58164 |
|
|
O |
ASMANEX 400 µg |
plv inh 1x30 dávok |
MSD-NL |
NL |
30 |
18.149999999999999 |
16.649999999999999 |
S |
1.5 |
8.2644999999999996E-2 |
0 |
ALG, TRN |
|
|
|
|
R03BA07 |
|
|
|
Mometazón |
inhal. 400 mcg (60 dávok) |
0.4 |
mg |
|
|
|
|
|
|
|
|
0.55500000000000005 |
|
|
|
58165 |
|
|
O |
ASMANEX 400 µg |
plv inh 1x60 dávok |
MSD-NL |
NL |
60 |
33.1 |
33.1 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03BA08 |
|
|
|
Ciklezonid |
inhal. 160 mcg (120 dávok) |
160 |
mcg |
|
|
|
|
|
|
|
|
0.27200000000000002 |
|
|
|
42227 |
|
|
O |
ALVESCO 160 Inhalátor |
sol inh 1x(120dávokx160mcg) |
NCD-1 |
DE |
120 |
36.35 |
32.64 |
S |
3.71 |
0.102063 |
3.71 |
ALG, TRN |
|
|
|
|
R03BB01 |
|
|
|
Ipratrópiumbromid |
inhal. aerosol 20 mcg |
0.12 |
mg |
|
|
|
|
|
|
|
|
0.16 |
|
|
|
32992 |
|
|
O |
ATROVENT N 20 ug |
sol inh 10 ml (200 dávok) |
BOE |
DE |
33.332999999999998 |
5.27 |
5.27 |
I |
0 |
0 |
0 |
|
|
|
|
|
R03BB04 |
|
|
|
Tiotropiumbromid |
inhal. 18 mcg (30 ks) |
18 |
µg |
|
|
|
|
|
|
|
|
1.111 |
|
|
|
33490 |
|
|
O |
Spiriva 18 mikrogramov |
plv icd 30x18 ug |
BOE |
DE |
30 |
35.6 |
33.33 |
S |
2.27 |
6.3764000000000001E-2 |
2.27 |
TRN |
ind.obm. |
|
|
|
R03BB04 |
|
|
|
Tiotropiumbromid |
inhal. 18 mcg (90 ks) |
18 |
µg |
|
|
|
|
|
|
|
|
1.111 |
|
|
|
95777 |
|
|
O |
Spiriva 18 mikrogramov, inhalačný prášok v tvrdej kapsule |
plv icd 90x18 µg (blis.Al/PVC/Al) |
BOE |
DE |
90 |
107.16 |
99.99 |
S |
7.17 |
6.6908999999999996E-2 |
6.81 |
TRN |
ind.obm. |
|
|
|
R03BB04 |
|
|
|
Tiotropiumbromid |
inhal. sol. 2,5 mcg |
5 |
mcg |
|
|
|
|
|
|
|
|
1.1240000000000001 |
|
|
|
44379 |
|
|
O |
Spiriva Respimat |
sol inh 1x(1inh+1náplň/60 vstrekov) |
BOE |
DE |
30 |
35.46 |
33.72 |
S |
1.74 |
4.9069000000000002E-2 |
1.74 |
TRN |
ind.obm. |
|
|
|
R03BB05 |
|
|
|
Aklidíniumbromid |
inhal. 322 mcg (60 dávok) |
644 |
µg |
|
|
|
|
|
|
|
|
1.1679999999999999 |
|
|
|
2192A |
|
|
O |
Bretaris Genuair 322 mikrogramov inhalačný prášok |
plv inh 1x60x375 µg/1 dávka (inh.plast./nehrdz.oceľ) |
LTD-1 |
ES |
30 |
35.67 |
35.04 |
S |
0.63 |
1.7662000000000001E-2 |
0.63 |
TRN |
ind.obm. |
|
|
|
R03BB05 |
|
|
|
Aklidíniumbromid |
inhal. 322 mcg (180 dávok) |
644 |
µg |
|
|
|
|
|
|
|
|
1.1679999999999999 |
|
|
|
2193A |
|
|
O |
Bretaris Genuair 322 mikrogramov inhalačný prášok |
plv inh 3x60x375 µg/1 dávka (inh.plast./nehrdz.oceľ) |
LTD-1 |
ES |
90 |
108.99 |
105.12 |
S |
3.87 |
3.5508000000000005E-2 |
1.89 |
TRN |
ind.obm. |
|
|
|
R03BB06 |
|
|
|
Glykopyróniumbromid |
inhal. 44 mcg (30 ks) |
44 |
mcg |
|
|
|
|
|
|
|
|
1.0609999999999999 |
|
|
|
3012A |
|
|
O |
Seebri Breezhaler |
plv icd 30x1 (blis.AI/AI-perf.) + inhalátor |
NEH |
GB |
30 |
33.520000000000003 |
31.83 |
S |
1.69 |
5.0418000000000004E-2 |
1.69 |
TRN |
ind.obm. |
|
|
|
R03BB06 |
|
|
|
Glykopyróniumbromid |
inhal. 44 mcg (90 ks) |
44 |
mcg |
|
|
|
|
|
|
|
|
1.0609999999999999 |
|
|
|
3013A |
|
|
O |
Seebri Breezhaler |
plv icd 90x(3x30x1)(blis.AI/AI-spol.bal.)+3xinhalátor |
NEH |
GB |
90 |
113.61 |
95.49 |
S |
18.12 |
0.159493 |
5.07 |
TRN |
ind.obm. |
|
|
|
R03BC01 |
|
|
|
Nátrium chromoglykolát |
p.o. 100 mg (100 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
0.16500000000000001 |
|
|
|
93797 |
X |
|
O |
NALCROM |
cps 100x100 mg |
FIS |
GB |
125 |
23.25 |
20.63 |
S |
2.62 |
0.11268800000000001 |
2.62 |
ALG, GIT |
|
|
|
|
R03BC03 |
|
|
|
Nedokromil |
inhal. aerosol 2 mg |
8 |
mg |
|
|
|
|
|
|
|
|
0.37 |
|
|
|
56242 |
|
|
O |
TILADE MINT |
sus inh 2x112 dáv. |
FIS |
GB |
56 |
20.18 |
20.18 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03CC02 |
|
|
|
Salbutamol |
p.o. 4 mg (25 ks) |
12 |
mg |
|
|
|
|
|
|
|
|
0.34399999999999997 |
|
|
|
1417A |
X |
|
O |
Salbutamol WZF Polfa 4 mg |
tbl 25x4 mg (blis.PVC/Al) |
WZF |
PL |
8.33 |
3.48 |
2.87 |
S |
0.61 |
0.175287 |
0.61 |
ALG, GER, INT, KLF, PED, TRN |
|
|
|
|
R03CC02 |
|
|
|
Salbutamol |
p.o. 0,4 mg/ml |
12 |
mg |
|
|
|
|
|
|
|
|
0.26 |
|
|
|
09961 |
X |
|
O |
VENTOLIN |
sir 1x150 ml |
GWL |
GB |
5 |
1.37 |
1.3 |
S |
7.0000000000000007E-2 |
5.1094999999999995E-2 |
7.0000000000000007E-2 |
ALG, GER, INT, KLF, PED, TRN, URM |
|
|
|
|
R03DA04 |
|
|
|
Teofylín |
p.o. predĺžené uvoľňovanie 100 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.13700000000000001 |
|
|
|
61237 |
X |
|
G |
THEOPLUS |
tbl plg 30x100 mg |
PFB |
FR |
7.5129999999999999 |
1.46 |
1.03 |
S |
0.43 |
0.29452100000000003 |
0.43 |
|
|
|
|
|
R03DA04 |
|
|
|
Teofylín |
p.o. predĺžené uvoľňovanie 125 mg (50 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.21 |
|
|
|
25255 |
X |
|
G |
AFONILUM SR 125 MG |
cps plg 50x125 mg |
KNO |
DE |
15.615 |
3.33 |
3.28 |
S |
0.05 |
1.5015000000000001E-2 |
0.05 |
|
|
|
|
|
R03DA04 |
|
|
|
Teofylín |
p.o. predĺžené uvoľňovanie 200 mg (50 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
5.5E-2 |
|
|
|
44305 |
X |
|
O |
EUPHYLLIN CRN200 (RESPICUR 200) |
cps plg 50x200 mg |
BGL |
DE |
25 |
4.3 |
1.38 |
S |
2.92 |
0.67906999999999995 |
2.92 |
|
|
|
|
|
R03DA04 |
|
|
|
Teofylín |
p.o. predĺžené uvoľňovanie 250 mg (50 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
5.6000000000000001E-2 |
|
|
|
76650 |
X |
|
G |
AFONILUM SR 250 MG |
cps plg 50x250 mg |
KNO |
DE |
31.256 |
4.58 |
1.75 |
S |
2.83 |
0.61790400000000001 |
2.83 |
|
|
|
|
|
R03DA04 |
|
|
|
Teofylín |
p.o. predĺžené uvoľňovanie 300 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.1105 |
|
|
|
61238 |
X |
|
G |
THEOPLUS |
tbl plg 30x300 mg |
PFB |
FR |
22.513000000000002 |
3.02 |
2.4900000000000002 |
S |
0.53 |
0.17549700000000001 |
0.53 |
|
|
|
|
|
R03DA04 |
|
|
|
Teofylín |
p.o. predĺžené uvoľňovanie 300 mg (50 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.1105 |
|
|
|
44307 |
X |
|
O |
EUPHYLLIN CRN300 (RESPICUR 300) |
cps plg 50x300 mg |
BGL |
DE |
37.512999999999998 |
5.99 |
4.1500000000000004 |
S |
1.84 |
0.30717899999999998 |
0.88 |
|
|
|
|
|
R03DA04 |
|
|
|
Teofylín |
p.o. predĺžené uvoľňovanie 400 mg (50 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.10299999999999999 |
|
|
|
44309 |
X |
|
O |
EUPHYLLIN CRN400 (RESPICUR 400) |
cps plg 50x400 mg |
BGL |
DE |
50 |
7.95 |
5.15 |
S |
2.8 |
0.35220100000000004 |
2.8 |
|
|
|
|
|
R03DA05 |
|
|
|
Aminofylín |
parent. 24 mg/ml |
0.6 |
g |
|
|
|
|
|
|
|
|
1.4539 |
|
|
|
00610 |
|
|
G |
SYNTOPHYLLIN |
inj 5x10 ml/240 mg |
HBS |
SK |
2 |
2.91 |
2.91 |
I |
0 |
0 |
0 |
|
|
|
|
|
R03DC01 |
|
|
|
Zafirlukast |
p.o. 20 mg (56 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.59699999999999998 |
|
|
|
25291 |
X |
|
O |
ACCOLATE 20 |
tbl flm 56x20 mg |
AZC |
GB |
28 |
17.88 |
16.72 |
S |
1.1599999999999999 |
6.4877000000000004E-2 |
1.1599999999999999 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 4 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.45300000000000001 |
|
|
|
20458 |
X |
|
G |
Actamone 4 mg |
tbl mnd 28x4 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
2949A |
X |
|
G |
ASTMASAN 4mg žuvacie tablety |
tbl mnd 28x4 mg (blis.Al/Al) |
SAN |
SI |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05089 |
X |
|
G |
Monkasta 4mg |
tbl mnd 28x4mg |
KRK |
SI |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
06003 |
X |
|
G |
Montelukast Mylan 4 mg, |
tbl mnd 28x4 mg (blis. Al/Al) |
GNS |
UK |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
51861 |
X |
|
G |
Montelukast Teva 4 mg |
tbl mnd 28x4 mg |
TEV |
IL |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
22047 |
X |
|
G |
Montexal 4 mg žuvacie tablety |
tbl mnd 28x4 mg (blis.OPA/Al/PVC/Al) |
MAP |
BG |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20356 |
X |
|
G |
SPIROMON 4 mg žuvacie tablety |
tbl mnd 28x4 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
89461 |
X |
|
G |
Montelukast STADA 4 mg žuvacie tablety |
tbl mnd 30x4 mg (blis.nylon/Alu/PVC bez označenia dní) |
STD |
DE |
12 |
5.44 |
5.44 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
22916 |
X |
|
O |
MONTELUKAST MSD 4 MG |
tbl mnd 28x4 mg |
MSD |
NL |
11.2 |
8.01 |
5.07 |
S |
2.94 |
0.36704099999999995 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
89241 |
X |
|
G |
Miralust 4mg |
tbl mnd 28x4mg (blis.PA/AI/PVC/AI) |
ZKL |
PL |
11.2 |
9.3800000000000008 |
5.07 |
S |
4.3099999999999996 |
0.45948800000000001 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 4 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.45300000000000001 |
|
|
|
22919 |
X |
|
O |
MONTELUKAST MSD 4 MG |
tbl mnd 56x4 mg |
MSD |
NL |
22.4 |
13.64 |
10.15 |
S |
3.49 |
0.25586500000000001 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 4 mg (98-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.45300000000000001 |
|
|
|
05097 |
X |
|
G |
Monkasta 4 mg žuvacie tablety |
tbl mnd 100x4mg |
KRK |
SL |
40 |
18.100000000000001 |
18.100000000000001 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 4 mg gra por (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.5349999999999999 |
|
|
|
09565 |
X |
|
G |
Montelukast Teva 4 mg granulát |
gra 28x4 mg (vre.ílov.sulf./LDPE/Al/surlyn) |
TEV-SK |
SK |
11.2 |
17.190000000000001 |
17.190000000000001 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
64444 |
X |
|
O |
SINGULAIR 4 mg granulát |
gro por 28 x 4 mg |
MSD |
NL |
11.2 |
17.190000000000001 |
17.190000000000001 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 5 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.55300000000000005 |
|
|
|
88874 |
X |
|
G |
Astmasan 5 mg žuvacie tablety |
tbl mnd 28x5 mg |
SAN |
SI |
14 |
7.73 |
7.73 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
51837 |
X |
|
G |
Montelukast Teva 5 mg |
tbl mnd 28x5 mg |
TEV |
IL |
14 |
7.73 |
7.73 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20467 |
X |
|
G |
Actamone 5 mg |
tbl mnd 28x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
14 |
7.74 |
7.74 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05108 |
X |
|
G |
Monkasta 5mg |
tbl mnd 28x5mg |
KRK |
SI |
14 |
7.74 |
7.74 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
22054 |
X |
|
G |
Montexal 5 mg žuvacie tablety |
tbl mnd 28x5 mg (blis.OPA/Al/PVC/Al) |
MAP |
BG |
14 |
7.74 |
7.74 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20349 |
X |
|
G |
SPIROMON 5 mg žuvacie tablety |
tbl mnd 28x5 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
14 |
7.74 |
7.74 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
3190A |
X |
|
G |
Belokast 5 mg |
tbl mnd 28(2x14)x5 mg (blis.Al/Al) |
BLU-SK |
SK |
14 |
7.82 |
7.74 |
S |
0.08 |
1.023E-2 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05872 |
X |
|
O |
MONTELUKAST MSD 5 MG |
tbl mnd 28x5 mg |
MSD |
NL |
14 |
9.83 |
7.74 |
S |
2.09 |
0.21261399999999997 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
89242 |
X |
|
G |
Miralust 5mg |
tbl mnd 28x5mg (blis.PA/AI/PVC/AI) |
ZKL |
PL |
14 |
10.17 |
7.74 |
S |
2.4300000000000002 |
0.23893799999999998 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 5 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.55300000000000005 |
|
|
|
05874 |
X |
|
O |
MONTELUKAST MSD 5 MG |
tbl mnd 56x5 mg (Al/Al) |
MSD |
NL |
28 |
18.27 |
15.48 |
S |
2.79 |
0.15270899999999998 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 5 mg (98-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.55300000000000005 |
|
|
|
05116 |
X |
|
G |
Monkasta 5mg žuvacie tablety |
tbl mnd 100x5mg |
KRK |
SL |
50 |
27.6 |
27.6 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20471 |
X |
|
G |
Actamone 5 mg |
tbl mnd 98x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
49 |
27.1 |
27.1 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.26300000000000001 |
|
|
|
20474 |
X |
|
G |
Actamone 10 mg |
tbl flm 28x10 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
82220 |
X |
|
G |
Astmasan 10 mg filmom obalené tablety |
tbl flm 28x10 mg |
SAN |
SI |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05053 |
X |
|
G |
Monkasta 10mg |
tbl flm 28x10mg |
KRK |
SI |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
22467 |
X |
|
G |
Montelukast Mylan 10 mg |
tbl flm 28x10 mg |
GNS |
UK |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
51849 |
X |
|
G |
Montelukast Teva 10 mg |
tbl flm 28x10 mg |
TEV |
IL |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20343 |
X |
|
G |
SPIROMON 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
3191A |
X |
|
G |
Belokast 10 mg |
tbl flm 28(2x14)x10 mg (blis.Al/Al) |
BLU-SK |
SK |
28 |
7.82 |
7.36 |
S |
0.46 |
5.8823999999999994E-2 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
22061 |
X |
|
G |
Montexal 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.PAD/PVC/Al) |
MAP |
BG |
28 |
7.82 |
7.36 |
S |
0.46 |
5.8823999999999994E-2 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05876 |
X |
|
O |
MONTELUKAST MSD 10 MG |
tbl flm 28x10 mg |
MSD |
NL |
28 |
10 |
7.36 |
S |
2.64 |
0.26400000000000001 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
89240 |
X |
|
G |
Miralust 10mg |
tbl flm 28x10mg (blis.PA/AI/PVC/AI) |
ZKL |
PL |
28 |
11.66 |
7.36 |
S |
4.3 |
0.368782 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 10 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.26300000000000001 |
|
|
|
20344 |
X |
|
G |
SPIROMON 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
56 |
14.72 |
14.72 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05878 |
X |
|
O |
MONTELUKAST MSD 10 MG |
tbl flm 56x10 mg (Al/Al) |
MSD |
NL |
56 |
18.489999999999998 |
14.73 |
S |
3.76 |
0.20335300000000001 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 10 mg (98 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.26300000000000001 |
|
|
|
20478 |
X |
|
G |
Actamone 10 mg |
tbl flm 98x10 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
98 |
25.76 |
25.76 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05060 |
X |
|
G |
Monkasta 10 filmom obalené tablety |
tbl flm 98x10mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
98 |
25.76 |
25.76 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20345 |
X |
|
G |
SPIROMON 10 mg filmom obalené tablety |
tbl flm 98x10 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
98 |
25.76 |
25.76 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DX05 |
|
|
|
Omalizumab |
s.c. 75 mg/ml |
16 |
mg |
|
|
|
|
|
|
|
|
39.4 |
|
|
|
68692 |
|
|
O |
Xolair 75 mg |
sol inj 1x 0,5 ml/75 mg |
NEH |
GB |
4.6879999999999997 |
196.54 |
184.71 |
AS |
11.83 |
6.0191000000000001E-2 |
11.83 |
ALG, TRN |
ind.obm., ZP |
|
|
|
R03DX05 |
|
|
|
Omalizumab |
s.c. 150 mg/ml |
16 |
mg |
|
|
|
|
|
|
|
|
39.06 |
|
|
|
68695 |
|
|
O |
XOLAIR 150 mg |
sol inj 1 x 1 ml/150 mg |
NEH |
GB |
9.375 |
366.07 |
366.07 |
A |
0 |
0 |
0 |
ALG, DER, TRN |
ind.obm., ZP |
|
|
|
R03DX07 |
|
|
|
Roflumilast |
p.o. 500 mcg (30 ks) |
500 |
µg |
|
|
|
|
|
|
|
|
1.3340000000000001 |
|
|
|
21490 |
X |
|
O |
Daxas |
tbl 30x500 mcg |
NCD |
DE |
30 |
46.3 |
40.020000000000003 |
S |
6.28 |
0.13563700000000001 |
6.28 |
TRN |
ind.obm. |
|
|
|
R05CA03 |
|
|
|
Guajafenezín |
parent. 0,05 g/ml |
0.9 |
g |
|
|
|
|
|
|
|
|
0.74690000000000001 |
|
|
|
58249 |
|
|
G |
GUAJACURAN 5% |
sol inj 10x10 ml |
ZNT |
CZ |
5.5540000000000003 |
10.08 |
4.1500000000000004 |
S |
5.93 |
0.58829399999999998 |
5.93 |
|
|
|
|
|
R05CB01 |
|
|
|
Acetylcysteín |
parent. 100 mg/ml |
0.5 |
g |
|
|
|
|
|
|
|
|
0.63670000000000004 |
|
|
|
88939 |
|
|
G |
ACC INJEKT |
sol inj 5x3 ml |
SAN-SLO-1 |
SI |
3 |
1.91 |
1.91 |
I |
0 |
0 |
0 |
GER, INT, KLF, PED, PLM, TRN |
|
|
|
|
R05CB13 |
|
|
|
Alfadornáza |
inhal. 1 mg/ml |
2.5 |
mg |
|
|
|
|
|
|
|
|
18.88 |
|
|
|
80404 |
|
|
O |
PULMOZYME |
sol inh 30x2,5 ml |
HLR-SK |
SK |
30 |
566.07000000000005 |
566.07000000000005 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm., ZP |
|
|
|
R05DA04 |
|
|
|
Kodeín |
p.o. 15 mg (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.49790000000000001 |
|
|
|
24942 |
|
|
G |
CODEIN SLOVAKOFARMA (BLIST.) |
tbl 10x15 mg |
ZNT |
SK |
1.5 |
3.23 |
0.75 |
S |
2.48 |
0.76780199999999998 |
2.48 |
AGG, ALG, GER, INT, KLF, MFC, ONK, ORL, PLM, TRN |
|
|
|
|
R05DA04 |
|
|
|
Kodeín |
p.o. 30 mg (10 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.49790000000000001 |
|
|
|
24946 |
|
|
G |
CODEIN SLOVAKOFARMA (BLIST.) |
tbl 10x30 mg |
ZNT |
SK |
3 |
4.12 |
1.49 |
S |
2.63 |
0.63834999999999997 |
2.63 |
AGG, ALG, GER, INT, KLF, MFC, ONK, ORL, PLM, TRN |
|
|
|
|
R06AA02 |
|
|
|
Difenhydramín |
p.o. 50 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.11990000000000001 |
|
|
|
35202 |
X |
|
G |
Calmaben |
tbl obd 30x50 mg |
RCW |
AT |
30 |
4.97 |
3.6 |
S |
1.37 |
0.27565400000000001 |
1.37 |
|
|
|
|
|
R06AB03 |
|
|
|
Dimetindén |
p.o. predĺžené uvoľňovanie 4 mg (20 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
26616 |
X |
|
O |
FENISTIL |
cps plg 20x4 mg |
XNC |
CH |
20 |
6.58 |
2.2000000000000002 |
S |
4.38 |
0.66565299999999994 |
4.38 |
|
|
|
|
U50 |
R06AB03 |
|
|
|
Dimetindén |
p.o. 1 mg/ml |
4 |
mg |
|
|
|
|
|
|
|
|
0.53800000000000003 |
|
|
|
26252 |
X |
|
O |
Fenistil |
gto por 1x20 ml |
XNC |
CH |
5 |
3.27 |
2.69 |
S |
0.57999999999999996 |
0.17736999999999997 |
0.57999999999999996 |
|
|
|
|
|
R06AD02 |
|
|
|
Prometazín |
p.o. 25 mg (20 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
33200 |
X |
|
G |
PROTHAZIN |
tbl flm 20x25 mg |
UCB |
BE |
20 |
2.12 |
2.12 |
I |
0 |
0 |
0 |
|
|
|
|
U50 |
R06AD02 |
|
|
|
Prometazín |
p.o. 1 mg/ml |
25 |
mg |
|
|
|
|
|
|
|
|
0.36180000000000001 |
|
|
|
22887 |
X |
|
G |
PROMETHAZIN 5 BERLIN-CHEMIE |
sir 1x100 ml/105 mg |
BCE |
DE |
4.1959999999999997 |
2.52 |
1.52 |
S |
1 |
0.39682499999999998 |
1 |
|
|
|
|
|
R06AD03 |
|
|
|
Tietilperazín |
p.o. 6,5 mg (50 ks) |
13 |
mg |
|
|
|
|
|
|
|
|
0.16600000000000001 |
|
|
|
09844 |
X |
|
O |
TORECAN |
tbl obd 50x6,5 mg |
KRK |
SI |
25 |
4.6100000000000003 |
4.1500000000000004 |
S |
0.46 |
9.9783000000000011E-2 |
0.46 |
|
|
|
|
|
R06AD03 |
|
|
|
Tietilperazín |
p.rect. 6,5 mg (6 ks) |
13 |
mg |
|
|
|
|
|
|
|
|
0.77010000000000001 |
|
|
|
09847 |
|
|
O |
TORECAN |
sup 6x6,5 mg |
KRK |
SI |
3 |
2.52 |
2.31 |
S |
0.21 |
8.333299999999999E-2 |
0.21 |
|
|
|
|
|
R06AE07 |
|
|
|
Cetirizín |
p.o. 10 mg (10 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
92358 |
X |
|
G |
Cetirizine Sandoz 10mg |
tbl flm 10x10 mg |
SAN |
AT |
10 |
1.49 |
0.86 |
S |
0.63 |
0.422819 |
0.4 |
|
|
|
|
U51 |
08460 |
X |
|
G |
Cetixin 10 mg filmom obalené tablety |
tbl flm 10x10 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
10 |
1.49 |
0.86 |
S |
0.63 |
0.422819 |
0.4 |
|
|
|
|
U51 |
43872 |
X |
|
G |
ALERID |
tbl flm 10x10 mg |
CIA |
IN |
10 |
1.67 |
0.86 |
S |
0.81 |
0.48503000000000002 |
0.4 |
|
|
|
|
U51 |
28950 |
X |
|
G |
ZODAC |
tbl flm 10x10 mg |
ZNT |
CZ |
10 |
1.7 |
0.86 |
S |
0.84 |
0.494118 |
0.4 |
|
|
|
|
U51 |
R06AE07 |
|
|
|
Cetirizín |
p.o. 10 mg (20 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
64867 |
X |
|
G |
ALERID |
tbl flm 20x10 mg |
CIA |
IN |
20 |
2.88 |
1.72 |
S |
1.1599999999999999 |
0.40277799999999997 |
0.8 |
|
|
|
|
U51 |
R06AE07 |
|
|
|
Cetirizín |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
08463 |
X |
|
G |
Cetixin 10 mg filmom obalené tablety |
tbl flm 30x10 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
30 |
4.41 |
2.59 |
S |
1.82 |
0.41269799999999995 |
1.19 |
|
|
|
|
U51 |
28951 |
X |
|
G |
ZODAC |
tbl flm 30x10 mg |
ZNT |
CZ |
30 |
4.6500000000000004 |
2.59 |
S |
2.06 |
0.44301099999999999 |
1.19 |
|
|
|
|
U51 |
R06AE07 |
|
|
|
Cetirizín |
p.o. 10 mg (50-60 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
92363 |
X |
|
G |
Cetirizine Sandoz 10mg |
tbl flm 60x10 mg |
SAN |
AT |
60 |
7.56 |
5.17 |
S |
2.39 |
0.31613800000000003 |
2.39 |
|
|
|
|
U51 |
08464 |
X |
|
G |
Cetixin 10 mg filmom obalené tablety |
tbl flm 50x10 mg (blis.PVC/PVDC/Al) |
VTB |
FI |
50 |
6.31 |
4.3099999999999996 |
S |
2 |
0.31695699999999999 |
1.99 |
|
|
|
|
U51 |
05496 |
X |
|
G |
ZODAC |
tbl flm 60x10 mg |
ZNT |
CZ |
60 |
7.94 |
5.17 |
S |
2.77 |
0.34886600000000001 |
2.39 |
|
|
|
|
U51 |
13723 |
X |
|
G |
CETIRIZIN-RATIOPHARM 10 mg |
tbl flm 50x10 mg |
MCK |
DE |
50 |
6.82 |
4.3099999999999996 |
S |
2.5099999999999998 |
0.368035 |
1.99 |
|
|
|
|
U51 |
64868 |
X |
|
G |
ALERID |
tbl flm 50x10 mg |
CIA |
IN |
50 |
6.99 |
4.3099999999999996 |
S |
2.68 |
0.383405 |
1.99 |
|
|
|
|
U51 |
27002 |
X |
|
O |
ZYRTEC |
tbl obd 50x10 mg |
UCB |
BE |
50 |
10.24 |
4.3099999999999996 |
S |
5.93 |
0.57910200000000001 |
1.99 |
|
|
|
|
U51 |
R06AE07 |
|
|
|
Cetirizín |
p.o. 10 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
26478 |
X |
|
G |
ALERID |
tbl flm 100x10 mg |
CIA |
IN |
100 |
13.24 |
8.6199999999999992 |
S |
4.62 |
0.348943 |
3.98 |
|
|
|
|
U51 |
99600 |
X |
|
G |
ZODAC |
tbl flm 90x10 mg |
ZNT |
CZ |
90 |
13.08 |
7.76 |
S |
5.32 |
0.40672800000000003 |
3.58 |
|
|
|
|
U51 |
R06AE07 |
|
|
|
Cetirizín |
p.o. 10 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
0.16500000000000001 |
|
|
|
66830 |
X |
|
O |
Zyrtec |
gtt por 1x20 ml/200 mg |
UCB |
BE |
20 |
3.67 |
3.3 |
S |
0.37 |
0.10081699999999999 |
0.37 |
|
|
|
|
|
15927 |
X |
|
G |
ZODAC GTT |
gto por 1x20 ml |
ZNT |
CZ |
20 |
6.23 |
3.3 |
S |
2.93 |
0.47030500000000003 |
0.37 |
|
|
|
|
|
R06AE07 |
|
|
|
Cetirizín |
p.o. 1 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
0.1958 |
|
|
|
15926 |
X |
|
G |
ZODAC SIR |
sir 1x100 ml |
ZNT |
CZ |
10 |
3.06 |
1.96 |
S |
1.1000000000000001 |
0.35947699999999999 |
1.1000000000000001 |
|
|
|
|
|
R06AE09 |
|
|
|
Levocetirizín |
p.o. 5 mg (10 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
58807 |
X |
|
G |
Levocetirizin Teva 5 mg filmom obalené tablety |
tbl flm 10x5 mg |
TEV |
SK |
10 |
0.94 |
0.86 |
S |
0.08 |
8.5106000000000001E-2 |
0 |
|
|
|
|
U51 |
50071 |
X |
|
G |
Cezera 5mg |
tbl flm 10x5mg |
KRK |
SI |
10 |
1.86 |
0.86 |
S |
1 |
0.53763399999999995 |
0 |
|
|
|
|
U51 |
R06AE09 |
|
|
|
Levocetirizín |
p.o. 5 mg (20 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
80444 |
X |
|
G |
Zenaro 5 mg |
tbl flm 20x5 mg (blist. PVC/Aclar/PVC/Al) |
ZNT |
CZ |
20 |
3.02 |
1.72 |
S |
1.3 |
0.43046399999999996 |
0 |
|
|
|
|
U51 |
R06AE09 |
|
|
|
Levocetirizín |
p.o. 5 mg (28-30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
76320 |
X |
|
G |
Levocetirizin Actavis 5 mg |
tbl flm 30x5 mg ( blis.PVC/PVDC/Al) |
ACT |
IS |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1263A |
X |
|
G |
Levocetirizin Dr. Max 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.Al/OPA/Al/PVC) |
DMX |
GB |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
80445 |
X |
|
G |
Zenaro 5 mg |
tbl flm 28x5 mg (blist. PVC/Aclar/PVC/Al) |
ZNT |
CZ |
28 |
2.91 |
2.41 |
S |
0.5 |
0.17182099999999997 |
0 |
|
|
|
|
U51 |
58816 |
X |
|
G |
Levocetirizin Teva 5 mg filmom obalené tablety |
tbl flm 30x5 mg |
TEV |
SK |
30 |
3.41 |
2.59 |
S |
0.82 |
0.24046900000000002 |
0 |
|
|
|
|
U51 |
50075 |
X |
|
G |
Cezera 5mg |
tbl flm 30x5 mg |
KRK |
SI |
30 |
3.57 |
2.59 |
S |
0.98 |
0.27451000000000003 |
0 |
|
|
|
|
U51 |
33806 |
X |
|
O |
XYZAL |
tbl flm 28x5 mg |
UCB |
IT |
28 |
6.6 |
2.41 |
S |
4.1900000000000004 |
0.63484799999999997 |
0 |
|
|
|
|
U51 |
R06AE09 |
|
|
|
Levocetirizín |
p.o. 5 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
76322 |
X |
|
G |
Levocetirizin Actavis 5 mg |
tbl flm 50x5 mg ( blis.PVC/PVDC/Al) |
ACT |
IS |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1265A |
X |
|
G |
Levocetirizin Dr. Max 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.Al/OPA/Al/PVC) |
DMX |
GB |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
58819 |
X |
|
G |
Levocetirizin Teva 5 mg filmom obalené tablety |
tbl flm 60x5 mg |
TEV |
SK |
60 |
6.11 |
5.17 |
S |
0.94 |
0.15384600000000001 |
0 |
|
|
|
|
U51 |
80446 |
X |
|
G |
Zenaro 5 mg |
tbl flm 50x5 mg (blist. PVC/Aclar/PVC/Al) |
ZNT |
CZ |
50 |
5.21 |
4.3099999999999996 |
S |
0.9 |
0.17274500000000001 |
0 |
|
|
|
|
U51 |
50076 |
X |
|
G |
Cezera 5mg |
tbl flm 50x5 mg |
KRK |
SI |
50 |
5.25 |
4.3099999999999996 |
S |
0.94 |
0.17904800000000001 |
0 |
|
|
|
|
U51 |
32720 |
X |
|
O |
XYZAL |
tbl flm 50x5 mg |
UCB |
BE |
50 |
12.68 |
4.3099999999999996 |
S |
8.3699999999999992 |
0.66009499999999999 |
0 |
|
|
|
|
U51 |
R06AE09 |
|
|
|
Levocetirizín |
p.o. 5 mg (90 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
50078 |
X |
|
G |
Cezera 5mg |
tbl flm 90x5 mg |
KRK |
SI |
90 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
76326 |
X |
|
G |
Levocetirizin Actavis 5 mg |
tbl flm 90x5 mg ( blis.PVC/PVDC/Al) |
ACT |
IS |
90 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1269A |
X |
|
G |
Levocetirizin Dr. Max 5 mg filmom obalené tablety |
tbl flm 90x5 mg (blis.Al/OPA/Al/PVC) |
DMX |
GB |
90 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
80447 |
X |
|
G |
Zenaro 5 mg |
tbl flm 90x5 mg (blist. PVC/Aclar/PVC/Al) |
ZNT |
CZ |
90 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
58820 |
X |
|
G |
Levocetirizin Teva 5 mg filmom obalené tablety |
tbl flm 90x5 mg |
TEV |
SK |
90 |
8.07 |
7.76 |
S |
0.31 |
3.8414000000000004E-2 |
0 |
|
|
|
|
U51 |
93010 |
X |
|
O |
Xyzal |
tbl flm 90x5 mg |
UCB |
IT |
90 |
21.32 |
7.76 |
S |
13.56 |
0.63602300000000001 |
0 |
|
|
|
|
U51 |
R06AE09 |
|
|
|
Levocetirizín |
p.o. 0,5 mg/ml |
5 |
mg |
|
|
|
|
|
|
|
|
0.158 |
|
|
|
30100 |
X |
|
G |
Zenaro 0,5 mg/ml sirup |
sir 1x200 ml (fľ.skl.hnedá) |
ZNT |
CZ |
20 |
5.56 |
3.16 |
S |
2.4 |
0.43165500000000001 |
2.4 |
|
|
|
|
|
35383 |
X |
|
O |
XYZAL 5mg/10ml |
sol por 1x200ml/100mg |
UCB |
IT |
20 |
6.6 |
3.16 |
S |
3.44 |
0.52121200000000001 |
2.4 |
|
|
|
|
|
R06AX |
|
|
|
Ostatné antihistaminiká na systémové použitie |
p.o. bisulepin 2 mg (20 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
02479 |
|
|
O |
DITHIADEN |
tbl 20x2 mg |
ZNT |
CZ |
10 |
3.1 |
1.1000000000000001 |
S |
2 |
0.64516099999999998 |
2 |
|
|
|
|
U50 |
R06AX |
|
|
|
Ostatné antihistaminiká na systémové použitie |
parent. bisulepin 0,5 mg/ml |
4 |
mg |
|
|
|
|
|
|
|
|
3.1202000000000001 |
|
|
|
04071 |
|
|
O |
DITHIADEN |
inj 10x2 ml |
ZNT |
CZ |
2.5 |
7.79 |
7.79 |
I |
0 |
0 |
0 |
|
|
|
|
|
R06AX02 |
|
|
|
Cyproheptadin |
p.o. 4 mg (20 ks) |
12 |
mg |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
6739A |
X |
|
G |
Peritol |
tbl 20x4mg (blis.PVC/PVDC/Al) |
EGI |
HU |
6.6840000000000002 |
1.84 |
0.74 |
S |
1.1000000000000001 |
0.59782599999999997 |
1.1000000000000001 |
|
|
|
|
U50 |
R06AX13 |
|
|
|
Loratadin |
p.o. 10 mg (10 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
88734 |
X |
|
G |
FLONIDAN 10 mg |
tbl 10x10 mg |
LEK |
SI |
10 |
1.75 |
0.86 |
S |
0.89 |
0.508571 |
0.28000000000000003 |
|
|
|
|
U51 |
R06AX13 |
|
|
|
Loratadin |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
37422 |
X |
|
G |
Flonidan Solutab 10 mg |
tbl oro 30x10 mg |
SAN |
AT |
30 |
3.43 |
2.59 |
S |
0.84 |
0.24489799999999998 |
0.84 |
|
|
|
|
U51 |
53639 |
X |
|
G |
FLONIDAN 10 mg |
tbl 30x10 mg |
LEK |
SI |
30 |
3.91 |
2.59 |
S |
1.32 |
0.33759600000000001 |
0.84 |
|
|
|
|
U51 |
34381 |
X |
|
G |
LORATADIN-ratiopharm 10 mg |
tbl 30x10 mg |
MCK |
DE |
30 |
3.91 |
2.59 |
S |
1.32 |
0.33759600000000001 |
0.84 |
|
|
|
|
U51 |
33239 |
X |
|
G |
EROLIN |
tbl 30x10 mg |
EGI |
HU |
30 |
4.29 |
2.59 |
S |
1.7 |
0.39627000000000001 |
0.84 |
|
|
|
|
U51 |
15977 |
X |
|
O |
CLARITINE |
tbl 30x10 mg |
BAY-SK-1 |
SK |
30 |
8.36 |
2.59 |
S |
5.77 |
0.690191 |
0.84 |
|
|
|
|
U51 |
R06AX13 |
|
|
|
Loratadin |
p.o. 10 mg (50 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
33763 |
X |
|
G |
Loratadin-ratiopharm 10 mg |
tbl 50x10 mg |
MCK |
DE |
50 |
6.63 |
4.3099999999999996 |
S |
2.3199999999999998 |
0.34992499999999999 |
1.4 |
|
|
|
|
U51 |
R06AX13 |
|
|
|
Loratadin |
p.o.1 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
0.17799999999999999 |
|
|
|
01700 |
X |
|
G |
FLONIDAN 5 mg/5 ml |
sus por 1x120 ml |
LEK |
SI |
12 |
3.15 |
2.14 |
S |
1.01 |
0.320635 |
1.01 |
|
|
|
|
|
R06AX17 |
|
|
|
Ketotifén |
p.o. 1 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
76382 |
X |
|
G |
DENEREL |
tbl 30x1 mg |
MOE |
CY |
15 |
3.67 |
1.65 |
S |
2.02 |
0.55040900000000004 |
2.02 |
|
|
|
|
U50 |
18530 |
X |
|
G |
Ketotifen WZF Polfa |
tbl 30x1 mg |
WZF |
PL |
15 |
3.67 |
1.65 |
S |
2.02 |
0.55040900000000004 |
2.02 |
|
|
|
|
U50 |
R06AX26 |
|
|
|
Fexofenadín |
p.o. 120 mg (30 ks) |
0.12 |
g |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
46599 |
X |
|
G |
Fexofenadin Generics 120mg |
tbl flm 30x120mg |
GNC |
GB |
30 |
3.99 |
2.59 |
S |
1.4 |
0.35087699999999999 |
1.4 |
|
|
|
|
U51 |
94880 |
X |
|
G |
Fixit 120 |
tbl flm 30x120 mg |
ZNT |
SK |
30 |
5.9 |
2.59 |
S |
3.31 |
0.56101699999999999 |
1.4 |
|
|
|
|
U51 |
R06AX26 |
|
|
|
Fexofenadín |
p.o. 120 mg (60 ks) |
0.12 |
g |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
94883 |
X |
|
G |
Fixit 120 |
tbl flm 60x120 mg |
ZNT |
SK |
60 |
10.11 |
5.17 |
S |
4.9400000000000004 |
0.48862499999999998 |
2.8 |
|
|
|
|
U51 |
R06AX26 |
|
|
|
Fexofenadín |
p.o. 180 mg (30 ks) |
0.12 |
g |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
46608 |
X |
|
G |
Fexofenadin Generics 180mg |
tbl flm 30x180 mg |
GNC |
GB |
45 |
5.24 |
3.88 |
S |
1.36 |
0.25954199999999999 |
1.36 |
|
|
|
|
U51 |
94887 |
X |
|
G |
Fixit 180 |
tbl flm 30x180 mg |
ZNT |
SK |
45 |
7.2 |
3.88 |
S |
3.32 |
0.46111099999999999 |
1.36 |
|
|
|
|
U51 |
44844 |
X |
|
O |
TELFAST 180 |
tbl flm 30x180 mg |
HMR |
DE |
45 |
8.67 |
3.88 |
S |
4.79 |
0.55247999999999997 |
1.36 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 2,5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
39719 |
X |
|
O |
Aerius 2,5 mg orodispergovateľné tablety |
tbl oro 30x2,5 mg (blis.PVC/OPA/Al) |
MSD-GB-1 |
GB |
15 |
6.84 |
1.29 |
S |
5.55 |
0.81140400000000001 |
4.8899999999999997 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 2,5 mg (60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
39721 |
X |
|
O |
Aerius 2,5 mg orodispergovateľné tablety |
tbl oro 60x2,5 mg (blis.PVC/OPA/Al) |
MSD-GB-1 |
GB |
30 |
12.94 |
2.59 |
S |
10.35 |
0.79984499999999992 |
9.77 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 2,5 mg (90 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
39722 |
X |
|
O |
Aerius 2,5 mg orodispergovateľné tablety |
tbl oro 90x2,5 mg (blis.PVC/OPA/Al) |
MSD-GB-1 |
GB |
45 |
18.54 |
3.88 |
S |
14.66 |
0.79072299999999995 |
14.66 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 5 mg (10 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
13833 |
X |
|
G |
DESLOMED 5 mg filmom obalené tablety |
tbl flm 10x5 mg (blis.PVC/Aclar/Al) |
CRR |
SK |
10 |
0.86 |
0.86 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1800A |
X |
|
G |
Desloratadin Saneca 5 mg |
tbl 10x5 mg (blis.OPA/Al/PVC/Al) |
SNC |
SK |
10 |
1.86 |
0.86 |
S |
1 |
0.53763399999999995 |
0 |
|
|
|
|
U51 |
13745 |
X |
|
O |
Aerius 5 mg filmom obalené tablety |
tbl flm 10x5 mg (blis.PCTFE/PVC/Al) |
MSD-GB-1 |
GB |
10 |
2.02 |
0.86 |
S |
1.1599999999999999 |
0.57425700000000002 |
0 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
31907 |
X |
|
G |
Desloratadine Actavis 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
30 |
2.2999999999999998 |
2.2999999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31831 |
X |
|
G |
LOTERA 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PVC/PE/PVDC/Al) |
SVS |
CZ |
30 |
2.31 |
2.31 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
30401 |
X |
|
G |
Dasselta 5mg |
tbl flm 30x5mg |
KRK |
SI |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
13834 |
X |
|
G |
DESLOMED 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PVC/Aclar/Al) |
CRR |
SK |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1802A |
X |
|
G |
Desloratadin Saneca 5 mg |
tbl 30x5 mg (blis.OPA/Al/PVC/Al) |
SNC |
SK |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31035 |
X |
|
G |
DESLORATADIN ZENTIVA 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PCTFE/PVC/Al) |
ZNT |
CZ |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
13747 |
X |
|
O |
Aerius 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PCTFE/PVC/Al) |
MSD-GB-1 |
GB |
30 |
5.93 |
2.59 |
S |
3.34 |
0.56323800000000002 |
0 |
|
|
|
|
U51 |
39731 |
X |
|
O |
Aerius 5 mg orodispergovateľné tablety |
tbl oro 30x5 mg (blis.PVC/OPA/Al) |
MSD-GB-1 |
GB |
30 |
6.84 |
2.59 |
S |
4.25 |
0.62134500000000004 |
0 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 5 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
4237A |
X |
|
G |
DELESIT 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.PVC/Aclar/Al) |
CIA-GB-1 |
UK |
50 |
4.09 |
4.09 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31908 |
X |
|
G |
Desloratadine Actavis 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
50 |
4.09 |
4.09 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
30403 |
X |
|
G |
Dasselta 5mg |
tbl flm 50x5mg |
KRK |
SI |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
13835 |
X |
|
G |
DESLOMED 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.PVC/Aclar/Al) |
CRR |
SK |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1803A |
X |
|
G |
Desloratadin Saneca 5 mg |
tbl 50x5 mg (blis.OPA/Al/PVC/Al) |
SNC |
SK |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31038 |
X |
|
G |
DESLORATADIN ZENTIVA 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.PCTFE/PVC/Al) |
ZNT |
CZ |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
32134 |
X |
|
O |
Aerius 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.PCTFE/PVC/Al) |
MSD-GB-1 |
GB |
50 |
9.61 |
4.3099999999999996 |
S |
5.3 |
0.55150900000000003 |
0 |
|
|
|
|
U51 |
39733 |
X |
|
O |
Aerius 5 mg orodispergovateľné tablety |
tbl oro 60x5 mg (blis.PVC/OPA/Al) |
MSD-GB-1 |
GB |
60 |
12.94 |
5.17 |
S |
7.77 |
0.600464 |
0 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 5 mg (90-100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
31833 |
X |
|
G |
LOTERA 5 mg filmom obalené tablety |
tbl flm 90x5 mg (blis.PVC/PE/PVDC/Al) |
SVS |
CZ |
90 |
6.93 |
6.93 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
4238A |
X |
|
G |
DELESIT 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PVC/Aclar/Al) |
CIA-GB-1 |
UK |
100 |
8.15 |
8.15 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31910 |
X |
|
G |
Desloratadine Actavis 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
100 |
8.18 |
8.18 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
30405 |
X |
|
G |
Dasselta 5mg |
tbl flm 100x5mg |
KRK |
SI |
100 |
8.57 |
8.57 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31040 |
X |
|
G |
DESLORATADIN ZENTIVA 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PCTFE/PVC/Al) |
ZNT |
CZ |
100 |
8.57 |
8.57 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
13838 |
X |
|
G |
DESLOMED 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PVC/Aclar/Al) |
CRR |
SK |
100 |
8.6199999999999992 |
8.6199999999999992 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1806A |
X |
|
G |
Desloratadin Saneca 5 mg |
tbl 100x5 mg (blis.OPA/Al/PVC/Al) |
SNC |
SK |
100 |
8.6199999999999992 |
8.6199999999999992 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
13749 |
X |
|
O |
Aerius 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PCTFE/PVC/Al) |
MSD-GB-1 |
GB |
100 |
17.829999999999998 |
8.6199999999999992 |
S |
9.2100000000000009 |
0.51654500000000003 |
0 |
|
|
|
|
U51 |
37075 |
X |
|
O |
AERIUS 5mg |
tbl flm 90x5 mg |
MSD |
GB |
90 |
16.22 |
7.76 |
S |
8.4600000000000009 |
0.52157799999999999 |
0 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 0,5 mg/ml |
5 |
mg |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
31045 |
X |
|
G |
DESLORATADIN ZENTIVA 0,5 mg/ml |
sol por 1x150 ml/75 mg (fľ.skl.jant.) |
ZNT |
CZ |
15 |
3.83 |
2.25 |
S |
1.58 |
0.41253300000000004 |
1.58 |
|
|
|
|
|
0484A |
X |
|
G |
JOVESTO 0,5mg/ml perorálny roztok |
sol por 1 x 150ml/75mg+lyž.odm. (fľ.skl.jant.) |
SAN |
SI |
15 |
4.7300000000000004 |
2.25 |
S |
2.48 |
0.52431300000000003 |
1.58 |
|
|
|
|
|
39741 |
X |
|
O |
Aerius 0,5 ml/ml perorálny roztok |
sol por 1x150 ml/75 mg (fľa.skl.+plast.lyžica) |
MSD-GB-1 |
GB |
15 |
5.22 |
2.25 |
S |
2.97 |
0.56896599999999997 |
2.97 |
|
|
|
|
|
39738 |
X |
|
O |
Aerius 0,5 ml/ml perorálny roztok |
sol por 1x60 ml/30 mg (fľa.skl.+plast.lyžica) |
MSD-GB-1 |
GB |
6 |
2.67 |
0.9 |
S |
1.77 |
0.66292100000000009 |
1.19 |
|
|
|
|
|
R06AX28 |
|
|
|
Rupatadín |
p.o. 1 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
0.497 |
|
|
|
32377 |
|
|
O |
Rupafin 1mg / ml perorálny roztok |
sol por 1x120 ml (fľ.lPET) + peror.striek. |
XJU |
ES |
12 |
8.9499999999999993 |
5.96 |
S |
2.99 |
0.33407800000000004 |
2.99 |
ALG |
ind.obm. |
|
|
|
R06AX28 |
|
|
|
Rupatadín |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
39614 |
X |
|
O |
Rupafin 10 mg tablety |
tbl 30x10mg |
XJU |
ES |
30 |
9.58 |
8.1 |
S |
1.48 |
0.15448899999999999 |
0.48 |
|
|
|
|
U52 |
R06AX28 |
|
|
|
Rupatadín |
p.o. 10 mg (50 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
39615 |
X |
|
O |
Rupafin 10 mg tablety |
tbl 50x10mg |
XJU |
ES |
50 |
14.3 |
13.5 |
S |
0.8 |
5.5944000000000001E-2 |
0.8 |
|
|
|
|
U52 |
R06AX28 |
|
|
|
Rupatadín |
p.o. 10 mg (100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
39616 |
X |
|
O |
Rupafin 10 mg tablety |
tbl 100x10mg |
XJU |
ES |
100 |
28.6 |
27 |
S |
1.6 |
5.5944000000000001E-2 |
1.6 |
|
|
|
|
U52 |
R06AX29 |
|
|
|
Bilastín |
p.o. 20 mg (10 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
04073 |
|
|
O |
Omarit |
tbl 10x20 mg (blis.PA/Al/PVC/Al) |
MNR |
LU |
10 |
3.15 |
2.7 |
S |
0.45 |
0.14285700000000001 |
0 |
|
|
|
|
U52 |
R06AX29 |
|
|
|
Bilastín |
p.o. 20 mg (30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
04076 |
|
|
O |
Omarit |
tbl 30x20 mg (blis.PA/Al/PVC/Al) |
MNR |
LU |
30 |
8.06 |
8.06 |
I |
0 |
0 |
0 |
|
|
|
|
U52 |
R06AX29 |
|
|
|
Bilastín |
p.o. 20 mg (50 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
04078 |
|
|
O |
Omarit |
tbl 50x20 mg (blis. PA/Al/PVC/Al) |
MIOL |
LU |
50 |
15 |
13.5 |
S |
1.5 |
0.1 |
1.5 |
|
|
|
|
U52 |
R07AX |
|
|
|
Kolistimetát sodný |
inhal. 125 mg (56 ks) |
250 |
mg |
|
|
|
|
|
|
|
|
35.713999999999999 |
|
|
|
8339A |
|
|
O |
Colobreathe 1 662 500 IU inhalačný prášok v tvrdej kapsule |
plv icd 56(7x8)x1 662 500 IU (blis.PA/Al/PVC/polyester/Al+1 zar. na inh.prášku-Turbosin) |
FRS-1 |
GB |
28 |
1176.3699999999999 |
999.99 |
S |
176.38 |
0.14993600000000001 |
176.38 |
ALG, TRN |
|
|
|
|
S01AA11 |
|
|
|
Gentamycín |
loc.3 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.255 |
|
|
|
51664 |
|
|
O |
GENTAMICIN 0,3% WZF POLFA |
int opo 1x5 ml |
WZF |
PL |
5 |
2.52 |
1.28 |
S |
1.24 |
0.49206299999999997 |
1.24 |
|
|
|
|
|
S01AA12 |
|
|
|
Tobramycín |
loc. 3 mg/ml depot |
1 |
ml |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
85041 |
|
|
O |
TOBRAVISC 0,3% (3 mg/ml) |
int opo 1x5 ml/15 mg |
ALC-E |
E |
5 |
4.79 |
1.35 |
S |
3.44 |
0.718163 |
1.1299999999999999 |
OPH |
|
|
|
|
S01AA12 |
|
|
|
Tobramycín |
loc. 3 mg/g |
1 |
ml |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
93207 |
|
|
O |
TOBREX |
ung oph 1x3,5 g 0,3% |
ACU |
BE |
3.5 |
2.13 |
0.81 |
S |
1.32 |
0.61971799999999999 |
1.32 |
OPH |
|
|
|
|
S01AA12 |
|
|
|
Tobramycín |
loc. 3 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
86264 |
|
|
O |
TOBREX |
int opo 1x5 ml |
ACU |
BE |
5 |
2.2799999999999998 |
1.1499999999999999 |
S |
1.1299999999999999 |
0.495614 |
1.1299999999999999 |
OPH |
|
|
|
|
S01AA20 |
|
|
|
Antibiotiká v kombinácii s inými liečivami |
loc. neomyc./bacitracin/hydrok. ung. |
1 |
g |
|
|
|
|
|
|
|
|
0.1726 |
|
|
|
01077 |
|
|
G |
OPHTHALMO-FRAMYKOIN COMPOSITUM |
ung oph 1x5 g |
ZNT |
CZ |
5 |
3.14 |
0.86 |
S |
2.2799999999999998 |
0.72611500000000007 |
2.2799999999999998 |
OPH |
|
|
|
|
S01AA24 |
|
|
|
Kanamycín |
loc. 5 mg/g |
1 |
ml |
|
|
|
|
|
|
|
|
9.2899999999999996E-2 |
|
|
|
12967 |
|
|
O |
KANAMYCIN-POS |
ung oph 1x2,5 g |
URS |
DE |
2.5 |
3.4 |
0.23 |
S |
3.17 |
0.93235299999999999 |
3.17 |
|
|
|
|
|
S01AA24 |
|
|
|
Kanamycín |
loc. 5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
9.2899999999999996E-2 |
|
|
|
83772 |
|
|
O |
KANAMYCIN-POS |
int opo 1x5 ml |
URS |
DE |
5 |
2.96 |
0.46 |
S |
2.5 |
0.8445950000000001 |
2.5 |
|
|
|
|
|
S01AA30 |
|
|
|
Kombinácie rôznych antibiotík |
loc. neomycin/bacitracin ung. |
1 |
g |
|
|
|
|
|
|
|
|
0.1726 |
|
|
|
01076 |
|
|
O |
OPHTHALMO-FRAMYKOIN |
ung oph 5 g |
ZNT |
CZ |
5 |
3.54 |
0.86 |
S |
2.68 |
0.7570619999999999 |
2.68 |
|
|
|
|
|
S01AB04 |
|
|
|
Sulfacetamid |
loc.100 mg/ml. |
1 |
ml |
|
|
|
|
|
|
|
|
0.14940000000000001 |
|
|
|
93577 |
|
|
O |
SULPHACETAMID 10% Polpharma |
int opo 12x0,5 ml |
XPO |
PL |
6 |
1.62 |
0.9 |
S |
0.72 |
0.44444400000000001 |
0.72 |
|
|
|
|
|
S01AX11 |
|
|
|
Ofloxacín |
loc. 3 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.28999999999999998 |
|
|
|
33433 |
|
|
O |
UNIFLOX 0,3 % |
int oph/oto 1x10ml (PE) |
XUN |
SK |
10 |
3.22 |
2.9 |
S |
0.32 |
9.9379000000000009E-2 |
0.32 |
OPH, ORL |
|
|
|
U88 |
S01AX13 |
|
|
|
Ciprofloxacin |
loc. 3 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.28999999999999998 |
|
|
|
14611 |
|
|
G |
Ciplox 3,33 mg |
int opt 1x5 ml (liek.PE) |
CIA-GB-1 |
GB |
5 |
3.56 |
1.45 |
S |
2.11 |
0.59269700000000003 |
2.11 |
OPH, ORL |
|
|
|
U88 |
89831 |
|
|
O |
CILOXAN |
int opt 1x5 ml |
ACU |
BE |
5 |
3.57 |
1.45 |
S |
2.12 |
0.59383799999999998 |
2.11 |
OPH, ORL |
|
|
|
U88 |
S01AX19 |
|
|
|
Levofloxacin |
loc. 5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
1.1100000000000001 |
|
|
|
92187 |
|
|
O |
OFTAQUIX 5 mg/ml |
int opo 1x5 ml/25 mg (fľaša LDPE) |
SOY |
FR |
5 |
7.62 |
5.55 |
S |
2.0699999999999998 |
0.27165400000000001 |
2.0699999999999998 |
OPH |
|
|
|
U89 |
S01AX22 |
|
|
|
Moxifloxacin |
loc. 5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
1.1100000000000001 |
|
|
|
78700 |
|
|
O |
Vigamox |
int opo 1x5 ml/25 mg |
ACU |
BE |
5 |
6.94 |
5.55 |
S |
1.39 |
0.20028799999999999 |
1.39 |
OPH |
|
|
|
U89 |
S01BA01 |
|
|
|
Dexametazón |
loc. intravitreálny implantát |
700 |
µg |
|
|
|
|
|
|
|
|
1100.67 |
|
|
|
21707 |
|
|
O |
Ozurdex |
imp ivt 1x700 µg (vrecko s aplik.syst.) |
ALL |
IE |
1 |
1100.6600000000001 |
1100.6600000000001 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
S01BA02 |
|
|
|
Hydrokortizón |
loc.5 mg/g |
1 |
g |
|
|
|
|
|
|
|
|
0.18920000000000001 |
|
|
|
02668 |
|
|
O |
OPHTHALMO-HYDROCORTISON LÉČIVA |
ung oph 1x5 g 0,5% |
ZNT |
CZ |
5 |
1.76 |
0.95 |
S |
0.81 |
0.460227 |
0.81 |
ALG, DER, OPH, ORL |
|
|
|
|
S01BA07 |
|
|
|
Fluorometolón |
loc. 1 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.19700000000000001 |
|
|
|
93933 |
|
|
O |
EFFLUMIDEX |
int opu 5 ml |
ALL |
DE |
5 |
2.0499999999999998 |
0.99 |
S |
1.06 |
0.517073 |
1.06 |
OPH |
|
|
|
|
S01BA14 |
|
|
|
Loteprednol etabonát |
loc. 5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.53 |
|
|
|
94442 |
|
|
O |
Lotemax |
int opu 1x 5 ml |
MNN |
DE |
5 |
9.24 |
2.65 |
S |
6.59 |
0.71320300000000003 |
6.59 |
OPH |
|
|
|
|
S01BC03 |
|
|
|
Diklofenak |
loc. 1 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.33529999999999999 |
|
|
|
33187 |
|
|
O |
UNICLOPHEN 0,1% |
int opo 1x10 ml (fľa PE) |
XUN |
SK |
10 |
3.35 |
3.35 |
I |
0 |
0 |
0 |
OPH |
|
|
|
|
S01CA |
|
|
|
Kortikosteroidy kombinované s antinfektívami |
loc. chloramfen./dexametazón gtt./sus. |
1 |
ml |
|
|
|
|
|
|
|
|
0.55769999999999997 |
|
|
|
76499 |
|
|
O |
Spersadex comp. |
int opo 1x5 ml (fľ.LDPE) |
LTH |
FR |
5 |
4.0599999999999996 |
2.79 |
S |
1.27 |
0.31280799999999997 |
1.27 |
OPH |
|
|
|
|
S01CA01 |
|
|
|
Dexametazón a antiinfektíva |
loc. gentamicín |
1 |
ml |
|
|
|
|
|
|
|
|
0.29870000000000002 |
|
|
|
18639 |
|
|
O |
Dexa-Gentamicin |
int opo 1x5 ml |
URS |
DE |
5 |
2.62 |
1.49 |
S |
1.1299999999999999 |
0.43129800000000001 |
1.01 |
OPH |
|
|
|
|
S01CA01 |
|
|
|
Dexametazón a antiinfektíva |
loc. gentamicín masť |
1 |
ml |
|
|
|
|
|
|
|
|
0.29870000000000002 |
|
|
|
25345 |
|
|
O |
DEXA-GENTAMICIN |
ung oph 2,5 g |
URS |
DE |
2.5059999999999998 |
2.93 |
0.75 |
S |
2.1800000000000002 |
0.74402699999999999 |
1.52 |
OPH |
|
|
|
|
S01CA01 |
|
|
|
Dexametazón a antiinfektíva |
loc. tobramicín |
1 |
ml |
|
|
|
|
|
|
|
|
0.3 |
|
|
|
57866 |
|
|
O |
TOBRADEX |
int opu 1x5 ml |
ACU |
BE |
5 |
2.5099999999999998 |
1.5 |
S |
1.01 |
0.40238999999999997 |
1.01 |
OPH |
|
|
|
|
S01CA01 |
|
|
|
Dexametazón a antiinfektíva |
loc. tobramicín masť |
1 |
ml |
|
|
|
|
|
|
|
|
0.3 |
|
|
|
40587 |
|
|
O |
TOBRADEX |
ung oph 3,5 g |
ACU |
BE |
3.5 |
3.17 |
1.05 |
S |
2.12 |
0.66876999999999998 |
2.12 |
OPH |
|
|
|
|
S01EA05 |
|
|
|
Brimonidín |
loc. 2 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
40457 |
|
|
G |
BRIMONAL 0,2% |
int opo 1x10 ml |
XUN |
SK |
50 |
10.79 |
10.79 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
|
51889 |
|
|
G |
LUXFEN 2 mg/ml |
int opo 1x5ml/10mg |
PRW |
CZ |
25 |
6.91 |
5.5 |
S |
1.41 |
0.20405200000000001 |
0 |
OPH |
ind.obm. |
|
|
|
S01EB01 |
|
|
|
Pilokarpín |
loc. 20 mg/ml |
0.4 |
ml |
|
|
|
|
|
|
|
|
9.6299999999999997E-2 |
|
|
|
33228 |
|
|
O |
PILOKARPIN 2 % |
int opo 1x10 ml (PE) |
XUN |
SK |
25 |
3.07 |
2.41 |
S |
0.66 |
0.21498400000000001 |
0.66 |
OPH |
|
|
|
|
S01EB01 |
|
|
|
Pilokarpín |
loc.10 mg/ml |
0.4 |
ml |
|
|
|
|
|
|
|
|
0.1095 |
|
|
|
33175 |
|
|
O |
PILOKARPIN 1% (PE) |
int opo 1x10 ml |
XUN |
SK |
25 |
2.73 |
2.73 |
I |
0 |
0 |
0 |
OPH |
|
|
|
|
S01EC01 |
|
|
|
Acetazolamid |
p.o. 250 mg (20 ks) |
0.75 |
g |
|
|
|
|
|
|
|
|
0.29870000000000002 |
|
|
|
00113 |
|
|
G |
DILURAN (blis.) |
tbl 20x250 mg |
ZNT |
CZ |
6.6630000000000003 |
2.0699999999999998 |
1.99 |
S |
0.08 |
3.8647000000000001E-2 |
0.08 |
|
|
|
|
|
S01EC03 |
|
|
|
Dorsolamid |
loc. 20 mg/ml |
0.3 |
ml |
|
|
|
|
|
|
|
|
0.26500000000000001 |
|
|
|
84731 |
|
|
O |
TRUSOPT 2% očná instilácia |
int opo 1x5 ml/100 mg |
MSD |
FR |
16.667999999999999 |
5.59 |
4.42 |
S |
1.17 |
0.20930199999999999 |
1.17 |
OPH |
ind.obm. |
|
|
U55 |
89739 |
|
|
O |
TRUSOPT 2% |
int opo 3x5 ml/100 mg |
MSD |
NL |
50.003999999999998 |
18.940000000000001 |
13.25 |
S |
5.69 |
0.30042200000000002 |
3.51 |
OPH |
ind.obm. |
|
|
U55 |
02747 |
|
|
G |
Dozotens 20 mg/ml |
int opo 1x5 ml/100 mg |
PRS |
GR |
16.667999999999999 |
7.27 |
4.42 |
S |
2.85 |
0.39202199999999998 |
1.17 |
OPH |
ind.obm. |
|
|
U55 |
S01EC04 |
|
|
|
Brinzolamid 1% |
loc.10 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.26500000000000001 |
|
|
|
4058B |
|
|
G |
Brizadopt 10 mg/ml |
int opu 1x5 ml/50 mg (fľ.LDPE) |
PRW |
CZ |
25 |
6.75 |
6.63 |
S |
0.12 |
1.7778000000000002E-2 |
0.12 |
OPH |
ind.obm. |
|
|
U55 |
03907 |
|
|
O |
AZOPT |
int opu 1x5 ml |
ACU |
BE |
25 |
10.39 |
6.63 |
S |
3.76 |
0.36188599999999999 |
3.76 |
OPH |
ind.obm. |
|
|
U55 |
41157 |
|
|
O |
AZOPT |
int opu 3x5 ml |
ALC-GB |
GB |
75 |
32.19 |
19.88 |
S |
12.31 |
0.38241700000000001 |
11.28 |
OPH |
ind.obm. |
|
|
U55 |
S01EC54 |
|
|
|
Brinzolamid, kombinácie |
loc. brimonidín (1 ks) |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.55900000000000005 |
|
|
|
1228B |
|
|
O |
SIMBRINZA 10 mg/ml + 2 mg/ml očná suspenzná instilácia |
int opu 1x5 ml (fľ.LDPE) |
ALC |
GB |
25 |
16.760000000000002 |
13.98 |
S |
2.78 |
0.16587099999999999 |
2.78 |
OPH |
ind.obm. |
|
|
|
S01EC54 |
|
|
|
Brinzolamid, kombinácie |
loc. brimonidín (3 ks) |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.55900000000000005 |
|
|
|
1229B |
|
|
O |
SIMBRINZA 10 mg/ml + 2 mg/ml očná suspenzná instilácia |
int opu 3x5 ml (fľ.LDPE) |
ALC |
GB |
75 |
50.49 |
41.93 |
S |
8.56 |
0.169539 |
8.34 |
OPH |
ind.obm. |
|
|
|
S01ED01 |
|
|
|
Timolol |
loc. 2,5 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
2.9899999999999999E-2 |
|
|
|
33169 |
|
|
O |
TIMOLOL 0,25% (PE) |
int opo 10 ml |
XUN |
SK |
50 |
2.31 |
1.5 |
S |
0.81 |
0.35064899999999999 |
0.81 |
OPH |
|
|
|
|
S01ED01 |
|
|
|
Timolol |
loc. 5 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
3.9800000000000002E-2 |
|
|
|
33172 |
|
|
O |
TIMOLOL 0,5% (PE) |
int opo 1x10 ml |
XUN |
SK |
50 |
2.78 |
1.99 |
S |
0.79 |
0.28417300000000001 |
0 |
OPH |
|
|
|
|
S01ED01 |
|
|
|
Timolol |
loc. hypromelóza 5 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
5.9700000000000003E-2 |
|
|
|
13206 |
|
|
O |
UNITIMOLOL 0,5% (PE.FĽ.) |
int opo 3x5 ml |
XUN |
SK |
73.8 |
4.1100000000000003 |
4.1100000000000003 |
I |
0 |
0 |
0 |
OPH |
|
|
|
|
13204 |
|
|
O |
UNITIMOLOL 0,5% (PE.FĽ.) |
int opo 1x10 ml |
XUN |
SK |
46.9 |
2.73 |
2.73 |
I |
0 |
0 |
0 |
OPH |
|
|
|
|
S01ED02 |
|
|
|
Betaxolol |
loc. 2,5 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.12 |
|
|
|
27289 |
|
|
O |
BETOPTIC S |
int opu 1x5 ml |
ACU |
BE |
25 |
3.64 |
3 |
S |
0.64 |
0.17582400000000001 |
0.64 |
OPH |
|
|
|
U82 |
S01ED02 |
|
|
|
Betaxolol |
loc. 5 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.12 |
|
|
|
90415 |
|
|
O |
BETALMIC 0,5% |
int opo 1x10 ml |
XUN |
SK |
50 |
5.8 |
5.8 |
I |
0 |
0 |
0 |
OPH |
|
|
|
U82 |
91624 |
|
|
O |
BETOPTIC |
int opo 5 ml |
ALC |
CH |
25 |
3.06 |
3 |
S |
0.06 |
1.9608E-2 |
0 |
OPH |
|
|
|
U82 |
S01ED05 |
|
|
|
Karteolol |
loc. 20 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.17899999999999999 |
|
|
|
92976 |
|
|
G |
Carteol LP 2% |
int plg 1x3 ml |
CUA |
FR |
15 |
3.27 |
2.69 |
S |
0.57999999999999996 |
0.17736999999999997 |
0.57999999999999996 |
OPH |
|
|
|
|
92977 |
|
|
G |
Carteol LP 2% |
int plg 3x3 ml |
CUA |
FR |
45 |
9.94 |
8.06 |
S |
1.88 |
0.189135 |
1.74 |
OPH |
|
|
|
|
55844 |
|
|
O |
ARTEOPTIC 2% |
int opo 1x5 ml (fľ. PE) |
LTH |
FR |
25 |
6.52 |
4.4800000000000004 |
S |
2.04 |
0.31288300000000002 |
0.97 |
OPH |
|
|
|
|
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. brinzolamid int. opu. 10/5 mg (1 ks) |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.44700000000000001 |
|
|
|
62782 |
|
|
O |
Azarga |
int opu 1x5 ml |
ALC-GB |
GB |
25 |
13.15 |
11.18 |
S |
1.97 |
0.14981 |
1.97 |
OPH |
ind.obm. |
|
|
|
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. brinzolamid int. opu. 10/5 mg (3 ks) |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.44700000000000001 |
|
|
|
62783 |
|
|
O |
Azarga |
int opu 3x5 ml |
ALC-GB |
GB |
75 |
39.58 |
33.53 |
S |
6.05 |
0.15285500000000002 |
5.91 |
OPH |
ind.obm. |
|
|
|
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. dorzolamid int. oph., bez konzervačných látok |
0.4 |
ml |
|
|
|
|
|
|
|
|
0.42599999999999999 |
|
|
|
06651 |
|
|
O |
COSOPT FREE |
int opo 60x0,2 ml (4 vrecká s 15 jednod.obalmi) |
MSD |
NL |
30 |
16.7 |
12.78 |
S |
3.92 |
0.234731 |
0 |
OPH |
ind.obm. |
|
|
|
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. bimatoprost int. oph. |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.32100000000000001 |
|
|
|
35457 |
|
|
G |
Ganfort |
int opo, 3x3ml (300 µg/ ml+5 mg/ml) |
ALL |
IE |
90 |
48.56 |
28.89 |
S |
19.670000000000002 |
0.40506599999999998 |
19.670000000000002 |
OPH |
ind.obm. |
|
|
U54 |
35456 |
|
|
O |
Ganfort |
int opo 1x3ml |
ALL |
IE |
30 |
16.579999999999998 |
9.6300000000000008 |
S |
6.95 |
0.41918 |
6.56 |
OPH |
ind.obm. |
|
|
U54 |
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. brimonidín int.oph. |
0.17 |
ml |
|
|
|
|
|
|
|
|
0.376 |
|
|
|
97794 |
|
|
O |
COMBIGAN |
int opo 1x5ml |
ALL |
IE |
29.41 |
12.72 |
11.06 |
S |
1.66 |
0.13050300000000001 |
1.66 |
OPH |
ind.obm. |
|
|
|
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. dorzolamid int. oph. (1ks) |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.35199999999999998 |
|
|
|
14684 |
|
|
O |
COSOPT |
int opo 1x5 ml |
LMK |
FR |
25 |
8.7799999999999994 |
8.7799999999999994 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
|
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. dorzolamid int. oph. (3ks) |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.35199999999999998 |
|
|
|
89721 |
|
|
O |
COSOPT |
int opo 3x5 ml |
MSD |
NL |
75 |
26.34 |
26.34 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
|
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. latanoprost int. oph. |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.32100000000000001 |
|
|
|
08146 |
|
|
G |
Xaloptic combi |
int opo 3x2,5 ml (50 µg/1 ml + 5 mg/1 ml) (fľ.LDPE) |
PHC-2 |
PL |
75 |
26.78 |
24.08 |
S |
2.7 |
0.10082200000000001 |
2.7 |
OPH |
ind.obm. |
|
|
U54 |
05867 |
|
|
O |
XALACOM |
int opo 3x2,5 ml (fľ.HDPE) |
PFI-GB-3 |
GB |
75 |
29.31 |
24.08 |
S |
5.23 |
0.17843699999999998 |
2.7 |
OPH |
ind.obm. |
|
|
U54 |
81425 |
|
|
O |
XALACOM |
int opo 1x2,5 ml (fľ.HDPE) |
PFI-GB-3 |
GB |
25 |
10.029999999999999 |
8.0299999999999994 |
S |
2 |
0.199402 |
0.9 |
OPH |
ind.obm. |
|
|
U54 |
08145 |
|
|
G |
Xaloptic Combi |
int opo 1x2,5 ml (50 µg/1 ml + 5 mg/1 ml) (fľ.LDPE) |
PHC-2 |
PL |
25 |
12.23 |
8.0299999999999994 |
S |
4.2 |
0.343418 |
0.9 |
OPH |
ind.obm. |
|
|
U54 |
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. travoprost int. oph. (1ks) |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.32100000000000001 |
|
|
|
35206 |
|
|
O |
DuoTrav |
int opo 1x2,5 ml |
ACU |
BE |
25 |
14.56 |
8.0299999999999994 |
S |
6.53 |
0.44848900000000003 |
6.53 |
OPH |
ind.obm. |
|
|
U54 |
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. travoprost int. oph. (3ks) |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.32100000000000001 |
|
|
|
35207 |
|
|
O |
DuoTrav |
int opo 3x2,5 ml |
ACU |
BE |
75 |
45.85 |
24.08 |
S |
21.77 |
0.47480899999999998 |
19.59 |
OPH |
ind.obm. |
|
|
U54 |
S01EE01 |
|
|
|
Latanoprost |
loc. 50 mcg/ml |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.20300000000000001 |
|
|
|
4319A |
|
|
G |
MONOPOST 50 mikrogramov/ml |
int osd 30(6x5)x0,2 ml (obal LDPE jednodáv.) |
LTH |
FR |
60 |
12.16 |
12.16 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
U53 |
58892 |
|
|
O |
XALATAN |
int opo 3x2,5 ml (fľaša LDPE predtvarovaná) |
PFI-GB-3 |
GB |
75 |
19.48 |
15.23 |
S |
4.25 |
0.218172 |
4.25 |
OPH |
ind.obm. |
|
|
U53 |
1589B |
|
|
G |
Akistan 50 mikrogramov/ml očná roztoková instilácia |
int opo 3x 2,5 ml (fľ.PE s kvapkadlom) |
PML |
AT |
75 |
20.94 |
15.23 |
S |
5.71 |
0.27268399999999998 |
4.25 |
OPH |
ind.obm. |
|
|
U53 |
22562 |
|
|
G |
Arulatan 50 mikrogramov/ml |
int opo 1 x 2,5 ml |
MNN |
DE |
25 |
6.99 |
5.08 |
S |
1.91 |
0.27324700000000002 |
1.42 |
OPH |
ind.obm. |
|
|
U53 |
5256A |
|
|
G |
Akistan 50 mikrogramov/ml očná roztoková instilácia |
int opo 1x 2,5 ml (fľ.PE s kvapkadlom) |
PML |
AT |
25 |
7.32 |
5.08 |
S |
2.2400000000000002 |
0.30601099999999998 |
1.42 |
OPH |
ind.obm. |
|
|
U53 |
76586 |
|
|
G |
Solusin 50 mikrogramov/ml očná roztoková instilácia |
int opo 1x2,5 ml (fľ. LDPE) |
GNN |
CZ |
25 |
7.32 |
5.08 |
S |
2.2400000000000002 |
0.30601099999999998 |
1.42 |
OPH |
ind.obm. |
|
|
U53 |
80243 |
|
|
G |
UNILAT 50 mikrogramov/ml očná roztoková instilácia |
int opo 1x2,5 ml/125 ug (fľ. PE s kvapkadlom) |
XUN |
SK |
25 |
7.32 |
5.08 |
S |
2.2400000000000002 |
0.30601099999999998 |
1.42 |
OPH |
ind.obm. |
|
|
U53 |
76587 |
|
|
G |
Solusin 50 mikrogramov/ml očná roztoková instilácia |
int opo 3x2,5 ml (fľ. LDPE) |
GNN |
CZ |
75 |
24.03 |
15.23 |
S |
8.8000000000000007 |
0.36620900000000001 |
4.25 |
OPH |
ind.obm. |
|
|
U53 |
80249 |
|
|
G |
UNILAT 50 mikrogramov/ml očná roztoková instilácia |
int opo 3x2,5 ml/125 ug (fľ. PE s kvapkadlom) |
XUN |
SK |
75 |
24.5 |
15.23 |
S |
9.27 |
0.37836700000000001 |
4.25 |
OPH |
ind.obm. |
|
|
U53 |
21313 |
|
|
G |
LATALUX 50 mikrogramov očná roztoková instilácia |
int opo 1x2,5ml/125 ug (fľ LDPE) |
PRW |
CZ |
25 |
8.5299999999999994 |
5.08 |
S |
3.45 |
0.40445500000000001 |
1.42 |
OPH |
ind.obm. |
|
|
U53 |
3986A |
|
|
G |
Xaloptic |
int opo 3x2,5 ml (fľ. LDPE) |
PHK |
PL |
75 |
26.4 |
15.23 |
S |
11.17 |
0.42310599999999998 |
4.25 |
OPH |
ind.obm. |
|
|
U53 |
69810 |
|
|
O |
XALATAN |
int opo 1x2,5 ml (fľaša LDPE predtvarovaná) |
PFI-GB-3 |
GB |
25 |
8.81 |
5.08 |
S |
3.73 |
0.42338299999999995 |
1.42 |
OPH |
ind.obm. |
|
|
U53 |
78342 |
|
|
G |
Latanoprost Actavis 50 mikrogramov/ml |
int opo 3x2,5 ml/125 µg (fľ. LDPE) |
ACT-5 |
IS |
75 |
31.96 |
15.23 |
S |
16.73 |
0.52346700000000002 |
4.25 |
OPH |
ind.obm. |
|
|
U53 |
S01EE03 |
|
|
|
Bimatoprost |
loc. 0,1 mg/ml |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.20300000000000001 |
|
|
|
87160 |
|
|
O |
Lumigan |
int opo 3x3 ml/0,3 mg (fľaša LDPE) |
ALL |
IR |
90 |
45.05 |
18.27 |
S |
26.78 |
0.59445099999999995 |
26.78 |
OPH |
ind.obm. |
|
|
U53 |
87158 |
|
|
O |
Lumigan |
int opo 1x3 ml/0,3 mg (fľaša LDPE) |
ALL |
IE |
30 |
17.43 |
6.09 |
S |
11.34 |
0.6506019999999999 |
11.34 |
OPH |
ind.obm. |
|
|
U53 |
S01EE03 |
|
|
|
Bimatoprost |
loc. 0,3 mg/ml |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.33100000000000002 |
|
|
|
8688A |
|
|
G |
Bimican 0,3 mg/ml |
int opo 3x3 ml (fľ.PE) |
PHC-2 |
PL |
90 |
29.77 |
29.77 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
|
8687A |
|
|
G |
Bimican 0,3 mg/ml |
int opo 1x3 ml (fl.PE) |
PHC-2 |
PL |
30 |
11.77 |
9.93 |
S |
1.84 |
0.15633 |
0 |
OPH |
ind.obm. |
|
|
|
47592 |
|
|
O |
Lumigan 0,3 mg/ml očná roztoková instilácia |
int opo 1x3 ml/0,9 mg (fľaša LDPE) |
ALL |
IE |
30 |
14.61 |
9.93 |
S |
4.68 |
0.32032899999999997 |
0 |
OPH |
ind.obm. |
|
|
|
S01EE04 |
|
|
|
Travoprost |
loc. 30 mcg/ml (1ks) |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
9373A |
|
|
O |
IZBA 30 mikrogramov/ml očná roztoková instilácia |
int opo 1x2,5 ml (fľ.PP) |
ALC |
GB |
25 |
19 |
7 |
S |
12 |
0.631579 |
9.75 |
OPH |
ind.obm. |
|
|
|
S01EE04 |
|
|
|
Travoprost |
loc. 30 mcg/ml (3ks) |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
9374A |
|
|
O |
IZBA 30 mikrogramov/ml očná roztoková instilácia |
int opo 3x2,5 ml (fľ.PP) |
ALC |
GB |
75 |
50.25 |
21 |
S |
29.25 |
0.58209 |
29.25 |
OPH |
ind.obm. |
|
|
|
S01EE04 |
|
|
|
Travoprost |
loc. 40 mcg/ml |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.20300000000000001 |
|
|
|
9389A |
|
|
G |
Bondulc 40 mikrogramov/ml |
int opo 1x2,5 ml (fľ.PP) |
ACT-5 |
IS |
25 |
7.68 |
5.08 |
S |
2.6 |
0.33854200000000001 |
2.6 |
OPH |
ind.obm. |
|
|
U53 |
8333A |
|
|
G |
Travoprost Polpharma 40 mikrogramov/ml |
int opo 3x2,5 ml (fl.PE) |
ZKL-2 |
PL |
75 |
24.75 |
15.23 |
S |
9.52 |
0.38464599999999999 |
7.8 |
OPH |
ind.obm. |
|
|
U53 |
8332A |
|
|
G |
Travoprost Polpharma 40 mikrogramov/ml |
int opo 1x2,5 ml (fl.PE) |
ZKL-2 |
PL |
25 |
10.65 |
5.08 |
S |
5.57 |
0.52300499999999994 |
2.6 |
OPH |
ind.obm. |
|
|
U53 |
44755 |
|
|
O |
Travatan |
int opo 3x2,5 ml |
ALC-GB |
GB |
75 |
35.51 |
15.23 |
S |
20.28 |
0.57110700000000003 |
7.8 |
OPH |
ind.obm. |
|
|
U53 |
S01EE05 |
|
|
|
Tafluprost |
loc. 15 mcg/ml |
0.3 |
ml |
|
|
|
|
|
|
|
|
0.377 |
|
|
|
78611 |
|
|
O |
TAFLOTAN |
int opo 30 (3x10)x0,3 ml/4,5 mg (obal LDPE jednodávk.) |
SOY |
FI |
30 |
16.940000000000001 |
11.31 |
S |
5.63 |
0.33234900000000001 |
5.63 |
OPH |
ind.obm. |
|
|
|
78612 |
|
|
O |
TAFLOTAN |
int opo 90 (9x10)x0,3 ml/4,5 mg (obal LDPE jednodávk.) |
SOY |
FI |
90 |
57.04 |
33.93 |
S |
23.11 |
0.40515400000000001 |
16.89 |
OPH |
ind.obm. |
|
|
|
S01FA06 |
|
|
|
Tropikamid |
loc. 5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.16270000000000001 |
|
|
|
41549 |
|
|
O |
UNITROPIC 0,5% |
int opo 1x 10 ml |
XUN |
SK |
10 |
3.31 |
1.63 |
S |
1.68 |
0.50755300000000003 |
1.68 |
OPH |
ind.obm. |
|
|
|
S01GX |
|
|
|
Ostatné antialergiká |
loc. antazolin/tetryzolin gtt./sus. |
1 |
ml |
|
|
|
|
|
|
|
|
0.23569999999999999 |
|
|
|
91093 |
|
|
O |
SPERSALLERG |
int opo 1x10 ml (fľ.HDPE) |
LHH1 |
FR |
10 |
3.51 |
2.36 |
S |
1.1499999999999999 |
0.32763500000000001 |
1.1499999999999999 |
|
|
|
|
|
S01GX06 |
|
|
|
Emedastín |
loc. 0,5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
1.2569999999999999 |
|
|
|
66135 |
|
|
O |
EMADINE 0,05% |
int oph 1x5 ml |
ACU |
BE |
5 |
9.4499999999999993 |
6.29 |
S |
3.16 |
0.33439200000000002 |
3.16 |
ALG, OPH, ORL |
|
|
|
|
S01GX07 |
|
|
|
Azelastín |
loc. 0,5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.76700000000000002 |
|
|
|
13435 |
|
|
O |
ANTALERG (plast) |
int oph 1x10 ml |
XUN |
SK |
10 |
8.2799999999999994 |
7.67 |
S |
0.61 |
7.3671E-2 |
0.61 |
ALG, OPH, ORL |
|
|
|
|
54475 |
|
|
O |
ALLERGODIL OČNÁ INSTILÁCIA |
int oph 1x6 ml 0,5% |
MDM |
DE |
6 |
6.38 |
4.5999999999999996 |
S |
1.78 |
0.278997 |
0.37 |
ALG, OPH, ORL |
|
|
|
|
13436 |
|
|
O |
ANTALERG (plast) |
int oph 1x5 ml |
XUN |
SK |
5 |
5.78 |
3.84 |
S |
1.94 |
0.33563999999999999 |
0.31 |
ALG, OPH, ORL |
|
|
|
|
S01GX08 |
|
|
|
Ketotifén |
loc.0,25 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
1.429 |
|
|
|
33168 |
|
|
O |
Zaditen |
int opo 1x5 ml (fľ.LDPE) |
LTH |
FR |
5 |
9.1300000000000008 |
7.15 |
S |
1.98 |
0.21686699999999998 |
1.98 |
ALG, OPH |
|
|
|
|
S01GX09 |
|
|
|
Olopatadín |
loc. 1 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.84099999999999997 |
|
|
|
8694A |
|
|
G |
ALERPALUX 1 mg/ml |
int opo 1x5 ml (fľ.LDPE) |
PRW |
CZ |
5 |
4.2 |
4.2 |
I |
0 |
0 |
0 |
OPH, ALG |
|
|
|
|
23144 |
|
|
O |
OPATANOL 1 mg/ ml |
int opo 1x5 ml |
ACU |
BE |
5 |
6.48 |
4.21 |
S |
2.27 |
0.35030900000000004 |
0 |
OPH, ALG |
|
|
|
|
S01GX10 |
|
|
|
Epinastín |
loc. 0,5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.73699999999999999 |
|
|
|
42276 |
|
|
O |
PURIVIST |
int opo 1x 5 ml |
ALL |
IE |
5 |
6.6 |
3.69 |
S |
2.91 |
0.440909 |
2.91 |
ALG, OPH |
|
|
|
|
S01HA02 |
|
|
|
Oxybuprokain |
loc.4 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.28100000000000003 |
|
|
|
33232 |
|
|
O |
BENOXI |
int oph 1x10 ml (PE) |
XUN |
SK |
10 |
2.78 |
2.78 |
A |
0 |
0 |
0 |
OPH |
|
|
|
|
S01JA01 |
|
|
|
Fluoresceín |
parent. 100 mg/ml |
5 |
ml |
|
|
|
|
|
|
|
|
6.6390000000000002 |
|
|
|
44881 |
|
|
O |
Fluorescite |
sol inj 12 x 5ml |
ACU |
BE |
12 |
81.94 |
79.67 |
AS |
2.27 |
2.7703000000000002E-2 |
2.27 |
OPH |
|
|
|
|
S01LA01 |
|
|
|
Verteporfin |
parent. plv. |
15 |
mg |
|
|
|
|
|
|
|
|
1127.96 |
|
|
|
13730 |
|
|
O |
VISUDYNE |
plv ifo 1x15 mg |
CBV |
CH |
1 |
1127.96 |
1127.96 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
S01LA03 |
|
|
|
Pegaptanib |
loc. 0,3 mg |
0.3 |
mg |
|
|
|
|
|
|
|
|
558.99 |
|
|
|
97424 |
|
|
O |
MACUGEN 0,3 mg injekčný roztok |
sol inj 1x90 µl/0,3 mg (striek.naplnená+pripev.piest.tyčinkou, bez ihly) |
PRW |
CZ |
1 |
558.99 |
558.99 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
S01LA04 |
|
|
|
Ranibizumab |
intravitreálne 10 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
829.78 |
|
|
|
37085 |
|
|
O |
Lucentis |
sol inj 1x0,23 ml/2,3 mg |
NEH |
GB |
1 |
829.78 |
829.78 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
9706A |
|
|
O |
Lucentis 10 mg/ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj 1 x 0,165 ml/1,65 mg |
NEH |
GB |
1 |
829.78 |
829.78 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
S01LA05 |
|
|
|
Aflibercept |
intravitreálne 40 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
842.09 |
|
|
|
3407A |
|
|
O |
Eylea 40 mg/ml injekčný roztok v injekčnej liekovke |
sol inj 1x 0,1ml/4 mg (liek.inj.skl.) |
BYE |
DE |
1 |
842.09 |
842.09 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
S02AA04 |
|
|
|
Octan a vínan hlinitý |
loc.10% |
1 |
ml |
|
|
|
|
|
|
|
|
6.3100000000000003E-2 |
|
|
|
18362 |
|
|
G |
Instillatio aluminii acetico-tartarici |
int oto 1x20 g (fľa. plast.) |
VUL |
SK |
20 |
2.04 |
1.26 |
S |
0.78 |
0.382353 |
0.78 |
|
|
|
|
|
S02BA |
|
|
|
Kortikosteroidy |
loc. dexamet.+cinchok. |
1 |
ml |
|
|
|
|
|
|
|
|
0.85199999999999998 |
|
|
|
84575 |
|
|
O |
OTOBACID N |
int ots 1x5 ml (liek.skl.) |
CHS-SK |
SK |
5 |
5.75 |
4.26 |
S |
1.49 |
0.25913000000000003 |
1.49 |
ORL, PED, URM |
|
|
|
|
V01AA |
|
|
|
Extrakty alergénov |
parent. diagnostické alergény |
1 |
DF |
|
|
|
|
|
|
|
|
17.3 |
|
|
|
69225 |
|
|
O |
Soluprick SQ (DIAG.) |
sol inj 1x2 ml (alergén, kontrola) |
XLL |
AT |
1 |
16.78 |
16.78 |
A |
0 |
0 |
0 |
|
|
|
|
|
V01AA |
|
|
|
Extrakty alergénov |
p.o. H-AL |
1 |
DF |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
14593 |
|
|
O |
H-AL PER OS (MIX) |
gtt por 6x9 ml PNU |
SVF |
CZ |
6 |
31.84 |
27.06 |
S |
4.78 |
0.15012600000000001 |
4.78 |
ALG |
|
|
|
|
54545 |
|
|
O |
H-AL PER OS (POLLENS) JSK,JSA |
gtt por 6x9 ml |
SVF |
CZ |
6 |
53.64 |
45.59 |
S |
8.0500000000000007 |
0.15007500000000001 |
8.0500000000000007 |
ALG |
|
|
|
|
14592 |
|
|
O |
H-AL PER OS (MIX) |
gtt por 1x9 ml PNU |
SVF |
CZ |
1 |
25.51 |
21.68 |
S |
3.83 |
0.15013699999999999 |
0.8 |
ALG |
|
|
|
|
54543 |
|
|
O |
H-AL PER OS (POLLENS) JSK,JSA |
gtt por 1x9 ml |
SVF |
CZ |
1 |
25.84 |
21.96 |
S |
3.88 |
0.15015499999999998 |
1.34 |
ALG |
|
|
|
|
V01AA |
|
|
|
Extrakty alergénov |
parent. terapeutické |
1 |
DF |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
28409 |
|
|
O |
POLLINEX RYE (300SU+800SU+2KU) |
sus inj 3x0,5 ml |
AGT |
GB |
3 |
87.97 |
74.77 |
S |
13.2 |
0.15005100000000002 |
13.2 |
ALG |
|
|
|
|
28410 |
|
|
O |
POLLINEX TREE (300 SU+800 SU+2 KU) |
sus inj 3x0,5 ml |
AGT |
GB |
3 |
87.97 |
74.77 |
S |
13.2 |
0.15005100000000002 |
13.2 |
ALG |
|
|
|
|
28202 |
|
|
O |
POLLINEX RYE (2000 SU) |
sus inj 3x0,5 ml |
AGT |
GB |
3 |
104.82 |
89.1 |
S |
15.72 |
0.14997099999999999 |
13.2 |
ALG |
|
|
|
|
28203 |
|
|
O |
POLLINEX TREE (2000 SU) |
sus inj 3x0,5 ml |
AGT |
GB |
3 |
104.82 |
89.1 |
S |
15.72 |
0.14997099999999999 |
13.2 |
ALG |
|
|
|
|
69197 |
|
|
O |
ALUTARD SQ (TERAP.-vial 1,2,3,4) |
sus inj 4x5 ml 0,1-100 ku/ml |
XLL |
ES |
4 |
157.21 |
133.63 |
S |
23.58 |
0.14999000000000001 |
17.600000000000001 |
ALG |
|
|
|
|
69204 |
|
|
O |
ALUTARD SQ (TERAP.) |
sus inj 1x5 ml 100 ku/ ml |
XLL |
ES |
1 |
148.63999999999999 |
126.34 |
S |
22.3 |
0.15002700000000002 |
4.4000000000000004 |
ALG |
|
|
|
|
V01AA02 |
|
|
|
Extrakty alergénov |
p.o. tbl slg |
1 |
DF |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
85039 |
|
|
O |
Oralair 300 IR |
tbl slg 1x30x300 IR (blis. PA/Al/PVC/Al) |
SLG |
FR |
30 |
71.75 |
60.99 |
S |
10.76 |
0.14996499999999999 |
10.76 |
ALG |
|
|
|
|
85038 |
|
|
O |
Oralair 100 IR & 300 IR |
tbl slg 1x3x100 IR + 1x28x300 IR (blis.PA/Al/PVC/Al) |
SLG |
FR |
31 |
75.739999999999995 |
64.38 |
S |
11.36 |
0.14998699999999998 |
11.12 |
ALG |
|
|
|
|
85040 |
|
|
O |
Oralair 300 IR |
tbl slg 3x30x300 IR (blis. PA/Al/PVC/Al) |
SLG |
FR |
90 |
240.42 |
204.36 |
S |
36.06 |
0.14998799999999998 |
32.28 |
ALG |
|
|
|
|
V01AA02 |
|
|
|
Extrakty alergénov |
p.o. lyo por |
1 |
DF |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
37072 |
|
|
O |
GRAZAX |
lyo por 30x75 000 SQ-T |
AAO |
DK |
30 |
73.11 |
62.14 |
S |
10.97 |
0.15004799999999999 |
10.97 |
ALG |
|
|
|
|
V01AA02 |
|
|
|
Extrakty alergénov |
p.o. lyo por (100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
37073 |
|
|
O |
GRAZAX |
lyo por 100x75 000 SQ-T |
AAO |
DK |
100 |
292.56 |
248.68 |
S |
43.88 |
0.14998600000000001 |
36.57 |
ALG |
|
|
|
|
V01AA20 |
|
|
|
Extrakty alergénov |
p.o. terapeutické alergény |
1 |
DF |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
02657 |
|
|
G |
Pangramin SLIT Monodose |
sol slg 90x0,2 ml/200 STU |
AAO |
ES |
1 |
145.88999999999999 |
124.01 |
S |
21.88 |
0.149976 |
9.61 |
ALG |
|
|
|
|
V01AA20 |
|
|
|
Extrakty alergénov |
p.o. |
1 |
DF |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
56795 |
|
|
O |
STALORAL |
sol por 4x10 ml |
SLG |
FR |
4 |
56.22 |
47.79 |
S |
8.43 |
0.149947 |
8.43 |
ALG |
|
|
|
|
56796 |
|
|
O |
STALORAL |
sol por 2x10 ml |
SLG |
FR |
2 |
60.61 |
51.52 |
S |
9.09 |
0.149975 |
4.22 |
ALG |
|
|
|
|
V01AA20 |
|
|
|
Extrakty alergénov |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
44190 |
|
|
O |
PHOSTAL |
sus inj 4x5 ml |
SLG |
FR |
4 |
56.99 |
48.44 |
S |
8.5500000000000007 |
0.15002599999999999 |
0 |
ALG |
|
|
|
|
44191 |
|
|
O |
PHOSTAL |
sus inj 1x5 ml |
SLG |
FR |
1 |
48.74 |
41.43 |
S |
7.31 |
0.149979 |
0 |
ALG |
|
|
|
|
V01AA20 |
|
|
|
Extrakty alergénov |
p.o. terapeutické, dávkovacia pumpa |
1 |
DF |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
95607 |
|
|
O |
Staloral 300 |
sol slg 2x10ml (2x300IR/ml) |
SLG |
FR |
1 |
64.08 |
54.47 |
S |
9.61 |
0.14996899999999999 |
9.61 |
ALG |
|
|
|
|
95606 |
|
|
O |
Staloral 300 |
sol slg 3x10ml (1x10 IR/ml + 2x300IR/ml) |
SLG |
FR |
1 |
66.150000000000006 |
56.23 |
S |
9.92 |
0.14996200000000001 |
9.61 |
ALG |
|
|
|
|
V01AA20 |
|
|
|
Extrakty alergénov |
parent. diagnostické alergény |
1 |
DF |
|
|
|
|
|
|
|
|
16.28 |
|
|
|
53626 |
|
|
O |
ALYOSTAL PRICK |
sol inj 1x3 ml |
SLG |
FR |
1 |
16.27 |
16.27 |
A |
0 |
0 |
0 |
ALG |
|
|
|
|
V03A |
|
|
|
Všetky ostatné liečivá |
loc. antistafyl. fágový lyzát sus. |
20 |
ml |
|
|
|
|
|
|
|
|
12.534000000000001 |
|
|
|
24546 |
|
|
O |
STAFAL |
sol loc 1x10 ml |
IMZ |
CZ |
0.5 |
7.65 |
6.27 |
S |
1.38 |
0.180392 |
1.38 |
|
|
|
|
|
V03AB15 |
|
|
|
Naloxón |
parent. 0,4 mg/ml |
0.4 |
mg |
|
|
|
|
|
|
|
|
6.6 |
|
|
|
94763 |
|
|
G |
NALOXONE WZF POLFA |
sol inj 10x1 ml/0,4 mg |
WZF |
PL |
1 |
10.65 |
6.6 |
AS |
4.05 |
0.38028200000000001 |
4.05 |
|
|
|
|
|
V03AB25 |
|
|
|
Flumazenyl |
parent. 0,1 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
1.66 |
|
|
|
53544 |
|
|
G |
Flumazenil Pharmaselect 0,1 mg/ml |
sol ifc 5x5 ml/0,5 mg |
PML |
AT |
25 |
50.58 |
41.5 |
AS |
9.08 |
0.17951799999999998 |
9.08 |
ANS, GER, INT, KLF, PED, URM |
|
|
|
|
V03AC03 |
|
|
|
Deferasirox |
p.o. 250 mg (28 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1 |
|
|
|
36482 |
|
|
O |
EXJADE 250 mg |
tbl dsp 28x250 mg |
NEH |
GB |
350 |
347.35 |
347.35 |
I |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
V03AC03 |
|
|
|
Deferasirox |
p.o. 500 mg (28 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.95 |
|
|
|
36484 |
|
|
O |
EXJADE 500 mg |
tbl dsp 28x500 mg |
NEH |
GB |
700 |
659.16 |
659.16 |
I |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
V03AE01 |
|
|
|
Sulfonát polystyrénu |
p.o. 15 g (20 dávok) |
60 |
g |
|
|
|
|
|
|
|
|
3.419 |
|
|
|
15413 |
|
|
O |
CALCIUM RESONIUM |
plu pre 300 g |
XSS |
GB |
5 |
28.15 |
17.100000000000001 |
S |
11.05 |
0.39254 |
11.05 |
NEF |
|
|
|
|
V03AE01 |
|
|
|
Sulfonát polystyrénu |
p.o. 20 g (25 dávok) |
60 |
g |
|
|
|
|
|
|
|
|
3.03 |
|
|
|
39424 |
|
|
O |
Sorbisterit |
plu pre 1x500 g |
FMC |
DE |
8.3330000000000002 |
25.17 |
25.17 |
I |
0 |
0 |
0 |
NEF |
|
|
|
|
V03AE02 |
|
|
|
Sevelamer karbonát |
p.o. 800 mg (180 ks) |
6.4 |
g |
|
|
|
|
|
|
|
|
4.8920000000000003 |
|
|
|
77782 |
|
|
O |
Renvela |
tbl flm 180x 800 mg |
GZE |
NL |
22.5 |
110.06 |
110.06 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
0406B |
|
|
G |
Sevelamer carbonate Heaton 800 mg filmom obalené tablety |
tbl flm 180x800 mg (fľ.HDPE) |
|
|
22.5 |
110.06 |
110.06 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
0576B |
|
|
G |
Sevelamer carbonate Sandoz 800 mg |
tbl flm 180x800 mg (fľ.HDPE) |
SAN |
SI |
22.5 |
110.06 |
110.06 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AE02 |
|
|
|
Sevelamer karbonát |
p.o. 2,4 g (90 ks) |
6.4 |
g |
|
|
|
|
|
|
|
|
7.9 |
|
|
|
77849 |
|
|
O |
Renvela |
plu por 90x 2,4 g |
GZE |
NL |
33.75 |
266.63 |
266.63 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AE03 |
|
|
|
Hydrát uhličitanu lantanitého |
p.o. 500 mg (90 ks) |
2.25 |
g |
|
|
|
|
|
|
|
|
7.6 |
|
|
|
36379 |
|
|
O |
Fosrenol 500 mg žuvacie tablety |
tbl mnd 90x500 mg |
SHP |
GB |
20 |
151.84 |
151.84 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AE03 |
|
|
|
Hydrát uhličitanu lantanitého |
p.o. 750 mg (90 ks) |
2.25 |
g |
|
|
|
|
|
|
|
|
7.2430000000000003 |
|
|
|
36386 |
|
|
O |
Fosrenol 750 mg žuvacie tablety |
tbl mnd 90x750 mg |
SHP |
GB |
30 |
217.29 |
217.29 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AE04 |
|
|
|
Octan vápenatý a uhličitan horečnatý |
p.o. (180 ks) |
6 |
DF |
|
|
|
|
|
|
|
|
0.73 |
|
|
|
46292 |
|
|
O |
OsvaRen |
tbl flm 180 |
FMC-2 |
DE |
30 |
21.87 |
21.87 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AF |
|
|
|
Levofolinát disodný |
parent. |
30 |
mg |
|
|
|
|
|
|
|
|
6.43 |
|
|
|
49598 |
|
|
G |
Levofolic |
sol ijf 1x9 ml/450 mg |
MCW |
DE |
15 |
83.79 |
83.79 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
49596 |
|
|
G |
Levofolic |
sol ijf 1x4 ml/200 mg |
MCW |
DE |
6.6669999999999998 |
40.39 |
40.39 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
49594 |
|
|
G |
Levofolic |
sol ijf 1x1ml/ 50 mg |
MCW |
DE |
1.667 |
10.72 |
10.72 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
V03AF01 |
|
|
|
Mesna |
parent. nad 200 mg |
0.2 |
g |
|
|
|
|
|
|
|
|
2.0539999999999998 |
|
|
|
0382B |
|
|
O |
Uromitexan 400 mg |
sol inj 10x4 ml/400 mg (ampl.skl.) |
XBT-1 |
DE |
20 |
41.07 |
41.07 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
V03AF02 |
|
|
|
Dexrazoxan |
parent. |
1 |
g |
|
|
|
|
|
|
|
|
164.79 |
|
|
|
08483 |
|
|
G |
Cyrdanax 20 mg/ml |
plv ifo 1x500 mg (liek.inj.skl.hnedá) |
PML |
AT |
0.5 |
82.39 |
82.39 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
V03AF03 |
|
|
|
Kalcium folinát |
parent. |
60 |
mg |
|
|
|
|
|
|
|
|
4.51 |
|
|
|
27030 |
|
|
G |
CALCIUMFOLINAT |
sol inj 1x10 ml/100 mg |
EBW |
AT |
1.667 |
7.5 |
7.5 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
49568 |
|
|
G |
Calciumfolinat "Ebewe" 10 mg/ml |
sol inj 1x30 ml/300 mg |
EBW |
AT |
5 |
22.5 |
22.5 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
96966 |
|
|
G |
CALCIUMFOLINAT |
sol inj 5x3 ml/30 mg |
EBW |
AT |
2.5 |
11.26 |
11.26 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
V04 |
|
|
|
Diagnostiká |
loc. Trolab komôrky + sety |
1 |
DF |
|
|
|
|
|
|
|
|
0.18099999999999999 |
|
|
|
24811 |
|
|
O |
TROLAB |
liq der 100x10 komôrok |
HEM |
DE |
1000 |
94.07 |
94.07 |
A |
0 |
0 |
0 |
ALG, DER |
|
|
|
|
V04 |
|
|
|
Diagnostiká |
loc. Trolab liq. |
1 |
ml |
|
|
|
|
|
|
|
|
3.07 |
|
|
|
15093 |
|
|
O |
TROLAB |
liq der 23x5 ml (set) |
HEM |
DE |
115 |
310.68 |
310.68 |
A |
0 |
0 |
0 |
ALG, DER |
|
|
|
|
24101 |
|
|
O |
TROLAB |
liq der 1x5 ml |
HEM |
DE |
5 |
15.3 |
15.3 |
A |
0 |
0 |
0 |
ALG, DER |
|
|
|
|
V04CL |
|
|
|
Testy pre alergické choroby |
parent. inj. |
1 |
DF |
|
|
|
|
|
|
|
|
6.2 |
|
|
|
84296 |
|
|
O |
D-AL PRICK TEST (POLLENS) |
sol inj 1x3 ml/JSK,JSA |
SVF |
CZ |
1 |
8.91 |
6.2 |
AS |
2.71 |
0.30415300000000001 |
2.71 |
ALG, DER |
|
|
|
|
84304 |
|
|
O |
D-AL PRICK TEST (MIX) |
sol inj 1x3 ml/PNU |
SVF |
CZ |
1 |
9.6999999999999993 |
6.2 |
AS |
3.5 |
0.36082500000000001 |
2.71 |
ALG, DER |
|
|
|
|
V04CL |
|
|
|
Testy pre kontaktnú alergiu |
loc. |
1 |
DF |
|
|
|
|
|
|
|
|
13.677 |
|
|
|
96031 |
|
|
O |
TRUE TEST |
emp tdm 1x10 testov |
MKL |
DK |
10 |
140.74 |
136.77000000000001 |
AS |
3.97 |
2.8208E-2 |
3.97 |
ALG, DER |
|
|
|
|
V04CX |
|
|
|
Iné diagnostické prípravky |
p.o. 45 mg |
1 |
DF |
|
|
|
|
|
|
|
|
21.04 |
|
|
|
40754 |
|
|
O |
Helicobacter Test INFAI pre deti vo veku 3-11 rokov, 45 mg prášok na perorálny roztok |
plv por 1x45 mg (fla. polyst./tuby) |
IFI |
DE |
1 |
21.03 |
21.03 |
I |
0 |
0 |
0 |
|
|
|
|
|
V04CX |
|
|
|
Iné diagnostické prípravky |
p.o. 75 mg |
1 |
DF |
|
|
|
|
|
|
|
|
27.68 |
|
|
|
54292 |
|
|
O |
Helicobacter Test INFAI 75 mg prášok na perorálny roztok |
plv por 1x75 mg (fla. polyst.) |
IFI |
DE |
1 |
27.68 |
27.68 |
I |
0 |
0 |
0 |
|
|
|
|
|
V06DD |
|
|
|
Aminokyseliny a kombinácie s polypeptidmi |
p.o. aminokyseliny a analógy tbl. |
5 |
DF |
|
|
|
|
|
|
|
|
2.5665 |
|
|
|
88115 |
|
|
O |
KETOSTERIL |
tbl obd 1x100 |
FRE |
DE |
20 |
50.46 |
50.46 |
I |
0 |
0 |
0 |
NEF |
|
|
|
|
V07AB |
|
|
|
Rozpúšťadlá a riedidlá vrátane irigačných rozt. |
parent. voda na injekcie |
100 |
ml |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
97727 |
|
|
G |
WATER FOR INJECTION BIEFFE |
lif par 1x500 ml (sklo) |
BFF |
IT |
5 |
1.1299999999999999 |
1.1299999999999999 |
I |
0 |
0 |
0 |
|
|
|
|
|
34346 |
|
|
O |
Voda na injekciu Baxter-Viaflo |
lif par 20x500 ml |
BAX-CZ-1 |
CZ |
100 |
27.06 |
23 |
S |
4.0599999999999996 |
0.150037 |
0 |
|
|
|
|
|
67802 |
|
|
O |
AQUA PRO INJECTIONE IMUNA |
lif par 1x500 ml (skl.fľ.) |
IMA |
SK |
5 |
1.49 |
1.1499999999999999 |
S |
0.34 |
0.228188 |
0 |
|
|
|
|
|
37973 |
|
|
G |
STERILE WATER FOR INJECTION FRESENIUS |
lif par 1x500 ml (LDPE fľa.) |
FRK |
DE |
5 |
1.52 |
1.1499999999999999 |
S |
0.37 |
0.243421 |
0 |
|
|
|
|
|
V08AA01 |
|
|
|
Kyselina diatrizoová |
parent. |
10 |
ml |
|
|
|
|
|
|
|
|
2.31 |
|
|
|
25162 |
|
|
O |
UROGRAFIN 76% (amp.) |
sol inj 10x20 ml |
BAS |
DE |
20 |
35.79 |
35.79 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB02 |
|
|
|
Iohexol |
parent. 300 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.29 |
|
|
|
04330 |
|
|
G |
OMNIPAQUE 300 |
sol inj 10x50 ml (fľaša PP) |
NYE |
NO |
50 |
164.43 |
164.43 |
A |
0 |
0 |
0 |
|
|
|
|
|
39360 |
|
|
O |
OMNIPAQUE 300 |
sol inj 10x100 ml (fľaša PP) |
GHO |
NO |
100 |
334 |
329 |
AS |
5 |
1.4970000000000001E-2 |
0 |
|
|
|
|
|
V08AB02 |
|
|
|
Iohexol |
parent. 350 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
2.88 |
|
|
|
39566 |
|
|
O |
OMNIPAQUE 350 |
sol inj 10x100 ml (fľaša PP) |
GHO |
NO |
100 |
287.94 |
287.94 |
A |
0 |
0 |
0 |
|
|
|
|
|
39569 |
|
|
O |
OMNIPAQUE 350 |
sol inj 10x200 ml (fľaša PP) |
GHO |
NO |
200 |
652.09 |
576 |
AS |
76.09 |
0.116686 |
0 |
|
|
|
|
|
87603 |
|
|
O |
OMNIPAQUE 350 |
sol inj 10x50 ml (fľaša PP) |
NYE |
NO |
50 |
182.5 |
144 |
AS |
38.5 |
0.21095900000000001 |
0 |
|
|
|
|
|
V08AB04 |
|
|
|
Iopamidol |
parent. 300 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
4.99 |
|
|
|
40693 |
|
|
G |
SCANLUX 300 |
sol inj 10x100 ml |
SBA |
AT |
100 |
323.98 |
323.98 |
A |
0 |
0 |
0 |
|
|
|
|
|
40692 |
|
|
G |
SCANLUX 300 |
sol inj 10x50 ml |
SBA |
AT |
50 |
167.13 |
167.13 |
A |
0 |
0 |
0 |
|
|
|
|
|
87942 |
|
|
G |
Iopamigita 300 mg/ml injekčný a infúzny roztok |
sol ijf 10x100 ml/30 g (liek.inj.skl.-typ ll) |
ISG |
DE |
100 |
494.44 |
494.44 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB04 |
|
|
|
Iopamidol |
parent. 370 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
2.75 |
|
|
|
40694 |
|
|
G |
SCANLUX 370 |
sol inj 10x100 ml |
SBA |
AT |
100 |
274.56 |
274.56 |
A |
0 |
0 |
0 |
|
|
|
|
|
15954 |
|
|
G |
SCANLUX 370 |
sol inj 10x200 ml |
XGP |
DE |
200 |
653.96 |
550 |
AS |
103.96 |
0.15897 |
0 |
|
|
|
|
|
40695 |
|
|
G |
SCANLUX 370 |
sol inj 10x50 ml |
SBA |
AT |
50 |
178.92 |
137.5 |
AS |
41.42 |
0.23149999999999998 |
0 |
|
|
|
|
|
87973 |
|
|
G |
Iopamigita 370 mg/ml injekčný a infúzny roztok |
sol ijf 10x200 ml/74 g (liek.inj.skl.-typ ll) |
ISG |
DE |
200 |
745.85 |
550 |
AS |
195.85 |
0.26258599999999999 |
0 |
|
|
|
|
|
87972 |
|
|
G |
Iopamigita 370 mg/ml injekčný a infúzny roztok |
sol ijf 10x100 ml/37 g (liek.inj.skl.-typ ll) |
ISG |
DE |
100 |
525.02 |
275 |
AS |
250.02 |
0.47621000000000002 |
0 |
|
|
|
|
|
87970 |
|
|
G |
Iopamigita 370 mg/ml injekčný a infúzny roztok |
sol ijf 10x50 ml/18,5 g (liek.inj.skl.-typ ll) |
ISG |
DE |
50 |
263.72000000000003 |
137.5 |
AS |
126.22 |
0.47861400000000004 |
0 |
|
|
|
|
|
V08AB05 |
|
|
|
Iopromid |
parent. 300 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.74 |
|
|
|
77017 |
|
|
O |
ULTRAVIST-300 |
sol inj 10x100 ml |
BAS |
DE |
100 |
372.8 |
372.8 |
A |
0 |
0 |
0 |
|
|
|
|
|
77024 |
|
|
O |
ULTRAVIST-300 |
sol inj 10x20 ml |
BAS |
DE |
20 |
74.56 |
74.56 |
A |
0 |
0 |
0 |
|
|
|
|
|
77016 |
|
|
O |
ULTRAVIST-300 |
sol inj 10x50 ml |
BAS |
DE |
50 |
186.4 |
186.4 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB05 |
|
|
|
Iopromid |
parent. 370 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.29 |
|
|
|
77019 |
|
|
O |
ULTRAVIST-370 |
sol inj 10x100 ml |
BAS |
DE |
100 |
328.7 |
328.7 |
A |
0 |
0 |
0 |
|
|
|
|
|
93626 |
|
|
O |
ULTRAVIST-370 |
sol inj 1x200 ml |
BAS |
DE |
20 |
65.739999999999995 |
65.739999999999995 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB07 |
|
|
|
Ioversol |
parent. 240 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.66 |
|
|
|
98298 |
|
|
O |
OPTIRAY 240 |
sol inj 10x50 ml (fľašky) |
MAL-DE |
DE |
50 |
182.97 |
182.97 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB07 |
|
|
|
Ioversol |
parent. 300 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.2629999999999999 |
|
|
|
92367 |
|
|
O |
OPTIRAY 300 |
sol inj 10x100 ml (fľašky) |
MAL-DE |
DE |
100 |
324.89 |
324.89 |
A |
0 |
0 |
0 |
|
|
|
|
|
27385 |
|
|
O |
OPTIRAY 300 |
sol inj 10x100 ml (striekačky vysokotlakové) |
MAL-DE |
DE |
100 |
387.46 |
326.3 |
AS |
61.16 |
0.15784900000000002 |
0 |
|
|
|
|
|
68850 |
|
|
O |
OPTIRAY 300 |
sol inj 10x50 ml (fľašky) |
MAL-DE |
DE |
50 |
194.7 |
163.15 |
AS |
31.55 |
0.16204399999999999 |
0 |
|
|
|
|
|
92369 |
|
|
O |
OPTIRAY 300 |
sol inj 10x200 ml (fľašky) |
MAL-DE |
DE |
200 |
808.05 |
652.6 |
AS |
155.44999999999999 |
0.19237699999999999 |
0 |
|
|
|
|
|
68923 |
|
|
O |
OPTIRAY 300 |
sol inj 10x20 ml (fľašky) |
MAL-DE |
DE |
20 |
90.59 |
65.260000000000005 |
AS |
25.33 |
0.279611 |
0 |
|
|
|
|
|
V08AB07 |
|
|
|
Ioversol |
parent. 350 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.45 |
|
|
|
92371 |
|
|
O |
OPTIRAY 350 |
sol inj 10x200 ml (fľašky) |
MAL-DE |
DE |
200 |
689.94 |
689.94 |
A |
0 |
0 |
0 |
|
|
|
|
|
68925 |
|
|
O |
OPTIRAY 350 |
sol inj 10x100 ml (fľašky) |
MAL-DE |
DE |
100 |
360.4 |
345 |
AS |
15.4 |
4.2729999999999997E-2 |
0 |
|
|
|
|
|
68851 |
|
|
O |
OPTIRAY 350 |
sol inj 10x50 ml (fľašky) |
MAL-DE |
DE |
50 |
191.32 |
172.5 |
AS |
18.82 |
9.8368999999999998E-2 |
0 |
|
|
|
|
|
27391 |
|
|
O |
OPTIRAY 350 |
sol inj 10x100 ml (striekačky vysokotlakové) |
MAL-DE |
DE |
100 |
454.09 |
345 |
AS |
109.09 |
0.24023900000000001 |
0 |
|
|
|
|
|
27390 |
|
|
O |
OPTIRAY 350 |
sol inj 10x125 ml (striekačky vysokotlakové) |
MAL-DE |
DE |
125 |
640.39 |
431.25 |
AS |
209.14 |
0.32658199999999998 |
0 |
|
|
|
|
|
V08AB09 |
|
|
|
Iodixanol |
parent. 270mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
14979 |
|
|
O |
VISIPAQUE 270 |
sol inj 10x100 ml (plast. fľ.) (270 mg/ ml) |
GHO |
NO |
1000 |
370 |
330 |
AS |
40 |
0.10810800000000001 |
40 |
|
|
|
|
U72 |
14977 |
|
|
O |
VISIPAQUE 270 |
sol inj 10x50 ml (plast. fľ.) (270 mg/ ml) |
GHO |
NO |
500 |
185 |
165 |
AS |
20 |
0.10810800000000001 |
20 |
|
|
|
|
U72 |
V08AB09 |
|
|
|
Iodixanol |
parent. 320 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
14989 |
|
|
O |
VISIPAQUE 320 |
sol inj 10x100 ml (plast. fľ.) (320 mg/ ml) |
GHO |
NO |
1000 |
331.28 |
330 |
AS |
1.28 |
3.8640000000000002E-3 |
1.28 |
|
|
|
|
U72 |
14992 |
|
|
O |
VISIPAQUE 320 |
sol inj 10x200 ml (plast. fľ.) (320 mg/ ml) |
GHO |
NO |
2000 |
740 |
660 |
AS |
80 |
0.10810800000000001 |
2.56 |
|
|
|
|
U72 |
14987 |
|
|
O |
VISIPAQUE 320 |
sol inj 10x50 ml (plast. fľ.) (320 mg/ ml) |
GHO |
NO |
500 |
185 |
165 |
AS |
20 |
0.10810800000000001 |
0.64 |
|
|
|
|
U72 |
V08AB10 |
|
|
|
Iomeprol |
parent. 300 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
5.4 |
|
|
|
87273 |
|
|
O |
Iomeron 300 |
sol.inj. 10x 100 ml |
BCC |
DE |
100 |
551.19000000000005 |
540 |
AS |
11.19 |
2.0301999999999997E-2 |
11.19 |
|
|
|
|
|
87271 |
|
|
O |
IOMERON 300 |
sol inj 10x50 ml |
BCC |
IT |
50 |
310.93 |
270 |
AS |
40.93 |
0.131637 |
5.6 |
|
|
|
|
|
V08AB10 |
|
|
|
Iomeprol |
parent. 350 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
4.6509999999999998 |
|
|
|
87281 |
|
|
O |
IOMERON 350 |
sol inj 10x200 ml |
BCC |
DE |
200 |
930.2 |
930.2 |
A |
0 |
0 |
0 |
|
|
|
|
|
87279 |
|
|
O |
IOMERON 350 |
sol inj 10x100 ml |
BCC |
IT |
100 |
656.32 |
465.1 |
AS |
191.22 |
0.291352 |
0 |
|
|
|
|
|
87277 |
|
|
O |
IOMERON 350 |
sol inj 10x50 ml |
BCC |
IT |
50 |
343.5 |
232.55 |
AS |
110.95 |
0.32299900000000004 |
0 |
|
|
|
|
|
V08AB10 |
|
|
|
Iomeprol |
parent. 400 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
6.85 |
|
|
|
87287 |
|
|
O |
IOMERON 400 |
sol inj 10x200 ml |
BCC |
DE |
200 |
1370 |
1370 |
A |
0 |
0 |
0 |
|
|
|
|
|
87285 |
|
|
O |
IOMERON 400 |
sol inj 10x100 ml |
BCC |
IT |
100 |
704.1 |
685 |
AS |
19.100000000000001 |
2.7126999999999998E-2 |
0 |
|
|
|
|
|
87283 |
|
|
O |
IOMERON 400 |
sol inj 10x50 ml |
BCC |
IT |
50 |
389.46 |
342.5 |
AS |
46.96 |
0.120577 |
0 |
|
|
|
|
|
V08BA01 |
|
|
|
Síran barnatý so suspendujúcou latkou |
p.o. alebo p. rect. (1ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.62 |
|
|
|
94489 |
|
|
O |
MICROPAQUE CT |
sus pre 1x150 ml |
GUT |
FR |
1 |
7.62 |
7.62 |
A |
0 |
0 |
0 |
|
|
|
|
|
24742 |
|
|
O |
MICROPAQUE |
sus pre 1x2000 ml |
GUT |
FR |
1 |
24.1 |
7.62 |
AS |
16.48 |
0.6838169999999999 |
0 |
|
|
|
|
|
V08CA01 |
|
|
|
Kyselina gadopentonová |
parent. 0,5 mmol/ml |
1 |
ml |
|
|
|
|
|
|
|
|
2.0299999999999998 |
|
|
|
20956 |
|
|
O |
Magnetolux |
sol inj 10x15 ml |
SBA |
AT |
150 |
360.49 |
304.5 |
AS |
55.99 |
0.15531599999999998 |
55.99 |
|
|
|
|
|
46992 |
|
|
G |
Magnegita |
sol inj 10x20 ml |
ISG |
DE |
200 |
740 |
406 |
AS |
334 |
0.451351 |
74.650000000000006 |
|
|
|
|
|
V08CA02 |
|
|
|
Kyselina gadoterová |
parent. 0,5 mmol/ml (10 ml) |
15 |
ml |
|
|
|
|
|
|
|
|
55.697000000000003 |
|
|
|
8497A |
|
|
O |
DOTAREM 0,5 mmol/ml injekčný roztok v injekčných liekovkách |
sol inj 1x10 ml (liek.inj.skl.) |
GUT-2 |
FR |
0.66700000000000004 |
37.15 |
37.15 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA02 |
|
|
|
Kyselina gadoterová |
parent. 0,5 mmol/ml (15 ml) |
15 |
ml |
|
|
|
|
|
|
|
|
49.44 |
|
|
|
8498A |
|
|
O |
DOTAREM 0,5 mmol/ml injekčný roztok v injekčných liekovkách |
sol inj 1x15 ml (liek.inj.skl.) |
GUT-2 |
FR |
1 |
49.44 |
49.44 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA02 |
|
|
|
Kyselina gadoterová |
parent. 0,5 mmol/ml (20 ml) |
15 |
ml |
|
|
|
|
|
|
|
|
46.698999999999998 |
|
|
|
8499A |
|
|
O |
DOTAREM 0,5 mmol/ml injekčný roztok v injekčných liekovkách |
sol inj 1x20 ml (liek.inj.skl.) |
GUT-2 |
FR |
1.333 |
62.25 |
62.25 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA03 |
|
|
|
Gadodiamid |
parent. 0,5 mmol/ml |
10 |
ml |
|
|
|
|
|
|
|
|
32.17 |
|
|
|
78817 |
|
|
O |
OMNISCAN 0,5MMOL/ML (INJ.LIEK.) |
sol inj 10x20 ml |
NYI |
NO |
20 |
565 |
565 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA04 |
|
|
|
Gadoteridol |
parent. 0,5 mmol/ml |
1 |
ml |
|
|
|
|
|
|
|
|
3.86 |
|
|
|
54254 |
|
|
O |
PROHANCE |
sol inj 1x15 ml(fľaš.) |
BGL |
DE |
15 |
57.69 |
57.69 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA06 |
|
|
|
Gadoversetamid |
parent. 0,5 mmol/ml |
1 |
ml |
|
|
|
|
|
|
|
|
2.8820000000000001 |
|
|
|
44619 |
|
|
O |
Optimark 500 mikromolov/ml injekčný roztok v injekčnej liekovke |
sol inj 10x15 ml (liek.inj.skl.) |
MAL-DE |
DE |
150 |
432.28 |
432.28 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA09 |
|
|
|
Gadobutrol |
parent. 1 mmol/ml |
15 |
ml |
|
|
|
|
|
|
|
|
94.094999999999999 |
|
|
|
03132 |
|
|
O |
Gadovist 1,0 mmol/ml |
sol inj 1x15 ml (inj. liek.) |
BAS |
DE |
1 |
94.09 |
94.09 |
A |
0 |
0 |
0 |
|
|
|
|
|
03134 |
|
|
O |
GADOVIST 1,0 mmol/ ml |
sol inj 5x7,5 ml (napl.inj.striek.) |
BAS |
DE |
2.5 |
235.24 |
235.24 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA10 |
|
|
|
Kyselina gadoxetová |
parent. 0,25 mmol/ml |
10 |
ml |
|
|
|
|
|
|
|
|
139.93 |
|
|
|
41543 |
|
|
O |
Primovist 0,25 mmol/ml, injekčný roztok, naplnená injekčná striekačka |
sol inj 1x10ml |
BAS |
DE |
1 |
139.93 |
139.93 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08DA05 |
|
|
|
Mikrobubliny síranu hexafluoridu |
parent. 8 mcl/ml |
1 |
DF |
|
|
|
|
|
|
|
|
69.39 |
|
|
|
99442 |
|
|
O |
SonoVue |
plv iud 1x8 µl/ ml+5 ml solv.+oddel.prenos. systém MiniSpike |
BBV |
NL |
1 |
69.39 |
69.39 |
A |
0 |
0 |
0 |
GIT, KAR, NEU, RAT, URO |
|
|
|
|
V10XX02 |
|
|
|
Ibritumomabtiuxetán |
parent. 1,6 mg/ml (2 ml) |
1 |
DF |
|
|
|
|
|
|
|
|
9728.09 |
|
|
|
40792 |
|
|
O |
ZEVALIN |
kit rad 1x3,2 mg |
SPE |
NL |
1 |
9728.09 |
9728.09 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
9
55
600
600
95
False
False